Citrus Sinensis ID: 010432
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 511 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | yes | no | 0.919 | 0.953 | 0.714 | 0.0 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.863 | 0.9 | 0.719 | 0.0 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.690 | 0.860 | 0.568 | 1e-123 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.696 | 0.864 | 0.560 | 1e-120 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.741 | 0.974 | 0.533 | 1e-120 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.665 | 0.829 | 0.595 | 1e-119 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.686 | 0.888 | 0.534 | 1e-116 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.814 | 0.976 | 0.498 | 1e-114 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.616 | 0.809 | 0.559 | 1e-111 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.712 | 0.854 | 0.529 | 1e-110 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 715 bits (1846), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/525 (71%), Positives = 405/525 (77%), Gaps = 55/525 (10%)
Query: 1 MGFDGENGKVKKASWDSSKSKA---KKKKKKVEDE-----VEVEEEEETGCWVKLRFFGS 52
MG D K +W S K K K KKK D+ E EE E +GCWVK RF
Sbjct: 1 MGLDAVKAK---GNWKSEKPKETENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIG 57
Query: 53 CISSRSKVDSSVSG------TSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKL 106
CI S+S +D+S S T T ESKS N+ S DQP V S+TTTSNAES+SST +
Sbjct: 58 CIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVI 117
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
EEL ++S LRKFTFNDLKL+TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV
Sbjct: 118 SEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 177
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
AVKTLN DGLQGHKEWLAE+NFLG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHL
Sbjct: 178 AVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 237
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286
FRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLDA
Sbjct: 238 FRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDA------------ 285
Query: 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 346
DYNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+
Sbjct: 286 -------------DYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSK 332
Query: 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406
SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+DPRLEGHFSIK
Sbjct: 333 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIK 392
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNT 466
GAQK QLAA CLSRDPK RP MS+VVEALKPLP+LKDMASSSYYFQTMQAER+
Sbjct: 393 GAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQAERL------ 446
Query: 467 RNGIRAQGGSLSRNGQ-----RSLSIPNGSYASPYHHQFPHPSPK 506
+NG G SRNGQ R+LS P+GS SPY HQ P P PK
Sbjct: 447 KNGSGRSQGFGSRNGQHQPVFRTLSSPHGS--SPYRHQIPSPKPK 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 681 bits (1756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/474 (71%), Positives = 380/474 (80%), Gaps = 33/474 (6%)
Query: 37 EEEETGCWVKLRFFGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSN 96
EEE GCWVK R+ C SS S V++S++ +++ S+S S DQP V S+TTTSN
Sbjct: 42 EEEANGCWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSN 101
Query: 97 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
AES+ ST + EEL + S L+KF+F DLKLATRNFRPESLLGEGGFGCVFKGW+EENGTA
Sbjct: 102 AESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 161
Query: 157 PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
PVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEF
Sbjct: 162 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEF 221
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276
MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLD
Sbjct: 222 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDG-- 279
Query: 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336
+YNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPE
Sbjct: 280 -----------------------EYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPE 316
Query: 337 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 396
YVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+D
Sbjct: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLD 376
Query: 397 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQ 456
PRLEGHFS+KGAQK QLAA CLSRD K RP MSEVVE LKPLP+LKDMAS+SYYFQTMQ
Sbjct: 377 PRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQ 436
Query: 457 AERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSY-ASPYHHQFPHPSPK 506
AER+ + + +G SRNGQ R+LS P+G +SPY HQ P P PK
Sbjct: 437 AERLKAGSGSGSGRGFG----SRNGQPVFRTLSSPHGQAGSSPYRHQIPSPKPK 486
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 225/396 (56%), Positives = 279/396 (70%), Gaps = 43/396 (10%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C+S++ K +SS G ST Y++K + +V S T E E
Sbjct: 1 MGICLSAQVKAESS--GASTKYDAKDIGSLGSKASSVSVRPSPRT------------EGE 46
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ F+F +LK ATRNFRP+S+LGEGGFGCVFKGWI+E +PGTGL +AVK
Sbjct: 47 ILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVK 106
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN DG QGH+EWLAEVN+LG H +LVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR
Sbjct: 107 KLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRR 166
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286
L PL W +R+K+ALGAAKGLAFLH R VIYRDFKTSNILLD+
Sbjct: 167 GLYFQPLSWKLRLKVALGAAKGLAFLHSSETR-VIYRDFKTSNILLDS------------ 213
Query: 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 346
+YNAKLSDFGLAKDGP GDK+HVSTRVMGT+GYAAPEY+ TGHLT++
Sbjct: 214 -------------EYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTK 260
Query: 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406
SDVYSFGVVLLE+L+GRR++DKNRP+GE NLVEWA+P+L +R+ +R+ID RL+ +S++
Sbjct: 261 SDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSME 320
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 442
A K A L+ CL+ + K RP MSEVV L+ + +L
Sbjct: 321 EACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSL 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 433 bits (1114), Expect = e-120, Method: Compositional matrix adjust.
Identities = 223/398 (56%), Positives = 275/398 (69%), Gaps = 42/398 (10%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C+S++ K S G S Y S ND+ + ++ I + + E E
Sbjct: 1 MGICLSAQIKAVSP--GASPKYMSSEANDSLGSKSSSVSIRTN-----------PRTEGE 47
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+ +AVK
Sbjct: 48 ILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVK 107
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR
Sbjct: 108 KLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRR 167
Query: 230 S---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286
PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD+
Sbjct: 168 GSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDS------------ 214
Query: 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 346
+YNAKLSDFGLAKDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT++
Sbjct: 215 -------------EYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTK 261
Query: 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406
SDVYS+GVVLLE+L+GRR++DKNRP GE LVEWARP L +R+ +R+ID RL+ +S++
Sbjct: 262 SDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSME 321
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 444
A K A LA CL+ + K RP M+EVV L+ + L +
Sbjct: 322 EACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 432 bits (1111), Expect = e-120, Method: Compositional matrix adjust.
Identities = 225/422 (53%), Positives = 286/422 (67%), Gaps = 43/422 (10%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C S+R K D + +ST SK SRD + S+ S S + E E
Sbjct: 1 MGGCFSNRIKTDIA---SSTWLSSKFL---SRD--------GSKGSSTASFSYMPRTEGE 46
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+ +AVK
Sbjct: 47 ILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVK 106
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLENHLFRR
Sbjct: 107 RLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR 166
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286
PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD+
Sbjct: 167 GTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDS------------ 213
Query: 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 346
+YNAKLSDFGLA+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ +
Sbjct: 214 -------------NYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVK 260
Query: 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406
SDVYSFGVVLLE+L+GRR++DKN+P GEHNLV+WARP+L +RR R++DPRL+G +S+
Sbjct: 261 SDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLT 320
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNT 466
A K A LA C+S D K+RP M+E+V+ ++ L K+ + Q I SP
Sbjct: 321 RALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASKEQQNPQISIDNIINKSPQA 380
Query: 467 RN 468
N
Sbjct: 381 VN 382
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1104), Expect = e-119, Method: Compositional matrix adjust.
Identities = 222/373 (59%), Positives = 268/373 (71%), Gaps = 33/373 (8%)
Query: 99 SNSSTSKLEEELKVA---SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
S+ ST + ++ + +++ FT +L+ T++FRP+ +LGEGGFG V+KG+I++N
Sbjct: 34 SDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLR 93
Query: 156 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215
+K L VAVK LN +GLQGH+EWL EVNFLG L H NLVKLIGYC EDD RLLVYE
Sbjct: 94 VGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE 150
Query: 216 FMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
FM RGSLENHLFR++ PL WS RM IALGAAKGLAFLH AERPVIYRDFKTSNILLD+
Sbjct: 151 FMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDS 209
Query: 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 334
DY AKLSDFGLAK GP+GD+THVSTRVMGTYGYAA
Sbjct: 210 -------------------------DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 244
Query: 335 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 394
PEYVMTGHLT+RSDVYSFGVVLLEMLTGR+S+DK RP+ E NLV+WARP L ++R+ ++
Sbjct: 245 PEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQI 304
Query: 395 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQT 454
IDPRLE +S++ AQKA LA +CLS++PKARPLMS+VVE L+PL D
Sbjct: 305 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGDALIPCATTTA 364
Query: 455 MQAERIGSSPNTR 467
A +G P+ R
Sbjct: 365 GAAFAMGGVPDYR 377
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 418 bits (1074), Expect = e-116, Method: Compositional matrix adjust.
Identities = 211/395 (53%), Positives = 267/395 (67%), Gaps = 44/395 (11%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
GSC SSR K D +G S+ S + AA K E E
Sbjct: 1 MGSCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVAA---------------AQKTEGE 45
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KPGTGL +AVK
Sbjct: 46 ILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVK 105
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +GSLENHLFRR
Sbjct: 106 KLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRR 165
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286
PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDA
Sbjct: 166 GAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDA------------ 212
Query: 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 346
DYNAKLSDFGLA+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL +R
Sbjct: 213 -------------DYNAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNAR 259
Query: 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406
SDVYSFGV+LLE+L+G+R++D NRP E NLV+WARP+L +R+ ++D RL+ + +
Sbjct: 260 SDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPE 319
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441
A + A +A CLS +PK+RP M +VV AL+ L +
Sbjct: 320 EAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1063), Expect = e-114, Method: Compositional matrix adjust.
Identities = 230/461 (49%), Positives = 293/461 (63%), Gaps = 45/461 (9%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNS-STSKLEE 108
G+C+ S +KVDSS + S S+ +S+ + S + S + S T + E
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEG 60
Query: 109 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+ VAV
Sbjct: 61 EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAV 120
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
K L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLENHLFR
Sbjct: 121 KKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFR 180
Query: 229 R-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287
R + PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA
Sbjct: 181 RGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDA------------- 226
Query: 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 347
++N+KLSDFGLAK GP GDKTHVST+VMGT+GYAAPEYV TG LT++S
Sbjct: 227 ------------EFNSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKS 274
Query: 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 407
DVYSFGVVLLE+L+GRR++DK++ E +LV+WA P+LG++R+ +R++D RL G + KG
Sbjct: 275 DVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKG 334
Query: 408 AQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 467
A AA LA CL+ D K RP MSEV+ L L + K +G+
Sbjct: 335 AYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK------------PGTGVGNRQAQI 382
Query: 468 NGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPKPN 508
+ R GS+ + R SY P H P SP P
Sbjct: 383 DSPRGSNGSIVQKSPRRY-----SYDRPLLHITPGASPLPT 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-111, Method: Compositional matrix adjust.
Identities = 193/345 (55%), Positives = 248/345 (71%), Gaps = 30/345 (8%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160
++ K E E+ ++ ++ F+FN+LKLATRNFR +S++GEGGFGCVF+GW++E P K
Sbjct: 31 ATAHKTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKS 90
Query: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 220
+GL +AVK LN DG QGH+EWL E+N+LG L H NLVKLIGYC+ED+QRLLVYEFM +G
Sbjct: 91 SSGLVIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKG 150
Query: 221 SLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276
SLENHLF + PL W +R+K+AL AAKGLAFLH + + VIYRD K SNILLD+
Sbjct: 151 SLENHLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDS-- 207
Query: 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336
D+NAKLSDFGLA+DGP G++++VSTRVMGT+GYAAPE
Sbjct: 208 -----------------------DFNAKLSDFGLARDGPMGEQSYVSTRVMGTFGYAAPE 244
Query: 337 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 396
YV TGHL +RSDVYSFGVVLLE+L GR+++D NRP E NLV+WARP+L RR+ ++D
Sbjct: 245 YVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNLVDWARPYLTSRRKVLLIVD 304
Query: 397 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441
RL + +GA + A +A CLS +PK+RP M +VV AL L +
Sbjct: 305 TRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQD 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 400 bits (1028), Expect = e-110, Method: Compositional matrix adjust.
Identities = 209/395 (52%), Positives = 272/395 (68%), Gaps = 31/395 (7%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQ----PAAAVISSTTTSNAESNSSTSK 105
G+C+ S +KVD+S + S + +S+ P+ +S +T ++ T +
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 106 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 165
E E+ + L+ FTFN+LK AT+NFR ++LLGEGGFGCVFKGWI++ +PG+G+
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 166 VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
VAVK L +G QGHKEWL EVN+LG L H NLV L+GYC E + RLLVYEFMP+GSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 226 LFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284
LFRR + PL W+IRMK+A+GAAKGL FLHE A+ VIYRDFK +NILLDA
Sbjct: 181 LFRRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDA---------- 229
Query: 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 344
D+NAKLSDFGLAK GP GD THVST+V+GT+GYAAPEYV TG LT
Sbjct: 230 ---------------DFNAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLT 274
Query: 345 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 404
++SDVYSFGVVLLE+++GRR+MD + E++LV+WA P+LG++R+ +R++D +L G +
Sbjct: 275 AKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYP 334
Query: 405 IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
KGA AA LA CL+ D K RP MSEV+ L+ L
Sbjct: 335 QKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQL 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 511 | ||||||
| 359473277 | 481 | PREDICTED: probable receptor-like protei | 0.931 | 0.989 | 0.844 | 0.0 | |
| 255558222 | 495 | Protein kinase APK1B, chloroplast precur | 0.947 | 0.977 | 0.832 | 0.0 | |
| 351722951 | 485 | serine/threonine protein kinase-like pro | 0.935 | 0.985 | 0.841 | 0.0 | |
| 356498172 | 491 | PREDICTED: probable receptor-like protei | 0.945 | 0.983 | 0.843 | 0.0 | |
| 147857978 | 495 | hypothetical protein VITISV_008843 [Viti | 0.931 | 0.961 | 0.815 | 0.0 | |
| 356567562 | 487 | PREDICTED: probable receptor-like protei | 0.943 | 0.989 | 0.856 | 0.0 | |
| 356526888 | 487 | PREDICTED: probable receptor-like protei | 0.943 | 0.989 | 0.856 | 0.0 | |
| 224100247 | 478 | predicted protein [Populus trichocarpa] | 0.929 | 0.993 | 0.819 | 0.0 | |
| 224100451 | 445 | predicted protein [Populus trichocarpa] | 0.864 | 0.993 | 0.880 | 0.0 | |
| 53689728 | 603 | serine/threonine protein kinase-like [So | 0.921 | 0.781 | 0.808 | 0.0 |
| >gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/516 (84%), Positives = 454/516 (87%), Gaps = 40/516 (7%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGC-WVKLRFFGSCISSRSK 59
MG G + KV+ SW+ KSK +KKK EEETGC WVKLRF SCISSRSK
Sbjct: 1 MGLGGNDVKVE--SWEVGKSKGRKKKDG--------GEEETGCCWVKLRFMASCISSRSK 50
Query: 60 VDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKF 119
VDSS+SGTSTHYE++STNDTSRDQP A V+SSTTTSNAESNSSTSKLEEELKVASRLRKF
Sbjct: 51 VDSSISGTSTHYENRSTNDTSRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASRLRKF 110
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+FNDLK+ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH
Sbjct: 111 SFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 170
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
KEWLAEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRM
Sbjct: 171 KEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRM 230
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 231 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------------------------- 265
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
+YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM
Sbjct: 266 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 325
Query: 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419
LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL
Sbjct: 326 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 385
Query: 420 SRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSR 479
SRDPK RPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPN RNG+R Q G LSR
Sbjct: 386 SRDPKVRPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSR 445
Query: 480 NG---QRSLSIPNGSYASPYHH-QFPHPSPKPNGKP 511
NG QRSLSIPNGS+ASPYH Q+P+ SPKPNGKP
Sbjct: 446 NGHQQQRSLSIPNGSHASPYHQNQYPYQSPKPNGKP 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 864 bits (2232), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/520 (83%), Positives = 451/520 (86%), Gaps = 36/520 (6%)
Query: 1 MGFDGENG-KVKKASWDSSKSKAKKKKKK-VEDEV------EVEEEEETGCWVKLRFFGS 52
MG E+G + K +SW+ K K + KKK+ V + +V EE ETGCW K RF GS
Sbjct: 1 MGLGSEDGNRAKASSWEVCKPKGRNKKKQDVSNSSGGASPGDVVEEAETGCWFKFRFIGS 60
Query: 53 CISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKV 112
CISSRSKVDSSVSGTSTH ESKSTNDTSRDQP A ISSTTTSNAESNSSTSKLEEELK+
Sbjct: 61 CISSRSKVDSSVSGTSTHCESKSTNDTSRDQPTAPTISSTTTSNAESNSSTSKLEEELKI 120
Query: 113 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 172
ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN
Sbjct: 121 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 180
Query: 173 HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
HDGLQGHKEWLAEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP
Sbjct: 181 HDGLQGHKEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 240
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292
LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 241 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------------------ 282
Query: 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352
DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF
Sbjct: 283 -------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 335
Query: 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 412
GVVLLEM+TGRRSMDKNRP GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA
Sbjct: 336 GVVLLEMITGRRSMDKNRPIGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 395
Query: 413 QLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRA 472
QLAAHCLSRDPKARPLMSEVVE LKPLPNLKDMASSSYYFQ+MQA++I SSPN ++ R
Sbjct: 396 QLAAHCLSRDPKARPLMSEVVEVLKPLPNLKDMASSSYYFQSMQADKIASSPNAKSSNRT 455
Query: 473 QGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 510
QGG L RNG QRSLSIPNGS+ASPYHHQ+P SPKPNGK
Sbjct: 456 QGG-LLRNGQQQRSLSIPNGSHASPYHHQYPFQSPKPNGK 494
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2192), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/516 (84%), Positives = 453/516 (87%), Gaps = 38/516 (7%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
MG ENGKV + SWD KSK +KKKK E E E GCWV+LRF GSCISSRSKV
Sbjct: 1 MGLGAENGKVVE-SWDVCKSKGRKKKKGDE-----GGEAEAGCWVRLRFIGSCISSRSKV 54
Query: 61 DSSVSG--TSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSS-TSKLEEELKVASRL 116
D+SVSG TSTHY ESKSTNDTSRDQP A +SSTTTSNAESNSS TSKLEEELK+ASRL
Sbjct: 55 DTSVSGSGTSTHYAESKSTNDTSRDQPTAPAVSSTTTSNAESNSSSTSKLEEELKIASRL 114
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
RKF+FN+LKLATRNFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL
Sbjct: 115 RKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 174
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
QGHKEWLAEVNFLGDLVH NLVKL+GYCIE+DQRLLVYEFMPRGSLENHLFRRS+PLPWS
Sbjct: 175 QGHKEWLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLVYEFMPRGSLENHLFRRSIPLPWS 234
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM 296
IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 235 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---------------------- 272
Query: 297 LFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
+YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVL
Sbjct: 273 ---EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 329
Query: 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 416
LEMLTGRRSMDK+RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS+KGAQKAA LAA
Sbjct: 330 LEMLTGRRSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAALLAA 389
Query: 417 HCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGS 476
HCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQ MQA+RIG+SPNTRNG R QG
Sbjct: 390 HCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQAMQADRIGASPNTRNG-RMQGAL 448
Query: 477 LSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 510
L+RNG QRSLSIPNG+YASPYHHQFP PSPKPNGK
Sbjct: 449 LTRNGQQQRSLSIPNGTYASPYHHQFPQPSPKPNGK 484
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/517 (84%), Positives = 454/517 (87%), Gaps = 34/517 (6%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETG--CWVKLRFFGSCISSRS 58
MG GENGKV + SWD KSK +KKKK D EVEE E CWV+LRF GSCISSRS
Sbjct: 1 MGLGGENGKVVE-SWDVCKSKGGRKKKKKGDAEEVEEGAEAEAGCWVRLRFIGSCISSRS 59
Query: 59 KVDSSVS--GTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASR 115
KVD+SVS G STHY ESKSTNDTSRDQP A +SSTTTSNAESNSSTSKLEEELK+ASR
Sbjct: 60 KVDTSVSASGISTHYAESKSTNDTSRDQPTAPAVSSTTTSNAESNSSTSKLEEELKIASR 119
Query: 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 175
LRKF+FNDLK ATRNFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 120 LRKFSFNDLKSATRNFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 179
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
LQGHKEWLAEVNFLGDLVH NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPW
Sbjct: 180 LQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPW 239
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 240 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--------------------- 278
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVV
Sbjct: 279 ----DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV 334
Query: 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 415
LLEMLTGRRSMDK+RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS+KGAQKAAQLA
Sbjct: 335 LLEMLTGRRSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAAQLA 394
Query: 416 AHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGG 475
AHCLSRDPK+RPLMSEVVEALKPLP+LKDMASSSYYFQ MQA+R G+SPNTRNG R QG
Sbjct: 395 AHCLSRDPKSRPLMSEVVEALKPLPSLKDMASSSYYFQAMQADRFGASPNTRNG-RMQGA 453
Query: 476 SLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 510
L+RNG QRSLSIPNG+YASPYHHQFP PSPKPNGK
Sbjct: 454 LLTRNGQQQRSLSIPNGTYASPYHHQFPQPSPKPNGK 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2187), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/530 (81%), Positives = 449/530 (84%), Gaps = 54/530 (10%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGC-WVKLRFFGSCISSRSK 59
MG G + KV+ SW+ KSK +KKK EEETGC WVKLRF SCISSRSK
Sbjct: 1 MGLGGNDVKVE--SWEVGKSKGRKKKDG--------GEEETGCCWVKLRFMASCISSRSK 50
Query: 60 VDSSVSGTSTHY--------ESKSTN------DTSRDQPAAAVISSTTTSNAESNSSTSK 105
VDSS+SGTSTHY E +S N RDQP A V+SSTTTSNAESNSSTSK
Sbjct: 51 VDSSISGTSTHYDLGVXFDVEPRSLNVFWCDFGLCRDQPVAPVVSSTTTSNAESNSSTSK 110
Query: 106 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 165
LEEELKVASRLRKF+FNDLK+ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT
Sbjct: 111 LEEELKVASRLRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 170
Query: 166 VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
VAVKTLNHDGLQGHKEWLAEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENH
Sbjct: 171 VAVKTLNHDGLQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 230
Query: 226 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285
LFRR+LPLPW+IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 231 LFRRALPLPWAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----------- 279
Query: 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 345
+YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS
Sbjct: 280 --------------EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 325
Query: 346 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI 405
RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI
Sbjct: 326 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI 385
Query: 406 KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPN 465
KGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPN
Sbjct: 386 KGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPN 445
Query: 466 TRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYHH-QFPHPSPKPNGKP 511
RNG+R Q G LSRNG QRSLSIPNGS+ASPYH Q+P+ SPKPNGKP
Sbjct: 446 ARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQYPYQSPKPNGKP 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/514 (85%), Positives = 456/514 (88%), Gaps = 32/514 (6%)
Query: 1 MGFDG-ENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK 59
MG G ENGKV S D KSK +KKKKK + EVEE+EETGCW +LRF GSCISSRSK
Sbjct: 1 MGLGGAENGKVVVESLDVCKSKGRKKKKKED--GEVEEKEETGCWFRLRFIGSCISSRSK 58
Query: 60 VDSSVSGTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 118
VDSSVSGTST+Y ESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEE KV+SRLRK
Sbjct: 59 VDSSVSGTSTNYAESKSTIDTSRDQPTVPVVSSTTTSNAESNSSTSKLEEEFKVSSRLRK 118
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
HKEWLAEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR
Sbjct: 179 HKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------------------------ 274
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
+YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE
Sbjct: 275 -EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 333
Query: 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418
MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA LAAHC
Sbjct: 334 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAHLAAHC 393
Query: 419 LSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLS 478
LSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQA+R +SPNTRNG R QG L+
Sbjct: 394 LSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSASPNTRNG-RTQGALLT 452
Query: 479 RNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 510
RNG QRSLSIP+G++ASPYHHQFP PSPKPNGK
Sbjct: 453 RNGQQQRSLSIPHGTHASPYHHQFPQPSPKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2176), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/514 (85%), Positives = 455/514 (88%), Gaps = 32/514 (6%)
Query: 1 MGFDG-ENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK 59
MG G ENGKV S D KSK +KKKKK + EVEEEEETGCW +LRF GSCISSRSK
Sbjct: 1 MGLGGAENGKVVVESLDVCKSKGRKKKKKED--GEVEEEEETGCWFRLRFIGSCISSRSK 58
Query: 60 VDSSVSGTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 118
VDSSVSGTST+Y ESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEELKVASRLRK
Sbjct: 59 VDSSVSGTSTNYAESKSTIDTSRDQPTLRVVSSTTTSNAESNSSTSKLEEELKVASRLRK 118
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 119 FAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
HKEWLAEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR
Sbjct: 179 HKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------------------------ 274
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
+YN+KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE
Sbjct: 275 -EYNSKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 333
Query: 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418
MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY+LIDPRLEGHFSIKGAQKAA LAAHC
Sbjct: 334 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYKLIDPRLEGHFSIKGAQKAAHLAAHC 393
Query: 419 LSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLS 478
LSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQA+R SPNTRNG R QG L+
Sbjct: 394 LSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSVSPNTRNG-RTQGALLT 452
Query: 479 RNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 510
RNG QRSLSIP+G++ASPYHHQFP PSPKPNGK
Sbjct: 453 RNGQQQRSLSIPHGTHASPYHHQFPQPSPKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100247|ref|XP_002311801.1| predicted protein [Populus trichocarpa] gi|222851621|gb|EEE89168.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 824 bits (2128), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/514 (81%), Positives = 442/514 (85%), Gaps = 39/514 (7%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
MG E GKVK +SWD KSK +KKK + + GCWVKLR G CISSRSKV
Sbjct: 1 MGLGSEEGKVK-SSWDVCKSKERKKK----------DGTKAGCWVKLRLVGGCISSRSKV 49
Query: 61 DSSVSGTSTH-YESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKF 119
DSSVSGT ESKS NDTS DQPA V+SS+TTSN ESNSS SKLEEELKVASRLRKF
Sbjct: 50 DSSVSGTICESTESKSINDTSTDQPAVPVVSSSTTSNTESNSSLSKLEEELKVASRLRKF 109
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH
Sbjct: 110 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 169
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
KEWLAEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM
Sbjct: 170 KEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 229
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 230 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------------------------- 264
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
DYNAKLSDFGLAKD PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM
Sbjct: 265 DYNAKLSDFGLAKDAPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 324
Query: 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419
+TGRRSMDKNRPNGEHNLVEWARP+LGERRRFYRLIDPRL+GHFSIKGAQKAAQLAAHCL
Sbjct: 325 ITGRRSMDKNRPNGEHNLVEWARPYLGERRRFYRLIDPRLQGHFSIKGAQKAAQLAAHCL 384
Query: 420 SRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSR 479
SRDPKARPLMSEVV+ LKPLPNLKDMASSSYYFQTMQ +R+GSSPN +NG+R+Q G LSR
Sbjct: 385 SRDPKARPLMSEVVDTLKPLPNLKDMASSSYYFQTMQGDRVGSSPNAKNGVRSQAGLLSR 444
Query: 480 NG--QRSLSIPNGSYASPYHHQFPHPSPKPNGKP 511
NG QRS SIP+G +ASP+HHQ+PH SPKP+GKP
Sbjct: 445 NGHQQRSFSIPHGPHASPFHHQYPHQSPKPSGKP 478
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100451|ref|XP_002311881.1| predicted protein [Populus trichocarpa] gi|222851701|gb|EEE89248.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2109), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/470 (88%), Positives = 426/470 (90%), Gaps = 28/470 (5%)
Query: 42 GCWVKLRFFGSCISSRSKVDSSVSGTSTH-YESKSTNDTSRDQPAAAVISSTTTSNAESN 100
GCWVKLRF GSCISSRSKVDSSVSGT ESKSTNDTS DQPAA V+S++TTSN ESN
Sbjct: 1 GCWVKLRFIGSCISSRSKVDSSVSGTICESTESKSTNDTSIDQPAALVVSTSTTSNTESN 60
Query: 101 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160
SSTSKLEEELKVASRLRKFTFNDLK ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP
Sbjct: 61 SSTSKLEEELKVASRLRKFTFNDLKFATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 120
Query: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 220
GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRG
Sbjct: 121 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRG 180
Query: 221 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280
SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE ERPVIYRDFKTSNILLDA
Sbjct: 181 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEETERPVIYRDFKTSNILLDA------ 234
Query: 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 340
DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT
Sbjct: 235 -------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 275
Query: 341 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 400
GHLTSRSDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE
Sbjct: 276 GHLTSRSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 335
Query: 401 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERI 460
GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV ALKPLPNLKDMAS+SYYFQTMQAER+
Sbjct: 336 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVNALKPLPNLKDMASTSYYFQTMQAERV 395
Query: 461 GSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPN 508
GSSPN RNG+R+Q G LSRNG QRSLSIP+GS+ASPYH+Q+PH SPKPN
Sbjct: 396 GSSPNARNGVRSQAGLLSRNGHQQRSLSIPHGSHASPYHYQYPHKSPKPN 445
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|53689728|gb|AAU89742.1| serine/threonine protein kinase-like [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2105), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/527 (80%), Positives = 444/527 (84%), Gaps = 56/527 (10%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
+G DGE G+ SWD KSK KKKK+ EEETGCW KL F GSCISSRSKV
Sbjct: 115 LGGDGEKGE----SWDVEKSKGKKKKEV--------TEEETGCWTKLWFIGSCISSRSKV 162
Query: 61 DSSVSGTSTHY--------------ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKL 106
DSS+SG STH ESKSTN TSRDQP A +ISSTTTSNAESNSSTSKL
Sbjct: 163 DSSISGISTHCDKSTYVLTSCIALAESKSTN-TSRDQPVAPIISSTTTSNAESNSSTSKL 221
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
EEELKV+SRLRKF FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV
Sbjct: 222 EEELKVSSRLRKFAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 281
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
AVKTLNHDGLQ W AEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL
Sbjct: 282 AVKTLNHDGLQVLSIWQAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 341
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286
FRRS+PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA
Sbjct: 342 FRRSMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------------ 389
Query: 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 346
DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS+
Sbjct: 390 -------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSK 436
Query: 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406
SDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL+DPRLEGHFSIK
Sbjct: 437 SDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLVDPRLEGHFSIK 496
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNT 466
GAQKAAQLAA CLSRDPKARP+MS+VVEALKPLPNLKDMASSSYYFQTMQA+R+GSSP+T
Sbjct: 497 GAQKAAQLAARCLSRDPKARPMMSDVVEALKPLPNLKDMASSSYYFQTMQADRVGSSPST 556
Query: 467 RNGIRAQGGSLSRNGQ---RSLSIPNGSYASPYHHQFPHPSPKPNGK 510
+NG+R Q GS SRNGQ RSLSIPNGS+ASPYH QFP SPKPNGK
Sbjct: 557 KNGVRTQ-GSFSRNGQQHPRSLSIPNGSHASPYHQQFPQNSPKPNGK 602
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 511 | ||||||
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.477 | 0.494 | 0.696 | 3.2e-175 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.475 | 0.495 | 0.670 | 2.1e-169 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.344 | 0.388 | 0.857 | 1.8e-159 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.350 | 0.423 | 0.661 | 4.3e-111 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.285 | 0.356 | 0.726 | 4.3e-111 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.350 | 0.460 | 0.622 | 1.5e-110 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.350 | 0.420 | 0.640 | 1.5e-106 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.412 | 0.495 | 0.556 | 7.3e-105 | |
| TAIR|locus:2064712 | 462 | RIPK "RPM1-induced protein kin | 0.412 | 0.456 | 0.544 | 1.2e-102 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.342 | 0.424 | 0.627 | 1.1e-101 |
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 3.2e-175, Sum P(2) = 3.2e-175
Identities = 174/250 (69%), Positives = 186/250 (74%)
Query: 41 TGCWVKLRFF-G-----XXXXXXXXXXXXXXXXXTHYESKSTNDTSRDQPAAAVIXXXXX 94
+GCWVK RF G T ESKS N+ S DQP V
Sbjct: 46 SGCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTT 105
Query: 95 XXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 154
+ EEL ++S LRKFTFNDLKL+TRNFRPESLLGEGGFGCVFKGWIEENG
Sbjct: 106 SNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENG 165
Query: 155 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214
TAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLG+L+H NLVKL+GYCIEDDQRLLVY
Sbjct: 166 TAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVY 225
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLDA
Sbjct: 226 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDA 285
Query: 275 VRAENYGKFG 284
FG
Sbjct: 286 DYNAKLSDFG 295
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 2.1e-169, Sum P(2) = 2.1e-169
Identities = 163/243 (67%), Positives = 178/243 (73%)
Query: 42 GCWVKLRFFGXXXXXXXXXXXXXXXXXTHYESKSTNDTSRDQPAAAVIXXXXXXXXXXXX 101
GCWVK R+ + S+S S DQP V
Sbjct: 47 GCWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSL 106
Query: 102 XXXKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 161
+ EEL + S L+KF+F DLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPG
Sbjct: 107 STPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 166
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TGLTVAVKTLN DGLQGHKEWLAE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGS
Sbjct: 167 TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 226
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281
LENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLD
Sbjct: 227 LENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLS 286
Query: 282 KFG 284
FG
Sbjct: 287 DFG 289
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 802 (287.4 bits), Expect = 1.8e-159, Sum P(2) = 1.8e-159
Identities = 151/176 (85%), Positives = 162/176 (92%)
Query: 109 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
ELK +S+LR F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV
Sbjct: 81 ELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 140
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
KTLN DGLQGHKEWLAE+NFLG+LVH +LVKL+GYC+E+DQRLLVYEFMPRGSLENHLFR
Sbjct: 141 KTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFR 200
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284
R+LPLPWS+RMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD FG
Sbjct: 201 RTLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 256
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 622 (224.0 bits), Expect = 4.3e-111, Sum P(2) = 4.3e-111
Identities = 121/183 (66%), Positives = 140/183 (76%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+
Sbjct: 54 RTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGV 113
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
+AVK LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLEN
Sbjct: 114 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 173
Query: 225 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281
HLFRR PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD+
Sbjct: 174 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLS 232
Query: 282 KFG 284
FG
Sbjct: 233 DFG 235
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 4.3e-111, Sum P(2) = 4.3e-111
Identities = 106/146 (72%), Positives = 127/146 (86%)
Query: 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353
N +L DY AKLSDFGLAK GP+GD+THVSTRVMGTYGYAAPEYVMTGHLT+RSDVYSFG
Sbjct: 204 NILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFG 263
Query: 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
VVLLEMLTGR+S+DK RP+ E NLV+WARP L ++R+ ++IDPRLE +S++ AQKA
Sbjct: 264 VVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACS 323
Query: 414 LAAHCLSRDPKARPLMSEVVEALKPL 439
LA +CLS++PKARPLMS+VVE L+PL
Sbjct: 324 LAYYCLSQNPKARPLMSDVVETLEPL 349
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 1.5e-110, Sum P(2) = 1.5e-110
Identities = 114/183 (62%), Positives = 142/183 (77%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+
Sbjct: 42 RTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGI 101
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
+AVK LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLEN
Sbjct: 102 VIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLEN 161
Query: 225 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281
HLFRR PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD+
Sbjct: 162 HLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 282 KFG 284
FG
Sbjct: 221 DFG 223
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 600 (216.3 bits), Expect = 1.5e-106, Sum P(2) = 1.5e-106
Identities = 116/181 (64%), Positives = 137/181 (75%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+
Sbjct: 57 RTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
VAVK L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLEN
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 225 HLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283
HLFRR PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA F
Sbjct: 177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDF 235
Query: 284 G 284
G
Sbjct: 236 G 236
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 596 (214.9 bits), Expect = 7.3e-105, Sum P(2) = 7.3e-105
Identities = 119/214 (55%), Positives = 145/214 (67%)
Query: 73 SKSTNDTSRDQ-PAAAVIXXXXXXXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNF 131
SK ++ TSR P+ + E E+ + L+ FTFN+LK AT+NF
Sbjct: 27 SKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTEGEILSSPNLKAFTFNELKNATKNF 86
Query: 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 191
R ++LLGEGGFGCVFKGWI++ +PG+G+ VAVK L +G QGHKEWL EVN+LG
Sbjct: 87 RQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLTEVNYLGQ 146
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLA 250
L H NLV L+GYC E + RLLVYEFMP+GSLENHLFRR PL W+IRMK+A+GAAKGL
Sbjct: 147 LSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAVGAAKGLT 206
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284
FLHE A+ VIYRDFK +NILLDA FG
Sbjct: 207 FLHE-AKSQVIYRDFKAANILLDADFNAKLSDFG 239
|
|
| TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 538 (194.4 bits), Expect = 1.2e-102, Sum P(2) = 1.2e-102
Identities = 116/213 (54%), Positives = 141/213 (66%)
Query: 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353
N +L DY AKLSDFGLAKDGPEGD THVSTRVMGT GYAAPEY+MTGHLT+RSDVYSFG
Sbjct: 222 NILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFG 281
Query: 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
VVLLE+LTGRRS+DK R + E NLV+WARP L + R+ R++DPRLEG +S GA+KAA
Sbjct: 282 VVLLELLTGRRSVDKKRSSREQNLVDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAAT 341
Query: 414 LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQ 473
LA CLS PK RP MS VV L L + D+ ++ + T+ + R G + +
Sbjct: 342 LAYQCLSHRPKNRPCMSAVVSILNDLKDYNDIPMGTFTY-TVPNTPDNKEDDGRVGNKPR 400
Query: 474 GGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPK 506
S + Q+ S S SP P P+ K
Sbjct: 401 KSSHHHHHQQQQSNHPRSSPSPTTKS-PSPTAK 432
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 1.1e-101, Sum P(2) = 1.1e-101
Identities = 113/180 (62%), Positives = 139/180 (77%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E EL + L+ FTFN+LK ATRNFRP+S++GEGGFG V+KGWI+E +P KPG+G+ V
Sbjct: 59 EGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSGMVV 118
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENH 225
AVK L +G QGH++WLAEV+ LG L H+NLVKLIGYC + D RLLVYE+MP+GSLENH
Sbjct: 119 AVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENH 178
Query: 226 LFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284
LFRR P+PW R+K+A+GAA+GLAFLHE A+ VIYRDFK SNILLD+ FG
Sbjct: 179 LFRRGAEPIPWRTRIKVAIGAARGLAFLHE-AQ--VIYRDFKASNILLDSEFNAKLSDFG 235
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9LFP7 | Y5158_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7142 | 0.9197 | 0.9533 | yes | no |
| Q9SRH7 | Y3130_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7194 | 0.8630 | 0.9 | no | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 511 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.003 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.004 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.004 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-49
Identities = 76/302 (25%), Positives = 116/302 (38%), Gaps = 89/302 (29%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
LGEGGFG V+ ++ G VA+K + + E L E+ L L H
Sbjct: 1 LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+VKL G +++ LV E+ GSL++ L L ++I L +GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+I+RD K NILLD+ + KL+DFGL+K
Sbjct: 110 -SNGIIHRDLKPENILLDSD------------------------NGKVKLADFGLSKLLT 144
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 374
++GT Y APE ++ G+ + +SD++S GV+L E+
Sbjct: 145 SDKSL--LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------- 187
Query: 375 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
+ L L +DP+ RP E++E
Sbjct: 188 ----------------------------------PELKDLIRKMLQKDPEKRPSAKEILE 213
Query: 435 AL 436
L
Sbjct: 214 HL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 89/306 (29%), Positives = 129/306 (42%), Gaps = 55/306 (17%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
LGEG FG V+KG ++ + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VKL+G C E++ +V E+M G L ++L + L S + AL A+G+ +L
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
+ I+RD N L+ ++ K+SDFGL++
Sbjct: 119 E---SKNFIHRDLAARNCLVG-------------------------ENLVVKISDFGLSR 150
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372
D + D + APE + G TS+SDV+SFGV+L E+ T P
Sbjct: 151 DLYDDDYYRKRGG-KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PY 204
Query: 373 GEHNLVEWARPHL--GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430
+ E +L G R P L L C + DP+ RP S
Sbjct: 205 PGMSNEE-VLEYLKNGYRLPQPPNCPPEL------------YDLMLQCWAEDPEDRPTFS 251
Query: 431 EVVEAL 436
E+VE L
Sbjct: 252 ELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 90/309 (29%), Positives = 129/309 (41%), Gaps = 58/309 (18%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 188
+ LG G FG V+K GTG VAVK L + + E+
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L L H N+V+LI + D LV E+ G L R PL KIAL +G
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRG 110
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
L +LH +I+RD K NILLD ++ K++DF
Sbjct: 111 LEYLHSNG---IIHRDLKPENILLD-------------------------ENGVVKIADF 142
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 367
GLAK + ++T V GT Y APE ++ G + DV+S GV+L E+LTG+
Sbjct: 143 GLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK---- 196
Query: 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKA 425
L + + R++ P LE G+++A L CL++DP
Sbjct: 197 ---------PPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSK 247
Query: 426 RPLMSEVVE 434
RP E+++
Sbjct: 248 RPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 93/307 (30%), Positives = 133/307 (43%), Gaps = 56/307 (18%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
LGEG FG V+KG ++ G + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 251
H N+VKL+G C E++ ++V E+MP G L ++L R L S + AL A+G+ +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
L + I+RD N L+ + K+SDFGL+
Sbjct: 119 LE---SKNFIHRDLAARNCLVGE-------------------------NLVVKISDFGLS 150
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 371
+D + D V + APE + G TS+SDV+SFGV+L E+ T P
Sbjct: 151 RDLYDDDYYKVKGG-KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----P 204
Query: 372 NGEHNLVEWARPHL--GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
+ E +L G R P L +L C + DP+ RP
Sbjct: 205 YPGMSNAE-VLEYLKKGYRLPKPPNCPPEL------------YKLMLQCWAEDPEDRPTF 251
Query: 430 SEVVEAL 436
SE+VE L
Sbjct: 252 SELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 91/307 (29%), Positives = 135/307 (43%), Gaps = 62/307 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V+KG ++ GT VAVKTL + +E+L E + + L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+L+G C + + +V E+MP G L + L + L +++AL AKG+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+ ++RD N L+ ++ K+SDFGL++D
Sbjct: 120 -SKNFVHRDLAARNCLVT-------------------------ENLVVKISDFGLSRDIY 153
Query: 316 EGDKTHVST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
E D + M APE + G TS+SDV+SFGV+L E+ T
Sbjct: 154 EDDYYRKRGGGKLPIKWM------APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ---- 203
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
P + E L + YRL PR E + +L C + DP+ RP
Sbjct: 204 -PYPGMSNEE-VLELLEDG---YRL--PRPEN-----CPDELYELMLQCWAYDPEDRPTF 251
Query: 430 SEVVEAL 436
SE+VE L
Sbjct: 252 SELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 94/320 (29%), Positives = 133/320 (41%), Gaps = 79/320 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 195
LGEG FG V+KG K G VAVKTL D + K++L E + L H
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LPWSIRMKIALGAAK 247
N+V+L+G C E++ LV E+M G L ++L + L + A+ AK
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
G+ +L + ++RD N L+ D K+SD
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGE-------------------------DLVVKISD 148
Query: 308 FGLAKDGPEGDKTHVST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
FGL++D + D T R M APE + G TS+SDV+SFGV+L E+ T
Sbjct: 149 FGLSRDVYDDDYYRKKTGGKLPIRWM------APESLKDGIFTSKSDVWSFGVLLWEIFT 202
Query: 362 GRRSMDKNRPNGE---HNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 417
G L E +L R+ YRL P + + +L
Sbjct: 203 ----------LGATPYPGLSNEEVLEYL---RKGYRLPKPE---YCP----DELYELMLS 242
Query: 418 CLSRDPKARPLMSEVVEALK 437
C DP+ RP SE+VE L+
Sbjct: 243 CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 60/307 (19%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 189
+ LGEG FG V+ TG VA+K + ++ +E L E+ L
Sbjct: 1 YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKG 248
L H N+V+L ++D+ LV E+ G L + L R L R
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
L +LH + +++RD K NILLD +D + KL+DF
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLD-------------------------EDGHVKLADF 141
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
GLA+ G+K T V GT Y APE ++ D++S GV+L E+LTG+
Sbjct: 142 GLARQLDPGEKLT--TFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK----- 193
Query: 369 NRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
P G+ L+E + + F P E S +A L L +DP+ R
Sbjct: 194 -PPFPGDDQLLELFKKIGKPKPPF-----PPPEWDIS----PEAKDLIRKLLVKDPEKRL 243
Query: 428 LMSEVVE 434
E ++
Sbjct: 244 TAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F +G+GGFG V+K K TG VA+K + + + ++ + E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKAR--------HKR-TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
H N+VK G ++ D+ +V EF GSL++ L + L S + KGL
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+LH +I+RD K +NILL D KL DFGL
Sbjct: 113 YLHSNG---IIHRDIKAANILLT-------------------------SDGEVKLIDFGL 144
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
+ + + ++GT + APE + ++D++S G+ +E+ G+
Sbjct: 145 SAQLSDTKARN---TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 7e-31
Identities = 81/297 (27%), Positives = 128/297 (43%), Gaps = 59/297 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 193
LLG G FG V+ ++++ TG +AVK+ L+ D + + E+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKD--------TGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 194 HLNLVKLIGYCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRMKIALGAAKGLA 250
H N+V+ G ++++ L ++ E++ GSL + L ++ LP IR K +GLA
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR-KYTRQILEGLA 115
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+LH +++RD K +NIL+D D KL+DFG
Sbjct: 116 YLHS---NGIVHRDIKGANILVD-------------------------SDGVVKLADFGC 147
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370
AK + + + V GT + APE + +D++S G ++EM TG+
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK------P 201
Query: 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
P E A +G P + H S ++A CL RDPK RP
Sbjct: 202 PWSELGNPMAALYKIG-----SSGEPPEIPEHLS----EEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 72/230 (31%), Positives = 102/230 (44%), Gaps = 39/230 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHL 195
LGEG FG V + G TG VAVK+LNH G + H ++ E+ L L H
Sbjct: 12 LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+VK G C + R L+ E++P GSL ++L R + + + KG+ +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
+ I+RD NIL++ + K+SDFGLAK
Sbjct: 127 S---QRYIHRDLAARNILVE-------------------------SEDLVKISDFGLAKV 158
Query: 314 GPEGDKTHVST--RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
PE + + YA PE + T +S SDV+SFGV L E+ T
Sbjct: 159 LPEDKDYYYVKEPGESPIFWYA-PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 75/232 (32%), Positives = 109/232 (46%), Gaps = 46/232 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 193
L+G G FG V+KG E TG VA+K L + K + E++ L +L
Sbjct: 7 LIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VK IG IE L ++ E+ GSL + ++ P P S+ +GLA+L
Sbjct: 58 HPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
HE+ VI+RD K +NIL K G KL+DFG+A
Sbjct: 116 HEQG---VIHRDIKAANILT--------TKDGVV-----------------KLADFGVAT 147
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGR 363
+ K V+GT + APE + M+G T+ SD++S G ++E+LTG
Sbjct: 148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 98/401 (24%), Positives = 145/401 (36%), Gaps = 67/401 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
++R LGEG FG V+ + VA+K L KE L E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48
Query: 187 NFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIAL 243
L L H N+VKL + ++ LV E++ GSLE+ L R PL S + I
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
L +LH + +I+RD K NILLD
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDR------------------------DGRVV 141
Query: 304 KLSDFGLAK----DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVL 356
KL DFGLAK G + + +GT GY APE ++ + +S SD++S G+ L
Sbjct: 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201
Query: 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 416
E+LTG + + + + + P S + A+ L
Sbjct: 202 YELLTGLPPFEGEKNSSATSQT-LKIILELPTPSLASPLSPSNPELIS----KAASDLLK 256
Query: 417 HCLSRDPKARPLMSEVVE-ALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQ-- 473
L++DPK R S + L LK+ S A S P + + +
Sbjct: 257 KLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLN 316
Query: 474 -------GGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPKP 507
L + PNG +SP++ S
Sbjct: 317 SLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTAS 357
|
Length = 384 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 87/318 (27%), Positives = 135/318 (42%), Gaps = 70/318 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LG+G FG V++G VK VA+KT+N + + E+L E + + +
Sbjct: 14 LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALGAA 246
++V+L+G L+V E M +G L+++L L P + ++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
G+A+L A + ++RD A R N M+ +D K+
Sbjct: 130 DGMAYL---AAKKFVHRDL--------AAR-----------------NCMVAEDLTVKIG 161
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
DFG+ +D E D + + + APE + G T++SDV+SFGVVL EM T
Sbjct: 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT----- 216
Query: 367 DKNRPNGEHNLVEWARPHLG----ERRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLS 420
L E +P+ G E +F +ID GH K +L C
Sbjct: 217 ----------LAE--QPYQGLSNEEVLKF--VID---GGHLDLPENCPDKLLELMRMCWQ 259
Query: 421 RDPKARPLMSEVVEALKP 438
+PK RP E+V +LK
Sbjct: 260 YNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 55/303 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+G+G FG V+KG ++ VAVKT K +L E L H
Sbjct: 2 KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VKLIG C++ +V E +P GSL L ++ L ++++L AA G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE- 110
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+ I+RD N L+ NN+L K+SDFG++++
Sbjct: 111 --SKNCIHRDLAARNCLVGE-------------------NNVL------KISDFGMSREE 143
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 374
G T + APE + G TS SDV+S+G++L E + + N +
Sbjct: 144 EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
Query: 375 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
R + YR+ P+L + +L C + DP+ RP SE+
Sbjct: 204 ------TRERI---ESGYRMPAPQLCPE-------EIYRLMLQCWAYDPENRPSFSEIYN 247
Query: 435 ALK 437
L+
Sbjct: 248 ELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 53/234 (22%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
+ +G+G FG V G G VAVK L D +LAE + + L H
Sbjct: 12 ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLH 253
NLV+L+G ++ + +V E+M +GSL ++L R + + ++ AL +G+ +L
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
E+ ++RD N+L+ +D AK+SDFGLAK+
Sbjct: 120 ---EKNFVHRDLAARNVLVS-------------------------EDLVAKVSDFGLAKE 151
Query: 314 ---GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363
G + K V + APE + +++SDV+SFG++L E+ + GR
Sbjct: 152 ASQGQDSGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 91/323 (28%), Positives = 135/323 (41%), Gaps = 53/323 (16%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 187
R + +LGEG FG V + P GTG VAVKTL + Q + W E+N
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C E + L+ E++P GSL ++L + L L + + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQI 116
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
+G+A+LH + I+RD N+LLD D K+
Sbjct: 117 CEGMAYLHSQH---YIHRDLAARNVLLD-------------------------NDRLVKI 148
Query: 306 SDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
DFGLAK PEG + + V + A E + + SDV+SFGV L E+LT
Sbjct: 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HC 207
Query: 365 SMDKNRPNGEHNLVEWARPHLGERR------RFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418
++ P ++ + + R R RL P+ Q+ L +C
Sbjct: 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK-------NCPQEVYILMKNC 260
Query: 419 LSRDPKARPLMSEVVEALKPLPN 441
+ K RP ++ LK + +
Sbjct: 261 WETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 67/232 (28%), Positives = 97/232 (41%), Gaps = 44/232 (18%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV 193
LG+G FG V +G W G + VAVK L D L ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFL 252
H NL++L G + ++V E P GSL + L + +L S A+ A G+ +L
Sbjct: 55 HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
+ I+RD NILL D K+ DFGL +
Sbjct: 114 ES---KRFIHRDLAARNILL-------------------------ASDDKVKIGDFGLMR 145
Query: 313 DGPEGDKTHVST---RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
P+ + +V +V + + APE + T + SDV+ FGV L EM T
Sbjct: 146 ALPQNEDHYVMEEHLKV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 69/240 (28%), Positives = 107/240 (44%), Gaps = 50/240 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVH 194
LGEG FG V+KG E G T +VA+KTL N + + +E+ E + DL H
Sbjct: 13 LGEGAFGKVYKG--ELTGPNERLSAT--SVAIKTLKENAEP-KVQQEFRQEAELMSDLQH 67
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRM 239
N+V L+G C ++ +++E++ G L L R S L S +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
IA+ A G+ +L + ++RD N L + GL
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCL---------------VGEGL-------- 161
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
K+SDFGL++D D V ++ + + PE ++ G T+ SD++SFGVVL E+
Sbjct: 162 --TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 2e-22
Identities = 74/235 (31%), Positives = 100/235 (42%), Gaps = 53/235 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDL 192
LG+G FG V V K TG A+K L + KE L E N L +
Sbjct: 1 LGKGSFGKVLL----------VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI 50
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRM--KIALGAAKG 248
H +VKL Y + +++L LV E+ P G L +HL + + +I L
Sbjct: 51 NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA---- 105
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
L +LH +IYRD K NILLD D + KL+DF
Sbjct: 106 LEYLHSLG---IIYRDLKPENILLD-------------------------ADGHIKLTDF 137
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
GLAK+ + +T GT Y APE ++ D +S GV+L EMLTG+
Sbjct: 138 GLAKELSSEG-SRTNTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 70/240 (29%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGL-QGHKEWLAEVNFLGDLVH 194
LGEG FG VF G ++P VAVKTL K++ E L + H
Sbjct: 13 LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSL-------PLPWSIRMKI 241
N+VK G C E D ++V+E+M G L L L S ++I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
A+ A G+ +L A + ++RD T N L+ D
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGY-------------------------DL 159
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
K+ DFG+++D D V M + PE +M T+ SDV+SFGVVL E+ T
Sbjct: 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 66/252 (26%), Positives = 115/252 (45%), Gaps = 50/252 (19%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
LG G FG V+KG WI E VK + VA+K L + + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 248
++V+L+G C+ Q L+ + MP G L +++ L W +++ AKG
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+++L E + +++RD N+L V+ + K++DF
Sbjct: 122 MSYLEE---KRLVHRDLAARNVL---VKTPQH----------------------VKITDF 153
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 367
GLAK +K + + + A E ++ T +SDV+S+GV + E++T G + +
Sbjct: 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
Query: 368 KNRPNGEHNLVE 379
+L+E
Sbjct: 214 GIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 5e-22
Identities = 84/300 (28%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVH 194
+LG+G +G V+ G + VK V + T N + E L EV+ L L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+N+V+ +G C++D+ + EF+P GS+ + L R PLP + K G+A+LH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD- 313
V++RD K +N+ ML + KL DFG A+
Sbjct: 121 NC---VVHRDIKGNNV-------------------------MLMPNGIIKLIDFGCARRL 152
Query: 314 ---GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMD 367
G G +++ + GT + APE + +SD++S G + EM TG+ SMD
Sbjct: 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
Query: 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
+ A ++G R PRL FS A CL+RD RP
Sbjct: 213 RLA----------AMFYIGAHRGLM----PRLPDSFS----AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 93/330 (28%), Positives = 143/330 (43%), Gaps = 70/330 (21%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDG 175
+ T ND+ + + E+++ G G +KG +NG V VK +N +
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNS 728
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
+ +E+ +G L H N+VKLIG C + L++E++ +L L L W
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSW 779
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
R KIA+G AK L FLH V+ + I++D GK + L
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-------GKDEPHLRLSL--PG 830
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
+L D +S Y APE T +T +SD+Y FG++
Sbjct: 831 LLCTDTKCFISS-----------------------AYVAPETRETKDITEKSDIYGFGLI 867
Query: 356 LLEMLTGRRSMDKNRPNGEH-NLVEWAR-----PHLGERRRFYRLIDPRLEGHFSIKGAQ 409
L+E+LTG+ D G H ++VEWAR HL IDP + G S+ +
Sbjct: 868 LIELLTGKSPADAE--FGVHGSIVEWARYCYSDCHLD------MWIDPSIRGDVSVNQNE 919
Query: 410 --KAAQLAAHCLSRDPKARPLMSEVVEALK 437
+ LA HC + DP ARP ++V++ L+
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 79/301 (26%), Positives = 130/301 (43%), Gaps = 58/301 (19%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V+ G W+E+ VA+KT+ +G ++++ E + L H
Sbjct: 12 IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C E LV+EFM G L ++L + + + L +G+A+L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
VI+RD N L+ ++ K+SDFG+ +
Sbjct: 120 N---VIHRDLAARNCLVG-------------------------ENQVVKVSDFGMTRFVL 151
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 375
+ D+ ST +++PE +S+SDV+SFGV++ E+ + ++ +NR N E
Sbjct: 152 D-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE- 209
Query: 376 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435
+VE +RL PRL +Q +L HC P+ RP S ++
Sbjct: 210 -VVE-------TINAGFRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQ 254
Query: 436 L 436
L
Sbjct: 255 L 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 69/236 (29%), Positives = 103/236 (43%), Gaps = 49/236 (20%)
Query: 131 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
F E LG G FG V++G W + VA+K L D L +++ EV L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-----------NRVRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGA 245
L H +L+ L C + ++ E M +GSL R + LP+ I M A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDM--ACQV 113
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
A+G+A+L E + I+RD NIL+ +D K+
Sbjct: 114 AEGMAYLEE---QNSIHRDLAARNILVG-------------------------EDLVCKV 145
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+DFGLA+ E ++ Y + APE G +++SDV+SFG++L EM T
Sbjct: 146 ADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 9e-21
Identities = 76/298 (25%), Positives = 123/298 (41%), Gaps = 67/298 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
+G+G FG VFK V+ A+K ++ + +E + E L L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLP----WSIRMKIALGAAKGL 249
+++ ++ + +V E+ G L L +R PLP W ++I LG L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
A LH + +++RD K+ N+ LDA N K+ D G
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDA-------------------------YDNVKIGDLG 146
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
+AK D T+ + ++GT Y +PE +SDV++ GVVL E TG+ D
Sbjct: 147 VAK--LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA- 203
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
N + L+ + R + P + +S Q+ AQL CL++D + RP
Sbjct: 204 --NNQGALI----------LKIIRGVFPPVSQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 85/310 (27%), Positives = 130/310 (41%), Gaps = 73/310 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGT-APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
LLG G FG V++G ++G VK V++ G + K+ E+ L L H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS-IRM---KIALGAAKGLA 250
N+V+ +G E+D + E +P GSL L ++ P IR+ +I L GL
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILL----GLE 116
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+LH +R ++RD K +NIL+D N ++ KL+DFG+
Sbjct: 117 YLH---DRNTVHRDIKGANILVDT-------------------NGVV------KLADFGM 148
Query: 311 AKDGPEGDKTHVSTRVM-----GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRR 364
AK V G+ + APE + G +D++S G +LEM TG+
Sbjct: 149 AK--------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK- 199
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
P + V A +G + P + H S +A CL RDP
Sbjct: 200 -----PPWSQLEGVA-AVFKIGRSKEL-----PPIPDHLS----DEAKDFILKCLQRDPS 244
Query: 425 ARPLMSEVVE 434
RP +E++E
Sbjct: 245 LRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 92/303 (30%), Positives = 127/303 (41%), Gaps = 79/303 (26%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G W NGT V AVKTL G + +L E + L H
Sbjct: 14 LGAGQFGEVWMGTW---NGTTKV--------AVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LV+L C E++ +V E+M +GSL + L + L LP + M A A+G+A+L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYL 119
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
R I+RD NIL+ EN K++DFGLA+
Sbjct: 120 ES---RNYIHRDLAARNILVG----ENL---------------------VCKIADFGLAR 151
Query: 313 -------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365
EG K + + APE G T +SDV+SFG++L E++T R
Sbjct: 152 LIEDDEYTAREGAKFPIK--------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
Query: 366 MDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
P G N R L + R YR+ PR ++ L C +DP+
Sbjct: 204 -----PYPGMTN-----REVLEQVERGYRM--PRPPNC-----PEELYDLMLQCWDKDPE 246
Query: 425 ARP 427
RP
Sbjct: 247 ERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 66/254 (25%), Positives = 104/254 (40%), Gaps = 54/254 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
N +G+G FG VF+ G P +P T VAVK L + ++ E
Sbjct: 6 NIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAAL 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------ 230
+ + H N+VKL+G C L++E+M G L L RS
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 231 ---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287
LPL + ++ IA A G+A+L +ER ++RD T N L+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVG-------------- 164
Query: 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 347
++ K++DFGL+++ D S + PE + T+ S
Sbjct: 165 -----------ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES 213
Query: 348 DVYSFGVVLLEMLT 361
DV+++GVVL E+ +
Sbjct: 214 DVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 73/237 (30%), Positives = 110/237 (46%), Gaps = 41/237 (17%)
Query: 136 LLGEGGFGCVFKGW---IEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGD 191
LG G FG V++G I G+ P++ VAVKTL Q KE+L E + + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIR------VAVKTLRKGATDQEKKEFLKEAHLMSN 55
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALG 244
H N+VKL+G C+ ++ + ++ E M G L ++L F L L + I L
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLD 114
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
AKG +L + I+RD N L V + Y D K
Sbjct: 115 VAKGCVYLEQMH---FIHRDLAARNCL---VSEKGYDA-----------------DRVVK 151
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+ DFGLA+D + D + + APE ++ G T++SDV+SFGV++ E+LT
Sbjct: 152 IGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 73/308 (23%), Positives = 122/308 (39%), Gaps = 59/308 (19%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGD 191
E ++G G FG V +G ++ G + VA+KTL G + L E + +G
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+++L G + +++ E+M GSL+ L + + G A G+ +
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
L +E ++RD NIL++ + K+SDFGL+
Sbjct: 122 L---SEMNYVHRDLAARNILVN-------------------------SNLVCKVSDFGLS 153
Query: 312 K--DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
+ + E T ++ + APE + TS SDV+SFG+V+ E+++
Sbjct: 154 RRLEDSEATYTTKGGKI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS-------- 203
Query: 370 RPNGEHNLVEWARPH-LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428
GE + + + YRL P QL C +D RP
Sbjct: 204 --YGERPYWDMSNQDVIKAVEDGYRLPPPM-------DCPSALYQLMLDCWQKDRNERPT 254
Query: 429 MSEVVEAL 436
S++V L
Sbjct: 255 FSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 67/236 (28%), Positives = 100/236 (42%), Gaps = 57/236 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG G G V K +P TG +AVKT+ + K+ L E++ L
Sbjct: 9 LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V G + + E+M GSL+ L +P I KIA+ KGL +LHE
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+ +I+RD K SNIL+++ R + KL DFG
Sbjct: 119 -KHKIIHRDVKPSNILVNS-RGQ------------------------IKLCDFG------ 146
Query: 316 EGDKTHVSTRVM--------GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
VS +++ GT Y APE + + +SD++S G+ L+E+ TGR
Sbjct: 147 ------VSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 73/231 (31%), Positives = 106/231 (45%), Gaps = 46/231 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V KG K G + VAVKTL G KE+L E + + L H
Sbjct: 3 LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V+LIG C + +LV E P G L +L +R +P S ++A A G+A+L E
Sbjct: 57 CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYL--E 112
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
++ V +RD N+LL + AK+SDFG+++
Sbjct: 113 SKHFV-HRDLAARNVLLVN-------------------------RHQAKISDFGMSRALG 146
Query: 316 EGDKTHVSTRVMGTYG-----YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
G + +T T G + APE + G +S+SDV+S+GV L E +
Sbjct: 147 AGSDYYRAT----TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 72/241 (29%), Positives = 102/241 (42%), Gaps = 49/241 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E +P K + VAVK L L K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRMK 240
+VK G C + D ++V+E+M G L N R P L S +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
IA A G+ +L A + ++RD T N L+ N+L
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVG--------------------ANLL--- 161
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
K+ DFG+++D D V M + PE +M T+ SDV+SFGV+L E+
Sbjct: 162 --VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219
Query: 361 T 361
T
Sbjct: 220 T 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 83/320 (25%), Positives = 131/320 (40%), Gaps = 69/320 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+LGEG FG V +G + ++ + +K VAVKT+ D +E+L+E + D
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 194 HLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 242
H N++KLIG C E +++ FM G L + L L LP +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+ A G+ +L + R I+RD A R N ML +D
Sbjct: 120 VDIALGMEYL---SNRNFIHRDL--------AAR-----------------NCMLREDMT 151
Query: 303 AKLSDFGLAKDGPEGD---KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
++DFGL+K GD + ++ + + A E + TS+SDV++FGV + E+
Sbjct: 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVK---WIAIESLADRVYTSKSDVWAFGVTMWEI 208
Query: 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419
T R H + ++ R RL P + L C
Sbjct: 209 AT--RGQTPYPGVENHEIYDYL-------RHGNRLKQPE-------DCLDELYDLMYSCW 252
Query: 420 SRDPKARPLMSEVVEALKPL 439
DPK RP +++ E L+ +
Sbjct: 253 RADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 75/305 (24%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV 193
+LG+G G V+K TG A+K ++ DG + K+ L E+ L
Sbjct: 7 KVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
+VK G ++ + +V E+M GSL + L ++ +P + IA KGL +LH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK- 312
+R +I+RD K SN+L++ K++DFG++K
Sbjct: 117 --TKRHIIHRDIKPSNLLIN-------------------------SKGEVKIADFGISKV 149
Query: 313 --DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370
+ + T V GT Y +PE + + +D++S G+ LLE G+
Sbjct: 150 LENTLDQCNTFV-----GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204
Query: 371 PNGEHNLVEWARPHLGERRRFYRLID-------PRL-EGHFSIKGAQKAAQLAAHCLSRD 422
F+ L+ P L FS + + CL +D
Sbjct: 205 QPS-----------------FFELMQAICDGPPPSLPAEEFS----PEFRDFISACLQKD 243
Query: 423 PKARP 427
PK RP
Sbjct: 244 PKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 74/304 (24%), Positives = 117/304 (38%), Gaps = 64/304 (21%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W + + VA+K + +G +++ E + L H
Sbjct: 12 LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
NLV+L G C + +V E+M G L N+L R L + + + + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK--- 312
I+RD N L+ +D K+SDFGLA+
Sbjct: 120 G---FIHRDLAARNCLVG-------------------------EDNVVKVSDFGLARYVL 151
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372
D D+ S +A PE +S+SDV+SFGV++ E+ + + + N
Sbjct: 152 D----DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207
Query: 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432
E +VE G YRL P+L + + C P+ RP ++
Sbjct: 208 SE--VVE--SVSAG-----YRLYRPKL-------APTEVYTIMYSCWHEKPEDRPAFKKL 251
Query: 433 VEAL 436
+ L
Sbjct: 252 LSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 74/246 (30%), Positives = 102/246 (41%), Gaps = 38/246 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 195
LG G FG V++G V+ L VAVKTL Q ++L E + H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMK----IALGAAKG 248
N+V+LIG E R ++ E M G L++ L R + P P S+ MK A AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+L E I+RD N LL AK++DF
Sbjct: 129 CKYLEENH---FIHRDIAARNCLLTCKGPGRV----------------------AKIADF 163
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
G+A+D R M + PE + G TS++DV+SFGV+L E+ +
Sbjct: 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223
Query: 369 NRPNGE 374
R N E
Sbjct: 224 GRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 74/239 (30%), Positives = 108/239 (45%), Gaps = 62/239 (25%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G W N T PV AVKTL + K++LAE + L H
Sbjct: 14 LGAGQFGEVWEGLW---NNTTPV--------AVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
L++L C ++ +V E M GSL +L R+L LP I M A A G+A+L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
+ I+RD N+L+ G+ C K++DFGLA+
Sbjct: 120 EA---QNYIHRDLAARNVLV--------GENNIC-----------------KVADFGLAR 151
Query: 313 -------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363
+ EG K + + APE + + +SDV+SFG++L E++T GR
Sbjct: 152 VIKEDIYEAREGAKFPIK--------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 82/309 (26%), Positives = 114/309 (36%), Gaps = 73/309 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQG-HKEWLAEVNFLGDLVH 194
+G G FG V+ V TG +AVK + D KE E+ L L H
Sbjct: 8 IGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
NLVK G + ++ + E+ G+LE L L + L +GLA+LH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+++RD K +NI LD N ++ KL DFG A
Sbjct: 118 HG---IVHRDIKPANIFLD-------------------HNGVI------KLGDFGCAVKL 149
Query: 315 PEGDKTHVSTRV---MGTYGYAAPEYVMTGHLTSR---SDVYSFGVVLLEMLTGRR---S 365
T + V GT Y APE + G +D++S G V+LEM TG+R
Sbjct: 150 KNN-TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
Query: 366 MDKNRPNGEHNLVEWA---RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422
+D E+ G + + EG + CL D
Sbjct: 209 LDN----------EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD----------RCLESD 248
Query: 423 PKARPLMSE 431
PK RP SE
Sbjct: 249 PKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 7e-19
Identities = 67/322 (20%), Positives = 119/322 (36%), Gaps = 89/322 (27%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 187
+ +G+G FG V+ + +G +K L++ + ++ L EV
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMSEKEREDALNEVK 51
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSL---PLP----WSIRM 239
L L H N++K E+ +L V E+ G L + ++ P P +
Sbjct: 52 ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
++ L L +LH R +++RD K NI L + N ++
Sbjct: 111 QLCLA----LKYLHS---RKILHRDIKPQNIFLTS-------------------NGLV-- 142
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE------YVMTGHLTSRSDVYSFG 353
KL DFG++K T V GT Y +PE Y +SD++S G
Sbjct: 143 ----KLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQNKPY------NYKSDIWSLG 190
Query: 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID---PRLEGHFSIKGAQK 410
VL E+ T + + L +++ P + +S +
Sbjct: 191 CVLYELCTLKHPFEGENLLE---L-------------ALKILKGQYPPIPSQYS----SE 230
Query: 411 AAQLAAHCLSRDPKARPLMSEV 432
L + L +DP+ RP ++++
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 84/325 (25%), Positives = 136/325 (41%), Gaps = 68/325 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 188
LGEG FG V + P V+ G L VAVK L D + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------PL 233
L L N+++L+G C+++D ++ E+M G L L L L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 234 P---WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290
P +S + +AL A G+ +L + ++RD T N L+
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVG----------------- 172
Query: 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350
++ K++DFG++++ GD + R + + A E ++ G T+ SDV+
Sbjct: 173 --------ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 351 SFGVVLLEMLTGRRSMDKNRPNGE---HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 407
+FGV L E+L + K +P GE ++E A ++ R L P
Sbjct: 225 AFGVTLWEIL----MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP-------C 273
Query: 408 AQKAAQLAAHCLSRDPKARPLMSEV 432
Q +L C SRD + RP S++
Sbjct: 274 PQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 76/238 (31%), Positives = 107/238 (44%), Gaps = 40/238 (16%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R+ + LG+G FG V E P++ TG VAVK L H + +++ E+
Sbjct: 4 RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58
Query: 189 LGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L L H N+VK G C +R LV E++P GSL ++L + L + A
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
KG+ +L + ++RD T NIL V +EN K G
Sbjct: 119 KGMEYL---GSKRYVHRDLATRNIL---VESENRVKIG---------------------- 150
Query: 307 DFGLAKDGPEGDKTHVSTRVMG---TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
DFGL K P+ DK + R G + Y APE + + SDV+SFGVVL E+ T
Sbjct: 151 DFGLTKVLPQ-DKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 37/238 (15%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWL 183
L R LLG G FG V KG WI E + + VA+KT+ + G Q +E
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------VAIKTIQDRSGRQTFQEIT 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
+ +G L H +V+L+G C LV + P GSL +H+ + L + +
Sbjct: 58 DHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
AKG+ +L E +++R+ NILL + D
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKS-------------------------DSIV 148
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+++DFG+A DK + + + A E ++ G T +SDV+S+GV + EM++
Sbjct: 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 87/303 (28%), Positives = 133/303 (43%), Gaps = 58/303 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 194
LLG+G FG VFKG +++ VAVKT D Q K ++L+E L H
Sbjct: 2 LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VKLIG C + +V E +P G + L ++ L +K AL AA G+A+L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+ I+RD N L+ NN+L K+SDFG+++
Sbjct: 111 --SKNCIHRDLAARNCLVGE-------------------NNVL------KISDFGMSRQ- 142
Query: 315 PEGDKTHVSTRVMGT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 373
E D + S+ + + APE + G +S SDV+S+G++L E S+ G
Sbjct: 143 -EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF----SLGVCPYPG 197
Query: 374 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433
N + AR + + YR+ P+ K ++ C P+ RP SE+
Sbjct: 198 MTN--QQAREQV---EKGYRMSCPQ-------KCPDDVYKVMQRCWDYKPENRPKFSELQ 245
Query: 434 EAL 436
+ L
Sbjct: 246 KEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 9e-18
Identities = 72/238 (30%), Positives = 101/238 (42%), Gaps = 46/238 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E P + + VAVKTL K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIAL 243
+VK G C+E D ++V+E+M G L N R P L S + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
A G+ +L A + ++RD T N L+ N+L
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVG--------------------ENLL-----V 159
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
K+ DFG+++D D V M + PE +M T+ SDV+S GVVL E+ T
Sbjct: 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 44/233 (18%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGDLV 193
++G+G FGCV+ G I+ +G + AVK+LN L+ +++L E + D
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQK-------IHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 194 HLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLA 250
H N++ L+G C+ + L+V +M G L N F RS +++ I G AKG+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+L A + ++RD N +LD + + K++DFGL
Sbjct: 113 YL---ASKKFVHRDLAARNCMLD-------------------------ESFTVKVADFGL 144
Query: 311 AKD--GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
A+D E H T + A E + T T++SDV+SFGV+L E++T
Sbjct: 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 66/232 (28%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 193
LG+GGFG V A TG A K L+ L +G + L E L + V
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKV 50
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAF 251
+ + Y E L LV M G L+ H++ P P + + A GL
Sbjct: 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
LH+ R ++YRD K N+LLD N ++SD GLA
Sbjct: 111 LHQ---RRIVYRDLKPENVLLD-------------------------DHGNVRISDLGLA 142
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
+ G K GT GY APE + D ++ G L EM+ GR
Sbjct: 143 VELKGGKKIKGRA---GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 45/242 (18%)
Query: 137 LGEGGFG----CVFKGWIEENG-TAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLG 190
LGEG FG C +G E G AP G + VAVK L D + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--------- 241
L + N+++L+G C+ DD ++ E+M G L L +R + ++ I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 242 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
A+ A G+ +L A ++RD T N L+
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVG-------------------------N 164
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
Y K++DFG++++ GD + R + + A E ++ G T+ SDV++FGV L EM
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
Query: 360 LT 361
T
Sbjct: 225 FT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 61/258 (23%), Positives = 95/258 (36%), Gaps = 64/258 (24%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
+F+ ++GEG F V + T A+K L+ L + K E
Sbjct: 2 DFKFGKIIGEGSFSTVVLAK---------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52
Query: 187 NFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIAL 243
L L H ++KL Y +D++ L V E+ P G L ++ SL R A
Sbjct: 53 EVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
L +LH + +I+RD K NILLD +D +
Sbjct: 111 -ILLALEYLHS---KGIIHRDLKPENILLD-------------------------KDMHI 141
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVM------------------GTYGYAAPEYVMTGHLTS 345
K++DFG AK + GT Y +PE +
Sbjct: 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK 201
Query: 346 RSDVYSFGVVLLEMLTGR 363
SD+++ G ++ +MLTG+
Sbjct: 202 SSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 63/233 (27%), Positives = 95/233 (40%), Gaps = 48/233 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----HDGLQGHKEWLAEVNFLGDL 192
+GEG G VFK E TG TVA+K + G+ + L E+ L
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H +VKL+ +LV E+MP L L PLP + KG+A++
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
H +++RD K +N+L+ A D K++DFGLA+
Sbjct: 116 HANG---IMHRDLKPANLLISA-------------------------DGVLKIADFGLAR 147
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
E + S +V T Y APE ++ G D+++ G + E+L G
Sbjct: 148 LFSEEEPRLYSHQV-ATRWYRAPE-LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 79/300 (26%), Positives = 114/300 (38%), Gaps = 55/300 (18%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 193
S LGEG G V K + TG+ A+KT+ D K+ L E+
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 194 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGAAKG 248
+VK G +++ + E+ GSL++ + +R + + KIA KG
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
L++LH R +I+RD K SNILL + KL DF
Sbjct: 118 LSYLHS---RKIIHRDIKPSNILLT-------------------------RKGQVKLCDF 149
Query: 309 GLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367
G++ + T GT Y APE + + SDV+S G+ LLE+ R
Sbjct: 150 GVSGELVNSLAGTFT-----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
P GE L L D E IK +++ CL +DP RP
Sbjct: 205 ---PEGEPPLGPIELLSYIVNMPNPELKD---EPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 63/238 (26%), Positives = 107/238 (44%), Gaps = 47/238 (19%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 186
+ LGEG +G V+K ++ G VA+K + +G+ L E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ L +L H N+VKL+ + + LV+E+ L+ +L +R PL ++ I
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+GLA+ H +++RD K NIL++ D KL+
Sbjct: 109 RGLAYCH---SHRILHRDLKPQNILINR-------------------------DGVLKLA 140
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
DFGLA+ +T+ + V+ T Y APE ++ S + D++S G + EM+TG+
Sbjct: 141 DFGLARAFGIPLRTY-THEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 51/235 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG FG V +G TG VAVK + D + +L E + L H N
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KIALGAAKGLAFLHEE 255
LV+L+G I + +V E M +G+L N L R L I++ + +L A+G+ +L
Sbjct: 61 LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+ +++RD NIL+ +D AK+SDFGLA+ G
Sbjct: 119 --KKLVHRDLAARNILVS-------------------------EDGVAKVSDFGLARVGS 151
Query: 316 EG-DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDK 368
G D + + + + APE + +S+SDV+S+GV+L E+ + GR K
Sbjct: 152 MGVDNSKLPVK------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 8e-17
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 46/229 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGDLVH 194
+GEG G V+K TG VA+K + L+ + L E+ + D H
Sbjct: 27 IGEGASGEVYKA---------TDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V + D+ +V E+M GSL + + + + + + +GL +LH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH- 133
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+ VI+RD K+ NILL +D + KL+DFG A
Sbjct: 134 --SQNVIHRDIKSDNILLS-------------------------KDGSVKLADFGFAAQL 166
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 362
+ S V+GT + APE V+ + D++S G++ +EM G
Sbjct: 167 TKEKSKRNS--VVGTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 67/240 (27%), Positives = 95/240 (39%), Gaps = 48/240 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKI 241
+V+ G C E L+V+E+M G L N R P L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
A A G+ +L A ++RD T N L+ Q
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVG-------------------------QGL 159
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
K+ DFG+++D D V R M + PE ++ T+ SD++SFGVVL E+ T
Sbjct: 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 77/311 (24%), Positives = 133/311 (42%), Gaps = 62/311 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--------NHDGLQGH--KEWLAE 185
L+G+G +G V+ + N T TG +AVK + HD Q K +E
Sbjct: 8 LIGKGTYGRVY---LALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L DL HLN+V+ +G+ ++ + E++P GS+ + R +
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQV 117
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
+GLA+LH + +++RD K N+L+DA G C K+
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDAD--------GIC-----------------KI 149
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 363
SDFG++K + + + G+ + APE + + +++ D++S G V+LEM GR
Sbjct: 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423
RP + + A LG +R P + S+ + A C + +P
Sbjct: 210 ------RPWSDEEAIA-AMFKLGNKRS-----APPIPPDVSMNLSPVALDFLNACFTINP 257
Query: 424 KARPLMSEVVE 434
RP E+++
Sbjct: 258 DNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 46/243 (18%)
Query: 137 LGEGGFGCV-------FKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
LGEG FG V + + E+ + VAVK L D +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIR 238
L L N+ +L+G C D ++ E+M G L L + S L +S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ +A A G+ +L ++RD T N L+
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK------------------------ 165
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
+Y K++DFG++++ D V R + A E V+ G T++SDV++FGV L E
Sbjct: 166 -NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 359 MLT 361
+LT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 58/235 (24%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G +G V++G W + + LTVAVKTL D ++ E+L E + ++ H
Sbjct: 14 LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G C + ++ EFM G+L ++L R + + + +A + + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE 121
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK- 312
+ + I+RD N L+ N+++ K++DFGL++
Sbjct: 122 K---KNFIHRDLAARNCLVGE-------------------NHLV------KVADFGLSRL 153
Query: 313 ------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
G K + + APE + + +SDV++FGV+L E+ T
Sbjct: 154 MTGDTYTAHAGAKFPIK--------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 50/241 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLA--- 184
N+R LLG+G FG V+ TG +AVK + D KE A
Sbjct: 3 NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L +L H +V+ G C+ DD+ L ++ E+MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+G+ +LH +++RD K +NIL D+ G N
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDS--------------AG-----------NV 143
Query: 304 KLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEML 360
KL DFG +K T + + V GT + +PE V++G R +DV+S G ++EML
Sbjct: 144 KLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEML 201
Query: 361 T 361
T
Sbjct: 202 T 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 64/237 (27%), Positives = 109/237 (45%), Gaps = 46/237 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G + G +P T VA+KT+N ++ E+L E + + +
Sbjct: 14 LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P +++A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
A G+A+L+ ++RD N M+ +D+ K
Sbjct: 128 IADGMAYLNANK---FVHRDLAARNC-------------------------MVAEDFTVK 159
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+ DFG+ +D E D + + + +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 75/324 (23%), Positives = 111/324 (34%), Gaps = 76/324 (23%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDL 192
++GEG +G V K + TG VA+K + D K L EV L L
Sbjct: 7 GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+V L + LV+E++ R LE LP P ++R + +A+
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
H +I+RD K NIL+ + KL DFG A
Sbjct: 116 CHSHN---IIHRDIKPENILVS-------------------------ESGVLKLCDFGFA 147
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPE----YVMTGHLTSRSDVYSFGVVLLEMLTGR---- 363
+ + ++ V T Y APE G DV++ G ++ E+L G
Sbjct: 148 RALRARPASPLTDYV-ATRWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFP 203
Query: 364 ------------RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR----LEGHFSIKG 407
+ + P H + + P +P LE + K
Sbjct: 204 GDSDIDQLYLIQKCLGPLPP--SHQELFSSNPRF----AGVAFPEPSQPESLERRYPGKV 257
Query: 408 AQKAAQLAAHCLSRDPKARPLMSE 431
+ A CL DPK R E
Sbjct: 258 SSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 57/237 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K + TG VA+K + L+ E L E+ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKIK---LRFESEGIPKTALREIKLLKE 54
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L H N++KL+ L LV+EFM L + R LP S+ +GLA
Sbjct: 55 LNHPNIIKLLD-VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
F H +++RD K N+L++ + KL+DFGL
Sbjct: 113 FCHSHG---ILHRDLKPENLLIN-------------------------TEGVLKLADFGL 144
Query: 311 AK--DGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 363
A+ P TH V TR Y APE ++ ++ D++S G + E+L+ R
Sbjct: 145 ARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 46/243 (18%)
Query: 137 LGEGGFG----CVFKG---WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 188
LGEG FG C +G +++++ + V + VAVK L D + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP----------WSIR 238
+ L N+++L+ CI D ++ E+M G L L R +S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ +A A G+ +L + ++RD T N L+ GK
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLV--------GK---------------- 165
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
+Y K++DFG++++ GD + R + + + E ++ G T+ SDV++FGV L E
Sbjct: 166 -NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 359 MLT 361
+LT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 74/230 (32%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVHL 195
LGEG FG V E P TG VAVK+L + H L E+ L +L H
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+VK G C ED L+ EF+P GSL+ +L R + ++K A+ KG+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
R ++RD N+L V +E+ K G DFGL K
Sbjct: 126 --GSRQYVHRDLAARNVL---VESEHQVKIG----------------------DFGLTK- 157
Query: 314 GPEGDKTHVSTR--VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
E DK + + + + + APE ++ SDV+SFGV L E+LT
Sbjct: 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 76/318 (23%), Positives = 129/318 (40%), Gaps = 72/318 (22%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
L + + +G+G FG V G G VAVK + +D + +LAE
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAE 49
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 243
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+ + +L ++RD N+L+ +D A
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVS-------------------------EDNVA 141
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
K+SDFGL K E T + ++ + APE + +++SDV+SFG++L E+ +
Sbjct: 142 KVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA----QLAAHCL 419
R V + R L + + PR+E + + + C
Sbjct: 197 R-------------VPYPRIPLKD-------VVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236
Query: 420 SRDPKARPLMSEVVEALK 437
D RP ++ E L+
Sbjct: 237 HLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 41/236 (17%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
+ ++G G FG VF+G ++ G V VA+KTL + + ++L+E + +G
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQF 63
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G + +++ E+M G+L+ +L + + G A G+ +L
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
++ ++RD NIL+ N+ L K+SDFGL++
Sbjct: 124 ---SDMNYVHRDLAARNILV---------------------NSNL----ECKVSDFGLSR 155
Query: 313 ---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
D PEG T ++ + APE + TS SDV+SFG+V+ E+++ G R
Sbjct: 156 VLEDDPEGTYTTSGGKI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 70/257 (27%), Positives = 107/257 (41%), Gaps = 58/257 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQGH-KEWLAEVN 187
N LGEG FG V K +K G T VAVK L + ++ L+E N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---------------FRRSLP 232
L + H +++KL G C +D LL+ E+ GSL + L R S
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 233 L------PWSIRMKI--ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284
L ++ I A ++G+ +L AE +++RD N+L+ R
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRK------- 165
Query: 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 344
K+SDFGL++D E D ++ + A E + T
Sbjct: 166 ------------------MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207
Query: 345 SRSDVYSFGVVLLEMLT 361
++SDV+SFGV+L E++T
Sbjct: 208 TQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 73/281 (25%), Positives = 111/281 (39%), Gaps = 56/281 (19%)
Query: 165 TVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 223
VA+K ++ + Q E EV + H N+VK + D+ LV ++ GSL
Sbjct: 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87
Query: 224 NHLFRRSLP---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280
+ + S P L +I + KGL +LH + I+RD K NILL
Sbjct: 88 -DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLG------- 136
Query: 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 336
+D + K++DFG LA G V +GT + APE
Sbjct: 137 ------------------EDGSVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPE 176
Query: 337 YVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 394
VM ++D++SFG+ +E+ TG K P L P
Sbjct: 177 -VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP----------- 224
Query: 395 IDPRLEGHFSIKGAQKA-AQLAAHCLSRDPKARPLMSEVVE 434
P LE K K+ ++ + CL +DP RP E+++
Sbjct: 225 --PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 37/228 (16%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 193
+LG G FG V+KG W+ E T + VA+K LN G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIP------VAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H +LV+L+G C+ +L V + MP G L +++ + + + + AKG+ +L
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
E R +++RD N+L V++ N+ K++DFGLA+
Sbjct: 127 E---RRLVHRDLAARNVL---VKSPNH----------------------VKITDFGLARL 158
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+K + + + A E + T +SDV+S+GV + E++T
Sbjct: 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 82/314 (26%), Positives = 131/314 (41%), Gaps = 64/314 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRMKIALGA 245
++V+L+G + L+V E M G L+++L RSL P P +++ I + A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPP-TLQEMIQMAA 126
Query: 246 --AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
A G+A+L+ + ++RD A R N M+ D+
Sbjct: 127 EIADGMAYLNA---KKFVHRDL--------AAR-----------------NCMVAHDFTV 158
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
K+ DFG+ +D E D + + + APE + G T+ SD++SFGVVL E+ +
Sbjct: 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-- 216
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423
L E L + ++D ++ L C +P
Sbjct: 217 -------------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNP 262
Query: 424 KARPLMSEVVEALK 437
K RP E+V LK
Sbjct: 263 KMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 70/309 (22%), Positives = 117/309 (37%), Gaps = 65/309 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F+ LG+G +G V+K + A+K ++ G KE VN +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDL-GSMSQKEREDAVNEI 50
Query: 190 GDLVHLNLVKLIGY--CIEDDQRL-LVYEFMPRGSLENHLFRRSL---PLPWSIRMKIAL 243
L +N +I Y D +L +V E+ P G L + +R +P +I +
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+GL LHE + +++RD K++NI +L +
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANI-------------------------LLVANDLV 142
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
K+ D G++K K +++ +GT Y APE + +SD++S G +L EM T
Sbjct: 143 KIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423
+ AR R + R P + +S Q L P
Sbjct: 199 PPFE-------------ARSMQDLRYKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKP 241
Query: 424 KARPLMSEV 432
K RP ++
Sbjct: 242 KLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 41/233 (17%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F LGEG +G V+K +E G VA+K + + +E + E++ L
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+VK G ++ +V E+ GS+ + + + L I KGL
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+LH I+RD K NILL+ ++ AKL+DFG+
Sbjct: 114 YLHS---NKKIHRDIKAGNILLN-------------------------EEGQAKLADFGV 145
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
+ G D V+GT + APE + +++D++S G+ +EM G+
Sbjct: 146 S--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 71/252 (28%), Positives = 101/252 (40%), Gaps = 67/252 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-- 193
LGEG FG V K E G P TVAVK L D + K+ L DLV
Sbjct: 19 PLGEGAFGQVVKA--EAVGL--DNPNETSTVAVKMLKDDATE--KD-------LSDLVSE 65
Query: 194 ---------HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSI 237
H N++ L+G C ++ +V E+ G+L + L R S P
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 238 RMKI--------ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289
+ A A+G+ FL A + I+RD N+L+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVT---------------- 166
Query: 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349
+D+ K++DFGLA+D D +T + APE + T +SDV
Sbjct: 167 ---------EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217
Query: 350 YSFGVVLLEMLT 361
+SFGV+L E+ T
Sbjct: 218 WSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 60/245 (24%), Positives = 94/245 (38%), Gaps = 46/245 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKEWLAEV 186
+F ++G+G FG V +++ T A+K +N + L E
Sbjct: 1 HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L +L H LV L Y +D++ + LV + + G L HL ++ ++ I
Sbjct: 52 RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EI 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
L +LH + +I+RD K NILLD Q + +
Sbjct: 110 VLALEYLHS---KGIIHRDIKPDNILLDE------------------------QGH-VHI 141
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365
+DF +A T T GT GY APE + + D +S GV E L G+R
Sbjct: 142 TDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
Query: 366 MDKNR 370
+
Sbjct: 199 YRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 84/298 (28%), Positives = 129/298 (43%), Gaps = 70/298 (23%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G W NG VAVKTL G + +L E + L H
Sbjct: 14 LGNGQFGEVWMGTW---NGNT--------KVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LV+L + ++ +V E+M +GSL + L R+L LP + M A A G+A++
Sbjct: 62 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 118
Query: 253 HEEAER-PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
ER I+RD +++NIL+ + ++ K++DFGLA
Sbjct: 119 ----ERMNYIHRDLRSANILVG--------------------DGLV-----CKIADFGLA 149
Query: 312 KDGPEGDKTHVSTRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
+ + + T R + + APE + G T +SDV+SFG++L E++T R
Sbjct: 150 RLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
N R L + R YR+ P+ +L C +DP+ RP
Sbjct: 207 MNN---------REVLEQVERGYRMPCPQ-------DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 81/318 (25%), Positives = 124/318 (38%), Gaps = 87/318 (27%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
LKL + LG G FG V+ G+ + VA+K+L G +
Sbjct: 6 ETLKLVKK-------LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEA 47
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIR 238
+LAE N + L H LV+L + + ++ E+M GSL + L L + I
Sbjct: 48 FLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
M A A+G+AF+ + I+RD + +NIL+
Sbjct: 107 M--AAQIAEGMAFIER---KNYIHRDLRAANILVS------------------------- 136
Query: 299 QDYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351
+ K++DFGLA+ EG K + + APE + G T +SDV+S
Sbjct: 137 ETLCCKIADFGLARLIEDNEYTAREGAKFPIK--------WTAPEAINYGTFTIKSDVWS 188
Query: 352 FGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQ 409
FG++L E++T R N E NL R YR+ P +
Sbjct: 189 FGILLTEIVTYGRIPYPGMTNPEVIQNL-----------ERGYRMPRPD-------NCPE 230
Query: 410 KAAQLAAHCLSRDPKARP 427
+ +L C P+ RP
Sbjct: 231 ELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 42/214 (19%)
Query: 161 GTGLTVAVKTL----NHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214
TG +AVK + N Q + E+ + L H ++++++G ED L
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
E+M GS+ +HL + ++ + +GL++LH E +I+RD K +N+L+D+
Sbjct: 83 EWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDS 138
Query: 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTY 330
+++DFG LA G + +++GT
Sbjct: 139 T------------------------GQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTI 172
Query: 331 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
+ APE V+ G RS DV+S G V++EM T +
Sbjct: 173 AFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 74/311 (23%), Positives = 131/311 (42%), Gaps = 56/311 (18%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
E ++G G FG V +G ++ G + VA+KTL + +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N++ L G + +++ EFM G+L++ L + + + G A G+ +L
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
+E ++RD NIL+++ N++ K+SDFGL++
Sbjct: 123 ---SEMNYVHRDLAARNILVNS--------------------NLV-----CKVSDFGLSR 154
Query: 313 DGPEGDKTHVSTRVMG---TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDK 368
+ T +G + APE + TS SDV+S+G+V+ E+++ G R
Sbjct: 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214
Query: 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428
N +E + YRL P + QL C +D ARP
Sbjct: 215 MSNQDVINAIE----------QDYRLPPP-------MDCPTALHQLMLDCWQKDRNARPK 257
Query: 429 MSEVVEALKPL 439
++V L +
Sbjct: 258 FGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 37/226 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+GEG FG V++G + VAVKT + +E +L E + H
Sbjct: 13 CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++VKLIG ++ +V E P G L ++L L + + + + LA+L
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+ ++RD N+L+ + C+ KL DFGL++
Sbjct: 126 ---KRFVHRDIAARNVLVSSPD---------CV----------------KLGDFGLSR-Y 156
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
E + + +++ + APE + TS SDV+ FGV + E+L
Sbjct: 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 21/229 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 253
N++ L+G C +D ++ E+ +G+L +L RR + +S +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-------------IA 127
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA-KLSDFGLAK 312
+ + ++D + + R Y CI+ L N+L + N K++DFGLA+
Sbjct: 128 RVPDEQMTFKDLVSCTYQV--ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
D D +T + APE + T +SDV+SFGV++ E+ T
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 71/243 (29%), Positives = 97/243 (39%), Gaps = 66/243 (27%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---------GLQGHKEWLAEV 186
+LG+G FG V A +K GT AVK L D K LA
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSI--RMKIA 242
L L+ C + RL V E++ G L H+ R P + +I
Sbjct: 53 GKHPFLTQLHS------CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
LG L FLHE R +IYRD K N+LLD+ G
Sbjct: 107 LG----LQFLHE---RGIIYRDLKLDNVLLDSE--------GHI---------------- 135
Query: 303 AKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEML 360
K++DFG+ K+G G T + GT Y APE +++ + D ++ GV+L EML
Sbjct: 136 -KIADFGMCKEGILGGVTT---STFCGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEML 190
Query: 361 TGR 363
G+
Sbjct: 191 AGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 68/231 (29%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDL-VH 194
LG G FG V +E K + VAVK L +E L +E+ + L H
Sbjct: 43 LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLH 253
N+V L+G C L++ E+ G L N L R R L + + AKG+AFL
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
A + I+RD N+LL +GK K+ DFGLA+D
Sbjct: 158 --ASKNCIHRDLAARNVLL------THGKI-------------------VKICDFGLARD 190
Query: 314 GPEGDKTHV---STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
D +V + R+ + APE + T SDV+S+G++L E+ +
Sbjct: 191 -IMNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 60/240 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K N TG VA+K + ++ KE + E+ L
Sbjct: 7 IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54
Query: 192 LVHLNLVKLIGYCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSIR--MKIALG 244
L H N+V+L + +V+E+M G L++ + + I+ MK L
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLL- 110
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
+GL +LH +++RD K SNIL++ D K
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILIN-------------------------NDGVLK 140
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
L+DFGLA+ + T + T Y PE ++ D++S G +L E+ G+
Sbjct: 141 LADFGLARP-YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 73/309 (23%), Positives = 115/309 (37%), Gaps = 80/309 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGH-KEWL-AEVNFLGDLV 193
+G+G FG V K V+ G + K +++ + K+ L +EVN L +L
Sbjct: 8 IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 194 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLP----WSIRMKIAL 243
H N+V+ I+ + L V E+ G L L ++ + W I ++ L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 244 GAAKGLAFLH--EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
L H + V++RD K +NI LDA +
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDA-------------------------NN 147
Query: 302 NAKLSDFGLAKDGPEGD---KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
N KL DFGLAK KT+V GT Y +PE + +SD++S G ++ E
Sbjct: 148 NVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202
Query: 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418
+ P AR L + R+ +S + ++
Sbjct: 203 LCAL-------SPPFT------ARNQLQLASKIKEGKFRRIPYRYS----SELNEVIKSM 245
Query: 419 LSRDPKARP 427
L+ DP RP
Sbjct: 246 LNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 70/247 (28%), Positives = 100/247 (40%), Gaps = 66/247 (26%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGHKE---WLA 184
+F LG G FG V V+ G+G A+K L+ + K+ L
Sbjct: 1 DDFEFIKTLGTGSFGRVML----------VRHKGSGKYYALKILSKAKIVKLKQVEHVLN 50
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM--- 239
E L + H LV L G +DD L LV E++P G L +HL + P P + R
Sbjct: 51 EKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAA 108
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
++ L L +LH ++YRD K N+LLD
Sbjct: 109 QVVLA----LEYLHS---LDIVYRDLKPENLLLD-------------------------S 136
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVV 355
D K++DFG AK V R GT Y APE ++ G+ D ++ G++
Sbjct: 137 DGYIKITDFGFAK--------RVKGRTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGIL 187
Query: 356 LLEMLTG 362
+ EML G
Sbjct: 188 IYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 53/243 (21%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-----TLNHDGLQGHKEWLA----E 185
+L+G G FG V+ G + +G +AVK +++ + L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L +L H N+V+ +G ++ D + E++P GS+ L ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQI 115
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
KGL +LH R +I+RD K +NIL+D N G K+
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVD-----NKGGI--------------------KI 147
Query: 306 SDFGLAKDGPEGDKTHVSTR-----VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
SDFG++K E + T + G+ + APE V T ++D++S G +++EML
Sbjct: 148 SDFGISKK-LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
Query: 361 TGR 363
TG+
Sbjct: 207 TGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 21/229 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N++ L+G C +D ++ E+ +G+L +L R P G+ + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP---------------GMEYCYN 128
Query: 255 EAERPVIYRDFKT-SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA-KLSDFGLAK 312
+ P FK + R Y CI+ L N+L + N K++DFGLA+
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
D D +T + APE + T +SDV+SFGV+L E+ T
Sbjct: 189 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 67/282 (23%), Positives = 111/282 (39%), Gaps = 53/282 (18%)
Query: 162 TGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLI--GYCIEDDQRLLVYEF 216
TG VA+K L D + + + E L H N+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276
+P +L L LP ++ L LA H + +++RD K NI++
Sbjct: 61 VPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP---EGDKTHVS--TRVMGTYG 331
+AK+ DFG+ P + D ++ T V+GT
Sbjct: 117 VRP----------------------HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPT 154
Query: 332 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 391
Y APE + +T SD+Y++G++ LE LTG+R + G ++ E L
Sbjct: 155 YCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ-----GA-SVAEILYQQLSPVD-- 206
Query: 392 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433
+ P + GH Q+ L++DP+ R + +
Sbjct: 207 -VSLPPWIAGH-------PLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 56/300 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K + VA+K +N +G ++++ E + L H
Sbjct: 12 LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + +V EFM G L N+L +R L + + + +G+ +L +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316
I+RD N L+ + + K+SDFG+ + +
Sbjct: 121 ---FIHRDLAARNCLVSST----------GV---------------VKVSDFGMTRYVLD 152
Query: 317 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 376
D+ S+ ++ PE +S+SDV+SFGV++ E+ T + + + N E
Sbjct: 153 -DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-- 209
Query: 377 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436
+VE R +RL P+L + + C P+ RP +E++ A+
Sbjct: 210 VVE-------MISRGFRLYRPKLASMTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 63/256 (24%), Positives = 110/256 (42%), Gaps = 52/256 (20%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKE 181
+L L+ F E LGE FG ++KG + G + VA+KTL + + Q E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGE 53
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 230
+ E + + +L H N+V L+G ++ +++E++ +G L L RS
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 231 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285
L + IA+ A G+ +L + +++D NIL+
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIG------------ 158
Query: 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 345
+ + K+SD GL+++ D V + + + PE +M G +S
Sbjct: 159 -------------EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205
Query: 346 RSDVYSFGVVLLEMLT 361
SD++SFGVVL E+ +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 87/310 (28%), Positives = 133/310 (42%), Gaps = 70/310 (22%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
++ + R + LG+G FG V+ G W NGT VA+KTL G + +L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLK-PGTMMPEAFL 49
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
E + L H LV L + ++ +V EFM +GSL + L + L LP + M
Sbjct: 50 QEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM- 107
Query: 241 IALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
A A G+A++ ER I+RD + +NIL+ +N C
Sbjct: 108 -AAQIADGMAYI----ERMNYIHRDLRAANILV----GDNL----VC------------- 141
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLL 357
K++DFGLA+ + + T R + + APE + G T +SDV+SFG++L
Sbjct: 142 ----KIADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 194
Query: 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 417
E++T R N R L + R YR+ P+ + +L
Sbjct: 195 ELVTKGRVPYPGMVN---------REVLEQVERGYRMPCPQ-------GCPESLHELMKL 238
Query: 418 CLSRDPKARP 427
C +DP RP
Sbjct: 239 CWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 21/229 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 194
LGEG FG V + E G +P +TVAVK L + + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LH 253
N++ L+G C ++ ++ E+ +G+L L R P P F +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGP-------------DYTFDIT 124
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA-KLSDFGLAK 312
+ E + ++D + R Y + CI+ L N+L + N K++DFGLA+
Sbjct: 125 KVPEEQLSFKDLVSC--AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+ D ++ + APE + T +SDV+SFG+++ E+ T
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N++ L+G C +D ++ E+ +G+L +L R P M + K L E
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPP-----GMDYSFDTCK----LPE 128
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA-KLSDFGLAKD 313
E + ++D + R Y CI+ L N+L + N K++DFGLA+D
Sbjct: 129 EQ---LTFKDLVSC--AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
D +T + APE + T +SDV+SFGV+L E+ T
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 73/309 (23%), Positives = 120/309 (38%), Gaps = 80/309 (25%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 189
F +G+G FG V+K + T VA+K ++ + + E + E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ K G ++ + ++ E+ GS + L + L + I GL
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGL 111
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LHEE I+RD K +NILL + + KL+DFG
Sbjct: 112 EYLHEEG---KIHRDIKAANILLSE-------------------------EGDVKLADFG 143
Query: 310 LAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
++ G T ++ +GT + APE + ++D++S G+ +E+ G
Sbjct: 144 VS-----GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG---- 194
Query: 367 DKNRPNGE-HNLVEWARPHLGERRRFYRLID----PRLEGH-FS--IKGAQKAAQLAAHC 418
P + H + R LI P LEG+ FS K + C
Sbjct: 195 --EPPLSDLHPM------------RVLFLIPKNNPPSLEGNKFSKPFKD------FVSLC 234
Query: 419 LSRDPKARP 427
L++DPK RP
Sbjct: 235 LNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 63/242 (26%), Positives = 109/242 (45%), Gaps = 51/242 (21%)
Query: 130 NFRPESL-----LGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQG-HKEW 182
+ R E L LG G G V K VK TG +A K ++ K+
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSK----------VKHIPTGTVMAKKVVHIGAKSSVRKQI 50
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L E+ + + +V G + ++ + EFM GSL+ ++++ P+P I KIA
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIA 109
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+ +GL +L+ +++RD K SNIL+++ R +
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQ------------------------ 142
Query: 303 AKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
KL DFG++ G+ + ++ +GT Y +PE + G T +SDV+S G+ ++E+
Sbjct: 143 IKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197
Query: 362 GR 363
G+
Sbjct: 198 GK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 75/316 (23%), Positives = 118/316 (37%), Gaps = 57/316 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 188
N + + LG G FG VF + G V VK L E+ E++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIA 242
L H N+V+L+G C E + ++ E+ G L+ L + P P S + K+A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 243 LGA--AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
L A G+ L + ++RD N C+ +
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARN----------------CL---------VSSQ 153
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
K+S L+KD + + + + APE V +++SDV+SFGV++ E+
Sbjct: 154 REVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 420
T E L + RL +LE + +L C +
Sbjct: 213 T---------------QGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWA 257
Query: 421 RDPKARPLMSEVVEAL 436
+PK RP SE+V AL
Sbjct: 258 VNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 46/233 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K TGL A K + + + ++++ E++ L + H N
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V L +++ ++ EF G+L++ + L + + L FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL-AKDGP 315
VI+RD K NILL D + KL+DFG+ AK+
Sbjct: 124 ---VIHRDLKAGNILLT-------------------------LDGDVKLADFGVSAKNKS 155
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEMLTGR 363
K +GT + APE V ++D++S G+ L+E+
Sbjct: 156 TLQKRDT---FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 41/235 (17%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGD 191
E +LG G FG + +G ++ P K L VA+ TL G + +LAE LG
Sbjct: 10 ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTL-RAGCSDKQRRGFLAEALTLGQ 62
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+V+L G + ++V E+M G+L++ L + L M + G A G+ +
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG-L 310
L +E +++ +L+++ D K+S F L
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNS-------------------------DLVCKISGFRRL 154
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+D E T +S + +AAPE + H +S SDV+SFG+V+ E+++ G R
Sbjct: 155 QEDKSEAIYTTMSGKSPVL--WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 62/248 (25%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNH-----DGLQGHKEW 182
+ LGEG + V+K +E G VA+K L DG+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGI--NFTA 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--M 239
L E+ L +L H N++ L+ LV+EFM LE + +S+ L P I+ M
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM 108
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
+ L +GL +LH +++RD K +N+L+ +
Sbjct: 109 LMTL---RGLEYLH---SNWILHRDLKPNNLLIAS------------------------- 137
Query: 300 DYNAKLSDFGLAKD--GPEGDKTH-VSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVV 355
D KL+DFGLA+ P TH V TR Y APE + H D++S G +
Sbjct: 138 DGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAPELLFGARHYGVGVDMWSVGCI 192
Query: 356 LLEMLTGR 363
E+L
Sbjct: 193 FAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 66/247 (26%), Positives = 99/247 (40%), Gaps = 77/247 (31%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
LG+G FG V+ +E G VA+K + + W L EV L
Sbjct: 7 LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53
Query: 192 L-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIRMKIALGA 245
L H N+VKL E+D+ V+E+M E +L+ R+ P S+ I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
+GLA +H+ +RD K N+L+ K+
Sbjct: 109 LQGLAHIHKHG---FFHRDLKPENLLVS-------------------------GPEVVKI 140
Query: 306 SDFGLAKD----GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVL 356
+DFGLA++ P D +VSTR Y APE + L S S D+++ G ++
Sbjct: 141 ADFGLAREIRSRPPYTD--YVSTR-----WYRAPEIL----LRSTSYSSPVDIWALGCIM 189
Query: 357 LEMLTGR 363
E+ T R
Sbjct: 190 AELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 91/343 (26%), Positives = 137/343 (39%), Gaps = 61/343 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-V 193
+LG G FG V +E + K + TVAVK L HK ++E+ L +
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69
Query: 194 HLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL-FRRSLPLPWS--------------- 236
HLN+V L+G C + + L+V EF G+L N L +R P+
Sbjct: 70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVE 129
Query: 237 ---IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF-------- 285
+ +I G A L + + +T ++ + E+ + F
Sbjct: 130 QSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEF 189
Query: 286 -----CIYYGLFFNNMLFQDYNA-KLSDFGLAKDGPEGDKTHV---STRVMGTYGYAAPE 336
CI+ L N+L + N K+ DFGLA+D + D +V S R+ + APE
Sbjct: 190 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL--PLKWMAPE 246
Query: 337 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 396
+ T++SDV+SFGV+L E+ + S P + N R G R R
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGTRMRAPENAT 303
Query: 397 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
P + + C DPK RP S +VE L L
Sbjct: 304 PEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
+G G FG V+ N T VAVK +++ G Q +++W + EV FL L
Sbjct: 29 IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N ++ G +++ LV E+ GS + L PL I GA +GLA+LH
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
+I+RD K NILL + KL+DFG A
Sbjct: 139 SHN---MIHRDIKAGNILLT-------------------------EPGQVKLADFGSAS- 169
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 359
K+ + +GT + APE ++ G + DV+S G+ +E+
Sbjct: 170 -----KSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 84/305 (27%), Positives = 131/305 (42%), Gaps = 70/305 (22%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 54
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 111
Query: 246 AKGLAFLHEEAER-PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
A G+A++ ER ++RD + +NIL+ N++ K
Sbjct: 112 ASGMAYV----ERMNYVHRDLRAANILVG--------------------ENLV-----CK 142
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
++DFGLA+ + + T R + + APE + G T +SDV+SFG++L E+ T
Sbjct: 143 VADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422
R N R L + R YR+ P + + L C ++
Sbjct: 200 GRVPYPGMVN---------REVLDQVERGYRMPCPP-------ECPESLHDLMCQCWRKE 243
Query: 423 PKARP 427
P+ RP
Sbjct: 244 PEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 77/315 (24%), Positives = 130/315 (41%), Gaps = 76/315 (24%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----------LAE 185
LG G FGCV+K + NG +A+K +N K+ ++E
Sbjct: 7 HLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 186 VNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP----WSI 237
V + + L H N+V+ +E+D+ +V + + P G N L + W+I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+++ L L +LH+E + +++RD +NI ML
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNI-------------------------ML 147
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357
+D ++DFGLAK K T V+GT Y+ PE V ++DV++FG +L
Sbjct: 148 GEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILY 204
Query: 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 417
+M T P N++ A + + +P EG +S + +
Sbjct: 205 QMCT------LQPPFYSTNMLSLA------TKIVEAVYEPLPEGMYS----EDVTDVITS 248
Query: 418 CLSRDPKARPLMSEV 432
CL+ D +ARP + +V
Sbjct: 249 CLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 48/240 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 184
+ E ++G G FG V G ++ G + VA+KTL G+ E +L+
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLK----AGYTEKQRRDFLS 54
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E + +G H N++ L G + ++V E+M GSL+ L + + + G
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG 114
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
A G+ +L ++ ++RD NIL+++ N++ K
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNS--------------------NLV-----CK 146
Query: 305 LSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+SDFGL++ D PE T ++ + APE + TS SDV+S+G+V+ E+++
Sbjct: 147 VSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 77/327 (23%), Positives = 123/327 (37%), Gaps = 82/327 (25%)
Query: 124 LKLATRNFRPESLL------GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ 177
L+L P S L GEG G V TG VAVK ++ Q
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQ 58
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+ EV + D H N+V++ + D+ +V EF+ G+L + +
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--------IVTHT 110
Query: 238 RMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
RM + L K L+FLH + VI+RD K+ +ILL +
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTS----------------- 150
Query: 292 FFNNMLFQDYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 347
D KLSDFG ++K+ P ++GT + APE + +
Sbjct: 151 --------DGRVKLSDFGFCAQVSKEVPR------RKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 407
D++S G++++EM+ G P L +R + P+L+ K
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPP-------------LQAMKRIRDNLPPKLKNL--HKV 241
Query: 408 AQKAAQLAAHCLSRDPKARPLMSEVVE 434
+ + L RDP R +E++
Sbjct: 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 59/235 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ N T VAVKTL G + +L E N + L H
Sbjct: 14 LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 253
LV+L +++ ++ E+M +GSL + L + LP I + A+G+A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK- 312
+ I+RD + +N+L+ + L K++DFGLA+
Sbjct: 121 R---KNYIHRDLRAANVLV---------------------SESLM----CKIADFGLARV 152
Query: 313 ------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
EG K + + APE + G T +SDV+SFG++L E++T
Sbjct: 153 IEDNEYTAREGAKFPIK--------WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 73/262 (27%), Positives = 104/262 (39%), Gaps = 68/262 (25%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQG-HKEWLA 184
R++ LGEG FG V+K + TG VA+K L H+ G L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALR 56
Query: 185 EVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMP------RGSLENHLFRRSLPL 233
E+ L L H N+V LI +E +R VY P G LEN + +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES- 115
Query: 234 PWSIR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
I+ M L +G+ +LHE +++RD K +NIL+D N G
Sbjct: 116 --QIKCYMLQLL---EGINYLHENH---ILHRDIKAANILID-----NQG---------- 152
Query: 292 FFNNMLFQDYNAKLSDFGLAK---------DGPEGDKTHVSTRVMGTYGYAAPEYVM-TG 341
K++DFGLA+ G G T T ++ T Y PE ++
Sbjct: 153 ----------ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER 202
Query: 342 HLTSRSDVYSFGVVLLEMLTGR 363
T+ D++ G V EM T R
Sbjct: 203 RYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 74/240 (30%), Positives = 93/240 (38%), Gaps = 64/240 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHD-----GLQGH----KEWLAEV 186
LG GGFG V VK T A+K + G Q H KE L E
Sbjct: 1 LGVGGFGRVEL----------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC 50
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
N H +VKL Y D++ +Y E+ G L L R L ++ R IA
Sbjct: 51 N------HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIA- 100
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+LH R +IYRD K N+LLD G+
Sbjct: 101 CVVLAFEYLHN---RGIIYRDLKPENLLLD--------SNGY-----------------V 132
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
KL DFG AK G KT GT Y APE ++ D +S G++L E+LTGR
Sbjct: 133 KLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 66/256 (25%), Positives = 107/256 (41%), Gaps = 52/256 (20%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HK 180
++ L+T F E LGE FG V+KG + GTAP + VA+KTL D +G +
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLRE 53
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------- 230
E+ E L H N+V L+G ++ +++ + L L RS
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 231 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285
L + + I A G+ FL + V+++D T N+L+
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLV------------- 157
Query: 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 345
F N K+SD GL ++ D + + + +PE +M G +
Sbjct: 158 ------------FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI 205
Query: 346 RSDVYSFGVVLLEMLT 361
SD++S+GVVL E+ +
Sbjct: 206 DSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 71/328 (21%), Positives = 125/328 (38%), Gaps = 83/328 (25%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLA 184
NF+ E +G+G F V+K +G VA+K + + K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 237
E++ L L H N++K + IE+++ +V E G L H ++ +P W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+++ L +H + +++RD K +N+ + A
Sbjct: 112 FVQL----CSALEHMH---SKRIMHRDIKPANVFITA----------------------- 141
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357
KL D GL + KT + ++GT Y +PE + +SD++S G +L
Sbjct: 142 --TGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197
Query: 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID--------PRLEGHFSIKGAQ 409
EM P G++ Y L P H+S +
Sbjct: 198 EM------------------AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS----E 235
Query: 410 KAAQLAAHCLSRDPKARPLMSEVVEALK 437
+ L + C++ DP+ RP +S V++ K
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 55/247 (22%), Positives = 99/247 (40%), Gaps = 54/247 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 187
+ ++G G FG V + V +K + + + + A E
Sbjct: 1 KYEKIRVVGRGAFGIV---HLCRRKADQKL------VIIKQIPVEQMTKDERLAAQNECQ 51
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE-------NHLFRRSLPLPWSIRMK 240
L L H N+++ +ED ++V E+ P G+L N L L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+A LH + +++RD KT NILLD + ++
Sbjct: 112 LA---------LHHVHTKLILHRDLKTQNILLDKHK------------------MVV--- 141
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
K+ DFG++K K+ T V+GT Y +PE +SD+++ G VL E+
Sbjct: 142 ---KIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
Query: 361 TGRRSMD 367
+ +R+ +
Sbjct: 196 SLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 46/239 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-LAEVNF 188
NF+ LGEG + V+KG N T TG VA+K ++ D +G + E++
Sbjct: 1 NFKQLEKLGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALGA 245
+ +L H N+V+L +++ +LV+E+M + ++ H R +L L
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
KG+AF HE V++RD K N+L++ + KL
Sbjct: 110 LKGIAFCHENR---VLHRDLKPQNLLIN-------------------------KRGELKL 141
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
+DFGLA+ T + V T Y AP+ ++ S S D++S G ++ EM+TGR
Sbjct: 142 ADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 77/266 (28%), Positives = 106/266 (39%), Gaps = 65/266 (24%)
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
L + + NDL+ +G G G V+K ++ G +AVK
Sbjct: 3 LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYKMRFKKTGH---------VMAVK 46
Query: 170 TLNHDGLQGHKEWLAEVNFLGDL-VHL------NLVKLIGYCIEDDQRLLVYEFMPRGSL 222
+ G +KE + L DL V L +VK GY I D + E M L
Sbjct: 47 QMRRTG---NKEENKRI--LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CL 100
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282
+ L R P+P I K+ + K L +L E+ VI+RD K SNILLDA
Sbjct: 101 DKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDA-------- 150
Query: 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYVMTG 341
N KL DFG++ G D K TR G Y APE +
Sbjct: 151 -----------------SGNVKLCDFGIS--GRLVDSKAK--TRSAGCAAYMAPERIDPP 189
Query: 342 HLTS----RSDVYSFGVVLLEMLTGR 363
R+DV+S G+ L+E+ TG+
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 69/234 (29%), Positives = 97/234 (41%), Gaps = 53/234 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK E TG VA+K + D K L E+ L L H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV LI ++L LV+E+ ++ N L + +P + KI + + F H
Sbjct: 60 PNLVNLI-EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK- 312
+ I+RD K NIL+ + KL DFG A+
Sbjct: 118 KHN---CIHRDVKPENILIT-------------------------KQGQIKLCDFGFARI 149
Query: 313 -DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLT--SRSDVYSFGVVLLEMLTG 362
GP D T +V+TR Y APE ++ G DV++ G V E+LTG
Sbjct: 150 LTGPGDDYTDYVATR-----WYRAPE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/182 (30%), Positives = 79/182 (43%), Gaps = 46/182 (25%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 257
C + + RL V EF+ G L H+ R R LP +S + +AL FLHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHE--- 114
Query: 258 RPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG-PE 316
R +IYRD K N+LLDA + + KL+D+G+ K+G
Sbjct: 115 RGIIYRDLKLDNVLLDA-------------------------EGHIKLTDYGMCKEGIRP 149
Query: 317 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGE 374
GD T + GT Y APE + D ++ GV++ EM+ GR D N +
Sbjct: 150 GDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
Query: 375 HN 376
N
Sbjct: 207 QN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 45/225 (20%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262
C + RL LV E++ G L H+ +R LP A L FLHE R +IY
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119
Query: 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG-PEGDKTH 321
RD K N+LLD D + KL+D+G+ K+G GD T
Sbjct: 120 RDLKLDNVLLD-------------------------ADGHIKLTDYGMCKEGLGPGDTT- 153
Query: 322 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 381
+ GT Y APE + D ++ GV++ EM+ GR D N + N ++
Sbjct: 154 --STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211
Query: 382 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426
+ E+ R+ S+ KA+ + L++DPK R
Sbjct: 212 FQVILEK-------PIRIPRFLSV----KASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 63/234 (26%), Positives = 93/234 (39%), Gaps = 51/234 (21%)
Query: 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLN 196
G +G VF K TG A+K + + + L E + L
Sbjct: 4 GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+VKL Y + + L LV E++P G L L L + L +LH
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+I+RD K NIL+D+ N L KL+DFGL+K G
Sbjct: 113 G---IIHRDLKPDNILIDS-------------------NGHL------KLTDFGLSKVGL 144
Query: 316 EGDKTHVS------TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 362
+ +++ R++GT Y APE V+ G S++ D +S G +L E L G
Sbjct: 145 VRRQINLNDDEKEDKRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 91/347 (26%), Positives = 135/347 (38%), Gaps = 66/347 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-- 194
LG G FG V IE + K T TVAVK L H E A ++ L L+H
Sbjct: 15 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIG 68
Query: 195 --LNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL----------------FRRSLP--- 232
LN+V L+G C + L+V EF G+L N+L FR+
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYG 128
Query: 233 -LPWSIRMKI----ALGAAKGLAFLH---------EEAERPVIYRDFKTSNILL----DA 274
+ ++ ++ + ++ F+ EEAE+ +Y+ T L+
Sbjct: 129 DISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQV 188
Query: 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 333
+ + CI+ L N+L + N K+ DFGLA+D + +
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 248
Query: 334 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGERRRFY 392
APE + T +SDV+SFGV+L E+ S+ + G E+ R G R R
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIF----SLGASPYPGVKIDEEFCRRLKEGTRMRAP 304
Query: 393 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
P + Q C +P RP SE+VE L L
Sbjct: 305 DYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 88/308 (28%), Positives = 129/308 (41%), Gaps = 83/308 (26%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNF 188
+LG+GG+G VF+ + + A TG A+K L + H + AE N
Sbjct: 2 KVLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP-----WSIRMKIA 242
L + H +V LI Y + +L L+ E++ G L HL R + + + + +A
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
L LH++ +IYRD K NILLDA G +
Sbjct: 113 LE------HLHQQG---IIYRDLKPENILLDA--------------QG-----------H 138
Query: 303 AKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 360
KL+DFGL K+ EG TH GT Y APE +M +GH D +S G ++ +ML
Sbjct: 139 VKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDML 194
Query: 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHC 418
TG A P E R+ + ID L+G ++ +A L
Sbjct: 195 TG------------------APPFTAENRK--KTIDKILKGKLNLPPYLTPEARDLLKKL 234
Query: 419 LSRDPKAR 426
L R+P +R
Sbjct: 235 LKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 76/307 (24%), Positives = 115/307 (37%), Gaps = 74/307 (24%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFL 189
++ L+G G +G V++G TG VA+K +N D + EV L
Sbjct: 3 YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 190 GDLVHL---NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK----I 241
L N+ K G RL ++ E+ GS+ R+L I K I
Sbjct: 54 SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVI 106
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
L ++H+ VI+RD K +NIL+
Sbjct: 107 IREVLVALKYIHKV---GVIHRDIKAANILVTN-------------------------TG 138
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEML 360
N KL DFG+A + ST V GT + APE + G +++D++S G+ + EM
Sbjct: 139 NVKLCDFGVAALLNQNSSKR-STFV-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196
Query: 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG-HFSIKGAQKAAQLAAHCL 419
TG L+ ++P PRLE +S + + A CL
Sbjct: 197 TGNPPYSDVDAFRAMMLIPKSKP-------------PRLEDNGYS----KLLREFVAACL 239
Query: 420 SRDPKAR 426
+PK R
Sbjct: 240 DEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHL 195
LG G FGCV KG + + VA+K L ++ + E + E + L +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V++IG C E + +LV E G L L + + S +++ + G+ +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+ ++RD N+L ++ Q Y AK+SDFGL+K
Sbjct: 114 --KNFVHRDLAARNVL------------------------LVNQHY-AKISDFGLSK-AL 145
Query: 316 EGDKTHVSTRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
D ++ R G + + APE + +SRSDV+S+G+ + E +
Sbjct: 146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 73/270 (27%), Positives = 100/270 (37%), Gaps = 82/270 (30%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
+F ++G G FG V+ TG A+K L + + AE
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MK 240
+ L D +VKL Y +D++ L LV E+MP G L N L R+ + + R +
Sbjct: 53 DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+AL + L F+H RD K NIL+DA D
Sbjct: 112 LALDSVHKLGFIH---------RDIKPDNILIDA-------------------------D 137
Query: 301 YNAKLSDFGLAKDGPEGDKT----------------------HVSTRVM-----GTYGYA 333
+ KL+DFGL K + H RV GT Y
Sbjct: 138 GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYI 197
Query: 334 APEYVMTGH-LTSRSDVYSFGVVLLEMLTG 362
APE V+ G D +S GV+L EML G
Sbjct: 198 APE-VLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 59/265 (22%), Positives = 106/265 (40%), Gaps = 64/265 (24%)
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 239
L E+ L L H N++ + ++D+ L+ E+ G+L + + R+ +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
+ +A ++++H+ +++RD KT NI L K G
Sbjct: 107 LFQIVSA--VSYIHKAG---ILHRDIKTLNIFLT--------KAGL-------------- 139
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
KL DFG++K G + ++ V+GT Y +PE +SD+++ G VL E+
Sbjct: 140 ---IKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYEL 194
Query: 360 LTGRRSMDKNRPNGEHNLV------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
LT +R+ D P NLV + P + + + +
Sbjct: 195 LTLKRTFDATNPL---NLVVKIVQGNYT---------------PVVSVY-----SSELIS 231
Query: 414 LAAHCLSRDPKARPLMSEVVEALKP 438
L L +DP+ RP EV++
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 85/307 (27%), Positives = 124/307 (40%), Gaps = 72/307 (23%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAA 109
Query: 247 K---GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+ GL LH E +YRD K NILLD +YG +
Sbjct: 110 EILCGLEDLHREN---TVYRDLKPENILLD-----DYG--------------------HI 141
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
++SD GLA PEG+ + RV GT GY APE + T D + G ++ EM+ G+
Sbjct: 142 RISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYR-LIDPRL---EGHFSIKGAQKAAQLAAHCL 419
P G + + R +D R+ E +S K +++A + L
Sbjct: 199 ------------------SPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 420 SRDPKAR 426
++DPK R
Sbjct: 241 TKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 32/149 (21%)
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
E M GSL+ L +++ +P +I KI++ +GL +L E+ +++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNS 135
Query: 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 334
R E KL DFG++ G D ++ +GT Y +
Sbjct: 136 -RGE------------------------IKLCDFGVS--GQLIDS--MANSFVGTRSYMS 166
Query: 335 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
PE + H T +SD++S G+ L+EM GR
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 73/322 (22%), Positives = 121/322 (37%), Gaps = 75/322 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
NFR E +G G F V++ +G VA+K + L + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIAL 243
+ L L H N++K IED++ +V E G L H ++ +P K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
L +H R V++RD K +N+ + A G G G FF++
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGL----GRFFSS-------- 158
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
KT + ++GT Y +PE + +SD++S G +L EM
Sbjct: 159 ---------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM---- 199
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLID--------PRLEGHFSIKGAQKAAQLA 415
P G++ Y L P H+S ++ QL
Sbjct: 200 --------------AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS----EELRQLV 241
Query: 416 AHCLSRDPKARPLMSEVVEALK 437
C++ DP+ RP ++ V + K
Sbjct: 242 NMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 65/249 (26%), Positives = 94/249 (37%), Gaps = 69/249 (27%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
++GEG +G V+K + TG VA+K ++ +E E N L H
Sbjct: 13 VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 195 LNLVKLIG------YCIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIAL 243
N+ G DDQ LV E GS+ + + L W IA
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117
Query: 244 ---GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+GLA+LHE VI+RD K NILL ++
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLT-------------------------KN 149
Query: 301 YNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFG 353
KL DFG++ D G + + GT + APE + +RSDV+S G
Sbjct: 150 AEVKLVDFGVSAQLDSTLG-RRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLG 205
Query: 354 VVLLEMLTG 362
+ +E+ G
Sbjct: 206 ITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 82/301 (27%), Positives = 115/301 (38%), Gaps = 60/301 (19%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGA 245
L + V+ V + Y E D LV M G L+ H++ + A
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
GL LH+E ++YRD K NILLD + ++
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLD-------------------------DHGHIRI 143
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365
SD GLA PEG + RV GT GY APE V T D ++ G +L EM+ G+
Sbjct: 144 SDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
Query: 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425
+ + + VE RL+ ++ +S K + A L L +DPK
Sbjct: 201 FQQRKKKIKREEVE-------------RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKE 246
Query: 426 R 426
R
Sbjct: 247 R 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 48/238 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVH 194
LGEG FG V +G + ++ + L VAVKT+ +++L+E + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 195 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 243
N+++LIG C++ + +++ FM G L + L L LP + +K
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
A G+ +L + + I+RD A R N ML ++ N
Sbjct: 120 DIASGMEYL---SSKSFIHRDL--------AAR-----------------NCMLNENMNV 151
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
++DFGL+K GD + A E + T++SDV+SFGV + E+ T
Sbjct: 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 71/235 (30%), Positives = 103/235 (43%), Gaps = 51/235 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVK----PGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFL 189
+LG+G FG VF V+ P G A+K L L+ E + L
Sbjct: 3 VLGQGSFGKVFL----------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL 52
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
++ H +VKL Y + + +L L+ +F+ G L L + + ++ +A A
Sbjct: 53 AEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALA 110
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
L LH +IYRD K NILLD + + KL+DF
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDE-------------------------EGHIKLTDF 142
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTG 362
GL+K+ + +K S GT Y APE V GH S +D +SFGV++ EMLTG
Sbjct: 143 GLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 44/228 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K +E TG+ A K ++ + ++++ E++ L H N
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+VKL+ ++ ++ EF G+++ + PL + + L +LHE
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316
+I+RD K NIL D + KL+DFG++
Sbjct: 124 ---IIHRDLKAGNILFTL-------------------------DGDIKLADFGVSAKNTR 155
Query: 317 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEM 359
+ S +GT + APE VM R +DV+S G+ L+EM
Sbjct: 156 TIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 48/230 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K +E TG A K + + ++++ E+ L H
Sbjct: 20 LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHE 254
+VKL+G D + ++ EF P G+++ + R L P I++ I + L +LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLH- 127
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+I+RD K N+LL D + KL+DFG++
Sbjct: 128 --SMKIIHRDLKAGNVLLT-------------------------LDGDIKLADFGVSAKN 160
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEM 359
+ + S +GT + APE VM + ++D++S G+ L+EM
Sbjct: 161 VKTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 61/245 (24%), Positives = 110/245 (44%), Gaps = 51/245 (20%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI P + VA+K L + +KE L
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEIL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWS 236
E + + + ++ +L+G C+ +L + + MP G L ++++ + L L W
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWC 115
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM 296
+++ AKG+ +L E R +++RD N+L+ +
Sbjct: 116 VQI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQ-------------------- 146
Query: 297 LFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
+ K++DFGLAK +K + + + A E ++ T +SDV+S+GV +
Sbjct: 147 -----HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201
Query: 357 LEMLT 361
E++T
Sbjct: 202 WELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 9e-11
Identities = 75/308 (24%), Positives = 127/308 (41%), Gaps = 59/308 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
+G+G FG VFKG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ K G ++D + ++ E++ GS + L PL + I KGL +LH E
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 120
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+ I+RD K +N+LL +G+ KL+DFG+A G
Sbjct: 121 KK---IHRDIKAANVLL-----SEHGE--------------------VKLADFGVA--GQ 150
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 375
D +GT + APE + S++D++S G+ +E+ G + P
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL 210
Query: 376 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435
L+ P P LEG++S + + CL+++P RP E+++
Sbjct: 211 FLIPKNNP-------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 253
Query: 436 LKPLPNLK 443
+ K
Sbjct: 254 KFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 44/229 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
+G G FG VF G + + T VAVK+ K ++L E L H
Sbjct: 3 IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+LIG C + +V E + G L L +++ AA G+ +L +
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK 113
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA-KLSDFGLAKDG 314
CI+ L N L + N K+SDFG++++
Sbjct: 114 H-----------------------------CIHRDLAARNCLVTEKNVLKISDFGMSRE- 143
Query: 315 PEGDKTHVSTRVMGT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
E D + ST M + APE + G +S SDV+SFG++L E +
Sbjct: 144 -EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 60/229 (26%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
+G G FG V+ VA+K +++ G Q +++W + EV FL L
Sbjct: 23 IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N ++ G + + LV E+ GS + L PL I GA +GLA+LH
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
I+RD K NILL + KL+DFG A
Sbjct: 133 SHER---IHRDIKAGNILLT-------------------------EPGTVKLADFGSAS- 163
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 359
+ +GT + APE ++ G + DV+S G+ +E+
Sbjct: 164 -----LVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 67/234 (28%), Positives = 91/234 (38%), Gaps = 50/234 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLV 193
LG+GGFG E VK TG A K L+ L+ G K L E L +
Sbjct: 1 LGKGGFG--------EVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGL 249
+V L Y E L LV M G L+ H++ R L + I + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGI 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
LH ++YRD K N+LLD N +LSD G
Sbjct: 109 LHLHSMD---IVYRDMKPENVLLD-------------------------DQGNCRLSDLG 140
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
LA + +G T+ GT GY APE + + D ++ G + EM+ GR
Sbjct: 141 LAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/239 (23%), Positives = 96/239 (40%), Gaps = 47/239 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+LG+G FG V + ++ G+ VAVK L D +E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 194 HLNLVKLIGYCIED--DQRL----LVYEFMPRGSLENHLFRRSL-----PLPWSIRMKIA 242
H N++KLIG + RL ++ FM G L L + LP ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+ A G+ +L + + I+RD N +L+ ++
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLN-------------------------ENMT 151
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
++DFGL+K GD + A E + T+ SDV++FGV + E++T
Sbjct: 152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 40/178 (22%)
Query: 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267
D LV E++ G + L + LP + G+ LH+ R +I+RD K
Sbjct: 70 DYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKP 125
Query: 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM 327
N+L+D Q + KL+DFGL+++G + + +
Sbjct: 126 ENLLID-------------------------QTGHLKLTDFGLSRNG------LENKKFV 154
Query: 328 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 380
GT Y APE ++ SD +S G V+ E L G P N + W
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 61/248 (24%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 192
E ++GEG FG V + I+ K G + A+K L + H+++ E+ L L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 193 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR---------- 238
H N++ L+G C + E+ P G+L + L R+S L P +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
++ A A G+ +L +E+ I+RD N+L+
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVG---------------------- 153
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG--YAAPEYVMTGHLTSRSDVYSFG 353
++ +K++DFGL++ G++ +V + MG + A E + T++SDV+SFG
Sbjct: 154 ---ENLASKIADFGLSR----GEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205
Query: 354 VVLLEMLT 361
V+L E+++
Sbjct: 206 VLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 85/332 (25%), Positives = 120/332 (36%), Gaps = 90/332 (27%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLV 193
L+GEG +G V K +E TG VA+K + D K + E+ L L
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H NLV LI + LV+EF+ L + L + L S K +G+ F H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK- 312
+I+RD K NIL+ Q KL DFG A+
Sbjct: 118 SHN---IIHRDIKPENILVS-------------------------QSGVVKLCDFGFART 149
Query: 313 -DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG------- 362
P T +V+TR Y APE ++ R+ D+++ G ++ EMLTG
Sbjct: 150 LAAPGEVYTDYVATR-----WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
Query: 363 --------------------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH 402
+ KN L E + +RF P+L G
Sbjct: 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE-VKEIEPLEKRF-----PKLSG- 257
Query: 403 FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
LA CL DP RP S+++
Sbjct: 258 -------LVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 64/301 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + L H
Sbjct: 12 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEK 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + +V E+M G L N+L S +++ +G+A+L
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-- 118
Query: 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316
+ I+RD N L+D K+SDFGL++
Sbjct: 119 -KQFIHRDLAARNCLVD-------------------------DQGCVKVSDFGLSR--YV 150
Query: 317 GDKTHVSTRVMGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 372
D + S+ +G+ ++ PE ++ +S+SDV++FGV++ E+ + G+ ++ N
Sbjct: 151 LDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-N 207
Query: 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432
E VE + + R YR P L ++K + C + RP ++
Sbjct: 208 SE--TVE----KVSQGLRLYR---PHL-------ASEKVYAIMYSCWHEKAEERPTFQQL 251
Query: 433 V 433
+
Sbjct: 252 L 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 63/251 (25%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 183
L + +LG G FG V+KG WI P + VA+K L + + +KE L
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWS 236
E + + + +L+G C+ +L V + MP G L ++ + + L L W
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWC 115
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM 296
+++ AKG+++L E +++RD N+L V++ N+
Sbjct: 116 VQI------AKGMSYLEEVR---LVHRDLAARNVL---VKSPNH---------------- 147
Query: 297 LFQDYNAKLSDFGLAK----DGPE--GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350
K++DFGLA+ D E D V + M A E ++ T +SDV+
Sbjct: 148 ------VKITDFGLARLLDIDETEYHADGGKVPIKWM------ALESILHRRFTHQSDVW 195
Query: 351 SFGVVLLEMLT 361
S+GV + E++T
Sbjct: 196 SYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 72/245 (29%), Positives = 97/245 (39%), Gaps = 61/245 (24%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---------DGLQGHKE 181
FR ++LG G FG V A K TG A+K L + L K
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
N H LV L C + + + V E+ G L H+ P R
Sbjct: 52 IFETAN---SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAV 104
Query: 241 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
A GL +LHE ++YRD K N+LLD E +
Sbjct: 105 FYAACVVLGLQYLHE---NKIVYRDLKLDNLLLD---TEGF------------------- 139
Query: 300 DYNAKLSDFGLAKDGP-EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLL 357
K++DFGL K+G GD+T ST GT + APE V+T +R+ D + GV++
Sbjct: 140 ---VKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAPE-VLTETSYTRAVDWWGLGVLIY 192
Query: 358 EMLTG 362
EML G
Sbjct: 193 EMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 60/249 (24%)
Query: 131 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNF 188
LL EG FG +F G I+E KPG V VKT+ +H L E
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61
Query: 189 LGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK-- 240
L L H N++ ++ CIED + ++Y +M G+L+ LF + L P ++ +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQL 119
Query: 241 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+A+ A G+++LH+ R VI++D N ++D
Sbjct: 120 VHMAIQIACGMSYLHK---RGVIHKDIAARNCVID------------------------- 151
Query: 299 QDYNAKLSDFGLAKD-GPE-----GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352
++ K++D L++D P GD + + M A E ++ +S SDV+SF
Sbjct: 152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM------ALESLVNKEYSSASDVWSF 205
Query: 353 GVVLLEMLT 361
GV+L E++T
Sbjct: 206 GVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 60/238 (25%), Positives = 90/238 (37%), Gaps = 49/238 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
+G G FG V G G + + V VK L +L EV +L H
Sbjct: 3 IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 250
N+++ +G CIE LLV EF P G L+N+L + + ++A A GL
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLL 114
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+LH+ I+ D N L A D + K+ D+GL
Sbjct: 115 WLHQAD---FIHSDLALRNCQLTA-------------------------DLSVKIGDYGL 146
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYV-------MTGHLTSRSDVYSFGVVLLEMLT 361
A + D + APE V + T +S+++S GV + E+ T
Sbjct: 147 ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 64/270 (23%), Positives = 106/270 (39%), Gaps = 69/270 (25%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGD 191
L+G+GG G V+ + P VA+K + D L K +L E D
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSIR------ 238
L+H +V + Y I D VY MP G L + SL + +
Sbjct: 59 LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ I + ++H + V++RD K NILL G FG ++
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILL--------GLFG----------EVVI 154
Query: 299 QDYNAKLS-----DFGLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMTGHLTSRSDV 349
D+ A + + L D E + + + +++GT Y APE ++ + +D+
Sbjct: 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214
Query: 350 YSFGVVLLEMLT---------GRRSMDKNR 370
Y+ GV+L +MLT GR+ ++
Sbjct: 215 YALGVILYQMLTLSFPYRRKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 68/237 (28%), Positives = 91/237 (38%), Gaps = 53/237 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 193
LG+GGFG V A TG A K LN L +G++ + E L V
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAK-V 50
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GL 249
H + + Y + L LV M G L H++ P + A+ GL
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
LH+ R +IYRD K N+LLD D N ++SD G
Sbjct: 111 EHLHQ---RRIIYRDLKPENVLLD-------------------------NDGNVRISDLG 142
Query: 310 LA---KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
LA KDG K + GT G+ APE + D ++ GV L EM+ R
Sbjct: 143 LAVELKDGQSKTKGYA-----GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 41/123 (33%), Positives = 56/123 (45%), Gaps = 32/123 (26%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
A GL FLH + +IYRD K N++LDA + + K+
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDA-------------------------EGHIKI 142
Query: 306 SDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
+DFG+ K+ G KT TR GT Y APE + D ++FGV+L EML G+
Sbjct: 143 ADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 365 SMD 367
D
Sbjct: 200 PFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 70/241 (29%), Positives = 105/241 (43%), Gaps = 60/241 (24%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 193
E LG G FG V+ ++ VAVKT+ G + +LAE N + L
Sbjct: 11 EKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQ 59
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLA 250
H LVKL + + ++ EFM +GSL + L PLP I + A+G+A
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
F+ + R I+RD + +NIL+ A K++DFGL
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLV-------------------------CKIADFGL 148
Query: 311 AK-------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
A+ EG K + + APE + G T +SDV+SFG++L+E++T
Sbjct: 149 ARVIEDNEYTAREGAKFPIK--------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200
Query: 364 R 364
R
Sbjct: 201 R 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 62/300 (20%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 192
LG+G F ++KG ++ V PG ++V +K L H++ LA + + L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H +LVKL G C+ D + ++V E++ G L+ L R + ++ +A A L +L
Sbjct: 59 SHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
++ +++ + NIL+ YGL + F KLSD G+
Sbjct: 118 EDKK---LVHGNVCGKNILV--------------ARYGLNEGYVPF----IKLSDPGIPI 156
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNR 370
+ R+ + APE + G LT +D +SFG LLE+ +
Sbjct: 157 --TVLSREERVERI----PWIAPECIRNGQASLTIAADKWSFGTTLLEICS--------- 201
Query: 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA---HCLSRDPKARP 427
NGE L + E+ RFY+ + H A+LA C + DP RP
Sbjct: 202 -NGEEPLSTLSS---SEKERFYQ------DQH--RLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 81/306 (26%), Positives = 121/306 (39%), Gaps = 70/306 (22%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAA 109
Query: 247 K---GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+ GL L E ++YRD K NILLD + G +
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLD-----DRG--------------------HI 141
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
++SD GLA PEG+ V RV GT GY APE + T D + G ++ EM+ G+
Sbjct: 142 RISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLS 420
K + V+ +D R+ + +S K ++ A + L+
Sbjct: 199 SPFRKRKER-----VKREE------------VDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 421 RDPKAR 426
++PK R
Sbjct: 242 KNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 58/234 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K G VA+K + + + E++ L + H N
Sbjct: 11 IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIAL---GAAKGLAF 251
+V G + D+ +V E+ GSL++ + R L +IA KGLA+
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIAYVCRETLKGLAY 116
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
LHE I+RD K +NILL +D + KL+DFG++
Sbjct: 117 LHE---TGKIHRDIKGANILLT-------------------------EDGDVKLADFGVS 148
Query: 312 KDGPEGDKTHVSTR---VMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEM 359
T + +GT + APE G + D+++ G+ +E+
Sbjct: 149 -----AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 63/258 (24%), Positives = 100/258 (38%), Gaps = 80/258 (31%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 188
+ +G G +G V V TG VA+K +++ D L K L E+
Sbjct: 2 YELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL------LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N++ L+ + +V E M E L + I+
Sbjct: 53 LRHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHK-------VIKSPQP 99
Query: 243 LGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292
L +GL +LH VI+RD K SNIL+++
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNS------------------ 138
Query: 293 FNNMLFQDYNAKLSDFGLAK-DGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSR 346
N L K+ DFGLA+ P+ D+ +V TR Y APE +++ ++
Sbjct: 139 -NCDL------KICDFGLARGVDPDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTK 186
Query: 347 S-DVYSFGVVLLEMLTGR 363
+ D++S G + E+LT +
Sbjct: 187 AIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 72/233 (30%), Positives = 95/233 (40%), Gaps = 50/233 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGDL 192
+G+G FG V + G AVK L + KE +AE N L ++
Sbjct: 3 IGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGL 249
H LV L Y + +L V +++ G L HL R RS P P R + A A L
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LH +IYRD K NILLD+ + L+DFG
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDS-------------------------QGHVVLTDFG 141
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
L K+G E KT ++ GT Y APE + D + G VL EML G
Sbjct: 142 LCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 42/240 (17%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 183
+L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L + +V G D + + E M GSL+ + +++ +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
KGL +L E+ + +++RD K SNIL+++ R E
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNS-RGE------------------------I 143
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
KL DFG++ G D ++ +GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 144 KLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 37/116 (31%), Positives = 54/116 (46%), Gaps = 30/116 (25%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
GL FLH+ + +IYRD K N+LLD +D + K++D
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLD-------------------------KDGHIKIAD 139
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
FG+ K+ G+ ++ GT Y APE + D +SFGV+L EML G+
Sbjct: 140 FGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 42/226 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G FG V KG + + TVAVK L +D E L E N + L +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+V++IG C E + +LV E G L L + +I ++ + G+ +L E
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEE 113
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
++RD N+LL + Q Y AK+SDFGL+K
Sbjct: 114 TN---FVHRDLAARNVLL------------------------VTQHY-AKISDFGLSK-A 144
Query: 315 PEGDKTHVSTRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
D+ + + G + + APE + +S+SDV+SFGV++ E
Sbjct: 145 LGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 69/303 (22%), Positives = 123/303 (40%), Gaps = 64/303 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G G V+K + T +AVK + D ++ K+ ++E+ L
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++ G +++ + EFM GSL+ ++R+ +P + +IA+ KGL +L
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS- 113
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+++RD K SN+L++ R + KL DFG++
Sbjct: 114 --LKILHRDVKPSNMLVNT-RGQ------------------------VKLCDFGVSTQLV 146
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 375
++ +GT Y APE + SDV+S G+ +E+ GR + + N
Sbjct: 147 NS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN--- 199
Query: 376 NLVEWARPHLGERRRFYRLID---PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431
+ L + ++D P L G FS +K C+ + PK RP
Sbjct: 200 ------QGSLMPLQLLQCIVDEDPPVLPVGQFS----EKFVHFITQCMRKQPKERPAPEN 249
Query: 432 VVE 434
+++
Sbjct: 250 LMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 57/232 (24%)
Query: 204 CIEDDQRLL-VYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 257
C + + RL V E++ G L H+ R R LP +S + +AL +LHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE--- 114
Query: 258 RPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE- 316
R +IYRD K N+LLD+ + + KL+D+G+ K+G
Sbjct: 115 RGIIYRDLKLDNVLLDS-------------------------EGHIKLTDYGMCKEGLRP 149
Query: 317 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGE 374
GD T + GT Y APE + D ++ GV++ EM+ GR D + N +
Sbjct: 150 GDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206
Query: 375 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426
N ++ + E++ R+ S+ KAA + L++DPK R
Sbjct: 207 QNTEDYLFQVILEKQ-------IRIPRSLSV----KAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 66/249 (26%), Positives = 107/249 (42%), Gaps = 62/249 (24%)
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAF 251
H ++V L G C+ D + ++V EF+ G L+ + R+S L PW + K+A A L++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 252 LHEEAERPVIYRDFKTSNILL--DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
L ++ +++ + T NILL + + E G F KLSD G
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGE-CGPF-------------------IKLSDPG 157
Query: 310 LAKDGPEGDKTHVSTR--VMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSM 366
+ V +R + + APE V + +L+ +D +SFG L E+
Sbjct: 158 IP--------ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----- 204
Query: 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPK 424
NGE L + L E+ RFY EG + ++ A L HC++ DP
Sbjct: 205 -----NGEIPLKD---KTLAEKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPN 249
Query: 425 ARPLMSEVV 433
RP ++
Sbjct: 250 QRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 61/246 (24%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVH 194
++GEG FG V K I+ K G + A+K + + H+++ E+ L L H
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 195 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 238
N++ L+G C L E+ P G+L + L R+S L P
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ A A+G+ +L +++ I+RD NIL+ ENY
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILV----GENYV---------------- 150
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVV 355
AK++DFGL++ G + +V + MG + A E + T+ SDV+S+GV+
Sbjct: 151 -----AKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 200
Query: 356 LLEMLT 361
L E+++
Sbjct: 201 LWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 58/257 (22%)
Query: 117 RKFTFNDLKLATRNFR--PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
R + D ++A F+ PE L +G G FG V+ + + T V VA+
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEV-------VAI 55
Query: 169 KTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
K +++ G Q +++W + EV FL + H N ++ G + + LV E+ GS +
Sbjct: 56 KKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDL 114
Query: 226 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285
L PL I GA +GLA+LH +I+RD K NILL
Sbjct: 115 LEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLT------------ 159
Query: 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GH 342
+ KL+DFG A + +GT + APE ++ G
Sbjct: 160 -------------EPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEGQ 200
Query: 343 LTSRSDVYSFGVVLLEM 359
+ DV+S G+ +E+
Sbjct: 201 YDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 54/223 (24%), Positives = 84/223 (37%), Gaps = 67/223 (30%)
Query: 225 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284
++ + L +P I KIA+ K L +LH + VI+RD K SN+L++ G+
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINR-----NGQV- 143
Query: 285 FCIYYGLFFNNMLFQDYNAKLSDFG--------LAKDGPEGDKTHVSTRVMGTYGYAAPE 336
KL DFG +AK G K Y APE
Sbjct: 144 -------------------KLCDFGISGYLVDSVAKTIDAGCKP-----------YMAPE 173
Query: 337 YV----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 392
+ +SDV+S G+ ++E+ TGR D W P + ++
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTP-FQQLKQVV 221
Query: 393 RLIDPRL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
P+L FS + CL ++ K RP E+++
Sbjct: 222 EEPSPQLPAEKFSP----EFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 55/245 (22%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 192
+ ++GEG FG V K I+ K G + A+K + + H+++ E+ L L
Sbjct: 12 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 193 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA------LGA 245
H N++ L+G C L E+ P G+L + L R+S L IA L +
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123
Query: 246 AKGLAFLHEEA-------ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ L F + A ++ I+RD NIL+
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG------------------------- 158
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVL 356
++Y AK++DFGL++ G + +V + MG + A E + T+ SDV+S+GV+L
Sbjct: 159 ENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213
Query: 357 LEMLT 361
E+++
Sbjct: 214 WEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 44/241 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
N+R LLG+G FG V+ + V G L + + + KE A E+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEI 55
Query: 187 NFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L +L H +V+ G C+ D ++ L ++ E+MP GS+++ L + L S+ K
Sbjct: 56 QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTR 113
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+G+++LH +++RD K +NIL D+ N
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAG-------------------------NV 145
Query: 304 KLSDFGLAKDGPEGDKTHVSTR-VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
KL DFG +K + R V GT + +PE + ++DV+S G ++EMLT
Sbjct: 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTE 205
Query: 363 R 363
+
Sbjct: 206 K 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 56/247 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 184
N+R LLG+G FG V+ + + TG +AVK + + + + KE A
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L +L+H +V+ G + +R L E MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+G+++LH +++RD K +NIL D+V N
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVG-------------------------N 144
Query: 303 AKLSDFGLAKD------GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
KL DFG +K G K+ V GT + +PE + ++D++S G +
Sbjct: 145 VKLGDFGASKRLQTICLSGTGMKS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199
Query: 357 LEMLTGR 363
+EMLT +
Sbjct: 200 VEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 57/242 (23%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVN 187
+ + +G+G G V+ TA + TG VA+K +N Q KE + E+
Sbjct: 19 KKYTRFEKIGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA- 246
+ + H N+V + + D+ +V E++ GSL + + M AA
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--------MDEGQIAAV 120
Query: 247 -----KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
+ L FLH VI+RD K+ NILL G+ D
Sbjct: 121 CRECLQALEFLHS---NQVIHRDIKSDNILL-----------------GM--------DG 152
Query: 302 NAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
+ KL+DFG A+ PE K + ++GT + APE V + D++S G++ +EM+
Sbjct: 153 SVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
Query: 361 TG 362
G
Sbjct: 210 EG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 53/245 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K + TG VA+K + D G+ + E
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 242
++ L +L H N+VKL+ +++ LV+EF+ + F + P +P +
Sbjct: 50 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYL 106
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+GLAF H + R V++RD K N+L++ +
Sbjct: 107 FQLLQGLAFCH--SHR-VLHRDLKPQNLLINT-------------------------EGA 138
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLT 361
KL+DFGLA+ G T + T Y APE ++ + ++ D++S G + EM+T
Sbjct: 139 IKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
Query: 362 GRRSM 366
RR++
Sbjct: 197 -RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 50/236 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG+G +G V+ A T + +A+K + + + E+ L H
Sbjct: 15 VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--KGLAFLH 253
N+V+ +G E+ + E +P GSL L + PL + + I +GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG---- 309
+ +++RD K N+L++ Y G+ K+SDFG
Sbjct: 126 DNQ---IVHRDIKGDNVLVNT-------------YSGV-----------VKISDFGTSKR 158
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 363
LA P + GT Y APE + G + +D++S G ++EM TG+
Sbjct: 159 LAGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 67/246 (27%), Positives = 97/246 (39%), Gaps = 72/246 (29%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG+G FG VF A +K GT A+K L D V + D V
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKD-----------VVLMDDDVEC 41
Query: 196 NLV--KLIG-----------YCI--EDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSI 237
+V +++ YC + V E++ G L H+ + LP
Sbjct: 42 TMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY 101
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+I G L FLH + ++YRD K NILLD
Sbjct: 102 AAEIICG----LQFLHSKG---IVYRDLKLDNILLD------------------------ 130
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357
D + K++DFG+ K+ GD + GT Y APE ++ + D +SFGV+L
Sbjct: 131 -TDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLY 187
Query: 358 EMLTGR 363
EML G+
Sbjct: 188 EMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 73/263 (27%), Positives = 114/263 (43%), Gaps = 45/263 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V I+ + K + TVAVK L +K + E+ L + H
Sbjct: 15 LGRGAFGKV----IQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 195 LNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL-FRRSLPLPWSIR------MKIALGAA 246
LN+V L+G C + L+V E+ G+L N+L +R P+ + MK G
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 247 --------------------KGLAFLHEEAERPVIYRDFKTSNILL----DAVRAENYGK 282
K L+ + E+ E +Y++ T L+ R +
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190
Query: 283 FGFCIYYGLFFNNMLFQDYNA-KLSDFGLAKDGPEGDKTHV---STRVMGTYGYAAPEYV 338
CI+ L N+L + N K+ DFGLA+D + D +V R+ + APE +
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL--PLKWMAPESI 247
Query: 339 MTGHLTSRSDVYSFGVVLLEMLT 361
T++SDV+SFGV+L E+ +
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 42/240 (17%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 183
+L +F S LG G G V K KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L + +V G D + + E M GSL+ + + + +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+GLA+L E+ + +++RD K SNIL+++ R E
Sbjct: 111 AVLRGLAYLREKHQ--IMHRDVKPSNILVNS-RGE------------------------I 143
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
KL DFG++ G D ++ +GT Y +PE + H + +SD++S G+ L+E+ GR
Sbjct: 144 KLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 39/166 (23%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y + D +L L+ +++ G L HL++R +R+ IA L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ---LGII 127
Query: 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD--GPEGDK 319
YRD K NILLD + + L+DFGL+K+ E ++
Sbjct: 128 YRDIKLENILLD-------------------------SEGHVVLTDFGLSKEFLAEEEER 162
Query: 320 THVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTG 362
+ GT Y APE + GH D +S GV+ E+LTG
Sbjct: 163 AY---SFCGTIEYMAPEVIRGGSGGH-DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 59/299 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
+G+G FG V+KG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ + G ++ + ++ E++ GS + L + PL + I KGL +LH E
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 120
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+ I+RD K +N+LL + + KL+DFG+A G
Sbjct: 121 RK---IHRDIKAANVLLS-------------------------EQGDVKLADFGVA--GQ 150
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 375
D +GT + APE + ++D++S G+ +E+ G P
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL 210
Query: 376 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
L+ P P LEG +S + + CL++DP+ RP E+++
Sbjct: 211 FLIPKNSP-------------PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 72/239 (30%), Positives = 100/239 (41%), Gaps = 48/239 (20%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
FR +LG+GGFG V A TG A K L ++ K +N
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 191 DLVHLN--LVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +N V + Y E D LV M G L+ H++ ++ P + AA+
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAE 110
Query: 248 ---GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
GL LH E ++YRD K NILLD +YG + +
Sbjct: 111 ITCGLEDLHRER---IVYRDLKPENILLD-----DYG--------------------HIR 142
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
+SD GLA + PEG+ + RV GT GY APE V T D + G ++ EM+ G+
Sbjct: 143 ISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 75/309 (24%), Positives = 123/309 (39%), Gaps = 65/309 (21%)
Query: 133 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 185
PE L +G+G FG VFKG +N T V VA+K ++ + + E + E
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L + K G ++ + ++ E++ GS + L R+ P +
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEI 110
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
KGL +LH E + I+RD K +N+LL + + KL
Sbjct: 111 LKGLDYLHSEKK---IHRDIKAANVLLS-------------------------EQGDVKL 142
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365
+DFG+A G D +GT + APE + S++D++S G+ +E+ G
Sbjct: 143 ADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
Query: 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425
P L+ P P L G FS + + CL++DP
Sbjct: 201 NSDMHPMRVLFLIPKNNP-------------PTLTGEFS----KPFKEFIDACLNKDPSF 243
Query: 426 RPLMSEVVE 434
RP E+++
Sbjct: 244 RPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 55/237 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
+GEG +G V+KG TG VA+K + L+ +E + E++ L +
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKIAL-GAAK 247
L H N+V L +++ + L++EF+ L+ +L SLP + +K L +
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQ 112
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
G+ F H R V++RD K N+L+D N G I KL+D
Sbjct: 113 GILFCH---SRRVLHRDLKPQNLLID-----NKG----VI----------------KLAD 144
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
FGLA+ G V T + T Y APE ++ S D++S G + EM T +
Sbjct: 145 FGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 63/239 (26%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 133 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 183
PE L +G G FG V+ N VA+K +++ G Q +++W +
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDII 63
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
EV FL L H N ++ G + + LV E+ GS + L PL +
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
GA +GLA+LH +I+RD K NILL +
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLS-------------------------EPGLV 154
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 359
KL DFG A + +GT + APE ++ G + DV+S G+ +E+
Sbjct: 155 KLGDFGSAS------IMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 74/260 (28%), Positives = 104/260 (40%), Gaps = 68/260 (26%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGL 176
FT DLK +G G FG V K + +GT +AVK D
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEK 44
Query: 177 QGHKEWLAEVNFLGDLVH-----LNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-----HL 226
+ K L ++ D+V +VK G + + E M SL+ +
Sbjct: 45 E-QKRLLMDL----DVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYE 98
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286
+S+ +P I KIA+ K L +L EE + +I+RD K SNILLD
Sbjct: 99 VLKSV-IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD------------- 142
Query: 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS- 345
++ N KL DFG++ G D TR G Y APE +
Sbjct: 143 ------------RNGNIKLCDFGIS--GQLVDSI-AKTRDAGCRPYMAPERIDPSARDGY 187
Query: 346 --RSDVYSFGVVLLEMLTGR 363
RSDV+S G+ L E+ TG+
Sbjct: 188 DVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 67/322 (20%), Positives = 121/322 (37%), Gaps = 71/322 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
NF+ E +G G F V++ + + +K V+ + ++ + E++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALK-------KVQIFEMMDAKARQDCVKEIDL 55
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGA 245
L L H N++K + IED++ +V E G L + ++ +P K +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
+ +H R V++RD K +N+ + A G G G FF++
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGL----GRFFSS---------- 158
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365
KT + ++GT Y +PE + +SD++S G +L EM
Sbjct: 159 -------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------ 199
Query: 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLID-------PRLEG-HFSIKGAQKAAQLAAH 417
P G++ + L P L H+S +K +L +
Sbjct: 200 ------------AALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS----EKLRELVSM 243
Query: 418 CLSRDPKARPLMSEVVEALKPL 439
C+ DP RP + V + K +
Sbjct: 244 CIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 39/115 (33%), Positives = 50/115 (43%), Gaps = 30/115 (26%)
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
L FLH VIYRD K NILLDA G C KL+DF
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAE--------GHC-----------------KLADF 140
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
G+ K+G T +T GT Y APE + D ++ GV++ EM+ G+
Sbjct: 141 GMCKEGILNGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 69/288 (23%), Positives = 119/288 (41%), Gaps = 75/288 (26%)
Query: 84 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 143
P+++ SS+++S + S S +K EL+ R+ + +G G G
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELE---RVNR------------------IGSGAGG 88
Query: 144 CVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVHLNLVKLI 201
V+K + TG A+K + NH+ ++ E+ L D+ H N+VK
Sbjct: 89 TVYK---------VIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCH 138
Query: 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
+ + ++ EFM GSLE L +A G+A+LH R ++
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR---RHIV 190
Query: 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEG-DKT 320
+RD K SN+L+++ + N K++DFG+++ + D
Sbjct: 191 HRDIKPSNLLINSAK-------------------------NVKIADFGVSRILAQTMDPC 225
Query: 321 HVSTRVMGTYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEMLTGR 363
+ S +GT Y +PE + T D++S GV +LE GR
Sbjct: 226 NSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 96/388 (24%), Positives = 144/388 (37%), Gaps = 93/388 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V ++E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + +S GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LH +E+ V+YRD K N++LD +D + K++DFG
Sbjct: 109 DYLH--SEKNVVYRDLKLENLMLD-------------------------KDGHIKITDFG 141
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
L K+G + T + GT Y APE + D + GVV+ EM+ GR
Sbjct: 142 LCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK----- 424
L+ L E RF R + P +A L + L +DPK
Sbjct: 200 DHEKLFELI------LMEEIRFPRTLSP------------EAKSLLSGLLKKDPKQRLGG 241
Query: 425 ----ARPLMS---------EVVEALKPLPNLKDMASSS----YYFQTMQAERIGSSPNTR 467
A+ +M + V K +P K +S Y+ + A+ I +P +
Sbjct: 242 GPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQ 301
Query: 468 NGIRAQGGSLSRNGQRSLSIPNGSYASP 495
+ + +R P SY++
Sbjct: 302 DDSMETVDN-----ERRPHFPQFSYSAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 65/252 (25%), Positives = 104/252 (41%), Gaps = 55/252 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G GGFG V+ K TG A+K L+ ++ + E L + + L
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIML 48
Query: 196 NLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+LV + Y +L + + M G L HL + + +R A
Sbjct: 49 SLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEII 107
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
GL +H R V+YRD K +NILLD + + ++S
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLD-------------------------EHGHVRIS 139
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 365
D GLA D + K H S +GT+GY APE + G S +D +S G +L ++L G
Sbjct: 140 DLGLACDFSK-KKPHAS---VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
Query: 366 MDKNRPNGEHNL 377
+++ +H +
Sbjct: 196 FRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 72/281 (25%), Positives = 99/281 (35%), Gaps = 83/281 (29%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN-------FL 189
+G+GG+G VF K TG VA+K + L L EV L
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIR 238
LVKL+ Y +DD+ L L E++P G L R +
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AE 109
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
M A+ A L ++H RD K N L+D
Sbjct: 110 MFEAVDALHELGYIH---------RDLKPENFLID------------------------- 135
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLL 357
+ KL+DFGL+K + V+G+ Y APE V+ G + D +S G +L
Sbjct: 136 ASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLY 189
Query: 358 EMLTGRRSMDKNRPNGEH-NLVEWA----RPHLGERRRFYR 393
E L G + PN NL W RP + R
Sbjct: 190 EFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 42/229 (18%)
Query: 159 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 218
KPG V +K G +G L E L ++ H +++++ + +V +P
Sbjct: 87 KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137
Query: 219 --RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276
L +L +RS PLP + I +GL +LH A+R +I+RD KT NI ++ V
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQR-IIHRDVKTENIFINDVD 194
Query: 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336
G G Q + GLA GT APE
Sbjct: 195 QVCIGDLGAA------------QFPVVAPAFLGLA----------------GTVETNAPE 226
Query: 337 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 385
+ S++D++S G+VL EML ++ ++ P+ V+ HL
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 38/116 (32%), Positives = 54/116 (46%), Gaps = 30/116 (25%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
GL FLH + +IYRD K N++LD +D + K++D
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLD-------------------------RDGHIKIAD 139
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
FG+ K+ GD ++ GT Y APE + T D +SFGV+L EML G+
Sbjct: 140 FGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 69/242 (28%), Positives = 106/242 (43%), Gaps = 61/242 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
LG+G +G V+K + T VA+K + D + + A E+ FL +
Sbjct: 15 LGKGAYGIVWKA---------IDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62
Query: 192 LV-HLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
L H N+VKL+ E+D+ + LV+E+M E L R ++ R I
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQL 116
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
K L ++H VI+RD K SNILL++ D KL
Sbjct: 117 LKALKYIHS---GNVIHRDLKPSNILLNS-------------------------DCRVKL 148
Query: 306 SDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLT 361
+DFGLA+ + E + V T + T Y APE ++ ++ D++S G +L EML
Sbjct: 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 362 GR 363
G+
Sbjct: 209 GK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 78/302 (25%), Positives = 118/302 (39%), Gaps = 72/302 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 194
++G GGFG V+ K TG A+K L+ ++ + E LA L + +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLA----LNERIM 47
Query: 195 LNLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L+LV + Y +L + + M G L HL + + +R A
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEI 106
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
GL +H R V+YRD K +NILLD + G + ++
Sbjct: 107 ILGLEHMHN---RFVVYRDLKPANILLD--------EHG-----------------HVRI 138
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 364
SD GLA D + K H S +GT+GY APE + G S +D +S G +L ++L G
Sbjct: 139 SDLGLACDFSK-KKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 194
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
+++ +H E R + L FS + L L RD
Sbjct: 195 PFRQHKTKDKH-----------EIDRMTLTMAVELPDSFS----PELRSLLEGLLQRDVN 239
Query: 425 AR 426
R
Sbjct: 240 RR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 50/170 (29%), Positives = 72/170 (42%), Gaps = 33/170 (19%)
Query: 194 HLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H L +L C + RL V EF+ G L H+ ++S + A L FL
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFL 112
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
H+ + +IYRD K N+LLD + + KL+DFG+ K
Sbjct: 113 HD---KGIIYRDLKLDNVLLD-------------------------HEGHCKLADFGMCK 144
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
+G KT ++ GT Y APE + D ++ GV+L EML G
Sbjct: 145 EGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 73/308 (23%), Positives = 120/308 (38%), Gaps = 76/308 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V A VK +G VAVK ++ Q + EV + D H N
Sbjct: 28 IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L K L+
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALS 130
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG- 309
LH + VI+RD K+ +ILL D KLSDFG
Sbjct: 131 VLHAQG---VIHRDIKSDSILLT-------------------------HDGRVKLSDFGF 162
Query: 310 ---LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
++K+ P ++GT + APE + D++S G++++EM+ G
Sbjct: 163 CAQVSKEVPR------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
Query: 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426
P ++ R +L + + + P L+G L RDP R
Sbjct: 217 FNEPPLKAMKMI---RDNLPPKLKNLHKVSPSLKGFLD------------RLLVRDPAQR 261
Query: 427 PLMSEVVE 434
+E+++
Sbjct: 262 ATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 85/300 (28%), Positives = 113/300 (37%), Gaps = 73/300 (24%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E T G A+K L + + E + E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LH R V+YRD K N++LD +D + K++DFG
Sbjct: 109 EYLHS---RDVVYRDIKLENLMLD-------------------------KDGHIKITDFG 140
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSM 366
L K+G T + GT Y APE + D + GVV+ EM+ GR +
Sbjct: 141 LCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
Query: 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426
D R L E L E RF R + P +A L A L +DPK R
Sbjct: 199 DHER------LFELI---LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 39/206 (18%)
Query: 161 GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFM 217
GTG A+K L + K+ E + L +L H +V ++ ++++ + EF+
Sbjct: 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277
G L HL R++ P + +LH + +IYRD K N+LLD
Sbjct: 101 VGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLD---- 152
Query: 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 337
+ K++DFG AK P+ T + GT Y APE
Sbjct: 153 ---------------------NKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEV 186
Query: 338 VMT-GHLTSRSDVYSFGVVLLEMLTG 362
+ + GH D ++ GV+L E + G
Sbjct: 187 IQSKGH-GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 65/255 (25%), Positives = 102/255 (40%), Gaps = 77/255 (30%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAE 185
F + +GEG +G V++ +G VA+K + DG+ L E
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISS--LRE 56
Query: 186 VNFLGDLVHLNLVKL---------------IGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
+ L +L H N+V+L + YC +D LL + MP
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT----------- 103
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290
P S + L +GL +LHE +I+RD K SN+LL + G C+
Sbjct: 104 -PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLT-----DKG----CL--- 147
Query: 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV--MTGHLTSRSD 348
K++DFGLA+ G T + T Y APE + T + T+ D
Sbjct: 148 -------------KIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAID 191
Query: 349 VYSFGVVLLEMLTGR 363
+++ G +L E+L +
Sbjct: 192 MWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 64/283 (22%), Positives = 112/283 (39%), Gaps = 67/283 (23%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TG VAVK ++ Q + EV + D H N+V + + D+ +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 222 LENHLFRRSLPLPWSIRMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275
L + + RM + L + L++LH + VI+RD K+ +ILL +
Sbjct: 106 LTD--------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTS- 153
Query: 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 331
D KLSDFG ++K+ P+ ++GT
Sbjct: 154 ------------------------DGRIKLSDFGFCAQVSKEVPK------RKSLVGTPY 183
Query: 332 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 391
+ APE + + D++S G++++EM+ G + P L RR
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAMRRI 230
Query: 392 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
+ PR++ + + L R+P R E+++
Sbjct: 231 RDNLPPRVKDSHKVSSVLRG--FLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 46/208 (22%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
+G VAVK ++ Q + EV + D H N+V++ + ++ ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 222 LENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278
L + + + L +IA + L +LH + VI+RD K+ +ILL
Sbjct: 105 LTDIVSQTRLN-----EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTL---- 152
Query: 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAA 334
D KLSDFG ++KD P+ ++GT + A
Sbjct: 153 ---------------------DGRVKLSDFGFCAQISKDVPK------RKSLVGTPYWMA 185
Query: 335 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
PE + + D++S G++++EM+ G
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 58/246 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 184
N+R LLG G FG V+ + + TG +AVK + + D + KE A
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKI 241
E+ L +L H +V+ G C+ D +++L ++ E+MP GS+++ L + L ++ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
+G+++LH +++RD K +NIL D+
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAG------------------------- 143
Query: 302 NAKLSDFGLAKD------GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
N KL DFG +K G K+ V GT + +PE + ++DV+S
Sbjct: 144 NVKLGDFGASKRIQTICMSGTGIKS-----VTGTPYWMSPEVISGEGYGRKADVWSVACT 198
Query: 356 LLEMLT 361
++EMLT
Sbjct: 199 VVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 42/192 (21%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWSI 237
EV L + H N+V E+ + +V E+ G L LF L W +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+I+LG L +H+ R +++RD K+ NI L N M+
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSK-------------------NGMV 140
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357
AKL DFG+A+ D ++ +GT Y +PE +++D++S G VL
Sbjct: 141 -----AKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLY 193
Query: 358 EMLTGRRSMDKN 369
E+ T + + N
Sbjct: 194 ELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 58/238 (24%), Positives = 103/238 (43%), Gaps = 57/238 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K T T+A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 246
+ H N+V+L + + LV+E++ L+ H+ F ++ L + +I
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI----L 112
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+G+A+ H V++RD K N+L+D N L KL+
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRT------------------NAL------KLA 145
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
DFGLA+ G T + T Y APE ++ + H ++ D++S G + EM+ +
Sbjct: 146 DFGLAR--AFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 30/119 (25%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+GL ++H V++RD K SN+LL+ C + K+
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTN----------C---------------DLKIC 148
Query: 307 DFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
DFGLA+ PE D T T + T Y APE ++ +++ D++S G +L EML+ R
Sbjct: 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 52/187 (27%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPWSI 237
E L ++ H +++L + E DQR L + E++P G L ++L F S L ++
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ AL +LH + ++YRD K NILLD
Sbjct: 109 EIVCAL------EYLHS---KEIVYRDLKPENILLD------------------------ 135
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVM-TGHLTSRSDVYSFGVV 355
++ + KL+DFG AK K T + GT Y APE + GH + D ++ G++
Sbjct: 136 -KEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGIL 187
Query: 356 LLEMLTG 362
+ EML G
Sbjct: 188 IYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 72/233 (30%), Positives = 98/233 (42%), Gaps = 48/233 (20%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 191
++G+G FG V + +G AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGL 249
+ H LV L Y + ++L V +F+ G L HL R RS P P + R A A L
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LH ++YRD K NILLD+ G + L+DFG
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQ--------GHVV-----------------LTDFG 141
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
L K+G T +T GT Y APE + + D + G VL EML G
Sbjct: 142 LCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 67/216 (31%), Positives = 83/216 (38%), Gaps = 51/216 (23%)
Query: 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
LV F+ G L +HL R R A + L L + VIYRD K NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENIL 125
Query: 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 330
LD Y G + L DFGL K + + DKT+ GT
Sbjct: 126 LD--------------YQG-----------HIALCDFGLCKLNMKDDDKTNT---FCGTP 157
Query: 331 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 390
Y APE ++ T D ++ GV+L EMLTG P + N+ E R L E R
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL------PPFYDENVNEMYRKILQEPLR 211
Query: 391 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426
F D + A L LSRDP R
Sbjct: 212 FPDGFD------------RDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 70/244 (28%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K + TG VA+K + L+ E + E++ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVALKKIR---LETEDEGVPSTAIREISLLKE 54
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA---- 246
L H N+V+L+ + + +L LV+EF+ L+ + S P L
Sbjct: 55 LNHPNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSP-------LTGLDPPLIKS 103
Query: 247 ------KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+G+A+ H V++RD K N+L+D ++
Sbjct: 104 YLYQLLQGIAYCHS---HRVLHRDLKPQNLLID-------------------------RE 135
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEM 359
KL+DFGLA+ G T + T Y APE ++ S D++S G + EM
Sbjct: 136 GALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEM 193
Query: 360 LTGR 363
+ R
Sbjct: 194 VNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 87/300 (29%), Positives = 116/300 (38%), Gaps = 73/300 (24%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LH V+YRD K N++LD +D + K++DFG
Sbjct: 109 GYLHS---CDVVYRDLKLENLMLD-------------------------KDGHIKITDFG 140
Query: 310 LAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMD 367
L K+G +G GT Y APE V+ + R+ D + GVV+ EM+ GR
Sbjct: 141 LCKEGISDGATM---KTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF- 195
Query: 368 KNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426
N +H L E L E RF R + P +A L A L +DPK R
Sbjct: 196 ---YNQDHEKLFELI---LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 67/248 (27%), Positives = 100/248 (40%), Gaps = 64/248 (25%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFL 189
+GEG +G V+K TG VA+K + L KE + E+ L
Sbjct: 13 GQIGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKIL 60
Query: 190 GDLVHLNLVKLIGYCIEDDQRL----------LVYEFMPR---GSLENHLFRRSLPLPWS 236
L H N+V L + L LV+E+M G LE+ L S S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM 296
MK L +GL + H+ + ++RD K SNILL+ N G+
Sbjct: 121 F-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLN-----NKGQI------------- 155
Query: 297 LFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVV 355
KL+DFGLA+ + + +V+ T Y PE ++ + DV+S G +
Sbjct: 156 -------KLADFGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCI 207
Query: 356 LLEMLTGR 363
L E+ T +
Sbjct: 208 LGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 64/248 (25%), Positives = 99/248 (39%), Gaps = 56/248 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
+F +LG+G FG V A K GT A+K L D + + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMK 240
L + + C + RL V E++ G L H+ F+ + ++ +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ GL FLH R +IYRD K N++LD+ +
Sbjct: 112 V------GLFFLHR---RGIIYRDLKLDNVMLDS-------------------------E 137
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
+ K++DFG+ K E V+TR GT Y APE + D +++GV+L EM
Sbjct: 138 GHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194
Query: 360 LTGRRSMD 367
L G+ D
Sbjct: 195 LAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 48/169 (28%), Positives = 66/169 (39%), Gaps = 44/169 (26%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI----RMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W+ + +AL A + F+H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 258 RPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEG 317
RD K N+LLD G KL+DFG
Sbjct: 166 -----RDVKPDNMLLDK-----SGHL--------------------KLADFGTCMKMDAN 195
Query: 318 DKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTG 362
T V GT Y +PE + + G+ D +S GV L EML G
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 68/252 (26%), Positives = 101/252 (40%), Gaps = 40/252 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ----GHKEWLA 184
+F ++G G FG V K TG A+K L D L+ GH A
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIR--A 50
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA- 242
E + L + L +VK+ Y +D L L+ EF+P G + L ++ + IA
Sbjct: 51 ERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 243 ----LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ + L F+H RD K N+LLD+ FG C +
Sbjct: 110 TVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 299 QDYNAKL-SDFGL----AKDGPEG---DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350
++ N L SDF +K E ++ ++ +GT Y APE M D +
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 351 SFGVVLLEMLTG 362
S GV++ EML G
Sbjct: 221 SLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 70/258 (27%), Positives = 104/258 (40%), Gaps = 52/258 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F ++G G FG V K TG A+K L + KE +A +
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAE 51
Query: 190 GD-LVHLN---LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI--- 241
D LV + +VK+ Y +D + L L+ EF+P G + L ++ + + I
Sbjct: 52 RDILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110
Query: 242 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL-------F 292
A+ A L F+H RD K N+LLDA FG C GL F
Sbjct: 111 VLAIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEF 159
Query: 293 FNNML--------FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 344
+ N+ FQ+ N+K K+ + ++ +GT Y APE M
Sbjct: 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKN-----RRQLAYSTVGTPDYIAPEVFMQTGYN 214
Query: 345 SRSDVYSFGVVLLEMLTG 362
D +S GV++ EML G
Sbjct: 215 KLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 68/232 (29%), Positives = 96/232 (41%), Gaps = 46/232 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 191
++G+G FG V + +G+ AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L H LV L Y + ++L V +++ G L HL R L R A A +
Sbjct: 53 LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+LH +IYRD K NILLD+ + L+DFGL
Sbjct: 111 YLHSLN---IIYRDLKPENILLDS-------------------------QGHVVLTDFGL 142
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
K+G E ++T ++ GT Y APE + D + G VL EML G
Sbjct: 143 CKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 56/214 (26%)
Query: 166 VAVKTLNHDGLQGHKEWLA----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFM 217
V ++T +GHK + E+ L + N++K+ G+ I+ L L+ E+
Sbjct: 46 VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277
RG L L + L + ++ +A+ KGL L++ +P Y++ + + L+
Sbjct: 105 TRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT---- 157
Query: 278 ENYG-KFGFCIYYGLF----FNN---MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 329
ENY K + F N M++ Y F
Sbjct: 158 ENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS-------------------- 197
Query: 330 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
EY T + D+YS GVVL E+ TG+
Sbjct: 198 ------EY------TIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 66/255 (25%), Positives = 99/255 (38%), Gaps = 43/255 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEV-- 186
+F ++G G FG V K TG A+K L + L+ KE +A V
Sbjct: 2 DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50
Query: 187 --NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-- 241
+ L + + +VKL Y +D+ L L+ E++P G + L ++ R I
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 242 ---ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
A+ + L ++H RD K N+LLDA FG C +
Sbjct: 110 TILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160
Query: 299 QDYN-AKLSDFGLAKDGPEGDKTHVST-----RVM-----GTYGYAAPEYVMTGHLTSRS 347
+ + A S+F P K T R + GT Y APE +
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220
Query: 348 DVYSFGVVLLEMLTG 362
D +S GV++ EML G
Sbjct: 221 DWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 49/170 (28%), Positives = 69/170 (40%), Gaps = 45/170 (26%)
Query: 203 YC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEA 256
+C +DD+ L +V E+MP G L N + +P W + + +AL A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316
RD K N+LLD K G + KL+DFG E
Sbjct: 166 ------RDVKPDNMLLD--------KHG-----------------HLKLADFGTCMKMDE 194
Query: 317 GDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTG 362
T V GT Y +PE + + G+ D +S GV L EML G
Sbjct: 195 TGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 8e-07
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 47/229 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G VF + TG VA+K +N + + E+ + +L + N
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLH 253
+V + + D+ +V E++ GSL + + + +IA + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCRECLQALEFLH 132
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
VI+RD K+ N+LL + FGFC A+
Sbjct: 133 ANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFC------------------------AQI 165
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
PE K + ++GT + APE V + D++S G++ +EM+ G
Sbjct: 166 TPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 41/150 (27%), Positives = 58/150 (38%), Gaps = 29/150 (19%)
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288
RS PLP + I + LA+LH R +I+RD KT NI LD
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLD--------------- 219
Query: 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 348
+ NA L DFG A T GT +PE + +++D
Sbjct: 220 ----------EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTD 269
Query: 349 VYSFGVVLLEMLTGRRSM-DKNRPNGEHNL 377
++S G+VL EM ++ K + L
Sbjct: 270 IWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 76/310 (24%), Positives = 121/310 (39%), Gaps = 70/310 (22%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 242
+E++ L H +VK DD+ LL+ E+ G L + +R LP+ ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
L + + L E R +++RD K++NI F + G+
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANI--------------FLMPTGII---------- 208
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
KL DFG +K + V++ GT Y APE + ++D++S GV+L E+LT
Sbjct: 209 -KLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT- 266
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRR------FYRLIDPRLEGHFSIKGAQKAAQLAA 416
RP G +R Y DP F + L
Sbjct: 267 -----------------LHRPFKGPSQREIMQQVLYGKYDP-----FPCPVSSGMKALLD 304
Query: 417 HCLSRDPKARPLMSEVV--EALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQG 474
LS++P RP +++ E LK + NL FQ + SP+ R I Q
Sbjct: 305 PLLSKNPALRPTTQQLLHTEFLKYVANL---------FQDIVRHSETISPHDREEILRQ- 354
Query: 475 GSLSRNGQRS 484
L +G+R+
Sbjct: 355 --LQESGERA 362
|
Length = 478 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 66/239 (27%), Positives = 99/239 (41%), Gaps = 53/239 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G + +G P + V VK L +Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKG 248
NL++ +G C E LLV EF P G L+ +L RS P P +++ ++A A G
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACEIALG 112
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
L LH+ I+ D N LL A D K+ D+
Sbjct: 113 LLHLHKNN---FIHSDLALRNCLLTA-------------------------DLTVKIGDY 144
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYV--MTGHL-----TSRSDVYSFGVVLLEML 360
GL+ + + D ++ + APE V + G+L T S+V+S GV + E+
Sbjct: 145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 83/351 (23%), Positives = 127/351 (36%), Gaps = 77/351 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 192
LG G FG V +E K +TVAVK L +E L +++LG+
Sbjct: 43 LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 97
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H+N+V L+G C L++ E+ G L N L R+ A A
Sbjct: 98 -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLH 156
Query: 253 HEE--AERPVIYRDFK---------------------------TSNILLD---AVRAENY 280
E + Y D K TS IL + A+ E+
Sbjct: 157 QREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDL 216
Query: 281 GKFGFCIYYGLFF---NNMLFQDYNA-----------KLSDFGLAKDGPEGDKTHVSTRV 326
F + + G+ F N + +D A K+ DFGLA+D V
Sbjct: 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 327 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 386
+ APE + T SDV+S+G++L E+ + L P +
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMP 321
Query: 387 ERRRFYRLIDPRLEGH--FSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVE 434
+FY++I EG+ S + A + + C DP RP ++V+
Sbjct: 322 VDSKFYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 137 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + VFKG + EN VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFL 252
H N+V L D LV+E++ + L+ ++ + +KI L +GLA+
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH-NVKIFLYQILRGLAYC 120
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
H R V++RD K N+L++ R E KL+DFGLA+
Sbjct: 121 HR---RKVLHRDLKPQNLLINE-RGE------------------------LKLADFGLAR 152
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
KT+ + V T Y P+ ++ + +++ D++ G + EM +GR
Sbjct: 153 AKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 61/284 (21%), Positives = 119/284 (41%), Gaps = 62/284 (21%)
Query: 91 STTTSNAESNSSTSKLEEELKVASRLRKFTFNDL-KLATRNFRPESLLGEGGFGCVFKGW 149
N++ + E+E K+ ND+ + ++++ +++G G FG V++
Sbjct: 34 KLDEEERSHNNNAGEDEDEEKMID-------NDINRSPNKSYKLGNIIGNGSFGVVYEA- 85
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY----CI 205
+ T VA+K + D ++E L + +L H+N++ L Y C
Sbjct: 86 --------ICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYYTECF 133
Query: 206 EDDQRLL----VYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259
+ +++ + V EF+P+ H R + LP + + + LA++H +
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--- 190
Query: 260 VIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK 319
+ +RD K N+L+D + KL DFG AK+ G +
Sbjct: 191 ICHRDLKPQNLLIDP------------------------NTHTLKLCDFGSAKNLLAGQR 226
Query: 320 THVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 362
S + + Y APE ++ + T+ D++S G ++ EM+ G
Sbjct: 227 ---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 45/166 (27%), Positives = 68/166 (40%), Gaps = 38/166 (22%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 258 RPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK-DGPE 316
RD K N+LLD FG C+ K++ G+ + D
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCM----------------KMNKEGMVRCDTAV 204
Query: 317 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
G ++S V+ + G G+ D +S GV L EML G
Sbjct: 205 GTPDYISPEVLKSQG-------GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 5e-06
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL-AKDGP 315
VI+RD K+ NILL D + KL+DFG A+ P
Sbjct: 137 ---VIHRDIKSDNILLG-------------------------MDGSVKLTDFGFCAQITP 168
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
E K + ++GT + APE V + D++S G++ +EM+ G
Sbjct: 169 EQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 35/119 (29%), Positives = 53/119 (44%), Gaps = 36/119 (30%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+GL ++H +I+RD K SNI AV +D K+
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNI---AVN----------------------EDCELKIL 160
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 363
DFGLA+ + +V+TR Y APE +M H D++S G ++ E+LTG+
Sbjct: 161 DFGLARHTDDEMTGYVATR-----WYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA+K +N + + E+ + + + N
Sbjct: 27 IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSNQ 135
Query: 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL-AKDGP 315
VI+RD K+ NILL D + KL+DFG A+ P
Sbjct: 136 ---VIHRDIKSDNILLG-------------------------MDGSVKLTDFGFCAQITP 167
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
E K + ++GT + APE V + D++S G++ +EM+ G
Sbjct: 168 EQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 44/171 (25%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 257
C + RL V E++ G L + F+ + ++ + I GL FLH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSKG- 121
Query: 258 RPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEG 317
+IYRD K N++LD+ + + K++DFG+ K E
Sbjct: 122 --IIYRDLKLDNVMLDS-------------------------EGHIKIADFGMCK---EN 151
Query: 318 DKTHVSTRVM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367
V+T+ GT Y APE + D ++FGV+L EML G+ +
Sbjct: 152 MWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 52/176 (29%), Positives = 72/176 (40%), Gaps = 42/176 (23%)
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
+H + +I+RD K++NILL C +N L KL DFG +
Sbjct: 156 VHHVHSKHMIHRDIKSANILL-------------C-------SNGL-----VKLGDFGFS 190
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 371
K V GT Y APE + ++D++S GV+L E+LT +R D
Sbjct: 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---- 246
Query: 372 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
GE N+ E L R DP L S + ++ LS DPK RP
Sbjct: 247 -GE-NMEEVMHKTLAGR------YDP-LPPSIS----PEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 6e-06
Identities = 61/243 (25%), Positives = 99/243 (40%), Gaps = 71/243 (29%)
Query: 139 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGDLV 193
EG +G V++ TG VA+K L + KE L E+N L L
Sbjct: 15 EGTYGVVYRA---------RDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62
Query: 194 HLNLVKL----IGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIR-----MKI 241
H N+V + +G + D+ +V E++ + +E P+ M
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQSEVKCLMLQ 114
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
L G+A LH+ +++RD KTSN+LL+ N G
Sbjct: 115 LL---SGVAHLHD---NWILHRDLKTSNLLLN-----NRGIL------------------ 145
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 360
K+ DFGLA+ G T+++ T Y APE ++ ++ D++S G + E+L
Sbjct: 146 --KICDFGLAR--EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201
Query: 361 TGR 363
T +
Sbjct: 202 TKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 46/185 (24%), Positives = 71/185 (38%), Gaps = 49/185 (26%)
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGL 249
N+V L Y + +D LV + G L +H+ + L +P W+ M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA---- 100
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
LH E ++ RD +NILLD + +L+ F
Sbjct: 101 --LHREG---IVCRDLNPNNILLD-------------------------DRGHIQLTYFS 130
Query: 310 LAKD-GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
+ D V Y APE T D +S G +L E+LTG +++ +
Sbjct: 131 RWSEVEDSCDGEAVENM------YCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVE 183
Query: 369 NRPNG 373
P+G
Sbjct: 184 CHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 64/269 (23%), Positives = 103/269 (38%), Gaps = 82/269 (30%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
DL + RP LG G G VF + V VAVK + Q K
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49
Query: 183 LAEVNFLGDLVHLNLVKL--------------IGYCIEDDQRLLVYEFMP--------RG 220
L E+ + L H N+VK+ +G E + +V E+M +G
Sbjct: 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG 109
Query: 221 SL-ENH--LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277
L E H LF L +GL ++H V++RD K +N+ ++
Sbjct: 110 PLSEEHARLFMYQL--------------LRGLKYIHSAN---VLHRDLKPANVFINT--- 149
Query: 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAP 335
+D K+ DFGLA+ D K ++S ++ + Y +P
Sbjct: 150 ---------------------EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSP 187
Query: 336 EYVMT-GHLTSRSDVYSFGVVLLEMLTGR 363
+++ + T D+++ G + EMLTG+
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 35/164 (21%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y + D +L L+ +++ G L HL +R +++ L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLG---II 127
Query: 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH 321
YRD K NILLD+ + + L+DFGL+K+ E D+
Sbjct: 128 YRDIKLENILLDS-------------------------NGHVVLTDFGLSKEFHE-DEVE 161
Query: 322 VSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTG 362
+ GT Y AP+ V GH D +S GV++ E+LTG
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 44/230 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + V+KG NG VA+K ++ +G + E + L L H
Sbjct: 13 LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 254
N+V L + V+E+M L ++ + L P+++R+ +GLA++H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH- 120
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+ +++RD K N+L+ Y G KL+DFGLA+
Sbjct: 121 --GQHILHRDLKPQNLLIS--------------YLG-----------ELKLADFGLARAK 153
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
+T+ S V T Y P+ ++ +S D++ G + +EML G+
Sbjct: 154 SIPSQTYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 40/206 (19%)
Query: 162 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMP 218
TG VA+K + K E+ L L H N++ L I + + V E +
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278
+ H S PL +GL ++H V++RD K SNIL++ E
Sbjct: 93 --GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILIN----E 143
Query: 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 338
N C + K+ DFGLA+ +VSTR Y APE +
Sbjct: 144 N------C---------------DLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIM 177
Query: 339 MTGH-LTSRSDVYSFGVVLLEMLTGR 363
+T D++S G + EML G+
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 43/170 (25%), Positives = 69/170 (40%), Gaps = 51/170 (30%)
Query: 230 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289
S PL ++ + A+G+ FL A + I+RD N+LL R
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRV------------ 250
Query: 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGT----YGYAAPEYVMTGHLTS 345
AK+ DFGLA+D D +V V G + APE + T
Sbjct: 251 -------------AKICDFGLARD-IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTV 293
Query: 346 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 395
+SDV+S+G++L E+ S+ K+ P + +FY+++
Sbjct: 294 QSDVWSYGILLWEIF----SLGKS-----------PYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 57/250 (22%), Positives = 89/250 (35%), Gaps = 73/250 (29%)
Query: 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVH 194
G G +G V+K G A+K D Q + E+ L +L H
Sbjct: 9 GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 195 LNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLF----------RRSLP------LPWS 236
N+V L+ +E + L++++ E+ L+ R S+P L W
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE----NYGKFGFCIYYGLF 292
I G+ +LH V++RD K +NIL+ E G G
Sbjct: 117 I--------LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGL----ARL 161
Query: 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYS 351
FN L + D V+ T Y APE ++ H T D+++
Sbjct: 162 FNAPLKPLA--------------DLDP------VVVTIWYRAPELLLGARHYTKAIDIWA 201
Query: 352 FGVVLLEMLT 361
G + E+LT
Sbjct: 202 IGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 59/265 (22%), Positives = 97/265 (36%), Gaps = 87/265 (32%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 187
++P +G G +G V + +G VA+K + H D K L E+
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR---------LLVYEFM---------PRGSLENHLFRR 229
L H N++ I D R +V + M L R
Sbjct: 57 ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111
Query: 230 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289
L + + +GL ++H VI+RD K SN+L++
Sbjct: 112 FL---YQL--------LRGLKYIHSAN---VIHRDLKPSNLLVN---------------- 141
Query: 290 GLFFNNMLFQDYNAKLSDFGLAK---DGPEGDKT----HVSTRVMGTYGYAAPEYVMTGH 342
+D ++ DFG+A+ P K +V+TR Y APE +++
Sbjct: 142 ---------EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR-----WYRAPELLLSLP 187
Query: 343 LTSRS-DVYSFGVVLLEMLTGRRSM 366
+ + D++S G + EML GRR +
Sbjct: 188 EYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 60/241 (24%), Positives = 91/241 (37%), Gaps = 63/241 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK E T VA+K L+ D L E+ L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALG 244
N+V+L D + LV+E+ G ++ + + +
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----------FQ 107
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
KGLAF H V++RD K N+L++ N L K
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINK-------------------NGEL------K 139
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
L+DFGLA+ G + + T Y P+ + L S S D++S G + E+
Sbjct: 140 LADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197
Query: 364 R 364
R
Sbjct: 198 R 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 54/245 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWL 183
NF +LG G +G VF + + TG A+K L L H
Sbjct: 1 NFELLKVLGTGAYGKVF--LVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM--- 239
E N L + + + Y + + +L L+ +++ G + HL++R +R
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG 112
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
+I L L LH+ ++YRD K NILLD+
Sbjct: 113 EIILA----LEHLHKLG---IVYRDIKLENILLDS------------------------- 140
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLL 357
+ + L+DFGL+K+ +K + GT Y APE + GH D +S G+++
Sbjct: 141 EGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIF 198
Query: 358 EMLTG 362
E+LTG
Sbjct: 199 ELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 30/118 (25%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+GL +LH +++RD K N+L++ +N + K+
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVN--------------------SNCVL-----KIC 145
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
DFGLA+ + H++ V+ Y Y APE +M + H TS D++S G + E+L R
Sbjct: 146 DFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 64/232 (27%), Positives = 90/232 (38%), Gaps = 45/232 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E + G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAS-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H L L Y + RL V E++ G L HL R + R A L +
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDY 110
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
LH ++YRD K N++LD +D + K++DFGL
Sbjct: 111 LHSGK---IVYRDLKLENLMLD-------------------------KDGHIKITDFGLC 142
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
K+G T + GT Y APE + D + GVV+ EM+ GR
Sbjct: 143 KEGITDAATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 77/313 (24%), Positives = 128/313 (40%), Gaps = 75/313 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVH 194
LG+G +G V+K +P TG+T+A+K + + L K + + E++ L V
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF 251
+V G + + E+M GSL+ L+ + +P + +I KGL F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
L EE +I+RD K +N+L++ + KL DFG++
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNG-------------------------NGQVKLCDFGVS 150
Query: 312 KDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHLTSR------SDVYSFGVVLLEMLTGRR 364
+ KT++ G Y APE + +G SDV+S G+ +LEM GR
Sbjct: 151 GNLVASLAKTNI-----GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSR 421
P N+ + ++D P L +S A A CL++
Sbjct: 206 PYP---PETYANIFA----------QLSAIVDGDPPTLPSGYS----DDAQDFVAKCLNK 248
Query: 422 DPKARPLMSEVVE 434
P RP ++++E
Sbjct: 249 IPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 42/229 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + VFKG + T VA+K + + +G + EV+ L +L H
Sbjct: 13 LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V L + LV+E++ L+ +L + +GL++ H+
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
R +++RD K N+L++ + E KL+DFGLA+
Sbjct: 122 --RKILHRDLKPQNLLINE-KGE------------------------LKLADFGLARAKS 154
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
KT+ + V T Y P+ ++ + ++ D++ G +L EM TGR
Sbjct: 155 VPTKTYSNEVV--TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 58/244 (23%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 186
+ P + +G G +G V+K P +G VA+K++ N DGL + EV
Sbjct: 2 YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLP--LSTVREV 50
Query: 187 NFLGDLVHL---NLVKLIGYC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSI 237
L L N+V+L+ C D+ LV+E + + L +L + P LP
Sbjct: 51 ALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAET 109
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ +GL FLH +++RD K NIL+ +
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS----------------------- 143
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
KL+DFGLA+ ++ T V+ T Y APE ++ + D++S G +
Sbjct: 144 --GGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197
Query: 357 LEML 360
EM
Sbjct: 198 AEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 53/209 (25%), Positives = 77/209 (36%), Gaps = 70/209 (33%)
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
L LH+ ++YRD K NILLDA + L DF
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDA-------------------------TGHIALCDF 140
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSM 366
GL+K +KT + GT Y APE ++ G+ T D +S GV++ EM G
Sbjct: 141 GLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGY-TKHVDFWSLGVLVFEMCCG---- 193
Query: 367 DKNRPNGEHNLVEWARPHLGERRRFYRLID------PR----LEGHFSIKGAQKAAQLAA 416
W+ + + ++ YR I P+ EG +KG
Sbjct: 194 -------------WSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG--------- 231
Query: 417 HCLSRDPKARPLMSEVVEALKPLPNLKDM 445
L+R+P+ R LK P D+
Sbjct: 232 -LLNRNPQHRLGAHRDAVELKEHPFFADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 59/200 (29%), Positives = 80/200 (40%), Gaps = 35/200 (17%)
Query: 167 AVKTLNHDGLQGHKE---WLAEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL 222
AVK L + KE ++E N L ++ H LV L D+ V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282
HL R L R A A L +LH ++YRD K NILLD+
Sbjct: 84 FYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDLKPENILLDSQ------- 132
Query: 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 342
G + L+DFGL K+ E + T ++ GT Y APE +
Sbjct: 133 -GHIV-----------------LTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQP 172
Query: 343 LTSRSDVYSFGVVLLEMLTG 362
D + G VL EML G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 62/239 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + V+KG + G VA+K L H+ +G + E + L DL
Sbjct: 13 LGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKDLK 61
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM---KIAL-GAA 246
H N+V L LV+E++ +++ + M ++ L
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHNVRLFLFQLL 113
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+GLA+ H+ R V++RD K N+L+ R E KL+
Sbjct: 114 RGLAYCHQ---RRVLHRDLKPQNLLISE-RGE------------------------LKLA 145
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGR 363
DFGLA+ KT+ + V T Y P+ ++ T + TS D++ G + EM TGR
Sbjct: 146 DFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 60/249 (24%), Positives = 98/249 (39%), Gaps = 57/249 (22%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----- 183
+ + + +GEG +G VFK +NG G VA+K + +Q +E +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49
Query: 184 ---AEVNFLGDLVHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LP 234
A + L H N+V+L C + + LV+E + + L +L + P +P
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294
+ +GL FLH V++RD K NIL+ +
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTS-------------------- 145
Query: 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 354
KL+DFGLA+ T V+ T Y APE ++ + D++S G
Sbjct: 146 -----SGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197
Query: 355 VLLEMLTGR 363
+ EM +
Sbjct: 198 IFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 81/321 (25%), Positives = 126/321 (39%), Gaps = 77/321 (23%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F L+G G +G V+KG VK TG A+K ++ G + +E E+N L
Sbjct: 8 FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 57
Query: 191 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 115
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
I +GL+ LH+ VI+RD K N+LL ++
Sbjct: 116 ICREILRGLSHLHQHK---VIHRDIKGQNVLLT-------------------------EN 147
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPEYVMTGH-----LTSRSDVYSFG 353
KL DFG++ + D+T V R +GT + APE + +SD++S G
Sbjct: 148 AEVKLVDFGVSA---QLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
Query: 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
+ +EM G + P L+ R PRL+ S K ++K
Sbjct: 204 ITAIEMAEGAPPLCDMHPMRALFLIP-------------RNPAPRLK---SKKWSKKFQS 247
Query: 414 LAAHCLSRDPKARPLMSEVVE 434
CL ++ RP ++++
Sbjct: 248 FIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 32/118 (27%), Positives = 53/118 (44%), Gaps = 34/118 (28%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+GL ++H +I+RD K SN+ ++ +D K+
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVN-------------------------EDCELKIL 162
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 363
DFGLA+ + +V+TR Y APE ++ H D++S G ++ E+LTGR
Sbjct: 163 DFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 61/256 (23%), Positives = 99/256 (38%), Gaps = 48/256 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLV 193
LG G FG V K T A+KTL + + AE + L +
Sbjct: 9 LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAK 247
+ +VKL Y +D L V +++P G + + L R L + + +A+ +
Sbjct: 60 NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN----- 302
+ F+H RD K NIL+D FG C + N+ +Q +
Sbjct: 119 KMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 303 -AKLSDF--------------GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 347
+ SD L + + + ++ ++GT Y APE ++ T
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229
Query: 348 DVYSFGVVLLEMLTGR 363
D +S GV+L EML G+
Sbjct: 230 DWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 46/231 (19%)
Query: 137 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + V+KG + +N VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVYKGRSKLTDN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N+V L + LV+E++ + L+ +L + +GL + H
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
R V++RD K N+L++ R E KL+DFGLA+
Sbjct: 122 R---RKVLHRDLKPQNLLINE-RGE------------------------LKLADFGLARA 153
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
KT+ + V T Y P+ ++ + +++ D++ G + EM TGR
Sbjct: 154 KSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 64/242 (26%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT----LNHDGLQGHKEWLAEVNFLG 190
+ +GEG +G V+K TG VA+K L+ +G+ L E+ L
Sbjct: 5 AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53
Query: 191 DLV---HLNLVKLIGYC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR- 238
L H N+V+L+ C D+ L LV+E + + L + LP P +I+
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKD 111
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
M+ L +G+ FLH +++RD K NIL+ +
Sbjct: 112 LMRQLL---RGVDFLHSHR---IVHRDLKPQNILVTS----------------------- 142
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357
D K++DFGLA+ T V+ T Y APE ++ + D++S G +
Sbjct: 143 --DGQVKIADFGLAR---IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197
Query: 358 EM 359
E+
Sbjct: 198 EL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 71/307 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
+GEG FG +E+G V +K +N + +E EV L ++ H
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYV---------IKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSIRMKIALGAAK 247
N+V+ E+ +V ++ G L LF L W +++ +AL
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---- 114
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
+H+ R +++RD K+ NI L +D KL D
Sbjct: 115 --KHVHD---RKILHRDIKSQNIFLT-------------------------KDGTIKLGD 144
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367
FG+A+ ++ +GT Y +PE ++SD+++ G VL EM T + + +
Sbjct: 145 FGIAR--VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
Query: 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
NLV L R Y P + H+S +QL R+P+ RP
Sbjct: 203 A---GNMKNLV------LKIIRGSY----PPVSSHYSYDLRNLVSQL----FKRNPRDRP 245
Query: 428 LMSEVVE 434
++ ++E
Sbjct: 246 SVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 34/118 (28%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
GL ++H +I+RD K N+ ++ +D K+
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVN-------------------------EDCELKIL 159
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 363
DFGLA+ +V TR Y APE ++ H D++S G ++ EMLTG+
Sbjct: 160 DFGLARHADAEMTGYVVTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 69/265 (26%), Positives = 103/265 (38%), Gaps = 71/265 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+G+G FG VFK A K T VA+K + ++ KE L E+ L
Sbjct: 20 IGQGTFGEVFK--------ARHKK-TKQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 192 LVHLNLVKLIGYCIEDDQR--------LLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV+EF G L N + +L + MK
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-MK 126
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ L GL ++H +++RD K +NIL+ + +L
Sbjct: 127 MLL---NGLYYIHRNK---ILHRDMKAANILITK-------------------DGIL--- 158
Query: 301 YNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFG 353
KL+DFGLA+ + K + T + T Y PE + L R D++ G
Sbjct: 159 ---KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL----LGERDYGPPIDMWGAG 211
Query: 354 VVLLEMLTGRRSMDKNRPNGEHNLV 378
++ EM T M N + L+
Sbjct: 212 CIMAEMWTRSPIMQGNTEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 34/118 (28%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
KGL ++H +I+RD K N+ ++ +D K+
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVN-------------------------EDCELKIL 160
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 363
DFGLA+ +V TR Y APE ++ H T D++S G ++ EMLTG+
Sbjct: 161 DFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 54/239 (22%)
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H++L + G C+ + ++V EF+ G L+ L + +P + ++ +A A L++L
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
+ + +++ + NILL + G F KLSD G++
Sbjct: 135 D---KNLVHGNVCAKNILL--------ARLGLAEGTSPFI----------KLSDPGVSFT 173
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372
++ RV + APE V G L++ +D +SFG LLE+ +
Sbjct: 174 ALSREE-----RV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF----------D 217
Query: 373 GEHNLVEWARPHLGERRRFY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
GE L E E+ RFY RL +P ++ A L + CL+ +P RP
Sbjct: 218 GEVPLKERTPS---EKERFYEKKHRLPEP---------SCKELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 64/253 (25%), Positives = 92/253 (36%), Gaps = 51/253 (20%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LG G FG V A K VA+K + K+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
+E L + H V L G ++ LV EF+ G L RR+ P +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG--- 133
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
AA+ + ++YRD K N+LLD K GF
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD--------KDGFI--------------- 170
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
K++DFG AK V TR + GT Y APE ++ +D ++ G+ + E
Sbjct: 171 --KMTDFGFAKV--------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220
Query: 359 MLTGRRSMDKNRP 371
+L G N P
Sbjct: 221 ILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 68/249 (27%), Positives = 100/249 (40%), Gaps = 61/249 (24%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F ++G G +G V+KG VK TG A+K ++ + +E E+N L
Sbjct: 18 FELVEVVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTEDE-EEEIKLEINMLK 67
Query: 191 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AY 125
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
I +GLA LH VI+RD K N+LL ++
Sbjct: 126 ICREILRGLAHLHAHK---VIHRDIKGQNVLLT-------------------------EN 157
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPEYVMTGH-----LTSRSDVYSFG 353
KL DFG++ + D+T V R +GT + APE + RSD++S G
Sbjct: 158 AEVKLVDFGVSA---QLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213
Query: 354 VVLLEMLTG 362
+ +EM G
Sbjct: 214 ITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 60/246 (24%), Positives = 93/246 (37%), Gaps = 53/246 (21%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ P +G G +G V + T VA+K + + D K L E
Sbjct: 4 DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE 54
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENH-LFRRSLPLPWSIR 238
+ L L H N++ + + R +VYE M + H + R S L
Sbjct: 55 IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+GL ++H V++RD K SN+LL+A N L
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNA-------------------NCDL- 147
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 357
K+ DFGLA+ +K T + T Y APE ++ T+ DV+S G +
Sbjct: 148 -----KICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200
Query: 358 EMLTGR 363
E+L +
Sbjct: 201 ELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 55/244 (22%), Positives = 96/244 (39%), Gaps = 62/244 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK----TLNHDGLQGHKEWLAEVNFLGDL 192
+GEG +G V+K TG VA+K ++ +G+ L E++ L L
Sbjct: 9 IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57
Query: 193 VHLN-LVKLIGYCIEDDQR-------LLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 241
+V+L+ +E + LV+E++ + ++++ PLP
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
KG+A H+ V++RD K N+L+D K +
Sbjct: 116 MYQLLKGVAHCHK---HGVMHRDLKPQNLLVD--------KQKGLL-------------- 150
Query: 302 NAKLSDFGLAKDG--PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLE 358
K++D GL + P TH + T Y APE ++ H ++ D++S G + E
Sbjct: 151 --KIADLGLGRAFSIPVKSYTH----EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE 204
Query: 359 MLTG 362
M
Sbjct: 205 MSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 63/245 (25%), Positives = 94/245 (38%), Gaps = 48/245 (19%)
Query: 137 LGEGGFGCVFKGWIEENGT----APVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGD 191
LGEG +G V K + G VK K G+ G H L E+ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
+ H N++ L+ +E D LV + M L+ + R + L S I L GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGLNV 134
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
LH+ ++RD +NI ++ G C K++DFGLA
Sbjct: 135 LHK---WYFMHRDLSPANIFIN--------SKGIC-----------------KIADFGLA 166
Query: 312 K--------DGPEGDKTHVSTRVMG----TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLE 358
+ D D+T M T Y APE +M D++S G + E
Sbjct: 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226
Query: 359 MLTGR 363
+LTG+
Sbjct: 227 LLTGK 231
|
Length = 335 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 36/206 (17%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHL-----FRRSLPLPWSI 237
AE + L + + +V+L Y +D D V +++P G + + L F L +
Sbjct: 50 AERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ A+ + + F+H RD K NIL+D FG C + ++
Sbjct: 109 ELTCAVESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 298 FQ--DYNAKLS-DFGLAKDGPE----GDKTH-------------VSTRVMGTYGYAAPEY 337
+Q D+ + S DF P GD+ ++ ++GT Y APE
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219
Query: 338 VMTGHLTSRSDVYSFGVVLLEMLTGR 363
++ T D +S GV+L EML G+
Sbjct: 220 LLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 67/246 (27%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
++ +GEG F V K + G A+K + H + L +VN L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKK-----HFKSLEQVNNLR 46
Query: 191 DLV-------HLNLVKLIGYCIEDDQ--RL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
++ H N+++LI + D + RL LV+E M +L + R PLP
Sbjct: 47 EIQALRRLSPHPNILRLIE-VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS 104
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
K L +H + +RD K NIL+ D
Sbjct: 105 YMYQLLKSLDHMHRNG---IFHRDIKPENILIK--------------------------D 135
Query: 301 YNAKLSDFGLAK----DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 355
KL+DFG + P + ++STR Y APE ++T G+ + D+++ G V
Sbjct: 136 DILKLADFGSCRGIYSKPPYTE--YISTR-----WYRAPECLLTDGYYGPKMDIWAVGCV 188
Query: 356 LLEMLT 361
E+L+
Sbjct: 189 FFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 41/233 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G F +FKG E G T V +K L+ + + + + L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEE 255
LV G C+ D+ ++V E++ GSL+ +L + + S ++++ AK LA+ LH
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAWALHFL 116
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG-----L 310
++ + + + N+LL G F KLSD G L
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFI-----------------KLSDPGISITVL 159
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 362
K+ + R+ + PE + +L+ +D +SFG L E+ +G
Sbjct: 160 PKE-------ILLERI----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 39/210 (18%)
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 250
+VKL Y +D L V +++P G + + L F L + + A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI---------YYGLFFNNMLFQD- 300
F+H RD K NIL+D FG C YY + QD
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK--GDHHRQDS 170
Query: 301 --YNAKLSDFGLAKDGP-EGDKTHVSTRVM-----GTYGYAAPEYVM-TGHLTSRSDVYS 351
+ + S+ + P E + R + GT Y APE ++ TG+ T D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWS 229
Query: 352 FGVVLLEMLTGRRSMDKNRPNG-EHNLVEW 380
GV+L EML G+ + P + ++ W
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 44/168 (26%), Positives = 64/168 (38%), Gaps = 36/168 (21%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y +D L LV E+ P G L + L R + A+ + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYV 124
Query: 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH 321
+RD K N+L+D + G + KL+DFG A +K
Sbjct: 125 HRDIKPENVLID--------RTG-----------------HIKLADFGSAA-RLTANKMV 158
Query: 322 VSTRVMGTYGYAAPEY--VMTGHLTSRSDV----YSFGVVLLEMLTGR 363
S +GT Y APE M G V +S GV+ EM+ GR
Sbjct: 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEW-LAEVNF 188
F ++GEG +G V K +E T VA+K + + + KE L E+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKM 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGA 245
L L N+V+L + LV+E++ + LE +P P +R I
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQL 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
K + + H+ +++RD K N+L+ N++L KL
Sbjct: 110 IKAIHWCHKND---IVHRDIKPENLLISH-------------------NDVL------KL 141
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
DFG A++ EG + T + T Y +PE ++ D++S G +L E+ G+
Sbjct: 142 CDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 65/272 (23%), Positives = 93/272 (34%), Gaps = 80/272 (29%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAE 185
++F+ LLG+G G VF + GT + A+K L+ + + L E
Sbjct: 1 KHFKKIKLLGKGDVGRVF--LVRLKGTGKL-------FALKVLDKKEMIKRNKVKRVLTE 51
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 242
L L H L L + LV ++ P G L + P L +
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEV---AR 106
Query: 243 LGAAK---GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
AA+ L +LH ++YRD K NILL +
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLH-------------------------E 138
Query: 300 DYNAKLSDFGLAK--------------DGPEGDKTH----------VSTRVM---GTYGY 332
+ LSDF L+K G + S R GT Y
Sbjct: 139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEY 198
Query: 333 AAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
APE + GH S D ++ G++L EML G
Sbjct: 199 IAPEVISGDGH-GSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 61/283 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
+G G FG V I TG+ V VK L + + E+L + + L H
Sbjct: 3 IGNGWFGKVLLSEI--------YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 248
N+++ +G C+E LLV+E+ G L+++L R S L + ++A A G
Sbjct: 55 PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAG 111
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+ +H+ +F S++ A+R N L D K+ D+
Sbjct: 112 VTHMHKH--------NFLHSDL---ALR-----------------NCFLTSDLTVKVGDY 143
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYV-------MTGHLTSRSDVYSFGVVLLEMLT 361
G+ + D + APE V +T T S+V++ GV L E+
Sbjct: 144 GIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF- 202
Query: 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 404
+N +L + + + + +L P+LE +S
Sbjct: 203 ------ENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 11/105 (10%)
Query: 56 SRSKVDSSVSGTSTHYESKSTNDTSRDQPA-AAVISSTTTSNAESNSSTSKLEEELKVAS 114
SRS + SG+ E+ ++ D+ R + A + T+ +N + ++ KV
Sbjct: 45 SRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTY 104
Query: 115 RLRKFTFN----------DLKLATRNFRPESLLGEGGFGCVFKGW 149
L + D+ ++T+ F+ SLLGEG FG V + W
Sbjct: 105 ALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAW 149
|
Length = 467 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 57/251 (22%), Positives = 105/251 (41%), Gaps = 49/251 (19%)
Query: 185 EVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 242
E L L H N+V + ED +V F G L + L ++ LP + ++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+ A L +LHE+ +++RD KT N+ L N++
Sbjct: 109 VQIAMALQYLHEKH---ILHRDLKTQNVFLTR-------------------TNII----- 141
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
K+ D G+A+ ++ +++ ++GT Y +PE +SDV++ G + EM T
Sbjct: 142 -KVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422
+ + + N +LV YR+I+ +L + + +L A LS+
Sbjct: 199 KHAFNAKDMN---SLV-------------YRIIEGKLP-PMPKDYSPELGELIATMLSKR 241
Query: 423 PKARPLMSEVV 433
P+ RP + ++
Sbjct: 242 PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 67/246 (27%), Positives = 96/246 (39%), Gaps = 66/246 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLV-H 194
+G+G +G V+K +++G+ AVK L D + E + AE N L L H
Sbjct: 30 IGKGTYGKVYKVTNKKDGS---------LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78
Query: 195 LNLVKLIGYCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGAA 246
N+VK G + D Q LV E GS L L L ++ I GA
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
GL LH +I+RD K +NILL + KL
Sbjct: 139 LGLQHLHNNR---IIHRDVKGNNILLTT-------------------------EGGVKLV 170
Query: 307 DFGLAKDGPEGDKTHVSTRV-----MGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVL 356
DFG++ STR+ +GT + APE + +R DV+S G+
Sbjct: 171 DFGVSAQ-------LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA 223
Query: 357 LEMLTG 362
+E+ G
Sbjct: 224 IELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 68/242 (28%), Positives = 94/242 (38%), Gaps = 58/242 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLV- 193
+G+G +G VFK ++NG+ AVK L+ HD +E AE N L L
Sbjct: 26 IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIHDI---DEEIEAEYNILKALSD 73
Query: 194 HLNLVKLIG-YCIED----DQRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGA 245
H N+VK G Y +D DQ LV E GS L +R + I I A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
GL LH I+RD K +NILL + KL
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTT-------------------------EGGVKL 165
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV-----MTGHLTSRSDVYSFGVVLLEML 360
DFG++ +GT + APE + + +R DV+S G+ +E+
Sbjct: 166 VDFGVSAQ--LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223
Query: 361 TG 362
G
Sbjct: 224 DG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 48/197 (24%), Positives = 76/197 (38%), Gaps = 48/197 (24%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
A+G+ FL A + ++RD N+LL GK K+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLL------AQGKI-------------------VKI 278
Query: 306 SDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
DFGLA+D D +VS + APE + T+ SDV+S+G++L E+ +
Sbjct: 279 CDFGLARDIMH-DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS--- 334
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
L P + FY I Q+ + C + +P+
Sbjct: 335 ------------LGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPE 382
Query: 425 ARPL---MSEVVEALKP 438
RP +S++VE+L P
Sbjct: 383 KRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 38/180 (21%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRM 239
E L L H +VK +E D ++ E+ L+ L ++L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
I L G+ ++H+ R +++RD K NI L NN+L
Sbjct: 112 FIQL--LLGVHYMHQ---RRILHRDLKAKNIFLK--------------------NNLL-- 144
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
K+ DFG+++ ++T GT Y +PE + S+SD++S G +L EM
Sbjct: 145 ----KIGDFGVSR--LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 70/305 (22%), Positives = 110/305 (36%), Gaps = 65/305 (21%)
Query: 78 DTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLL 137
++ D P+ A S + + + + L A K +D LA +FR L
Sbjct: 103 ASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQA----KLKHDDEFLA--HFRVIDDL 156
Query: 138 GEGGFG----CVFKGWIEE-------NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 186
G FG C + EE N T KP +A + E E+
Sbjct: 157 PAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLE--NEI 214
Query: 187 NFLGDLVHLNLVKL--------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
LG L H N++K+ Y I +Y FM + + + PL R
Sbjct: 215 LALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQTR 270
Query: 239 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM 296
MK L A + ++H+ + +I+RD K NI L+
Sbjct: 271 AIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNC---------------------- 302
Query: 297 LFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
D L DFG A E ++ +GT +PE + +D++S G++L
Sbjct: 303 ---DGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358
Query: 357 LEMLT 361
L+ML+
Sbjct: 359 LDMLS 363
|
Length = 501 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 52/229 (22%), Positives = 102/229 (44%), Gaps = 44/229 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + V+KG + NG VA+K + +G + E + L L H
Sbjct: 13 LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 254
N+V L + LV+E++ L ++ + L P ++++ + +GL+++H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIH- 120
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+R +++RD K N+L+ + G+ KL+DFGLA+
Sbjct: 121 --QRYILHRDLKPQNLLI-----SDTGEL--------------------KLADFGLAR-- 151
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 362
+ +H + + T Y P+ ++ + ++ D++ G + +EM+ G
Sbjct: 152 AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 29/118 (24%), Positives = 52/118 (44%), Gaps = 34/118 (28%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+GL ++H +I+RD K SN+ ++ +D ++
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVN-------------------------EDCELRIL 160
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 363
DFGLA+ + +V+TR Y APE ++ H D++S G ++ E+L G+
Sbjct: 161 DFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 74/329 (22%), Positives = 121/329 (36%), Gaps = 72/329 (21%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 188
++ + ++G+G +G V + + TG VA+K +N + + L E+
Sbjct: 2 YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L L H ++V++ + +R +V+E M S + + + + L
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+ L ++H V +RD K NIL +A D
Sbjct: 111 QLLRALKYIHTAN---VFHRDLKPKNILANA-------------------------DCKL 142
Query: 304 KLSDFGLAK----DGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLL 357
K+ DFGLA+ D P T + T Y APE + T D++S G +
Sbjct: 143 KICDFGLARVAFNDTP---TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 199
Query: 358 EMLTGRRSMDKNRPNGEH------NLVEWARPHLGER------RRFYRLIDPRLEGHFSI 405
E+LTG+ N H +L+ P R RR+ + + FS
Sbjct: 200 EVLTGKPLFPGK--NVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQ 257
Query: 406 K---GAQKAAQLAAHCLSRDPKARPLMSE 431
K A +L L+ DPK RP E
Sbjct: 258 KFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 34/127 (26%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
GL ++H V++RD K N+L++A D K+ D
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNA-------------------------DCELKICD 148
Query: 308 FGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
FGLA+ + P + + T + T Y APE +++ +++ DV+S G +L E+L GR
Sbjct: 149 FGLARGFSENPGENAGFM-TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GR 206
Query: 364 RSMDKNR 370
+ + K +
Sbjct: 207 KPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 35/136 (25%), Positives = 62/136 (45%), Gaps = 13/136 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K TG A+K + + + E+ + D H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V G + D+ + EF GSL++ ++ + PL S ++ +GL +LH +
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 257 ERPVIYRDFKTSNILL 272
+ ++RD K +NILL
Sbjct: 127 K---MHRDIKGANILL 139
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 511 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.32 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.83 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.52 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.46 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.42 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.36 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.34 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.28 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.21 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.21 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.07 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.87 | |
| PLN02236 | 344 | choline kinase | 96.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.76 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.53 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.36 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.09 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.97 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.64 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.58 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.43 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.4 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.1 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.77 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.6 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.5 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.38 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.66 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.76 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 92.62 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.31 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.09 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-54 Score=430.70 Aligned_cols=290 Identities=58% Similarity=0.995 Sum_probs=252.4
Q ss_pred cccccChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC
Q 010432 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194 (511)
Q Consensus 115 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H 194 (511)
....|++.++..++++|....+||+|+||.||+|...+ |..||||++.........+|.+|+.+|.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 34579999999999999999999999999999999864 47899998877654314569999999999999
Q ss_pred CCcceEeeEEEeCC-eEEEEEEccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 195 ~nIv~l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
||||+|+|||.+.+ ..+||+||+++|+|.++|+.... .++|..+++|+.++|.||+|||....++||||||||+||||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 99999999999988 59999999999999999987665 89999999999999999999999887899999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
| +++.+||+|||+|+..... .....+...||.+|+|||++..+..+.|+|||||
T Consensus 211 D-------------------------~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySF 264 (361)
T KOG1187|consen 211 D-------------------------EDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSF 264 (361)
T ss_pred C-------------------------CCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccc
Confidence 9 5899999999999776541 1211221179999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE-GHFSI-KGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
||+|+||+||+.+.+...+.....+..|+...+.+. .+.+++|+.+. ..+.. .....+..+..+|++.+|.+||+|.
T Consensus 265 GVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~ 343 (361)
T KOG1187|consen 265 GVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMS 343 (361)
T ss_pred hHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHH
Confidence 999999999999998766566666888987776665 78899999987 56664 5778899999999999999999999
Q ss_pred HHHHHhcCCCC
Q 010432 431 EVVEALKPLPN 441 (511)
Q Consensus 431 eil~~L~~l~~ 441 (511)
+|++.|+.+..
T Consensus 344 ~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 344 QVVKELEGILS 354 (361)
T ss_pred HHHHHHHhhcc
Confidence 99999965543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-53 Score=409.02 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=210.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-------HHHHHHHHHHHhCCCCCCcce
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~E~~il~~l~H~nIv~ 199 (511)
..+.|.+.+.||+|+||.|-+|..+. ||+.||||++++..... ...+.+|++||++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 45678889999999999999998765 89999999998653321 223579999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
++++|...+..||||||+.||+|.+++..++ .+.+.....++.|++.||.|||++| |+||||||+|||+....
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~--- 313 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDA--- 313 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCC---
Confidence 9999999999999999999999999997653 6788888999999999999999999 99999999999998532
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC---CCccccchhHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVL 356 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~---~~~~~DIwSlGvil 356 (511)
++..+||+|||+|+..+... ...+.|||+.|.|||++.+.. +..++||||+||||
T Consensus 314 -------------------e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvL 371 (475)
T KOG0615|consen 314 -------------------EDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVL 371 (475)
T ss_pred -------------------cceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceE
Confidence 36789999999999886543 355689999999999998654 34488999999999
Q ss_pred HHHHhCCCCCCCCCCCC-chhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLTGRRSMDKNRPNG-EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|-+|+|.+||....... ....+...+. .+........+++..+||.+||..||++|||+.|+|++
T Consensus 372 fvcLsG~pPFS~~~~~~sl~eQI~~G~y--------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 372 FVCLSGYPPFSEEYTDPSLKEQILKGRY--------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred EEEeccCCCcccccCCccHHHHHhcCcc--------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 99999999998654322 1111111110 01122334567899999999999999999999999985
Q ss_pred h
Q 010432 436 L 436 (511)
Q Consensus 436 L 436 (511)
-
T Consensus 438 p 438 (475)
T KOG0615|consen 438 P 438 (475)
T ss_pred h
Confidence 4
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=401.87 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=210.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+++.++.||+|..|+|||++|+. |++.+|+|++.... ....+++.+|++|+++.+||+||.+||+|..+.
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 45556789999999999999986 78899999995443 234567899999999999999999999999988
Q ss_pred -eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 209 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 209 -~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+.|+||||++|+|..++..- +.+++...-.|+.+|++||.|||. ++ ||||||||+|||+..
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNs------------ 214 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNS------------ 214 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeecc------------
Confidence 599999999999999998544 579999999999999999999996 66 999999999999994
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.+.|||||||.++.+.+. ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||
T Consensus 215 -------------kGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~ 277 (364)
T KOG0581|consen 215 -------------KGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPY 277 (364)
T ss_pred -------------CCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCC
Confidence 888999999999987664 356689999999999999999999999999999999999999999
Q ss_pred CCCCC--CCchhHHHhhhhhhccccccccccCCccCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 367 DKNRP--NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 367 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
....+ .....+..+ +++.. .+..+. .+++++++|+..||++||.+||++.++++|-
T Consensus 278 ~~~~~~~~~~~~Ll~~-------------Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 278 PPPNPPYLDIFELLCA-------------IVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCcCCCCCCHHHHHHH-------------HhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 76422 112222221 22211 122222 3678999999999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-53 Score=423.79 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=213.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..|...++||+|||+.||.+++.. +|..||+|++.+... ...+.+.+|++|.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 569999999999999999999866 788999999987433 33467889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.+++|||+|+|..++|..++. +...+++.+++.++.||+.||.|||+++ |||||||..|+||+
T Consensus 89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~------------ 152 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLN------------ 152 (592)
T ss_pred cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeec------------
Confidence 9999999999999999999986 4568999999999999999999999999 99999999999999
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
++.+|||+|||||..+...... ..+.||||.|+|||++....++..+||||+|||||-||+|++|
T Consensus 153 -------------~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PP 217 (592)
T KOG0575|consen 153 -------------ENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPP 217 (592)
T ss_pred -------------CcCcEEecccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCC
Confidence 5889999999999988754332 3458999999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|...........+... +. .++...+.++++||.++|+.||.+|||+++|+.+
T Consensus 218 Fetk~vkety~~Ik~~--------------~Y----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 218 FETKTVKETYNKIKLN--------------EY----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccchHHHHHHHHHhc--------------Cc----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9865332222111111 11 1122346788999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-53 Score=405.36 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=204.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..+|.+.+.||+|+||+||+|+++. ++..||||.+.+... +..+.+..|+.||+.|+|||||+|++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 3578889999999999999999987 567999999987743 33456789999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++.+|||||||.||||.+||++++ .+++..++.++.|||.||++||+++ ||||||||+||||+....
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~-------- 147 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTAR-------- 147 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCC--------
Confidence 9999999999999999999997654 7999999999999999999999999 999999999999986311
Q ss_pred eeecccccccccccc--CceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 286 CIYYGLFFNNMLFQD--YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.+ ..+||+|||+|+.+.... ...+.||++.|||||++..+.|+.|+|+||+|+|||+|++|+
T Consensus 148 -------------~~~~~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 148 -------------NDTSPVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred -------------CCCCceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCC
Confidence 12 679999999999987543 245689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
.||+......... +... .. .+....+...+..+.+|+...|+.+|.+|-++.+-..
T Consensus 212 ~Pf~a~t~~eL~~---~~~k----~~--------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 212 PPFDAETPKELLL---YIKK----GN--------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred CCccccCHHHHHH---HHhc----cc--------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 9998654322111 1110 00 0111122222334456777777777777766655443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=397.99 Aligned_cols=263 Identities=29% Similarity=0.374 Sum_probs=214.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|+++++||+|+||+||.++.++ |++.||+|++++..... .+....|..||.+++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 3579999999999999999999875 78899999998765432 35578999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
++.+.+|||+||+.||.|..+|.+. ..+++..+..++.+|+.||.|||+++ ||||||||+||||+
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd----------- 159 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLD----------- 159 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeec-----------
Confidence 9999999999999999999999654 57999999999999999999999999 99999999999999
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.+++++|+||||++........ ..++|||+.|||||++.+..|+..+|+|||||++|||++|.+
T Consensus 160 --------------~~GHi~LtDFgL~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 160 --------------EQGHIKLTDFGLCKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred --------------CCCcEEEeccccchhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCC
Confidence 5899999999999965443322 344899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCc
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 444 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~ 444 (511)
||....... +.......+ ....+.-.+.++++|+.++|..||++|.....=...++..+.+..
T Consensus 224 PF~~~~~~~------~~~~I~~~k-----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 224 PFYAEDVKK------MYDKILKGK-----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred CCcCccHHH------HHHHHhcCc-----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 998654322 111111111 011111235788999999999999999743333333555655555
Q ss_pred CCC
Q 010432 445 MAS 447 (511)
Q Consensus 445 ~~~ 447 (511)
+.+
T Consensus 287 inW 289 (357)
T KOG0598|consen 287 INW 289 (357)
T ss_pred CCH
Confidence 543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=410.76 Aligned_cols=255 Identities=35% Similarity=0.583 Sum_probs=210.9
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcE-EEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~-vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+.+.+.||+|+||+||+|.++ |.. ||||++....... .+.|.+|+.+|.+|+|||||+|+|+|.+.
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 344456999999999999995 445 9999998754332 35899999999999999999999999988
Q ss_pred C-eEEEEEEccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 208 D-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 208 ~-~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
. ..+|||||+++|+|.+++.. ....+++..++.|+.|||.||.|||++++ ||||||||+||||+.
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~----------- 178 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDL----------- 178 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcC-----------
Confidence 7 79999999999999999987 47789999999999999999999999874 999999999999994
Q ss_pred eeeccccccccccccC-ceeeecCCCcccCCCCCcceeeeeccccccccCCcccc--cCCCCccccchhHHHHHHHHHhC
Q 010432 286 CIYYGLFFNNMLFQDY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DIwSlGvil~elltg 362 (511)
+. ++||||||+++...... ...+...||+.|||||++. ...|+.|+||||||++||||+||
T Consensus 179 --------------~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~ 242 (362)
T KOG0192|consen 179 --------------KGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTG 242 (362)
T ss_pred --------------CCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHC
Confidence 54 89999999998765432 1233468999999999999 56999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
+.||....... .. ..++....+..++..+++.+..||.+||+.||..||++.+|+..|+.+..
T Consensus 243 ~~Pf~~~~~~~---~~-------------~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 243 EIPFEDLAPVQ---VA-------------SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCCCHHH---HH-------------HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 99998654311 11 11111122333344467889999999999999999999999999986643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-52 Score=382.94 Aligned_cols=267 Identities=27% Similarity=0.335 Sum_probs=214.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
+.|+.+.++|+|+||+||+|++++ ||+.||||++...... -.+-.+||+++|++|+|+|+|.|+.+|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 357888899999999999999887 8999999999755332 23457899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
...++||+|||+. ++.+-|.+....++...+..|+.|++.|+.|+|+++ ||||||||+||||+
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit------------- 135 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILIT------------- 135 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEe-------------
Confidence 9999999999966 666667777778999999999999999999999999 99999999999999
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||||||+|+.+..... ..+..+.|.+|+|||++.+ ..|+..+||||+||++.||++|.+.
T Consensus 136 ------------~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL 201 (396)
T KOG0593|consen 136 ------------QNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPL 201 (396)
T ss_pred ------------cCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcC
Confidence 488899999999998874332 3566789999999999987 6899999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhc--------cccccccccCCccCCC--CC---HHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLG--------ERRRFYRLIDPRLEGH--FS---IKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--~~---~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|.+..+.+..-.+......+. ....+..+.-|..... .. ...+.-+.+|+..||+.||++|++.+++
T Consensus 202 ~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 202 WPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred CCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence 998876655443333222211 1111111111111111 11 1234578899999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+.+
T Consensus 282 l~H 284 (396)
T KOG0593|consen 282 LHH 284 (396)
T ss_pred hcC
Confidence 863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-52 Score=379.01 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=206.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEee-EEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG-YCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~-~~~ 205 (511)
.+|+++++||+|+||+||++.+.. +|..||.|.++..... ....+..|+.+|++|+|||||++++ .|.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 468888999999999999999876 6889999999865443 3356889999999999999999998 455
Q ss_pred eCCe-EEEEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCcEEeccccccc
Q 010432 206 EDDQ-RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERP--VIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~~-~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~--iiHrDLKp~NILl~~~~~~~ 279 (511)
++.. ++||||||.+|||.+.+. .....+++..+++++.|++.||.++|..- ++ |+||||||.||+|+
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~------ 162 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLT------ 162 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEc------
Confidence 5555 789999999999999885 34567999999999999999999999843 33 99999999999999
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+||||++.+..... .....+|||.||+||.+.+.+|+.++||||+||++|||
T Consensus 163 -------------------~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEM 221 (375)
T KOG0591|consen 163 -------------------ANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEM 221 (375)
T ss_pred -------------------CCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 478899999999998765433 35568999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+.-+.||.+... ..+...+. .-.+..-.....+.++..||..|+..||..||+...++..+
T Consensus 222 caL~~PF~g~n~---~~L~~KI~-------------qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 222 CALQSPFYGDNL---LSLCKKIE-------------QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HhcCCCcccccH---HHHHHHHH-------------cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 999999987621 11111111 00111111245678999999999999999999855554443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=401.67 Aligned_cols=261 Identities=30% Similarity=0.454 Sum_probs=215.6
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEee
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
.+.+..+.+.+++.||+|.||.||+|++.. ...||+|.++..... .+.|.+|+++|++|+|+|||+|++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~----------~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG----------STKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYG 268 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC----------CCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEE
Confidence 333444556667789999999999999964 337999999876433 467999999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+|..++.++||||||+.|+|.++|.. .+..+.....+.++.|||+||+||++++ +|||||.++||||+
T Consensus 269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~-------- 337 (468)
T KOG0197|consen 269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVD-------- 337 (468)
T ss_pred EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeec--------
Confidence 99998899999999999999999986 4567899999999999999999999999 99999999999999
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
++..+||+|||||+...+ +.+.......-++.|.|||.+..+.|+.|||||||||+||||+|
T Consensus 338 -----------------~~~~vKIsDFGLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT 399 (468)
T KOG0197|consen 338 -----------------EDLVVKISDFGLARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFT 399 (468)
T ss_pred -----------------cCceEEEcccccccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhc
Confidence 578899999999995444 33333444445789999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 362 -GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 362 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
|+.||...... ++ .+.++...+-..|..|+..+.+||..||+.+|++||||..+...|+.+.
T Consensus 400 ~G~~py~~msn~---ev--------------~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 400 YGRVPYPGMSNE---EV--------------LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred cCCCCCCCCCHH---HH--------------HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 77777654321 11 1222333333445567899999999999999999999999998887653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=393.83 Aligned_cols=267 Identities=26% Similarity=0.341 Sum_probs=215.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHH--HHHHHHHHhCCC-CCCcceEeeE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDLV-HLNLVKLIGY 203 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~--~~~E~~il~~l~-H~nIv~l~~~ 203 (511)
.-++|.++++||.|+||.||+|+.+. +|..||||.++..-.. .++ -+||+..|++|+ |||||+|.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 34678999999999999999999876 6779999999876433 233 368999999998 9999999999
Q ss_pred EEeCC-eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 204 CIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 204 ~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+.+.+ .+++||||| ..+|++++..+...+++..++.|+.||+.||+|+|.+| +.||||||+|||+..
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~-------- 145 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISG-------- 145 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecc--------
Confidence 99988 999999999 45999999988889999999999999999999999999 999999999999983
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-cCCCCccccchhHHHHHHHHHh
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DIwSlGvil~ellt 361 (511)
...+||+|||+||....... .|..+-|.+|+|||++. .+-|+.++||||+|||++|+.+
T Consensus 146 -----------------~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s 205 (538)
T KOG0661|consen 146 -----------------NDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS 205 (538)
T ss_pred -----------------cceeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH
Confidence 66799999999998766443 45678899999999886 5678999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhh-----hcccccccccc--------CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPH-----LGERRRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
-++.|.+..+.+....+-.+... +.+...+-..+ ...+..-++ .++.++.+||.+||.+||++|||
T Consensus 206 LrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpT 284 (538)
T KOG0661|consen 206 LRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPT 284 (538)
T ss_pred hcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCcc
Confidence 99999987765443222211111 11101111111 111111222 26788999999999999999999
Q ss_pred HHHHHHHh
Q 010432 429 MSEVVEAL 436 (511)
Q Consensus 429 ~~eil~~L 436 (511)
|.+++++-
T Consensus 285 A~~al~~p 292 (538)
T KOG0661|consen 285 ASQALQHP 292 (538)
T ss_pred HHHHhcCc
Confidence 99999853
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=390.22 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=212.3
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCC-CCCCcceEe
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKLI 201 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l-~H~nIv~l~ 201 (511)
....+|..++.||+|+|++|++|+.+. +++.||||++.+.-... .+-+.+|-.+|.+| .||.||+||
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy 140 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLY 140 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEE
Confidence 345689999999999999999999876 78899999997653322 23467899999999 899999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
..|+++..+|+|+||+++|+|.++|.+. +.|++..++.++.+|+.||+|||++| ||||||||+||||+
T Consensus 141 ~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd-------- 208 (604)
T KOG0592|consen 141 FTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLD-------- 208 (604)
T ss_pred EEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEc--------
Confidence 9999999999999999999999999665 57999999999999999999999999 99999999999999
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcc---------e--eeeeccccccccCCcccccCCCCccccch
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT---------H--VSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~---------~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DIw 350 (511)
+++++||+|||.|+.+...... . ....++||..|.+||+|.....+..+|||
T Consensus 209 -----------------~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiW 271 (604)
T KOG0592|consen 209 -----------------KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLW 271 (604)
T ss_pred -----------------CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchH
Confidence 5999999999999976542221 0 12458999999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 351 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
+||||||+|+.|.+||.+.++.-. +.+++. +.-.|+..+++.+.+|+.++|..||.+|+++.
T Consensus 272 AlGCilyQmlaG~PPFra~Neyli----------------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 272 ALGCILYQMLAGQPPFRAANEYLI----------------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred HHHHHHHHHhcCCCCCccccHHHH----------------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 999999999999999986543211 111211 11123334458899999999999999999998
Q ss_pred HHHHH
Q 010432 431 EVVEA 435 (511)
Q Consensus 431 eil~~ 435 (511)
+|.+|
T Consensus 334 qIk~H 338 (604)
T KOG0592|consen 334 QIKAH 338 (604)
T ss_pred HHhhC
Confidence 87764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=387.06 Aligned_cols=270 Identities=25% Similarity=0.308 Sum_probs=216.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
...+.|+.+++||+|.||.||+|++.. +|+.||+|.+..+.. .......|||.||++|+|||||+|.+.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~ei 184 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEI 184 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeE
Confidence 345678899999999999999999876 788999999987653 334557899999999999999999998
Q ss_pred EEeC--CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 204 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
..+. ..+|||+|||+. ||.-++......|++.++..|+.||+.||+|||+++ |+|||||.+||||+
T Consensus 185 vt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLid-------- 252 (560)
T KOG0600|consen 185 VTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILID-------- 252 (560)
T ss_pred EEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEc--------
Confidence 8876 689999999966 999999887788999999999999999999999999 99999999999999
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~ell 360 (511)
+++.+||+|||||+.+....... .+..+-|.+|+|||+++|. .|+.++|+||.||||.||+
T Consensus 253 -----------------n~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~ 314 (560)
T KOG0600|consen 253 -----------------NNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF 314 (560)
T ss_pred -----------------CCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH
Confidence 58899999999999766544332 4556779999999999864 7999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccc-cc---c--ccccCC------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGER-RR---F--YRLIDP------RLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~---~--~~~~~~------~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
+|++.|.+..+......+-..+..-.+. +. + .....+ .+... ....+....+|+..||..||.+|.|
T Consensus 315 ~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~t 393 (560)
T KOG0600|consen 315 LGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGT 393 (560)
T ss_pred cCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCcccccc
Confidence 9999999887655544443332211110 00 0 011111 01111 1123567889999999999999999
Q ss_pred HHHHHHH
Q 010432 429 MSEVVEA 435 (511)
Q Consensus 429 ~~eil~~ 435 (511)
|.++|+.
T Consensus 394 A~~aL~s 400 (560)
T KOG0600|consen 394 ASSALQS 400 (560)
T ss_pred HHHHhcC
Confidence 9999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-49 Score=389.24 Aligned_cols=266 Identities=26% Similarity=0.336 Sum_probs=210.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEee
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
...++|+++++||+|+||.||+|+-+. ||..||+|++++..... .+.+..|-.+|...++++||+||.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY 208 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY 208 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence 346799999999999999999998765 89999999999875433 345778999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
.|++.+++||||||++|||+..+|.+. ..|++..+..++.+++.|++.||..| +|||||||+|+|||.
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~-------- 276 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDA-------- 276 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecC--------
Confidence 999999999999999999999999655 47999999999999999999999999 999999999999994
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCC----------------------CCcc--------------------
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE----------------------GDKT-------------------- 320 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~----------------------~~~~-------------------- 320 (511)
.+++||+||||+.-+.. .+..
T Consensus 277 -----------------~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 339 (550)
T KOG0605|consen 277 -----------------KGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKR 339 (550)
T ss_pred -----------------CCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHh
Confidence 78888888888852210 0000
Q ss_pred ---eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCC
Q 010432 321 ---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 397 (511)
Q Consensus 321 ---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (511)
......+|||.|||||++.+..|+..+|+||||||+||||.|.+||....+......+...+..+..
T Consensus 340 nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------- 409 (550)
T KOG0605|consen 340 NRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------- 409 (550)
T ss_pred hhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC----------
Confidence 0011368999999999999999999999999999999999999999987765443322221211111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCcC
Q 010432 398 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 445 (511)
Q Consensus 398 ~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~ 445 (511)
.-....+.++++||.+||. ||++|.. ..=++.++..+.++.+
T Consensus 410 ----P~~~~~s~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 410 ----PEEVDLSDEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGV 451 (550)
T ss_pred ----CCcCcccHHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccC
Confidence 1111234789999999999 9999986 2223333444444443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=355.71 Aligned_cols=266 Identities=26% Similarity=0.370 Sum_probs=215.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.+|..+++||+|.||+||+|++.. ||+.||||.++.....+ ....+||++.|+.++|+||+.|+++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 467888899999999999999876 78899999998764432 3467899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+.+-||+||++. ||+..|+.+...+....+..++.++++||+|||++. |+||||||.|+|++
T Consensus 73 ~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis------------- 135 (318)
T KOG0659|consen 73 KSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLIS------------- 135 (318)
T ss_pred CCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEc-------------
Confidence 9999999999954 999999888889999999999999999999999999 99999999999999
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+|+......... +..+-|.+|+|||++.| ..|+..+||||.|||+.||+-|.+-
T Consensus 136 ------------~~g~lKiADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~ 201 (318)
T KOG0659|consen 136 ------------SDGQLKIADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF 201 (318)
T ss_pred ------------CCCcEEeecccchhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC
Confidence 48899999999999987765543 22367999999999986 4799999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhh-----hhccccc------cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARP-----HLGERRR------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~-----~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
|.+.++.+....+-.+.. .+++... +...-.+.+.. .-..++.++.+|+.+||.+||.+|+++.|+++
T Consensus 202 fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 202 FPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred CCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 988766544333322211 1111111 11111111111 22334677799999999999999999999987
Q ss_pred H
Q 010432 435 A 435 (511)
Q Consensus 435 ~ 435 (511)
+
T Consensus 281 ~ 281 (318)
T KOG0659|consen 281 H 281 (318)
T ss_pred c
Confidence 4
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=377.70 Aligned_cols=259 Identities=30% Similarity=0.443 Sum_probs=205.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.++...+.||+|+||.||++.+.+ +|..+|||.+........+.+.+|+.+|.+|+|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 356677899999999999999876 57899999998764333456889999999999999999999754444
Q ss_pred --eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 209 --QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 209 --~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.++|.|||+++|+|.+++.+.+..+++..++.+++||+.||.|||+++ ||||||||+||||+.
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~------------ 152 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDP------------ 152 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeC------------
Confidence 688999999999999999876558999999999999999999999999 999999999999983
Q ss_pred eeccccccccccccCceeeecCCCcccCCC-CCcceeeeeccccccccCCcccccCC-CCccccchhHHHHHHHHHhCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~-~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++.... ...........||+.|||||++..+. ...++|||||||++.||+||+.
T Consensus 153 ------------~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 153 ------------SNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred ------------CCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 157899999999987653 11111223468999999999998632 3359999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
||... ... ..+.. .+......+.++...+.++.+++.+|+..||.+||||.++|++.-.
T Consensus 221 PW~~~--~~~---~~~~~----------~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 221 PWSEF--FEE---AEALL----------LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cchhh--cch---HHHHH----------HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 99753 111 11111 1111111223444457889999999999999999999999987643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=357.59 Aligned_cols=239 Identities=28% Similarity=0.363 Sum_probs=206.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
..++|+.++.||.|+||+|.+++.+. +|..||+|++++...-. .+...+|..+|+.+.||+++++++.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t 112 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT 112 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe
Confidence 34689999999999999999999887 67899999998765433 3456789999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
|.+.+.+||||||++||.|..+|++ .+++++..++.++.||+.||+|||+++ ||+|||||+|||||
T Consensus 113 ~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD---------- 178 (355)
T KOG0616|consen 113 FKDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLD---------- 178 (355)
T ss_pred eccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeec----------
Confidence 9999999999999999999999954 458999999999999999999999999 99999999999999
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+|+..... ..+.||||.|+|||++...+|+.++|+|||||++|||+.|.
T Consensus 179 ---------------~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 179 ---------------QNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred ---------------cCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 5899999999999987553 34579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
+||...++....+. ++.. .-.++..++.++++|+.++|+.|-.+|
T Consensus 239 pPF~~~~~~~iY~K----------------I~~~--~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 239 PPFYDDNPIQIYEK----------------ILEG--KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCCcCCChHHHHHH----------------HHhC--cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 99987765322211 1111 112344456789999999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=383.81 Aligned_cols=252 Identities=27% Similarity=0.345 Sum_probs=208.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC----c-ccHHHHHHHHHHHhCCC-CCCcceE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----L-QGHKEWLAEVNFLGDLV-HLNLVKL 200 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~----~-~~~~~~~~E~~il~~l~-H~nIv~l 200 (511)
..++|.+.+.||+|+||+|++|++.. ++..||||++.... . ...+.+.+|+.+++.++ ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 45689999999999999999999876 67899999877641 1 22345668999999998 9999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+.++.....+++|||||.||+|.+++.. ..++.+..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~------ 155 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDG------ 155 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecC------
Confidence 9999999999999999999999999987 668999999999999999999999999 999999999999994
Q ss_pred CCcceeeecccccccccccc-CceeeecCCCcccCC-CCCcceeeeeccccccccCCcccccCC-CC-ccccchhHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQD-YNAKLSDFGLAKDGP-EGDKTHVSTRVMGTYGYAAPEYVMTGH-LT-SRSDVYSFGVVL 356 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~-~~~kl~DFGla~~~~-~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~-~~~DIwSlGvil 356 (511)
+ +.+||+|||++.... ... ...+.+||+.|+|||++.+.. |+ .++||||+||+|
T Consensus 156 -------------------~~~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 156 -------------------NEGNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVIL 213 (370)
T ss_pred -------------------CCCCEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHH
Confidence 5 889999999999874 222 245689999999999999877 85 789999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG-AQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|.|++|+.||........ ......... .++... +.++..|+.+||..||.+|+++.+|+.+
T Consensus 214 y~ml~G~~PF~d~~~~~l------~~ki~~~~~------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 214 YVLLCGRLPFDDSNVPNL------YRKIRKGEF------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred HHHHhCCCCCCCccHHHH------HHHHhcCCc------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 999999999986322111 111111101 111122 6788999999999999999999999954
Q ss_pred hc
Q 010432 436 LK 437 (511)
Q Consensus 436 L~ 437 (511)
=+
T Consensus 276 ~w 277 (370)
T KOG0583|consen 276 PW 277 (370)
T ss_pred hh
Confidence 43
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=380.80 Aligned_cols=248 Identities=29% Similarity=0.392 Sum_probs=211.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|.+.+.||+|+||+||||+.+. +.+.||||.+.+.... ..+.+.+|++|+++|+|||||.++++|..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 468888999999999999998776 7889999999765433 34568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
..++|+|+|||.| +|..+|... ..++++.+..|+.|++.||.|||+++ |+|||+||.|||++
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~------------- 134 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLE------------- 134 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeec-------------
Confidence 9999999999965 999999654 57999999999999999999999999 99999999999999
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
..+.+|+||||+|+.... .+.+.+.+.|||.|||||++.+++|+..+|+||+|||+|||++|++||
T Consensus 135 ------------~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 135 ------------KGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred ------------CCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc
Confidence 488999999999998765 345678899999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.... ...++. ....+ +. ..+...+..+..|+..+|.+||.+|.+..+++.+
T Consensus 201 ~a~s---i~~Lv~---~I~~d---------~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 201 YARS---ITQLVK---SILKD---------PV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred hHHH---HHHHHH---HHhcC---------CC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 7432 111111 11111 11 1223557889999999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=403.95 Aligned_cols=268 Identities=29% Similarity=0.456 Sum_probs=225.2
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.+.+.+.+..+.||+|.||+||+|+...... ......||||.++..... .+.+|.||+++|..|+|||||+|+|+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p----~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLP----GQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCC----CccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3445566777889999999999998764321 124568999999987665 66789999999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhC---------CC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcE
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRR---------SL----PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~---------~~----~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NI 270 (511)
|..++.+|||+|||..|||.+||..+ +. +++..+.+.|+.|||.||+||-++. +|||||..+|+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhc
Confidence 99999999999999999999999643 12 2788899999999999999999988 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccch
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIw 350 (511)
||. ++..|||+||||++.....+++.......-.++|||||.|+.++|+++||||
T Consensus 635 LVg-------------------------e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVW 689 (774)
T KOG1026|consen 635 LVG-------------------------ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVW 689 (774)
T ss_pred eec-------------------------cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhh
Confidence 999 5889999999999998888877766555668899999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 351 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 351 SlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
||||+|||+++ |+.||.+...... ++.++. ..+ -..+..++.+++.||..||+.+|.+||+|
T Consensus 690 s~GVvLWEIFsyG~QPy~glSn~EV---Ie~i~~-------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 690 SFGVVLWEIFSYGKQPYYGLSNQEV---IECIRA-------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSF 752 (774)
T ss_pred hhhhhhhhhhccccCcccccchHHH---HHHHHc-------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCH
Confidence 99999999998 8899987654322 222211 111 33455678999999999999999999999
Q ss_pred HHHHHHhcCCCC
Q 010432 430 SEVVEALKPLPN 441 (511)
Q Consensus 430 ~eil~~L~~l~~ 441 (511)
.||-..|+.+..
T Consensus 753 ~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 753 KEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHHHHHh
Confidence 999999986644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=381.67 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=214.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
...|....+||+|+.|.||.|+... +++.||||++........+-+++|+.+|+.++|+|||++++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~---------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIS---------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeeeeecc---------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 3568888899999999999998765 6779999999988777767789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+.+|+||||++||+|.+.+.. ..+++.++..|+++++.||+|||.++ |||||||.+|||++
T Consensus 343 deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~-------------- 403 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLT-------------- 403 (550)
T ss_pred ceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEec--------------
Confidence 999999999999999998843 35899999999999999999999999 99999999999999
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||++..+..... ...+.+||+.|||||++....|++++||||||++++||+-|.+||.
T Consensus 404 -----------~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 404 -----------MDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred -----------cCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 477899999999988766443 2455789999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...+.....++. . ........+...+..+++|+.+||+.|+.+|+++.|+|++
T Consensus 471 nE~PlrAlyLIa--~-------------ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 471 NENPLRALYLIA--T-------------NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCChHHHHHHHh--h-------------cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 544322111110 0 0111222334557899999999999999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=382.62 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=206.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+....++-||.|+-|.||+|+++ ++.||||.++.- -..+++-|++|+|+||+.|.|+|..
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeecc-----------CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecC
Confidence 3344455678999999999999985 568999988632 1357888999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
..-+|||||||..|-|++.|.. ...+.......|..+||.||.|||.+. |||||||.-||||..
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~------------ 247 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISY------------ 247 (904)
T ss_pred CceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeec------------
Confidence 9999999999999999999954 457888889999999999999999999 999999999999995
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+..|||+|||.++...+.. ....++||..|||||++.+.+.+.|+|||||||||||||||..||
T Consensus 248 -------------~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPY 311 (904)
T KOG4721|consen 248 -------------DDVVKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPY 311 (904)
T ss_pred -------------cceEEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCc
Confidence 6679999999999876542 244589999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.+...... ++..-...+....+..+++.++-||+.||+..|..||+|.+|+.+|+-.
T Consensus 312 kdVdssAI----------------IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 312 KDVDSSAI----------------IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccchhee----------------EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 75432110 1111122234445666788999999999999999999999999998643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=356.91 Aligned_cols=268 Identities=24% Similarity=0.289 Sum_probs=213.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|+.+..|++|+||.||+|+++. |++.||+|+++.+... -.-.-+||+.+|.+++|||||.+-.+..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 3578888999999999999999876 7889999999865421 1124589999999999999999998876
Q ss_pred e--CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 206 E--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 206 ~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
. -+.+|||||||+. ||..++.....++...++..++.|++.||+|||.+. |+|||||++|+|+.
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~---------- 211 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLS---------- 211 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeec----------
Confidence 5 3679999999966 999999888889999999999999999999999999 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg 362 (511)
+.+.+||+|||+|+.+..... ..+..+-|.+|+|||++.+. .|++++|+||+|||+.||+++
T Consensus 212 ---------------~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~ 274 (419)
T KOG0663|consen 212 ---------------HKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQ 274 (419)
T ss_pred ---------------cCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhc
Confidence 588899999999999877643 25566789999999999864 699999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhh--------hcccc-----ccccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPH--------LGERR-----RFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~--------~~~~~-----~~~~~~~~~~~~~~~~~-~~~~~~~Li~~cl~~dP~~RPs 428 (511)
++.|.+....+..+.+-..... +.+.. .+.......++..|... .++...+|+..+|.+||.+|.|
T Consensus 275 kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t 354 (419)
T KOG0663|consen 275 KPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT 354 (419)
T ss_pred CCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc
Confidence 9999988766554433222111 00000 00000001122223222 3577889999999999999999
Q ss_pred HHHHHHH
Q 010432 429 MSEVVEA 435 (511)
Q Consensus 429 ~~eil~~ 435 (511)
+.+.|++
T Consensus 355 A~~~L~h 361 (419)
T KOG0663|consen 355 AEDGLKH 361 (419)
T ss_pred HHHhhcc
Confidence 9999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=380.85 Aligned_cols=270 Identities=26% Similarity=0.440 Sum_probs=216.9
Q ss_pred ccChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCC
Q 010432 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHL 195 (511)
Q Consensus 118 ~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~ 195 (511)
..+..++.+..+.+.+...||+|.||+||+|+|.. .||||+++...... .+.|..|+.+|++-+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~ 448 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHE 448 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchh
Confidence 34456777777888899999999999999999976 79999998775543 45799999999999999
Q ss_pred CcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccc
Q 010432 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 196 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 275 (511)
||+-++|||..+.. .||+.+|+|-+|+.+|+.....|.....+.|++||+.||.|||.++ |||||||..||+|.
T Consensus 449 NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~-- 522 (678)
T KOG0193|consen 449 NILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLH-- 522 (678)
T ss_pred hheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEc--
Confidence 99999999988776 9999999999999999877778999999999999999999999999 99999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhH
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSF 352 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSl 352 (511)
++..|||+||||+.....-..........|...|||||+++ ..+|+..+|||||
T Consensus 523 -----------------------~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaF 579 (678)
T KOG0193|consen 523 -----------------------EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAF 579 (678)
T ss_pred -----------------------cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhh
Confidence 47899999999997533222111223356889999999997 4589999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
||++|||++|..||......... | ..+... +.+.+ ......+++++++|+..||.+++++||.+.+|
T Consensus 580 GiV~YELltg~lPysi~~~dqIi----f---mVGrG~-----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i 646 (678)
T KOG0193|consen 580 GIVWYELLTGELPYSIQNRDQII----F---MVGRGY-----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQL 646 (678)
T ss_pred hHHHHHHHhCcCCcCCCChhheE----E---Eecccc-----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence 99999999999999833221110 0 011110 00000 11223457899999999999999999999999
Q ss_pred HHHhcCCCC
Q 010432 433 VEALKPLPN 441 (511)
Q Consensus 433 l~~L~~l~~ 441 (511)
+..|+.+..
T Consensus 647 l~~l~~l~~ 655 (678)
T KOG0193|consen 647 LSKLEELLP 655 (678)
T ss_pred HHHHHHhhh
Confidence 997766544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=362.26 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=213.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH-HHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.+.|++.+.||.|..++||+|++.. ++..||||+++.+..... +.+.+|+..|+.++||||++++..|..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 4689999999999999999999876 678999999988766543 678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+..+|+||.||.+|++.+++... ...+++..+..|+++++.||.|||.+| .||||||+.||||+
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~------------ 160 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILID------------ 160 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEc------------
Confidence 99999999999999999999643 345899999999999999999999999 99999999999999
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCC-cceee-eeccccccccCCcccc--cCCCCccccchhHHHHHHHHHh
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD-KTHVS-TRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~-~~~~~-~~~~Gt~~y~aPE~~~--~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.|||+|||.+-.+.... ..... ..++||+.|||||++. ...|+.|+||||||++..||.+
T Consensus 161 -------------~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~ 227 (516)
T KOG0582|consen 161 -------------SDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH 227 (516)
T ss_pred -------------CCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence 58999999999987654433 22222 5679999999999965 3589999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|..||....+.....+ .+..... ...-..+..+....++..+++++..||++||.+|||+++++++
T Consensus 228 G~aPf~k~pPmkvLl~------tLqn~pp--~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 228 GHAPFSKYPPMKVLLL------TLQNDPP--TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCCcccCChHHHHHH------HhcCCCC--CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 9999987655322111 1111110 0000111222223345689999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=370.96 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=211.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
..|+.+++||+|+||.||+|.+.. +++.||||++..+.... .+++.+|+.+|..++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 357777899999999999999876 78899999998775443 46788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..++++||||.||++.+.|.. +..+.+..+..++++++.||.|||.++ .||||||+.|||+..
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~------------- 146 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSE------------- 146 (467)
T ss_pred ccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEec-------------
Confidence 999999999999999999854 345578888889999999999999999 999999999999984
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
++.+||+|||.+..+...... ..+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+.
T Consensus 147 ------------~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 147 ------------SGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred ------------cCcEEEEecceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 688999999999887664433 356899999999999998899999999999999999999999998
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...+.... -++.....+.....+++.+++|+..||++||+.||+|.+++++
T Consensus 213 ~~hPmrvl-----------------flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 213 KLHPMRVL-----------------FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccCcceEE-----------------EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 76553211 1222222223333556889999999999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=379.02 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=209.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
+-|++++.||.|+-|.|-+|++.. ||+.+|||++.+... .....+.+|+-||+-|.||||++||++|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 458888999999999999999876 899999999977621 11245779999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+..++|||+||+++|.|+++|.++ +++++..+.+++.||+.|+.|+|..+ |+||||||+|+||+.
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~----------- 147 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDV----------- 147 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhc-----------
Confidence 999999999999999999999765 47999999999999999999999999 999999999999994
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~~ 364 (511)
+..+||+|||+|.....+. ...+.||++.|.|||++.+.+| +.++||||+|||||-||||+.
T Consensus 148 --------------~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~L 210 (786)
T KOG0588|consen 148 --------------KNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKL 210 (786)
T ss_pred --------------ccCEeeeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCC
Confidence 5569999999998765543 2445799999999999999999 579999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||++.+ ...+...++.. .-+++...+.++.+||.+||..||.+|.|+.||++|-
T Consensus 211 PFdDdN---ir~LLlKV~~G---------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 211 PFDDDN---IRVLLLKVQRG---------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred CCCCcc---HHHHHHHHHcC---------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 998542 12222111110 1112233467899999999999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=382.44 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=207.3
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCC-CCCCcceE
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKL 200 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l-~H~nIv~l 200 (511)
....++|.++++||+|+||+|+++..+. +++.||||+++++..- ..+..+.|.+|+... +||.+++|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 3456789999999999999999999876 6789999999988653 345678899998877 59999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+.+|+..+++|+||||+.||||..++ +...+++..+..|+..|+.||+|||+++ |||||||.+|||||
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD------- 502 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLD------- 502 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEc-------
Confidence 99999999999999999999965544 3357999999999999999999999999 99999999999999
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.++++||+|||+++....... ...++|||+.|||||++.+..|+.++|+|||||+|||||
T Consensus 503 ------------------~eGh~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML 562 (694)
T KOG0694|consen 503 ------------------TEGHVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML 562 (694)
T ss_pred ------------------ccCcEEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH
Confidence 489999999999998653322 245699999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
.|..||.+.++....+. ++.. ...++.-.+.++..||+++|.+||++|..+
T Consensus 563 ~Gq~PF~gddEee~Fds----------------I~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 563 VGESPFPGDDEEEVFDS----------------IVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCCCCCCCCCHHHHHHH----------------HhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 99999987654332211 1111 122334457889999999999999999855
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=376.72 Aligned_cols=267 Identities=29% Similarity=0.432 Sum_probs=205.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
+..++|++.++||+|+||.||+|.+.... ...++..||||+++.... .....+.+|+.+|.++ +|||||+++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 34568999999999999999999864211 112567899999975432 2235688999999999 89999999998
Q ss_pred EEeC-CeEEEEEEccCCCCHHHHHhhCC----------------------------------------------------
Q 010432 204 CIED-DQRLLVYEFMPRGSLENHLFRRS---------------------------------------------------- 230 (511)
Q Consensus 204 ~~~~-~~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------- 230 (511)
+... ..+++|||||++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 45889999999999999986421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccC
Q 010432 231 ---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301 (511)
Q Consensus 231 ---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (511)
..+++..++.++.||+.||+|||+++ |+||||||+|||++ +++
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~-------------------------~~~ 211 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLS-------------------------ENN 211 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEc-------------------------CCC
Confidence 24777888999999999999999988 99999999999998 477
Q ss_pred ceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHh
Q 010432 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 380 (511)
Q Consensus 302 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~ 380 (511)
.+||+|||+++...............+|+.|||||++.+..++.++|||||||+||||++ |..||....... .+...
T Consensus 212 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~ 289 (338)
T cd05102 212 VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQR 289 (338)
T ss_pred cEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHH
Confidence 899999999987543322222233456789999999999999999999999999999997 999997643211 11110
Q ss_pred hhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 381 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
..... ....+...+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 290 ----~~~~~----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 290 ----LKDGT----------RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred ----HhcCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 00111223567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=362.27 Aligned_cols=262 Identities=26% Similarity=0.345 Sum_probs=208.5
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------------cHHHHHHHHHHHh
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKEWLAEVNFLG 190 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------------~~~~~~~E~~il~ 190 (511)
....++|++++.||+|.||.|-+|++.. +++.||||++.+.... ..+.+.+|+.||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 3456899999999999999999999876 6789999999754321 1246889999999
Q ss_pred CCCCCCcceEeeEEEe--CCeEEEEEEccCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 010432 191 DLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (511)
Q Consensus 191 ~l~H~nIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp 267 (511)
+|+|||||+|+.+..+ .+.+|||+|||..|.+... ....+ +.+.+++.|+++++.||+|||.++ ||||||||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKP 238 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKP 238 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccch
Confidence 9999999999999876 4689999999999887532 22334 899999999999999999999999 99999999
Q ss_pred CcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCc---ceeeeeccccccccCCcccccCC--
Q 010432 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMTGH-- 342 (511)
Q Consensus 268 ~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~---~~~~~~~~Gt~~y~aPE~~~~~~-- 342 (511)
+|+||+ .++++||+|||.+.....+.. .......+|||.|||||++.++.
T Consensus 239 sNLLl~-------------------------~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~ 293 (576)
T KOG0585|consen 239 SNLLLS-------------------------SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSF 293 (576)
T ss_pred hheEEc-------------------------CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCc
Confidence 999999 479999999999986632211 11123368999999999987632
Q ss_pred --CCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 010432 343 --LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 420 (511)
Q Consensus 343 --~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~ 420 (511)
.+.+.||||+||+||.|+.|+.||.+...... +..++...+......+..+.+++||.+||.
T Consensus 294 ~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l----------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~ 357 (576)
T KOG0585|consen 294 SYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL----------------FDKIVNDPLEFPENPEINEDLKDLIKRLLE 357 (576)
T ss_pred cccchhhhhhhhhhhHHHhhhccCCcccchHHHH----------------HHHHhcCcccCCCcccccHHHHHHHHHHhh
Confidence 35689999999999999999999976533211 122333333333333457889999999999
Q ss_pred cCCCCCCCHHHHHHHhcCCCC
Q 010432 421 RDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 421 ~dP~~RPs~~eil~~L~~l~~ 441 (511)
+||.+|.+..+|..+......
T Consensus 358 KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 358 KDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cChhheeehhhheecceeccC
Confidence 999999999999988876544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=352.26 Aligned_cols=296 Identities=23% Similarity=0.256 Sum_probs=220.3
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhCCCCCCcceEe
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~E~~il~~l~H~nIv~l~ 201 (511)
.+..+.|++++.||.|.-|+||+|+.+. ++..+|+|++.+...... .+...|-+||+.++||.++.||
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence 3455678889999999999999999876 567999999987765433 3466799999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+.|..+...|||||||+||+|..+++++ +..+++..++.++.+|+.||+|||-.| ||+|||||+||||...+..++
T Consensus 144 a~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 144 ASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIML 220 (459)
T ss_pred heeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEe
Confidence 9999999999999999999999988754 567999999999999999999999999 999999999999998777777
Q ss_pred CCcceeeeccccccccc-----ccc--Ccee---e----------------ecCCCcccCC---CCCcceeeeecccccc
Q 010432 281 GKFGFCIYYGLFFNNML-----FQD--YNAK---L----------------SDFGLAKDGP---EGDKTHVSTRVMGTYG 331 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~-----~~~--~~~k---l----------------~DFGla~~~~---~~~~~~~~~~~~Gt~~ 331 (511)
+||+++........-.. ... ..+. + .|++...... ..........++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 77777754421000000 000 0000 0 1222110000 0011112445899999
Q ss_pred ccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHH
Q 010432 332 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA 411 (511)
Q Consensus 332 y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (511)
|+|||++.+...+.++|+|+|||+||||+.|..||.+...... +..++-..+...-....+..+
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~a 364 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAA 364 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHH
Confidence 9999999999999999999999999999999999987654321 222222222222222456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCcCCCC
Q 010432 412 AQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASS 448 (511)
Q Consensus 412 ~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~ 448 (511)
++||+++|.+||.+|.....=...+++.+.++.+++.
T Consensus 365 kDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 365 KDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 9999999999999999855444555667777766653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=353.70 Aligned_cols=269 Identities=27% Similarity=0.343 Sum_probs=209.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecC--CCcccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
...|..++.||+|+||.|..|.+.. +|+.||||.+.. ......++.+||+++|+.++|+|||.+++.+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred cceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 4567778899999999999999876 778999999973 33334467889999999999999999999886
Q ss_pred e-----CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 206 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~-----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
. -..+|+|+|+| +.||.+.|.. +..+....+..++.||+.||.|+|+.+ |+||||||.|+|++.
T Consensus 92 p~~~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~------ 160 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNA------ 160 (359)
T ss_pred cccccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeecc------
Confidence 5 34689999999 6699988854 345999999999999999999999999 999999999999994
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-cCCCCccccchhHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DIwSlGvil~el 359 (511)
+..+||||||+|+...........+..+-|.+|+|||++. ...|+.++||||.||||.||
T Consensus 161 -------------------~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEm 221 (359)
T KOG0660|consen 161 -------------------DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEM 221 (359)
T ss_pred -------------------CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHH
Confidence 7778999999999875432233346678899999999886 56899999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccc----------cccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGER----------RRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~---~~~~~~~~~Li~~cl~~dP~~R 426 (511)
++|++.|.+........++......-.+. ..+.+.+.......+. ....+.+.+|+.+||..||.+|
T Consensus 222 L~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kR 301 (359)
T KOG0660|consen 222 LTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKR 301 (359)
T ss_pred HcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCcccc
Confidence 99999999876554444333222111000 0011111111111111 1345789999999999999999
Q ss_pred CCHHHHHHH
Q 010432 427 PLMSEVVEA 435 (511)
Q Consensus 427 Ps~~eil~~ 435 (511)
+|++|.|++
T Consensus 302 ita~eAL~h 310 (359)
T KOG0660|consen 302 ITAEEALAH 310 (359)
T ss_pred CCHHHHhcC
Confidence 999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=343.88 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=211.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
+.++|++.+.||+|.|+.||++.+.. +|+.+|+|+++.... ...+++.+|++|.+.|+|||||+|++.+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 45678888899999999999997765 899999999976543 3457788999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
......|||+|++.||+|..-|..+ ..+++..+-.+++||+.+|.|+|.++ |||||+||+|+||.+..
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~-------- 147 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKA-------- 147 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeecc--------
Confidence 9999999999999999998877655 45788889999999999999999999 99999999999998643
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
..--+||+|||+|..+..+. .....+|||.|||||++...+|+..+|||+.|||||-|+.|++
T Consensus 148 --------------~~A~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~ 210 (355)
T KOG0033|consen 148 --------------KGAAVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 210 (355)
T ss_pred --------------CCCceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCC
Confidence 24568999999999887332 2445789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
||.+.... .+.+.+... +-...+......++++++|+++||..||.+|.|+.|.|++-+
T Consensus 211 PF~~~~~~---rlye~I~~g-----------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 211 PFWDEDQH---RLYEQIKAG-----------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred CCCCccHH---HHHHHHhcc-----------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 99864321 121111110 000111122234678999999999999999999999998643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.41 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=211.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHH---HHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~---~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.+|++.+.||+|.||.|-+|.... .|+.||||.++++...+.. .+.+|++||..|+||||+.+|.+|.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 468888999999999999998754 6889999999988766544 3678999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+.+.|||||..+|.|++|+..+ +.+++..+..+++||+.|+.|+|.++ ++|||||.+|||||
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD------------ 187 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLD------------ 187 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeec------------
Confidence 999999999999999999999665 47999999999999999999999998 99999999999999
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~~ 364 (511)
++.++||+||||+..+.... ..+++||++-|.+||++.+.+| ++.+|-|||||+||.|+.|..
T Consensus 188 -------------~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtM 251 (668)
T KOG0611|consen 188 -------------QNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTM 251 (668)
T ss_pred -------------CCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccc
Confidence 58889999999998876543 3566999999999999999998 678999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
||++... ..++..+. ...+. ..+.+..+.-||++||..||++|.|+.+|..+++
T Consensus 252 PFDG~Dh---k~lvrQIs-------------~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 252 PFDGRDH---KRLVRQIS-------------RGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ccCCchH---HHHHHHhh-------------ccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 9987532 12222111 11111 1112456778999999999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=348.07 Aligned_cols=266 Identities=25% Similarity=0.321 Sum_probs=206.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCC-cceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLN-LVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~n-Iv~l~~~~~ 205 (511)
..|..+++||+|+||+||+|+.+. +|+.||+|.+...... .....++|+.+|++|+|+| ||.|++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 346666789999999999999876 7889999999876432 2345789999999999999 999999999
Q ss_pred eCC------eEEEEEEccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 206 EDD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 206 ~~~------~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
..+ .++||+||+ .-+|..++.... ..++...+..++.||+.||+|||+++ |+||||||.||||+
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~--- 154 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLIS--- 154 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEEC---
Confidence 877 789999999 459999997654 46788899999999999999999999 99999999999999
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVV 355 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvi 355 (511)
+.+.+||+|||+|+........ .+..++|.+|+|||++.+. .|+..+||||+|||
T Consensus 155 ----------------------~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI 210 (323)
T KOG0594|consen 155 ----------------------SSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI 210 (323)
T ss_pred ----------------------CCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence 4888999999999976544332 4556889999999999976 79999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhcccccccc---ccCC--ccCC-----CCCHH---HHHHHHHHHHHhcccC
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR---LIDP--RLEG-----HFSIK---GAQKAAQLAAHCLSRD 422 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~~-----~~~~~---~~~~~~~Li~~cl~~d 422 (511)
++||++++..|.+..+......+-..... +....+.. +.+- .+.. .+... ......+|+.+||+++
T Consensus 211 faEm~~~~~LFpG~se~~ql~~If~~lGt-P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~ 289 (323)
T KOG0594|consen 211 FAEMFTRRPLFPGDSEIDQLFRIFRLLGT-PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYD 289 (323)
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHHHHcCC-CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccC
Confidence 99999999999887653221111111110 00000100 0000 0000 00111 1247889999999999
Q ss_pred CCCCCCHHHHHHH
Q 010432 423 PKARPLMSEVVEA 435 (511)
Q Consensus 423 P~~RPs~~eil~~ 435 (511)
|.+|.|+..++.+
T Consensus 290 p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 290 PAKRISAKGALTH 302 (323)
T ss_pred cccCcCHHHHhcC
Confidence 9999999999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=356.59 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=202.6
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.|++.+.||+|+||.||+|.+.. +++.||||.+...... ....+.+|+.+|++++|+||+++++++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 37778899999999999999876 6789999998754322 22457889999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++..++|||||++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~------------ 136 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLD------------ 136 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEEC------------
Confidence 99999999999999999887543 346899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||++........ .....||..|||||++.+..++.++|||||||++|||++|+.|
T Consensus 137 -------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 200 (285)
T cd05631 137 -------------DRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200 (285)
T ss_pred -------------CCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence 467899999999987543221 2335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
|............. ..... ....++...+..+.+|+.+||+.||.+||+ +++++++
T Consensus 201 f~~~~~~~~~~~~~---~~~~~-----------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 201 FRKRKERVKREEVD---RRVKE-----------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCCCCcchhHHHHH---HHhhc-----------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 98654322111110 00000 011122234578899999999999999997 7788764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=355.95 Aligned_cols=272 Identities=28% Similarity=0.445 Sum_probs=207.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCC-------CccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcce
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~-------~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~ 199 (511)
.++|++.++||+|+||.||+|.+...... .+..+++..||||++...... ....|.+|+.+|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 45788999999999999999987543211 122345668999999765332 2356889999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ii 261 (511)
+++++...+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999985421 23677888999999999999999998 99
Q ss_pred ecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC
Q 010432 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 341 (511)
Q Consensus 262 HrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~ 341 (511)
||||||+|||++ +++.+||+|||+++...............++..|||||++.+.
T Consensus 161 H~dlkp~Nill~-------------------------~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 161 HRDLATRNCLVG-------------------------ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred ccCcchhheEEc-------------------------CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence 999999999998 4778999999999876544333333345568899999999888
Q ss_pred CCCccccchhHHHHHHHHHh--CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhc
Q 010432 342 HLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419 (511)
Q Consensus 342 ~~~~~~DIwSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl 419 (511)
.++.++|||||||++|||++ +..||...... ............... ......+..++..+.+|+.+||
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl 285 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDE---QVIENAGEFFRDQGR-------QVYLFRPPPCPQGLYELMLQCW 285 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH---HHHHHHHHHhhhccc-------cccccCCCCCCHHHHHHHHHHc
Confidence 99999999999999999987 55677654321 111111111110000 0000111223567899999999
Q ss_pred ccCCCCCCCHHHHHHHhc
Q 010432 420 SRDPKARPLMSEVVEALK 437 (511)
Q Consensus 420 ~~dP~~RPs~~eil~~L~ 437 (511)
+.||.+|||+.+|.+.|+
T Consensus 286 ~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 286 SRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCchhCcCHHHHHHHHh
Confidence 999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=330.22 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=210.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|-||.||+|+.+. ++..||+|++.+... ....++.+|++|-..|+||||+++|++|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred hhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 4679999999999999999999876 677999999976542 2345788999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
.+....||++||...|+|...|.. ....+++.....++.|+|.||.|+|..+ ||||||||+|+|++.
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~--------- 159 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGS--------- 159 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCC---------
Confidence 999999999999999999999973 3456899999999999999999999988 999999999999994
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.+.+||+|||.+....... ..+.|||..|.+||++.+..++..+|+|++|++.||++.|.
T Consensus 160 ----------------~~~lkiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ 219 (281)
T KOG0580|consen 160 ----------------AGELKIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGL 219 (281)
T ss_pred ----------------CCCeeccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcC
Confidence 7789999999998765332 34579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
+||......... ..+. -+ .-.++...+..+.+||.+||..+|.+|....|++++-.
T Consensus 220 ppFes~~~~etY---krI~-----------k~----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 220 PPFESQSHSETY---KRIR-----------KV----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred CchhhhhhHHHH---HHHH-----------Hc----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 999765421111 1000 01 11122334678899999999999999999999998753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=371.88 Aligned_cols=264 Identities=26% Similarity=0.394 Sum_probs=205.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.++||+|+||.||+|++... ....++..||||+++.... ...+.+.+|+.+|..+ +|||||+++++|
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 345788999999999999999976321 1123567899999975432 2335688999999999 899999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC------------------------------------------------------
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 230 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------------------ 230 (511)
...+..++|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986421
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 231 --------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 231 --------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~----------------- 248 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLT----------------- 248 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEE-----------------
Confidence 24678889999999999999999988 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 369 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~ 369 (511)
++..+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 249 --------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 249 --------HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred --------CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 467799999999987654332222223345678999999999999999999999999999998 88888654
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
.... ......... .....+...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 321 ~~~~--~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 321 PVDS--KFYKMIKEG--------------YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CchH--HHHHHHHhC--------------ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 3211 111111110 0000111124678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=365.77 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=212.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|..+++||+|+||.+++++++. .+..|++|.+....... ++...+|+.+++++.|||||.+++.|..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~---------~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKS---------DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhcc---------CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 578899999999999999999876 45689999998766443 3457899999999999999999999999
Q ss_pred CCe-EEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 207 DDQ-RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 207 ~~~-~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
++. ++|||+||+||+|.+.|.... ..++++.+..|+.||+.||.|||+++ |+|||||+.||++..
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk---------- 141 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTK---------- 141 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccc----------
Confidence 887 999999999999999997554 67999999999999999999999888 999999999999994
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+..|||+|||+|+.+..... ...+.+||+.||+||++.+.+|+.|+|||||||++|||++-++
T Consensus 142 ---------------~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~ 204 (426)
T KOG0589|consen 142 ---------------DKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKP 204 (426)
T ss_pred ---------------cCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhccc
Confidence 67789999999999876542 2445789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|...+.. .++..+.. ......+...+.+++.|+..||..+|..||++.++|..
T Consensus 205 aF~a~~m~---~Li~ki~~--------------~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 205 AFKASNMS---ELILKINR--------------GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCccchH---HHHHHHhh--------------ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99865432 12111111 11222344457889999999999999999999999975
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=378.63 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=211.2
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeE-
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGY- 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~- 203 (511)
+...++++.++|.+|||+.||+|.+.. .|..||+|++-..+....+.+.+|+++|++|. |+|||.|++.
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 344577888999999999999999875 34799999998776666778899999999996 9999999993
Q ss_pred EEe------CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 204 CIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 204 ~~~------~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
... .-+++|.||||.||.|-+++..+ ...|.+.++++|+.|+++|+.+||... +||||||||-+||||.
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls--- 180 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLS--- 180 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEc---
Confidence 221 13567999999999999999754 345999999999999999999999987 8899999999999999
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc-ee------eeeccccccccCCcccc---cCCCCcc
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HV------STRVMGTYGYAAPEYVM---TGHLTSR 346 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~------~~~~~Gt~~y~aPE~~~---~~~~~~~ 346 (511)
.++..||||||.|......... .. .-...-|+.|+|||++. +.+++.|
T Consensus 181 ----------------------~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK 238 (738)
T KOG1989|consen 181 ----------------------ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK 238 (738)
T ss_pred ----------------------CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch
Confidence 4778999999999753322110 00 00124699999999885 6789999
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 347 ~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
+|||||||+||-|+....||..... ..+++..+...-....+..+.+||..||+.||++|
T Consensus 239 sDIWALGclLYkLCy~t~PFe~sg~--------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~R 298 (738)
T KOG1989|consen 239 SDIWALGCLLYKLCYFTTPFEESGK--------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDER 298 (738)
T ss_pred hHHHHHHHHHHHHHHhCCCcCcCcc--------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccC
Confidence 9999999999999999999975422 12333333333334668899999999999999999
Q ss_pred CCHHHHHHHhcCCCCC
Q 010432 427 PLMSEVVEALKPLPNL 442 (511)
Q Consensus 427 Ps~~eil~~L~~l~~~ 442 (511)
|++-+|+..+.++.+.
T Consensus 299 PnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 299 PNIYQVLEEIFELANK 314 (738)
T ss_pred CCHHHHHHHHHHHhcC
Confidence 9999999988776554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=350.49 Aligned_cols=260 Identities=26% Similarity=0.367 Sum_probs=201.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC--
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 207 (511)
.|...+++|.|+||.||+|.... +++.||||.+..+..- -.+|+.||++++|||||+|+.+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 46667899999999999999986 5779999998765422 23799999999999999999888753
Q ss_pred -C--eEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 208 -D--QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 208 -~--~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+ ...|||||++. +|.+.++. .+..++...+.-+..||.+||.|||+.+ |+||||||.|||+|.
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~------- 160 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDP------- 160 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcC-------
Confidence 2 23499999976 99998863 3567888889999999999999999988 999999999999996
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~ell 360 (511)
+.+.+||||||.|+.+..+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+
T Consensus 161 -----------------~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl 220 (364)
T KOG0658|consen 161 -----------------DTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELL 220 (364)
T ss_pred -----------------CCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHh
Confidence 5789999999999987665543 234568999999999864 7999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhh-cccc------------ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHL-GERR------------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
-|++.|.+...... +...+...- +... .+.++....+...+....++++.+|+.++|+++|.+|.
T Consensus 221 ~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~ 298 (364)
T KOG0658|consen 221 KGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL 298 (364)
T ss_pred cCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence 99999998654333 222222110 0000 11111111111112334468899999999999999999
Q ss_pred CHHHHHHH
Q 010432 428 LMSEVVEA 435 (511)
Q Consensus 428 s~~eil~~ 435 (511)
++.+++.+
T Consensus 299 ~~~~~l~h 306 (364)
T KOG0658|consen 299 SALEALAH 306 (364)
T ss_pred CHHHHhcc
Confidence 99999863
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=355.65 Aligned_cols=267 Identities=23% Similarity=0.330 Sum_probs=203.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.++||.|+||.||+|++.. ++..||+|+++.... .....+.+|+.++++++||||+++++++..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 579999999999999999998865 677999999975432 2234678999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+. |+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~-------------- 137 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLIN-------------- 137 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEC--------------
Confidence 99999999996 5999998766666889999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 138 -----------~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 204 (288)
T cd07871 138 -----------EKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204 (288)
T ss_pred -----------CCCCEEECcCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4778999999999865432221 223568999999998875 56899999999999999999999999
Q ss_pred CCCCCCCchhHHHhhh--------hhhccccccccccCCccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 367 DKNRPNGEHNLVEWAR--------PHLGERRRFYRLIDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
...........+.... ........+.....+..... .....+.++.+||.+||+.||.+|||+.|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 205 PGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 7654322211111000 00000011111111110000 00122467889999999999999999999987
Q ss_pred H
Q 010432 435 A 435 (511)
Q Consensus 435 ~ 435 (511)
+
T Consensus 285 h 285 (288)
T cd07871 285 H 285 (288)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=371.58 Aligned_cols=266 Identities=26% Similarity=0.396 Sum_probs=207.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
...++|++.+.||+|+||.||+|++...+. ..++..||||+++..... ....+.+|+.+|+.+ +|+|||+++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGK----EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCc----ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 344579999999999999999998754221 124568999999765332 235688999999999 89999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCC-----------------------------------------------------
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------- 230 (511)
|...+..++|||||++|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999985321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccccc
Q 010432 231 ----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294 (511)
Q Consensus 231 ----------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~ 294 (511)
..+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~--------------------- 246 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLT--------------------- 246 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEe---------------------
Confidence 24678889999999999999999988 99999999999998
Q ss_pred ccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 010432 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 373 (511)
Q Consensus 295 ~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~ 373 (511)
++..+||+|||+++...............++..|||||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 247 ----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 247 ----DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred ----CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 467899999999987654332222223345678999999998999999999999999999997 999997543211
Q ss_pred chhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 374 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
....... . ......+...+.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 323 --~~~~~~~----~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 323 --KFYKMVK----R----------GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred --HHHHHHH----c----------ccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111100 0 001111111246789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=361.97 Aligned_cols=243 Identities=31% Similarity=0.388 Sum_probs=197.4
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 211 (511)
++||+|+||.||+|++.. +|+.||||+++.... .....+.+|+.+|++++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 369999999999999865 678999999975432 22345788999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccc
Q 010432 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291 (511)
Q Consensus 212 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~ 291 (511)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~------------------ 129 (323)
T cd05571 72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLD------------------ 129 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEEC------------------
Confidence 999999999999998654 47899999999999999999999998 99999999999998
Q ss_pred cccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 010432 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 371 (511)
Q Consensus 292 ~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~ 371 (511)
.++.+||+|||+++........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 130 -------~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 200 (323)
T cd05571 130 -------KDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred -------CCCCEEEeeCCCCcccccCCCc--ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH
Confidence 4778999999999864322211 2335799999999999999999999999999999999999999975422
Q ss_pred CCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 372 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
. .+.... ... + ..++...+..+.+||.+||+.||++|| ++.+++++
T Consensus 201 ~---~~~~~~---~~~--------~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 201 E---KLFELI---LME--------E----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred H---HHHHHH---HcC--------C----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 111110 000 0 011223357789999999999999999 78888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=363.58 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.+|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 578899999999999999999875 678999999975422 22356889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~------------ 152 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLD------------ 152 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEC------------
Confidence 999999999999999999999654 46889999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 153 -------------~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 214 (329)
T PTZ00263 153 -------------NKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214 (329)
T ss_pred -------------CCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCC
Confidence 47789999999998764422 235799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
|....... ..... .... ..++...+..+.+||.+||+.||.+||+ +.+++.+
T Consensus 215 f~~~~~~~---~~~~i---~~~~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 215 FFDDTPFR---IYEKI---LAGR------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCHHH---HHHHH---hcCC------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 97543211 11110 0000 0111123467889999999999999996 5666654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=371.15 Aligned_cols=272 Identities=28% Similarity=0.439 Sum_probs=215.5
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcc
Q 010432 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLV 198 (511)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv 198 (511)
..+++..++..+.++||+|+||.||+|+++..+.. ....||||..+... .....+|++|+++|++++|||||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 44455556777779999999999999999753221 01228999998633 23346799999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
++||++.....++||||+|.||+|.++|......++..+.+.++.++|.||+|||+++ +|||||..+|||++.
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~---- 297 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSK---- 297 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecC----
Confidence 9999999999999999999999999999887767999999999999999999999999 999999999999983
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
+..+||+|||+++....- ........-+..|+|||.+....|+.++|||||||++||
T Consensus 298 ---------------------~~~vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~E 354 (474)
T KOG0194|consen 298 ---------------------KGVVKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWE 354 (474)
T ss_pred ---------------------CCeEEeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEe
Confidence 566899999999875411 111111134689999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 359 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 359 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
+++ |..||.+..... +..++ +...++...+...+..+..++.+||..||++||+|.++.+.|+
T Consensus 355 if~~g~~Py~g~~~~~---v~~kI-------------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 355 IFENGAEPYPGMKNYE---VKAKI-------------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred eeccCCCCCCCCCHHH---HHHHH-------------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 999 788997654321 11111 0111122223344678899999999999999999999999998
Q ss_pred CCCCCCc
Q 010432 438 PLPNLKD 444 (511)
Q Consensus 438 ~l~~~~~ 444 (511)
.+.....
T Consensus 419 ~~~~~~~ 425 (474)
T KOG0194|consen 419 ALEKKKE 425 (474)
T ss_pred HHHhccc
Confidence 7765433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.57 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=202.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 368899999999999999999875 677999999975432 22345788999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~------------ 135 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLD------------ 135 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEEC------------
Confidence 999999999999999999999654 46889999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 136 -------------~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~p 197 (291)
T cd05612 136 -------------KEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197 (291)
T ss_pred -------------CCCCEEEEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 47789999999998764321 235799999999999988999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 436 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~L 436 (511)
|....... ..... .... ..++...+..+.+||.+||+.||.+||+ +.+++++-
T Consensus 198 f~~~~~~~---~~~~i---~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 198 FFDDNPFG---IYEKI---LAGK------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CCCCCHHH---HHHHH---HhCC------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 97643211 11110 0000 0112223567899999999999999995 88887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=353.04 Aligned_cols=245 Identities=20% Similarity=0.318 Sum_probs=198.4
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEEEe----C
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE----D 207 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~~~----~ 207 (511)
..||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.+|.+++|||||++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 5799999999999987 46799999998654333 3567799999999999999999999877 3
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
...++|||||++|+|.+++... ..+++...+.++.|++.||.|||.. + ++||||||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~------------- 157 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVT------------- 157 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEEC-------------
Confidence 5688999999999999999654 4688999999999999999999984 6 88999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc--CCCCccccchhHHHHHHHHHhCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+++.+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 158 ------------~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~ 220 (283)
T PHA02988 158 ------------ENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220 (283)
T ss_pred ------------CCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence 47789999999998654322 22468999999999875 689999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
||....... +.... ... .....++..++..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 221 Pf~~~~~~~---~~~~i---~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 221 PFENLTTKE---IYDLI---INK----------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCHHH---HHHHH---Hhc----------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 997543211 11111 000 0011122234678999999999999999999999999997654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=353.08 Aligned_cols=268 Identities=23% Similarity=0.298 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|+++. +++.||||++..... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 368999999999999999999875 677999999975432 223567899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..++||||++++.|..+. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~------------- 134 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLIS------------- 134 (287)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc-------------
Confidence 99999999999887665443 44457899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 135 ------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf 201 (287)
T cd07848 135 ------------HNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201 (287)
T ss_pred ------------CCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCC
Confidence 4778999999999876443221 123357899999999999889999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhc--------cccccccccCCccC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLG--------ERRRFYRLIDPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~------~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
...........+........ ....+.....+... .......+..+.+||.+||+.||++|||+.++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~ 281 (287)
T cd07848 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281 (287)
T ss_pred CCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 76433221111111000000 00000000000000 00111235679999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 282 l~h 284 (287)
T cd07848 282 LNH 284 (287)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=359.44 Aligned_cols=259 Identities=26% Similarity=0.312 Sum_probs=217.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCC-CCCcceEee
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLV-HLNLVKLIG 202 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~-H~nIv~l~~ 202 (511)
....|++.+.||+|.||.||+|+.+. +|+.||+|++.+..... ...+.+|+.||++|. |||||.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34578888999999999999999876 78899999998765532 357899999999998 999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+|.+.+.+++|||+|.||.|.+.|... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+.....
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~----- 173 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDE----- 173 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccC-----
Confidence 999999999999999999999999776 3999999999999999999999999 999999999999985321
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.+..+|++|||++....... .....+||+.|+|||++....|+..+||||+||++|.|++|
T Consensus 174 ----------------~~~~ik~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G 234 (382)
T KOG0032|consen 174 ----------------GSGRIKLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSG 234 (382)
T ss_pred ----------------CCCcEEEeeCCCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhC
Confidence 24589999999999876622 34568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
..||.+.........+. .. +..+........+..+.+++..||..||.+|+++.++|++-+
T Consensus 235 ~~PF~~~~~~~~~~~i~--~~------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 235 VPPFWGETEFEIFLAIL--RG------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCCCcCCChhHHHHHHH--cC------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 99998765443222111 10 011222233345788999999999999999999999999743
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=362.14 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|++.. +++.||||+++.... .....+.+|+.+|..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 368899999999999999999875 677999999975422 23356789999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~------------ 135 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLID------------ 135 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEC------------
Confidence 999999999999999999999644 46889999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 136 -------------~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 197 (333)
T cd05600 136 -------------ASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197 (333)
T ss_pred -------------CCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCC
Confidence 477899999999986543 12345799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|...........+.... ...............+.++.+||.+||..+|.+||++.+++++-
T Consensus 198 f~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 198 FSGSTPNETWENLKYWK----------ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCCCCHHHHHHHHHhcc----------ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 97643321111110000 00000000000113357889999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=348.68 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=207.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|++.... ..+..||+|.++..... ....+.+|+.++.+++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPS------KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCC------CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 357889999999999999999875422 24679999999865332 23568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..+|||||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~------------- 141 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVN------------- 141 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEc-------------
Confidence 99999999999999999999766567899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.+..+||+|||.+......... ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 142 ------------~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p 208 (266)
T cd05064 142 ------------SDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred ------------CCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCC
Confidence 4778999999988764322111 1112345678999999999999999999999999999875 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|....... ..... ... .....+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 209 ~~~~~~~~---~~~~~----~~~----------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 209 YWDMSGQD---VIKAV----EDG----------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred cCcCCHHH---HHHHH----HCC----------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 97543211 11111 000 00111223456789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=354.35 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=216.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.=|.+.+.||+|.|++|-+|++.- ||..||||++.+...... ..+++|++.|+-++|||||+||.+...
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVF---------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVF---------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhc---------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 458888899999999999998866 889999999988765433 468899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
...+|||+|+-.+|+|++||.+....+.+..+.+++.||+.|+.|+|..+ +|||||||+|+++-.
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFE------------ 153 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFE------------ 153 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEee------------
Confidence 99999999999999999999988888999999999999999999999988 999999999998864
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCC-ccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DIwSlGvil~elltg~~p 365 (511)
+-+-|||.|||++..+..+.. .++.||+..|-|||++.+..|+ +++||||||||||.|++|++|
T Consensus 154 ------------KlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~P 218 (864)
T KOG4717|consen 154 ------------KLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPP 218 (864)
T ss_pred ------------ecCceEeeeccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCc
Confidence 467799999999988776554 4568999999999999999996 579999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|...+......+ ++|= .-..+...+.++++||..||..||.+|.+.++|+..-
T Consensus 219 FqeANDSETLTm----------------ImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 219 FQEANDSETLTM----------------IMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred cccccchhhhhh----------------hhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 986654322111 1111 1234556688999999999999999999999998643
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=359.24 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=205.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++++.||+|+||.||++++.. ++..||+|++..... .....+.+|+++|++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4689999999999999999999875 678999999976532 223568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~------------ 138 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVN------------ 138 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEc------------
Confidence 99999999999999999998654 4688999999999999999999974 4 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 139 -------------~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 201 (331)
T cd06649 139 -------------SRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201 (331)
T ss_pred -------------CCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 47789999999998654322 2335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhh-hhcccc-------------------------------cc-ccccCCccCCCCCHHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARP-HLGERR-------------------------------RF-YRLIDPRLEGHFSIKGAQKAA 412 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~-~~~~~~-------------------------------~~-~~~~~~~~~~~~~~~~~~~~~ 412 (511)
|....... +...... ...... .. ..+.............+.++.
T Consensus 202 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (331)
T cd06649 202 IPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQ 278 (331)
T ss_pred CCCCCHHH---HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHH
Confidence 96543211 1110000 000000 00 000000000001112457899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHh
Q 010432 413 QLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 413 ~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+||.+||+.||++|||+.+|+++.
T Consensus 279 ~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 279 EFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred HHHHHHccCCcccCCCHHHHhcCh
Confidence 999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=366.53 Aligned_cols=267 Identities=22% Similarity=0.316 Sum_probs=209.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-C-----CCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H-----LNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H-----~nIv~l~ 201 (511)
..+|+++++||+|+||.|.+|++.. |++.||||++++.. ....+...|+.||..|+ | -|||+++
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 3478999999999999999999876 78899999998764 22345677999999996 4 4899999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
++|...+++|||+|++ .-+|+++|..+. ..++...++.++.||+.||.+||+.+ |||+||||+||||...
T Consensus 255 d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~----- 325 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDP----- 325 (586)
T ss_pred eccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccC-----
Confidence 9999999999999999 569999997653 56999999999999999999999999 9999999999999853
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
....|||+|||.|+....... +.+-+..|+|||++.+.+|+.+.||||||||++||+
T Consensus 326 ------------------~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~ 382 (586)
T KOG0667|consen 326 ------------------KRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELF 382 (586)
T ss_pred ------------------CcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHh
Confidence 245799999999998655432 356788999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhh--------hcccccccc------------------------------ccCCccC--
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPH--------LGERRRFYR------------------------------LIDPRLE-- 400 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~------------------------------~~~~~~~-- 400 (511)
+|.+.|.+..+.+....+..+... ......++. ..+....
T Consensus 383 tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~ 462 (586)
T KOG0667|consen 383 TGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPG 462 (586)
T ss_pred cCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCC
Confidence 999999887665443322211100 000000000 0000001
Q ss_pred -----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 401 -----GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 401 -----~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..........+.+++.+||.+||.+|+|..++++|-
T Consensus 463 ~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 463 SRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHP 503 (586)
T ss_pred CcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCc
Confidence 011113356789999999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=386.73 Aligned_cols=265 Identities=29% Similarity=0.425 Sum_probs=216.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+.++.+.||+|.||.||.|......... ....||||.++.... +...+|++|..+|++++|||||+++|++.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 456677789999999999999987532210 134699999987643 445689999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
....+|++|||++|||..||+.. ...+.....+.++.|||.|+.||++++ +|||||..+|+||+.
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~------ 837 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDE------ 837 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecc------
Confidence 99999999999999999999865 566899999999999999999999998 999999999999994
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
...|||+|||+|+.....+.+.......-...|||||.+..+.|+.|+|||||||+|||++
T Consensus 838 -------------------~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 838 -------------------RRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred -------------------cCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence 6789999999999776666554444334467999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 361 T-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 361 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
| |..||.......... . +.+.. +-..+..++..+.+||..||+.+|++||++..|++.+..+
T Consensus 899 slG~~PY~~~~n~~v~~---~----~~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 899 SLGATPYPSRSNFEVLL---D----VLEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred hCCCCCCCCcchHHHHH---H----HHhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 9 778887654322111 0 00101 2223445678899999999999999999999999977765
Q ss_pred CC
Q 010432 440 PN 441 (511)
Q Consensus 440 ~~ 441 (511)
.+
T Consensus 962 ~~ 963 (1025)
T KOG1095|consen 962 SN 963 (1025)
T ss_pred hh
Confidence 44
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.32 Aligned_cols=266 Identities=21% Similarity=0.309 Sum_probs=201.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 3679999999999999999999865 5779999999754322 23457889999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..++||||+ .++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~------------- 137 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLIS------------- 137 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC-------------
Confidence 99999999999 56898888766667899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 138 ------------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 203 (303)
T cd07869 138 ------------DTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203 (303)
T ss_pred ------------CCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 477899999999975433221 1233568999999998875 4588999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhcc--cc---ccc---cccCCccC----CCCC-----HHHHHHHHHHHHHhcccCCCCCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGE--RR---RFY---RLIDPRLE----GHFS-----IKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~--~~---~~~---~~~~~~~~----~~~~-----~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|....... ............ .. ... ......+. .... ...+..+.+|+.+||+.||.+|||
T Consensus 204 f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s 281 (303)
T cd07869 204 FPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281 (303)
T ss_pred CCCCccHH--HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC
Confidence 97643211 111111000000 00 000 00000000 0000 011356889999999999999999
Q ss_pred HHHHHHH
Q 010432 429 MSEVVEA 435 (511)
Q Consensus 429 ~~eil~~ 435 (511)
+.+++++
T Consensus 282 ~~~~l~h 288 (303)
T cd07869 282 AQAALSH 288 (303)
T ss_pred HHHHhcC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=358.18 Aligned_cols=272 Identities=26% Similarity=0.405 Sum_probs=225.4
Q ss_pred ccChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCC
Q 010432 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLN 196 (511)
Q Consensus 118 ~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~n 196 (511)
..+..+..+..+...+.++||.|.||.||+|.+.... ++...-||||..+.+. ....+.|+.|..+|++++|||
T Consensus 378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHph 452 (974)
T KOG4257|consen 378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPH 452 (974)
T ss_pred CCCCCcceeehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcc
Confidence 3344445556667777889999999999999987642 3356679999999854 344577999999999999999
Q ss_pred cceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 197 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
||+|+|+|.+. ..|||||+++.|.|..||..+...++......++.||+.||.|||+.. +|||||..+|||+.+
T Consensus 453 IikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsS-- 526 (974)
T KOG4257|consen 453 IIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSS-- 526 (974)
T ss_pred hhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecC--
Confidence 99999999754 589999999999999999988889999999999999999999999988 999999999999995
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil 356 (511)
...|||+|||+++...+...+... +..-++.|||||.+....++.++|||-|||.+
T Consensus 527 -----------------------p~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCm 582 (974)
T KOG4257|consen 527 -----------------------PQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCM 582 (974)
T ss_pred -----------------------cceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHH
Confidence 455999999999998876665543 44567899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||++. |..||.+-...+.. ..+...-+...+..|++.+..|+.+||++||.+||.+.+|...
T Consensus 583 WEIl~lGvkPfqgvkNsDVI-----------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 583 WEILSLGVKPFQGVKNSDVI-----------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred HHHHHhcCCccccccccceE-----------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHH
Confidence 99886 89999865433211 1111222344566778999999999999999999999999998
Q ss_pred hcCCCC
Q 010432 436 LKPLPN 441 (511)
Q Consensus 436 L~~l~~ 441 (511)
|..+..
T Consensus 646 lsdv~q 651 (974)
T KOG4257|consen 646 LSDVLQ 651 (974)
T ss_pred HHHHHH
Confidence 876644
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=348.12 Aligned_cols=262 Identities=28% Similarity=0.472 Sum_probs=209.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.+.||+|+||.||+|.+..... ..+...||+|.+...... ....+.+|+.++.+++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 478889999999999999998765321 124568999999755332 235688999999999999999999999998
Q ss_pred CeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
...+++|||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 99999999999999999996431 35788889999999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
+ +++.+||+|||+++...............+++.|+|||++.+..++.++|||||
T Consensus 158 ~-------------------------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 158 G-------------------------EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred c-------------------------CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 8 477899999999987544333222334567889999999988899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 353 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 353 Gvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
||++|||++ |..||.+.... .+...+.. ......+..++..+.+|+.+||+.||.+||++.+
T Consensus 213 G~il~el~~~g~~p~~~~~~~---~~~~~i~~--------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~ 275 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGFSNQ---EVIEMIRS--------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKD 275 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHH---HHHHHHHc--------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999998 99999764332 11111110 0111122344678999999999999999999999
Q ss_pred HHHHhcCC
Q 010432 432 VVEALKPL 439 (511)
Q Consensus 432 il~~L~~l 439 (511)
|+++|+.+
T Consensus 276 i~~~l~~~ 283 (283)
T cd05048 276 IHTRLRSW 283 (283)
T ss_pred HHHHHhcC
Confidence 99999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=356.46 Aligned_cols=244 Identities=29% Similarity=0.374 Sum_probs=197.9
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 211 (511)
++||+|+||.||++++.. ++..||||++..... .....+.+|+.+|+.++||||+++++++..++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 369999999999999865 678999999975432 22346788999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccc
Q 010432 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291 (511)
Q Consensus 212 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~ 291 (511)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~------------------ 129 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLD------------------ 129 (328)
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEEC------------------
Confidence 999999999999888543 46899999999999999999999998 99999999999998
Q ss_pred cccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 010432 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 371 (511)
Q Consensus 292 ~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~ 371 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 130 -------~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 130 -------KDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred -------CCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 477899999999986432211 12345799999999999989999999999999999999999999975432
Q ss_pred CCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 010432 372 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 436 (511)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~L 436 (511)
. ..... .... .. .++...+.++.+|+.+||+.||.+|| ++.+++++-
T Consensus 201 ~---~~~~~---~~~~--------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 201 E---KLFEL---ILME--------DI----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred H---HHHHH---hccC--------Cc----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 1 11110 0000 00 11222356789999999999999997 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=352.64 Aligned_cols=256 Identities=29% Similarity=0.361 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
+|++.+.||+|+||.||+++...+. .++..||+|++..... ...+.+.+|+.+|..+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH------DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 5888999999999999999875322 2688999999975321 2234577899999999 599999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..++..++|||||++|+|.+++..+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~----------- 139 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLD----------- 139 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEEC-----------
Confidence 9999999999999999999998654 46899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+++........ ......||+.|||||++.+. .++.++|||||||+||||++|+
T Consensus 140 --------------~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 140 --------------SEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred --------------CCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 4778999999999865433222 12245799999999998865 4789999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
.||............ ..... ..++. ++...+..+.+|+.+||+.||++|| ++.+++++
T Consensus 205 ~pf~~~~~~~~~~~~--~~~~~--------~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 205 SPFTLEGERNTQSEV--SRRIL--------KCDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCCCCHHHH--HHHHh--------cCCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 999754322111110 00000 01111 1222356789999999999999999 67777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=355.56 Aligned_cols=244 Identities=31% Similarity=0.377 Sum_probs=197.3
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 211 (511)
+.||+|+||.||++++.. +|..||+|+++.... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 369999999999999865 678999999975422 22345778999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccc
Q 010432 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291 (511)
Q Consensus 212 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~ 291 (511)
|||||+++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~------------------ 129 (323)
T cd05595 72 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLD------------------ 129 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEc------------------
Confidence 999999999999888554 46899999999999999999999998 99999999999998
Q ss_pred cccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 010432 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 371 (511)
Q Consensus 292 ~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~ 371 (511)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 130 -------~~~~~kL~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 200 (323)
T cd05595 130 -------KDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred -------CCCCEEecccHHhccccCCCCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence 4778999999998864332211 2235799999999999999999999999999999999999999975432
Q ss_pred CCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 010432 372 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 436 (511)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~L 436 (511)
.. .... ..... . .++...++.+.+||.+||+.||.+|| ++.+++++-
T Consensus 201 ~~---~~~~---~~~~~--------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 201 ER---LFEL---ILMEE--------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HH---HHHH---HhcCC--------C----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 11 1110 00000 0 11223357789999999999999998 888888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.78 Aligned_cols=241 Identities=32% Similarity=0.340 Sum_probs=194.8
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
||+|+||.||+|++.. +++.||||+++... ......+.+|+.+|.+++||||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999999875 67799999997532 22234678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~-------------------- 127 (312)
T cd05585 72 LAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLD-------------------- 127 (312)
T ss_pred EcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEEC--------------------
Confidence 9999999999999654 46899999999999999999999998 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 373 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~ 373 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 128 -----~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~- 199 (312)
T cd05585 128 -----YQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN- 199 (312)
T ss_pred -----CCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-
Confidence 477899999999986433221 123467999999999999999999999999999999999999999754221
Q ss_pred chhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 010432 374 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 435 (511)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs---~~eil~~ 435 (511)
......... ...++...+..+.+||.+||+.||.+||+ +.+++.+
T Consensus 200 -----~~~~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 200 -----EMYRKILQE------------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -----HHHHHHHcC------------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 111111111 01122233577899999999999999985 5566554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=369.91 Aligned_cols=285 Identities=20% Similarity=0.283 Sum_probs=200.0
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC------CC
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH------LN 196 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H------~n 196 (511)
++....++|+++++||+|+||+||+|++.. +++.||||+++... .....+..|+.++..++| .+
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~ 192 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFP 192 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcc
Confidence 344556889999999999999999999865 57799999996532 122345567777776654 45
Q ss_pred cceEeeEEEeC-CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEecc
Q 010432 197 LVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 197 Iv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~ 274 (511)
|+++++++... .++|||||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+ .+ ||||||||+||||+.
T Consensus 193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~ 267 (467)
T PTZ00284 193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMET 267 (467)
T ss_pred eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEec
Confidence 88999988764 5789999998 78999988654 478999999999999999999997 47 999999999999985
Q ss_pred ccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHH
Q 010432 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 354 (511)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGv 354 (511)
.+.... .. .......+...+||+|||++...... .+..+||+.|||||++.+..|+.++|||||||
T Consensus 268 ~~~~~~--~~-------~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv 333 (467)
T PTZ00284 268 SDTVVD--PV-------TNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333 (467)
T ss_pred CCcccc--cc-------cccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHH
Confidence 321000 00 00001112346999999998653321 23468999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc----------cccccc---cCCccC-----------CCCCHHHHHH
Q 010432 355 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER----------RRFYRL---IDPRLE-----------GHFSIKGAQK 410 (511)
Q Consensus 355 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---~~~~~~-----------~~~~~~~~~~ 410 (511)
+||||++|+.||...........+......+... ..++.. +.+... ..........
T Consensus 334 il~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (467)
T PTZ00284 334 IIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL 413 (467)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHH
Confidence 9999999999997654322222211111100000 000000 000000 0000112456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 411 AAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 411 ~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+.+||.+||++||.+|||+.|+++|-
T Consensus 414 ~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 414 LCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 78999999999999999999999854
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.21 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=203.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
.|.+.+.||+|+||.||+|....+ .+..||+|.+..........+.+|+.+|+.++|||||++++++..++.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 488899999999999999987542 256899998765544444567789999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 210 RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+||||||+++|+|.++|.. ....+++..+..++.||+.||.|||+++ ||||||||+||||+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~------------- 203 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLM------------- 203 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEEC-------------
Confidence 9999999999999998853 2446889999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 204 ------------~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf 271 (478)
T PTZ00267 204 ------------PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271 (478)
T ss_pred ------------CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 47789999999998765433222334567999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...... .+.... ... .. ..++...+..+.+||.+||+.||++||++.+++.+
T Consensus 272 ~~~~~~---~~~~~~---~~~------~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 272 KGPSQR---EIMQQV---LYG------KY-----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCHH---HHHHHH---HhC------CC-----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 753221 111110 000 00 01112235678999999999999999999998753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=358.08 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=194.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+|+.+++||+|+||.||+|++.. +++.||||++...... ....+.+|+.+|+.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 356677899999999999998865 5779999999654322 235688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+.+++|||||++|+|.... ...+..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~-------------- 202 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLIN-------------- 202 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEc--------------
Confidence 9999999999999986532 3567778899999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----CCCCccccchhHHHHHHHHHhC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DIwSlGvil~elltg 362 (511)
+++.+||+|||+++....... ......||..|+|||++.. ..++.++|||||||++|||++|
T Consensus 203 -----------~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g 269 (353)
T PLN00034 203 -----------SAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269 (353)
T ss_pred -----------CCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhC
Confidence 477899999999987543221 1233579999999998742 2345689999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.||..........+..... .. .........+.++.+||.+||+.||++||++.||+++
T Consensus 270 ~~pf~~~~~~~~~~~~~~~~--~~------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 270 RFPFGVGRQGDWASLMCAIC--MS------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCCCCccHHHHHHHHh--cc------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99997432222111111000 00 0111122345789999999999999999999999985
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=358.01 Aligned_cols=247 Identities=26% Similarity=0.304 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|.+.+.||+|+||.||+|.+... .+..||+|++.... ......+.+|+.+++.++|||||++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 5788999999999999999987541 23589999986532 122356788999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~------------ 165 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLD------------ 165 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEEC------------
Confidence 999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++..... .....||+.|||||++.+..++.++|||||||++|||++|..|
T Consensus 166 -------------~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~P 227 (340)
T PTZ00426 166 -------------KDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227 (340)
T ss_pred -------------CCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCC
Confidence 4778999999999875432 1235799999999999988999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
|....... ..... .... ..++...+..+.+||.+||+.||.+|+ ++.+++++
T Consensus 228 f~~~~~~~---~~~~i---~~~~------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 228 FYANEPLL---IYQKI---LEGI------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCHHH---HHHHH---hcCC------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 97543211 00000 0000 011122346788999999999999995 78888765
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=363.74 Aligned_cols=267 Identities=23% Similarity=0.361 Sum_probs=207.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCC-CCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~-H~nIv~l~~~ 203 (511)
...++|++.++||+|+||.||+|.+..... ..++..||||+++..... ..+.+.+|+.+|+++. |||||+++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSR----SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCC----CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 345789999999999999999998753211 123568999999754332 2356889999999996 9999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCC-----------------------------------------------------
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------- 230 (511)
|...+..|||||||++|+|.++|....
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999999885421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 010432 231 ------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (511)
Q Consensus 231 ------------------------------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~ 268 (511)
..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 23677888899999999999999988 999999999
Q ss_pred cEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCcccc
Q 010432 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 348 (511)
Q Consensus 269 NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~D 348 (511)
|||++ ++..+||+|||+++...............++..|+|||++.+..++.++|
T Consensus 267 Nill~-------------------------~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 321 (400)
T cd05105 267 NVLLA-------------------------QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSD 321 (400)
T ss_pred hEEEe-------------------------CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhh
Confidence 99998 46779999999998754433222223345788999999999889999999
Q ss_pred chhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 349 VYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 349 IwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
||||||++|||++ |..||....... ...... ... .....+...+..+.+|+.+||+.||++||
T Consensus 322 iwSlGvil~ellt~g~~P~~~~~~~~--~~~~~~----~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RP 385 (400)
T cd05105 322 VWSYGILLWEIFSLGGTPYPGMIVDS--TFYNKI----KSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRP 385 (400)
T ss_pred HHHHHHHHHHHHHCCCCCCcccchhH--HHHHHH----hcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCc
Confidence 9999999999997 999987532211 010000 000 01111223457889999999999999999
Q ss_pred CHHHHHHHhcCCC
Q 010432 428 LMSEVVEALKPLP 440 (511)
Q Consensus 428 s~~eil~~L~~l~ 440 (511)
++.+|.+.|+.+.
T Consensus 386 t~~~l~~~l~~l~ 398 (400)
T cd05105 386 SFLHLSDIVESLL 398 (400)
T ss_pred CHHHHHHHHHHHc
Confidence 9999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=353.33 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=206.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+|++.+.||+|+||.||+|++...+.. ....||||+++.... ....++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCc-----cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 35799999999999999999987653221 234699999975432 234578899999999999999999999876
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
. ..++|+||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~------------- 143 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVK------------- 143 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEec-------------
Confidence 5 578999999999999999876667899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
++..+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 144 ------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p 211 (316)
T cd05108 144 ------------TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211 (316)
T ss_pred ------------CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 467899999999997654333222222345678999999999999999999999999999998 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
|.+.... .+.... .... ....+..++..+.+|+.+||..||.+||++.+++..|..+.
T Consensus 212 ~~~~~~~---~~~~~~----~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 212 YDGIPAS---EISSIL----EKGE----------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCHH---HHHHHH----hCCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9753221 111111 0000 00111123467889999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=355.10 Aligned_cols=266 Identities=26% Similarity=0.372 Sum_probs=203.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||.||+|.+.. ++..||+|++...... ....+.+|+++|++++|+||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 4689999999999999999998865 6779999998765322 23568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++..+|||||+++|+|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~------------ 138 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVN------------ 138 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEc------------
Confidence 99999999999999999998654 4688999999999999999999974 5 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||++....... .....||..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 139 -------------~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 201 (333)
T cd06650 139 -------------SRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201 (333)
T ss_pred -------------CCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 46779999999997653321 2235689999999999988999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhh-hhccc------c-----------------ccccccC---CccCCCC-CHHHHHHHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARP-HLGER------R-----------------RFYRLID---PRLEGHF-SIKGAQKAAQLAAH 417 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~-~~~~~------~-----------------~~~~~~~---~~~~~~~-~~~~~~~~~~Li~~ 417 (511)
|................. ..... . ....+.+ ....... ....+.++.+|+.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 281 (333)
T cd06650 202 IPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNK 281 (333)
T ss_pred CCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHH
Confidence 975432111100000000 00000 0 0000000 0000000 01134678999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 010432 418 CLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 418 cl~~dP~~RPs~~eil~~ 435 (511)
||+.||++||++.+++.+
T Consensus 282 ~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 282 CLIKNPAERADLKQLMVH 299 (333)
T ss_pred hccCCcccCcCHHHHhhC
Confidence 999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.97 Aligned_cols=254 Identities=25% Similarity=0.302 Sum_probs=197.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.|++++.||+|+||+||+|++.. ++..||||++..... .....+.+|+.+|++++|+|||++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 58889999999999999999865 678999999976432 223457899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+.++||||||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~------------- 135 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILID------------- 135 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEEC-------------
Confidence 99999999999999999998654 46889999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCc---------------------------------------------ce
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK---------------------------------------------TH 321 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~---------------------------------------------~~ 321 (511)
.++.+||+|||+++....... ..
T Consensus 136 ------------~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (381)
T cd05626 136 ------------LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC 203 (381)
T ss_pred ------------CCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccc
Confidence 367899999999864311000 00
Q ss_pred eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCC
Q 010432 322 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 401 (511)
Q Consensus 322 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (511)
.....+||+.|||||++.+..++.++|||||||++|||++|..||......... ... ..... .+..
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~i----~~~~~--------~~~~ 269 (381)
T cd05626 204 LAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ--LKV----INWEN--------TLHI 269 (381)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHH--HHH----Hcccc--------ccCC
Confidence 012357999999999999899999999999999999999999999764322110 000 00000 0000
Q ss_pred CCCHHHHHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 010432 402 HFSIKGAQKAAQLAAHCL--SRDPKARPLMSEVVEA 435 (511)
Q Consensus 402 ~~~~~~~~~~~~Li~~cl--~~dP~~RPs~~eil~~ 435 (511)
......+.++.+||.+|| ..+|..||++.+|+.+
T Consensus 270 ~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 270 PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 001123567889998844 5566669999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=368.96 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=196.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
..+|++.++||+|+||.||+|.+.. +++.||||++.... ....+|+.+|+.++|+|||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 4679999999999999999999865 67799999986542 2345799999999999999999887532
Q ss_pred --------CeEEEEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 208 --------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 208 --------~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
..+++||||++ ++|.+++. .....+++..++.++.||+.||+|||+++ ||||||||+||||+.
T Consensus 132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~-- 205 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDP-- 205 (440)
T ss_pred ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcC--
Confidence 24679999996 57877664 23457899999999999999999999998 999999999999984
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVV 355 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvi 355 (511)
+...+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||+
T Consensus 206 ----------------------~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi 260 (440)
T PTZ00036 206 ----------------------NTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260 (440)
T ss_pred ----------------------CCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHH
Confidence 245699999999987644322 2235789999999998764 68999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc--------c-----ccccccCCccCCCCCHHHHHHHHHHHHHhcccC
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--------R-----RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~-----~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~d 422 (511)
||||++|.+||.+...... +........... . .+.......+...++...+.++.+||.+||+.|
T Consensus 261 l~elltG~~pf~~~~~~~~--~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~d 338 (440)
T PTZ00036 261 IAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338 (440)
T ss_pred HHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCC
Confidence 9999999999976543211 111110000000 0 000000011111122233578999999999999
Q ss_pred CCCCCCHHHHHHH
Q 010432 423 PKARPLMSEVVEA 435 (511)
Q Consensus 423 P~~RPs~~eil~~ 435 (511)
|.+|||+.+++++
T Consensus 339 P~~R~ta~e~l~h 351 (440)
T PTZ00036 339 PLKRLNPIEALAD 351 (440)
T ss_pred hhHCcCHHHHhCC
Confidence 9999999999975
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.43 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=200.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||+||+|++.. +++.||||++..... .....+.+|+.+|..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 478999999999999999999876 678999999975421 22345778999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++..|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~------------ 135 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLD------------ 135 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEEC------------
Confidence 999999999999999999998654 46899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcce------------------------------------eeeecccc
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH------------------------------------VSTRVMGT 329 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~------------------------------------~~~~~~Gt 329 (511)
.++.+||+|||+++......... .....+||
T Consensus 136 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 202 (364)
T cd05599 136 -------------AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGT 202 (364)
T ss_pred -------------CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccC
Confidence 47789999999987543211000 01124699
Q ss_pred ccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHH
Q 010432 330 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQ 409 (511)
Q Consensus 330 ~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (511)
+.|+|||++.+..++.++|||||||++|||++|..||........ .... ...... .. +.. ....++
T Consensus 203 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~---~~~i---~~~~~~---~~---~~~--~~~~s~ 268 (364)
T cd05599 203 PDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET---YRKI---INWKET---LQ---FPD--EVPLSP 268 (364)
T ss_pred ccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH---HHHH---HcCCCc---cC---CCC--CCCCCH
Confidence 999999999999999999999999999999999999975432111 1100 000000 00 000 112356
Q ss_pred HHHHHHHHhcccCCCCCCC---HHHHHHH
Q 010432 410 KAAQLAAHCLSRDPKARPL---MSEVVEA 435 (511)
Q Consensus 410 ~~~~Li~~cl~~dP~~RPs---~~eil~~ 435 (511)
.+.+||.+||. +|.+|++ +.+++++
T Consensus 269 ~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 269 EAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 78899999996 9999998 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.00 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=207.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc----c----HHHHHHHHHHHhCC-CCCC
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----G----HKEWLAEVNFLGDL-VHLN 196 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----~----~~~~~~E~~il~~l-~H~n 196 (511)
.+-.+|...+.||.|..++|.++.++. +|..+|+|++...... . .+.-.+|+.||+++ .||+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~---------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~ 84 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKE---------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPY 84 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcc---------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCc
Confidence 345678888999999999999998766 7889999998653221 1 23356799999999 6999
Q ss_pred cceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 197 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
|+++.+++..+..+|+|+|.|+.|.|.++|.. .-.+++.....|++|+..|++|||..+ ||||||||+|||++
T Consensus 85 II~l~D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILld--- 157 (411)
T KOG0599|consen 85 IIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLD--- 157 (411)
T ss_pred EEEeeeeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeec---
Confidence 99999999999999999999999999999954 457899999999999999999999998 99999999999999
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc------CCCCccccch
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVY 350 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~DIw 350 (511)
++.++||+|||+|+.+..+.. ....||||+|+|||.+.. ..|+..+|+|
T Consensus 158 ----------------------dn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~W 212 (411)
T KOG0599|consen 158 ----------------------DNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEW 212 (411)
T ss_pred ----------------------cccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHH
Confidence 689999999999999877654 345899999999998853 3688999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 351 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
|+|||||.|+.|.+||....... +.+...... ++. ...-..+.+...++||.+||+.||.+|.|+.
T Consensus 213 a~GVImyTLLaGcpPFwHRkQml------MLR~ImeGk---yqF-----~speWadis~~~KdLIsrlLqVdp~~Ritak 278 (411)
T KOG0599|consen 213 ACGVIMYTLLAGCPPFWHRKQML------MLRMIMEGK---YQF-----RSPEWADISATVKDLISRLLQVDPTKRITAK 278 (411)
T ss_pred HHHHHHHHHHcCCCchhHHHHHH------HHHHHHhcc---ccc-----CCcchhhccccHHHHHHHHHeeCchhcccHH
Confidence 99999999999999996432111 111111111 111 1122234567889999999999999999999
Q ss_pred HHHHHh
Q 010432 431 EVVEAL 436 (511)
Q Consensus 431 eil~~L 436 (511)
|+|.+-
T Consensus 279 e~LaHp 284 (411)
T KOG0599|consen 279 EALAHP 284 (411)
T ss_pred HHhcCh
Confidence 999753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=359.84 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=197.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||+||+|++.. +++.||||++..... .....+.+|+.++.+++|+||+++++++.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 478999999999999999998865 678999999975422 12245778999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+...+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~------------ 135 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLD------------ 135 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEEC------------
Confidence 999999999999999999999654 47899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc---------------------------------eeeeeccccccc
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT---------------------------------HVSTRVMGTYGY 332 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~---------------------------------~~~~~~~Gt~~y 332 (511)
.++.+||+|||+++........ ......+||+.|
T Consensus 136 -------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y 202 (363)
T cd05628 136 -------------SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDY 202 (363)
T ss_pred -------------CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccc
Confidence 4778999999999754321100 001235799999
Q ss_pred cCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHH
Q 010432 333 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 412 (511)
Q Consensus 333 ~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (511)
+|||++.+..++.++|||||||++|||++|+.||......... ..+. .... ... +... ...+..+.
T Consensus 203 ~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~---~~i~---~~~~---~~~---~p~~--~~~s~~~~ 268 (363)
T cd05628 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY---KKVM---NWKE---TLI---FPPE--VPISEKAK 268 (363)
T ss_pred cCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHH---cCcC---ccc---CCCc--CCCCHHHH
Confidence 9999999999999999999999999999999999764322111 1000 0000 000 0110 11246778
Q ss_pred HHHHHhcc--cCCCCCCCHHHHHHH
Q 010432 413 QLAAHCLS--RDPKARPLMSEVVEA 435 (511)
Q Consensus 413 ~Li~~cl~--~dP~~RPs~~eil~~ 435 (511)
+||.+|+. .++..||++.+|+++
T Consensus 269 ~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 269 DLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHHcCChhhcCCCCCHHHHhCC
Confidence 88888664 233356899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=359.52 Aligned_cols=262 Identities=20% Similarity=0.218 Sum_probs=199.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
..+|++++.||+|+||.||+|.+.. +++.||||.... ..+.+|+.+|++|+|||||++++++..+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 4679999999999999999999876 678999997542 3467899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++|||++ .++|..++... ..+++..++.|+.||+.||.|||+++ ||||||||+|||++
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~-------------- 216 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFIN-------------- 216 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEc--------------
Confidence 9999999999 57898888554 46889999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 217 -----------~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 217 -----------HPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred -----------CCCCEEEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 4678999999999754322111 1234679999999999999999999999999999999999998876
Q ss_pred CCCCCCc-----hhHHHhhhhhh--ccc---------cccc-cc-----cCCccCCCC--CHHHHHHHHHHHHHhcccCC
Q 010432 368 KNRPNGE-----HNLVEWARPHL--GER---------RRFY-RL-----IDPRLEGHF--SIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 368 ~~~~~~~-----~~~~~~~~~~~--~~~---------~~~~-~~-----~~~~~~~~~--~~~~~~~~~~Li~~cl~~dP 423 (511)
....... ..+........ ... ...+ .. ..+...... ....+.++.+||.+||+.||
T Consensus 285 ~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP 364 (391)
T PHA03212 285 EKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDA 364 (391)
T ss_pred CcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCCh
Confidence 4322110 01110000000 000 0000 00 000000000 01235678999999999999
Q ss_pred CCCCCHHHHHHH
Q 010432 424 KARPLMSEVVEA 435 (511)
Q Consensus 424 ~~RPs~~eil~~ 435 (511)
.+|||+.|++++
T Consensus 365 ~~Rpta~elL~h 376 (391)
T PHA03212 365 HHRPSAEALLDF 376 (391)
T ss_pred hhCCCHHHHhcC
Confidence 999999999974
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=350.84 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=194.5
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHH---hCCCCCCcceEeeEE
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFL---GDLVHLNLVKLIGYC 204 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il---~~l~H~nIv~l~~~~ 204 (511)
|++++.||+|+||.||+|.+.. +++.||||+++.... ...+.+.+|++++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 6778899999999999998865 678999999975421 2234566676655 567899999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..|+||||+++|+|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~----------- 135 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLD----------- 135 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEEC-----------
Confidence 999999999999999999988753 46899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++....... .....+||+.|||||++.+..++.++|||||||++|||++|+.
T Consensus 136 --------------~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~ 199 (324)
T cd05589 136 --------------TEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199 (324)
T ss_pred --------------CCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCC
Confidence 477899999999875433221 1234679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
||....... .... ..... . .++...+..+.+||.+||+.||.+|| ++.+++++
T Consensus 200 pf~~~~~~~---~~~~---i~~~~--------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 200 PFPGDDEEE---VFDS---IVNDE--------V----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCHHH---HHHH---HHhCC--------C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 997543211 1110 00000 0 11122356788999999999999999 45666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=354.67 Aligned_cols=244 Identities=30% Similarity=0.380 Sum_probs=196.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 211 (511)
+.||+|+||.||+|++.. ++..||+|++..... .....+.+|++++..++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 369999999999998865 678999999976422 22345678999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 212 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|||||+++|+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~----------------- 130 (325)
T cd05594 72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLD----------------- 130 (325)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEEC-----------------
Confidence 999999999999888543 468999999999999999999997 67 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++........ .....||+.|||||++.+..++.++|||||||+||||++|+.||....
T Consensus 131 --------~~~~~kL~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 131 --------KDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred --------CCCCEEEecCCCCeecCCCCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 4778999999999754322211 223579999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 436 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~L 436 (511)
... ..... ... .. .++...+.++.+|+.+||+.||++|+ ++.+++++-
T Consensus 201 ~~~---~~~~i---~~~--------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 201 HEK---LFELI---LME--------EI----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred HHH---HHHHH---hcC--------CC----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 211 11110 000 00 11122356789999999999999996 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.25 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=208.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.+.||+|+||.||+|.+...+. +...||||.++..... ....|.+|+.++++++|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 578899999999999999999865321 3568999998765432 235688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+|||++
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~-------------- 140 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVN-------------- 140 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc--------------
Confidence 9999999999999999999766667899999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
++..+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 141 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~ 209 (266)
T cd05033 141 -----------SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred -----------CCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCC
Confidence 477899999999998753222222222345678999999998899999999999999999998 99998
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
...... ........ . .....+...+..+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus 210 ~~~~~~---~~~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 210 WDMSNQ---DVIKAVED----G----------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCHH---HHHHHHHc----C----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 643211 11111110 0 00011122356789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=342.97 Aligned_cols=261 Identities=30% Similarity=0.438 Sum_probs=207.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|.+.+.||+|+||.||+|.+.... ...++..||||.++..... ....+.+|+++|++++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLE----PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeecccc----CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 356888899999999999999875421 0124678999999765443 34678999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
....++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEc
Confidence 999999999999999999996432 34788889999999999999999998 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlG 353 (511)
.++.+||+|||+++...............+++.|+|||++.+..++.++||||||
T Consensus 157 -------------------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 211 (280)
T cd05049 157 -------------------------YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 211 (280)
T ss_pred -------------------------CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHH
Confidence 4788999999999865433322222334567899999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 354 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 354 vil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|++|||++ |..||...... ......... .....+...+..+.+|+.+||+.||++||++.||
T Consensus 212 ~il~e~~~~g~~p~~~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 212 VVLWEIFTYGKQPWYGLSNE---EVIECITQG--------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred HHHHHHHhcCCCCCCCCCHH---HHHHHHHcC--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 99999998 99998654321 111111100 0011112235778999999999999999999999
Q ss_pred HHHhc
Q 010432 433 VEALK 437 (511)
Q Consensus 433 l~~L~ 437 (511)
++.|+
T Consensus 275 l~~l~ 279 (280)
T cd05049 275 HERLQ 279 (280)
T ss_pred HHHhh
Confidence 99886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=354.96 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=197.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.++||+|+||.||+|++.. ++..||||++.... ......+.+|+.+|++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 47888999999999999999865 67899999987432 22234688999999999999999999988643
Q ss_pred -----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 208 -----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 208 -----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
...|+||||| +++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~--------- 137 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILAN--------- 137 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC---------
Confidence 2479999999 57999988544 46899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCccccc--CCCCccccchhHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 138 ----------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el 201 (338)
T cd07859 138 ----------------ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 201 (338)
T ss_pred ----------------CCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHH
Confidence 4778999999999864332211 11234579999999998865 6789999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhh--------hhc--cccccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARP--------HLG--ERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~Li~~cl~~dP~~R 426 (511)
++|+.||...........+..... ... ....+...+.......+. ...+..+.+|+.+||+.||++|
T Consensus 202 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 281 (338)
T cd07859 202 LTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDR 281 (338)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccC
Confidence 999999976432111110000000 000 000000000000000000 0124567899999999999999
Q ss_pred CCHHHHHHH
Q 010432 427 PLMSEVVEA 435 (511)
Q Consensus 427 Ps~~eil~~ 435 (511)
|++.+++++
T Consensus 282 pt~~e~l~h 290 (338)
T cd07859 282 PTAEEALAD 290 (338)
T ss_pred CCHHHHhcC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=350.73 Aligned_cols=246 Identities=29% Similarity=0.378 Sum_probs=196.2
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
++||+|+||.||+++...+. .+++.||||+++.... .....+.+|+.+|+.++||||+++++++..++..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 57999999999999875322 2678999999975321 2224567899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|+||||+++|+|.+++... ..+.+..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~----------------- 134 (323)
T cd05584 76 YLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLD----------------- 134 (323)
T ss_pred EEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC-----------------
Confidence 9999999999999998654 46788888999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 135 --------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 135 --------AQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred --------CCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 477899999999975433221 1233579999999999998889999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
... . ........ ..++...+..+.+||.+||+.||.+|| ++.+++++
T Consensus 205 ~~~---~---~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 205 RKK---T---IDKILKGK------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHH---H---HHHHHcCC------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 211 1 11100000 011122356789999999999999999 78888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=353.58 Aligned_cols=254 Identities=24% Similarity=0.268 Sum_probs=203.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|.+.+.||+|+||.||+|++.. +++.||||+++.... .....+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 368899999999999999999875 677999999976432 22345778999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.+..+|||||+++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~------------ 136 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLID------------ 136 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEEC------------
Confidence 999999999999999999999776567999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc------cCCCCccccchhHHHHHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||++......... ......||+.|+|||++. ...++.++|||||||++|||
T Consensus 137 -------------~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 202 (330)
T cd05601 137 -------------RTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202 (330)
T ss_pred -------------CCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeee
Confidence 4778999999999876543322 223357999999999986 45678999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
++|+.||........ . ...... ...... . .....+..+.+|+.+||+ +|.+||++.+++++
T Consensus 203 ~~g~~Pf~~~~~~~~---~---~~i~~~-~~~~~~-----~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 203 IYGRSPFHEGTSAKT---Y---NNIMNF-QRFLKF-----P--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCCCCCCCCCHHHH---H---HHHHcC-CCccCC-----C--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 999999975432111 0 000000 000000 0 011235678999999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=355.23 Aligned_cols=265 Identities=28% Similarity=0.410 Sum_probs=205.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|.+...+ ...+++.||+|+++..... ....+.+|+.++.++ +|+||++++++|
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3467999999999999999999764321 1235689999999754322 234678899999999 899999999988
Q ss_pred Ee-CCeEEEEEEccCCCCHHHHHhhCC-----------------------------------------------------
Q 010432 205 IE-DDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (511)
Q Consensus 205 ~~-~~~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------- 230 (511)
.. +..++++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 456889999999999999885321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCce
Q 010432 231 -------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303 (511)
Q Consensus 231 -------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (511)
..+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~-------------------------~~~~v 212 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLS-------------------------ENNVV 212 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEe-------------------------CCCcE
Confidence 25788999999999999999999988 99999999999998 46789
Q ss_pred eeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhh
Q 010432 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 382 (511)
Q Consensus 304 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 382 (511)
||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||....... .+...
T Consensus 213 kL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~-- 288 (337)
T cd05054 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRR-- 288 (337)
T ss_pred EEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHH--
Confidence 9999999987644332222233456788999999999999999999999999999998 999997543211 11111
Q ss_pred hhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 383 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
..... ....+...+..+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus 289 --~~~~~----------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 289 --LKEGT----------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred --HhccC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 10000 0011122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=360.16 Aligned_cols=255 Identities=28% Similarity=0.338 Sum_probs=204.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|++.. +++.||||+++.... .....+.+|+.+|..++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 368899999999999999999875 678999999975422 22356788999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~------------ 135 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILID------------ 135 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC------------
Confidence 999999999999999999999765 57899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCC---------------------------cceeeeeccccccccCCccc
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD---------------------------KTHVSTRVMGTYGYAAPEYV 338 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~---------------------------~~~~~~~~~Gt~~y~aPE~~ 338 (511)
.++.+||+|||+++...... .........||+.|+|||++
T Consensus 136 -------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (350)
T cd05573 136 -------------ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL 202 (350)
T ss_pred -------------CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 47789999999998755432 00112335799999999999
Q ss_pred ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHh
Q 010432 339 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418 (511)
Q Consensus 339 ~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~c 418 (511)
.+..++.++|||||||+||||++|+.||.......... .... .. ..+........+..+.+||.+|
T Consensus 203 ~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~------~i~~-~~-------~~~~~p~~~~~~~~~~~li~~l 268 (350)
T cd05573 203 RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN------KIIN-WK-------ESLRFPPDPPVSPEAIDLICRL 268 (350)
T ss_pred cCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH------HHhc-cC-------CcccCCCCCCCCHHHHHHHHHH
Confidence 99999999999999999999999999997654211100 0000 00 0000000011357889999999
Q ss_pred cccCCCCCCC-HHHHHHHh
Q 010432 419 LSRDPKARPL-MSEVVEAL 436 (511)
Q Consensus 419 l~~dP~~RPs-~~eil~~L 436 (511)
|. ||.+||+ +.+++++.
T Consensus 269 l~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 269 LC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred cc-ChhhcCCCHHHHhcCC
Confidence 97 9999999 99999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=361.04 Aligned_cols=253 Identities=26% Similarity=0.309 Sum_probs=197.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.|+++++||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|++++|+|||++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 58889999999999999999875 677999999975432 223467889999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~------------- 135 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILID------------- 135 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC-------------
Confidence 99999999999999999998654 46889999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCC---------------------------------------------cce
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD---------------------------------------------KTH 321 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~---------------------------------------------~~~ 321 (511)
.++.+||+|||+++...... ...
T Consensus 136 ------------~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (382)
T cd05625 136 ------------RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRC 203 (382)
T ss_pred ------------CCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence 47789999999985321000 000
Q ss_pred eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCC
Q 010432 322 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 401 (511)
Q Consensus 322 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (511)
.....+||+.|+|||++.+..|+.++|||||||+||||++|+.||......... ... .... ..+..
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--~~i----~~~~--------~~~~~ 269 (382)
T cd05625 204 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ--MKV----INWQ--------TSLHI 269 (382)
T ss_pred cccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHH--HHH----HccC--------CCcCC
Confidence 012357999999999999999999999999999999999999999765332110 000 0000 00000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 010432 402 HFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 435 (511)
Q Consensus 402 ~~~~~~~~~~~~Li~~cl~~dP~~RPs---~~eil~~ 435 (511)
......++++.+||.+|+ .+|.+|++ +.+++++
T Consensus 270 p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 270 PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 001123567888998876 59999997 8887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=360.92 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||.||+|++.. +++.||||++..... .....+.+|+++|++++|||||++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 478899999999999999998875 678999999865321 22345788999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++..|||||||++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~------------ 135 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILID------------ 135 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEC------------
Confidence 999999999999999999998653 46889999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc---------------------------------------------
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--------------------------------------------- 320 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--------------------------------------------- 320 (511)
.++.+||+|||+++........
T Consensus 136 -------------~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (377)
T cd05629 136 -------------RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRR 202 (377)
T ss_pred -------------CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc
Confidence 4778999999999632210000
Q ss_pred eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccC
Q 010432 321 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 400 (511)
Q Consensus 321 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (511)
......+||+.|+|||++.+..++.++|||||||+||||++|..||........ .... ...... + .+.
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~~i---~~~~~~---~---~~p 270 (377)
T cd05629 203 LMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET---YRKI---INWRET---L---YFP 270 (377)
T ss_pred ccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH---HHHH---HccCCc---c---CCC
Confidence 000124699999999999999999999999999999999999999975432111 0000 000000 0 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHh
Q 010432 401 GHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEAL 436 (511)
Q Consensus 401 ~~~~~~~~~~~~~Li~~cl~~dP~~R---Ps~~eil~~L 436 (511)
. ....+.++.+||.+||. +|.+| +++.+++.+-
T Consensus 271 ~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 271 D--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 0 01124678999999997 77765 5999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=350.63 Aligned_cols=242 Identities=27% Similarity=0.362 Sum_probs=194.6
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCC-CcceEeeEEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHL-NLVKLIGYCI 205 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~-nIv~l~~~~~ 205 (511)
+|++++.||+|+||.||+|++.. +++.||||++..... ...+.+..|+.++..+.|+ +|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 58889999999999999999865 677999999975421 2335678899999999765 5888999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~------------ 135 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLD------------ 135 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEc------------
Confidence 999999999999999999988654 46889999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 136 -------------~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p 200 (324)
T cd05587 136 -------------AEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200 (324)
T ss_pred -------------CCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 477899999999875432221 12345799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
|...... ....... .. ...++...+..+.+|+.+||+.||.+|++.
T Consensus 201 f~~~~~~---~~~~~i~---~~------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 201 FDGEDED---ELFQSIM---EH------------NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCHH---HHHHHHH---cC------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 9754321 1111110 00 011112235678999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=344.18 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=197.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCC---CCCCcceEeeE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGY 203 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~H~nIv~l~~~ 203 (511)
++|++.+.||+|+||.||+|++... ++..||||+++..... ....+.+|+.+++.+ +||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 3689999999999999999987531 4678999998754322 224566788777765 69999999998
Q ss_pred EEe-----CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 204 CIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 204 ~~~-----~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
+.. ...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~---- 144 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVT---- 144 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEc----
Confidence 852 456899999995 6999998653 345899999999999999999999998 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ 357 (511)
.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 145 ---------------------~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 200 (290)
T cd07862 145 ---------------------SSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200 (290)
T ss_pred ---------------------CCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHH
Confidence 47789999999998654331 123457899999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhhhccccccc-------cccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY-------RLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
||++|++||...........+..... ......+. ........ .......+..+.+|+.+||+.||++||
T Consensus 201 el~~g~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 279 (290)
T cd07862 201 EMFRRKPLFRGSSDVDQLGKILDVIG-LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279 (290)
T ss_pred HHHcCCCCcCCCCHHHHHHHHHHHhC-CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence 99999999986543221111100000 00000000 00000000 001112356788999999999999999
Q ss_pred CHHHHHHH
Q 010432 428 LMSEVVEA 435 (511)
Q Consensus 428 s~~eil~~ 435 (511)
|+.+++++
T Consensus 280 s~~~~l~h 287 (290)
T cd07862 280 SAYSALSH 287 (290)
T ss_pred CHHHHhcC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=350.46 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=195.5
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
++||+|+||.||+|++.. +++.||||+++..... ....+.+|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 369999999999999876 6779999999864322 234577899999998 799999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|||||||++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~----------------- 130 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLD----------------- 130 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEC-----------------
Confidence 9999999999999888544 57999999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 131 --------~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 200 (329)
T cd05588 131 --------AEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred --------CCCCEEECcCccccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccc
Confidence 477899999999975322211 1234679999999999999999999999999999999999999996432
Q ss_pred CCC--chhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 010432 371 PNG--EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL------MSEVVEA 435 (511)
Q Consensus 371 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs------~~eil~~ 435 (511)
... ......+....... .. ..++...+..+.+||.+||+.||.+||+ +.+++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~---------~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 201 MSDNPDQNTEDYLFQVILE---------KQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ccccccccchHHHHHHHHc---------CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 211 11111111111100 00 0112223567899999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=342.88 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=205.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++|++.+.||+|+||.||+|.+... ....++..||||.+..... ....++.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 467899999999999999999987531 1123567899999865432 23346889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
.+...++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~--- 153 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA--- 153 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEc---
Confidence 9999999999999999999986422 23567888999999999999999988 99999999999998
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil 356 (511)
+++.+||+|||+++...............+++.|||||++.+..++.++|||||||++
T Consensus 154 ----------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 211 (277)
T cd05062 154 ----------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211 (277)
T ss_pred ----------------------CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence 4778999999999865443332222233567889999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|||++ |..||...... ........ . . ....+...+..+.+|+.+||+.||++||++.++++.
T Consensus 212 ~el~~~~~~p~~~~~~~---~~~~~~~~----~-~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 212 WEIATLAEQPYQGMSNE---QVLRFVME----G-G---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHcCCCCCCCCCCHH---HHHHHHHc----C-C---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999 68888654321 11111100 0 0 001112234678999999999999999999999998
Q ss_pred hc
Q 010432 436 LK 437 (511)
Q Consensus 436 L~ 437 (511)
|+
T Consensus 275 l~ 276 (277)
T cd05062 275 IK 276 (277)
T ss_pred hh
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.37 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=201.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++.+.||+|+||.||++.++. +..||+|.+..... ....+.+|+.+|++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 458888999999999999998753 45799999875432 3467889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~--------------- 134 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVS--------------- 134 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEc---------------
Confidence 999999999999999999765556899999999999999999999988 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~ 367 (511)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 135 ----------~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~ 203 (256)
T cd05114 135 ----------STGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203 (256)
T ss_pred ----------CCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence 4678999999999865432221 1122345678999999988899999999999999999999 899996
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..... ........ .. .... +...+..+.+|+.+||+.||.+||++.+|++.|
T Consensus 204 ~~~~~---~~~~~i~~----~~---~~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 204 KKSNY---EVVEMISR----GF---RLYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHH---HHHHHHHC----CC---CCCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 54321 11111110 00 0001 111246789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=352.19 Aligned_cols=242 Identities=29% Similarity=0.363 Sum_probs=194.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 212 (511)
+.||+|+||.||+++..... .+|..||+|++...... ....+.+|+.+|++++||||+++++++..++..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP------DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 57999999999999874321 26889999999754322 23456789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~------------------- 132 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLD------------------- 132 (318)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEEC-------------------
Confidence 99999999999998554 46899999999999999999999998 99999999999998
Q ss_pred ccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~ 372 (511)
+++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 133 ------~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 204 (318)
T cd05582 133 ------EEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204 (318)
T ss_pred ------CCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH
Confidence 477899999999986544322 123467999999999999888999999999999999999999999754321
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
...... .... ..++...+..+.+||.+||+.||.+||++.+
T Consensus 205 ---~~~~~i---~~~~------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 205 ---ETMTMI---LKAK------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---HHHHHH---HcCC------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111110 0000 0112223567899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.61 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=197.8
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
+.||+|+||.||+|.+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 369999999999999865 577999998865432 2235688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~-------------------- 128 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVT-------------------- 128 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEc--------------------
Confidence 9999999999999766567899999999999999999999988 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 372 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~ 372 (511)
.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 129 -----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~ 203 (252)
T cd05084 129 -----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203 (252)
T ss_pred -----CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence 467799999999986543221111111123567999999998899999999999999999998 88888643221
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
. .... .. .......+...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus 204 ~---~~~~----~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 204 Q---TREA----IE----------QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred H---HHHH----HH----------cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1 0000 00 00111122233578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.53 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=205.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+|++.+.||+|+||.||+|.+...+. ..+..||+|.+...... ....+.+|+.++++++|+||+++++++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 467888999999999999998643211 25678999999754322 235688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR----------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
+..|+||||+++|+|.+++..+ ...+++..++.++.|++.||.|||+++ |+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence 9999999999999999998532 124788889999999999999999988 999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchh
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwS 351 (511)
++ ++..+||+|||+++...............++..|+|||++.+..++.++||||
T Consensus 157 i~-------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05090 157 IG-------------------------EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211 (283)
T ss_pred Ec-------------------------CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHH
Confidence 98 46779999999998764433222233345678899999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 352 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 352 lGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
|||++|||++ |..||...... ......... . ....+...+..+.+++.+||+.||.+||++.
T Consensus 212 lG~il~el~~~g~~p~~~~~~~---~~~~~~~~~----~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 274 (283)
T cd05090 212 FGVVLWEIFSFGLQPYYGFSNQ---EVIEMVRKR----Q----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFK 274 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcC----C----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence 9999999998 99998654321 111111110 0 0011122356789999999999999999999
Q ss_pred HHHHHhcC
Q 010432 431 EVVEALKP 438 (511)
Q Consensus 431 eil~~L~~ 438 (511)
+|++.|..
T Consensus 275 ~i~~~l~~ 282 (283)
T cd05090 275 DIHTRLRS 282 (283)
T ss_pred HHHHHhhc
Confidence 99998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=336.34 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=212.8
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeE
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
|.++.+||+|+||.||+|.++. +|+.||||.+..+. +..+++.|+.||.+++.+++|++||.+.....+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 5567789999999999998876 78899999997653 456789999999999999999999999998899
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|||||||-.|++.+.++.+..++.+..+..+++..+.||+|||... -||||||..||||..
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT---------------- 164 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNT---------------- 164 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcc----------------
Confidence 9999999999999999988889999999999999999999999987 899999999999984
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
++.+||+|||.|-.+.+.-. ..+++.||+.|||||++..-.|+.++||||||++..||..|++||.+..
T Consensus 165 ---------~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 165 ---------DGIAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred ---------cchhhhhhccccchhhhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 88899999999987655322 2456789999999999999999999999999999999999999998665
Q ss_pred CCCchhHHHhhhhhhccccccccc-cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+... ++-+ ..|.....-+..++.++.++++.||..+|++|-|+.+++++
T Consensus 234 PMRA----------------IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 234 PMRA----------------IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ccce----------------eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 4321 1111 11111222356678999999999999999999999999875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=348.65 Aligned_cols=242 Identities=28% Similarity=0.418 Sum_probs=192.4
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
++||+|+||.||+|++.. +++.||||+++.... .....+..|..++..+ +||||+++++++..++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 369999999999999865 677999999975421 2233456677777654 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~----------------- 130 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLD----------------- 130 (316)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEEC-----------------
Confidence 9999999999999988654 46899999999999999999999988 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 131 --------~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 131 --------KDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred --------CCCCEEEccCcCCeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 477899999999986433221 2334679999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 434 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~-eil~ 434 (511)
.. .+.... ... ...++...+.++.+|+.+||+.||.+||++. ++++
T Consensus 201 ~~---~~~~~i---~~~------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 201 ED---ELFDSI---LND------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HH---HHHHHH---HcC------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 21 111111 000 0111222356788999999999999999875 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=356.52 Aligned_cols=267 Identities=24% Similarity=0.252 Sum_probs=204.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
...+|++++.||+|+||.||+|..... .++..||||.+... ..+.+|+.+|++|+|+|||++++++..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 346799999999999999999976432 24678999998654 235689999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
....|+|||++ +++|.+++ .....+++..++.|+.||+.||.|||+++ ||||||||+|||++
T Consensus 158 ~~~~~lv~e~~-~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~------------- 219 (392)
T PHA03207 158 KSTVCMVMPKY-KCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLD------------- 219 (392)
T ss_pred CCEEEEEehhc-CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEc-------------
Confidence 99999999999 46899988 44457999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||+||||++|+.||
T Consensus 220 ------------~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 220 ------------EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred ------------CCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 47789999999998765443322233467999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhcccc-ccc-----------cccCCccCCCCC-------HHHHHHHHHHHHHhcccCCCCCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERR-RFY-----------RLIDPRLEGHFS-------IKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~-------~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
.+............+...+.... .+. ..........+. ...+.++.+||.+||..||.+||
T Consensus 288 ~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp 367 (392)
T PHA03207 288 FGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367 (392)
T ss_pred CCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC
Confidence 77554322111111110000000 000 000000000000 11245788999999999999999
Q ss_pred CHHHHHHH
Q 010432 428 LMSEVVEA 435 (511)
Q Consensus 428 s~~eil~~ 435 (511)
++.+++.+
T Consensus 368 sa~e~l~~ 375 (392)
T PHA03207 368 SAQDILSL 375 (392)
T ss_pred CHHHHhhC
Confidence 99999986
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=362.20 Aligned_cols=254 Identities=24% Similarity=0.279 Sum_probs=199.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.+|++++.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|++++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 368999999999999999999875 678999999965321 22345788999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~------------ 135 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILID------------ 135 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEEC------------
Confidence 999999999999999999999654 46888999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCC-----------------------------------------cceeee
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD-----------------------------------------KTHVST 324 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~-----------------------------------------~~~~~~ 324 (511)
.++.+||+|||+|....... ......
T Consensus 136 -------------~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (376)
T cd05598 136 -------------RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAH 202 (376)
T ss_pred -------------CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccccc
Confidence 47789999999985321000 000012
Q ss_pred eccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCC
Q 010432 325 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 404 (511)
Q Consensus 325 ~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (511)
..+||+.|||||++.+..++.++|||||||+||||++|+.||........... . . .... .+.....
T Consensus 203 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i---~-~~~~-------~~~~~~~ 268 (376)
T cd05598 203 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK---V---I-NWET-------TLHIPSQ 268 (376)
T ss_pred ccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHH---H---h-ccCc-------cccCCCC
Confidence 35799999999999999999999999999999999999999976543211100 0 0 0000 0000011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 010432 405 IKGAQKAAQLAAHCLSRDPKARP---LMSEVVEA 435 (511)
Q Consensus 405 ~~~~~~~~~Li~~cl~~dP~~RP---s~~eil~~ 435 (511)
...+..+.+||.+|+ .+|.+|+ ++.+++++
T Consensus 269 ~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 269 AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 123467788999977 5999999 89999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.57 Aligned_cols=252 Identities=29% Similarity=0.405 Sum_probs=202.5
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
+|++.++||+|+||.||++.+.. +++.||||++...... ....+.+|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 47888999999999999998865 5779999999754322 22457789999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~------------ 136 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLD------------ 136 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEEC------------
Confidence 99999999999999999888653 346899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.++|+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 137 -------------~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p 200 (285)
T cd05605 137 -------------DYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200 (285)
T ss_pred -------------CCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC
Confidence 467899999999987543222 2235789999999999988999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
|.......... ........ ....++...+..+.+|+.+||+.||.+|| ++.+++++
T Consensus 201 f~~~~~~~~~~---~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 201 FRQRKEKVKRE---EVERRVKE-----------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CCCCchhhHHH---HHHHHhhh-----------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 97643321110 00000000 01112223457789999999999999999 78888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=348.68 Aligned_cols=241 Identities=30% Similarity=0.390 Sum_probs=190.5
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhCCCCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
+.||+|+||+||+|++.. +|+.||||++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 369999999999999875 678999999975422 12234555655 46789999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~----------------- 130 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLD----------------- 130 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEEC-----------------
Confidence 9999999999999988654 47899999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 131 --------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 131 --------SQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred --------CCCcEEEeccCCCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 477899999999976433222 1234579999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
.. .+ ........ ..+. ...+..+.+||.+||+.||.+||++.+.+
T Consensus 201 ~~---~~---~~~i~~~~--------~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 201 TA---EM---YDNILNKP--------LRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred HH---HH---HHHHHcCC--------CCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 21 11 11111100 0011 12256789999999999999999985333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=353.90 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=207.5
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E 215 (511)
+||+|.||+||-|++.. |...+|||.+.........-+..|+.+.+.|+|.|||+++|.+.+++++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 69999999999999887 667899999987665555567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 216 FMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 216 ~~~~g~L~~~l~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
-++||+|..+|...-+++ .+...-.+..||++||.|||++. |||||||-+|+|+..
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNT------------------- 710 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNT------------------- 710 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEee-------------------
Confidence 999999999998776777 77888899999999999999999 999999999999985
Q ss_pred cccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 371 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DIwSlGvil~elltg~~pf~~~~~ 371 (511)
-.+.+||+|||.++.+..-.. ...++.||..|||||++..+ .|+.++|||||||++.||.||++||.....
T Consensus 711 -----ySGvlKISDFGTsKRLAginP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 711 -----YSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred -----ccceEEecccccchhhccCCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 267899999999998654332 24458899999999999854 699999999999999999999999975432
Q ss_pred CCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 372 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.... +++.---...+.++.+.+.+++.+|.+|+.+||.+||++.++|+.
T Consensus 784 pqAA---------------MFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 784 PQAA---------------MFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hhHh---------------hhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 2110 111111112445677788999999999999999999999999873
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=356.06 Aligned_cols=246 Identities=29% Similarity=0.422 Sum_probs=205.5
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
-|..++.||.|+||.||-|++.. +...||||.+.....+.. .+++.|+.+|++|+|||+|.+.|||..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 35556779999999999999876 677999999987765544 457899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+...||||||| -|+-.++|.-...++.+-.+..|+.+.+.||+|||+++ .||||||..||||+
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLs------------- 160 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLS------------- 160 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEec-------------
Confidence 99999999999 66888888766678989999999999999999999999 99999999999999
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg~ 363 (511)
+.+.|||+|||.|..... .+.++|||.|||||++. .+.|+-++||||||++..||...+
T Consensus 161 ------------e~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERk 222 (948)
T KOG0577|consen 161 ------------EPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 222 (948)
T ss_pred ------------CCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcC
Confidence 588899999999987654 34589999999999986 578999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|+...+... +..++.. .-.|.+ ...+++..+..|+..||++-|.+|||..+++.+
T Consensus 223 PPlFnMNAMS-------ALYHIAQ------NesPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 223 PPLFNMNAMS-------ALYHIAQ------NESPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCccCchHHH-------HHHHHHh------cCCCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 9986543211 1111110 011122 245778999999999999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=369.52 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=203.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||+||+|++.. +++.||||++...... ....+.+|+.+|..++|+||++++..+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 34689999999999999999998865 6789999999765432 234578899999999999999998877
Q ss_pred EeCC--------eEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 205 IEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 205 ~~~~--------~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
...+ .+++||||+++|+|.++|..+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~ 177 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC 177 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence 5432 367999999999999998643 346889999999999999999999988 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlG 353 (511)
.++.+||+|||+++..............+||+.|+|||++.+..++.++||||||
T Consensus 178 -------------------------~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlG 232 (496)
T PTZ00283 178 -------------------------SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232 (496)
T ss_pred -------------------------CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHH
Confidence 4778999999999875443222223446799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 354 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
|+||||++|+.||...... .+. ...... . ...++...+..+.+|+.+||+.||.+||++.+++
T Consensus 233 vilyeLltG~~Pf~~~~~~---~~~---~~~~~~------~-----~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 233 VLLYELLTLKRPFDGENME---EVM---HKTLAG------R-----YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred HHHHHHHHCCCCCCCCCHH---HHH---HHHhcC------C-----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 9999999999999754211 111 111100 0 0111223357899999999999999999999998
Q ss_pred HH
Q 010432 434 EA 435 (511)
Q Consensus 434 ~~ 435 (511)
++
T Consensus 296 ~~ 297 (496)
T PTZ00283 296 NM 297 (496)
T ss_pred hC
Confidence 75
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=349.40 Aligned_cols=237 Identities=29% Similarity=0.406 Sum_probs=191.2
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
++||+|+||.||+|+++. +++.||||++.... ......+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 369999999999999875 57799999997542 12334577888888876 799999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~----------------- 130 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLD----------------- 130 (320)
T ss_pred EEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEEC-----------------
Confidence 9999999999999988654 46899999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 131 --------~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 131 --------HEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred --------CCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 477899999999876432221 1234679999999999998999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
... +.... .... ..++...+..+.+|+.+||+.||.+||++
T Consensus 201 ~~~---~~~~i---~~~~------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 201 EDD---LFEAI---LNDE------------VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHH---HHHHH---hcCC------------CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 211 11111 1000 01111235678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=319.94 Aligned_cols=266 Identities=26% Similarity=0.343 Sum_probs=210.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
+..++|++.+.||+|||+-||+++... ++..||+|++......+.+..++|++..++++||||++++++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 456789999999999999999998654 78899999998877677788999999999999999999998775
Q ss_pred eC-----CeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 206 ED-----DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 206 ~~-----~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
.+ ...||+++|...|+|.+.+... +..+++.+++.|+.+|++||++||+.. ++++||||||.|||+.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls---- 163 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLS---- 163 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEec----
Confidence 43 3489999999999999998643 457999999999999999999999987 6799999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce-------eeeeccccccccCCcccc---cCCCCccc
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVM---TGHLTSRS 347 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~Gt~~y~aPE~~~---~~~~~~~~ 347 (511)
+.+.++|.|||.++...-..... .......|..|+|||++. +...+.++
T Consensus 164 ---------------------~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ert 222 (302)
T KOG2345|consen 164 ---------------------DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERT 222 (302)
T ss_pred ---------------------CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccccccc
Confidence 46789999999998653211100 011234689999999886 45678999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 348 DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
|||||||+||+|+.|..||......+.. -...+..+.+.-.-....++.+.+|++.||+.||.+||
T Consensus 223 DIWSLGCtLYa~mf~~sPfe~~~~~GgS--------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP 288 (302)
T KOG2345|consen 223 DIWSLGCTLYAMMFGESPFERIYQQGGS--------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP 288 (302)
T ss_pred chhhhhHHHHHHHHcCCcchHHhhcCCe--------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC
Confidence 9999999999999999999743221110 00111221111111122578899999999999999999
Q ss_pred CHHHHHHHhcCCC
Q 010432 428 LMSEVVEALKPLP 440 (511)
Q Consensus 428 s~~eil~~L~~l~ 440 (511)
++.+++..++.+.
T Consensus 289 ~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 289 TIPELLSKLDDLI 301 (302)
T ss_pred CHHHHHHHHHhhc
Confidence 9999999887653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=355.60 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=221.7
Q ss_pred ChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcce
Q 010432 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~ 199 (511)
.++.++.-..+..+.++||-|.||.||.|.|+. -...||||.++.+... .++|+.|+.+|+.++|||+|+
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk---------yslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVq 327 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 327 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeec---------cceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHH
Confidence 346777777788889999999999999999986 3568999999977543 578999999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
|+|+|..+..+|||+|||.+|+|.+||+..+ ..++.-..+.++.||..||+||..++ +|||||..+|+|+.
T Consensus 328 LLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVg----- 399 (1157)
T KOG4278|consen 328 LLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVG----- 399 (1157)
T ss_pred HhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhcccc-----
Confidence 9999999999999999999999999997644 34677777899999999999999988 99999999999999
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
++..|||+||||++.+..+..+ ......-.+.|.|||.+....++.|+|||+|||+|||
T Consensus 400 --------------------EnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWE 458 (1157)
T KOG4278|consen 400 --------------------ENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWE 458 (1157)
T ss_pred --------------------ccceEEeeccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHH
Confidence 5788999999999988664433 2222234678999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 359 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 359 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
+.| |..||.+... .+.+.++...++-.-+..|++.+.+||+.||+++|.+||++.||-+.++
T Consensus 459 IATYGMsPYPGidl-----------------SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 459 IATYGMSPYPGIDL-----------------SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred HHhcCCCCCCCccH-----------------HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 998 6778765422 1223344444444555667899999999999999999999999999887
Q ss_pred CC
Q 010432 438 PL 439 (511)
Q Consensus 438 ~l 439 (511)
.+
T Consensus 522 tm 523 (1157)
T KOG4278|consen 522 TM 523 (1157)
T ss_pred HH
Confidence 65
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=347.72 Aligned_cols=243 Identities=28% Similarity=0.395 Sum_probs=193.5
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
++||+|+||.||+|+++. +|..||||+++.... .....+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 469999999999999875 678999999975421 2234567788888754 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|||||||.+|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~----------------- 130 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLD----------------- 130 (316)
T ss_pred EEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEC-----------------
Confidence 9999999999999988654 46889999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 131 --------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 131 --------RDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred --------CCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 467899999999875432221 1334679999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 435 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~-eil~~ 435 (511)
.. .+...... ..+.+ +...+.++.+|+.+||+.||.+||++. +++++
T Consensus 201 ~~---~~~~~~~~-----------~~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 201 ED---ELFESIRV-----------DTPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HH---HHHHHHHh-----------CCCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 21 11111110 01111 112346789999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.46 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=206.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.+|.+.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+++++.++|+||+++++++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 457888899999999999999865 57799999987543 23457889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~-------------- 138 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVG-------------- 138 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEc--------------
Confidence 999999999999999998653 345899999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
++..+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 139 -----------~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 206 (263)
T cd05052 139 -----------ENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206 (263)
T ss_pred -----------CCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 4778999999999876543221 1112234678999999998999999999999999999998 89998
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
...... ....... .......+...+..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 207 ~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 207 PGIDLS---QVYELLE--------------KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHH---HHHHHHH--------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 754221 1111110 0011112223357899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=351.06 Aligned_cols=265 Identities=29% Similarity=0.456 Sum_probs=219.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.......+.++||+|-||.|.+|.... +..||||+++...... ..+|.+|+++|.+|+|||||+|+|+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 345667788999999999999998742 5799999999876544 47899999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l-~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
..++.+++||||+++|+|.+||.+...+. .-.....|+.||+.||+||.+.+ +|||||.+.|||++
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~---------- 671 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVD---------- 671 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeec----------
Confidence 99999999999999999999998764333 55566789999999999999998 99999999999999
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh--
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-- 361 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-- 361 (511)
.++++||+|||+++.+..++.+....+.+-+++|||||.+..+++++++|||+||++|||+++
T Consensus 672 ---------------~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C 736 (807)
T KOG1094|consen 672 ---------------GEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLC 736 (807)
T ss_pred ---------------CcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHH
Confidence 589999999999999988888888888888999999999999999999999999999999875
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
...||...... +.++.....+...... .....+.-++..+.+||.+||..|-.+||++++|...|..
T Consensus 737 ~e~Py~~lt~e---~vven~~~~~~~~~~~-------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 737 REQPYSQLTDE---QVVENAGEFFRDQGRQ-------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred hhCchhhhhHH---HHHHhhhhhcCCCCcc-------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 67888654322 2222222222221111 1112234467889999999999999999999999988764
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=346.57 Aligned_cols=242 Identities=28% Similarity=0.420 Sum_probs=193.2
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
+.||+|+||+||+|++.. ++..||||+++.... .....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 369999999999999875 677999999976421 2234566788888764 999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
+|||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~----------------- 130 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLD----------------- 130 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEEC-----------------
Confidence 9999999999999998653 46889999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 131 --------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 131 --------TDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred --------CCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 467899999999975432221 1234579999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 434 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~-eil~ 434 (511)
.. .+...... ..+. ++...+..+.+|+.+||+.||.+||++. ++++
T Consensus 201 ~~---~~~~~i~~-----------~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 201 EE---ELFQSIRM-----------DNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HH---HHHHHHHh-----------CCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 21 11111110 0011 1112346789999999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.72 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=194.7
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
++||+|+||.||+|++.. +++.||||+++.... .....+..|.+++..+ +||||+++++++..++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 369999999999999865 677999999976422 2234567899998866 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|||||||++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~----------------- 130 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLD----------------- 130 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC-----------------
Confidence 9999999999999988644 46889999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 131 --------~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 131 --------AEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred --------CCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 477899999999986433222 1234579999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-------LMSEVVEA 435 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-------s~~eil~~ 435 (511)
... ..... .... ..++...+.++.+|+.+||+.||++|| ++.+++++
T Consensus 201 ~~~---~~~~i---~~~~------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 201 EDD---LFESI---LHDD------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHH---HHHHH---HcCC------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 211 11111 1000 001112246789999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.89 Aligned_cols=242 Identities=25% Similarity=0.333 Sum_probs=195.1
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
+|++.+.||+|+||.||+|++.. ++..||||++..... .....+..|..++..+ +|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 57889999999999999999865 677999999976432 1223467788888877 6899999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..+|||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~------------ 135 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLD------------ 135 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEEC------------
Confidence 999999999999999999988654 46889999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 136 -------------~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~P 200 (323)
T cd05616 136 -------------SEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200 (323)
T ss_pred -------------CCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCC
Confidence 477899999999975432221 12346799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
|...... .+..... .. ...++...+.++.+|+.+||+.||.+|+++
T Consensus 201 f~~~~~~---~~~~~i~---~~------------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 201 FEGEDED---ELFQSIM---EH------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCHH---HHHHHHH---hC------------CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 9754321 1111111 00 011122335778999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.06 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=194.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
+.||+|+||.||+|++.. +++.||+|+++.... .....+.+|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 369999999999999875 677999999986432 2234567899988877 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~----------------- 130 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLD----------------- 130 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEC-----------------
Confidence 9999999999999888544 47899999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 131 --------~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (329)
T cd05618 131 --------SEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred --------CCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCC
Confidence 477899999999975432221 1234679999999999999999999999999999999999999996422
Q ss_pred CCCc--hhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 010432 371 PNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 435 (511)
Q Consensus 371 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~------~eil~~ 435 (511)
.... .....+..... ... ...++...+..+.+||.+||+.||.+||++ .+++++
T Consensus 201 ~~~~~~~~~~~~~~~~i---------~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 201 SSDNPDQNTEDYLFQVI---------LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CcCCcccccHHHHHHHH---------hcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1110 11111111100 000 011222335678899999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.99 Aligned_cols=246 Identities=28% Similarity=0.409 Sum_probs=195.1
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
||+|+||+||+|.+.. +++.||||.+...... ..+.+..|+.+|+.++|+||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 7999999999998875 6779999999754322 224567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 214 YEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~----------------- 131 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLD----------------- 131 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC-----------------
Confidence 999999999988743 3346899999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
+++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 132 --------~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 132 --------NDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred --------CCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 4678999999999865443221 233578999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
...... .... .+... ...++...+..+.+|+.+||+.||++|| ++.+++++
T Consensus 202 ~~~~~~--~~~~----------~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 202 EKVENK--ELKQ----------RILND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cchhHH--HHHH----------hhccc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 221110 0000 00000 0112223457789999999999999999 55666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.72 Aligned_cols=265 Identities=29% Similarity=0.445 Sum_probs=209.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
..+|.+.+.||+|+||.||++...... ...++..||+|.+..........+.+|+.+|++++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCC----CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 357889999999999999999864311 1124567999999765544456789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccc
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 275 (511)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~-- 154 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVG-- 154 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc--
Confidence 99999999999999999986432 24899999999999999999999988 99999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHH
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi 355 (511)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||+
T Consensus 155 -----------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~i 211 (288)
T cd05093 155 -----------------------ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211 (288)
T ss_pred -----------------------cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHH
Confidence 477899999999986644332222233456788999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 356 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 356 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
+|||++ |..||....... ....... . .. .. .+...+..+.+|+.+||+.||.+||++.+++.
T Consensus 212 l~~l~t~g~~p~~~~~~~~---~~~~i~~---~--~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 212 LWEIFTYGKQPWYQLSNNE---VIECITQ---G--RV-----LQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHhCCCCCCCCCCHHH---HHHHHHc---C--Cc-----CC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999998 899986543211 1111100 0 00 00 11123467899999999999999999999999
Q ss_pred HhcCCCC
Q 010432 435 ALKPLPN 441 (511)
Q Consensus 435 ~L~~l~~ 441 (511)
.|+.+..
T Consensus 275 ~l~~~~~ 281 (288)
T cd05093 275 LLQNLAK 281 (288)
T ss_pred HHHHHHH
Confidence 9887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=357.91 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=203.2
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEee
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
...++|++.++||+|+||.||+|++.. ++..||||++..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345789999999999999999999875 678999999975321 22245778999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++.+++..|||||||++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~--------- 176 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLD--------- 176 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEc---------
Confidence 999999999999999999999988543 5788889999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC----CCCccccchhHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||++......... .....+||+.|||||++.+. .++.++|||||||+|||
T Consensus 177 ----------------~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilye 239 (370)
T cd05596 177 ----------------KSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (370)
T ss_pred ----------------CCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHH
Confidence 4788999999999875432211 12345799999999998653 47899999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 436 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~--RPs~~eil~~L 436 (511)
|++|+.||........ ... ....... + .+.. ....+..+.+||.+||+.+|.+ |+++.+++++-
T Consensus 240 lltG~~Pf~~~~~~~~---~~~---i~~~~~~---~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 240 MLVGDTPFYADSLVGT---YSK---IMDHKNS---L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHhCCCCcCCCCHHHH---HHH---HHcCCCc---C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 9999999976432111 000 0000000 0 0000 1123578899999999999988 99999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.91 Aligned_cols=261 Identities=27% Similarity=0.405 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+|++.+.||+|+||.||+|.+..++.. ....|++|.+..... ....++..|+.++++++||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 4788899999999999999998653221 123588888864322 22346778888999999999999999875 4
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++++||+++|+|.+++......+++..++.++.||+.||.|||+++ ++||||||+|||++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~-------------- 143 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLK-------------- 143 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEc--------------
Confidence 5578999999999999999776667999999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
++..+||+|||+++...............|+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 144 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 144 -----------SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred -----------CCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 477899999999987644332222334567889999999998899999999999999999998 99999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
.+...... ..... .... ... +..++..+.+++.+||..||.+||++.++++.|..+.
T Consensus 213 ~~~~~~~~---~~~~~----~~~~---~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 213 AGMRPHEV---PDLLE----KGER---LAQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCCHHHH---HHHHH----CCCc---CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 75432211 11111 0000 000 1112356788999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=342.22 Aligned_cols=264 Identities=28% Similarity=0.425 Sum_probs=210.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.+|.+.+.||+|+||.||+|++..... ..++..|++|.+........+.+.+|+.++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 468888999999999999998643211 1245679999997665544567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 209 QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 9999999999999999996432 34789999999999999999999998 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlG 353 (511)
+++.+||+|||+++...............|+..|+|||++.+..++.++||||||
T Consensus 158 -------------------------~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 212 (291)
T cd05094 158 -------------------------ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212 (291)
T ss_pred -------------------------cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHH
Confidence 4778999999999876543332223345678899999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 354 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 354 vil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|++|||++ |..||....... ....... . ........++..+.+|+.+||+.||.+||++.+|
T Consensus 213 ~il~el~t~g~~p~~~~~~~~---~~~~~~~----~----------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 213 VILWEIFTYGKQPWFQLSNTE---VIECITQ----G----------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred HHHHHHHhCCCCCCCCCCHHH---HHHHHhC----C----------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 99999999 999986543211 1111100 0 0001112235678999999999999999999999
Q ss_pred HHHhcCCCC
Q 010432 433 VEALKPLPN 441 (511)
Q Consensus 433 l~~L~~l~~ 441 (511)
++.|+.+..
T Consensus 276 ~~~l~~~~~ 284 (291)
T cd05094 276 YKILHALGK 284 (291)
T ss_pred HHHHHHHHh
Confidence 999987744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.68 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=202.6
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
|.+.+.||+|+||.||+|.+..+.. ++..||||+++..... ....+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5678899999999999998865321 4578999999865332 2356889999999999999999999887654
Q ss_pred e------EEEEEEccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 209 Q------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 209 ~------~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
. .++||||+++|+|..++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~---- 147 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLR---- 147 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEEC----
Confidence 4 78999999999999988532 235889999999999999999999988 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ 357 (511)
++..+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 148 ---------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~ 206 (273)
T cd05035 148 ---------------------EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 206 (273)
T ss_pred ---------------------CCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHH
Confidence 46789999999998765433222222234577899999998889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 358 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 358 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||++ |..||...... ......... .....+..++..+.+++.+||+.||.+||++.+|++.|
T Consensus 207 el~~~g~~p~~~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 207 EIATRGQTPYPGVENH---EIYDYLRHG--------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred HHHhCCCCCCCCCCHH---HHHHHHHcC--------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 88888654321 111111100 00111223457899999999999999999999999998
Q ss_pred cCC
Q 010432 437 KPL 439 (511)
Q Consensus 437 ~~l 439 (511)
+.+
T Consensus 270 ~~~ 272 (273)
T cd05035 270 ENI 272 (273)
T ss_pred Hhh
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=341.80 Aligned_cols=254 Identities=34% Similarity=0.560 Sum_probs=196.5
Q ss_pred CCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEE
Q 010432 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (511)
Q Consensus 133 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 211 (511)
+.+.||.|.||.||+|.+... ....+..|+||.++..... ..+.+.+|++++++++||||++++|++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 346799999999999999831 1125679999999664332 3567999999999999999999999999888899
Q ss_pred EEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 212 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 212 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
+|||||++|+|.++|... ...+++..+..|+.||+.||.|||+++ |+|+||+++|||++
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~----------------- 137 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLD----------------- 137 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEE-----------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc-----------------
Confidence 999999999999999876 567999999999999999999999988 99999999999999
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 369 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~ 369 (511)
.++.+||+|||++................+...|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 138 --------~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 138 --------SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp --------TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred --------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 477899999999988744333322333457889999999998889999999999999999999 67888654
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
.. ..+..... .... ...+..++..+.+||.+||+.||.+||++.+|++.|
T Consensus 210 ~~---~~~~~~~~----~~~~----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 DN---EEIIEKLK----QGQR----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp CH---HHHHHHHH----TTEE----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc---cccccccc----cccc----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 21 11111111 1110 111122356789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=355.91 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=201.9
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceE
Q 010432 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKL 200 (511)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l 200 (511)
+....++|++.+.||+|+||.||+|++.. +++.||+|++..... .....+.+|+.+++.++||||+++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeE
Confidence 34456789999999999999999999876 677999999964321 223457789999999999999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
++++..++..|+|||||++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~------- 176 (370)
T cd05621 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLD------- 176 (370)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEC-------
Confidence 99999999999999999999999998543 5788999999999999999999998 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC----CCCccccchhHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVL 356 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DIwSlGvil 356 (511)
+++.+||+|||++......... .....+||+.|||||++.+. .++.++|||||||+|
T Consensus 177 ------------------~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~il 237 (370)
T cd05621 177 ------------------KHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred ------------------CCCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHH
Confidence 4778999999999876432221 12346799999999998754 378999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVE 434 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~--RPs~~eil~ 434 (511)
|||++|+.||........ . ........ .+........+..+.+|+.+||..++.+ |+++.++++
T Consensus 238 yell~G~~Pf~~~~~~~~---~---~~i~~~~~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 238 FEMLVGDTPFYADSLVGT---Y---SKIMDHKN--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHHHhCCCCCCCCCHHHH---H---HHHHhCCc--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 999999999975432111 0 00000000 0000011123567889999999865544 889999988
Q ss_pred H
Q 010432 435 A 435 (511)
Q Consensus 435 ~ 435 (511)
+
T Consensus 304 h 304 (370)
T cd05621 304 H 304 (370)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.64 Aligned_cols=266 Identities=28% Similarity=0.404 Sum_probs=209.0
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEee
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~ 202 (511)
....++|++.+.||+|+||.||++.+..... ......||+|.+..... .....+.+|+.++.++ +|+||+++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3455678999999999999999998864221 12456899999976432 2234588999999999 8999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp 267 (511)
++..++..++||||+++|+|..++... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp 160 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAA 160 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccce
Confidence 999999999999999999999998632 245889999999999999999999988 99999999
Q ss_pred CcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccc
Q 010432 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 347 (511)
Q Consensus 268 ~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~ 347 (511)
+|||++ +++.+||+|||+++...............++..|+|||++.+..++.++
T Consensus 161 ~Nil~~-------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 215 (293)
T cd05053 161 RNVLVT-------------------------EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS 215 (293)
T ss_pred eeEEEc-------------------------CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccc
Confidence 999998 4778999999999876543322222223456789999999888999999
Q ss_pred cchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 348 DVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 348 DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
|||||||++|||++ |..||........ .... .. ......+...+..+.+|+.+||..||.+|
T Consensus 216 Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~----~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 278 (293)
T cd05053 216 DVWSFGVLLWEIFTLGGSPYPGIPVEEL---FKLL----KE----------GYRMEKPQNCTQELYHLMRDCWHEVPSQR 278 (293)
T ss_pred ceeehhhHHHHHhcCCCCCCCCCCHHHH---HHHH----Hc----------CCcCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 99999999999997 9999865432111 1100 00 00111122335678999999999999999
Q ss_pred CCHHHHHHHhcCC
Q 010432 427 PLMSEVVEALKPL 439 (511)
Q Consensus 427 Ps~~eil~~L~~l 439 (511)
||+.++++.|+.+
T Consensus 279 ps~~eil~~l~~~ 291 (293)
T cd05053 279 PTFKQLVEDLDRM 291 (293)
T ss_pred cCHHHHHHHHHHh
Confidence 9999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=348.90 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=206.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCC-CCCCcceEee
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l-~H~nIv~l~~ 202 (511)
+....|+++++||+||.+.||++...+ ...||+|.+.... ......|.+|+..|.+| .|.+||+||+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 345679999999999999999998653 3467887765432 23345689999999999 5999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
|-..++.+||||||= ..||..+|.+....++.-.++.|..|++.|+.++|.+| |||.||||.|+|+-
T Consensus 428 YEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV--------- 494 (677)
T KOG0596|consen 428 YEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV--------- 494 (677)
T ss_pred eeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE---------
Confidence 999999999999986 55999999877666664578899999999999999999 99999999999997
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-----------CCCccccchh
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----------HLTSRSDVYS 351 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----------~~~~~~DIwS 351 (511)
.+.+||+|||+|...............+||+.||+||.+... ..+.++||||
T Consensus 495 -----------------kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWS 557 (677)
T KOG0596|consen 495 -----------------KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWS 557 (677)
T ss_pred -----------------eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhh
Confidence 788999999999988877666666678999999999998632 2567899999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHH
Q 010432 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG-AQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 352 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
||||||+|+.|+.||..... ...++..+.+|...-+|+..- ..++.++|+.||++||++||++.
T Consensus 558 LGCILYqMvYgktPf~~~~n---------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~ 622 (677)
T KOG0596|consen 558 LGCILYQMVYGKTPFGQIIN---------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIP 622 (677)
T ss_pred hhhHHHHHHhcCCchHHHHH---------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcH
Confidence 99999999999999963210 112334555654433333221 22399999999999999999999
Q ss_pred HHHHH
Q 010432 431 EVVEA 435 (511)
Q Consensus 431 eil~~ 435 (511)
++|++
T Consensus 623 eLLqh 627 (677)
T KOG0596|consen 623 ELLQH 627 (677)
T ss_pred HHhcC
Confidence 99985
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=346.42 Aligned_cols=244 Identities=26% Similarity=0.355 Sum_probs=193.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
++||+|+||.||+|++.. +++.||||+++..... ....+.+|+.++.++ +|+||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 369999999999999876 5779999999865322 234577899999888 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|||||||++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~----------------- 130 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLD----------------- 130 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEe-----------------
Confidence 9999999999999888543 46999999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 131 --------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 131 --------ADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred --------CCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 477899999999985332221 1234679999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
................. . ...++...+..+.+|+.+||+.||.+|+++
T Consensus 201 ~~~~~~~~~~~~~~~~~---------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 201 DNPDMNTEDYLFQVILE---------K--PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCcccccHHHHHHHHHh---------C--CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 32221111111111100 0 001122234678899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.88 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|.+.+.||+|+||.||+|.+..... ..++..||+|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4678999999999999999998864110 114678999988754332 23468999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+|||++..+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~---- 153 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKG---- 153 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccC----
Confidence 889999999999999999986542 25889999999999999999999998 99999999999998421
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
+...+||+|||+++...............++..|+|||++.+..++.++|||||||++|||+
T Consensus 154 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 154 ------------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred ------------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 23468999999998764322211122233467899999999899999999999999999999
Q ss_pred h-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 361 T-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 361 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
+ |..||....... +...... ......+...+..+.+|+.+||+.+|++||++.+|+++|.
T Consensus 216 ~~g~~pf~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 216 SLGYMPYPGRTNQE---VMEFVTG--------------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCCCCCCCCCHHH---HHHHHHc--------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 7 999997543221 1111100 0011112223567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=338.54 Aligned_cols=272 Identities=26% Similarity=0.399 Sum_probs=209.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCC-------ccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcce
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~-------~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~ 199 (511)
..+|++.+.||+|+||.||+|.+...+... .....+..||+|.+...... ....+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999886533211 12234567999999865432 3456889999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
+++++..++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 26899999999999999999999988 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ ++..++|+|||+++...............+|+.|+|||++.+..++.++||
T Consensus 161 ili~-------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVG-------------------------KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeec-------------------------CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 9998 467899999999987654433333334567889999999988889999999
Q ss_pred hhHHHHHHHHHh--CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 350 YSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 350 wSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
|||||++|||++ |..||...... ............. ........+...+.++.+|+.+||+.||.+||
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 285 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQ---QVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRP 285 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChH---HHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCC
Confidence 999999999998 66777543211 1111111110000 00000111122346899999999999999999
Q ss_pred CHHHHHHHhc
Q 010432 428 LMSEVVEALK 437 (511)
Q Consensus 428 s~~eil~~L~ 437 (511)
++.+|++.|+
T Consensus 286 t~~el~~~L~ 295 (296)
T cd05051 286 TFREIHLFLQ 295 (296)
T ss_pred CHHHHHHHhc
Confidence 9999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=340.26 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=204.4
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+|++.+.||+|+||.||+|.+..... ...+..||||+++...... ...+.+|+.++..++||||+++++++...+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 46777889999999999998754211 1145789999998654322 346889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 209 QRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
..++++||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 999999999999999998522 134788889999999999999999988 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlG 353 (511)
++..+||+|||+++...............+++.|+|||++.+..++.++||||||
T Consensus 159 -------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05091 159 -------------------------DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213 (283)
T ss_pred -------------------------CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHH
Confidence 4677999999999876544333223334567899999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 354 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 354 vil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|++|||++ |..||.+.... ........ . .....+..++..+.+|+.+||+.+|.+||++.+|
T Consensus 214 ~~l~el~~~g~~p~~~~~~~---~~~~~i~~-------------~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 214 VVLWEVFSYGLQPYCGYSNQ---DVIEMIRN-------------R-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHH---HHHHHHHc-------------C-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 99999998 88888654321 11111110 0 0011122345778999999999999999999999
Q ss_pred HHHhcC
Q 010432 433 VEALKP 438 (511)
Q Consensus 433 l~~L~~ 438 (511)
+..|+.
T Consensus 277 ~~~l~~ 282 (283)
T cd05091 277 HSRLRT 282 (283)
T ss_pred HHHhhC
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.70 Aligned_cols=265 Identities=24% Similarity=0.379 Sum_probs=205.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCC-CCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~-H~nIv~l~~~~ 204 (511)
..++|.+.++||+|+||.||+|++.... ...++..||||+++...... ...+++|+.+|.++. |||||++++++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 3456888899999999999999975321 11246689999998653322 346889999999997 99999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC------------------------------------------------------
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 230 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------------------ 230 (511)
...+..++|||||++|+|.+++.+..
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999986431
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 010432 231 -------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (511)
Q Consensus 231 -------------------------------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp 267 (511)
..+++..++.|+.||+.||.|||+.+ |+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 13566778889999999999999988 99999999
Q ss_pred CcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccc
Q 010432 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 347 (511)
Q Consensus 268 ~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~ 347 (511)
+|||++ ++..+||+|||+++...............|++.|||||++.+..++.++
T Consensus 268 ~NiLl~-------------------------~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 322 (401)
T cd05107 268 RNVLIC-------------------------EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS 322 (401)
T ss_pred ceEEEe-------------------------CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHh
Confidence 999998 4677999999999865432221122234578899999999988899999
Q ss_pred cchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 348 DVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 348 DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
|||||||++|||++ |..||........ ...... . ......+...+..+.+|+.+||..+|.+|
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~--~~~~~~----~----------~~~~~~p~~~~~~l~~li~~cl~~~P~~R 386 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQ--FYNAIK----R----------GYRMAKPAHASDEIYEIMQKCWEEKFEIR 386 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHH--HHHHHH----c----------CCCCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 99999999999998 8889865322110 000000 0 00111122235789999999999999999
Q ss_pred CCHHHHHHHhcCC
Q 010432 427 PLMSEVVEALKPL 439 (511)
Q Consensus 427 Ps~~eil~~L~~l 439 (511)
|++.+|++.|+.+
T Consensus 387 Ps~~ell~~L~~~ 399 (401)
T cd05107 387 PDFSQLVHLVGDL 399 (401)
T ss_pred cCHHHHHHHHHHH
Confidence 9999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=348.33 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=196.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
...+|++++.||+|+||.||+|++.. ++..||+|+.... ....|+.+|++++|+|||++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34579999999999999999999865 5678999985433 23579999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
....++||||+ .++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~------------- 191 (357)
T PHA03209 129 GAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFIN------------- 191 (357)
T ss_pred CCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC-------------
Confidence 99999999999 56999998776678999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.+..+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 192 ------------~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 192 ------------DVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ------------CCCCEEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 467899999999975432211 23357999999999999999999999999999999999976655
Q ss_pred CCCCCCCchh--------HHHhhhhhhccccccc---------cccC--CccCCCC-------CHHHHHHHHHHHHHhcc
Q 010432 367 DKNRPNGEHN--------LVEWARPHLGERRRFY---------RLID--PRLEGHF-------SIKGAQKAAQLAAHCLS 420 (511)
Q Consensus 367 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~---------~~~~--~~~~~~~-------~~~~~~~~~~Li~~cl~ 420 (511)
....+..... +.............+. ..++ ......+ ....+..+.+||.+||+
T Consensus 257 f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 336 (357)
T PHA03209 257 FEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLT 336 (357)
T ss_pred ccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHc
Confidence 4332221110 0000000000000000 0000 0000000 01123456789999999
Q ss_pred cCCCCCCCHHHHHHH
Q 010432 421 RDPKARPLMSEVVEA 435 (511)
Q Consensus 421 ~dP~~RPs~~eil~~ 435 (511)
.||.+|||+.||+++
T Consensus 337 ~dP~~Rpta~e~l~h 351 (357)
T PHA03209 337 FDAAMRPSAEEILNY 351 (357)
T ss_pred CCcccCcCHHHHhcC
Confidence 999999999999975
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=345.68 Aligned_cols=249 Identities=27% Similarity=0.325 Sum_probs=193.9
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhCCCCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
+.||+|+||+||+|++.. +++.||+|++..... .....+..|.. +++.++|+||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 369999999999999875 577999999975421 12234445544 56789999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++|+|.+++... ..+.+..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~----------------- 130 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLD----------------- 130 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEC-----------------
Confidence 9999999999999998654 46788888899999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... .....+||+.|||||++.+..++.++|||||||++|||++|..||....
T Consensus 131 --------~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 131 --------SQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred --------CCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 477899999999986433221 1234679999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
... ..... .... ..+....+..+.+|+.+||+.||.+||++.+.+..+.....
T Consensus 201 ~~~---~~~~i---~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 201 TAE---MYDNI---LNKP------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred HHH---HHHHH---HhCC------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 211 11111 0000 01111235678999999999999999998865554444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.35 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=209.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
...+|++.++||.|+||.||+|.+.. +..||+|++..........+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 34578899999999999999998864 56899999987665455678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~------------ 138 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVG------------ 138 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEc------------
Confidence 99999999999999999999753 346899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
++..+||+|||++......... .....++..|+|||++....++.++|||||||++|+|++ |+.
T Consensus 139 -------------~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~ 203 (261)
T cd05148 139 -------------EDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203 (261)
T ss_pred -------------CCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 4778999999999876443221 123346788999999988899999999999999999998 899
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||...... ........ ......+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 204 p~~~~~~~---~~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 204 PYPGMNNH---EVYDQITA--------------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCcCCHH---HHHHHHHh--------------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 99654321 11111110 011112223457789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=337.07 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=206.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|...++||+|+||.||++..... ....++..||+|.+..........+.+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 35788889999999999999976431 11235678999998766544456789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEc
Confidence 99999999999999999986532 24788999999999999999999988 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlG 353 (511)
++..+||+|||+++...............+++.|+|||++.+..++.++||||||
T Consensus 157 -------------------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 211 (280)
T cd05092 157 -------------------------QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211 (280)
T ss_pred -------------------------CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHH
Confidence 4778999999999865443322222234467889999999989999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 354 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 354 vil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|++|||++ |..||....... ...... ... ....+...+..+.+|+.+||+.||.+||++.+|
T Consensus 212 ~il~el~~~g~~p~~~~~~~~---~~~~~~----~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 212 VVLWEIFTYGKQPWYQLSNTE---AIECIT----QGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred HHHHHHHcCCCCCCccCCHHH---HHHHHH----cCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99999998 899986433211 111000 000 001111235678999999999999999999999
Q ss_pred HHHhc
Q 010432 433 VEALK 437 (511)
Q Consensus 433 l~~L~ 437 (511)
++.|+
T Consensus 275 ~~~l~ 279 (280)
T cd05092 275 HSRLQ 279 (280)
T ss_pred HHHHh
Confidence 99885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=333.31 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++.+.||+|+||.||+|.+.. +..||||.+..... ....+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 467888999999999999998753 34699999875543 3467899999999999999999999999888
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~--------------- 134 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVD--------------- 134 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEc---------------
Confidence 899999999999999999765557899999999999999999999988 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~ 367 (511)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 135 ----------~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 203 (256)
T cd05113 135 ----------DQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203 (256)
T ss_pred ----------CCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 4778999999999865443221 1122346678999999988889999999999999999998 999986
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
...... ....... .. ....+...+..+.+++.+||+.||.+||++.+|+..|+
T Consensus 204 ~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 204 RFNNSE---TVEKVSQ----GL----------RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCHHH---HHHHHhc----CC----------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 543211 1111110 00 00011112578899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=344.36 Aligned_cols=238 Identities=28% Similarity=0.362 Sum_probs=188.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhCCCCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
++||+|+||.||+|++.. ++..||||++..... .....+.+|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 369999999999999875 577999999975422 12234555654 57889999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|+|||||++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~----------------- 130 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLD----------------- 130 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEEC-----------------
Confidence 9999999999999888543 46888889999999999999999988 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 131 --------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 131 --------SQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred --------CCCCEEEccCCCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 477899999999986433221 1234679999999999998899999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
.. .+... .... ...++...+..+.+++.+||+.||.+||++.
T Consensus 201 ~~---~~~~~---i~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 201 VS---QMYDN---ILHK------------PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HH---HHHHH---HhcC------------CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 11111 1100 0011122346789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=345.58 Aligned_cols=243 Identities=28% Similarity=0.407 Sum_probs=195.4
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 210 (511)
+.||+|+||+||+|++.. ++..||||+++.... .....+.+|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 369999999999999865 577999999975421 2234567899999888 799999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|+||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~----------------- 130 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLD----------------- 130 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEEC-----------------
Confidence 9999999999999988654 47899999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
+++.+||+|||+++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 131 --------~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 131 --------SEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred --------CCCcEEecccCCCeecCcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 4778999999999753222211 233579999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 435 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~-----~eil~~ 435 (511)
.. ...... ... . ..++...+..+.+||.+||+.||.+||++ .+++++
T Consensus 201 ~~---~~~~~i---~~~--------~----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 201 ED---ELFQSI---LED--------E----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HH---HHHHHH---HcC--------C----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 21 111110 000 0 01112235678999999999999999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=346.16 Aligned_cols=251 Identities=28% Similarity=0.353 Sum_probs=196.1
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhCCCCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
+.||+|+||+||+|++.. +|+.||||++..... .....+..|.. +++.++||||+++++++..++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 369999999999999865 678999999975421 22234556655 46789999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~----------------- 130 (325)
T cd05604 72 YFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLD----------------- 130 (325)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEEC-----------------
Confidence 999999999999988854 347899999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
+++.+||+|||+++....... .....+||+.|||||++.+..++.++|||||||++|||++|..||....
T Consensus 131 --------~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 131 --------SQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred --------CCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 477899999999976432221 1234679999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCC
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 443 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 443 (511)
... +. ....... ..+. ...+..+.+++.+||+.||.+||++.+.++.+...+.+.
T Consensus 201 ~~~---~~---~~~~~~~--------~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 201 VAE---MY---DNILHKP--------LVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred HHH---HH---HHHHcCC--------ccCC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence 211 11 1111000 0011 122467889999999999999999876555555554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=343.11 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=202.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|.+.+.||+|+||.||+|++.. ++..||||.++..... ....+.+|+.++++++|+||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 568999999999999999998865 5779999999754322 234678899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+. ++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~-------------- 138 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLIN-------------- 138 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC--------------
Confidence 99999999996 5898888766666899999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 139 -----------~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf 205 (309)
T cd07872 139 -----------ERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205 (309)
T ss_pred -----------CCCCEEECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4778999999999764432221 223468999999998865 56899999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhh--------hhccccccccccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARP--------HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
...........+..... .......+.....+.... ......+.++.+||.+||+.||.+|||+.|+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 206 PGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 76543222111111000 000000000000000000 001123567889999999999999999999987
Q ss_pred H
Q 010432 435 A 435 (511)
Q Consensus 435 ~ 435 (511)
+
T Consensus 286 h 286 (309)
T cd07872 286 H 286 (309)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=333.56 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=204.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||.||+|.+.. +..||||.++.... ..+++.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 34678999999999999999998643 45799999976543 34678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~------------ 137 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVG------------ 137 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEc------------
Confidence 999999999999999999996543 46899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 138 -------------~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 203 (261)
T cd05068 138 -------------ENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203 (261)
T ss_pred -------------CCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 4778999999999876532211 1111223467999999998899999999999999999999 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||...... .+..... .. .....+...+..+.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus 204 p~~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 204 PYPGMTNA---EVLQQVD----QG----------YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCHH---HHHHHHH----cC----------CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99754321 1111100 00 00011122357789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=359.34 Aligned_cols=264 Identities=24% Similarity=0.275 Sum_probs=200.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
...|.+.+.||+|+||.||+|.+.. +++.||||.... ..+.+|+++|++|+|+|||++++++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4579999999999999999999875 577999996432 2457899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..+||||++ .++|..++......+++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~-------------- 294 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVN-------------- 294 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEEC--------------
Confidence 9999999999 57999998766667999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||+++...............||+.|||||++.+..++.++|||||||+||||++|..++.
T Consensus 295 -----------~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 295 -----------GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred -----------CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 467799999999986544322222334679999999999999999999999999999999999887654
Q ss_pred CCCCCC-----chhHHHhhhh---hhccccc-----cc--------cccCCccCCC-CC--HHHHHHHHHHHHHhcccCC
Q 010432 368 KNRPNG-----EHNLVEWARP---HLGERRR-----FY--------RLIDPRLEGH-FS--IKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 368 ~~~~~~-----~~~~~~~~~~---~~~~~~~-----~~--------~~~~~~~~~~-~~--~~~~~~~~~Li~~cl~~dP 423 (511)
...... ...+...+.. ...+... +. ....+..... +. ......+.+||.+||+.||
T Consensus 364 ~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP 443 (461)
T PHA03211 364 SASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDG 443 (461)
T ss_pred cCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccCh
Confidence 322110 1111111110 0000000 00 0000000000 00 0123468899999999999
Q ss_pred CCCCCHHHHHHH
Q 010432 424 KARPLMSEVVEA 435 (511)
Q Consensus 424 ~~RPs~~eil~~ 435 (511)
.+|||+.|||++
T Consensus 444 ~~RPsa~elL~h 455 (461)
T PHA03211 444 ARRPSAAELLRL 455 (461)
T ss_pred hhCcCHHHHhhC
Confidence 999999999985
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=332.81 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=206.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|++.. ++..||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 578999999999999999999865 577999998865332 22346789999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
..+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~--------- 140 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFIT--------- 140 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEc---------
Confidence 99999999999999999988853 2345788999999999999999999988 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.++|+|||++......... .....|++.|+|||++.+..++.++||||||+++|||++|
T Consensus 141 ----------------~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g 202 (267)
T cd08228 141 ----------------ATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ----------------CCCCEEECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcC
Confidence 4677999999999875442211 1234688999999999888899999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
+.||....... ........ .. ..........+..+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 203 ~~p~~~~~~~~-~~~~~~~~----------~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 203 QSPFYGDKMNL-FSLCQKIE----------QC---DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCccccccH-HHHHHHHh----------cC---CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99996532211 11111110 00 001111223457789999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=339.15 Aligned_cols=272 Identities=27% Similarity=0.432 Sum_probs=204.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCC-----CccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTA-----PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~-----~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~ 201 (511)
.++|++.+.||+|+||.||+|++...+.. ....+....||||.++..... ....|.+|+++|++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35799999999999999999987542110 011123446999999765322 234688999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcE
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NI 270 (511)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985432 23678889999999999999999998 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccch
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIw 350 (511)
|++ ++..+||+|||++................++..|+|||++.+..++.++|||
T Consensus 161 ll~-------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 215 (295)
T cd05097 161 LVG-------------------------NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVW 215 (295)
T ss_pred EEc-------------------------CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHH
Confidence 998 4677999999999875443322222334567899999999988999999999
Q ss_pred hHHHHHHHHHh--CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 351 SFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 351 SlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
||||++|||++ |..||...... ................ .....+...+..+.+|+.+||+.||++||+
T Consensus 216 SlG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs 285 (295)
T cd05097 216 AFGVTLWEMFTLCKEQPYSLLSDE---QVIENTGEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285 (295)
T ss_pred HHHHHHHHHHHcCCCCCCcccChH---HHHHHHHHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 99999999998 56677643321 1111111111100000 000011123468999999999999999999
Q ss_pred HHHHHHHhc
Q 010432 429 MSEVVEALK 437 (511)
Q Consensus 429 ~~eil~~L~ 437 (511)
+.+|++.|+
T Consensus 286 ~~~i~~~l~ 294 (295)
T cd05097 286 FNKIHHFLR 294 (295)
T ss_pred HHHHHHHHh
Confidence 999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=341.25 Aligned_cols=265 Identities=25% Similarity=0.371 Sum_probs=208.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|.+.+.||+|+||.||+|.+... ....++..||||.++.... ...+.+.+|+.+++++ +|+||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 345789999999999999999986321 1122567899999876532 2235688999999999 799999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~---------- 175 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLT---------- 175 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEc----------
Confidence 99999999999999999999996543 34899999999999999999999988 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-C
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 362 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g 362 (511)
++..+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 176 ---------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g 240 (302)
T cd05055 176 ---------------HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240 (302)
T ss_pred ---------------CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCC
Confidence 467799999999987654332222223456788999999998899999999999999999998 9
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
..||....... ....... .......+...+..+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 241 ~~p~~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 241 SNPYPGMPVDS--KFYKLIK--------------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCcCCCCchH--HHHHHHH--------------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 99987543211 1111110 0000011112246789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=334.43 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=204.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.++||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4678999999999999999998643 45799999875432 346788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~------------- 137 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVS------------- 137 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEec-------------
Confidence 9999999999999999998653 456888999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
+++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 138 ------------~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p 204 (261)
T cd05072 138 ------------ESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204 (261)
T ss_pred ------------CCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCC
Confidence 4778999999999876543221 1222346778999999988889999999999999999998 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|...... ........ .. .. ......+..+.+|+.+||..+|++||++.++++.|+.+
T Consensus 205 ~~~~~~~---~~~~~~~~----~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 205 YPGMSNS---DVMSALQR----GY------RM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCHH---HHHHHHHc----CC------CC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9653221 11111110 00 00 01112346789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=337.36 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=204.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+|++.++||+|+||+||+|++..++.. ....||+|+++..... ....+.+|+.++..+.|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 45788999999999999999987653221 1235899999765332 24568899999999999999999999875
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
...+++|||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~------------- 143 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVK------------- 143 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc-------------
Confidence 4578999999999999999766667899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
++..+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 144 ------------~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 211 (279)
T cd05109 144 ------------SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ------------CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 467799999999987654322211222345678999999998899999999999999999998 8899
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
|...... .+..+... .. ....+...+..+.+++.+||+.||++||++.++++.|+.+.
T Consensus 212 ~~~~~~~---~~~~~~~~----~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 212 YDGIPAR---EIPDLLEK----GE----------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCCCHH---HHHHHHHC----CC----------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 8653221 11111110 00 00111223567899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.30 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=203.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
..+|++.+.||+|+||.||+|++.. ++..||+|++..........+.+|+.++++++|+||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3579999999999999999999865 5779999999765444445678899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~-------------- 140 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLT-------------- 140 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEC--------------
Confidence 9999999999999999988644 46899999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.
T Consensus 141 -----------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~ 207 (267)
T cd06646 141 -----------DNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207 (267)
T ss_pred -----------CCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 467799999999986543221 112346889999999874 4457889999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||....+..... .+ ... ....+... .....+..+.+||.+||+.||++||++++|+++|
T Consensus 208 p~~~~~~~~~~~--~~------~~~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 208 PMFDLHPMRALF--LM------SKS---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cccccchhhhhe--ee------ecC---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 986433211100 00 000 00001111 1112357889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=338.37 Aligned_cols=261 Identities=28% Similarity=0.404 Sum_probs=204.6
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+|++.+.||+|+||.||+|....... ......||+|.+...... ....+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKG----RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCC----CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 47888999999999999998753211 113457999988755432 2356889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 010432 209 QRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDL 265 (511)
..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 999999999999999988532 124788899999999999999999988 999999
Q ss_pred CCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCc
Q 010432 266 KTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 345 (511)
Q Consensus 266 Kp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~ 345 (511)
||+|||++ ++..+||+|||+++...............++..|+|||++.+..++.
T Consensus 154 kp~nill~-------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 208 (290)
T cd05045 154 AARNVLVA-------------------------EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208 (290)
T ss_pred hhheEEEc-------------------------CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence 99999998 47789999999998654332221222345678899999998888999
Q ss_pred cccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCC
Q 010432 346 RSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 346 ~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
++|||||||++|||++ |..||....+.. +..... .......+...+..+.+|+.+||+.+|.
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~ 271 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPER---LFNLLK--------------TGYRMERPENCSEEMYNLMLTCWKQEPD 271 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh--------------CCCCCCCCCCCCHHHHHHHHHHccCCcc
Confidence 9999999999999998 999996543211 111111 0011111222356789999999999999
Q ss_pred CCCCHHHHHHHhcCC
Q 010432 425 ARPLMSEVVEALKPL 439 (511)
Q Consensus 425 ~RPs~~eil~~L~~l 439 (511)
+||++.++++.|+.+
T Consensus 272 ~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 272 KRPTFADISKELEKM 286 (290)
T ss_pred cCCCHHHHHHHHHHH
Confidence 999999999999765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=334.88 Aligned_cols=272 Identities=32% Similarity=0.437 Sum_probs=204.1
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC--
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 207 (511)
|.+++.||+|+||+||++.+... ...++..||+|.++.... .....+.+|+++|++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 48889999999999999875421 123677999999976533 2345688999999999999999999988653
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++||||+++|+|.+++... .+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~-------------- 141 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLD-------------- 141 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEc--------------
Confidence 4688999999999999998653 5899999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
++..+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 142 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 210 (283)
T cd05080 142 -----------NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210 (283)
T ss_pred -----------CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCC
Confidence 46789999999998765432211 112234567899999998888999999999999999999999998
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
........ ......... .....+...++.......+...+..+.+|+.+||+.||++||++.+|++.|+.+
T Consensus 211 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 211 QSPPKKFE-EMIGPKQGQ-MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCcchhh-hhhcccccc-cchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 64322110 011000000 000011111111111122333457899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=331.18 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=201.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.+|++.+.||+|+||.||+|.++. +..+|+|.+..... ....+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 357888999999999999998753 44799999875433 3357889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~--------------- 134 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVG--------------- 134 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEEC---------------
Confidence 999999999999999999765567899999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~ 367 (511)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 135 ----------~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 135 ----------EDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred ----------CCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence 4778999999999865432211 1111234568999999998899999999999999999999 899997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
...... ....... . .....+...+..+.+|+.+||..+|++||++.++++.|
T Consensus 204 ~~~~~~---~~~~~~~----~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 204 RFSNSE---VVESVSA----G----------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHH---HHHHHHc----C----------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 543211 1111100 0 01111122457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.46 Aligned_cols=250 Identities=27% Similarity=0.383 Sum_probs=197.0
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
||+|+||.||+++.+. +|+.||+|.+...... ....+..|++++++++||||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999999875 6789999999753322 223456799999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 214 YEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
|||+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~------------------- 129 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLD------------------- 129 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEc-------------------
Confidence 9999999999888543 345889999999999999999999988 99999999999998
Q ss_pred ccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~ 372 (511)
++..++|+|||++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 130 ------~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~ 200 (277)
T cd05607 130 ------DQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200 (277)
T ss_pred ------CCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch
Confidence 477899999999987644321 23357899999999999888999999999999999999999999754321
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
... .......... .... .....+.++.+|+.+||+.||.+||++.|+++.+...
T Consensus 201 ~~~--~~~~~~~~~~----------~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 201 VAK--EELKRRTLED----------EVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred hhH--HHHHHHhhcc----------cccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 111 1111111100 0000 0012356789999999999999999998877655543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.96 Aligned_cols=261 Identities=23% Similarity=0.271 Sum_probs=202.7
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcc
Q 010432 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLV 198 (511)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv 198 (511)
.++....++|++.+.||+|+||.||+|++.. +++.||+|++..... .....+.+|+.+++.++||||+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv 106 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence 3445566899999999999999999999876 678999999864321 2224577899999999999999
Q ss_pred eEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
++++++..++..++|||||++|+|.+++... .++...+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 107 ~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~----- 176 (371)
T cd05622 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLD----- 176 (371)
T ss_pred eEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEC-----
Confidence 9999999999999999999999999998543 5788889999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC----CCCccccchhHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGV 354 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DIwSlGv 354 (511)
.++.+||+|||+++........ .....+||+.|||||++.+. .++.++|||||||
T Consensus 177 --------------------~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGv 235 (371)
T cd05622 177 --------------------KSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235 (371)
T ss_pred --------------------CCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhH
Confidence 4778999999999876432211 12346799999999998753 3789999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHH
Q 010432 355 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEV 432 (511)
Q Consensus 355 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~--RPs~~ei 432 (511)
+||||++|+.||........ .......... +........+..+.+||.+||..++.+ |+++.+|
T Consensus 236 ilyell~G~~Pf~~~~~~~~------~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei 301 (371)
T cd05622 236 FLYEMLVGDTPFYADSLVGT------YSKIMNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEI 301 (371)
T ss_pred HHHHHHhCCCCCCCCCHHHH------HHHHHcCCCc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHH
Confidence 99999999999975432111 0100000000 000011123577899999999844433 7799999
Q ss_pred HHHh
Q 010432 433 VEAL 436 (511)
Q Consensus 433 l~~L 436 (511)
+++.
T Consensus 302 ~~h~ 305 (371)
T cd05622 302 KRHL 305 (371)
T ss_pred hcCc
Confidence 8865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=333.33 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=197.9
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC-
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 207 (511)
|.+.++||+|+||.||+|.+...+ ....||+|.++.... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 356788999999999999886521 123699999876432 2235688999999999999999999987532
Q ss_pred -----CeEEEEEEccCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 208 -----DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 208 -----~~~~lv~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
...++||||+.+|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~---- 146 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLN---- 146 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEc----
Confidence 246899999999999998742 2235889999999999999999999988 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ 357 (511)
++..+||+|||+++...............+++.|+|||++.+..++.++|||||||++|
T Consensus 147 ---------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~ 205 (272)
T cd05075 147 ---------------------ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205 (272)
T ss_pred ---------------------CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHH
Confidence 47789999999998765433221122234677899999999889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 358 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 358 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||++ |+.||...... .+..... .... ...+...+..+.+||.+||+.||++|||+.+|++.|
T Consensus 206 el~~~g~~p~~~~~~~---~~~~~~~----~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 206 EIATRGQTPYPGVENS---EIYDYLR----QGNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred HHHcCCCCCCCCCCHH---HHHHHHH----cCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999 78898653221 1111111 0000 001112346789999999999999999999999998
Q ss_pred cCC
Q 010432 437 KPL 439 (511)
Q Consensus 437 ~~l 439 (511)
+.+
T Consensus 269 ~~~ 271 (272)
T cd05075 269 EKA 271 (272)
T ss_pred Hhh
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=341.96 Aligned_cols=266 Identities=27% Similarity=0.387 Sum_probs=206.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
.++|.+.+.||+|+||.||+|++..... ....+...||+|.++.... .....+.+|+.++.++ +|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 4679999999999999999998754211 0112346799999986532 2335688899999999 7999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcE
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NI 270 (511)
..+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 9999999999999999999996532 24788999999999999999999988 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccch
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIw 350 (511)
|++ +++.+||+|||+++...............+++.|+|||++.+..++.++|||
T Consensus 172 ll~-------------------------~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 172 LVT-------------------------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred EEc-------------------------CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 998 4678999999999866432221112222345789999999988999999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 351 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 351 SlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
||||++|||++ |..||...... .+..... .. .....+...+..+.+|+.+||..+|.+||++
T Consensus 227 slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 289 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPVE---ELFKLLK----EG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 289 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH----cC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCH
Confidence 99999999998 88888643211 1111110 00 0111122335788999999999999999999
Q ss_pred HHHHHHhcCCC
Q 010432 430 SEVVEALKPLP 440 (511)
Q Consensus 430 ~eil~~L~~l~ 440 (511)
.+|++.|+.+.
T Consensus 290 ~evl~~l~~~~ 300 (307)
T cd05098 290 KQLVEDLDRIL 300 (307)
T ss_pred HHHHHHHHHHH
Confidence 99999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.01 Aligned_cols=274 Identities=26% Similarity=0.370 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe--
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-- 206 (511)
.+|++++.||+|+||.||+|.... ....++..||||.+........+.+.+|+++|++++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 478889999999999999998642 1123678999999976654445678899999999999999999998754
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
....++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~------------- 142 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVE------------- 142 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEEC-------------
Confidence 34688999999999999999765557899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCccee-eeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 143 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 210 (284)
T cd05081 143 ------------SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210 (284)
T ss_pred ------------CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence 477899999999987654332211 1112345569999999888999999999999999999998876
Q ss_pred CCCCCCCCchhHHHhhhhhhcc---ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGE---RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
+...... ........... ...+...+............+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 211 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 211 SCSPPAE----FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCCcchh----hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 6432110 00000000000 0000001111111111223356799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=341.15 Aligned_cols=270 Identities=26% Similarity=0.396 Sum_probs=209.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
....+|.+.+.||+|+||.||+|++..... .....+..||+|.+.... ......+.+|+.+++.+ +|+||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 345678899999999999999998643111 011245689999987543 22345688999999999 89999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~ 268 (511)
+......++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 999999999999999999999996531 24778889999999999999999998 999999999
Q ss_pred cEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCcccc
Q 010432 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 348 (511)
Q Consensus 269 NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~D 348 (511)
|||++ +++.+||+|||+++...............+++.|+|||++.+..++.++|
T Consensus 167 Nili~-------------------------~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (304)
T cd05101 167 NVLVT-------------------------ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221 (304)
T ss_pred eEEEc-------------------------CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhh
Confidence 99998 46789999999998765433222222345678899999999889999999
Q ss_pred chhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 349 VYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 349 IwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
||||||++|||++ |..||...... .+..... ... ....+..++..+.+|+.+||+.+|.+||
T Consensus 222 i~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 222 VWSFGVLMWEIFTLGGSPYPGIPVE---ELFKLLK----EGH----------RMDKPANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCC----------cCCCCCCCCHHHHHHHHHHcccChhhCC
Confidence 9999999999998 78888643221 1111110 000 0111223457889999999999999999
Q ss_pred CHHHHHHHhcCCCCC
Q 010432 428 LMSEVVEALKPLPNL 442 (511)
Q Consensus 428 s~~eil~~L~~l~~~ 442 (511)
++.+|++.|+++..+
T Consensus 285 s~~e~l~~l~~~~~~ 299 (304)
T cd05101 285 TFKQLVEDLDRILTL 299 (304)
T ss_pred CHHHHHHHHHHHHHh
Confidence 999999999876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=336.03 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=207.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++|++.+.||+|+||.||+|.+..... ..++..||+|.+..... .....+.+|+.+|+.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 34678899999999999999998864221 12457899999875532 22346889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
.....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~--- 153 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVA--- 153 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEc---
Confidence 9999999999999999999986421 23678889999999999999999988 99999999999998
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil 356 (511)
.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++
T Consensus 154 ----------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 154 ----------------------EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred ----------------------CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 4778999999999865543322222334578899999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|||++ |..||...... ....... ... ....+..++..+.+|+.+||+.+|++|||+.+|++.
T Consensus 212 ~el~t~g~~p~~~~~~~---~~~~~~~----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 212 WEMATLAEQPYQGLSNE---EVLKFVI----DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred HHhhccCCCCCccCCHH---HHHHHHh----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99998 89998654321 1111111 000 011122235788999999999999999999999998
Q ss_pred hc
Q 010432 436 LK 437 (511)
Q Consensus 436 L~ 437 (511)
|+
T Consensus 275 l~ 276 (277)
T cd05032 275 LK 276 (277)
T ss_pred hc
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=344.02 Aligned_cols=257 Identities=20% Similarity=0.239 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||++++.. +++.||||++.... ......+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 478999999999999999999876 57799999997532 122345788999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..|+||||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~------------ 136 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLD------------ 136 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEEC------------
Confidence 999999999999999999999765567899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----CCCCccccchhHHHHHHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DIwSlGvil~ell 360 (511)
.++.+||+|||++......... ......||+.|||||++.. ..++.++|||||||++|||+
T Consensus 137 -------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (331)
T cd05597 137 -------------KNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202 (331)
T ss_pred -------------CCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh
Confidence 4778999999999765443221 1223469999999999863 45788999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 436 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~--RPs~~eil~~L 436 (511)
+|+.||....... .......... ...+ .. .....+..+.+||.+||..++.+ |+++.+++++-
T Consensus 203 ~g~~Pf~~~~~~~------~~~~i~~~~~-~~~~-----~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 203 YGETPFYAESLVE------TYGKIMNHKE-HFQF-----PP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred hCCCCCCCCCHHH------HHHHHHcCCC-cccC-----CC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 9999997543211 1000000000 0000 00 01113567889999988654433 78999998863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=352.26 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=197.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||.||+|++.. +++.||||++.... ......+.+|+.++..++|+||+++++++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 368889999999999999999875 67899999997532 122345778999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.+.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~------------ 135 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLD------------ 135 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEEC------------
Confidence 999999999999999999998654 46899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc---------------------------------eeeeeccccccc
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT---------------------------------HVSTRVMGTYGY 332 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~---------------------------------~~~~~~~Gt~~y 332 (511)
.++.+||+|||+++........ ......+||+.|
T Consensus 136 -------------~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 202 (360)
T cd05627 136 -------------AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDY 202 (360)
T ss_pred -------------CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccc
Confidence 4778999999998754321100 001235799999
Q ss_pred cCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHH
Q 010432 333 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 412 (511)
Q Consensus 333 ~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (511)
+|||++.+..++.++|||||||++|||++|+.||.......... .+ ...... .. +... ...+..+.
T Consensus 203 ~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~---~i---~~~~~~---~~---~p~~--~~~s~~~~ 268 (360)
T cd05627 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR---KV---MNWKET---LV---FPPE--VPISEKAK 268 (360)
T ss_pred cCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHH---HH---HcCCCc---ee---cCCC--CCCCHHHH
Confidence 99999999999999999999999999999999997654321110 00 000000 00 0000 11246788
Q ss_pred HHHHHhcccCCCCCCC---HHHHHHH
Q 010432 413 QLAAHCLSRDPKARPL---MSEVVEA 435 (511)
Q Consensus 413 ~Li~~cl~~dP~~RPs---~~eil~~ 435 (511)
+||.+|+. ||.+|++ +.+++++
T Consensus 269 ~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 269 DLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99999874 9999995 5566543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=343.18 Aligned_cols=243 Identities=25% Similarity=0.339 Sum_probs=194.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCC-CCCcceEeeEEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-H~nIv~l~~~~~ 205 (511)
+|+..+.||+|+||.||+|++.. +++.||||++..... ...+.+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 46778899999999999999865 678999999975422 22345778999998885 577888999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~------------ 135 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLD------------ 135 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC------------
Confidence 999999999999999999998543 46899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 136 -------------~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p 200 (323)
T cd05615 136 -------------SEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200 (323)
T ss_pred -------------CCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCC
Confidence 477899999999986433221 12335699999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
|...... .+..... .. ...++...+..+.+|+.+||+.||.+|++..
T Consensus 201 f~~~~~~---~~~~~i~---~~------------~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 201 FDGEDED---ELFQSIM---EH------------NVSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCCHH---HHHHHHH---hC------------CCCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 9764321 1111111 00 0011122356789999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=339.14 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCC-CCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|....++ ....+++|.++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 47889999999999999999886532 12357899887432 22335688999999999 79999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence 999999999999999999996432 24788899999999999999999988 999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchh
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwS 351 (511)
++ ++..+||+|||++........ ......+..|+|||++.+..++.++||||
T Consensus 152 l~-------------------------~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 203 (297)
T cd05089 152 VG-------------------------ENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWS 203 (297)
T ss_pred EC-------------------------CCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHH
Confidence 98 467899999999875322111 11122356799999998889999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 352 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 352 lGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
|||++|||++ |..||....... +..... .......+...+..+.+|+.+||+.+|.+||++.
T Consensus 204 lG~il~el~t~g~~pf~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 266 (297)
T cd05089 204 FGVLLWEIVSLGGTPYCGMTCAE---LYEKLP--------------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFA 266 (297)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHH---HHHHHh--------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999999997 999997543211 111100 0011111222356789999999999999999999
Q ss_pred HHHHHhcCCCCC
Q 010432 431 EVVEALKPLPNL 442 (511)
Q Consensus 431 eil~~L~~l~~~ 442 (511)
+|++.|+.+...
T Consensus 267 ~i~~~l~~~~~~ 278 (297)
T cd05089 267 QISVQLSRMLEA 278 (297)
T ss_pred HHHHHHHHHHHh
Confidence 999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=335.94 Aligned_cols=272 Identities=26% Similarity=0.418 Sum_probs=204.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCC-------ccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcce
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~-------~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~ 199 (511)
.++|++.+.||+|+||.||++.+....... ....++..||+|++...... ....+.+|+.+|+.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998764321100 11224567999999765322 3357889999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
+++++...+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986532 23677889999999999999999998 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ +++.++|+|||+++...............++..|+|||++.++.++.++||
T Consensus 161 ili~-------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 215 (296)
T cd05095 161 CLVG-------------------------KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDV 215 (296)
T ss_pred EEEc-------------------------CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhh
Confidence 9998 467899999999986544332222223345678999999888899999999
Q ss_pred hhHHHHHHHHHh--CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 350 YSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 350 wSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
|||||++|||++ |..||........ ............. ... ...+..++..+.+|+.+||+.||.+||
T Consensus 216 wSlG~~l~el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp 285 (296)
T cd05095 216 WAFGVTLWEILTLCKEQPYSQLSDEQV---IENTGEFFRDQGR--QVY-----LPKPALCPDSLYKLMLSCWRRNAKERP 285 (296)
T ss_pred hHHHHHHHHHHHhCCCCCccccChHHH---HHHHHHHHhhccc--ccc-----CCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 999999999998 6788865432211 1111000000000 000 001122347789999999999999999
Q ss_pred CHHHHHHHhc
Q 010432 428 LMSEVVEALK 437 (511)
Q Consensus 428 s~~eil~~L~ 437 (511)
++.+|++.|+
T Consensus 286 ~~~~i~~~l~ 295 (296)
T cd05095 286 SFQEIHATLL 295 (296)
T ss_pred CHHHHHHHHh
Confidence 9999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.44 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=211.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+.|+++..||.|+||.||+|..+. ++...|.|++........++++-|++||..++||+||+|++.|..++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 457778889999999999998775 67788899998777666788999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
.+||+.|||.||-....+..-+..+.+.++..+++|++.||.|||+++ |||||||..|||+.
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~T--------------- 164 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLT--------------- 164 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEE---------------
Confidence 999999999999999888777788999999999999999999999999 99999999999999
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHHHhCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.++|+|||.+....... .....+.|||+|||||++. ..+|+.++||||||++|.||..+.
T Consensus 165 ----------ldGdirLADFGVSAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiE 232 (1187)
T KOG0579|consen 165 ----------LDGDIRLADFGVSAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIE 232 (1187)
T ss_pred ----------ecCcEeeecccccccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccC
Confidence 48889999999987543322 2244589999999999875 468999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+|-....+.. -++..+.. + .|.+ ..+..++..+.+++.+||..||..||++++++++-
T Consensus 233 PPHhelnpMR--VllKiaKS---e--------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 233 PPHHELNPMR--VLLKIAKS---E--------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred CCccccchHH--HHHHHhhc---C--------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 9976544321 11111111 0 1111 12445678899999999999999999999999853
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.48 Aligned_cols=261 Identities=25% Similarity=0.434 Sum_probs=206.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|+..+.||+|+||.||+|++...+. ....||+|.+..... .....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 3468888999999999999999865321 234799999876532 234568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~------------- 141 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVN------------- 141 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEc-------------
Confidence 99999999999999999999766667899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceee-eeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
++..+||+|||++............ .....+..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 142 ------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~ 209 (268)
T cd05063 142 ------------SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209 (268)
T ss_pred ------------CCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCC
Confidence 4778999999999866443222111 11223567999999988889999999999999999998 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||...... ....... .. .........+..+.+|+.+||+.+|++||++.+|++.|+++
T Consensus 210 p~~~~~~~---~~~~~i~----~~----------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 210 PYWDMSNH---EVMKAIN----DG----------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCcCCHH---HHHHHHh----cC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99654321 1111111 00 01111122356789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.09 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=197.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|++.. +|..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT 90 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence 4689999999999999999998865 678999999975422 23356789999999999999999999986
Q ss_pred eCC------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
... ..|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~------ 157 (359)
T cd07876 91 PQKSLEEFQDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK------ 157 (359)
T ss_pred cCCCccccceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEC------
Confidence 543 4799999995 467776632 4788889999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 -------------------~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 215 (359)
T cd07876 158 -------------------SDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215 (359)
T ss_pred -------------------CCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence 47789999999998643321 12335789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchh-HH-----------H----hhhhhhcccccc-----ccccCCcc---CCCCCHHHHHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHN-LV-----------E----WARPHLGERRRF-----YRLIDPRL---EGHFSIKGAQKAAQLA 415 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~-~~-----------~----~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~Li 415 (511)
++|+.||.......... .. . ............ ........ ........+..+.+||
T Consensus 216 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (359)
T cd07876 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295 (359)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHH
Confidence 99999997653211100 00 0 000000000000 00000000 0001112246789999
Q ss_pred HHhcccCCCCCCCHHHHHHHh
Q 010432 416 AHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 416 ~~cl~~dP~~RPs~~eil~~L 436 (511)
.+||+.||++|||+.|++++-
T Consensus 296 ~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 296 SKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHhccCcccCCCHHHHhcCc
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=351.25 Aligned_cols=267 Identities=25% Similarity=0.342 Sum_probs=200.1
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++++.||+|+||.||+|.+.. +++.||||.+.... ....+.+.+|+.+|+.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 47889999999999999998765 67799999986532 22335688999999999999999999999877
Q ss_pred C-----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 208 ~-----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+ ..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~--------- 137 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVN--------- 137 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEEC---------
Confidence 6 7899999995 688888754 347899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHh
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+++........ ......+|+.|+|||++.+. .++.++|||||||++|||++
T Consensus 138 ----------------~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 200 (372)
T cd07853 138 ----------------SNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG 200 (372)
T ss_pred ----------------CCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHc
Confidence 4778999999999865432211 12334689999999998864 57999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhh---------hcc-cccccc-ccC-CccC--CCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPH---------LGE-RRRFYR-LID-PRLE--GHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~---------~~~-~~~~~~-~~~-~~~~--~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
|+.||...........+...... ... ...+.. ... +... .......++.+.+||.+||+.||.+||
T Consensus 201 g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 280 (372)
T cd07853 201 RRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280 (372)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence 99999765432221111100000 000 000000 000 0000 001112356789999999999999999
Q ss_pred CHHHHHHHh
Q 010432 428 LMSEVVEAL 436 (511)
Q Consensus 428 s~~eil~~L 436 (511)
|+.+++++-
T Consensus 281 t~~e~l~hp 289 (372)
T cd07853 281 SAADALAHP 289 (372)
T ss_pred CHHHHhcCH
Confidence 999999753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=328.71 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=197.7
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~ 214 (511)
.||+|+||.||+|.+... ..+..||+|++...... ..+.+.+|+.++++++|+||+++++++. .+..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecC-------CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 389999999999987532 13567999999765332 2356889999999999999999999875 45789999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccccc
Q 010432 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294 (511)
Q Consensus 215 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~ 294 (511)
||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~--------------------- 129 (257)
T cd05115 74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLV--------------------- 129 (257)
T ss_pred EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEc---------------------
Confidence 999999999999766667999999999999999999999988 99999999999998
Q ss_pred ccccccCceeeecCCCcccCCCCCccee-eeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 010432 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 372 (511)
Q Consensus 295 ~~~~~~~~~kl~DFGla~~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~ 372 (511)
.+..+||+|||++........... .....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 130 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 130 ----NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred ----CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 477899999999986544322211 111234678999999988889999999999999999996 99999754321
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
. ....... ......+..++.++.+|+.+||..||++||++.+|++.|+.+
T Consensus 206 ~---~~~~~~~--------------~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 206 E---VMSFIEQ--------------GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred H---HHHHHHC--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1 1111100 001112223457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=332.12 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=200.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.++||+|+||.||+|.+.. ++..||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 367888999999999999998765 677999999976532 2235688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~-------------- 129 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVN-------------- 129 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEEC--------------
Confidence 9999999999999997553 4678888999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 130 -----------~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 194 (279)
T cd06619 130 -----------TRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194 (279)
T ss_pred -----------CCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence 47789999999998654322 233578999999999998899999999999999999999999997
Q ss_pred CCCCCCchh-HHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 368 KNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 368 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
......... .......... ...+.+. ....+.++.+|+.+||+.||++||++.+++++..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 195 QIQKNQGSLMPLQLLQCIVD-------EDPPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred hhcccccccchHHHHHHHhc-------cCCCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 532211110 0000000000 0001110 1123467899999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.34 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=204.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+|++.+.||+|+||.||+|.+...+. .+..||||.+.... ......|..|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 357788999999999999999876332 24579999987642 22345789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++||||+++|+|.+++......+++..++.++.|++.||.|||+++ ++|+||||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~-------------- 140 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVN-------------- 140 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEc--------------
Confidence 9999999999999999999766667899999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeee-cc--ccccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTR-VM--GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~-~~--Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~ 363 (511)
.+..+||+|||++.............. .. ++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 141 -----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~ 209 (269)
T cd05065 141 -----------SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 209 (269)
T ss_pred -----------CCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCC
Confidence 477899999999986544322111111 11 2457999999998999999999999999999886 99
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.||...... ......... .....+.+.+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 210 ~p~~~~~~~---~~~~~i~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 210 RPYWDMSNQ---DVINAIEQD--------------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCCCCHH---HHHHHHHcC--------------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999654321 111111100 00011123356788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=329.06 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=203.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
++|.+.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 478999999999999999998765 6779999998754321 12457889999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~---------- 138 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRD---------- 138 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc----------
Confidence 99999999999999999999998654 46889999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCccee-eeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
+++.++|+|||+++.......... .....|+..|+|||++.+..++.++|||||||++|||++|
T Consensus 139 ---------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 139 ---------------SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred ---------------CCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 467899999999976543221111 1234688899999999988899999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+.||....... ..... ........++...+..+.+|+.+||..+|.+||++.+++++.
T Consensus 204 ~~p~~~~~~~~--~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 204 KPPWAEFEAMA--AIFKI--------------ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred CCCccccchHH--HHHHH--------------hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 99996532210 00000 000011122233457789999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=332.84 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=195.9
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~ 214 (511)
+.||+|+||.||+|.+...+.. .......||+|.+........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 3699999999999987643211 00124468999887654444467889999999999999999999999989999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccccc
Q 010432 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294 (511)
Q Consensus 215 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~ 294 (511)
||+++|+|..++......+++..++.++.||+.||.|||+++ |+||||||+|||++..+....+
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~------------- 142 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTG------------- 142 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccC-------------
Confidence 999999999999776667899999999999999999999988 9999999999999853321111
Q ss_pred ccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCC-CCCCCCCCC
Q 010432 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR-RSMDKNRPN 372 (511)
Q Consensus 295 ~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~-~pf~~~~~~ 372 (511)
....++++|||++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|. .||......
T Consensus 143 ----~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 143 ----NPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212 (258)
T ss_pred ----CCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence 2334899999998765432 22468899999999986 45799999999999999999995 555432211
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
.. .. ..... ..++.....++.+|+.+||+.||++|||+.+|++.|+
T Consensus 213 ~~---~~----~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 KK---LQ----FYEDR------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HH---HH----HHHcc------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 10 00 00000 0111122467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.83 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=206.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+|++.+.||+|+||.||+|.+...+. .+..||+|.++..... ....+.+|+.++++++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 578889999999999999998764221 3457999998764322 235688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~-------------- 140 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVN-------------- 140 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEEC--------------
Confidence 9999999999999999999776667899999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceee-eeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.+..++|+|||++............ ....++..|+|||++.+..++.++|||||||++||+++ |..|
T Consensus 141 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p 209 (267)
T cd05066 141 -----------SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209 (267)
T ss_pred -----------CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCC
Confidence 4778999999999876543221111 11234568999999998899999999999999999886 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|....... ...... ... ....+...+..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus 210 ~~~~~~~~---~~~~~~----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 210 YWEMSNQD---VIKAIE----EGY----------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cccCCHHH---HHHHHh----CCC----------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 97543211 111111 000 0011122356789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.32 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=194.7
Q ss_pred ccccCCCceEEEEEEcCCCCCC---------------ccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAP---------------VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 200 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~---------------~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l 200 (511)
.||+|+||.||+|.+...+... ........||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999875322111 0122345799999976544334568899999999999999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
++++..+...+|||||+++|+|..++......+++..++.++.||+.||+|||+++ |+||||||+|||++..+...
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~- 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE- 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc-
Confidence 99999999999999999999999998766667899999999999999999999988 99999999999997421100
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~el 359 (511)
.....+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||
T Consensus 158 -----------------~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 158 -----------------GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred -----------------CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 01335899999998654322 12357889999998875 5689999999999999999
Q ss_pred H-hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 360 L-TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 360 l-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
+ +|..||.......... .. .... .+.. .....+.+||.+||+.+|++||++.+|++.|.
T Consensus 215 ~~~g~~p~~~~~~~~~~~---~~----~~~~--------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 215 CFDGEVPLKERTPSEKER---FY----EKKH--------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HhCCCCCccccChHHHHH---HH----Hhcc--------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 5 6899987543321111 10 0000 0011 11356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=328.11 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=204.5
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|.+.+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 47788899999999999999875 577999999875432 2345688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~------------- 135 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLD------------- 135 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEe-------------
Confidence 9999999999999999999764 457899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++........ .....|++.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 136 ------------~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 201 (256)
T cd08529 136 ------------AYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201 (256)
T ss_pred ------------CCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 4778999999999876543221 23356899999999999989999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..... ........ . . ....++...+..+.+++.+||+.+|++||++.+++++
T Consensus 202 ~~~~~---~~~~~~~~---~----------~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 202 DANNQ---GALILKII---R----------G-VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCH---HHHHHHHH---c----------C-CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 75431 11111100 0 0 0111122345778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.75 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=196.6
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
.||+|+||.||+|.++.. .++..||+|+++..... ..+.+.+|+.+++.++|+||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 589999999999976532 25678999998755322 2356889999999999999999999875 4567899
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||.|||++
T Consensus 74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~-------------------- 129 (257)
T cd05116 74 MELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLV-------------------- 129 (257)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEc--------------------
Confidence 9999999999998644 46899999999999999999999988 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 371 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~ 371 (511)
++..+||+|||+++......... ......++..|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 130 -----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 130 -----TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred -----CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 46779999999998765433221 1122344679999999988889999999999999999998 9999975432
Q ss_pred CCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 372 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
. ........ . .....+...+.++.+||.+||+.||++||++.+|.+.|+.
T Consensus 205 ~---~~~~~i~~----~----------~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 205 N---EVTQMIES----G----------ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred H---HHHHHHHC----C----------CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1 11111110 0 0111122345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=336.56 Aligned_cols=266 Identities=25% Similarity=0.362 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.+.||+|+||.||++.+.. ++..||+|.+...... ...++.+|++++.+++||||+++++++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 368899999999999999998765 6778999998755322 234688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ ++ |+||||||+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~------------- 134 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVN------------- 134 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEe-------------
Confidence 9999999999999999999654 568999999999999999999997 46 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.+||+|||++....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 135 ------------~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~ 198 (308)
T cd06615 135 ------------SRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198 (308)
T ss_pred ------------cCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 46779999999987653321 23357899999999998888999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhcccc----------------ccccccCC---ccCCCCC-HHHHHHHHHHHHHhcccCCCCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERR----------------RFYRLIDP---RLEGHFS-IKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~---~~~~~~~-~~~~~~~~~Li~~cl~~dP~~R 426 (511)
....................... ...+..+. ......+ ...+..+.+|+.+||..||++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (308)
T cd06615 199 PPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKER 278 (308)
T ss_pred CCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhC
Confidence 65432211111100000000000 00000000 0000000 1235678999999999999999
Q ss_pred CCHHHHHHHh
Q 010432 427 PLMSEVVEAL 436 (511)
Q Consensus 427 Ps~~eil~~L 436 (511)
|++.+|+++.
T Consensus 279 pt~~~ll~~~ 288 (308)
T cd06615 279 ADLKELTKHP 288 (308)
T ss_pred cCHHHHhcCh
Confidence 9999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=333.98 Aligned_cols=252 Identities=31% Similarity=0.418 Sum_probs=200.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.|+..++||+|+||.||+|.+.. +++.||||.+....... ...+.+|+.++++++|+||+.+++.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 36778899999999999999876 67899999987543222 2357789999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~------------ 136 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLD------------ 136 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEEC------------
Confidence 99999999999999999988543 346899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.++|+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 137 -------------~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P 200 (285)
T cd05630 137 -------------DHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200 (285)
T ss_pred -------------CCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 467799999999976543221 1234789999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
|............... .. ... ..++...+..+.+|+.+||+.||.+||| +.+++++
T Consensus 201 f~~~~~~~~~~~~~~~---~~-------~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 201 FQQRKKKIKREEVERL---VK-------EVQ----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CCCCCccchHHHHHhh---hh-------hhh----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 9764322111110000 00 000 0111223467899999999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=351.07 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=207.8
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCe
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
..+.++||+|.||+|++|.|..-.. +-..||||.++.+... ...+|++|+.+|.+|+|+|+|+|||+..+ ..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psg------k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSG------KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCC------cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 4455789999999999999976322 3457999999887655 55789999999999999999999999887 67
Q ss_pred EEEEEEccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 210 RLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
+.||||+++.|+|.+.|++ ....|.......++.|||.||.||.+++ +|||||..+||||..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllas-------------- 247 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLAS-------------- 247 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecc--------------
Confidence 8899999999999999986 4456888889999999999999999988 999999999999985
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeee-eccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~-~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
...||||||||.+.+...+...... ...-...|+|||.+....++.++|||+|||+||||+| |..||
T Consensus 248 -----------prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 248 -----------PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred -----------cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 5569999999999987765544322 2344678999999999999999999999999999998 67888
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
.+...... .+.+|..-+..-+..|+++++++|..||..+|.+||+|..|.+
T Consensus 317 ~G~~g~qI-----------------L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 317 VGCRGIQI-----------------LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCHHHH-----------------HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 76543211 1222222223344567899999999999999999999999974
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=335.23 Aligned_cols=265 Identities=26% Similarity=0.404 Sum_probs=205.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
...++|++.++||+|+||.||+|.++.... ...+..||+|.+..... .....+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIK----GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCC----CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 346789999999999999999998753111 11356899999875432 2234578899999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 275 (511)
...+..++||||+++|+|.+++.... ..+.+..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~-- 153 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVA-- 153 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEc--
Confidence 99999999999999999999996421 23456778899999999999999988 99999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHH
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi 355 (511)
.+..+||+|||+++...............++..|+|||++.+..++.++|||||||+
T Consensus 154 -----------------------~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~ 210 (288)
T cd05061 154 -----------------------HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210 (288)
T ss_pred -----------------------CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHH
Confidence 477899999999986544332222223346778999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 356 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 356 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
+|||++ |..||...... ....... +.. ....+...+..+.+|+.+||+.||++||++.++++
T Consensus 211 l~el~~~~~~p~~~~~~~---~~~~~~~-------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 211 LWEITSLAEQPYQGLSNE---QVLKFVM-------------DGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred HHHHHhCCCCCCCCCCHH---HHHHHHH-------------cCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 78888653221 1111110 000 00111123468999999999999999999999999
Q ss_pred HhcCC
Q 010432 435 ALKPL 439 (511)
Q Consensus 435 ~L~~l 439 (511)
.|+..
T Consensus 274 ~l~~~ 278 (288)
T cd05061 274 LLKDD 278 (288)
T ss_pred HHHhh
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.40 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.++||+|+||.||++++.. +++.||+|++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 478899999999999999999875 577999999964321 12234778999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..||||||+++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~------------ 136 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMD------------ 136 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEC------------
Confidence 999999999999999999999765567899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~ell 360 (511)
.++.+||+|||++......... .....+||+.|||||++. ...++.++|||||||+||||+
T Consensus 137 -------------~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell 202 (332)
T cd05623 137 -------------MNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202 (332)
T ss_pred -------------CCCCEEEeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh
Confidence 4778999999999765432221 223357999999999986 346889999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~--RPs~~eil~~ 435 (511)
+|+.||........ ... .......+ .+. ......+..+.+|+.+||..++.+ |+++.+++++
T Consensus 203 ~g~~Pf~~~~~~~~---~~~---i~~~~~~~------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 203 YGETPFYAESLVET---YGK---IMNHKERF------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCCCCCCCHHHH---HHH---HhCCCccc------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99999975432111 110 11000000 000 011123578899999999765544 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=334.07 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=195.9
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCC---CCCCcceEeeEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGYC 204 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~H~nIv~l~~~~ 204 (511)
+|++.+.||+|+||.||+|++.. +++.||+|.++..... ....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 48888999999999999999876 6789999999754322 223456777777665 799999999988
Q ss_pred Ee-----CCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 205 IE-----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 205 ~~-----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
.. ....++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~----- 142 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVT----- 142 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC-----
Confidence 64 345789999996 58988886533 35899999999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++||
T Consensus 143 --------------------~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 143 --------------------SGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 199 (288)
T ss_pred --------------------CCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHH
Confidence 477899999999987543221 223568999999999998899999999999999999
Q ss_pred HHhCCCCCCCCCCCCchh-HHHhhhh----hhcccccc-ccccCCc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 359 MLTGRRSMDKNRPNGEHN-LVEWARP----HLGERRRF-YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~-~~~~~~~----~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
|++|++||.......... +...... .+...... .....+. .........+..+.+|+.+||+.||.+|||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 279 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA 279 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH
Confidence 999999997543321110 1110000 00000000 0000000 0001111235678899999999999999999
Q ss_pred HHHHHH
Q 010432 430 SEVVEA 435 (511)
Q Consensus 430 ~eil~~ 435 (511)
.+++.+
T Consensus 280 ~~~l~h 285 (288)
T cd07863 280 FRALQH 285 (288)
T ss_pred HHHhcC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=345.90 Aligned_cols=265 Identities=29% Similarity=0.405 Sum_probs=202.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|.+.... ...+++.||||+++..... ....+.+|+.+|.++ +|+||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 4568999999999999999999864311 1225789999999765332 234688999999999 789999999988
Q ss_pred EeC-CeEEEEEEccCCCCHHHHHhhCC-----------------------------------------------------
Q 010432 205 IED-DQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (511)
Q Consensus 205 ~~~-~~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------- 230 (511)
... ...++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 56789999999999999986421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccc
Q 010432 231 -------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297 (511)
Q Consensus 231 -------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (511)
..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~------------------------ 213 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS------------------------ 213 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEc------------------------
Confidence 13677888899999999999999988 99999999999998
Q ss_pred cccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCchh
Q 010432 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 376 (511)
Q Consensus 298 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~ 376 (511)
++..+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 214 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~ 290 (343)
T cd05103 214 -ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E 290 (343)
T ss_pred -CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H
Confidence 467899999999987543322211222346778999999988899999999999999999997 899986532211 1
Q ss_pred HHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 377 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.... ...... ...+...+..+.+++.+||+.||.+||++.+|+++|+.+
T Consensus 291 ~~~~----~~~~~~----------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 291 FCRR----LKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHH----HhccCC----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1110 000000 000111245789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.66 Aligned_cols=249 Identities=28% Similarity=0.366 Sum_probs=207.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHH---HHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~---~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
-++|..+++||+|.||+|-+++-+. +++.||||++++.......+ -+.|-++|+..+||.+..|...|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKa---------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKA---------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecc---------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 3578888999999999999998765 88999999999876554443 46799999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
+..+.+|+||||..||.|.-+|.+ ...+++...+.+...|+.||.|||+++ ||+||||.+|+||+
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLD----------- 302 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLD----------- 302 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheec-----------
Confidence 999999999999999999998854 457888889999999999999999988 99999999999999
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+++++||+||||++....... ...++||||.|+|||++....|+.++|+|.+||++|||++|+.
T Consensus 303 --------------kDGHIKitDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRL 366 (516)
T KOG0690|consen 303 --------------KDGHIKITDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRL 366 (516)
T ss_pred --------------cCCceEeeecccchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccC
Confidence 599999999999986443222 2446899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 434 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~ 434 (511)
||+.........++.. + .-.|+...+++++.|+..+|.+||.+|. .+.||.+
T Consensus 367 PFyn~dh~kLFeLIl~------e------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 367 PFYNKDHEKLFELILM------E------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred cccccchhHHHHHHHh------h------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 9986543322222111 0 1123344467899999999999999995 3556654
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=336.01 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=191.2
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe--CCeEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRL 211 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~ 211 (511)
..+||+|+||+||+|+++.. .+++.||+|.+..... ...+.+|+.+|++++||||+++++++.. +...|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 45899999999999987542 1467899999975532 2457899999999999999999998864 45688
Q ss_pred EEEEccCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 212 LVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 212 lv~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+||||+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+.....
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~------ 146 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP------ 146 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCC------
Confidence 999999 46888887421 235888999999999999999999998 999999999999953211
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHh
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ellt 361 (511)
..+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 147 ---------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 211 (317)
T cd07868 147 ---------------ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (317)
T ss_pred ---------------CcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh
Confidence 3567999999999875432211 11234578999999999876 458999999999999999999
Q ss_pred CCCCCCCCCCCCch------hHHHhhhhhhc--------------cccccccccCCc------cCC---CCCHHHHHHHH
Q 010432 362 GRRSMDKNRPNGEH------NLVEWARPHLG--------------ERRRFYRLIDPR------LEG---HFSIKGAQKAA 412 (511)
Q Consensus 362 g~~pf~~~~~~~~~------~~~~~~~~~~~--------------~~~~~~~~~~~~------~~~---~~~~~~~~~~~ 412 (511)
|++||......... .........+. ............ +.. ......+..+.
T Consensus 212 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (317)
T cd07868 212 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 291 (317)
T ss_pred CCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHH
Confidence 99999754332110 00000000000 000000000000 000 00001134678
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 010432 413 QLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 413 ~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+||.+||+.||.+|||+.|++++
T Consensus 292 dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 292 HLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHHhccCcccCCCHHHHhcC
Confidence 99999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=328.53 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=206.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|.+.. ++..||||.+..... ....++.+|+.+++.++|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 468888999999999999999765 577999998865332 22346889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
.++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~--------- 140 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFIT--------- 140 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc---------
Confidence 99999999999999999998853 2346899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.++|+|||++......... .....|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 141 ----------------~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 141 ----------------ATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ----------------CCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhC
Confidence 4678999999998865443221 2235689999999999888899999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
..||....... ....... ..... ........+..+.+|+.+||+.||.+|||+.+|++.++++
T Consensus 203 ~~p~~~~~~~~-~~~~~~~----------~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 203 QSPFYGDKMNL-YSLCKKI----------EQCDY---PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCcccccchH-HHHhhhh----------hcCCC---CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 99996532210 1111000 00000 1111123467899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=334.00 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=204.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+..........+.+|+.+++.++|+||+++++++..+.
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 589999999999999999998765 57799999998766555567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~--------------- 150 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG--------------- 150 (296)
T ss_pred EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEc---------------
Confidence 99999999999999999854 35788999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
+++.+||+|||++......... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 151 ----------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 151 ----------MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred ----------CCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 4678999999998865432211 2234689999999999888899999999999999999999999975
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...... +..... . .......+...+..+.+|+.+||..||++||++.+|+++
T Consensus 219 ~~~~~~--~~~~~~----~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 219 ENPLRA--LYLIAT----N---------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCHHHh--HHHHhc----C---------CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 432111 100000 0 000001122335678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=331.91 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=202.1
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeE
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
|++.+.||+|+||.||+|.+.. ++..+|+|.+..........+.+|+.+++.++|+||+++++++..++..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 6777889999999999998865 5778999999765544456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++++|..++......+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~----------------- 137 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFT----------------- 137 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEc-----------------
Confidence 9999999999999988665567999999999999999999999988 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||++........ ......||..|+|||++. +..++.++|||||||++|||++|+.|
T Consensus 138 --------~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 207 (282)
T cd06643 138 --------LDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207 (282)
T ss_pred --------cCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence 467899999999976533211 123356899999999884 45678899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|....... ........ ..+.+ ..+...+..+.+||.+||+.||.+||++.+++++-
T Consensus 208 ~~~~~~~~--~~~~~~~~-----------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 208 HHELNPMR--VLLKIAKS-----------EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ccccCHHH--HHHHHhhc-----------CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 97543211 11111000 00000 11122356789999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=332.85 Aligned_cols=251 Identities=30% Similarity=0.407 Sum_probs=199.1
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
|+..+.||+|+||+||+|.+.. +++.||+|.+...... ....+.+|+.+|++++|+||+.+++++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 6677889999999999999875 6779999999754322 223477899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~------------- 136 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLD------------- 136 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEC-------------
Confidence 9999999999999999888653 346999999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
++..+||+|||++........ .....|+..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 137 ------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~ 201 (285)
T cd05632 137 ------------DYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201 (285)
T ss_pred ------------CCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 367899999999976543221 22357899999999999889999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
........... ........ ...+....+..+.+|+.+||+.||.+||+ +.+++.+
T Consensus 202 ~~~~~~~~~~~---~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 202 RGRKEKVKREE---VDRRVLET-----------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCCCHHHHHHH---HHHhhhcc-----------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 75432111110 00000000 01112223567889999999999999999 5566553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=326.07 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=207.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|.+.. +|+.||+|.++.... .....+.+|++++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 578999999999999999999865 577999999864322 22456889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
..+..++||||+++|+|..++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~--------- 140 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFIT--------- 140 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEEC---------
Confidence 99999999999999999998853 2345889999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.++|+|||++......... .....|+..|+|||++.+..++.++|||||||++|+|++|
T Consensus 141 ----------------~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g 202 (267)
T cd08224 141 ----------------ATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ----------------CCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHC
Confidence 4778999999998765432211 2234689999999999988999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
+.||...... ...+...... ......+ ...+..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus 203 ~~p~~~~~~~-~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 203 QSPFYGDKMN-LYSLCKKIEK--------------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCcccCCcc-HHHHHhhhhc--------------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999644311 0011110000 0001111 134567899999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=342.72 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=198.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||++++.. +++.||||++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 478999999999999999999875 677999999975321 12234778999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..||||||+++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~------------ 136 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLD------------ 136 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEc------------
Confidence 999999999999999999999765567899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----CCCCccccchhHHHHHHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DIwSlGvil~ell 360 (511)
.++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||+||||+
T Consensus 137 -------------~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell 202 (331)
T cd05624 137 -------------MNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202 (331)
T ss_pred -------------CCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhh
Confidence 4778999999999865443221 1233579999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~--RPs~~eil~~ 435 (511)
+|+.||....... .... .......+ .+... ....+..+.+|+.+||..++.+ |+++.+++++
T Consensus 203 ~g~~Pf~~~~~~~---~~~~---i~~~~~~~------~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 203 YGETPFYAESLVE---TYGK---IMNHEERF------QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred hCCCCccCCCHHH---HHHH---HHcCCCcc------cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999997543211 1100 00000000 00000 0123577899999999876544 4578888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.87 Aligned_cols=267 Identities=25% Similarity=0.403 Sum_probs=205.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
...+|.+.+.||+|+||.||+|++..... ........||+|.++.... .....+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34678899999999999999998643111 1112456899999875432 2235688999999999 699999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 99899999999999999999996431 34788899999999999999999988 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ +++.+||+|||+++...............++..|||||++.+..++.++||
T Consensus 165 ill~-------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 165 VLVT-------------------------EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred EEEc-------------------------CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence 9998 477899999999987644322111122234568999999998899999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||||++|||++ |..||....... +..... ... ....+..++..+.+|+.+||+.||++||+
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps 282 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEE---LFKLLR----EGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPT 282 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 999999999999 888886543211 111111 000 01112223567889999999999999999
Q ss_pred HHHHHHHhcCCC
Q 010432 429 MSEVVEALKPLP 440 (511)
Q Consensus 429 ~~eil~~L~~l~ 440 (511)
+.++++.|+.+.
T Consensus 283 ~~~ll~~l~~~~ 294 (314)
T cd05099 283 FKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHHHH
Confidence 999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=328.46 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=202.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++++.....||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++.
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec
Confidence 344556666789999999999998765 56789999988765555567889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
.++..++||||+++++|.+++......+ ++..+..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~--------- 143 (268)
T cd06624 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNT--------- 143 (268)
T ss_pred cCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcC---------
Confidence 9999999999999999999997654445 78888999999999999999988 999999999999973
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC--CCCccccchhHHHHHHHHHh
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DIwSlGvil~ellt 361 (511)
+...++|+|||++......... .....|+..|+|||++... .++.++|||||||++|+|++
T Consensus 144 ---------------~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~ 206 (268)
T cd06624 144 ---------------YSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206 (268)
T ss_pred ---------------CCCeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh
Confidence 3567999999999765432211 2234589999999998654 37899999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|+.||........ ..+..... .....++......+.+|+.+||+.+|.+||++.+++.+
T Consensus 207 g~~p~~~~~~~~~---~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 207 GKPPFIELGEPQA---AMFKVGMF------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCCCccccChhh---hHhhhhhh------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999964322110 00000000 00111223345778999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.60 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|.+.+.||+|+||.||+|++.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 467778899999999999998865 57799999998665444456788999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~--------------- 140 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLT--------------- 140 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC---------------
Confidence 999999999999999988544 47899999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||++........ ......|+..|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 141 ----------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p 208 (267)
T cd06645 141 ----------DNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208 (267)
T ss_pred ----------CCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence 367799999999876543211 123357899999999874 45688999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|....+.... ...... ....+.... ....+..+.+|+.+||+.||++||++.+|+++
T Consensus 209 ~~~~~~~~~~--~~~~~~---------~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 209 MFDLHPMRAL--FLMTKS---------NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccccchhhH--Hhhhcc---------CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 8654321110 000000 000010100 01234578899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=331.96 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+.|++++.||.|+||.||+|++.. ++..||+|.+..........+.+|+.+++.++|+||+++++++..+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 578999999999999999998865 57799999998765555567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++++|..++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~--------------- 144 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLT--------------- 144 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEc---------------
Confidence 999999999999999888665667899999999999999999999988 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHHHhCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|.
T Consensus 145 ----------~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 212 (292)
T cd06644 145 ----------LDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212 (292)
T ss_pred ----------CCCCEEEccCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCC
Confidence 467899999999876433211 123356889999999885 345788999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.||....... ....... ...+. ...+...+.++.+||.+||+.||++||++.+++++
T Consensus 213 ~p~~~~~~~~--~~~~~~~-----------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 213 PPHHELNPMR--VLLKIAK-----------SEPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCccccHHH--HHHHHhc-----------CCCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9996543211 1111100 00000 01112334678999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.06 Aligned_cols=241 Identities=27% Similarity=0.321 Sum_probs=187.2
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCC---CCCCcceEeeEEEeCCeE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL---VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~~~~ 210 (511)
||+|+||+||+|++.. ++..||||++...... ....+..|..++..+ .||||+++++++...+..
T Consensus 1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999999875 6789999999653221 123455677777665 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
|+||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~----------------- 130 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLD----------------- 130 (330)
T ss_pred EEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEEC-----------------
Confidence 9999999999999988653 46899999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKN 369 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf~~~ 369 (511)
.++.+||+|||+++........ ....+||+.|||||++.+. .++.++|||||||++|||++|+.||...
T Consensus 131 --------~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 131 --------ATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred --------CCCCEEEecCCcCcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 4778999999999764332221 2346799999999998754 5899999999999999999999999754
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL----MSEVVE 434 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs----~~eil~ 434 (511)
.... +.... .... ..+.. ...+..+.+|+.+||+.||.+||+ +.++++
T Consensus 201 ~~~~---~~~~i---~~~~--------~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 201 DTQQ---MYRNI---AFGK--------VRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHH---HHHHH---HcCC--------CCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3211 11000 0000 00110 112467889999999999999995 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=326.83 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=202.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+|++.+.||+|+||.||++.+.. ++..||+|.++... ....+.+.+|+.+++.++|+||+++++++..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 47888999999999999998865 67799999986543 223456788999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..++||||+++|+|.+++... ...++...++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~-------------- 134 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLT-------------- 134 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEC--------------
Confidence 999999999999999988643 445889999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
+++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 135 -----------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 135 -----------QNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred -----------CCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence 477899999999986544222 1233568999999999988889999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..... ....... .. . ....+...+..+.+|+.+||+.||++||++.+|+..
T Consensus 202 ~~~~~---~~~~~~~---~~--~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 202 ANSWK---NLILKVC---QG--S---------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCHH---HHHHHHh---cC--C---------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 53221 1110000 00 0 001122235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.71 Aligned_cols=253 Identities=27% Similarity=0.378 Sum_probs=199.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
+.+.|++.+.||+|+||.||+|.+.. +++.||+|++.... .....+.+|+.++.++ +|+||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 45678888999999999999998865 67799999997653 3345688999999998 7999999999987
Q ss_pred eC------CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 206 ED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 206 ~~------~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
.. ...++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~----- 145 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT----- 145 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEEC-----
Confidence 53 4689999999999999998753 356899999999999999999999988 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFG 353 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlG 353 (511)
++..+||+|||++........ ......|+..|+|||++. ...++.++||||||
T Consensus 146 --------------------~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 203 (272)
T cd06637 146 --------------------ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203 (272)
T ss_pred --------------------CCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence 477899999999986543221 123357899999999986 34688899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 354 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
|++|||++|..||........ ... ... ... ........+..+.+|+.+||..||.+||++.+++
T Consensus 204 v~l~el~~g~~p~~~~~~~~~-----~~~--~~~------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 204 ITAIEMAEGAPPLCDMHPMRA-----LFL--IPR------NPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred HHHHHHHhCCCCccccCHHHH-----HHH--Hhc------CCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 999999999999964332111 000 000 000 0001112346789999999999999999999998
Q ss_pred HH
Q 010432 434 EA 435 (511)
Q Consensus 434 ~~ 435 (511)
.+
T Consensus 268 ~~ 269 (272)
T cd06637 268 KH 269 (272)
T ss_pred hC
Confidence 74
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=334.92 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.+.||+|+||.||+|++.. ++..||+|.+..... .....+.+|+.++++++|+||+++++++..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 578999999999999999998865 677999999975432 2234678899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+. ++|.+++......+++..+..++.||+.||.|||+++ |+|+||||+|||++
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~-------------- 138 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLIN-------------- 138 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEEC--------------
Confidence 99999999996 6999998766667899999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||++......... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 139 -----------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f 205 (301)
T cd07873 139 -----------ERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205 (301)
T ss_pred -----------CCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC
Confidence 4778999999999865432221 223457899999998865 45788999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhh--------hhccccccccccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARP--------HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
...........+..... .......+.....+.... ......+..+.+||.+||+.||.+|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 206 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 76533211110000000 000000000000000000 011123567899999999999999999999998
Q ss_pred Hh
Q 010432 435 AL 436 (511)
Q Consensus 435 ~L 436 (511)
+-
T Consensus 286 h~ 287 (301)
T cd07873 286 HP 287 (301)
T ss_pred Cc
Confidence 54
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.81 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=198.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++|+||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 45789999999999999999998765 677999999975432 2235678999999999999999999988
Q ss_pred EeC------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 205 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 205 ~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
... ...++||||++ ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~----- 153 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK----- 153 (355)
T ss_pred eccccccccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEC-----
Confidence 643 35799999995 477777643 4788889999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++||
T Consensus 154 --------------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (355)
T cd07874 154 --------------------SDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_pred --------------------CCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHH
Confidence 477899999999986543221 233578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhH-HHh---------------hhhhhcccccccccc-----CCcc---CCCCCHHHHHHHHHH
Q 010432 359 MLTGRRSMDKNRPNGEHNL-VEW---------------ARPHLGERRRFYRLI-----DPRL---EGHFSIKGAQKAAQL 414 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~-~~~---------------~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~~~~~~~L 414 (511)
|++|+.||.+......... ... .............+. ...+ ........+..+.+|
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (355)
T cd07874 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHH
Confidence 9999999976432111000 000 000000000000000 0000 000111224678999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 010432 415 AAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 415 i~~cl~~dP~~RPs~~eil~~ 435 (511)
|.+||+.||.+|||+.|++++
T Consensus 291 i~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 291 LSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCchhcCCHHHHhcC
Confidence 999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=360.06 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=219.9
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
...+.++||.|.||.|++|+++..++ ....||||.++.... +.+.+|+.|+.||.+++||||++|.|+.....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgk------re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGK------REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred heEEEEEEecccccceecccccCCCC------cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 44677899999999999999987544 456899999997644 34567999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
.++||.|||++|+|..||+.+.+.+.+.+..-+++.||.||.||-+.+ +|||||.++|||++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNs-------------- 766 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNS-------------- 766 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeecc--------------
Confidence 999999999999999999988888999999999999999999999999 999999999999994
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccc--cccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G--t~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
+..+|++||||++.+.++... ..++..| +++|.|||.+...+++.++|||||||+|||.++ |..|
T Consensus 767 -----------nLvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP 834 (996)
T KOG0196|consen 767 -----------NLVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 834 (996)
T ss_pred -----------ceEEEeccccceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc
Confidence 888999999999987665422 2222222 579999999999999999999999999999886 8899
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|......+.. ..+...++..-+.+++..+.+||..||++|-.+||.|.+|+.+|+++..
T Consensus 835 YWdmSNQdVI-----------------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 835 YWDMSNQDVI-----------------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ccccchHHHH-----------------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 8755432211 1222333444566788999999999999999999999999999988753
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=324.89 Aligned_cols=252 Identities=34% Similarity=0.516 Sum_probs=205.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
+.||+|+||.||+|.+.... .++..||||.+....... ...+.+|+.++..++|+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 46999999999999986521 136789999998765433 46788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 214 YEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
|||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~------------ 139 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVG------------ 139 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEEC------------
Confidence 9999999999999765 467899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
+++.+||+|||.+................++..|+|||.+....++.++|||||||++|||++ |..
T Consensus 140 -------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 140 -------------EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred -------------CCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 468899999999988765432222334567899999999988899999999999999999999 699
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
||...... .+..... . ......+...+.++.+++.+||+.||.+||++.+++++|+
T Consensus 207 p~~~~~~~---~~~~~~~----~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 207 PYPGLSNE---EVLEYLR----K----------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCHH---HHHHHHH----c----------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99765221 1111111 0 0011122233578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.94 Aligned_cols=275 Identities=24% Similarity=0.323 Sum_probs=204.1
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceE
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKL 200 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l 200 (511)
+......+|++++.||+|+||+||+|++.. ++..||+|++...... ....|.+|+.+|.+|+|||||++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl 77 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence 334456789999999999999999999875 6779999999765332 23568899999999999999999
Q ss_pred eeEEEe--CCeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeEecccCCCcEE
Q 010432 201 IGYCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE----RPVIYRDFKTSNIL 271 (511)
Q Consensus 201 ~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~----~~iiHrDLKp~NIL 271 (511)
+++|.. ...+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||..+. .+||||||||+|||
T Consensus 78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 998865 45689999999999999998642 3469999999999999999999998431 34999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc--CCCCccccc
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDV 349 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DI 349 (511)
|+..... +.+. ............+||+|||++........ .....||+.|+|||++.+ ..++.++||
T Consensus 158 L~s~~~~-lg~i-------~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDV 226 (1021)
T PTZ00266 158 LSTGIRH-IGKI-------TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDM 226 (1021)
T ss_pred eecCccc-cccc-------cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHH
Confidence 9742100 0000 00000011245689999999987643321 233579999999999864 458999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 350 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 350 wSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
||||||||||++|..||...... ..+... +... +.+.. ...+..+.+||..||+.+|.+||++
T Consensus 227 WSLG~ILYELLTGk~PF~~~~~~--~qli~~----lk~~--------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa 289 (1021)
T PTZ00266 227 WALGCIIYELCSGKTPFHKANNF--SQLISE----LKRG--------PDLPI---KGKSKELNILIKNLLNLSAKERPSA 289 (1021)
T ss_pred HHHHHHHHHHHHCCCCCCcCCcH--HHHHHH----HhcC--------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCH
Confidence 99999999999999999753321 111111 1000 00000 1124678999999999999999999
Q ss_pred HHHHH
Q 010432 430 SEVVE 434 (511)
Q Consensus 430 ~eil~ 434 (511)
.++|.
T Consensus 290 ~QlL~ 294 (1021)
T PTZ00266 290 LQCLG 294 (1021)
T ss_pred HHHhc
Confidence 99985
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.83 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|.++.++ ....+|+|.++.... .....+.+|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 57888999999999999999986521 123568887764322 2335688899999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nil 156 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 156 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEE
Confidence 999999999999999999996432 25788999999999999999999988 999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchh
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwS 351 (511)
++ .+..+||+|||++........ .....++..|+|||++.+..++.++||||
T Consensus 157 i~-------------------------~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 208 (303)
T cd05088 157 VG-------------------------ENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWS 208 (303)
T ss_pred ec-------------------------CCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchh
Confidence 98 467899999999974321111 11123467899999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 352 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 352 lGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
|||++|||+| |..||....... ...... . ......+...+..+.+|+.+||+.+|++||++.
T Consensus 209 lG~il~ellt~g~~p~~~~~~~~---~~~~~~----~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 271 (303)
T cd05088 209 YGVLLWEIVSLGGTPYCGMTCAE---LYEKLP----Q----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 271 (303)
T ss_pred hhhHHHHHHhcCCCCcccCChHH---HHHHHh----c----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999999998 999996543211 111110 0 001111112346789999999999999999999
Q ss_pred HHHHHhcCCCC
Q 010432 431 EVVEALKPLPN 441 (511)
Q Consensus 431 eil~~L~~l~~ 441 (511)
++++.|+.+..
T Consensus 272 ~il~~l~~~~~ 282 (303)
T cd05088 272 QILVSLNRMLE 282 (303)
T ss_pred HHHHHHHHHHH
Confidence 99999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=327.36 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=201.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|+.++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 4578899999999999999997653 45799999976543 3467899999999999999999999875 4
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
...++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~------------- 136 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVG------------- 136 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEe-------------
Confidence 5689999999999999998653 345899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
++..++|+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 137 ------------~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p 203 (260)
T cd05070 137 ------------DGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred ------------CCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCC
Confidence 4678999999999865443211 1122345678999999988889999999999999999999 8899
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
|...... ........ ......+...+..+.+|+.+||..||++|||+.++++.|+.
T Consensus 204 ~~~~~~~---~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 204 YPGMNNR---EVLEQVER--------------GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCHH---HHHHHHHc--------------CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9653221 11111100 00111122335679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=326.44 Aligned_cols=257 Identities=22% Similarity=0.359 Sum_probs=194.7
Q ss_pred CccccCCCceEEEEEEcCCCCCC---ccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAP---VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~---~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 211 (511)
+.||+|+||.||+|+........ ........||+|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 36899999999999865321100 011234578999987654444456888999999999999999999999998999
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccc
Q 010432 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291 (511)
Q Consensus 212 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~ 291 (511)
+||||+++|+|..++......+++..++.++.||+.||+|||+++ |+||||||+|||++..+...
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~------------ 145 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDG------------ 145 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccC------------
Confidence 999999999999988766667899999999999999999999988 99999999999997422100
Q ss_pred cccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-cCCCCccccchhHHHHHHHHH-hCCCCCCCC
Q 010432 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML-TGRRSMDKN 369 (511)
Q Consensus 292 ~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DIwSlGvil~ell-tg~~pf~~~ 369 (511)
.....+|++|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|..||...
T Consensus 146 ------~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 146 ------ECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred ------CCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 01234899999998765332 2245788999999886 567899999999999999998 588887643
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
....... .... ..... ......+.+||.+||+.||.+||++.+|++.|+
T Consensus 214 ~~~~~~~-------~~~~---~~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 214 TLAEKER-------FYEG---QCMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred chhHHHH-------HHhc---CccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 2211100 0000 00000 112467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=332.04 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=207.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++|.+.+.||+|+||.||+|.+.... ..++..||+|++..... .....+.+|+.+|++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3568899999999999999999986521 12467899999875432 22356889999999999999999999877
Q ss_pred e-CCeEEEEEEccCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 206 E-DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 206 ~-~~~~~lv~E~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
. +...++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~---- 151 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVID---- 151 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEc----
Confidence 6 567899999999999999986432 45889999999999999999999988 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ 357 (511)
++..+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 152 ---------------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~ 210 (280)
T cd05043 152 ---------------------EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLW 210 (280)
T ss_pred ---------------------CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHH
Confidence 46789999999998764433222223345678899999999889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 358 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 358 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|+++ |+.||...... .+..+... .. .......++..+.+++.+||..||++||++.++++.|
T Consensus 211 el~~~g~~p~~~~~~~---~~~~~~~~----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 211 ELMTLGQTPYVEIDPF---EMAAYLKD----GY----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred HHhcCCCCCcCcCCHH---HHHHHHHc----CC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 9999 99999754321 11111111 00 0011112356789999999999999999999999999
Q ss_pred cCCC
Q 010432 437 KPLP 440 (511)
Q Consensus 437 ~~l~ 440 (511)
+.+.
T Consensus 274 ~~~~ 277 (280)
T cd05043 274 TDFH 277 (280)
T ss_pred HHHH
Confidence 7653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=341.10 Aligned_cols=268 Identities=27% Similarity=0.399 Sum_probs=207.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
...+|++.+.||+|+||.||+|.+...... ....+..||+|.++.... .....+.+|+.+++++ +|+||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKD--KPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCc--cCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 345789999999999999999987542211 112345799998875432 2235788999999999 899999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999999986432 24778889999999999999999988 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ ++..+||+|||+++...............++..|+|||++.+..++.++||
T Consensus 165 ill~-------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (334)
T cd05100 165 VLVT-------------------------EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219 (334)
T ss_pred EEEc-------------------------CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence 9998 467899999999987654332222222345678999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||||++|||++ |..||....... ...... .. .....+...+..+.+|+.+||+.+|.+||+
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~---~~~~~~----~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 282 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEE---LFKLLK----EG----------HRMDKPANCTHELYMIMRECWHAVPSQRPT 282 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcC
Confidence 999999999998 888886542211 111100 00 011112223567899999999999999999
Q ss_pred HHHHHHHhcCCCC
Q 010432 429 MSEVVEALKPLPN 441 (511)
Q Consensus 429 ~~eil~~L~~l~~ 441 (511)
+.+|++.|+.+..
T Consensus 283 ~~ell~~l~~~~~ 295 (334)
T cd05100 283 FKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHHHHhh
Confidence 9999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=325.54 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=199.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEE-eC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-ED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-~~ 207 (511)
.+|.+.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.++++++|+||+++++++. .+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----------~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----------cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 4788899999999999999976 35689999987543 2356889999999999999999999765 45
Q ss_pred CeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~------------- 136 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVS------------- 136 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEc-------------
Confidence 67899999999999999997543 34889999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
+++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 137 ------------~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p 199 (256)
T cd05082 137 ------------EDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred ------------CCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 47789999999998654322 12345678999999988899999999999999999998 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|..... ..+....... .........+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 200 ~~~~~~---~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 200 YPRIPL---KDVVPRVEKG--------------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCH---HHHHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 864321 1111111100 01111223357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=331.77 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=205.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||.|+||.||+|.+.. ++..||+|++..........+.+|+.++++++|+||+++++++..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 3568899999999999999998865 5779999999766544556788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++||||+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~-------------- 137 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLT-------------- 137 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEC--------------
Confidence 9999999999999999998766667999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHHHhC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.++|+|||++......... .....||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 138 -----------~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g 204 (280)
T cd06611 138 -----------LDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQM 204 (280)
T ss_pred -----------CCCCEEEccCccchhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhC
Confidence 4778999999998765432221 23356899999999875 34578899999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.||....... .+..... ...+.+ ..+...+..+.+|+.+||+.+|.+||++.+|+++
T Consensus 205 ~~p~~~~~~~~--~~~~~~~-----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 205 EPPHHELNPMR--VLLKILK-----------SEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCcccCCHHH--HHHHHhc-----------CCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 99997543211 1111100 000000 1112235678999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=344.76 Aligned_cols=264 Identities=23% Similarity=0.286 Sum_probs=198.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 4689999999999999999998865 577999999975422 23356789999999999999999999875
Q ss_pred eC------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
.. ...|+||||+. ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~------ 160 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK------ 160 (364)
T ss_pred ccccccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEEC------
Confidence 43 35799999995 578777743 4788889999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||+||||
T Consensus 161 -------------------~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 161 -------------------SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred -------------------CCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence 47789999999998654322 12335789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHh----------------hhhhhccccccc-----cccCCcc---CCCCCHHHHHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEW----------------ARPHLGERRRFY-----RLIDPRL---EGHFSIKGAQKAAQLA 415 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~Li 415 (511)
++|+.||...........+.. ..........+. ....... ...........+.+||
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 999999976542211110000 000000000000 0000000 0001111245789999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 010432 416 AHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 416 ~~cl~~dP~~RPs~~eil~~ 435 (511)
.+||+.||.+|||+.+++++
T Consensus 299 ~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 299 SKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhcCcCcccCCCHHHHhcC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=324.93 Aligned_cols=253 Identities=30% Similarity=0.477 Sum_probs=199.3
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
++||+|+||.||+|.+.... +++..||+|.+...... ..+.+.+|+.+++.++|+|||++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999875422 13478999999866543 3456889999999999999999999876 4568999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++|+|.+++.... .+++..++.++.|++.||+|||..+ |+|+||||+|||++
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~-------------------- 129 (257)
T cd05060 74 MELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLV-------------------- 129 (257)
T ss_pred EEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEc--------------------
Confidence 99999999999996554 7899999999999999999999988 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCccee-eeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 371 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~ 371 (511)
.++.+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 130 -----~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 130 -----NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred -----CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 477899999999987644332211 111234578999999998899999999999999999998 9999965432
Q ss_pred CCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 372 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
..+....... . ....+...+..+.+||.+||..+|++||++.+|++.|+.+.
T Consensus 205 ---~~~~~~~~~~----~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 205 ---AEVIAMLESG----E----------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---HHHHHHHHcC----C----------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1121111110 0 00111223567899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=324.33 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=206.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++.+.||.|+||.||+|.+.. ++..||+|++..........+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 578899999999999999998865 56789999998765555577899999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..+++|||+.+++|.+++......+++..+..++.|++.||.|||+++ |+|+||||+||+++
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~--------------- 135 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLT--------------- 135 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEEC---------------
Confidence 999999999999999998766567999999999999999999999988 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC---CCCccccchhHHHHHHHHHhCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||++........ ......|+..|+|||++.+. .++.++|||||||++|||++|..|
T Consensus 136 ----------~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p 203 (262)
T cd06613 136 ----------EDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203 (262)
T ss_pred ----------CCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 467799999999986543221 12335688999999998776 889999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|........ ...... . ....+ ........+..+.+|+.+||..+|.+||++.+|+.+
T Consensus 204 ~~~~~~~~~--~~~~~~------~---~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 204 MFDLHPMRA--LFLISK------S---NFPPP--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCCCCHHHH--HHHHHh------c---cCCCc--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 975432111 000000 0 00000 011123346779999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=326.82 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=203.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|+++++||+|+||.||+|... .++.||+|.+..... ....+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT- 71 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence 4567999999999999999999864 356899999976543 3467899999999999999999999864
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+..++||||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~------------ 136 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVS------------ 136 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEc------------
Confidence 56789999999999999998643 346889999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
++..++|+|||++......... ......++..|+|||++....++.++|||||||++|||++ |+.
T Consensus 137 -------------~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~ 202 (260)
T cd05067 137 -------------ETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202 (260)
T ss_pred -------------CCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCC
Confidence 4778999999999876532211 1223356788999999988889999999999999999999 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
||...... ....... .. .....+...+..+.+|+.+||+.+|++||++++++..|+.
T Consensus 203 p~~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 203 PYPGMTNP---EVIQNLE----RG----------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCChH---HHHHHHH----cC----------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99754321 1111110 00 0001111234679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=326.27 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=201.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.++||+|+||.||+|.+.. ...||||.++.... ..+.+.+|+.++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 4579999999999999999998753 23699999986433 3467899999999999999999999874 4
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~------------- 136 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVG------------- 136 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEc-------------
Confidence 5689999999999999999653 345789999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 137 ------------~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p 203 (262)
T cd05071 137 ------------ENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203 (262)
T ss_pred ------------CCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 4778999999999865443321 1122346778999999988899999999999999999999 8888
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|....... ....... ..........+..+.+|+.+||+.||++||++.++++.|+..
T Consensus 204 ~~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 204 YPGMVNRE---VLDQVER--------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCChHH---HHHHHhc--------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 86543211 1110000 000111223457789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=329.39 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=207.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+|++.+.||+|+||.||+|.++.++.. ....||+|.+...... ....+.+|+.++++++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCC-----cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 35788899999999999999998653221 2347999998766432 23568899999999999999999999987
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
...++||||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~------------- 143 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVK------------- 143 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEc-------------
Confidence 7889999999999999999776667999999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
++..+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.|
T Consensus 144 ------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 211 (279)
T cd05057 144 ------------TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ------------CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCC
Confidence 467799999999987654332222222234678999999988899999999999999999998 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|....... +..... ... ....+..++..+.+++.+||..||.+||++.++++.|..+..
T Consensus 212 ~~~~~~~~---~~~~~~----~~~----------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 212 YEGIPAVE---IPDLLE----KGE----------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCHHH---HHHHHh----CCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 97543211 111111 000 001111234578899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=324.53 Aligned_cols=250 Identities=29% Similarity=0.496 Sum_probs=204.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||.|+||.||+|.. .|+.||||.+..... ...++.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-----------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 45788999999999999999976 356899999986644 446789999999999999999999999988
Q ss_pred CeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~------------- 136 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVS------------- 136 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEe-------------
Confidence 99999999999999999996543 36899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+++....... ...++..|+|||++....++.++|||||||++|||++ |..|
T Consensus 137 ------------~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p 199 (256)
T cd05039 137 ------------EDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred ------------CCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 477899999999987633221 2345678999999988889999999999999999997 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|...... .+..... .. .....+...+..+.+|+.+||..+|.+||++.++++.|+.+
T Consensus 200 ~~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 200 YPRIPLK---DVVPHVE----KG----------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCHH---HHHHHHh----cC----------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 8654221 1111111 00 01111122357889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=330.98 Aligned_cols=274 Identities=28% Similarity=0.410 Sum_probs=204.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+.|++++.||+|+||.||+|++... ...++..||+|.++.... .....+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccC-----CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 3578899999999999999986431 123678999999875532 2235688999999999999999999998775
Q ss_pred --CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 208 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
...++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~------------ 143 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVE------------ 143 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEc------------
Confidence 5688999999999999999765556899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++........ .......|+..|+|||++.+..++.++|||||||++|||++++.
T Consensus 144 -------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~ 210 (284)
T cd05079 144 -------------SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCD 210 (284)
T ss_pred -------------CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCC
Confidence 4678999999999876543221 11223457788999999988889999999999999999999877
Q ss_pred CCCCCCCCCchhHHHhhhhhhccc--cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGER--RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|+...... ......+...+. ......+........+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 211 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 211 SESSPMTL----FLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CCccccch----hhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 65321110 000000000000 000000000001111122457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.40 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=193.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
+.||+|+||.||+|.+... .++..+|+|.++..... ....+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCC-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 3689999999999987532 14568999998765432 234688999999999999999999999998899999
Q ss_pred EEccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeec
Q 010432 214 YEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~ 289 (511)
|||+++|+|.+++... ....++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~---------------- 134 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLT---------------- 134 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEc----------------
Confidence 9999999999998642 224567788899999999999999988 99999999999998
Q ss_pred cccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-------CCCccccchhHHHHHHHHHh-
Q 010432 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-------HLTSRSDVYSFGVVLLEMLT- 361 (511)
Q Consensus 290 ~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-------~~~~~~DIwSlGvil~ellt- 361 (511)
.+..+||+|||+++...............|+..|+|||++.+. .++.++|||||||++|||++
T Consensus 135 ---------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05087 135 ---------ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205 (269)
T ss_pred ---------CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhC
Confidence 4678999999999765443322222335678899999988632 35789999999999999996
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
|..||....... ...... . ........+.+. ...+..+.+|+.+|| .+|++|||+.+|+..|.
T Consensus 206 g~~p~~~~~~~~---~~~~~~--~---~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 206 GSQPYRHLSDEQ---VLTYTV--R---EQQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCCChHH---HHHHHh--h---cccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 999996543211 111100 0 000111111111 122456889999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=330.50 Aligned_cols=276 Identities=29% Similarity=0.376 Sum_probs=209.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
+.|++.+.||+|+||.||+|++...+ ..++..||||++...... ....+.+|+.+++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 46778899999999999999876421 125789999999866543 34678999999999999999999999877
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
....++||||+++++|.+++......+++..++.++.|++.||+|||+++ |+|+||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~------------ 143 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVE------------ 143 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEc------------
Confidence 56789999999999999999766556899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.+..++|+|||++.......... ......++..|+|||++.+..++.++|||||||++|||++|..
T Consensus 144 -------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~ 210 (284)
T cd05038 144 -------------SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210 (284)
T ss_pred -------------CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence 46789999999998776332221 1112345667999999988899999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||............. .........+...+........+..++..+.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus 211 p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 211 PSQSPPAEFLRMIGI--AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred Ccccccchhcccccc--ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 986532211000000 0000000000011111111111223356789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=331.62 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=204.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|.+... ....++..||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 46799999999999999999987531 0112567899999976533 223568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDL 265 (511)
++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||.++ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 999999999999999999996421 24678888999999999999999988 999999
Q ss_pred CCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCc
Q 010432 266 KTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 345 (511)
Q Consensus 266 Kp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~ 345 (511)
||+|||++ +++.+||+|||++................++..|+|||++.+..++.
T Consensus 157 ~p~nil~~-------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 211 (288)
T cd05050 157 ATRNCLVG-------------------------ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT 211 (288)
T ss_pred cHhheEec-------------------------CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc
Confidence 99999998 47789999999998654332221122234567899999998889999
Q ss_pred cccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCC
Q 010432 346 RSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 346 ~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
++|||||||++|||++ |..||.+.... ....... .. .. ...+...+..+.+|+.+||+.||.
T Consensus 212 ~~Dv~slG~il~el~~~~~~p~~~~~~~---~~~~~~~----~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~ 274 (288)
T cd05050 212 ESDVWAYGVVLWEIFSYGMQPYYGMAHE---EVIYYVR----DG-NV---------LSCPDNCPLELYNLMRLCWSKLPS 274 (288)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cC-CC---------CCCCCCCCHHHHHHHHHHcccCcc
Confidence 9999999999999998 88888643221 1111110 00 00 001112356789999999999999
Q ss_pred CCCCHHHHHHHhcC
Q 010432 425 ARPLMSEVVEALKP 438 (511)
Q Consensus 425 ~RPs~~eil~~L~~ 438 (511)
+||++.||++.|++
T Consensus 275 ~Rpt~~el~~~l~~ 288 (288)
T cd05050 275 DRPSFASINRILQR 288 (288)
T ss_pred cCCCHHHHHHHhhC
Confidence 99999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=324.07 Aligned_cols=252 Identities=29% Similarity=0.446 Sum_probs=201.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
++||+|+||.||+|.+...+ ++...||||.+..... ...+.+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 46899999999999986421 1344799999987765 445678999999999999999999999988 889999
Q ss_pred EEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 214 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+|+||||+|||++
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~------------------- 131 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLA------------------- 131 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEe-------------------
Confidence 99999999999997654 56899999999999999999999988 99999999999998
Q ss_pred ccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 370 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~ 370 (511)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 132 ------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 132 ------SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ------cCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 46789999999998765432211 1123457889999999988899999999999999999998 999996442
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
... ....... ... ....+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus 206 ~~~---~~~~~~~---~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 206 GSQ---ILKKIDK---EGE----------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHH---HHHHHHh---cCC----------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 211 1111110 000 00111223567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.22 Aligned_cols=267 Identities=28% Similarity=0.387 Sum_probs=216.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
..+.|+.-++||+||||.||-+..+. ||+.||.|.+.+..... ....+.|-.||.+++.+.||.+-..
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred cccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 34678888999999999999998876 88999999997654332 2346789999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
|...+.+||||..|+||||.-+|.+.+ ..+++..++.++.+|+.||++||..+ ||+|||||+|||||
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLD--------- 321 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLD--------- 321 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeec---------
Confidence 999999999999999999999887653 46999999999999999999999988 99999999999999
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
+.++++|+|+|||.....+... ...+||.+|||||++.+..|+..+|+|||||+||||+.|
T Consensus 322 ----------------d~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G 382 (591)
T KOG0986|consen 322 ----------------DHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAG 382 (591)
T ss_pred ----------------cCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcc
Confidence 6899999999999988775542 334899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPN 441 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~-eil~~L~~l~~ 441 (511)
+.||.......... .+.+.+. .-...++..+++++++|...+|++||.+|.... +=.+.+...+.
T Consensus 383 ~sPFr~~KeKvk~e-------------Evdrr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf 448 (591)
T KOG0986|consen 383 HSPFRQRKEKVKRE-------------EVDRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF 448 (591)
T ss_pred cCchhhhhhhhhHH-------------HHHHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence 99997543322110 0001100 012335566789999999999999999998554 33444455666
Q ss_pred CCcCCC
Q 010432 442 LKDMAS 447 (511)
Q Consensus 442 ~~~~~~ 447 (511)
+++++.
T Consensus 449 Fk~lnw 454 (591)
T KOG0986|consen 449 FKDLNW 454 (591)
T ss_pred cccCCH
Confidence 666554
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.34 Aligned_cols=247 Identities=31% Similarity=0.454 Sum_probs=196.9
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
++||+|+||.||+|... .+..||+|.+....... ...+.+|+.++++++|+||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 36999999999999864 35689999987654322 24688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++++|.+++......+++..++.++.|++.||.|||+++ ++||||||+||+++
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~-------------------- 127 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVG-------------------- 127 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEc--------------------
Confidence 9999999999998765566899999999999999999999988 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 372 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~ 372 (511)
+++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 128 -----~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 128 -----ENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred -----CCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 4778999999999764332211 1112244678999999988889999999999999999998 99999754321
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
. ...... .. .....+...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 202 ~---~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 202 Q---AREQVE----KG----------YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred H---HHHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1 111110 00 011112223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=325.17 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=194.1
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEe-CCeEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRLL 212 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~l 212 (511)
+.||+|+||.||+|.+.... .....||||.+.... ......+.+|+.+++.++||||+++++++.. ++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCC------CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 36899999999999875422 135689999986432 2234578899999999999999999997764 556889
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
||||+.+|+|.+++......+.+..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~------------------- 132 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLD------------------- 132 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEc-------------------
Confidence 99999999999999765556778888999999999999999988 99999999999998
Q ss_pred ccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC-CCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKN 369 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg-~~pf~~~ 369 (511)
+++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++| .+||...
T Consensus 133 ------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 133 ------ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred ------CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 46789999999998654322111 11223567889999999888999999999999999999995 5556432
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.. ..+..... . . ... ..+...+..+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 207 ~~---~~~~~~~~---~-~------~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 207 DS---FDITVYLL---Q-G------RRL----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CH---HHHHHHHh---c-C------CCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 21 11111110 0 0 000 01112246789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=340.61 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=196.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++++.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.+|++++|+||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 34689999999999999999998765 677999999975432 2234577899999999999999999987
Q ss_pred EeC------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 205 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 205 ~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
... ...|++||++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~----- 152 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVN----- 152 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEEC-----
Confidence 643 3568999998 7899888743 46899999999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ 357 (511)
.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 153 --------------------~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 207 (343)
T cd07878 153 --------------------EDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207 (343)
T ss_pred --------------------CCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHH
Confidence 4778999999999875432 223578999999999876 57899999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhhhccc------------cccccccCCccCCC---CCHHHHHHHHHHHHHhcccC
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGER------------RRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRD 422 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~---~~~~~~~~~~~Li~~cl~~d 422 (511)
+|++|+.||........ +..+........ ..+...+....... ......+.+.+|+.+||+.|
T Consensus 208 el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 285 (343)
T cd07878 208 ELLKGKALFPGNDYIDQ--LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLD 285 (343)
T ss_pred HHHHCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCC
Confidence 99999999975432111 100000000000 00000000000000 00012345789999999999
Q ss_pred CCCCCCHHHHHHH
Q 010432 423 PKARPLMSEVVEA 435 (511)
Q Consensus 423 P~~RPs~~eil~~ 435 (511)
|.+|||+.+++++
T Consensus 286 p~~R~s~~ell~h 298 (343)
T cd07878 286 SDKRISASEALAH 298 (343)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.92 Aligned_cols=248 Identities=29% Similarity=0.445 Sum_probs=199.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
++||+|+||.||+|.+.. ++.||+|.+...... ....+.+|++++++++|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 469999999999998753 568999998765443 345788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++++|.+++......+++..++.++.+++.||.|||+++ |+||||||+|||++
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~-------------------- 127 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVG-------------------- 127 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEc--------------------
Confidence 9999999999999765567889999999999999999999998 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 372 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~ 372 (511)
.+..+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 128 -----~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~ 202 (251)
T cd05041 128 -----ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202 (251)
T ss_pred -----CCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence 477899999999986543222111112234677999999988899999999999999999999 88888654321
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
.. ...... ......+...+..+.+|+.+||..+|.+||++.+|++.|.
T Consensus 203 ~~---~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 203 QT---RERIES--------------GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HH---HHHHhc--------------CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11 111100 0011112233568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=310.42 Aligned_cols=253 Identities=29% Similarity=0.431 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 206 (511)
++.+.+..||.|+.|.||+++++. +|...|||.+..... ...+++++.++++.+- +.|.||+.+|||..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 455667789999999999999976 788999999987644 3345678888887666 48999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..+++.||.| ..-+..++.+-..++++..+-++...++.||.||-.++. |||||+||+|||+|
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlD------------- 226 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD------------- 226 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEc-------------
Confidence 99999999998 445666676667789999999999999999999987543 99999999999999
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg~ 363 (511)
+.+.+||||||++-.+.+.. ..++..|.+.|||||.+. ...|+.++||||||++|+||.||+
T Consensus 227 ------------e~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~ 291 (391)
T KOG0983|consen 227 ------------ERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQ 291 (391)
T ss_pred ------------cCCCEEeecccccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhccc
Confidence 58899999999998775533 345678999999999986 457899999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.||.+....- .....+. . ...|.+.... .+++.+.+|+..||++|+.+||...+++++
T Consensus 292 yPy~~c~tdF--e~ltkvl---n-------~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 292 YPYKGCKTDF--EVLTKVL---N-------EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCCCccH--HHHHHHH---h-------cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 9998643221 1111111 1 1112233222 257889999999999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=333.94 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=203.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+|+..+.||+|+||.||+|.+...+.. ....||+|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 35788889999999999999988653221 1236899988765332 22368899999999999999999999875
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
. ..++++||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~------------- 143 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVK------------- 143 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeec-------------
Confidence 4 467999999999999999776667899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
++..+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 144 ------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p 211 (303)
T cd05110 144 ------------SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211 (303)
T ss_pred ------------CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 367799999999987644322212223346788999999998999999999999999999997 8999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
|...... ....+... ... ...+..++..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 212 ~~~~~~~---~~~~~~~~----~~~----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 212 YDGIPTR---EIPDLLEK----GER----------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCCCHH---HHHHHHHC----CCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 8654211 11111110 000 0011123467889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.75 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=206.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+|++++++++|+||+++++++..+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 578999999999999999999875 467999999976532 567899999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..|+++||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||+|+||+++
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~--------------- 133 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLN--------------- 133 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEC---------------
Confidence 999999999999999999766678899999999999999999999988 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 134 ----------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 134 ----------EEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred ----------CCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999987654321 12234588999999999888999999999999999999999999975
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
........ ... ....+ ....+...+..+.+++.+||+.||.+||++.+|+++
T Consensus 202 ~~~~~~~~---~~~----------~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 202 IHPMRAIF---MIP----------NKPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cchhhhhh---hhc----------cCCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 43221100 000 00000 011122345678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=328.91 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=198.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||+|+||.||+|++.. ++..||||.+..... .....+.+|+.++++++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 47888999999999999999865 577999999875432 2235678999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+..++||||+. ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~------------ 135 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLID------------ 135 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEc------------
Confidence 99999999996 6898888643 256899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 136 -------------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 200 (285)
T cd07861 136 -------------NKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200 (285)
T ss_pred -------------CCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence 477899999999976543221 1223467899999998865 457899999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhh----------hccccccccccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPH----------LGERRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
||........ ........ ......+....+.... .......+.++.+||.+||+.||.+|||+.+
T Consensus 201 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 278 (285)
T cd07861 201 LFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278 (285)
T ss_pred CCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 9975432111 10000000 0000000000000000 0001123567889999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
|+.+
T Consensus 279 ll~~ 282 (285)
T cd07861 279 ALNH 282 (285)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.82 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
..+|++.+.||+|+||.||+|.... ++..||||.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3689999999999999999998765 5779999999876555556788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~-------------- 149 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLG-------------- 149 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC--------------
Confidence 999999999999999999854 35788999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.++|+|||++......... .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.
T Consensus 150 -----------~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 150 -----------MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred -----------CCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4778999999999765433211 223468999999999998889999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.......... . . .........+...+..+.+|+.+||+.||++||++.+|+++
T Consensus 217 ~~~~~~~~~~--~----~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 217 NENPLRALYL--I----A---------TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCcchheee--e----c---------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5432111000 0 0 00000011122335678899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.92 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++++.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.++++++|+||+++++++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 368889999999999999998865 577999999875422 2235688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
+..++||||+++++|..++... ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~----------- 137 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVN----------- 137 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEEC-----------
Confidence 9999999999999999888653 2368999999999999999999996 46 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC------CCCccccchhHHHHHHH
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~------~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||++....... .....|+..|+|||++.+. .++.++|||||||++|+
T Consensus 138 --------------~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~ 199 (286)
T cd06622 138 --------------GNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199 (286)
T ss_pred --------------CCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHH
Confidence 46789999999997654322 2234688899999998543 35889999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|++|..||.......... ... .+... ....++...+.++.+||.+||+.+|++||++.+++++-
T Consensus 200 l~~g~~pf~~~~~~~~~~---~~~----------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 200 MALGRYPYPPETYANIFA---QLS----------AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred HHhCCCCCCCcchhhHHH---HHH----------HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 999999996543211110 000 00000 01122233567889999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.56 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=201.0
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---------HHHHHHHHHHHhCCCCCCcceE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLVHLNLVKL 200 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~~E~~il~~l~H~nIv~l 200 (511)
+|.+...||+|+||.||+|.+.. ++..||+|.+....... .+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 46778899999999999998765 56789999987543321 1357789999999999999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
++++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~------- 140 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVD------- 140 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEc-------
Confidence 99999999999999999999999999654 46889999999999999999999988 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcc----eeeeeccccccccCCcccccCCCCccccchhHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil 356 (511)
++..+||+|||+++........ .......|+..|+|||++.+..++.++|||||||++
T Consensus 141 ------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il 202 (267)
T cd06628 141 ------------------NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLV 202 (267)
T ss_pred ------------------CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHH
Confidence 4778999999999876532111 011234688999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|+|++|+.||....... ... . ..... ....+...+..+.++|.+||+.||.+||++.+|+++
T Consensus 203 ~~l~~g~~p~~~~~~~~--~~~---~--------~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 203 VEMLTGKHPFPDCTQLQ--AIF---K--------IGENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHhhCCCCCCCccHHH--HHH---H--------HhccC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 99999999997532110 000 0 00011 111222345788999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.69 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=194.1
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLL 212 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~l 212 (511)
++||+|+||.||+|++..++ ....+|+|.++.... .....+.+|+.++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 36899999999999986521 123578998875432 2335688999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 213 VYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~---- 146 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVG---- 146 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEc----
Confidence 999999999999986432 24788999999999999999999988 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ 357 (511)
++..+||+|||++........ ......+..|+|||++....++.++|||||||++|
T Consensus 147 ---------------------~~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 147 ---------------------ENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred ---------------------CCCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 477899999999864321111 11123466799999998889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 358 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 358 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||++ |..||...... ....... . ......+...+..+.+|+.+||+.||.+||++.+++..|
T Consensus 203 el~~~g~~pf~~~~~~---~~~~~~~----~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 203 EIVSLGGTPYCGMTCA---ELYEKLP----Q----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred HHHcCCCCCccccCHH---HHHHHHh----C----------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 9997 99999653221 1111110 0 000111122346789999999999999999999999998
Q ss_pred cCC
Q 010432 437 KPL 439 (511)
Q Consensus 437 ~~l 439 (511)
+.+
T Consensus 266 ~~~ 268 (270)
T cd05047 266 NRM 268 (270)
T ss_pred HHh
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=324.50 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=205.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.++||+|+||.||+|.+.. +..||||.+..... ...++.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 45689999999999999999998753 45799999986543 34678999999999999999999999998
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
....++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~------------ 137 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVG------------ 137 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEc------------
Confidence 889999999999999999997543 46899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.
T Consensus 138 -------------~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 203 (261)
T cd05034 138 -------------ENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203 (261)
T ss_pred -------------CCCCEEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence 4788999999999876542211 1112335678999999998889999999999999999998 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
||...... ......... +....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 204 p~~~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 204 PYPGMTNR---EVLEQVERG--------------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHH---HHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 99654321 111111000 0001111225678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=363.14 Aligned_cols=259 Identities=23% Similarity=0.336 Sum_probs=200.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.++||+|+||.||+|++.. +++.||||++...... ..+++.+|+.++++++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 579999999999999999998865 6789999999754322 2356889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 275 (511)
+++..++||||++||+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd-- 147 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLG-- 147 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEc--
Confidence 999999999999999999988531 123556778899999999999999998 99999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCc----------------ceeeeeccccccccCCcccc
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK----------------THVSTRVMGTYGYAAPEYVM 339 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~----------------~~~~~~~~Gt~~y~aPE~~~ 339 (511)
.++.+||+|||+++....... .......+||+.|||||++.
T Consensus 148 -----------------------~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~ 204 (932)
T PRK13184 148 -----------------------LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL 204 (932)
T ss_pred -----------------------CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc
Confidence 477899999999986521100 00112357999999999999
Q ss_pred cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhc
Q 010432 340 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419 (511)
Q Consensus 340 ~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl 419 (511)
+..++.++|||||||++|||++|+.||......... . ... ...+... ......+..+.+++.+||
T Consensus 205 g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~----~-~~~---------i~~P~~~-~p~~~iP~~L~~LI~rcL 269 (932)
T PRK13184 205 GVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS----Y-RDV---------ILSPIEV-APYREIPPFLSQIAMKAL 269 (932)
T ss_pred CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh----h-hhh---------ccChhhc-cccccCCHHHHHHHHHHc
Confidence 999999999999999999999999999753221110 0 000 0000000 000123467889999999
Q ss_pred ccCCCCCC-CHHHHHHHhcCC
Q 010432 420 SRDPKARP-LMSEVVEALKPL 439 (511)
Q Consensus 420 ~~dP~~RP-s~~eil~~L~~l 439 (511)
+.||++|| ++.++++.|+.+
T Consensus 270 ~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 270 AVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred cCChhhCcCHHHHHHHHHHHH
Confidence 99999997 566677766543
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=327.29 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|.+.++||+|+||.||+|.+.... .....||||...... ....+.+.+|+.++++++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 356888899999999999999876421 134579999987654 2334578899999999999999999998865
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++|+|.+++......+++..++.++.|++.||.|||+++ ++|+||||+|||++
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~------------- 141 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVS------------- 141 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEe-------------
Confidence 5578999999999999999765556899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.+..+||+|||+++........ ..+...++..|+|||++....++.++|||||||++|||++ |..|
T Consensus 142 ------------~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 208 (270)
T cd05056 142 ------------SPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208 (270)
T ss_pred ------------cCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCC
Confidence 3678999999999876543221 1222345678999999988889999999999999999996 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|....... ...... .... ...+...+..+.+|+.+||..+|.+||++.+++..|+.+.+
T Consensus 209 f~~~~~~~---~~~~~~----~~~~----------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 209 FQGVKNND---VIGRIE----NGER----------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCHHH---HHHHHH----cCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 97543221 111110 0000 01112335688999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.19 Aligned_cols=264 Identities=19% Similarity=0.222 Sum_probs=194.9
Q ss_pred CCCccccC--CCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 133 PESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 133 ~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++++||+| +|++||++.++. +|+.||||++...... ....+.+|+.+++.++|||||++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 46789999 788999998876 6889999999765322 2245678999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~-------------- 135 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILIS-------------- 135 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEe--------------
Confidence 999999999999999998653 345899999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcce-----eeeeccccccccCCccccc--CCCCccccchhHHHHHHHHH
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil~ell 360 (511)
.++.++++|||.+.......... ......++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 -----------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 204 (327)
T cd08227 136 -----------VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 204 (327)
T ss_pred -----------cCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHH
Confidence 36779999998765432211100 0112356788999999875 46899999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccc---------------------ccccc---------ccCCccCCCCCHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGER---------------------RRFYR---------LIDPRLEGHFSIKGAQK 410 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~---------~~~~~~~~~~~~~~~~~ 410 (511)
+|+.||........ ............ ..+.. ..............+..
T Consensus 205 ~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd08227 205 NGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282 (327)
T ss_pred HCCCCCCCcchhHH--HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHH
Confidence 99999975322110 000000000000 00000 00000001112234568
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 411 AAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 411 ~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.+|+.+||+.||++|||+.+|+++
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhcC
Confidence 8999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=322.19 Aligned_cols=252 Identities=29% Similarity=0.497 Sum_probs=201.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 467888999999999999998753 45799999875543 2357889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~--------------- 134 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVG--------------- 134 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEc---------------
Confidence 999999999999999999766667899999999999999999999988 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~ 367 (511)
.+..+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 135 ----------~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 135 ----------ENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred ----------CCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 4678999999999865432211 1112335678999999998899999999999999999998 999996
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
..... .+..... .. .....+. ..+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 204 ~~~~~---~~~~~~~----~~---~~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 204 NRSNS---EVVETIN----AG---FRLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred cCCHH---HHHHHHh----CC---CCCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 53221 1111110 00 0111111 12467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.99 Aligned_cols=253 Identities=28% Similarity=0.405 Sum_probs=200.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence 3568889999999999999998753 34699998875432 3467889999999999999999999875 5
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+.+|+|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~------------- 136 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVG------------- 136 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEc-------------
Confidence 5689999999999999999653 345789999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
+++.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 137 ------------~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p 203 (260)
T cd05069 137 ------------DNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred ------------CCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 4778999999999865433221 1122346778999999988899999999999999999999 8999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
|....... ........ .....+...+..+.+|+.+||..||.+||++.+|++.|+.
T Consensus 204 ~~~~~~~~---~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 204 YPGMVNRE---VLEQVERG--------------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCHHH---HHHHHHcC--------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 97543211 11111100 0011122335778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.52 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=204.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|+..+.||.|+||.||.++... ++..|++|.+..... .....+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 58889999999999999998765 577999999875532 3345688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++|||||++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~------------- 135 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLT------------- 135 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEe-------------
Confidence 9999999999999999999764 456899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
++..+||+|||++........ ......|++.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 136 ------------~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08221 136 ------------KAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF 201 (256)
T ss_pred ------------CCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCC
Confidence 467899999999987644332 123456899999999998888999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
....... .. ..... ..+. ......+..+.+++.+||..+|.+||++.++++++
T Consensus 202 ~~~~~~~---~~---~~~~~----------~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 202 DATNPLN---LV---VKIVQ----------GNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCHHH---HH---HHHHc----------CCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 6543211 11 00000 0000 01123356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=328.80 Aligned_cols=264 Identities=25% Similarity=0.319 Sum_probs=199.0
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||+|+||.||+|++.. +|..||+|.+...... ....+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 47888999999999999999876 6779999999754321 224577899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++||||+. ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~-------------- 133 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLIN-------------- 133 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEc--------------
Confidence 99999999996 5888888665567999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++........ .....++..|+|||++.+. .++.++|||||||++|||++|..||
T Consensus 134 -----------~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 134 -----------KNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred -----------CCCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 4678999999999865433221 2234678999999988764 4789999999999999999999887
Q ss_pred CCCCCCCchhHHHhhhhhhcc--c---cccccccC----CccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGE--R---RRFYRLID----PRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~----~~~~~-----~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
....... ..+ ......... . .......+ +.... ......+..+.+|+.+||+.||.+|||+.++
T Consensus 201 ~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 201 FPGNDVD-DQL-KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred cCCCCHH-HHH-HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 5432211 111 000000000 0 00000000 00000 0111235778899999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+.+
T Consensus 279 l~h 281 (284)
T cd07839 279 LQH 281 (284)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=324.60 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=203.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.+.||.|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++|+||+++++++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 368888999999999999999865 57799999997654 22335678999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++|+||+++++|.+++... .+++..+..++.|++.||.|||+++ |+|+||+|+||+++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~-------------- 132 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLS-------------- 132 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEC--------------
Confidence 9999999999999999998654 7899999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
+++.++|+|||+++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 133 -----------~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 133 -----------EEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred -----------CCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 477899999999987654321 1233568899999999998889999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
....... ..... ....+.+... ..+..+.+++.+||..||++||++.+++++
T Consensus 200 ~~~~~~~---~~~~~----------~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 200 DLHPMRV---LFLIP----------KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cCchHHH---HHHhh----------hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 5432111 00000 0001111111 135678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.46 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=204.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.+|++.+.||.|+||.||+|.+.. +++.||||.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 468999999999999999998765 67799999997665555667889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++++|..++.. ..+++..+..++.|++.||.|||+++ |+|+||||+||+++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~--------------- 149 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLG--------------- 149 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC---------------
Confidence 99999999999999998854 35899999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
+++.+||+|||++......... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 150 ----------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 150 ----------MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred ----------CCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4778999999998865443221 2234689999999999888899999999999999999999999976
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
....... ..... .. .+ ....+...+..+.+||.+||..||.+||++.+|+.+
T Consensus 218 ~~~~~~~--~~~~~---~~--------~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 218 ENPLRAL--YLIAT---NG--------TP--ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCHHHHH--HHHHh---cC--------Cc--ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 4331110 00000 00 00 001112234678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=328.21 Aligned_cols=263 Identities=29% Similarity=0.381 Sum_probs=203.7
Q ss_pred cChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCc
Q 010432 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNL 197 (511)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nI 197 (511)
+.++.+....++|++.+.||+|+||.||+|.+.. +++.||+|++.... .....+.+|+.+++++ +|+||
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i 77 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNV 77 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCe
Confidence 3445556677899999999999999999998865 57799999886532 2235678899999999 79999
Q ss_pred ceEeeEEE-----eCCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 198 VKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 198 v~l~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
+++++++. .++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~n 154 (286)
T cd06638 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNN 154 (286)
T ss_pred eeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHh
Confidence 99999884 34578999999999999998753 2346888999999999999999999988 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCC
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLT 344 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~ 344 (511)
|+++ +++.+||+|||+++........ .....|++.|+|||++. +..++
T Consensus 155 ili~-------------------------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~ 207 (286)
T cd06638 155 ILLT-------------------------TEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYD 207 (286)
T ss_pred EEEC-------------------------CCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhcccccc
Confidence 9998 4677999999999865432211 22346899999999875 34578
Q ss_pred ccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCC
Q 010432 345 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 345 ~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
.++|||||||++|||++|+.||....... .+... . ....+.+ ..+...+..+.+||.+||+.||+
T Consensus 208 ~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~~-----~------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~ 272 (286)
T cd06638 208 ARCDVWSLGITAIELGDGDPPLADLHPMR--ALFKI-----P------RNPPPTL--HQPELWSNEFNDFIRKCLTKDYE 272 (286)
T ss_pred chhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhhc-----c------ccCCCcc--cCCCCcCHHHHHHHHHHccCCcc
Confidence 89999999999999999999997543211 00000 0 0000000 01112245789999999999999
Q ss_pred CCCCHHHHHHHh
Q 010432 425 ARPLMSEVVEAL 436 (511)
Q Consensus 425 ~RPs~~eil~~L 436 (511)
+||++.+|++++
T Consensus 273 ~Rps~~ell~~~ 284 (286)
T cd06638 273 KRPTVSDLLQHV 284 (286)
T ss_pred cCCCHHHHhhcc
Confidence 999999999865
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.50 Aligned_cols=260 Identities=30% Similarity=0.464 Sum_probs=199.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
+.||+|+||.||+|++..... ....+..||||.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 368999999999998864221 012346899998865432 2345788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 214 YEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~--------- 145 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYD--------- 145 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCC---------
Confidence 9999999999999642 234788999999999999999999988 9999999999999842100
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
....+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 146 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~ 214 (269)
T cd05044 146 -----------ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214 (269)
T ss_pred -----------CCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCC
Confidence 123799999999986544322222223346788999999999999999999999999999998 99999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
...... ....... .. .....+...+..+.+||.+||..+|.+||++.+|++.|+
T Consensus 215 ~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 215 PALNNQ---EVLQHVT----AG----------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccCHH---HHHHHHh----cC----------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 643221 1111110 00 011112234578899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=326.41 Aligned_cols=254 Identities=31% Similarity=0.506 Sum_probs=200.7
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHH--HHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~--~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
|++.+.||+|+||+||+++... +++.||+|++......... ...+|+.++++++|+||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 5678899999999999999876 6779999999877543322 2456999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+.+++|.+++. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~--------------- 132 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLD--------------- 132 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEES---------------
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccc---------------
Confidence 9999999999999999997 3346899999999999999999999998 99999999999999
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.++|+|||++....... .......+|..|+|||++. +..++.++||||||+++|+|++|..||.
T Consensus 133 ----------~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~ 200 (260)
T PF00069_consen 133 ----------ENGEVKLIDFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE 200 (260)
T ss_dssp ----------TTSEEEESSGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred ----------cccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 47789999999998642111 1233467899999999988 7889999999999999999999999998
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
........... ........ .... . ........+.+|+.+||+.||++||++.+++++
T Consensus 201 ~~~~~~~~~~~---~~~~~~~~--~~~~----~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 201 ESNSDDQLEII---EKILKRPL--PSSS----Q--QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSSHHHHHHHH---HHHHHTHH--HHHT----T--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhhhhhh---hhcccccc--cccc----c--ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 55111111111 11000000 0000 0 000013789999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=329.76 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=190.4
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe--CCeEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLL 212 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~l 212 (511)
.+||+|+||.||+|++.... ++..||+|.+..... ...+.+|+.+|++++||||+++++++.. +...++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~-------~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK-------DEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecCCC-------ccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 57999999999999875421 467899999975532 2457899999999999999999998854 567899
Q ss_pred EEEccCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 213 VYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
||||+. ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+.....
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~------- 146 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP------- 146 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCC-------
Confidence 999995 5888877421 235788899999999999999999998 999999999999953211
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg 362 (511)
.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 147 --------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg 212 (317)
T cd07867 147 --------------ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred --------------CCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC
Confidence 3568999999999876443221 11233578999999999876 4589999999999999999999
Q ss_pred CCCCCCCCCCCc-------hhHHHhhhhh----------hccccccccccC---------Ccc---CCCCCHHHHHHHHH
Q 010432 363 RRSMDKNRPNGE-------HNLVEWARPH----------LGERRRFYRLID---------PRL---EGHFSIKGAQKAAQ 413 (511)
Q Consensus 363 ~~pf~~~~~~~~-------~~~~~~~~~~----------~~~~~~~~~~~~---------~~~---~~~~~~~~~~~~~~ 413 (511)
++||........ ..+....... ......+..... ..+ ...........+.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (317)
T cd07867 213 EPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292 (317)
T ss_pred CCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHH
Confidence 999975432211 0000000000 000000000000 000 00001112356889
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 010432 414 LAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 414 Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|+.+||+.||.+|||+.|++++
T Consensus 293 ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 293 LLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhccCcccccCHHHHhcC
Confidence 9999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=319.39 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=193.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCc-cCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
+.||+|+||.||+|.+...+.... .......|++|.+...... ...+.+|+.+|++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999999876331100 0112346888887755433 5678899999999999999999999988 778999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.....
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~--------------- 140 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLN--------------- 140 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccc---------------
Confidence 9999999999999765557899999999999999999999988 9999999999999842210
Q ss_pred cccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC--CCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 370 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DIwSlGvil~ellt-g~~pf~~~~ 370 (511)
......+||+|||++...... ....++..|+|||++.+. .++.++|||||||++|||++ |..||....
T Consensus 141 ---~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 141 ---EGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ---cCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 001226999999999875441 123567889999998876 78999999999999999999 577776543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
...... +.. ... ... ......+.+|+.+||..+|.+||++.+|++.|+
T Consensus 212 ~~~~~~---~~~----~~~--------~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 212 SSEKER---FYQ----DQH--------RLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred chhHHH---HHh----cCC--------CCC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 211100 000 000 000 001267889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=324.82 Aligned_cols=260 Identities=26% Similarity=0.391 Sum_probs=205.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++++.||+|+||+||++.+.. ++..||+|++..... ...+.+.+|+++++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 3568888999999999999998865 577999999875432 234678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+..++||||+++++|.+++... ..+++..+..++.+++.||.|||+ ++ |+||||||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~------------ 138 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVN------------ 138 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEEC------------
Confidence 99999999999999999988553 468999999999999999999997 46 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.++|+|||++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 139 -------------~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p 201 (284)
T cd06620 139 -------------SRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201 (284)
T ss_pred -------------CCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCC
Confidence 47789999999987543221 1235789999999999888999999999999999999999999
Q ss_pred CCCCCCCCc-----hhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGE-----HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|........ ..+.......... ..+.+ .....+..+.+|+.+||+.||++||++.+++++..-+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 202 FAFSNIDDDGQDDPMGILDLLQQIVQE-------PPPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred CcccchhhhhhhhhhHHHHHHHHHhhc-------cCCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 975433211 1111111111100 00111 1112456789999999999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.57 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=200.9
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
+|++.+.||+|+||.||++.+.. +++.||+|.+..... ...+.+.+|+.++++++|+||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 48889999999999999999865 567899999975433 223467889999999999999999998764
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+...++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+|+||||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~------------ 136 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLT------------ 136 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEe------------
Confidence 44688999999999999998753 346899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.++|+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 137 -------------~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 201 (257)
T cd08223 137 -------------RTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201 (257)
T ss_pred -------------cCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 477899999999986543221 12345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|...... . ........ . ....+...+..+.+|+.+||+.||.+||++.+++++
T Consensus 202 ~~~~~~~---~---~~~~~~~~----------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 202 FNAKDMN---S---LVYRIIEG----------K-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCHH---H---HHHHHHhc----------C-CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 9743211 1 11110000 0 011222345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=322.85 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=204.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
..|+.++.||.|+||.||+|.+.. ++..||||++..... .....+.+|+.++++++|+||+++++++.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 357788899999999999998865 577999999875532 2345688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~-------------- 135 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLS-------------- 135 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEc--------------
Confidence 999999999999999998854 36888999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.++|+|||++........ ......++..|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 136 -----------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 136 -----------EQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred -----------CCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 467799999999976544321 1223468899999999988889999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
......... .+............+..+.+|+.+||+.+|++||++.+++.+-
T Consensus 203 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 203 DMHPMRVLF-----------------LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CcChHhHhh-----------------hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 543221100 0011111223345677899999999999999999999998864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=323.52 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=204.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++++.||+|+||.||+|+.+.... ......||+|.+...... ....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 578899999999999999999864321 224568999998765433 345789999999999999999999999988
Q ss_pred CeEEEEEEccCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~------ 151 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVS------ 151 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEe------
Confidence 89999999999999999996433 15899999999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|
T Consensus 152 -------------------~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l 211 (275)
T cd05046 152 -------------------SQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211 (275)
T ss_pred -------------------CCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHH
Confidence 4678999999998754332211 12234567889999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 360 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 360 lt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
++ |..||....... ...... .. .+........+..+.+++.+||+.||.+||++.+++..|.
T Consensus 212 ~~~~~~p~~~~~~~~---~~~~~~----~~---------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 212 FTQGELPFYGLSDEE---VLNRLQ----AG---------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HhCCCCCccccchHH---HHHHHH----cC---------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 99 788886432211 111110 00 0000111123567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.53 Aligned_cols=259 Identities=27% Similarity=0.359 Sum_probs=201.8
Q ss_pred hHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcce
Q 010432 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVK 199 (511)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~ 199 (511)
..++....+.|++.+.||.|+||.||+|++.. +++.||+|++..... ....+..|+.++.++ +|+||++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~ 77 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIAT 77 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEE
Confidence 34444566789999999999999999999865 577999999865432 235678899999998 7999999
Q ss_pred EeeEEEe------CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 200 LIGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 200 l~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
+++++.. .+..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili 154 (282)
T cd06636 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLL 154 (282)
T ss_pred EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 9999853 46789999999999999988653 345888889999999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccc
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRS 347 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~ 347 (511)
+ +++.++|+|||++........ ......|+..|+|||++. ...++.++
T Consensus 155 ~-------------------------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~ 207 (282)
T cd06636 155 T-------------------------ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRS 207 (282)
T ss_pred C-------------------------CCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCccc
Confidence 8 477799999999876533211 122356899999999886 35688899
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 348 DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
|||||||++|||++|..||.......... . . ..... ........+..+.+||.+||+.||.+||
T Consensus 208 DvwslG~~l~el~~g~~p~~~~~~~~~~~--~-----~------~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (282)
T cd06636 208 DIWSLGITAIEMAEGAPPLCDMHPMRALF--L-----I------PRNPP---PKLKSKKWSKKFIDFIEGCLVKNYLSRP 271 (282)
T ss_pred chhHHHHHHHHHHhCCCCccccCHHhhhh--h-----H------hhCCC---CCCcccccCHHHHHHHHHHhCCChhhCc
Confidence 99999999999999999996543211100 0 0 00000 0111122456899999999999999999
Q ss_pred CHHHHHHH
Q 010432 428 LMSEVVEA 435 (511)
Q Consensus 428 s~~eil~~ 435 (511)
++.+|+++
T Consensus 272 ~~~ell~~ 279 (282)
T cd06636 272 STEQLLKH 279 (282)
T ss_pred CHHHHhcC
Confidence 99999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=338.33 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=210.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
....|.++..||+|.|++|.+|++.. ++..||||++.+..... ...+.+|+++|+.|+|||||+++.+.
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34679999999999999999999876 78899999998775443 24588999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.....+|+||||+.+|.++++|.+.+ .+.+..+..++.|+++|++|||+++ |||||||++||||+
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~----------- 189 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLD----------- 189 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccc-----------
Confidence 99999999999999999999997665 4555889999999999999999999 99999999999999
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~ 363 (511)
.+..+||+|||++..+.... ...+.+|++.|.|||++.+..| ++++|+||+|++||-|+.|.
T Consensus 190 --------------~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~Gs 252 (596)
T KOG0586|consen 190 --------------ENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGS 252 (596)
T ss_pred --------------cccceeeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecc
Confidence 57889999999999876433 3456899999999999998887 57999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
.||++..-..... +.+...++- +.-.+.++.+||+++|..+|.+|+++++|..+-+
T Consensus 253 LPFDG~~lk~Lr~----------------rvl~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 253 LPFDGQNLKELRP----------------RVLRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred cccCCcccccccc----------------hheeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 9998754322110 001111111 1112467889999999999999999999987543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=321.56 Aligned_cols=254 Identities=28% Similarity=0.389 Sum_probs=189.6
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~ 214 (511)
.||+|+||.||+|..... .....+|+|.+...... ....+.+|+.+++.++|+||+++++++......++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 589999999999976432 13457899988654322 2346889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 215 EFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 215 E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
||+++|+|.+++.... ...++...+.++.||+.||+|||+++ |+||||||+|||++
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~----------------- 134 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLT----------------- 134 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEec-----------------
Confidence 9999999999996532 23467788899999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-------CCCCccccchhHHHHHHHHHh-C
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-G 362 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DIwSlGvil~ellt-g 362 (511)
++..+||+|||++................++..|+|||++.. ..++.++|||||||++|||++ |
T Consensus 135 --------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (269)
T cd05042 135 --------ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA 206 (269)
T ss_pred --------CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC
Confidence 477899999999976433222211223456778999998742 356889999999999999999 7
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
..||....... .+... ... ....+..+. .....+..+.+++..|| .||++||++.+|++.|.
T Consensus 207 ~~p~~~~~~~~--~~~~~----~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 207 DQPYPDLSDEQ--VLKQV----VRE--QDIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCCcCCHHH--HHHHH----hhc--cCccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 78886442211 01000 000 001111111 12233567788999999 59999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=320.06 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=196.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.+|+..+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 368899999999999999998765 6779999998654321 12457889999999999999999998
Q ss_pred EEe--CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 204 CIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 204 ~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+.. ....+++|||+++++|.+++... ..+++...+.++.|++.||.|||+++ |+||||||+||+++
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~-------- 140 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRD-------- 140 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEC--------
Confidence 875 36778999999999999998654 35889999999999999999999988 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.+..+||+|||+++........ .......|+..|+|||++.+..++.++|||||||++|||+
T Consensus 141 -----------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 141 -----------------SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred -----------------CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 4678999999999865331111 1112345889999999999888999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|+.||....... .. .. .........++......+.+|+ +||..+|++||++.+|+++
T Consensus 204 ~g~~pf~~~~~~~--~~----~~----------~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 204 TEKPPWAEYEAMA--AI----FK----------IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HCCCCccccchHH--HH----HH----------HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 9999997532110 00 00 0000011222333456677888 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.34 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.|+..+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.++++++|+||+++++++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 35566789999999999998765 577999999875432 22346889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+|+||+|+||+++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~--------------- 135 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLS--------------- 135 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEe---------------
Confidence 99999999999999998853 46889999999999999999999988 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
+++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 136 ----------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 136 ----------EQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred ----------CCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 467899999999986544221 12234688999999999988999999999999999999999999864
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
....... .. +............+..+.+|+.+||+.+|++||++.+|+++
T Consensus 204 ~~~~~~~---~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 204 LHPMRVL---FL--------------IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cchhhHH---hh--------------hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4321110 00 00001111222345678999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=317.20 Aligned_cols=255 Identities=33% Similarity=0.500 Sum_probs=202.8
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCe
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
|++.+.||.|+||.||+|.+...+. ..+..||+|.+...... ....+.+|+.++..++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 4567899999999999999875321 13478999999766443 44678899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
.+++|||+++++|.+++...... +++..+..++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~--------------- 137 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVG--------------- 137 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEc---------------
Confidence 99999999999999999754433 899999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~ 367 (511)
+++.++|+|||+++.......... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 138 ----------~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 138 ----------ENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred ----------cCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999987655422211 12337889999999988889999999999999999998 788886
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
.... ..+..... ... ....+...+..+.+++.+||..||.+|||+.++++.|
T Consensus 207 ~~~~---~~~~~~~~----~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 207 GMSN---EEVLEYLK----KGY----------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCH---HHHHHHHh----cCC----------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 5321 11111111 000 0011112357789999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=323.18 Aligned_cols=267 Identities=28% Similarity=0.351 Sum_probs=201.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|+++. +++.||+|++..... ...+.+.+|+.++++++|+||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 468899999999999999999865 577999999865432 223557899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
....++||||+++++|..++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~------------- 134 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILIT------------- 134 (286)
T ss_pred CCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEc-------------
Confidence 999999999999888877764 3446899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||++......... .....++..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 135 ------------~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p 200 (286)
T cd07847 135 ------------KQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL 200 (286)
T ss_pred ------------CCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 4678999999999876543321 223457889999999876 5688999999999999999999999
Q ss_pred CCCCCCCCchhHHHhh-hhhhcc------ccccc-cccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 366 MDKNRPNGEHNLVEWA-RPHLGE------RRRFY-RLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~-~~~~~~------~~~~~-~~~~~~~~~~~~-----~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|.+............. ...... ...+. ....+......+ ...+..+.+|+.+||+.||++||++.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 280 (286)
T cd07847 201 WPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280 (286)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence 9765432211111100 000000 00000 000000000000 1225678899999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+.+
T Consensus 281 l~~ 283 (286)
T cd07847 281 LEH 283 (286)
T ss_pred hcC
Confidence 864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=320.62 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=201.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 45689999999999999999997643 44699998875432 33578899999999999999999999877
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
...+++|||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~------------ 136 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS------------ 136 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEc------------
Confidence 7789999999999999999653 345788899999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||++......... ......++..|+|||++....++.++|||||||++|+|++ |..
T Consensus 137 -------------~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~ 202 (260)
T cd05073 137 -------------ASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 202 (260)
T ss_pred -------------CCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCC
Confidence 4778999999999865433221 1222346678999999988889999999999999999999 899
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
||...... .+...... . .........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 203 p~~~~~~~---~~~~~~~~----~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 203 PYPGMSNP---EVIRALER----G----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCHH---HHHHHHhC----C----------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99754221 11111110 0 0001112235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=321.61 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=199.7
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
|.+.++||+|+||.||+|.+.... .++..||||++..... ...+++.+|+.+|++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567789999999999999876432 2578999999976532 22456889999999999999999999886532
Q ss_pred ------eEEEEEEccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 209 ------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 209 ------~~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
..++++||+.+|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~---- 147 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLN---- 147 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEc----
Confidence 247899999999999887422 234788899999999999999999988 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ 357 (511)
.+..+||+|||+++...............+++.|++||.+....++.++|||||||++|
T Consensus 148 ---------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~ 206 (273)
T cd05074 148 ---------------------ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206 (273)
T ss_pred ---------------------CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHH
Confidence 47789999999998765433222222345678899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 358 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 358 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||++ |+.||...... .+..+... ... ...+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 207 el~~~g~~p~~~~~~~---~~~~~~~~----~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 207 EIMTRGQTPYAGVENS---EIYNYLIK----GNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred HHhhCCCCCCCCCCHH---HHHHHHHc----CCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 88888644221 11111110 000 001112346889999999999999999999999999
Q ss_pred cCC
Q 010432 437 KPL 439 (511)
Q Consensus 437 ~~l 439 (511)
+.+
T Consensus 270 ~~~ 272 (273)
T cd05074 270 ELI 272 (273)
T ss_pred Hhh
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=317.60 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=203.0
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|+.+|++++|+||+++++.+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 57888999999999999998865 5779999999765322 235688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~------------ 136 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDK------------ 136 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC------------
Confidence 9999999999999999999754 345899999999999999999999998 999999999999974
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
++..+||+|||++........ .....|+..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 137 ------------~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 201 (256)
T cd08220 137 ------------HKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201 (256)
T ss_pred ------------CCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 345689999999987654322 12356899999999999888999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
....... ...... .. ....++...+..+.+|+.+||+.||++|||+.+++++
T Consensus 202 ~~~~~~~---~~~~~~---~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 202 EAANLPA---LVLKIM---SG-----------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCchHH---HHHHHH---hc-----------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 6543211 111100 00 0001112235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.10 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=189.3
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~ 214 (511)
.||+|+||.||+|+..... ....+++|.+..... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 5999999999999764321 234577887765432 33467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccc
Q 010432 215 EFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291 (511)
Q Consensus 215 E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~ 291 (511)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~------------------ 133 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLT------------------ 133 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEc------------------
Confidence 9999999999996532 34567778899999999999999988 99999999999998
Q ss_pred cccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-------CCCCccccchhHHHHHHHHHh-CC
Q 010432 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GR 363 (511)
Q Consensus 292 ~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DIwSlGvil~ellt-g~ 363 (511)
.++.+||+|||++................|+..|+|||++.. ..++.++|||||||++|||++ |.
T Consensus 134 -------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~ 206 (268)
T cd05086 134 -------SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206 (268)
T ss_pred -------CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCC
Confidence 477899999999865332221112233568899999998753 245789999999999999997 46
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
.||...... ...... ... ......++.+... ....+.+|+..|| .+|++||++.+|++.|.
T Consensus 207 ~p~~~~~~~---~~~~~~---~~~--~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 207 QPYSHLSDR---EVLNHV---IKD--QQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCHH---HHHHHH---Hhh--cccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 677543221 111111 100 1111222222222 3467888999999 68999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=319.14 Aligned_cols=256 Identities=22% Similarity=0.375 Sum_probs=203.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
+|+..+.||+|+||.||+|.... ++..||+|++...... ....+.+|+.++++++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 47888999999999999998755 6779999999754321 23568899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~--------- 138 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDS--------- 138 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC---------
Confidence 99999999999999999999998653 46889999999999999999999998 999999999999974
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
+...+||+|||++......... .......||..|+|||++.+..++.++|||||||++|+|++
T Consensus 139 ---------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 139 ---------------TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred ---------------CCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh
Confidence 2346999999999876442111 11223568999999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|..||............. ..........++...+..+.+++.+||..+|.+||++.+++++
T Consensus 204 g~~p~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 204 AKPPWNAEKHSNHLALIF-------------KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCCCCCCcchHHHHH-------------HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 999996443221111110 0000011222334456789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=324.08 Aligned_cols=265 Identities=25% Similarity=0.351 Sum_probs=198.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.+.||+|+||.||+|..+. +++.||||.+...... ....+.+|+.++++++|+||+++++++..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 578999999999999999998765 5779999998754322 224567899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+. ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~-------------- 137 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLIS-------------- 137 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEc--------------
Confidence 99999999996 5999998766667899999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 138 -----------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~ 204 (291)
T cd07844 138 -----------ERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204 (291)
T ss_pred -----------CCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4678999999998764322111 122356889999998875 56899999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhcc--cccc---------c----cccC-CccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 367 DKNRPNGEHNLVEWARPHLGE--RRRF---------Y----RLID-PRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~--~~~~---------~----~~~~-~~~~~~~-~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
....... ..+. .....+.. ...+ . .... ..+.... .......+.+++.+||+.||.+||++
T Consensus 205 ~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~ 282 (291)
T cd07844 205 PGSTDVE-DQLH-KIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA 282 (291)
T ss_pred CCCccHH-HHHH-HHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH
Confidence 6543111 0000 00000000 0000 0 0000 0000000 00012677899999999999999999
Q ss_pred HHHHHH
Q 010432 430 SEVVEA 435 (511)
Q Consensus 430 ~eil~~ 435 (511)
.+++++
T Consensus 283 ~e~l~~ 288 (291)
T cd07844 283 AEAMKH 288 (291)
T ss_pred HHHhcC
Confidence 999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=323.29 Aligned_cols=264 Identities=26% Similarity=0.342 Sum_probs=203.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.++++++|+||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 57888999999999999999865 577999999976542 2235788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~-------------- 133 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLIS-------------- 133 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEc--------------
Confidence 9999999999 99999998766667999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.++|+|||++......... ......|+..|+|||++.+. .++.++|||||||++|||++|.++|
T Consensus 134 -----------~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 134 -----------ADGVLKIADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred -----------CCCcEEEeeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 4677999999999876543321 12235689999999988654 5689999999999999999998888
Q ss_pred CCCCCCCchhHHHhhhhhhc-----------cccccccccCCccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLG-----------ERRRFYRLIDPRLE----GHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~----~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
....... ........+. .......+..+... .....+.+..+.+|+.+||+.||.+||++.+
T Consensus 202 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 278 (286)
T cd07832 202 PGENDIE---QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278 (286)
T ss_pred CCCCHHH---HHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence 6543211 1111111000 00000000000000 0001123478899999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
++++
T Consensus 279 ~l~h 282 (286)
T cd07832 279 ALRH 282 (286)
T ss_pred HhhC
Confidence 9975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=320.77 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=200.0
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc----------cHHHHHHHHHHHhCCCCCCcce
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----------~~~~~~~E~~il~~l~H~nIv~ 199 (511)
+|.+.+.||.|+||.||+|.... +++.||||.++..... ..+.+.+|+.+++.++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 57788899999999999998765 5779999988642110 1135678999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
+++++...+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~------ 142 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVD------ 142 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEc------
Confidence 999999999999999999999999998654 47899999999999999999999988 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC--CCccccchhHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLL 357 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DIwSlGvil~ 357 (511)
.++.++|+|||+++...............|+..|+|||++.... ++.++||||||+++|
T Consensus 143 -------------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~ 203 (272)
T cd06629 143 -------------------ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVL 203 (272)
T ss_pred -------------------CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHH
Confidence 47789999999998654322221223356899999999987654 889999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||++|..||....... .+... . . ......+........+..+.+|+.+||..+|.+||++.+|+++
T Consensus 204 ~l~~g~~p~~~~~~~~--~~~~~----~-~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 204 EMFAGRRPWSDEEAIA--AMFKL----G-N-----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHhCCCCCcCcchHH--HHHHh----h-c-----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 9999999996432110 00000 0 0 0000111111222335789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=318.78 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=198.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.+|++.++||+|+||.||+|.+.. ++..||||.+..... .....+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 478899999999999999998865 678999999864321 112467889999999999999999998
Q ss_pred EEeC--CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 204 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+.+. ..+++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+|||++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~-------- 140 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRD-------- 140 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEec--------
Confidence 8763 4678999999999999998654 45788889999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.++.++|+|||+++........ .......|+..|+|||++.+..++.++|||||||++|||+
T Consensus 141 -----------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 203 (265)
T cd06652 141 -----------------SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203 (265)
T ss_pred -----------------CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence 4778999999999865332111 0122346899999999998888999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|+.||...... ... .. ..........+...+..+.+++.+||. +|++||++++|+++
T Consensus 204 ~g~~p~~~~~~~-----~~~-~~----------~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 204 TEKPPWAEFEAM-----AAI-FK----------IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hCCCCCCccchH-----HHH-HH----------HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 999999643211 000 00 000001122334456778899999994 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=324.53 Aligned_cols=268 Identities=27% Similarity=0.361 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|.+.. +++.||||+++.... .....+.+|++++++++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 368899999999999999998875 577999999875432 223578899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..++||||++++.|..++ .....+++..+..++.||+.||.|||.++ |+|+||+|+||+++
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~------------- 134 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVS------------- 134 (288)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC-------------
Confidence 99999999999876665554 44456899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||++......... ......|+..|+|||++.+. .++.++||||||+++|+|++|+.|
T Consensus 135 ------------~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 201 (288)
T cd07833 135 ------------ESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL 201 (288)
T ss_pred ------------CCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 4778999999999876554321 12335688999999999887 889999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhcc--------ccccc--cccCCc----cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGE--------RRRFY--RLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~----~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
|..................... ...+. +..... +...++...+..+.+||.+||..+|++||++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 281 (288)
T cd07833 202 FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281 (288)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence 9754322111000000000000 00000 000000 000112223678999999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
|+.+
T Consensus 282 il~~ 285 (288)
T cd07833 282 LLQH 285 (288)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=317.98 Aligned_cols=246 Identities=30% Similarity=0.482 Sum_probs=197.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++.+.||+|+||.||++.. ++..||+|.++... ....+.+|+.++++++|+||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5688999999999999999864 46689999987543 235788999999999999999999998654
Q ss_pred eEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~-------------- 134 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVS-------------- 134 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEc--------------
Confidence 4799999999999999997543 35889999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
.++.+||+|||++....... .....+..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 135 -----------~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 198 (254)
T cd05083 135 -----------EDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198 (254)
T ss_pred -----------CCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 46789999999997643321 12234678999999988899999999999999999998 99999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
....... ...... .. .........+..+.+|+.+||+.+|++||++.+|++.|+.
T Consensus 199 ~~~~~~~---~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 199 PKMSLKE---VKECVE----KG----------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ccCCHHH---HHHHHh----CC----------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7543211 111110 00 0111112235778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=358.32 Aligned_cols=255 Identities=29% Similarity=0.415 Sum_probs=194.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.-..+|+.+++||+||||.||+++.+- .|+.||||+|..... .....+.+|+.+|++|+|||||+||..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 345689999999999999999999987 577999999987642 2234578999999999999999999877
Q ss_pred EeCC----------------------------------------------------------------------------
Q 010432 205 IEDD---------------------------------------------------------------------------- 208 (511)
Q Consensus 205 ~~~~---------------------------------------------------------------------------- 208 (511)
.+..
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 5321
Q ss_pred -------------------------------------------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 010432 209 -------------------------------------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245 (511)
Q Consensus 209 -------------------------------------------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi 245 (511)
.+||.||||+..+|.+++.++...-.....++++++|
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREI 706 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHH
Confidence 2389999999877777775543222467788999999
Q ss_pred HHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCC----------
Q 010432 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP---------- 315 (511)
Q Consensus 246 ~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~---------- 315 (511)
+.||.|+|++| ||||||||.||+|+ .+..|||+|||+|+...
T Consensus 707 lEGLaYIH~~g---iIHRDLKP~NIFLd-------------------------~~~~VKIGDFGLAt~~~~~~~~~d~~~ 758 (1351)
T KOG1035|consen 707 LEGLAYIHDQG---IIHRDLKPRNIFLD-------------------------SRNSVKIGDFGLATDLKENLESIDQDL 758 (1351)
T ss_pred HHHHHHHHhCc---eeeccCCcceeEEc-------------------------CCCCeeecccccchhhhhhhhhHhhcc
Confidence 99999999999 99999999999999 47789999999998721
Q ss_pred ------CCCcceeeeeccccccccCCcccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhc
Q 010432 316 ------EGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 386 (511)
Q Consensus 316 ------~~~~~~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 386 (511)
.+......+..+||.-|+|||++.+. .|+.|+|+|||||||+||+. ||....+. ...+..
T Consensus 759 ~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--a~iL~~------ 827 (1351)
T KOG1035|consen 759 SFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--ASILTN------ 827 (1351)
T ss_pred CccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH--HHHHHh------
Confidence 01111134567899999999998754 59999999999999999995 56543211 111110
Q ss_pred cccccccccCCccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 387 ERRRFYRLIDPRLE--GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 387 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+-+..++ ..+..+..+.-..+|.+||+.||.+||||.|+|+.
T Consensus 828 -------LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 828 -------LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred -------cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 1111111 22333344566789999999999999999999974
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=323.89 Aligned_cols=266 Identities=24% Similarity=0.327 Sum_probs=199.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
+.+|.+.+.||+|+||.||+|.... ++..||||++....... ...+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 4679999999999999999998865 57799999997553322 2457789999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..++||||+. ++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~------------- 137 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLIS------------- 137 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEc-------------
Confidence 999999999995 7888877665556888889999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++........ .....+++.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 138 ------------~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 203 (291)
T cd07870 138 ------------YLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203 (291)
T ss_pred ------------CCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 4678999999999865432221 223457899999999875 4578899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhc-----------cccccccc-cCCccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLG-----------ERRRFYRL-IDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|........ .+.. ...... ........ ......... ....+..+.+|+.+||+.||.+|||
T Consensus 204 f~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t 281 (291)
T cd07870 204 FPGVSDVFE-QLEK-IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281 (291)
T ss_pred CCCchhHHH-HHHH-HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC
Confidence 975433111 1110 000000 00000000 000000000 0011467889999999999999999
Q ss_pred HHHHHHH
Q 010432 429 MSEVVEA 435 (511)
Q Consensus 429 ~~eil~~ 435 (511)
+.+++.+
T Consensus 282 ~~~~l~h 288 (291)
T cd07870 282 AQDALLH 288 (291)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.87 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.+.||.|+||+||+|.+.. ++..||+|++...... ....+.+|+.+|+.++|+||+++++.+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 478999999999999999998765 5678999999755432 345788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+..++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~------------ 136 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLG------------ 136 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEc------------
Confidence 9999999999999999999653 246899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg 362 (511)
++..++|+|||++.......... ......|+..|+|||++... .++.++|||||||++|||++|
T Consensus 137 -------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g 203 (267)
T cd06610 137 -------------EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203 (267)
T ss_pred -------------CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhC
Confidence 46779999999998765533221 22335689999999998876 789999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.||....... ........ ..+.+.... ....+..+.+|+.+||+.||++||++.+|+++
T Consensus 204 ~~p~~~~~~~~--~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 204 AAPYSKYPPMK--VLMLTLQN-----------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCccccChhh--hHHHHhcC-----------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 99997543321 11111110 001111110 12345778999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=313.95 Aligned_cols=277 Identities=22% Similarity=0.284 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..|+++..||+|.||.||+|...+.+. ...+.+|||.++.... .-.....+|+.+++.|+|+|||.|..+|..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~-----kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTND-----KRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCc-----ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 468899999999999999997654321 1244899999986532 112457899999999999999999999887
Q ss_pred -CCeEEEEEEccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+..++|++||.+. ||.+.|+- ....++...+..|+.||+.|+.|||++. |+||||||.|||+...+.
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgp---- 170 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGP---- 170 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCC----
Confidence 7789999999976 99988852 2346889999999999999999999998 999999999999986432
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccC-CCCccccchhHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~el 359 (511)
+.+.|||+|||+++...+.-... ....++-|.+|+|||++.+. .|+.+.||||.|||+.||
T Consensus 171 -----------------erG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaEl 233 (438)
T KOG0666|consen 171 -----------------ERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAEL 233 (438)
T ss_pred -----------------ccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHH
Confidence 46899999999999876644332 23346779999999999875 689999999999999999
Q ss_pred HhCCCCCCCCCCCCc-------hhHHHhhhhhh-----------ccccccccccC---CccCCCCCH--------HHHHH
Q 010432 360 LTGRRSMDKNRPNGE-------HNLVEWARPHL-----------GERRRFYRLID---PRLEGHFSI--------KGAQK 410 (511)
Q Consensus 360 ltg~~pf~~~~~~~~-------~~~~~~~~~~~-----------~~~~~~~~~~~---~~~~~~~~~--------~~~~~ 410 (511)
+|-.+.|.+...... ..+.. +...+ .........+. ......... .-++.
T Consensus 234 Ltl~PlF~g~E~k~~~~~Pfq~dQl~r-If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~ 312 (438)
T KOG0666|consen 234 LTLEPLFKGREEKIKTKNPFQHDQLDR-IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPS 312 (438)
T ss_pred HccCccccchhhhcccCCCchHHHHHH-HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCch
Confidence 999999976433211 11111 11111 00011100000 000000000 01244
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 411 AAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 411 ~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..+|+.+||.+||.+|.|+.+.+++.
T Consensus 313 a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 313 ALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHHHhccCchhhccHHHHhccc
Confidence 78999999999999999999999865
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.04 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=202.1
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
+|++.+.||.|+||.||+|.+.. ++..||+|++...... ..+.+..|+.++++++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 47888999999999999998865 5779999999765432 23468889999999999999999998764
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeEecccCCCcEEeccccc
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH-----EEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH-----~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
+...+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+ |+|+||||+||+++
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~---- 144 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLD---- 144 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEe----
Confidence 45678999999999999998643 457899999999999999999999 666 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ 357 (511)
+++.+||+|||++......... .....|+..|+|||++.+..++.++||||||+++|
T Consensus 145 ---------------------~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~ 201 (265)
T cd08217 145 ---------------------ANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIY 201 (265)
T ss_pred ---------------------cCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHH
Confidence 4788999999999876543321 22356899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|++|+.||..... ..+..... ......++...+..+.+|+.+||+.+|++||++.+|+++
T Consensus 202 ~l~~g~~p~~~~~~---~~~~~~~~--------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 202 ELCALSPPFTARNQ---LQLASKIK--------------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHCCCcccCcCH---HHHHHHHh--------------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 99999999975431 11111111 000112223345788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=328.05 Aligned_cols=253 Identities=28% Similarity=0.357 Sum_probs=201.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|.... +++.||||.+...... ....+.+|+++++.++|+||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 368889999999999999998865 5779999999865433 2346888999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.....|+||||+.+++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~----------- 137 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLH----------- 137 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEc-----------
Confidence 999999999999999999998653 356899999999999999999999988 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcc---------------------------eeeeeccccccccCCcc
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT---------------------------HVSTRVMGTYGYAAPEY 337 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~---------------------------~~~~~~~Gt~~y~aPE~ 337 (511)
.++.++|+|||++......... .......||..|+|||+
T Consensus 138 --------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 203 (316)
T cd05574 138 --------------ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203 (316)
T ss_pred --------------CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHH
Confidence 4678999999998754322110 01113468999999999
Q ss_pred cccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHH
Q 010432 338 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 417 (511)
Q Consensus 338 ~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~ 417 (511)
+.+..++.++|||||||++|+|++|..||....... .+.. +.............+..+.+|+.+
T Consensus 204 ~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~ 267 (316)
T cd05574 204 ISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE--TFSN--------------ILKKEVTFPGSPPVSSSARDLIRK 267 (316)
T ss_pred HcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH--HHHH--------------HhcCCccCCCccccCHHHHHHHHH
Confidence 998889999999999999999999999997543211 1100 010000000111146789999999
Q ss_pred hcccCCCCCCC----HHHHHH
Q 010432 418 CLSRDPKARPL----MSEVVE 434 (511)
Q Consensus 418 cl~~dP~~RPs----~~eil~ 434 (511)
||+.||++||+ +.++++
T Consensus 268 ~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 268 LLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HccCCHhHCCCchhhHHHHHc
Confidence 99999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.82 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=199.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
+|++.+.||.|+||.||+|... ++..||||.+...... ....+.+|+.+|++++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4788899999999999999753 4678999998754321 12357889999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+...+..++||||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~---------- 136 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLM---------- 136 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEEC----------
Confidence 99999999999999999999999654 46889999999999999999999988 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCC----cceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.++|+|||++....... .........|+..|+|||++.+..++.++|||||||++|+|
T Consensus 137 ---------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 201 (265)
T cd06631 137 ---------------PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201 (265)
T ss_pred ---------------CCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHH
Confidence 47789999999997643211 11112235689999999999988899999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
++|..||........ .... .... ...+ ..+...+..+.++|.+||+.+|.+||++.+++++
T Consensus 202 ~~g~~p~~~~~~~~~--~~~~-----~~~~----~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 202 ATGKPPLASMDRLAA--MFYI-----GAHR----GLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HhCCCccccCChHHH--HHHh-----hhcc----CCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999975322111 0000 0000 0001 1122335778999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=341.29 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=196.7
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCe
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
..+||+|+|-+||+|.+.. +|..||--.++... ....++|..|+.+|+.|+|+|||++|++|.+...
T Consensus 45 ~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred hhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 3579999999999999865 67788865554332 2234679999999999999999999999998665
Q ss_pred --EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 210 --RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 210 --~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+-+|+|++..|+|..|+.+. +.++...+..|++||+.||.|||++. +||||||||.+||+|+.
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG------------- 180 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNG------------- 180 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcC-------------
Confidence 67899999999999999554 57889999999999999999999987 88999999999999986
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
..+.|||+|+|||....... ...++|||.|||||+.. ..|+..+||||||+.|+||+|+..||.
T Consensus 181 -----------~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 181 -----------NLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred -----------CcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 57889999999999865432 23378999999999776 899999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..... .+..+ +......+..+.....+++++||.+||.. ..+|||+.|+|++
T Consensus 245 EC~n~-----AQIYK----------KV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 245 ECTNP-----AQIYK----------KVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhCCH-----HHHHH----------HHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 43221 11111 01111111112222257899999999999 9999999999974
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=326.13 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=199.5
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeE
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
|.....||+|+||.||++.+.. ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 4444679999999999998765 5779999998765544456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~----------------- 152 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLT----------------- 152 (292)
T ss_pred EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEc-----------------
Confidence 999999999999998843 35889999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
+++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 --------~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 153 --------SDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred --------CCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 467899999999976533221 1223568999999999988889999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
... ...... ....+.+.. ....+..+.+++.+||..||.+|||+.+++++
T Consensus 223 ~~~---~~~~~~----------~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 223 PLQ---AMRRIR----------DNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHH---HHHHHH----------hcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 211 010000 011111111 11234678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=325.37 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=200.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||++.+.. +++.||||.+..... .....+.+|+.+++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368889999999999999999875 677999999876532 22346778999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~------------ 135 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLIT------------ 135 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEEC------------
Confidence 999999999999999999999654 46899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCc-------------ceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK-------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~-------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
.++.+||+|||+++....... ........|+..|+|||++.+..++.++|||||
T Consensus 136 -------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (305)
T cd05609 136 -------------SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202 (305)
T ss_pred -------------CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHH
Confidence 477899999999874211100 001112467889999999988899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
||++|||++|..||.+.... .+.... ... ....+... ...+..+.+||.+||+.||++||++.++
T Consensus 203 G~vl~el~~g~~pf~~~~~~---~~~~~~---~~~-----~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 203 GIILYEFLVGCVPFFGDTPE---ELFGQV---ISD-----DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred HHHHHHHHhCCCCCCCCCHH---HHHHHH---Hhc-----ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCH
Confidence 99999999999999754321 111100 000 00001000 1235678999999999999999997666
Q ss_pred HHHhc
Q 010432 433 VEALK 437 (511)
Q Consensus 433 l~~L~ 437 (511)
++.|+
T Consensus 268 ~~ll~ 272 (305)
T cd05609 268 FEVKQ 272 (305)
T ss_pred HHHHh
Confidence 66554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=323.52 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=200.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
+|++.+.||+|+||.||+|.+.. +++.||||.+...... ....+..|+.++++++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 47788899999999999999865 5779999999765433 224567899999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..++||||+ +|+|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~----------- 136 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIA----------- 136 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEc-----------
Confidence 9999999999999 99999999665447899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+++........ .....+++.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 137 --------------~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 137 --------------SDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred --------------CCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 4778999999999876543221 222356889999998864 46789999999999999999998
Q ss_pred CCCCCCCCCCchhHHHhhhhh-------hccccccccccCCccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPH-------LGERRRFYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
++|........ +....... +................ ......+..+.+||.+||+.||++|||+.+
T Consensus 201 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 201 PFLPGDSDIDQ--LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred ccccCCccHHH--HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 88865433211 11110000 00000000000000000 011223578899999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
|+++
T Consensus 279 ~l~~ 282 (298)
T cd07841 279 ALEH 282 (298)
T ss_pred HhhC
Confidence 9984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=317.02 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=202.5
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||+|+||.||+++... +++.||||.+..... ....++.+|+.++++++|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 58888999999999999998865 577999999875432 2335688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~------------- 135 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLT------------- 135 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc-------------
Confidence 9999999999999999998653 345789999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.+..++|+|||++......... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 136 ------------~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08218 136 ------------KDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201 (256)
T ss_pred ------------CCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCc
Confidence 4677999999999865443221 12346889999999998888999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...... . ........ . ....+...+..+.++|.+||+.+|.+||++.+|+++
T Consensus 202 ~~~~~~---~---~~~~~~~~----------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 202 EAGNMK---N---LVLKIIRG----------S-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCCHH---H---HHHHHhcC----------C-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 643211 1 11110000 0 011122335678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=323.32 Aligned_cols=261 Identities=29% Similarity=0.368 Sum_probs=202.6
Q ss_pred ChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcc
Q 010432 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLV 198 (511)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv 198 (511)
.+.++....++|++.+.||+|+||.||+|.... +++.||+|++..... ....+.+|+.++.++ +|+||+
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~ 82 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVV 82 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeE
Confidence 334444567889999999999999999998865 677999999865422 235677899999999 899999
Q ss_pred eEeeEEEeC-----CeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcE
Q 010432 199 KLIGYCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (511)
Q Consensus 199 ~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NI 270 (511)
++++++... ...++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 83 ~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~ni 159 (291)
T cd06639 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNI 159 (291)
T ss_pred EEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHE
Confidence 999998754 358999999999999998853 3456899999999999999999999988 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-----CCCc
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTS 345 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~~ 345 (511)
|++ +++.+||+|||++......... .....|+..|+|||++... .++.
T Consensus 160 li~-------------------------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 212 (291)
T cd06639 160 LLT-------------------------TEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDA 212 (291)
T ss_pred EEc-------------------------CCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCC
Confidence 998 4677999999999875432221 2234689999999987643 3688
Q ss_pred cccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 010432 346 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425 (511)
Q Consensus 346 ~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~ 425 (511)
++|||||||++|||++|+.||...... ..+..+... ..+.+ ..+......+.+||.+||+.||++
T Consensus 213 ~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~~~~~-----------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~ 277 (291)
T cd06639 213 RCDVWSLGITAIELGDGDPPLFDMHPV--KTLFKIPRN-----------PPPTL--LHPEKWCRSFNHFISQCLIKDFEA 277 (291)
T ss_pred ccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHHHhcC-----------CCCCC--CcccccCHHHHHHHHHHhhcChhh
Confidence 999999999999999999999754321 111111000 00000 011223457899999999999999
Q ss_pred CCCHHHHHHH
Q 010432 426 RPLMSEVVEA 435 (511)
Q Consensus 426 RPs~~eil~~ 435 (511)
||++.+|+++
T Consensus 278 Rps~~~il~~ 287 (291)
T cd06639 278 RPSVTHLLEH 287 (291)
T ss_pred CcCHHHHhcC
Confidence 9999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.90 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=194.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHH-HhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF-LGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~i-l~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|.+.. +|..||||+++.... .....+..|+.+ ++.++|+||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 368899999999999999999875 678999999976532 223456667765 566799999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEeccccccccCC
Q 010432 207 DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++..++||||++ |+|.+++.. ....+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~--------- 138 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLIN--------- 138 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEEC---------
Confidence 999999999995 688887753 234689999999999999999999986 7 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc----CCCCccccchhHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||++....... ..+...|+..|+|||++.+ ..++.++|||||||++|+
T Consensus 139 ----------------~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 139 ----------------RNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred ----------------CCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 47789999999998654321 1223468999999998864 457889999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|++|+.||...... ...+... .. ...+.+. ....+..+.+||.+||..+|.+||++.+|+++
T Consensus 200 l~~g~~p~~~~~~~-~~~~~~~----~~-------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 200 LATGRFPYDSWKTP-FQQLKQV----VE-------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhCCCCCCccccC-HHHHHHH----Hh-------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999642211 0111000 00 0000010 11235678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=319.16 Aligned_cols=254 Identities=29% Similarity=0.396 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|+..+.||.|+||.||+|.+.. +++.||+|.+..... .....+.+|++++++++||||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 367788899999999999999865 577999999976543 2345688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++++|.+++......+++..+..++.|++.||+|||+ .+ ++|+||||+||+++
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~------------- 135 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVN------------- 135 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEEC-------------
Confidence 99999999999999999997655678999999999999999999999 88 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.++|+|||++........ ....|+..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 136 ------------~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 199 (265)
T cd06605 136 ------------SRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199 (265)
T ss_pred ------------CCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 467899999999876543221 1156899999999999889999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
........ ............ . ....+. ..+..+.+||.+||..||.+||++.+++.+
T Consensus 200 ~~~~~~~~-~~~~~~~~~~~~-------~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 200 PPENDPPD-GIFELLQYIVNE-------P----PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Cccccccc-cHHHHHHHHhcC-------C----CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 65422111 111111111100 0 011111 146778999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.21 Aligned_cols=267 Identities=25% Similarity=0.348 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||.|+||.||+|.+.. +++.||||.++..... ....+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 478889999999999999999865 5779999999754322 22356789999999999999999999987
Q ss_pred C--CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 207 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 207 ~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
. ...||||||+. ++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+|||++
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~----------- 140 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLN----------- 140 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEEC-----------
Confidence 7 88999999996 5999988765557899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+++........ .....+++.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 141 --------------~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (293)
T cd07843 141 --------------NRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204 (293)
T ss_pred --------------CCCcEEEeecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence 4678999999999876553211 2234578899999988754 4689999999999999999999
Q ss_pred CCCCCCCCCCchhHH-Hhhh-------hhhccc-----cccccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCH
Q 010432 364 RSMDKNRPNGEHNLV-EWAR-------PHLGER-----RRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~-~~~~-------~~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
.||...........+ .... ...... ..........+...++.. .++.+.+||.+||+.||++|||+
T Consensus 205 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~ 284 (293)
T cd07843 205 PLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284 (293)
T ss_pred CCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence 999754332111100 0000 000000 000000001111112221 35678999999999999999999
Q ss_pred HHHHHH
Q 010432 430 SEVVEA 435 (511)
Q Consensus 430 ~eil~~ 435 (511)
.|++++
T Consensus 285 ~ell~~ 290 (293)
T cd07843 285 EDALKH 290 (293)
T ss_pred HHHhcC
Confidence 999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=324.75 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=199.6
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeE
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
|.....||+|+||.||+|.+.. ++..||||.+........+.+.+|+.++..++||||+++++++..++..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 3344579999999999998765 5779999999765545556788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++++|..++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~----------------- 151 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLT----------------- 151 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEc-----------------
Confidence 999999999999987744 35889999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||++......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 --------~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 152 --------LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred --------cCCcEEEeechhHhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4778999999999755432211 223568999999999998899999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
... ........ . .+.. ......+..+.++|.+||+.+|.+||++.+|+++
T Consensus 222 ~~~---~~~~~~~~---~-------~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 222 PVQ---AMKRLRDS---P-------PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHH---HHHHHhcc---C-------CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 211 11111000 0 0000 0011224678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.78 Aligned_cols=246 Identities=28% Similarity=0.392 Sum_probs=201.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||++.+.. +++.||+|++..... .....+.+|+++|++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 368899999999999999999875 577999999975432 22356889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+|||++
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~------------ 135 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLD------------ 135 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEC------------
Confidence 999999999999999999998654 57899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 136 -------------~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 197 (290)
T cd05580 136 -------------SDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197 (290)
T ss_pred -------------CCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 4778999999999876543 2235689999999999888899999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
|...... ...... ... ...++...+..+.+++.+||..||.+|+ ++.+++++
T Consensus 198 ~~~~~~~---~~~~~~---~~~------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 198 FFDDNPI---QIYEKI---LEG------------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCCCCHH---HHHHHH---hcC------------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 9754311 111000 000 0011122357789999999999999999 66666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=358.12 Aligned_cols=258 Identities=24% Similarity=0.294 Sum_probs=211.5
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcc
Q 010432 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLV 198 (511)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv 198 (511)
.++....++|+++++||+|+||.|.+++++. |++.||+|++++... ....-|..|-.||..-+.+.||
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence 4455667899999999999999999999986 788999999987422 2224588899999999999999
Q ss_pred eEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
+|+..|+++.++||||||++||||..++.+-. .+++..++.|+..|+.||.-||+.| +|||||||+|||||
T Consensus 139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld----- 209 (1317)
T KOG0612|consen 139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLD----- 209 (1317)
T ss_pred HHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEec-----
Confidence 99999999999999999999999999997665 8999999999999999999999999 99999999999999
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc----c-CCCCccccchhHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----T-GHLTSRSDVYSFG 353 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~----~-~~~~~~~DIwSlG 353 (511)
..+++||+|||.+-.+..... ..+...+|||.|++||++. + +.|+..+|+||+|
T Consensus 210 --------------------~~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlG 268 (1317)
T KOG0612|consen 210 --------------------KSGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLG 268 (1317)
T ss_pred --------------------ccCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhH
Confidence 489999999999987765433 3455678999999999986 3 6799999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---
Q 010432 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPL--- 428 (511)
Q Consensus 354 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~cl~~dP~~RPs--- 428 (511)
|++|||+.|..||+.... +.... .+++..-...|| .+.++++++||.+.+. +|+.|..
T Consensus 269 V~~YEMlyG~TPFYadsl------veTY~----------KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrng 331 (1317)
T KOG0612|consen 269 VFMYEMLYGETPFYADSL------VETYG----------KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNG 331 (1317)
T ss_pred HHHHHHHcCCCcchHHHH------HHHHH----------HHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhccccc
Confidence 999999999999985432 11111 111111111122 2357889999999885 7888887
Q ss_pred HHHHHHH
Q 010432 429 MSEVVEA 435 (511)
Q Consensus 429 ~~eil~~ 435 (511)
+.++..|
T Consensus 332 iedik~H 338 (1317)
T KOG0612|consen 332 IEDIKNH 338 (1317)
T ss_pred HHHHHhC
Confidence 8877664
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=323.98 Aligned_cols=267 Identities=28% Similarity=0.358 Sum_probs=200.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.++||+|+||.||+|.+.. +++.||+|++...... ..+.+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368889999999999999999865 5779999998654322 23567899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..++||||+++++|..+... ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~------------- 134 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVS------------- 134 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEC-------------
Confidence 9999999999999888877643 345899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.++|+|||++........ ......|+..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 135 ------------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~ 200 (286)
T cd07846 135 ------------QSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL 200 (286)
T ss_pred ------------CCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence 477899999999987544322 1233568899999998875 4578899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhcccc-c-------cccccCCccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERR-R-------FYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~-----~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|..........-.......+.... . ......+.... ......+..+.+|+.+||+.+|++||++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 280 (286)
T cd07846 201 FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280 (286)
T ss_pred CCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence 965432110000000000000000 0 00000000000 0011235678999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 281 l~~ 283 (286)
T cd07846 281 LHH 283 (286)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.90 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=200.5
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
+|+..+.||+|+||.||+|.... ++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 47778899999999999998864 567999999865432 1235688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..+...++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~----------- 136 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVD----------- 136 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC-----------
Confidence 9999999999999999999998654 46889999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC-CCccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||++....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+
T Consensus 137 --------------~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~ 199 (258)
T cd06632 137 --------------TNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199 (258)
T ss_pred --------------CCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence 47789999999998754432 123456899999999987666 899999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.||...... ....... .... ...++...+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 200 ~pf~~~~~~--~~~~~~~-----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 200 PPWSQLEGV--AAVFKIG-----RSKE---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCcccCcHH--HHHHHHH-----hccc---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 999754311 0010000 0000 011122235778999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.17 Aligned_cols=254 Identities=29% Similarity=0.399 Sum_probs=200.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+|+.+++++ .|+||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 35789999999999999999999865 567999999876543 235688999999999 7999999999997
Q ss_pred eCC------eEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 206 EDD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 206 ~~~------~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
... ..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||+|+||+++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~--- 147 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLT--- 147 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEc---
Confidence 644 489999999999999988642 357899999999999999999999998 99999999999998
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----CCCCccccchh
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYS 351 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DIwS 351 (511)
+++.+||+|||++........ ......|+..|+|||++.. ..++.++||||
T Consensus 148 ----------------------~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 203 (275)
T cd06608 148 ----------------------KNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203 (275)
T ss_pred ----------------------cCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHH
Confidence 477899999999976543221 1223568999999998753 35778999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 352 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
|||+||+|++|..||...... ..+..... ...+ ....+...+..+.+|+.+||..||.+|||+.+
T Consensus 204 lG~il~~l~~g~~p~~~~~~~--~~~~~~~~-----------~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 268 (275)
T cd06608 204 LGITAIELADGKPPLCDMHPM--RALFKIPR-----------NPPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268 (275)
T ss_pred hHHHHHHHHhCCCCccccchH--HHHHHhhc-----------cCCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence 999999999999999643221 11111100 0000 01112234578899999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
|+++
T Consensus 269 ll~~ 272 (275)
T cd06608 269 LLEH 272 (275)
T ss_pred HhcC
Confidence 9874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=320.02 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|.+.+.||+|+||.||++.... ++..||+|.+........+.+.+|+.++++++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 689999999999999999998754 56789999987654444567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++|+||+++++|.+++... .+++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~--------------- 149 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG--------------- 149 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEc---------------
Confidence 999999999999999998543 5788899999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
+++.+||+|||++......... .....|++.|+|||++....++.++|||||||++|+|++|+.||..
T Consensus 150 ----------~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 150 ----------MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred ----------CCCCEEEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4678999999998765443221 2234689999999999888899999999999999999999999975
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
......... .. . ........+...+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 218 ~~~~~~~~~--~~---~----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 218 ENPLRALYL--IA---T----------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CChhhheee--hh---c----------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 433211000 00 0 0000001112235678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.67 Aligned_cols=268 Identities=28% Similarity=0.396 Sum_probs=201.9
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC-
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 207 (511)
.+...+.||+|+||.||+|+++. +|+.||||.++.... ...+.+.+|+++|++|+|+|||+++++-...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred ceeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 34556789999999999999876 899999999987543 3446788999999999999999999875443
Q ss_pred -----CeEEEEEEccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 208 -----DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 208 -----~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
....+|||||.+|||...|.+. ...+++...+.++.+++.||.|||+++ ||||||||.||++-...+
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Ged--- 158 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGED--- 158 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCC---
Confidence 3467999999999999999753 567999999999999999999999999 999999999999963211
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-cCCCCccccchhHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DIwSlGvil~el 359 (511)
.....||+|||.|+.+.++. ..+.++||..|.+||++. ...|+.-+|.|||||++|+.
T Consensus 159 ------------------gq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~c 217 (732)
T KOG4250|consen 159 ------------------GQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYEC 217 (732)
T ss_pred ------------------CceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHH
Confidence 13456999999999987765 466789999999999998 48899999999999999999
Q ss_pred HhCCCCCCCCCCCCc-hhHHHhhhhhhc-c------------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 010432 360 LTGRRSMDKNRPNGE-HNLVEWARPHLG-E------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425 (511)
Q Consensus 360 ltg~~pf~~~~~~~~-~~~~~~~~~~~~-~------------~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~ 425 (511)
+||..||-....... ... .|...... . ...+...+ | ............+..++..+|..+|.+
T Consensus 218 aTG~lPF~p~~~pk~~~~~-~~~~~tkkp~~v~i~~~~~eNgpv~~s~~l-P-~p~~Ls~~l~~~~~kwLa~~L~~~~~~ 294 (732)
T KOG4250|consen 218 ATGELPFIPFGGPKNNKEI-MWHIITKKPSGVAIGAQEEENGPVEWSSTL-P-QPNHLSRGLATRLTKWLASMLEWNPRK 294 (732)
T ss_pred hccCCCCCcCCCccccchh-hhhhhccCCCceeEeeecccCCceeeeccC-C-CcccccHHHHhhhhHHHHHHHhhhHHH
Confidence 999999975433211 111 11100000 0 00000001 0 122233344566778889999999999
Q ss_pred CC--CHHHHHHHh
Q 010432 426 RP--LMSEVVEAL 436 (511)
Q Consensus 426 RP--s~~eil~~L 436 (511)
|. .+.+....+
T Consensus 295 ~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 295 RGHEGFDRFFAEV 307 (732)
T ss_pred hCCCCcchHHHHH
Confidence 98 544444333
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=316.93 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=203.5
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
+|++.+.||.|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 57888999999999999998865 577999999976432 234578899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+...++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~------------- 134 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLD------------- 134 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEc-------------
Confidence 99999999999999999998654 57899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.++|+|||++........ .....|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 135 ------------~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 199 (258)
T cd05578 135 ------------EQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199 (258)
T ss_pred ------------CCCCEEEeecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCC
Confidence 477899999999987654321 23356889999999998888999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM--SEVVE 434 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~--~eil~ 434 (511)
..........+..... . ....++...+..+.++|.+||+.||.+||++ .|+++
T Consensus 200 ~~~~~~~~~~~~~~~~----~-----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 200 RGHSRTIRDQIRAKQE----T-----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CCCCccHHHHHHHHhc----c-----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 8654321111111100 0 0111222335788999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=321.22 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 468889999999999999998865 5779999998754322 2246789999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..++||||+. |+|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~------------ 149 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLT------------ 149 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEC------------
Confidence 9999999999996 6888877655567899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg 362 (511)
+++.+||+|||++...... ....|+..|+|||++. ...++.++|||||||++|||++|
T Consensus 150 -------------~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg 210 (307)
T cd06607 150 -------------EPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (307)
T ss_pred -------------CCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence 4778999999999765432 2246889999999874 45688999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..||........ ... ... ..........++..+.+|+.+||+.||++||++.+|+.+.
T Consensus 211 ~~p~~~~~~~~~---~~~----~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 211 KPPLFNMNAMSA---LYH----IAQ---------NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCCCCccHHHH---HHH----Hhc---------CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 999965422110 000 000 0000111123467899999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.77 Aligned_cols=258 Identities=23% Similarity=0.232 Sum_probs=203.4
Q ss_pred hcCCCCC-CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 128 TRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
+++|.+. ++||-|-.|.|..|.++. |++.+|+|++... ....+|++..-.. .|||||.++++|.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVye 125 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYE 125 (400)
T ss_pred hhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhh
Confidence 4556554 479999999999998876 8889999998644 3456788876555 6999999999886
Q ss_pred e----CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 206 E----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~----~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+ ...+.+|||+++||.|+..+..+ ...+.+..+..|+.||+.|+.|||+.+ |.||||||+|+|.....
T Consensus 126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~---- 198 (400)
T KOG0604|consen 126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTS---- 198 (400)
T ss_pred hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCC----
Confidence 4 34577999999999999999765 456999999999999999999999999 99999999999998643
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.+..+||+|||+|+...... ...+.+-|+.|.|||++-...|+..+|+||+|||+|-|+
T Consensus 199 ------------------~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlL 257 (400)
T KOG0604|consen 199 ------------------PNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_pred ------------------CCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhh
Confidence 47789999999999865422 234467899999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
+|.+||+......... .+ ..-.+.-.-.+...-....++.+++||+.+|..+|.+|.|+.+++++-+
T Consensus 258 CGyPPFYS~hg~aisp-------gM---k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 258 CGYPPFYSNHGLAISP-------GM---KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred cCCCcccccCCccCCh-------hH---HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 9999998654321110 00 0000001111122222345788999999999999999999999998654
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=312.09 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=207.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.++.+++|+||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 368889999999999999998875 578999999977644 3346789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~------------- 134 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLIN------------- 134 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEEC-------------
Confidence 9999999999999999999654 578999999999999999999999 88 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.++|+|||++......... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 135 ------------~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 200 (264)
T cd06623 135 ------------SKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF 200 (264)
T ss_pred ------------CCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 4778999999999876543322 12346889999999999889999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..........+...... .. ....+.. .+..+.+++.+||..+|++||++.+++++
T Consensus 201 ~~~~~~~~~~~~~~~~~----------~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 201 LPPGQPSFFELMQAICD----------GP----PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccccccCHHHHHHHHhc----------CC----CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 76543111122111110 00 0111122 45789999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=314.35 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=199.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc----------ccHHHHHHHHHHHhC-CCCCCcc
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGD-LVHLNLV 198 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~----------~~~~~~~~E~~il~~-l~H~nIv 198 (511)
+|++.+.||+|+||.||+|.+..+ ++..||+|.+..... ....++.+|+.++.+ ++|+||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 478889999999999999998641 456899998864321 122457789988875 7999999
Q ss_pred eEeeEEEeCCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEecc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~ 274 (511)
++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ |+|+||||+|||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~- 148 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLG- 148 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEEC-
Confidence 999999999999999999999999988743 34568999999999999999999996 56 99999999999998
Q ss_pred ccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHH
Q 010432 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 354 (511)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGv 354 (511)
.++.+||+|||++....... ......|+..|+|||++.+..++.++||||||+
T Consensus 149 ------------------------~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ 201 (269)
T cd08528 149 ------------------------EDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGC 201 (269)
T ss_pred ------------------------CCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHH
Confidence 47789999999998755432 223456899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 355 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 355 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
++|||++|+.||....... ..... .. ...........+..+.+||.+||+.||++||++.++..
T Consensus 202 ll~~l~~g~~p~~~~~~~~---~~~~~---~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 202 ILYQMCTLQPPFYSTNMLS---LATKI---VE----------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHHHhCCCcccccCHHH---HHHHH---hh----------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 9999999999996432211 11000 00 00000001123467899999999999999999999999
Q ss_pred Hhc
Q 010432 435 ALK 437 (511)
Q Consensus 435 ~L~ 437 (511)
+|+
T Consensus 266 ~~~ 268 (269)
T cd08528 266 MIS 268 (269)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=316.22 Aligned_cols=260 Identities=28% Similarity=0.365 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|+..+.||.|+||.||+|.+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 367888999999999999999865 577999999975533 2345688999999999999999999988653
Q ss_pred --CeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 208 --DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 208 --~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+.+++||||+++++|.+++.. ....++...+..++.||+.||.|||+.+ ++|+||+|+||+++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~--------- 139 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLT--------- 139 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEe---------
Confidence 468999999999999988643 3456888999999999999999999988 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.+..++|+|||++........ ....++..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 140 ----------------~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g 199 (287)
T cd06621 140 ----------------RKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199 (287)
T ss_pred ----------------cCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 467799999999876543221 234578899999999988999999999999999999999
Q ss_pred CCCCCCCCCC--CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 363 RRSMDKNRPN--GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 363 ~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
..||...... ....+..+.... ... . +.... ......++.+.+|+.+||+.||.+|||+.||+.+-.
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~---~-~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 200 RFPFPPEGEPPLGPIELLSYIVNM--PNP---E-LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCCCCcccCCCCChHHHHHHHhcC--Cch---h-hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 9999765321 111111111110 000 0 00000 001124578899999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=321.75 Aligned_cols=270 Identities=24% Similarity=0.327 Sum_probs=198.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 3579999999999999999998765 6789999998654322 2235678999999999999999999987
Q ss_pred eCC--------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 206 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 206 ~~~--------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
... ..++||||+. ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~---- 153 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILIT---- 153 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEC----
Confidence 654 4599999995 5898888766567899999999999999999999998 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCcccccC-CCCccccchhHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGV 354 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGv 354 (511)
.++.+||+|||++......... .......++..|+|||++.+. .++.++||||||+
T Consensus 154 ---------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 212 (310)
T cd07865 154 ---------------------KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC 212 (310)
T ss_pred ---------------------CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHH
Confidence 4778999999999865432211 112234678899999988654 4788999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc-----cc--cc-cccCC-ccCCCC-----CHHHHHHHHHHHHHhcc
Q 010432 355 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-----RR--FY-RLIDP-RLEGHF-----SIKGAQKAAQLAAHCLS 420 (511)
Q Consensus 355 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~--~~-~~~~~-~~~~~~-----~~~~~~~~~~Li~~cl~ 420 (511)
++|||++|+.||...........+.......... .. .. ....+ ...... .......+.+||.+||.
T Consensus 213 ~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~ 292 (310)
T cd07865 213 IMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292 (310)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhc
Confidence 9999999999997654322222221111100000 00 00 00000 000000 00123567899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 010432 421 RDPKARPLMSEVVEA 435 (511)
Q Consensus 421 ~dP~~RPs~~eil~~ 435 (511)
.||.+||++.+++++
T Consensus 293 ~~P~~R~t~~e~l~h 307 (310)
T cd07865 293 LDPAKRIDADTALNH 307 (310)
T ss_pred CChhhccCHHHHhcC
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=316.01 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
-|++.+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.++.+++|+||+++++++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 46778899999999999998765 577999999865432 22356888999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~--------------- 135 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLS--------------- 135 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEEC---------------
Confidence 99999999999999998853 36889999999999999999999988 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 136 ----------~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 136 ----------EHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred ----------CCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 467799999999876543221 12234688999999999888889999999999999999999999965
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..... ..... .. .....+....+..+.+++.+||+.+|.+||++.+++++
T Consensus 204 ~~~~~---~~~~~----~~----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 204 LHPMK---VLFLI----PK----------NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cchHH---HHHHH----hc----------CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 33211 00000 00 00111122335678999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=315.34 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=199.5
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCC---CCCcceEeeEEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV---HLNLVKLIGYCI 205 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~---H~nIv~l~~~~~ 205 (511)
.|++.+.||+|+||.||+|.+.. ++..||||.+..... .....+.+|+.+++++. |+||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 47788899999999999999865 577999999876532 23456888999999986 999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~------------ 135 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVT------------ 135 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEc------------
Confidence 99999999999999999998854 37889999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+++.++|+|||++......... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 136 -------------~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 200 (277)
T cd06917 136 -------------NTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200 (277)
T ss_pred -------------CCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCC
Confidence 4678999999999876543321 233568999999998865 457899999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||.......... . . .....+.+... ..+..+.+++.+||+.||++||++.+++.+
T Consensus 201 p~~~~~~~~~~~---~----~------~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 201 PYSDVDAFRAMM---L----I------PKSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCChhhhhh---c----c------ccCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 997543211100 0 0 00000111110 135678999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=345.90 Aligned_cols=278 Identities=18% Similarity=0.216 Sum_probs=190.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCcc------CCCCcEE----EEEEecCCCcccHHHHHHHHHHHhCCCCCC
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK------PGTGLTV----AVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~------~~~~~~v----AvK~~~~~~~~~~~~~~~E~~il~~l~H~n 196 (511)
..++|++++.||+|+||+||+|.++........ ...+... +.|.+... ......+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCCC
Confidence 457899999999999999999987542110000 0000111 11211111 112345789999999999999
Q ss_pred cceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 197 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
||++++++...+..|+|||++ .++|..++.... .......+..|+.||+.||.|||+++ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 568888775432 12335667789999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
+ .++.+||+|||+++........ ......||+.|+|||++.+..|+.++|||||
T Consensus 301 ~-------------------------~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 354 (501)
T PHA03210 301 N-------------------------CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSC 354 (501)
T ss_pred C-------------------------CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence 8 4778999999999876543221 1234679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCC-CCCCCchhHHHhhhhh------hcc-ccccccccCCc-c---CCCCC-----HHHHHHHHHHH
Q 010432 353 GVVLLEMLTGRRSMDK-NRPNGEHNLVEWARPH------LGE-RRRFYRLIDPR-L---EGHFS-----IKGAQKAAQLA 415 (511)
Q Consensus 353 Gvil~elltg~~pf~~-~~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~-~---~~~~~-----~~~~~~~~~Li 415 (511)
||+||||++|..++.. ........+....... +.. ...++..++.. + ...++ ...+..+.++|
T Consensus 355 Gvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li 434 (501)
T PHA03210 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPL 434 (501)
T ss_pred HHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHH
Confidence 9999999999865433 2222222222111100 000 00000000000 0 00000 01235678899
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 010432 416 AHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 416 ~~cl~~dP~~RPs~~eil~~ 435 (511)
.+||+.||.+|||+.|++.+
T Consensus 435 ~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 435 VKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhccCcccCcCHHHHhhC
Confidence 99999999999999999975
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=319.28 Aligned_cols=263 Identities=26% Similarity=0.365 Sum_probs=198.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++++.||.|+||.||+|++.. ++..||||.+...... ....+.+|++++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 48889999999999999998865 6779999998754322 234688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+. ++|..++... ...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~------------- 134 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLIN------------- 134 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC-------------
Confidence 99999999995 6898888643 356899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC-CCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||++......... .....++..|+|||++.+.. ++.++|||||||++|||+||+.|
T Consensus 135 ------------~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p 200 (284)
T cd07860 135 ------------TEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 200 (284)
T ss_pred ------------CCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 4778999999999865432211 22345788999999887644 68899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccc--------------cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGER--------------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
|....... .+........... ..+.......+ .......+..+.+||.+||+.||.+||++.+
T Consensus 201 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 277 (284)
T cd07860 201 FPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277 (284)
T ss_pred CCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence 97543211 1111110000000 00000000000 0001123466889999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
++.+
T Consensus 278 ~l~~ 281 (284)
T cd07860 278 ALAH 281 (284)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=315.82 Aligned_cols=260 Identities=24% Similarity=0.313 Sum_probs=196.4
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCC-CCCcceEeeEEEeC-
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED- 207 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~- 207 (511)
|++.+.||+|+||.||+|.+.. ++..||+|+++.... .......+|+.++.++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 6678899999999999999865 577999999876422 22234567999999995 99999999999987
Q ss_pred -CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||+. |+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~------------- 134 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIK------------- 134 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEc-------------
Confidence 88999999996 5888888765567899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+ +.+||+|||+++....... .....++..|+|||++.. ..++.++|||||||++|||++|..|
T Consensus 135 ------------~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p 198 (282)
T cd07831 135 ------------D-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL 198 (282)
T ss_pred ------------C-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence 4 6799999999987644322 123468899999997754 5578899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccc-------cccccCCccCCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRR-------FYRLIDPRLEGH-------FSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-------~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
|........ ............. .....+...... .....+..+.+||.+||+.||++||++.+
T Consensus 199 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 275 (282)
T cd07831 199 FPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ 275 (282)
T ss_pred CCCCCHHHH---HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence 976543211 1111110000000 000000000000 01123678999999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
++++
T Consensus 276 ~l~~ 279 (282)
T cd07831 276 ALRH 279 (282)
T ss_pred HhhC
Confidence 9875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=316.73 Aligned_cols=250 Identities=27% Similarity=0.382 Sum_probs=200.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
.|...+.||+|+||.||++.+.. ++..||||.+........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 35555789999999999998765 567999999876544445668899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeec
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~ 289 (511)
.++|+||+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++
T Consensus 91 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~---------------- 149 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLT---------------- 149 (285)
T ss_pred EEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEc----------------
Confidence 9999999999999999865 46889999999999999999999998 99999999999998
Q ss_pred cccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 010432 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369 (511)
Q Consensus 290 ~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~ 369 (511)
.++.++|+|||++......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 ---------~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 150 ---------SDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred ---------CCCcEEEcccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 4778999999998765432211 22356899999999998888999999999999999999999999754
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..... ...... ...+.+. .....+..+.+|+.+||+.+|++||++.+++++
T Consensus 219 ~~~~~---~~~~~~----------~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 219 PPLQA---MKRIRD----------NLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CHHHH---HHHHHh----------cCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 32111 111110 0000111 011134678999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=321.84 Aligned_cols=268 Identities=26% Similarity=0.323 Sum_probs=199.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|.+.. +|..||+|.++..... ....+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 4679999999999999999999865 6789999999754322 1234678999999999999999999987
Q ss_pred eC--CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 206 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 206 ~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
.. +..++||||+. ++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~---------- 142 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLT---------- 142 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC----------
Confidence 65 56899999995 5899888765567899999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg 362 (511)
+++.+||+|||++......... .....++..|+|||++.+ ..++.++|||||||++|||++|
T Consensus 143 ---------------~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 205 (309)
T cd07845 143 ---------------DKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205 (309)
T ss_pred ---------------CCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC
Confidence 4778999999999876543211 122346788999998875 5678999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhh-hhccc-------c--ccccccCCccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARP-HLGER-------R--RFYRLIDPRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~-~~~~~-------~--~~~~~~~~~~~~--~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
+.||...........+..... ..... . .........+.. ......++.+.+||.+||+.||.+|||+.
T Consensus 206 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 285 (309)
T cd07845 206 KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE 285 (309)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHH
Confidence 999976543221111110000 00000 0 000000000000 00011256788999999999999999999
Q ss_pred HHHHH
Q 010432 431 EVVEA 435 (511)
Q Consensus 431 eil~~ 435 (511)
+++.+
T Consensus 286 ~il~h 290 (309)
T cd07845 286 EALES 290 (309)
T ss_pred HHhcC
Confidence 99974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=320.75 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.|...+.||+|+||.||+|++.. ++..||+|.+...... ....+.+|+.++++++|+||+++++++..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 36778899999999999998865 5779999999754322 23468889999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..++||||+. |+|.+++......+++..+..++.||+.||.|||+++ |+||||+|+||+++
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~------------- 159 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLT------------- 159 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEEC-------------
Confidence 999999999996 5888887665667899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||++...... ....|+..|+|||++. ...++.++|||||||++|||++|.
T Consensus 160 ------------~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 221 (317)
T cd06635 160 ------------EPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221 (317)
T ss_pred ------------CCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCC
Confidence 4678999999998764432 2346889999999874 456889999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
.||....... ....+.. ...........+..+.+|+.+||+.+|.+||++.+|++++..+.
T Consensus 222 ~p~~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 222 PPLFNMNAMS--ALYHIAQ--------------NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCCCCccHHH--HHHHHHh--------------ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 9986532111 0000000 00001111233567899999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.89 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=198.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.++++++|+||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 34789999999999999999998875 67799999986532 22234677899999999999999999988
Q ss_pred EeC------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 205 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 205 ~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
... ...|+||||+. ++|.+.+... ++...+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~----- 152 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK----- 152 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEC-----
Confidence 643 35799999995 5888887532 888899999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+
T Consensus 153 --------------------~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 209 (353)
T cd07850 153 --------------------SDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209 (353)
T ss_pred --------------------CCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHH
Confidence 477899999999987544321 223468899999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHH------------Hhhh----hhhccc-----cccccccCCcc----CCCCCHHHHHHHHH
Q 010432 359 MLTGRRSMDKNRPNGEHNLV------------EWAR----PHLGER-----RRFYRLIDPRL----EGHFSIKGAQKAAQ 413 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~------------~~~~----~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~~~~ 413 (511)
|++|+.||...........+ .... ...... ..+........ ........+..+.+
T Consensus 210 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
T cd07850 210 MIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD 289 (353)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHH
Confidence 99999999754321110000 0000 000000 00000100000 00001133567899
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 010432 414 LAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 414 Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||.+||+.||.+|||+.+++++
T Consensus 290 li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 290 LLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=311.40 Aligned_cols=254 Identities=30% Similarity=0.435 Sum_probs=201.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|.+.+.||+|+||.||+|.... ++..||+|.++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 47888999999999999998765 5779999999876543 446788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~-------------- 133 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLD-------------- 133 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC--------------
Confidence 9999999999999999998654 45788999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCccee--eeeccccccccCCcccccCC---CCccccchhHHHHHHHHHhC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHV--STRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~---~~~~~DIwSlGvil~elltg 362 (511)
+++.+||+|||++........... .....++..|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 134 -----------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g 202 (264)
T cd06626 134 -----------HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202 (264)
T ss_pred -----------CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhC
Confidence 477899999999987654332211 11246789999999998766 88999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.||....... ........ . ..+.+.. ....+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 203 ~~pf~~~~~~~--~~~~~~~~--~--------~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 203 KRPWSELDNEF--QIMFHVGA--G--------HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCccCCcchH--HHHHHHhc--C--------CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 99996542111 00000000 0 0011111 11125678899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.11 Aligned_cols=253 Identities=28% Similarity=0.378 Sum_probs=194.9
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCC-CCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~ 207 (511)
+|...+.||+|+||.||++.+.. ++..||||.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 45566789999999999998865 678999999975432 23356889999999996 99999999999999
Q ss_pred CeEEEEEEccCCCCHHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEeccccccccCC
Q 010432 208 DQRLLVYEFMPRGSLENHL---FR-RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l---~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
...+++|||+. ++|.++. .. ....+++..+..++.|++.||+|||+. + |+||||||+|||++
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~--------- 142 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLD--------- 142 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEc---------
Confidence 99999999985 4655543 22 235689999999999999999999974 6 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC---CCCccccchhHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++....... .....|+..|+|||++.+. .++.++|||||||++|||
T Consensus 143 ----------------~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 203 (288)
T cd06616 143 ----------------RNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203 (288)
T ss_pred ----------------cCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHH
Confidence 367799999999976543221 2234689999999998765 689999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
++|+.||..... .......... ...+.+........+..+.+|+.+||+.||++||++.+|+.+
T Consensus 204 ~~g~~p~~~~~~-----~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 204 ATGKFPYPKWNS-----VFDQLTQVVK-------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HhCCCCchhcch-----HHHHHhhhcC-------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999965421 1111110000 001111222222346789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=313.33 Aligned_cols=251 Identities=21% Similarity=0.356 Sum_probs=201.4
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||+|+||.||+|.+.. +|..||+|.+..... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 47788999999999999999876 567899999976432 2335678999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
...++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~------------ 136 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSK------------ 136 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcC------------
Confidence 99999999999999999986543 35789999999999999999999988 999999999999984
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+...+||+|||.+......... .....|++.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 137 ------------~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 202 (257)
T cd08225 137 ------------NGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202 (257)
T ss_pred ------------CCCeEEecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 2345799999999876543221 22346899999999998888999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...... ......... .. .......+..+.+++.+||..+|++||++.+|+++
T Consensus 203 ~~~~~~------~~~~~~~~~------~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 203 EGNNLH------QLVLKICQG------YF-----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCccHH------HHHHHHhcc------cC-----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 654221 111111100 00 01111234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=315.16 Aligned_cols=243 Identities=27% Similarity=0.352 Sum_probs=188.7
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHH---hCCCCCCcceEeeEEEeCCe
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFL---GDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il---~~l~H~nIv~l~~~~~~~~~ 209 (511)
+||+|+||.||++.+.. ++..||||.+....... ...+.+|..++ ...+|+||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999998865 67799999997643221 12334454433 34579999999999999999
Q ss_pred EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeec
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~ 289 (511)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~---------------- 131 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLD---------------- 131 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEEC----------------
Confidence 99999999999999988654 46899999999999999999999998 99999999999998
Q ss_pred cccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 290 ~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
++..++|+|||++....... .....||..|+|||++. +..++.++|||||||++|||++|..||..
T Consensus 132 ---------~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 132 ---------EHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred ---------CCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 46789999999997654322 12246899999999886 45689999999999999999999999975
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
........+.... . .. ....+...+..+.++|.+||+.||.+|| ++.+++++
T Consensus 199 ~~~~~~~~~~~~~---~--------~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 199 HKTKDKHEIDRMT---L--------TV----NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCCcCHHHHHHHh---h--------cC----CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 4332211111100 0 00 1112233457889999999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=315.57 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=199.9
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+|++.+.||.|+||.||+|++.. +|..||||+++..... ....+.+|+.++++++|+||+++++++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 58889999999999999999865 6779999999765432 2356778999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
..+|||||++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~------------- 134 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLIN------------- 134 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEC-------------
Confidence 9999999997 58988886543 46899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.++|+|||++........ ......+|..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 135 ------------~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 200 (284)
T cd07836 135 ------------KRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL 200 (284)
T ss_pred ------------CCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 477899999999976543221 1223457899999998865 4578899999999999999999999
Q ss_pred CCCCCCCCchhH-HHhhhh-------hhccccccccccCCc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 366 MDKNRPNGEHNL-VEWARP-------HLGERRRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 366 f~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
|........... ...... .+.....+....... ....+....+..+.+++.+||+.||.+||++.+|++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 201 FPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 976543211110 000000 000000000000000 000011123567889999999999999999999986
Q ss_pred H
Q 010432 435 A 435 (511)
Q Consensus 435 ~ 435 (511)
+
T Consensus 281 ~ 281 (284)
T cd07836 281 H 281 (284)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=320.39 Aligned_cols=274 Identities=23% Similarity=0.310 Sum_probs=199.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
+|++.++||+|+||.||+|.+... .++..||||.+.... ......+.+|+.++++++||||+++++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 478889999999999999998642 146799999998743 2223567889999999999999999999998
Q ss_pred C--CeEEEEEEccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 D--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ~--~~~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
. ...++||||++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++..+.
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~--- 146 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGP--- 146 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCC---
Confidence 8 88999999996 4777766422 236889999999999999999999988 999999999999984211
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCc-ceeeeeccccccccCCccccc-CCCCccccchhHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++....... ........+|..|+|||++.+ ..++.++|||||||++|+
T Consensus 147 ------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ 208 (316)
T cd07842 147 ------------------ERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAE 208 (316)
T ss_pred ------------------ccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 267899999999987644322 111223568899999998876 458899999999999999
Q ss_pred HHhCCCCCCCCCCCCch------hHHHhhhhhhc-----------cccccccccCCccCCCCC---------H--HHHHH
Q 010432 359 MLTGRRSMDKNRPNGEH------NLVEWARPHLG-----------ERRRFYRLIDPRLEGHFS---------I--KGAQK 410 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~------~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~ 410 (511)
|++|+.||......... .........+. ....+....+......++ . ..+..
T Consensus 209 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd07842 209 LLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288 (316)
T ss_pred HHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHH
Confidence 99999999765443200 00000000000 000000000000000000 0 23457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 411 AAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 411 ~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.+++.+||+.||++|||+.+++++
T Consensus 289 ~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 289 GFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 8899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=316.46 Aligned_cols=293 Identities=22% Similarity=0.257 Sum_probs=215.5
Q ss_pred cChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC--C-
Q 010432 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--L- 195 (511)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--~- 195 (511)
+.|........+|.+..++|+|.||.|-.+.++. ++..||||+++.-. ...+..+-|+++|.+|.+ |
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~ 148 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPN 148 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCC
Confidence 3343344457899999999999999999999876 57799999997543 223456779999999942 2
Q ss_pred ---CcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 196 ---NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 196 ---nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
-+|++.+||.-.++.|||+|.+ |-++.++|..+ -.+++...+..++.|++.+++|||+.+ ++|.||||+|||
T Consensus 149 g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENIL 224 (415)
T KOG0671|consen 149 GKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENIL 224 (415)
T ss_pred CceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEE
Confidence 2788889999999999999999 66999999764 457999999999999999999999999 999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchh
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwS 351 (511)
+.+.........+. .....-..+...|||+|||.|+...... ..++.|..|+|||++.+.+|+.++||||
T Consensus 225 fvss~~~~~~~~k~-----~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWS 294 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKK-----KVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWS 294 (415)
T ss_pred EeccceEEEeccCC-----ccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCcee
Confidence 98643221111110 0011123356789999999999865543 3356799999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc----c---------cc--------------ccccCCcc-CCCC
Q 010432 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER----R---------RF--------------YRLIDPRL-EGHF 403 (511)
Q Consensus 352 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~---------~~--------------~~~~~~~~-~~~~ 403 (511)
+||||+||+||...|+.........+++.+...++.. . ++ .+...+.. .-..
T Consensus 295 iGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~ 374 (415)
T KOG0671|consen 295 IGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ 374 (415)
T ss_pred eeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc
Confidence 9999999999999998876443333333333221110 0 00 00000000 0001
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 404 SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 404 ~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...+..++.+||.+||.+||.+|+|+.|++.+
T Consensus 375 ~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 375 DDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred CcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 22345679999999999999999999999874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.03 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=205.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+.|+....||+|+||.||+|.+.. ++..||+|++..... ....+.+|+++++.++|+||+++++++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 45678888999999999999999865 467899999986544 44678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++|+||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||+|+||+++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~------------- 150 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLS------------- 150 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEc-------------
Confidence 99999999999999999999765557899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 151 ------------~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~ 216 (286)
T cd06614 151 ------------KDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216 (286)
T ss_pred ------------CCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 477899999999876543221 122345788999999998888999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
........ ...... . . . +.. ......+..+.+||.+||+.+|.+||++.+|+++
T Consensus 217 ~~~~~~~~--~~~~~~----~--~----~-~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 217 LREPPLRA--LFLITT----K--G----I-PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCCCHHHH--HHHHHh----c--C----C-CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 65432110 000000 0 0 0 000 0111235678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=362.95 Aligned_cols=263 Identities=30% Similarity=0.509 Sum_probs=204.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
...|...++||+|+||.||+|++.. ++..||||.+...... ...|+++|++++|||||+++++|.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 3567888899999999999999865 5779999998754322 23568899999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..|+||||+++|+|.+++. .++|..+..|+.||+.||+|||....++|+||||||+|||++.
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~------------- 818 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG------------- 818 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC-------------
Confidence 99999999999999999994 4889999999999999999999654455999999999999984
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
+...++. ||........ ....||+.|||||++.+..++.++|||||||++|||+||+.||+
T Consensus 819 ------------~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 819 ------------KDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ------------CCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 4445554 5555432211 12368999999999999999999999999999999999999996
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
.... ....+..|.+..... ......+++.+.. .....+..++.+|+.+||+.||++||+|.+|++.|+.+..
T Consensus 880 ~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 880 AEFG-VHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccC-CCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4322 223344454433221 1222334444433 2344556778899999999999999999999999987643
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.73 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=205.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
+|++.+.||+|+||.||++.+.. ++..|++|++..........+.+|+.++++++|+||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47788899999999999999865 567999999987655455678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeec
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~ 289 (511)
.++++||+++++|.+++......+++..+..++.|++.||.|||.++ ++|+||+|+||+++
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~---------------- 132 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLT---------------- 132 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEc----------------
Confidence 99999999999999998765567899999999999999999999988 99999999999998
Q ss_pred cccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 010432 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369 (511)
Q Consensus 290 ~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~ 369 (511)
+++.++|+|||.+........ .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 133 ---------~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 133 ---------SDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ---------cCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 477899999999987655432 22356899999999998888999999999999999999999999754
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
....... .... ....... .....+..+.+++.+||+.||.+||++.+++++
T Consensus 201 ~~~~~~~---~~~~-----~~~~~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 201 PPMKALF---KIAT-----NGPPGLR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred chHHHHH---HHHh-----cCCCCcC-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3211110 0000 0000000 011124678999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.08 Aligned_cols=241 Identities=30% Similarity=0.424 Sum_probs=190.8
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
||+|+||+||+|.+.. +|+.||+|.+..... .....+.+|+.+|+.++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 6999999999998765 577999999875432 2234567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 214 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||+|+|||++
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~------------------- 129 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLD------------------- 129 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEC-------------------
Confidence 99999999999986543 36899999999999999999999998 99999999999998
Q ss_pred ccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~ 372 (511)
+++.+||+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 130 ------~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 200 (277)
T cd05577 130 ------DHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200 (277)
T ss_pred ------CCCCEEEccCcchhhhccCCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc
Confidence 477899999999986543211 22346788999999998888999999999999999999999999754331
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
....... ..... .....+...+..+.++|.+||+.||.+||++.+
T Consensus 201 ~~~~~~~--~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 201 VEKEELK--RRTLE------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccHHHHH--hcccc------------ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 1111000 00000 011122233578899999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=314.46 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=197.8
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
|++.+.||.|++|.||+|.+.. +|..||||++...... ....+.+|+.++++++|+||+++++++.+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 6778899999999999999865 5779999999765322 2356889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||+|+|||++
T Consensus 72 ~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~-------------- 133 (283)
T cd07835 72 KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLID-------------- 133 (283)
T ss_pred eEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEc--------------
Confidence 999999999 469999886543 36899999999999999999999988 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.++|+|||++......... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 134 -----------~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 200 (283)
T cd07835 134 -----------REGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200 (283)
T ss_pred -----------CCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4778999999999765432211 1223578899999988654 5789999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhh----------ccccccccccC---CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHL----------GERRRFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
....... .+........ .....+..... ...........+..+.+|+.+||+.||.+||++.+++
T Consensus 201 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 201 PGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred CCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 7543211 1111111000 00000000000 0000001112246788999999999999999999998
Q ss_pred HH
Q 010432 434 EA 435 (511)
Q Consensus 434 ~~ 435 (511)
++
T Consensus 279 ~~ 280 (283)
T cd07835 279 QH 280 (283)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=316.68 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=197.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|.+.. +++.||||.+..... .....+.+|+.++++++|+||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 478899999999999999998865 577999999865432 223567899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~----------- 137 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDR----------- 137 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEEC-----------
Confidence 999999999995 58888875432 33678888899999999999999988 999999999999974
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.+..+||+|||++........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 138 -------------~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~ 202 (294)
T PLN00009 138 -------------RTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202 (294)
T ss_pred -------------CCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 245699999999976543211 1223467899999998875 457899999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccc---------cccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFY---------RLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~----~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
||........ +..............+ ....+.... ......+..+.+++.+||+.||.+||++.+
T Consensus 203 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 280 (294)
T PLN00009 203 LFPGDSEIDE--LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280 (294)
T ss_pred CCCCCCHHHH--HHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence 9975432211 1110000000000000 000000000 011123467899999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
++++
T Consensus 281 ~l~~ 284 (294)
T PLN00009 281 ALEH 284 (294)
T ss_pred HhcC
Confidence 9873
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=279.31 Aligned_cols=266 Identities=24% Similarity=0.301 Sum_probs=207.0
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|...++||+|.||+||+|+.++ +++.||+|.++.+... .....++|+.+|+.|.|.|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 45556789999999999999876 7889999999865432 235688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..+-||+||| ..+|..+...-++.++.+.+..++.|+++||.|+|+++ ++||||||.|+||.
T Consensus 74 kkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin-------------- 135 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLIN-------------- 135 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEec--------------
Confidence 9999999999 55999998877788999999999999999999999999 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHh-CCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+++..+-.... ....+-|.+|++|.++.+. -|++..|+||.|||+.|+.. |++.
T Consensus 136 -----------~ngelkladfglarafgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 136 -----------RNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred -----------cCCcEEecccchhhhcCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 4889999999999987654322 3334669999999999875 58999999999999999986 6777
Q ss_pred CCCCCCCCchhHHHhhhhhhcc--ccccccccCCccCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGE--RRRFYRLIDPRLEGHFSI---------KGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---------~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
|.+....+....+-+......+ ...+..+.|...-+.++. .....-++|++++|.-+|.+|.++++.++
T Consensus 203 fpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 203 FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 7766544433323232221111 111222222221122211 11234578999999999999999999887
Q ss_pred H
Q 010432 435 A 435 (511)
Q Consensus 435 ~ 435 (511)
+
T Consensus 283 h 283 (292)
T KOG0662|consen 283 H 283 (292)
T ss_pred C
Confidence 4
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=316.65 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=196.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCC-CCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~-H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|.+.. +++.||||.+...... ....+.+|+.+++.+. |+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 368899999999999999999865 6779999998754321 2356788999999995 699999999988
Q ss_pred eCCe-----EEEEEEccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 206 EDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 206 ~~~~-----~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
..+. .|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~-- 145 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDK-- 145 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEec--
Confidence 7665 8999999975 898888643 245899999999999999999999988 999999999999983
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 355 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvi 355 (511)
+++.+||+|||+++........ .....+++.|+|||++.+ ..++.++|||||||+
T Consensus 146 ----------------------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 201 (295)
T cd07837 146 ----------------------QKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI 201 (295)
T ss_pred ----------------------CCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHH
Confidence 2678999999999865332111 122357889999998865 467999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhh-hcccccccccc-----------CCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPH-LGERRRFYRLI-----------DPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
+|+|++|..||........ +....... ......+.... .+..........+..+.+||.+||+.||
T Consensus 202 l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 279 (295)
T cd07837 202 FAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP 279 (295)
T ss_pred HHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCCh
Confidence 9999999999976432211 11100000 00000000000 0000000011235778999999999999
Q ss_pred CCCCCHHHHHHH
Q 010432 424 KARPLMSEVVEA 435 (511)
Q Consensus 424 ~~RPs~~eil~~ 435 (511)
.+||++.+++.+
T Consensus 280 ~~R~~~~eil~~ 291 (295)
T cd07837 280 AKRISAKAALTH 291 (295)
T ss_pred hhcCCHHHHhcC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=324.13 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=196.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||.||+|.+.. +|..||||.+..... .....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 4689999999999999999998865 678999999964322 233567889999999999999999998765
Q ss_pred C-----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 207 ~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
. ...++||||+. ++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~-------- 140 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN-------- 140 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEC--------
Confidence 4 35799999995 588887743 46899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCccccc-CCCCccccchhHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||++.......... ......||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 -----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el 203 (336)
T cd07849 141 -----------------TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203 (336)
T ss_pred -----------------CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHH
Confidence 47789999999998654322111 1223568999999998764 5689999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhcc--ccccccccCCc---------cCCCC-----CHHHHHHHHHHHHHhcccCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGE--RRRFYRLIDPR---------LEGHF-----SIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~---------~~~~~-----~~~~~~~~~~Li~~cl~~dP 423 (511)
++|+.||........ .......+.. ...+..+.+.. ..... ....+..+.+||.+||+.||
T Consensus 204 ~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 280 (336)
T cd07849 204 LSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNP 280 (336)
T ss_pred HhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCCh
Confidence 999999975432111 0000000000 00000000000 00000 01124678999999999999
Q ss_pred CCCCCHHHHHHH
Q 010432 424 KARPLMSEVVEA 435 (511)
Q Consensus 424 ~~RPs~~eil~~ 435 (511)
.+||++.+++++
T Consensus 281 ~~Rpt~~e~l~h 292 (336)
T cd07849 281 HKRITVEEALAH 292 (336)
T ss_pred hhCcCHHHHhcC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=308.34 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=198.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 478899999999999999998765 67899999885431 1223467889999999999999999999
Q ss_pred EEeC--CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 204 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+.+. ...++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~-------- 140 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRD-------- 140 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc--------
Confidence 8764 4678999999999999998654 35889999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.++.++|+|||+++........ .......|+..|+|||++.+..++.++|||||||++|+|+
T Consensus 141 -----------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 203 (264)
T cd06653 141 -----------------SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203 (264)
T ss_pred -----------------CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence 4677999999999865331110 1122356899999999998888999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|+.||...... ..... .........++...++.+.+++.+||+ +|..||++.+++.+
T Consensus 204 ~g~~p~~~~~~~--~~~~~--------------~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 204 TEKPPWAEYEAM--AAIFK--------------IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred hCCCCCCccCHH--HHHHH--------------HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 999999643211 11110 010111122333446789999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=307.03 Aligned_cols=248 Identities=21% Similarity=0.216 Sum_probs=192.9
Q ss_pred HHHhcCCCCCCcc--ccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEe
Q 010432 125 KLATRNFRPESLL--GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (511)
Q Consensus 125 ~~~~~~y~~~~~l--G~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~ 201 (511)
....++|++.+.+ |+|+||.||++..+. ++..+|+|.+........ |+.+...+ +|+||++++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~ 75 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLY 75 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEE
Confidence 3445677777776 999999999998865 677999999876432221 22222222 799999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++..++..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~------- 144 (267)
T PHA03390 76 YSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDR------- 144 (267)
T ss_pred EEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeC-------
Confidence 99999999999999999999999996553 7899999999999999999999998 999999999999984
Q ss_pred CcceeeeccccccccccccC-ceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
+. .++|+|||+++...... ...|+..|+|||++.+..++.++|||||||++|||+
T Consensus 145 ------------------~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 200 (267)
T PHA03390 145 ------------------AKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200 (267)
T ss_pred ------------------CCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 44 79999999998654321 246899999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-~~eil~~ 435 (511)
+|+.||....... .....+.... . . ........+..+.+||.+||+.||.+||+ +++++++
T Consensus 201 ~g~~p~~~~~~~~-~~~~~~~~~~-~----------~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 201 TGKHPFKEDEDEE-LDLESLLKRQ-Q----------K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HCCCCCCCCCcch-hhHHHHHHhh-c----------c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 9999997443221 1111111100 0 0 00111234678999999999999999996 6998864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=305.19 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=205.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|...+.||+|+||.||+|.+.. ++..|++|++..... ...+.+.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 47778899999999999998875 577999999976643 2346788999999999999999999999988
Q ss_pred --CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 208 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~------------ 135 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVD------------ 135 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEc------------
Confidence 88999999999999999997654 8899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 136 -------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 202 (260)
T cd06606 136 -------------SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202 (260)
T ss_pred -------------CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 4678999999999876654321112335689999999999888899999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|...... ..... ..........++...+..+.+|+.+||+.||.+||++.+++++
T Consensus 203 ~~~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 203 WSELGNP-----MAALY----------KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCCCch-----HHHHH----------hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 9765410 00000 0010011112223336789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.37 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=205.1
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|.+.+.||.|+||.||++.+.. ++..||+|++..... .....+.+|+++++.++|+|++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 57888999999999999999865 577999999986543 3345688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
+..++||||+++++|.+++... ...+++..+..++.+++.||.|||+++ ++|+||+|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~----------- 137 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLT----------- 137 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEc-----------
Confidence 9999999999999999999764 367999999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
++..++|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 138 --------------~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 201 (258)
T cd08215 138 --------------SNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201 (258)
T ss_pred --------------CCCcEEECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCC
Confidence 467899999999987654331 2233568999999999988889999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||...... .+.... ... . ....+...+..+.+++.+||..+|++||++.+++++
T Consensus 202 p~~~~~~~---~~~~~~---~~~-------~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 202 PFEGENLL---ELALKI---LKG-------Q----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCcHH---HHHHHH---hcC-------C----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 99654321 111110 000 0 011112335778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.62 Aligned_cols=263 Identities=21% Similarity=0.250 Sum_probs=192.9
Q ss_pred CccccC--CCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
..||+| +||+||+|++.. +|+.||||++...... ..+.+.+|+.+++.++||||++++++|..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 356666 999999999865 6789999999765332 235678899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeec
Q 010432 211 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~ 289 (511)
++||||+.+|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~---------------- 135 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS---------------- 135 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEe----------------
Confidence 9999999999999998654 235889999999999999999999988 99999999999998
Q ss_pred cccccccccccCceeeecCCCcccCCCCCcce-----eeeeccccccccCCccccc--CCCCccccchhHHHHHHHHHhC
Q 010432 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 290 ~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil~elltg 362 (511)
.++.+|++|||.+.......... ......++..|||||++.+ ..++.++|||||||++|||++|
T Consensus 136 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g 206 (328)
T cd08226 136 ---------GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG 206 (328)
T ss_pred ---------CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 36779999998654322111000 0011235677999999876 3578999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhh-h--------ccc--------ccc--------------ccccCCccCCCCCHHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPH-L--------GER--------RRF--------------YRLIDPRLEGHFSIKGAQKA 411 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~-~--------~~~--------~~~--------------~~~~~~~~~~~~~~~~~~~~ 411 (511)
..||....... ......... . ... ... .......+.......++..+
T Consensus 207 ~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (328)
T cd08226 207 RVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF 284 (328)
T ss_pred CCCCCCcChHH--HHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHH
Confidence 99997543211 111000000 0 000 000 00001111222233467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 412 AQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 412 ~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
.+||.+||+.||++|||+.+++++-
T Consensus 285 ~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 285 QNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCH
Confidence 9999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=312.70 Aligned_cols=265 Identities=18% Similarity=0.225 Sum_probs=188.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHHhCCCCC
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGDLVHL 195 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----------~~~~~E~~il~~l~H~ 195 (511)
..++|.+.++||+|+||.||+|.+..+.. .+..+|+|+......... .....+...+..+.|+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 34689999999999999999999865311 145677776543321110 1123344556778999
Q ss_pred CcceEeeEEEeCC----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 196 NLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 196 nIv~l~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
||+++++++.... ..+++||++ ..++.+.+.. ....++..+..|+.||+.||+|||+++ |+||||||+|||
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nil 158 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIM 158 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999776543 447889988 4477666643 234678888999999999999999988 999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCcc
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSR 346 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~ 346 (511)
++ .+..+||+|||+|+........ .......||+.|+|||++.+..++.+
T Consensus 159 l~-------------------------~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~ 213 (294)
T PHA02882 159 VD-------------------------GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR 213 (294)
T ss_pred Ec-------------------------CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH
Confidence 98 3677999999999865432111 11123469999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 347 ~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
+|||||||+||||++|+.||........ +.......+ ..++....+. ....++.+.+++..||..+|++|
T Consensus 214 ~DiwSlG~~l~el~~g~~P~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~r 283 (294)
T PHA02882 214 GDLESLGYCMLKWAGIKLPWKGFGHNGN--LIHAAKCDF-----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEK 283 (294)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccccchH--HHHHhHHHH-----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999976532221 111000000 0000000000 01124678999999999999999
Q ss_pred CCHHHHHHHhc
Q 010432 427 PLMSEVVEALK 437 (511)
Q Consensus 427 Ps~~eil~~L~ 437 (511)
|++.+|++.|.
T Consensus 284 p~~~~l~~~~~ 294 (294)
T PHA02882 284 PDYDALIKIFD 294 (294)
T ss_pred CCHHHHHHhhC
Confidence 99999998763
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.06 Aligned_cols=254 Identities=29% Similarity=0.415 Sum_probs=204.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
+-++.-...||.|.||.||-|...+ +|...|+|-++..... ....+.+|..+|..|+|||||++||+-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence 3466777889999999999998766 7889999988754332 2345789999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.+..+|.||||.+|+|.+.+. .+...++.....+..|++.||.|||++| ||||||||+||||+.
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~----------- 1369 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDF----------- 1369 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeec-----------
Confidence 9999999999999999999884 4445777778888999999999999999 999999999999994
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccC---CCCccccchhHHHHHHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~---~~~~~~DIwSlGvil~ell 360 (511)
++.+|++|||.|.......... ......||+.|||||++.+. ...-+.||||||||+.||+
T Consensus 1370 --------------~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1370 --------------NGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA 1435 (1509)
T ss_pred --------------CCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee
Confidence 7789999999998766542111 12246899999999999753 4567899999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||+.||...... |+- ++. +-..-.+.++...+.+-.++|.+||..||++|+++.+|+++
T Consensus 1436 tGkrPW~~~dne-------~aI--------My~-V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1436 TGKRPWAELDNE-------WAI--------MYH-VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred cCCCchhhccch-------hHH--------HhH-HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 999999754322 110 000 00111233444567888999999999999999999999875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.36 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=196.1
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
||.|+||.||+|++.. ++..||+|++...... ..+.+.+|+.+++.++|+||+++++++.++...++|
T Consensus 1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 7999999999999865 5779999999764322 235688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~-------------------- 127 (262)
T cd05572 72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLD-------------------- 127 (262)
T ss_pred EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEc--------------------
Confidence 9999999999999654 45889999999999999999999988 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 373 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~ 373 (511)
.++.++|+|||++........ .....|+..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 128 -----~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 199 (262)
T cd05572 128 -----SNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP 199 (262)
T ss_pred -----CCCCEEEeeCCcccccCcccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH
Confidence 477899999999987655321 223568999999999988889999999999999999999999997654211
Q ss_pred chhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 010432 374 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 434 (511)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~ 434 (511)
.. . ... .........++...+..+.++|.+||+.||++||+ +.|+++
T Consensus 200 ~~-~---~~~----------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 200 ME-I---YND----------ILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HH-H---HHH----------HhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11 1 100 00000111222223578999999999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.85 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=203.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lv 213 (511)
+.||+|+|+.|--|.... +|..||||++.+...-.+.++.+|++++.+. .|+||++|+++|.+++..|||
T Consensus 84 e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 479999999999998766 7889999999887656667899999999998 699999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
||-+.||.|..+|.++ ..+++..+..+..+|+.||.|||.+| |.||||||+|||...++
T Consensus 155 fEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn----------------- 213 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPN----------------- 213 (463)
T ss_pred EecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCC-----------------
Confidence 9999999999999765 46899999999999999999999999 99999999999998643
Q ss_pred cccccccCceeeecCCCcccCCCCCc-----ceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHHHhCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.-.-||||||-|..-...... +....+.+|+..|||||++. ...|+.++|.||||||||-||+|.
T Consensus 214 -----~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 214 -----KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred -----CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 234589999988764322111 11233468999999999874 346899999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhcc--ccccccccC-Ccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGE--RRRFYRLID-PRL--EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~--~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+||.+....+.. |-+...-. ...+++.+. ..+ +..-....+.+.++|+..+|..|+.+|.++.+++++
T Consensus 289 pPFvG~Cg~dCG----WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 289 PPFVGHCGADCG----WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCccCccCCcCC----ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 999876543211 11110000 011111111 111 111123457889999999999999999999999984
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=308.90 Aligned_cols=243 Identities=26% Similarity=0.355 Sum_probs=188.8
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHH---HHHhCCCCCCcceEeeEEEeCCe
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEV---NFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~---~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
+||+|+||.||+|++.. +++.||||.+....... ...+..|. ..++...||||+++++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 48999999999998765 67899999987643221 12233443 34555689999999999999999
Q ss_pred EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeec
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~ 289 (511)
.++||||+.+|+|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 72 ~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~---------------- 131 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLD---------------- 131 (278)
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEEC----------------
Confidence 9999999999999998854 347899999999999999999999988 99999999999998
Q ss_pred cccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 290 ~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
.+..+||+|||++....... .....|+..|+|||++.++ .++.++|||||||++|||++|+.||..
T Consensus 132 ---------~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~ 198 (278)
T cd05606 132 ---------EHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (278)
T ss_pred ---------CCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 46789999999997654322 1234689999999998754 689999999999999999999999976
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
............ . ..... .++...+..+.+|+.+||..+|.+|| ++.+++++
T Consensus 199 ~~~~~~~~~~~~---~--------~~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 199 HKTKDKHEIDRM---T--------LTMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCccchHHHHHH---h--------hccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 532221111000 0 00011 11222357899999999999999999 89999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.12 Aligned_cols=270 Identities=26% Similarity=0.318 Sum_probs=200.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
...++|++.+.||+|+||.||+|.+.. +++.||||+++.... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 345789999999999999999999875 577999999975432 223457789999999999999999999
Q ss_pred EEeCC----------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 204 CIEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 204 ~~~~~----------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
+.... ..++||||+++ +|..++......+++..++.++.||+.||+|||+.+ |+|+||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~ 150 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLN 150 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 87654 78999999965 788877665557899999999999999999999998 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSF 352 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSl 352 (511)
+++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||
T Consensus 151 -------------------------~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 204 (302)
T cd07864 151 -------------------------NKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204 (302)
T ss_pred -------------------------CCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence 4778999999999876543321 1122356888999998864 457899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhh-hhcc-cccc-----ccccC------CccCCCCCHHHHHHHHHHHHHhc
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-HLGE-RRRF-----YRLID------PRLEGHFSIKGAQKAAQLAAHCL 419 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~-~~~~-----~~~~~------~~~~~~~~~~~~~~~~~Li~~cl 419 (511)
||++|||++|+.||...........+..... .... ...+ ....+ ......+ ...+..+.+|+.+||
T Consensus 205 G~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l 283 (302)
T cd07864 205 GCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHML 283 (302)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHc
Confidence 9999999999999975432211111111000 0000 0000 00000 0000000 012567899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 010432 420 SRDPKARPLMSEVVEA 435 (511)
Q Consensus 420 ~~dP~~RPs~~eil~~ 435 (511)
+.||.+||++.+|+.+
T Consensus 284 ~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 284 TLDPSKRCTAEEALNS 299 (302)
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=312.65 Aligned_cols=266 Identities=24% Similarity=0.316 Sum_probs=200.6
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEEeC-
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 207 (511)
|++.+.||.|+||.||+|.+.. +++.||+|++.... ......+.+|+.++++++|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 6678899999999999999875 57799999998663 22335688999999999999999999999887
Q ss_pred -CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++||||++ ++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~------------- 134 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILIN------------- 134 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEc-------------
Confidence 88999999996 5899988765567899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||++......... ..+...++..|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 135 ------------~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p 201 (287)
T cd07840 135 ------------NDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201 (287)
T ss_pred ------------CCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCC
Confidence 4778999999999876554321 1223457889999998765 4678999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhh--cccccc-----ccccC------CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHL--GERRRF-----YRLID------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~------~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|................... .....+ ..... ..+...+...++..+.+++.+||+.+|.+||++.++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 281 (287)
T cd07840 202 FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281 (287)
T ss_pred CCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 97654321111110000000 000000 00000 000001111125778999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 282 l~~ 284 (287)
T cd07840 282 LQH 284 (287)
T ss_pred hhC
Confidence 874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.40 Aligned_cols=268 Identities=28% Similarity=0.343 Sum_probs=198.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
..++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+++++ +|+||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 34678899999999999999998865 57799999886432 22234577899999999 99999999999
Q ss_pred EEeC--CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 204 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+... ...++||||+. ++|..++... .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~-------- 141 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLN-------- 141 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc--------
Confidence 8653 36899999996 5999988543 6788999999999999999999988 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcc---eeeeeccccccccCCccccc-CCCCccccchhHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~---~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ 357 (511)
.++.+||+|||++......... .......||..|+|||++.+ ..++.++|||||||++|
T Consensus 142 -----------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~ 204 (337)
T cd07852 142 -----------------SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILG 204 (337)
T ss_pred -----------------CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHH
Confidence 4788999999999876443221 12234568999999998765 46789999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhh--------h--ccccccccccC----CccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPH--------L--GERRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
+|++|+.||.................. + .....+...+. ..+.. .....+..+.+||.+||+.||
T Consensus 205 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P 283 (337)
T cd07852 205 EMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNP 283 (337)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCc
Confidence 999999999754322111000000000 0 00000000000 00000 011135778999999999999
Q ss_pred CCCCCHHHHHHH
Q 010432 424 KARPLMSEVVEA 435 (511)
Q Consensus 424 ~~RPs~~eil~~ 435 (511)
++|||+.+++++
T Consensus 284 ~~Rps~~~il~~ 295 (337)
T cd07852 284 NKRLTAEEALEH 295 (337)
T ss_pred ccccCHHHHhhC
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=322.46 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=199.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|.... +|..||+|++..... .....+.+|+.+|++++|+||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 75 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRP 75 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence 689999999999999999998875 678999999976432 234567889999999999999999998763
Q ss_pred ----CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 207 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 207 ----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
....++||||+. |+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~--------- 141 (334)
T cd07855 76 PGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVN--------- 141 (334)
T ss_pred cCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc---------
Confidence 356899999994 6999988544 45899999999999999999999988 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCccccc-CCCCccccchhHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~el 359 (511)
+++.+||+|||++......... .......|+..|+|||++.+ ..++.++|||||||++|||
T Consensus 142 ----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el 205 (334)
T cd07855 142 ----------------EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205 (334)
T ss_pred ----------------CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHH
Confidence 4778999999999765432211 11223578999999998865 4689999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccc----------cccccc---cCCccC---CCCCHHHHHHHHHHHHHhcccCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGER----------RRFYRL---IDPRLE---GHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---~~~~~~---~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
++|+.||........... .....+.. ...... ...... .......+..+.++|.+||+.+|
T Consensus 206 ~~g~~pf~~~~~~~~~~~---~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 282 (334)
T cd07855 206 LGRRQLFPGKNYVHQLKL---ILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDP 282 (334)
T ss_pred HcCCCccCCCChHHHHHH---HHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCCh
Confidence 999999976433211110 00000000 000000 000000 00111235789999999999999
Q ss_pred CCCCCHHHHHHHh
Q 010432 424 KARPLMSEVVEAL 436 (511)
Q Consensus 424 ~~RPs~~eil~~L 436 (511)
.+||++.+++.+.
T Consensus 283 ~~Rpt~~~~l~~~ 295 (334)
T cd07855 283 EERITVEQALQHP 295 (334)
T ss_pred hhCcCHHHHHhCh
Confidence 9999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=314.58 Aligned_cols=245 Identities=28% Similarity=0.409 Sum_probs=195.8
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
|...+.||+|+||.||+|++.. ++..||||.+...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 6667789999999999998765 6779999999754332 224578899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..|+||||+. |+|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~-------------- 155 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLT-------------- 155 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEEC--------------
Confidence 99999999995 6888888766667999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+++.+||+|||++...... ....|+..|+|||++. ...++.++|||||||++|||++|..
T Consensus 156 -----------~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~ 218 (313)
T cd06633 156 -----------EPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218 (313)
T ss_pred -----------CCCCEEEeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 4678999999998754321 2356899999999984 4568899999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||.......... ... ... .........+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 219 p~~~~~~~~~~~---~~~--~~~-----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 219 PLFNMNAMSALY---HIA--QND-----------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCChHHHHH---HHH--hcC-----------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 997543211110 000 000 0000111224568999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=313.58 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=201.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
..+|..+.+||+|+||.|.+|..+. +.+.||||+++++..... +--+.|-++|.-. +-|.+++|+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg---------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ecccceEEEeccCccceeeeecccC---------cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 4578889999999999999998764 677999999998754322 2235688888776 57899999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
|+.-+.+|+||||+.||+|.-+|++- +.+.+..+..++.+||-||-|||+++ ||+||||.+||||+.
T Consensus 419 FQTmDRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~--------- 485 (683)
T KOG0696|consen 419 FQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDS--------- 485 (683)
T ss_pred hhhhhheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEecc---------
Confidence 99999999999999999999888554 46888899999999999999999999 999999999999994
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
++++||+|||+++...-...+ ..+++||+.|+|||++...+|+..+|+|||||+||||+.|+
T Consensus 486 ----------------eGHiKi~DFGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQ 547 (683)
T KOG0696|consen 486 ----------------EGHIKIADFGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 547 (683)
T ss_pred ----------------CCceEeeecccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCC
Confidence 889999999999875444332 44589999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
+||++..+... .. .+.+. .-.++...+.++..++...|...|.+|..
T Consensus 548 pPFdGeDE~el---F~-------------aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 548 PPFDGEDEDEL---FQ-------------AIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CCCCCCCHHHH---HH-------------HHHHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 99987654321 11 11111 12344556788999999999999999963
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=318.89 Aligned_cols=249 Identities=24% Similarity=0.302 Sum_probs=205.0
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 211 (511)
.++||.|.||+||-|+++. +|+.||||++.+... +...++.+|+.||.+++||.||.|...|...+.+|
T Consensus 569 devLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 3689999999999999887 789999999987644 23456788999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 212 LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 212 lv~E~~~~g~L~~~l-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
+|||-+ .||+.+.| ....+.+++.....++.||+.||.|||.++ |+|+||||+||||....
T Consensus 640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~-------------- 701 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASAS-------------- 701 (888)
T ss_pred EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCC--------------
Confidence 999999 55665555 456678999999999999999999999999 99999999999998632
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
+..++||||||+|+..++... ...++||+.|+|||+++...|+..-|+||.|||+|--++|..||....
T Consensus 702 --------~FPQvKlCDFGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 702 --------PFPQVKLCDFGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred --------CCCceeeccccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 356899999999999876443 455899999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+. .+-++.+.-. +...-..+.+..+.+||..+|+..-.+|.|....+.+.
T Consensus 771 dI--ndQIQNAaFM--------------yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 771 DI--NDQIQNAAFM--------------YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred ch--hHHhhccccc--------------cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 22 1111111111 11222234567889999999999999999999887654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.50 Aligned_cols=262 Identities=26% Similarity=0.341 Sum_probs=202.5
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
|++.+.||+|++|.||+|.+.. +++.+|+|.+...... ....+.+|+.+|++++|+||+++++++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 5677899999999999998765 5779999998765433 3456889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||++ ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++
T Consensus 72 ~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~--------------- 132 (283)
T cd05118 72 DLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLIN--------------- 132 (283)
T ss_pred CEEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEEC---------------
Confidence 9999999996 4999888776668899999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
+++.+||+|||.+........ ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.
T Consensus 133 ----------~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 133 ----------TEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred ----------CCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 467899999999987655431 12234678899999998876 78999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccc-----ccccc--------ccC--CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGER-----RRFYR--------LID--PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~--------~~~--~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
......... .....+... ..+.. ... ...........+.++.+||.+||+.||.+||++.++
T Consensus 201 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l 277 (283)
T cd05118 201 GKSEIDQLF---KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277 (283)
T ss_pred CCCHHHHHH---HHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence 544321110 100000000 00000 000 000011122346789999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+.+
T Consensus 278 l~~ 280 (283)
T cd05118 278 LAH 280 (283)
T ss_pred hhC
Confidence 874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=312.16 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=196.7
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~ 214 (511)
.+||+|+||.||++.... ++..||||.+..........+.+|+.+++.++|+||+++++++..++..++||
T Consensus 26 ~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 26 IKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 579999999999998865 67899999986554444566889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccccc
Q 010432 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294 (511)
Q Consensus 215 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~ 294 (511)
||+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+|+||||+||+++
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~--------------------- 150 (292)
T cd06657 97 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLT--------------------- 150 (292)
T ss_pred ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC---------------------
Confidence 99999999998743 35789999999999999999999998 99999999999998
Q ss_pred ccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 010432 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 374 (511)
Q Consensus 295 ~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~ 374 (511)
.++.++|+|||++......... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 151 ----~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~- 223 (292)
T cd06657 151 ----HDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK- 223 (292)
T ss_pred ----CCCCEEEcccccceeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 4677999999998765432211 223568999999999988889999999999999999999999997532211
Q ss_pred hhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 375 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
......... .+.+.. ....+..+.+++.+||+.||.+||++.+++.+
T Consensus 224 --~~~~~~~~~----------~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 224 --AMKMIRDNL----------PPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred --HHHHHHhhC----------CcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111111100 000000 01124568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=306.29 Aligned_cols=244 Identities=26% Similarity=0.321 Sum_probs=189.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHH-hCCCCCCcceEeeEEEeCCeE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFL-GDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il-~~l~H~nIv~l~~~~~~~~~~ 210 (511)
+.||+|+||.||+|.+.. +++.||||++....... ...+..|..++ ..++|+||+++++++..++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 569999999999998865 57799999997543221 12344555544 455899999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+|||++
T Consensus 73 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~----------------- 131 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLID----------------- 131 (260)
T ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC-----------------
Confidence 9999999999999998654 46899999999999999999999988 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
++..+||+|||+++.... .....|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 132 --------~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 132 --------QTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred --------CCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 467899999999986443 123468899999999988889999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
... ..... ...... .........+..+.+++.+||+.||++||++.++.+.|
T Consensus 198 ~~~---~~~~~---~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 198 PDA---VFDNI---LSRRIN--------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHH---HHHHH---HhcccC--------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 211 11100 000000 01111112357789999999999999999776555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.77 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=198.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|.+.+.||+|+||.||+|++.. ++..||||.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 3579999999999999999998765 67899999987532 222346778999999999999999999886
Q ss_pred eC-----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
.. ...||||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~------- 142 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLN------- 142 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc-------
Confidence 54 34799999994 7899888543 57899999999999999999999988 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++....... ......||..|+|||++.. ..++.++|||||||++|+|
T Consensus 143 ------------------~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 202 (337)
T cd07858 143 ------------------ANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202 (337)
T ss_pred ------------------CCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHH
Confidence 467899999999987644321 1233568899999998864 4689999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhh-hc---------ccccccccc----CCccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPH-LG---------ERRRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~----~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~ 425 (511)
++|+.||.................. .. ........+ +..+. ......+..+.+||.+||+.||.+
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~ 281 (337)
T cd07858 203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSK 281 (337)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhh
Confidence 9999999754321110000000000 00 000000000 00000 011124577899999999999999
Q ss_pred CCCHHHHHHH
Q 010432 426 RPLMSEVVEA 435 (511)
Q Consensus 426 RPs~~eil~~ 435 (511)
||++.+++++
T Consensus 282 Rps~~ell~h 291 (337)
T cd07858 282 RITVEEALAH 291 (337)
T ss_pred ccCHHHHHcC
Confidence 9999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.67 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=198.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.|...+.||+|+||.||+|++.. ++..||||.+...... ...++.+|+.+++.++|+||+++++++..
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 86 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 46677889999999999999865 5778999998753222 23467889999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ ++||||||+|||++
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~------------- 149 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLS------------- 149 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEEC-------------
Confidence 999999999995 6888887655567899999999999999999999988 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||++...... ....|+..|+|||++. ...++.++|||||||++|+|++|.
T Consensus 150 ------------~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 211 (308)
T cd06634 150 ------------EPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (308)
T ss_pred ------------CCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence 4678999999998765432 2346889999999875 356788999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.||........ ...... ...........+..+.+||.+||+.+|.+||++.+++.+..-.
T Consensus 212 ~p~~~~~~~~~--~~~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 212 PPLFNMNAMSA--LYHIAQ--------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred CCCccccHHHH--HHHHhh--------------cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 99865321110 000000 0000011123456789999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.71 Aligned_cols=273 Identities=28% Similarity=0.417 Sum_probs=200.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhC--CCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~ 205 (511)
.....++++||+|.||+||+|.+. ++.||||++.... ...|..|-+|.+. +.|+||++|+++-.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 356677789999999999999884 5799999997543 3568888888765 48999999999876
Q ss_pred eCC----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEecccCCCcEEeccc
Q 010432 206 EDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------ERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 206 ~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------~~~iiHrDLKp~NILl~~~ 275 (511)
..+ .++||+||.+.|+|.+||..+ .++|....+|+.-+++||+|||+.. +++|+|||||..||||.
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-- 350 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-- 350 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc--
Confidence 655 789999999999999999653 6899999999999999999999643 46799999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCC-----ccccc
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SRSDV 349 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~-----~~~DI 349 (511)
.++...|+|||||..+..+.........+||.+|||||++.+. .+. .+.||
T Consensus 351 -----------------------~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~Dv 407 (534)
T KOG3653|consen 351 -----------------------NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDV 407 (534)
T ss_pred -----------------------cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHH
Confidence 5889999999999887654433333447899999999998753 222 36899
Q ss_pred hhHHHHHHHHHhCCCCCCC-CCCCCchhHHHhhhhhhcccccccc-ccCCccCCCCCH-----HHHHHHHHHHHHhcccC
Q 010432 350 YSFGVVLLEMLTGRRSMDK-NRPNGEHNLVEWARPHLGERRRFYR-LIDPRLEGHFSI-----KGAQKAAQLAAHCLSRD 422 (511)
Q Consensus 350 wSlGvil~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~Li~~cl~~d 422 (511)
||+|.|||||+++..-++. ..+.....+...+.. .+.-..+.. .+....++.++. ....-+.+.+..||+.|
T Consensus 408 YamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~-hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhD 486 (534)
T KOG3653|consen 408 YAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN-HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHD 486 (534)
T ss_pred HHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC-CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCc
Confidence 9999999999998665542 111111111100000 000000000 011111222221 22467889999999999
Q ss_pred CCCCCCHHHHHHHhcCCCCC
Q 010432 423 PKARPLMSEVVEALKPLPNL 442 (511)
Q Consensus 423 P~~RPs~~eil~~L~~l~~~ 442 (511)
|+.|.|+.=+.+.+..+.-+
T Consensus 487 aeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 487 AEARLTAGCVEERMAELMML 506 (534)
T ss_pred hhhhhhhHHHHHHHHHHhcc
Confidence 99999999888887766544
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=305.78 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=203.1
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||+|+||.||++.+.. ++..||+|.+...... ....+.+|+.++++++|+||+++++++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 47888999999999999998765 5779999999764322 234678899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~----------- 137 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLV----------- 137 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEe-----------
Confidence 9999999999999999998652 346889999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
++..+||+|||++....... .....|+..|+|||.+.+..++.++|+||||+++|||++|+.
T Consensus 138 --------------~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~ 199 (256)
T cd08530 138 --------------ANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP 199 (256)
T ss_pred --------------cCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 46779999999998765531 222468899999999998899999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||...... .+..... .......+...+.++.+++.+||+.+|++||++.+++++
T Consensus 200 p~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 200 PFEARSMQ---DLRYKVQ--------------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCCHH---HHHHHHh--------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 99754321 1111000 001112223456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.11 Aligned_cols=269 Identities=28% Similarity=0.330 Sum_probs=197.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.++||+|+||.||+|.+.. ++..||||++...... ....+.+|+++++.++|+||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 4689999999999999999999865 5779999998654322 2245778999999999999999999875
Q ss_pred eCC--------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 206 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 206 ~~~--------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
... .+++||||+. ++|...+......+++..+..++.||+.||.|||+++ |+|+||||+|||++
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~---- 149 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILID---- 149 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC----
Confidence 433 4699999995 5788887666667999999999999999999999998 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc---------eeeeeccccccccCCccccc-CCCCccc
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT---------HVSTRVMGTYGYAAPEYVMT-GHLTSRS 347 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~---------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~ 347 (511)
+++.+||+|||+++........ ...+...|++.|+|||++.+ ..++.++
T Consensus 150 ---------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 208 (311)
T cd07866 150 ---------------------NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV 208 (311)
T ss_pred ---------------------CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchh
Confidence 4778999999999865432211 11123467889999998765 4588999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhh-----cccccccc--------ccCCccCCCCCHHHHHHHHHH
Q 010432 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-----GERRRFYR--------LIDPRLEGHFSIKGAQKAAQL 414 (511)
Q Consensus 348 DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~L 414 (511)
|||||||++|||++|++||.+.........+....... ........ ...+.+...+ ......+.+|
T Consensus 209 Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 287 (311)
T cd07866 209 DIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDL 287 (311)
T ss_pred HhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHH
Confidence 99999999999999999997644322111111000000 00000000 0000000000 1123578899
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 010432 415 AAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 415 i~~cl~~dP~~RPs~~eil~~ 435 (511)
+.+||+.||.+|||+.+++.+
T Consensus 288 i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 288 LSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHcccCcccCcCHHHHhcC
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=311.33 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=202.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cc------cHHHHHHHHHHHhCCCCCCcc
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQ------GHKEWLAEVNFLGDLVHLNLV 198 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~------~~~~~~~E~~il~~l~H~nIv 198 (511)
...++|-++.+||+|||+.||+|.+.. ..+.||||+-..+. .. ..+...+|.+|.+.|+||.||
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIV 530 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV 530 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceee
Confidence 345688899999999999999998875 46699999865432 11 123467899999999999999
Q ss_pred eEeeEEEe-CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 199 KLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 199 ~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
++|+||.- .+.+|-|+|||+|.+|.-||... ..+++..+..|+.||+.||.||.... +||||-||||.||||....
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~Gt- 607 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGT- 607 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCc-
Confidence 99999864 57789999999999999888544 47899999999999999999999876 8899999999999997422
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce-----eeeeccccccccCCcccccC----CCCcccc
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTG----HLTSRSD 348 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~----~~~~~~D 348 (511)
-.+.+||+||||++.+....... ......||.+|++||.+.-+ ..+.|+|
T Consensus 608 ---------------------acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVD 666 (775)
T KOG1151|consen 608 ---------------------ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVD 666 (775)
T ss_pred ---------------------ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccccee
Confidence 25679999999999876654432 23457899999999988633 5688999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 349 VYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 349 IwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||.|||+|..+.|+.||...... ..+.+.. .+..... ......+..+.++.++|++||++.-++|..
T Consensus 667 VWSvGVIFyQClYGrKPFGhnqsQ--QdILqeN--------TIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 667 VWSVGVIFYQCLYGRKPFGHNQSQ--QDILQEN--------TILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred eEeeehhhhhhhccCCCCCCchhH--HHHHhhh--------chhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhh
Confidence 999999999999999999754321 1111110 0000000 000111234678899999999999999988
Q ss_pred HHHHHH
Q 010432 429 MSEVVE 434 (511)
Q Consensus 429 ~~eil~ 434 (511)
..++..
T Consensus 735 V~qLA~ 740 (775)
T KOG1151|consen 735 VQQLAC 740 (775)
T ss_pred HHHHcc
Confidence 777654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=301.44 Aligned_cols=248 Identities=31% Similarity=0.491 Sum_probs=203.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|++++.+++|+||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 47888999999999999998765 567999999987654 2345788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~-------------- 133 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTT-------------- 133 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEC--------------
Confidence 9999999999999999998654 57899999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.++|+|||++......... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 134 -----------~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 134 -----------KDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred -----------CCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 3678999999999876554321 223568999999999888788999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
..... .... ..... . ...++...+..+.+++.+||..+|++||++.+++.
T Consensus 201 ~~~~~--~~~~---~~~~~--------~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 201 DLNPM--AALF---RIVQD--------D----HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CccHH--HHHH---HHhcc--------C----CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 54311 0000 00000 0 11112223577899999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.79 Aligned_cols=268 Identities=24% Similarity=0.296 Sum_probs=197.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC-
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 207 (511)
.+|.+.+.||.|+||.||+|.... ++..||+|.+........+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 689999999999999999998865 6789999999776655556788999999999999999999876543
Q ss_pred -------------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecc
Q 010432 208 -------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 208 -------------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~ 274 (511)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 35789999996 699888743 36889999999999999999999998 999999999999974
Q ss_pred ccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCccccc-CCCCccccchhH
Q 010432 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSF 352 (511)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSl 352 (511)
++..+||+|||+++......... ......|+..|+|||++.. ..++.++|||||
T Consensus 150 ------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl 205 (342)
T cd07854 150 ------------------------EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205 (342)
T ss_pred ------------------------CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence 35678999999997653321111 1122457889999998754 568899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhc--cccccccccC-----CccCCC-----CCHHHHHHHHHHHHHhcc
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--ERRRFYRLID-----PRLEGH-----FSIKGAQKAAQLAAHCLS 420 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-----~~~~~~-----~~~~~~~~~~~Li~~cl~ 420 (511)
||++|+|++|+.||................+... ....+..... ...... +....+.++.+|+.+||+
T Consensus 206 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 285 (342)
T cd07854 206 GCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILT 285 (342)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhC
Confidence 9999999999999975543211111000000000 0000000000 000000 001234678899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 010432 421 RDPKARPLMSEVVEA 435 (511)
Q Consensus 421 ~dP~~RPs~~eil~~ 435 (511)
.||.+||++.+++.+
T Consensus 286 ~dP~~R~t~~ell~h 300 (342)
T cd07854 286 FNPMDRLTAEEALMH 300 (342)
T ss_pred CCchhccCHHHHhCC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.24 Aligned_cols=255 Identities=27% Similarity=0.348 Sum_probs=196.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
+|++.+.||.|+||.||+|+..... .+|..||+|+++.... ...+.+.+|+.+|.++ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~------~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH------DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC------CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 4788899999999999999875321 2578999999975422 2235678899999999 699999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..+...++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~----------- 139 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLD----------- 139 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEC-----------
Confidence 9999999999999999999998654 46888999999999999999999988 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc--CCCCccccchhHHHHHHHHHhC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil~elltg 362 (511)
+++.+||+|||++......... ......|+..|+|||++.. ..++.++|||||||++|+|++|
T Consensus 140 --------------~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g 204 (290)
T cd05613 140 --------------SNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204 (290)
T ss_pred --------------CCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence 4778999999999865432211 1223568999999999875 3478899999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 434 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~ 434 (511)
..||........ ........... ...++...+..+.+|+.+||+.||++|| ++.+++.
T Consensus 205 ~~p~~~~~~~~~--~~~~~~~~~~~------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 205 ASPFTVDGEKNS--QAEISRRILKS------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCCCcCCcccc--HHHHHHHhhcc------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 999964322111 11111110000 0111222356788999999999999997 5666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=310.75 Aligned_cols=254 Identities=30% Similarity=0.435 Sum_probs=196.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|.+.. +++.||||.++..... ....+.+|+.++.++ .|+||+++++++.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 4678899999999999999999865 5779999999764322 234567788777777 4999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.....++||||+ +++|.+++......+++..+..++.||+.||+|||+ ++ |+||||+|+|||++
T Consensus 85 ~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~----------- 149 (296)
T cd06618 85 TDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLD----------- 149 (296)
T ss_pred cCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEc-----------
Confidence 999999999998 458887776555578999999999999999999997 46 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC----CCccccchhHHHHHHHHH
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DIwSlGvil~ell 360 (511)
+++.+||+|||++........ .....|+..|+|||++.+.. ++.++|||||||++|+|+
T Consensus 150 --------------~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~ 212 (296)
T cd06618 150 --------------ASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212 (296)
T ss_pred --------------CCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH
Confidence 477899999999976543222 12245788999999987543 889999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+|+.||...... ...... ..... .+... .....+..+.+|+.+||+.||.+||++.+++++.
T Consensus 213 ~g~~p~~~~~~~--~~~~~~---~~~~~-------~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 213 TGQFPYKNCKTE--FEVLTK---ILQEE-------PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred hCCCCCCcchhH--HHHHHH---HhcCC-------CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 999999643211 011100 00000 00000 0012356789999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=305.37 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=195.4
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
||.|+||.||+|++.. +|+.||+|++..... .....+.+|++++++++|+||+++++.+..+...|+|
T Consensus 1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999999865 578999999976543 2345688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++++|.+++.+.. .+++..+..++.||+.||+|||+++ |+|+||+|+|||++
T Consensus 72 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~-------------------- 127 (265)
T cd05579 72 MEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILID-------------------- 127 (265)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEc--------------------
Confidence 99999999999986544 7899999999999999999999988 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCc------ceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
+++.++|+|||++........ ........++..|+|||++....++.++||||||+++|+|++|..||.
T Consensus 128 -----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 128 -----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred -----CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 477899999999886543321 111233568899999999988889999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
...... ..... ...... .... ...+..+.+|+.+||+.+|.+||++..+.+.|+
T Consensus 203 ~~~~~~---~~~~~---~~~~~~--------~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 203 GETPEE---IFQNI---LNGKIE--------WPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCHHH---HHHHH---hcCCcC--------CCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 543211 11100 000000 0000 012577899999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=316.06 Aligned_cols=265 Identities=25% Similarity=0.300 Sum_probs=196.6
Q ss_pred cCCCC-CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--------------HHHHHHHHHHHhCCC
Q 010432 129 RNFRP-ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------HKEWLAEVNFLGDLV 193 (511)
Q Consensus 129 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--------------~~~~~~E~~il~~l~ 193 (511)
++|.. .+.||.|+||+||+|.+.. +++.||||.+....... ...+.+|+.+++.++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 45654 4679999999999998765 57799999987543221 124778999999999
Q ss_pred CCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 194 H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
|+||+++++++...+..++||||+. |+|.+++.. ...+++.....++.||+.||.|||+.+ |+|+||||+|||++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~ 153 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN 153 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence 9999999999999999999999995 699998854 346899999999999999999999988 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCc------------ceeeeeccccccccCCcccccC
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG 341 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~aPE~~~~~ 341 (511)
.++.+||+|||++........ ........++..|+|||++.+.
T Consensus 154 -------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 154 -------------------------SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred -------------------------CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 467899999999986541110 0011223568899999998764
Q ss_pred -CCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc--cccc------------cccCCccCCCCCHH
Q 010432 342 -HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--RRFY------------RLIDPRLEGHFSIK 406 (511)
Q Consensus 342 -~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~------------~~~~~~~~~~~~~~ 406 (511)
.++.++|||||||++|||++|..||......... ..+....... ..+. ......+. .....
T Consensus 209 ~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 284 (335)
T PTZ00024 209 EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPN 284 (335)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcC
Confidence 4789999999999999999999999765432111 1111000000 0000 00000000 00112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 407 ~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
.+..+.+|+.+||+.+|++||++.+++.+-
T Consensus 285 ~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 285 ASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 256788999999999999999999999754
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=317.67 Aligned_cols=267 Identities=25% Similarity=0.329 Sum_probs=201.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+|++.+.||.|+||.||+|++.. ++..||||.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 58889999999999999999765 57799999997643 23345788999999999999999999998876
Q ss_pred C-----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 208 ~-----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+ ..|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~--------- 137 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVN--------- 137 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc---------
Confidence 5 7899999996 5899888554 37899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~ell 360 (511)
+++.++|+|||++......... .......+|..|+|||++.+. .++.++|||||||++|+|+
T Consensus 138 ----------------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~ 201 (330)
T cd07834 138 ----------------SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201 (330)
T ss_pred ----------------CCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHH
Confidence 4788999999999876553210 112334689999999999877 8899999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhc-------ccccccccc---CCccC---CCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLG-------ERRRFYRLI---DPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~---~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
+|..||...........+........ ........+ ..... .......+..+.+||.+||+.+|.+||
T Consensus 202 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 281 (330)
T cd07834 202 TRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI 281 (330)
T ss_pred cCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC
Confidence 99999976543211111000000000 000000000 00000 000112356789999999999999999
Q ss_pred CHHHHHHH
Q 010432 428 LMSEVVEA 435 (511)
Q Consensus 428 s~~eil~~ 435 (511)
++.+++.+
T Consensus 282 t~~~ll~~ 289 (330)
T cd07834 282 TADEALAH 289 (330)
T ss_pred CHHHHHhC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=298.20 Aligned_cols=271 Identities=26% Similarity=0.351 Sum_probs=208.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..|+-..+||+|.||.||+|+.++ +|+.||+|++--+ ...-....++|+++|..|.|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 346666789999999999999876 6788999876432 22223567899999999999999999988753
Q ss_pred --------CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 207 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 207 --------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
...+||||.+|+. ||..+|......++...+.+++.++..||.|+|.+. |+|||+||+|+||+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt----- 158 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLIT----- 158 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEc-----
Confidence 2347999999965 999999877788999999999999999999999998 99999999999999
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCccccc-CCCCccccchhHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 355 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvi 355 (511)
.++.+||+|||+++.+...... ...+..+-|.+|++||.+.+ ..|+++.|||..|||
T Consensus 159 --------------------~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCi 218 (376)
T KOG0669|consen 159 --------------------KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCI 218 (376)
T ss_pred --------------------CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHH
Confidence 4889999999999865432221 12334566999999999886 579999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhc-----ccc--cccccc--CCccCCCCCH--------HHHHHHHHHHHHh
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-----ERR--RFYRLI--DPRLEGHFSI--------KGAQKAAQLAAHC 418 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~--~~~~~~~~~~--------~~~~~~~~Li~~c 418 (511)
+.||+||.+.|.+........++...+.... +.. .+++.+ .|...+.+.. .-.+++.+|+.++
T Consensus 219 maeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~l 298 (376)
T KOG0669|consen 219 MAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKL 298 (376)
T ss_pred HHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHH
Confidence 9999999999998876655555554443221 111 111111 1111111110 1135788999999
Q ss_pred cccCCCCCCCHHHHHHHhc
Q 010432 419 LSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 419 l~~dP~~RPs~~eil~~L~ 437 (511)
|..||.+|+.+++++++--
T Consensus 299 l~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 299 LKLDPTKRIDADQALNHDF 317 (376)
T ss_pred hccCcccCcchHhhhchhh
Confidence 9999999999999998754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.58 Aligned_cols=256 Identities=23% Similarity=0.268 Sum_probs=188.5
Q ss_pred CCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEEEccC
Q 010432 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 218 (511)
Q Consensus 141 ~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~ 218 (511)
++|.||.++... +++.||||+++... ......+.+|+.+++.++|+||+++++++...+..+++|||++
T Consensus 12 ~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 12 DLMIVHLAKHKP---------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred CCceEEEEEecC---------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 444555555443 57899999997652 2334578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccc
Q 010432 219 RGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297 (511)
Q Consensus 219 ~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (511)
+|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~------------------------ 135 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLS------------------------ 135 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEe------------------------
Confidence 99999998753 346889999999999999999999998 99999999999998
Q ss_pred cccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 298 FQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 298 ~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||.+......... .......++..|+|||++.. ..++.++|||||||++|||++|..||....
T Consensus 136 -~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 136 -GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred -cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4678999999998755332211 01123457889999999875 468899999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhcc----------cccccc----ccC----CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 371 PNGEHNLVEWARPHLGE----------RRRFYR----LID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~----------~~~~~~----~~~----~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
... ............ ...... ... ...........+.++.+|+.+||+.||++|||+.++
T Consensus 215 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 292 (314)
T cd08216 215 ATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292 (314)
T ss_pred HHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH
Confidence 211 111111100000 000000 000 001111223446788999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 293 l~~ 295 (314)
T cd08216 293 LNH 295 (314)
T ss_pred hcC
Confidence 974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=304.68 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=195.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---c--ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---L--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~--~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
+|.+.+.||+|+||.||++++.. ++..+++|+++... . .....+.+|+.++++++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 47888999999999999998765 33456666655321 1 1223567899999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
.+....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~-------- 140 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLK-------- 140 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEee--------
Confidence 999999999999999999988853 3456899999999999999999999988 99999999999997
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
+..+||+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 141 ------------------~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 200 (260)
T cd08222 141 ------------------NNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200 (260)
T ss_pred ------------------cCCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 34599999999987644322 1223568899999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|..||...... ... .... .. .....+...+..+.++|.+||..||++||++.+++++
T Consensus 201 ~~~~~~~~~~~---~~~---~~~~-------~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 201 LAHAFEGQNFL---SVV---LRIV-------EG----PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCCCccHH---HHH---HHHH-------cC----CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 99999643211 111 0000 00 0111233446788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=304.71 Aligned_cols=262 Identities=24% Similarity=0.301 Sum_probs=195.9
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCC---CCCCcceEeeEEE
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGYCI 205 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~H~nIv~l~~~~~ 205 (511)
|++.+.||+|+||.||+|+++. ++..||||+++..... ....+.+|+.+++++ +|+||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 5677899999999999999865 5779999999754322 123466788777665 6999999999998
Q ss_pred eCCe-----EEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 EDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~~-----~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
..+. .+++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||+|+|||++
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~------ 141 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVT------ 141 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEc------
Confidence 8776 899999996 58999886543 35899999999999999999999988 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
+++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||
T Consensus 142 -------------------~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 142 -------------------SDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred -------------------cCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHH
Confidence 467899999999987644322 1224578999999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhc-ccccc-------ccccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRF-------YRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~~~~---~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
++|..||........ +......... ....+ ........ ........+..+.+|+.+||+.||.+||+
T Consensus 200 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~ 277 (287)
T cd07838 200 FRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS 277 (287)
T ss_pred HhCCCcccCCChHHH--HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC
Confidence 999999976433211 1111100000 00000 00000000 01111233577889999999999999999
Q ss_pred HHHHHHH
Q 010432 429 MSEVVEA 435 (511)
Q Consensus 429 ~~eil~~ 435 (511)
+.+++.+
T Consensus 278 ~~~il~~ 284 (287)
T cd07838 278 AFEALQH 284 (287)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=306.35 Aligned_cols=266 Identities=29% Similarity=0.432 Sum_probs=203.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhC--CCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~ 204 (511)
..++..+.+.||+|.||.||+|+|+ |..||||++.... ...|.+|.+|.+. |+|+||+.|++.-
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 4567888999999999999999995 7799999997543 3568899888865 5999999999876
Q ss_pred EeC----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeEecccCCCcEEeccc
Q 010432 205 IED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-----EEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 205 ~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH-----~~~~~~iiHrDLKp~NILl~~~ 275 (511)
..+ ..+|||.+|.+.|+|++||.+ ..++....++++.-+|.||+||| .+|++.|.|||||..|||+.
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-- 350 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-- 350 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc--
Confidence 544 367999999999999999966 47899999999999999999999 45778899999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCcccccC----CC--Cccc
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG----HL--TSRS 347 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~----~~--~~~~ 347 (511)
.++.+.|+|+|||......... ...+..+||.+|||||++... .+ -..+
T Consensus 351 -----------------------kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~A 407 (513)
T KOG2052|consen 351 -----------------------KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRA 407 (513)
T ss_pred -----------------------cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHH
Confidence 4888999999999865543221 123346899999999998642 12 1358
Q ss_pred cchhHHHHHHHHHhC----------CCCCCCCCCCCchhHHHhhhhhhcccccc--ccccCCccCCC-CCHHHHHHHHHH
Q 010432 348 DVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRF--YRLIDPRLEGH-FSIKGAQKAAQL 414 (511)
Q Consensus 348 DIwSlGvil~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~L 414 (511)
||||||+|+||+..+ +.||++..+.+- .+.+.... .+-+.|.+... .+.+....+.+|
T Consensus 408 DIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP---------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~kl 478 (513)
T KOG2052|consen 408 DIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP---------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKL 478 (513)
T ss_pred HHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC---------CHHHHhcceeecccCCCCCcccccCHHHHHHHHH
Confidence 999999999999863 567765443321 01111100 01112222221 234556788899
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 010432 415 AAHCLSRDPKARPLMSEVVEALKPLPNL 442 (511)
Q Consensus 415 i~~cl~~dP~~RPs~~eil~~L~~l~~~ 442 (511)
|+.||..||..|-|+-.|-+.|.++.+.
T Consensus 479 MkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 479 MKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred HHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 9999999999999999999999877643
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.76 Aligned_cols=259 Identities=27% Similarity=0.345 Sum_probs=200.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
+|++.+.||+|+||.||+++..... .++..||||+++.... .....+.+|+.++.++ +|+||+++++++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH------DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc------cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 4778889999999999999865322 2577899999975422 2234578899999999 699999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..+...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~----------- 139 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLD----------- 139 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC-----------
Confidence 9999999999999999999998654 46889999999999999999999988 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC--CCccccchhHHHHHHHHHhC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DIwSlGvil~elltg 362 (511)
.++.++|+|||+++........ ......|+..|+|||++.+.. ++.++||||||+++|||++|
T Consensus 140 --------------~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg 204 (288)
T cd05583 140 --------------SEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204 (288)
T ss_pred --------------CCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence 4677999999999875443221 122346899999999987654 78899999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
..||........ ........... .+ ..+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 205 ~~p~~~~~~~~~--~~~~~~~~~~~--------~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 205 ASPFTVDGEQNS--QSEISRRILKS--------KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCcccCcccch--HHHHHHHHHcc--------CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 999964322111 11111111000 01 1112234678999999999999999998888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=337.65 Aligned_cols=269 Identities=29% Similarity=0.458 Sum_probs=213.2
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEe
Q 010432 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLI 201 (511)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~ 201 (511)
+++..++..+.+.||+|.||.|++|......... ......||||.++..... ..+.+..|+++|+.+ .|+|||.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 4445556667779999999999999876422211 112568999999876543 446789999999999 699999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLK 266 (511)
|+|......++|+|||..|+|.++|.... ..+.....+.++.|||.||+||++.. +|||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 99999999999999999999999997654 34888999999999999999999988 9999999
Q ss_pred CCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccc--cccccCCcccccCCCC
Q 010432 267 TSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTGHLT 344 (511)
Q Consensus 267 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G--t~~y~aPE~~~~~~~~ 344 (511)
.+|||+. ++..+||+|||+|+.......+.... ..| ...|||||.+....|+
T Consensus 446 aRNVLi~-------------------------~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft 499 (609)
T KOG0200|consen 446 ARNVLIT-------------------------KNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFT 499 (609)
T ss_pred hhhEEec-------------------------CCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCccc
Confidence 9999999 47789999999999766655443221 122 4569999999999999
Q ss_pred ccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 345 SRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 345 ~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
.++|||||||+||||+| |..||.+... ...+.+ .+....+...+..+..++.+||+.||+.+|
T Consensus 500 ~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~l~~--------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p 563 (609)
T KOG0200|consen 500 SKSDVWSFGILLWEIFTLGGTPYPGIPP--TEELLE--------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADP 563 (609)
T ss_pred ccchhhHHHHHHHHHhhCCCCCCCCCCc--HHHHHH--------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCc
Confidence 99999999999999999 6788865211 111111 122222333444567889999999999999
Q ss_pred CCCCCHHHHHHHhcCC
Q 010432 424 KARPLMSEVVEALKPL 439 (511)
Q Consensus 424 ~~RPs~~eil~~L~~l 439 (511)
++||++.++.+.|+.+
T Consensus 564 ~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 564 EDRPTFSECVEFFEKH 579 (609)
T ss_pred ccCCCHHHHHHHHHHH
Confidence 9999999999998874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=307.97 Aligned_cols=251 Identities=27% Similarity=0.351 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCC-CCCcceEeeEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-H~nIv~l~~~~ 204 (511)
++|.+.+.||+|+||.||+|.... ++..||+|++..... .....+.+|+.++.++. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 368899999999999999998865 577999999976432 22346788999999998 99999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~----------- 136 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLD----------- 136 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEEC-----------
Confidence 9999999999999999999999654 37999999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcc------------------eeeeeccccccccCCcccccCCCCcc
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSR 346 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~ 346 (511)
.++.++|+|||++......... .......|+..|+|||++....++.+
T Consensus 137 --------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~ 202 (280)
T cd05581 137 --------------KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202 (280)
T ss_pred --------------CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh
Confidence 4778999999999865443211 11223568899999999988889999
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 347 ~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
+|||||||++|+|++|+.||....... ..... .. ....++...++.+.+|+.+||+.||.+|
T Consensus 203 ~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~---~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R 264 (280)
T cd05581 203 SDLWALGCIIYQMLTGKPPFRGSNEYL---TFQKI---LK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDR 264 (280)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHH---Hh------------cCCCCCCccCHHHHHHHHHHhcCCHhhC
Confidence 999999999999999999997543110 00000 00 0111222235778999999999999999
Q ss_pred CCH----HHHHHH
Q 010432 427 PLM----SEVVEA 435 (511)
Q Consensus 427 Ps~----~eil~~ 435 (511)
|++ .+++++
T Consensus 265 ~~~~~~~~~ll~~ 277 (280)
T cd05581 265 LGVNEGYDELKAH 277 (280)
T ss_pred CCcccCHHHHhcC
Confidence 999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.47 Aligned_cols=264 Identities=27% Similarity=0.370 Sum_probs=197.7
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCC-CCCcceEeeEEEeCC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDD 208 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~ 208 (511)
|++.+.||+|+||.||+|+... +++.||||.+...... ......+|+..+++++ |+||+++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6678899999999999999865 5779999998754322 2234567999999999 999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..++||||+ +|+|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||+|+||+++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~-------------- 133 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVS-------------- 133 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEc--------------
Confidence 999999999 889999886543 46899999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.++|+|||++........ .....|+..|+|||++. ...++.++||||||+++|||++|+.||
T Consensus 134 -----------~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~ 199 (283)
T cd07830 134 -----------GPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199 (283)
T ss_pred -----------CCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence 478899999999986644322 22346889999999885 456789999999999999999999999
Q ss_pred CCCCCCCchhH-HHhhhhh----hccccccccccCCccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 367 DKNRPNGEHNL-VEWARPH----LGERRRFYRLIDPRLE-------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 367 ~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
........... ....... +.+........+..+. .......+..+.+|+.+||+.||++||++.|++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 200 PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 76533211100 0000000 0000000000000000 0000111467899999999999999999999986
Q ss_pred H
Q 010432 435 A 435 (511)
Q Consensus 435 ~ 435 (511)
+
T Consensus 280 ~ 280 (283)
T cd07830 280 H 280 (283)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.48 Aligned_cols=269 Identities=24% Similarity=0.293 Sum_probs=193.2
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCC-CCCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 206 (511)
+|++.+.||+|+||.||++++.... .+..||||++..... .....+.+|+.+++++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 4778889999999999999986521 167899999875321 2235678899999999 59999999987543
Q ss_pred C----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 207 D----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 207 ~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
. ...+++|||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~--------- 139 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVN--------- 139 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEc---------
Confidence 2 45789999984 699998854 457899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCccccc-CCCCccccchhHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++........ .......||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 140 ----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l 203 (332)
T cd07857 140 ----------------ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203 (332)
T ss_pred ----------------CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 4678999999999865432211 11223578999999998765 5689999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhh--------hh-ccc-ccccccc---CCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARP--------HL-GER-RRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~--------~~-~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
++|..||................. .+ ... ..+.... ............+..+.+|+.+||+.||.+|
T Consensus 204 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 283 (332)
T cd07857 204 LGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283 (332)
T ss_pred HhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccC
Confidence 999999975432111000000000 00 000 0000000 0000000011124678999999999999999
Q ss_pred CCHHHHHHH
Q 010432 427 PLMSEVVEA 435 (511)
Q Consensus 427 Ps~~eil~~ 435 (511)
|++.+++.+
T Consensus 284 ~t~~~ll~~ 292 (332)
T cd07857 284 ISVEEALEH 292 (332)
T ss_pred CCHHHHhcC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=316.30 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=193.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..+|.+.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.++++++|+||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 3689999999999999999998765 678999999875422 12345789999999999999999999987
Q ss_pred eCC------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
... ..++||||+. .+|..++ ...+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~------ 151 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN------ 151 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC------
Confidence 542 4689999995 4777765 236889999999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++||
T Consensus 152 -------------------~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~e 207 (342)
T cd07879 152 -------------------EDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAE 207 (342)
T ss_pred -------------------CCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHH
Confidence 47789999999998653321 23467889999999876 468999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhh--------hhccc--cccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARP--------HLGER--RRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKA 425 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~Li~~cl~~dP~~ 425 (511)
|++|+.||...........+..... ..... ............... ....+..+.+||.+||+.||.+
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 287 (342)
T cd07879 208 MLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDK 287 (342)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhh
Confidence 9999999976432111110000000 00000 000000000000000 0112467889999999999999
Q ss_pred CCCHHHHHHH
Q 010432 426 RPLMSEVVEA 435 (511)
Q Consensus 426 RPs~~eil~~ 435 (511)
||++.+++.+
T Consensus 288 R~~~~e~l~h 297 (342)
T cd07879 288 RLTATEALEH 297 (342)
T ss_pred CcCHHHHhcC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=305.29 Aligned_cols=264 Identities=27% Similarity=0.386 Sum_probs=200.3
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
|+..+.||+|+||.||+|+... +++.||+|++.... ......+.+|+.++++++|+||+++++++...+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 5667889999999999998865 57799999998653 222356788999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..++||||+. ++|.+++......+++..++.++.|++.||.|||+++ |+||||+|+||+++
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~--------------- 132 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILIN--------------- 132 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEc---------------
Confidence 9999999996 5999999765457999999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
+++.+||+|||+++........ .....++..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 133 ----------~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 133 ----------RDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred ----------CCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 4778999999999876543221 2224567889999998766 88999999999999999999999997
Q ss_pred CCCCCCchhH-HHhhh-------hhhccccccccccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNL-VEWAR-------PHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.......... ..... ........ ....-+.... ......+..+.+++.+||+.||.+||++.+++.+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 201 GDSEIDQLFKIFQILGTPTEESWPGVTKLPD-YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred CccHHHHHHHHHHHhCCCcHHHHHhhccccc-ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 6432211100 00000 00000000 0000000000 0001125679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.74 Aligned_cols=146 Identities=22% Similarity=0.259 Sum_probs=127.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|.++++||+|+||.||+|++.. +++.||||+++...... ...+.+|+.++..++|+||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 578999999999999999999875 57799999997643322 256788999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+.+||||||+.+++|.+++... ..+++..++.|+.||+.||+|||.++ ||||||||+||||+..+...+.+||+
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999999999999998653 46888999999999999999999988 99999999999999777677777776
Q ss_pred ee
Q 010432 286 CI 287 (511)
Q Consensus 286 ~~ 287 (511)
..
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.86 Aligned_cols=269 Identities=24% Similarity=0.343 Sum_probs=199.3
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcce
Q 010432 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~ 199 (511)
.++....++|.+.+.||+|+||.||+|.+.. ++..||||++..... ...+.+.+|+.++++++|+||++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~ 80 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccc
Confidence 3445567899999999999999999998765 677999999975422 22356788999999999999999
Q ss_pred EeeEEEeC------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 200 LIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 200 l~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
+++++... ...+++++++ +++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~ 154 (345)
T cd07877 81 LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 154 (345)
T ss_pred eeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEc
Confidence 99988643 3468888887 8899888753 35899999999999999999999998 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSF 352 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSl 352 (511)
+++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||
T Consensus 155 -------------------------~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 204 (345)
T cd07877 155 -------------------------EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 204 (345)
T ss_pred -------------------------CCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHH
Confidence 4778999999999865332 123468899999998866 568899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhh--------hhhccc--cccccccCCccCCCC---CHHHHHHHHHHHHHhc
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------PHLGER--RRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCL 419 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~Li~~cl 419 (511)
||++|||++|+.||...........+.... ..+... ..+...+.......+ ....+..+.+||.+||
T Consensus 205 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 284 (345)
T cd07877 205 GCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 284 (345)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHc
Confidence 999999999999996543221111000000 000000 000000000000000 0112567899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 010432 420 SRDPKARPLMSEVVEA 435 (511)
Q Consensus 420 ~~dP~~RPs~~eil~~ 435 (511)
+.||.+||++.+++.+
T Consensus 285 ~~dp~~R~t~~e~l~h 300 (345)
T cd07877 285 VLDSDKRITAAQALAH 300 (345)
T ss_pred CCChhhcCCHHHHhcC
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.61 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=198.1
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEee
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
...+++|++.+.||.|+||.||+|.+.. ++..||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 76 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence 3466789999999999999999998765 677999998864322 22356789999999999999999999
Q ss_pred EEEe-CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 203 YCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 203 ~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
++.. ....++||||+ +++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~-------- 142 (328)
T cd07856 77 IFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILIN-------- 142 (328)
T ss_pred eEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeEC--------
Confidence 9876 56788999999 6799888753 35788888899999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ell 360 (511)
+++.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 143 -----------------~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 143 -----------------ENCDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred -----------------CCCCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 46789999999998643321 22467889999998765 57899999999999999999
Q ss_pred hCCCCCCCCCCCCchhHH-Hhh--------hhhh-ccccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCC
Q 010432 361 TGRRSMDKNRPNGEHNLV-EWA--------RPHL-GERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKA 425 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~-~~~--------~~~~-~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~Li~~cl~~dP~~ 425 (511)
+|+.||............ ... .... .....+..... .....+ ...+..+.++|.+||+.+|++
T Consensus 201 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 278 (328)
T cd07856 201 EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQK 278 (328)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhh
Confidence 999999754321110000 000 0000 00000000000 000011 113467899999999999999
Q ss_pred CCCHHHHHHH
Q 010432 426 RPLMSEVVEA 435 (511)
Q Consensus 426 RPs~~eil~~ 435 (511)
||++.+++.+
T Consensus 279 R~t~~ell~~ 288 (328)
T cd07856 279 RISAAEALAH 288 (328)
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=318.23 Aligned_cols=246 Identities=26% Similarity=0.284 Sum_probs=199.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
+++.|.+...+|.|+|+.|-.+.+.. +++.+++|++.... .+..+|+.++... +|+||+++++.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc---------cccchhheeccccc----cccccccchhhhhcCCCcceeecceec
Confidence 35678888889999999999998876 67899999998762 2234677666665 7999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++.+.|+|||++.|+-|.+.+.... .+. ..+..|+.+|+.|+.|||++| ||||||||+|||++.
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~----------- 450 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDG----------- 450 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecC-----------
Confidence 9999999999999998888775433 222 677789999999999999999 999999999999951
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
..++++|+|||.++..... ..+.+-|..|.|||++....|+.++||||||++||+||+|+.|
T Consensus 451 -------------~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp 512 (612)
T KOG0603|consen 451 -------------SAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTL 512 (612)
T ss_pred -------------CCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCc
Confidence 4778999999999987654 2223568899999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
|...... .++... + ..+.+....+..+++|+.+||+.||.+||++.++..+-..
T Consensus 513 ~~~~P~~--~ei~~~-------------i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 513 FAAHPAG--IEIHTR-------------I----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cccCCch--HHHHHh-------------h----cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 9765432 111111 1 1223334557889999999999999999999999876443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=312.05 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=196.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+.+|++++|+||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 45689999999999999999998765 5779999998653222 234578999999999999999999998
Q ss_pred EeCC------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 205 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 205 ~~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
..+. ..++||||+ +++|..++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~----- 152 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVN----- 152 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc-----
Confidence 7643 458999999 7899888753 46899999999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ 357 (511)
+++.+||+|||++....... ....+++.|+|||++.+ ..++.++|||||||++|
T Consensus 153 --------------------~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~ 207 (343)
T cd07880 153 --------------------EDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207 (343)
T ss_pred --------------------CCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 47789999999998654321 22467899999998875 45889999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhhhccc------------cccccccCCccCC---CCCHHHHHHHHHHHHHhcccC
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGER------------RRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRD 422 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~---~~~~~~~~~~~~Li~~cl~~d 422 (511)
+|++|..||....... ............. ..+...+...... ......+..+.++|.+||+.|
T Consensus 208 ~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 285 (343)
T cd07880 208 EMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLD 285 (343)
T ss_pred HHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCC
Confidence 9999999997543211 1110000000000 0000000000000 011123456889999999999
Q ss_pred CCCCCCHHHHHHH
Q 010432 423 PKARPLMSEVVEA 435 (511)
Q Consensus 423 P~~RPs~~eil~~ 435 (511)
|.+|||+.+++.+
T Consensus 286 P~~R~t~~~~l~~ 298 (343)
T cd07880 286 AESRITAAEALAH 298 (343)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=323.90 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=211.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
..+..++||+|+||+||+|.+.-.++. -..+||||++..... +...+++.|+-+|.+|+|||+++|+++|....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 345567899999999999988654332 345899999976543 34578999999999999999999999998776
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
+.||++|++.|+|.+|++.....+-....+.|..|||+||.|||.+. ++||||..+|||+..
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVks-------------- 833 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKS-------------- 833 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecC--------------
Confidence 78999999999999999887778889999999999999999999988 999999999999984
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~ 367 (511)
-..+||.|||+++.+.............-.+.|||-|.+....|+.++|||||||++||++| |..|+.
T Consensus 834 -----------P~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 834 -----------PNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred -----------CCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 56799999999998876554433333445678999999999999999999999999999998 889988
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
+.......++.+ ...+...+..++.++..+|.+||..|+..||+|+++...+.+
T Consensus 903 gi~~~eI~dlle-----------------~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 903 GIPAEEIPDLLE-----------------KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCHHHhhHHHh-----------------ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 765433322221 111223344567889999999999999999999999876643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.54 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=201.6
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHH---HHHHHHHHHhCC-CCCCcceE
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL-VHLNLVKL 200 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~---~~~~E~~il~~l-~H~nIv~l 200 (511)
....++|.++++||+|+|++|.+++++. |.+.||+|++++.-....+ -+..|-.+..+. +||.+|-|
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvgl 316 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGL 316 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEeh
Confidence 3456899999999999999999999876 7889999999876443322 345677777666 79999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+.+|+.+..+++|.||++||+|.-++.+ ...++++.+..+...|..||.|||+.| ||+||||.+|+||+.
T Consensus 317 hscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvllda------ 386 (593)
T KOG0695|consen 317 HSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDA------ 386 (593)
T ss_pred hhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEcc------
Confidence 9999999999999999999999877754 457999999999999999999999999 999999999999995
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.+++||+|+|+++....... ...+++||+.|+|||++.+..|+..+|+|+|||+++||+
T Consensus 387 -------------------eghikltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm 445 (593)
T KOG0695|consen 387 -------------------EGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 445 (593)
T ss_pred -------------------CCceeecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH
Confidence 88999999999987544332 245689999999999999999999999999999999999
Q ss_pred hCCCCCCCCC-CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 361 TGRRSMDKNR-PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 361 tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
.|+.||+... .+...+...+....+- ...+ .++...+-.+..+++..|.+||.+|..
T Consensus 446 agrspfdivgm~n~d~ntedylfqvil---------ekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 446 AGRSPFDIVGMDNPDMNTEDYLFQVIL---------EKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cCCCCcceecCCCcccchhHHHHHHHh---------hhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 9999997432 1112222222221111 1111 112223456678999999999999963
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=293.07 Aligned_cols=254 Identities=27% Similarity=0.345 Sum_probs=195.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 206 (511)
.+.+.+..||.|+||+|++-.++. +|+..|||+++.... ....+++.|.++..+- +.||||++||.+..
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~---------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKP---------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCc---------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 344556679999999999988766 788999999987655 4456788898875554 79999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHh----hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 207 DDQRLLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++..||.||+| .-+|..+.. .....+++...-.|....+.||.||-..- .|||||+||+||||+.
T Consensus 135 EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr-------- 203 (361)
T KOG1006|consen 135 EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDR-------- 203 (361)
T ss_pred CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEec--------
Confidence 98999999999 457765542 13457889988899999999999998643 3999999999999994
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc--cCCCCccccchhHHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DIwSlGvil~ell 360 (511)
.+.+||||||++-.+.+.- ..+.-.|...|||||.+. ...|+.++||||||++|||+.
T Consensus 204 -----------------~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvA 263 (361)
T KOG1006|consen 204 -----------------HGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVA 263 (361)
T ss_pred -----------------CCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeee
Confidence 7789999999998765432 244567999999999986 346999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG-HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
||+.|+..-.. ..+.+....... .|.+.. .-..+.+..+..+|..||.+|-.+||...+++.
T Consensus 264 tG~fPyr~w~s-----vfeql~~Vv~gd-------pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 264 TGNFPYRKWDS-----VFEQLCQVVIGD-------PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCCCCcchHHH-----HHHHHHHHHcCC-------CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 99999975321 222222111110 011111 111335678999999999999999999998875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.69 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=197.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|++.. ++..||||++..... .....+.+|+.++++++|+||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 35689999999999999999999875 577999999875422 2234577899999999999999999988
Q ss_pred EeCCe------EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 205 IEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 205 ~~~~~------~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
...+. .++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~----- 152 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVN----- 152 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC-----
Confidence 76554 89999999 7799998854 46899999999999999999999988 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ 357 (511)
+++.+||+|||++...... .....+|..|+|||++.+ ..++.++|||||||++|
T Consensus 153 --------------------~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ 207 (343)
T cd07851 153 --------------------EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207 (343)
T ss_pred --------------------CCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHH
Confidence 4778999999999876432 223467899999998865 46789999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhhhc----cc------cccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCC
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLG----ER------RRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~~~----~~------~~~~~~~~~~~~~~~---~~~~~~~~~~Li~~cl~~dP~ 424 (511)
||++|+.||...........+........ .. ..+...+.......+ ....+..+.+||.+||+.||.
T Consensus 208 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~ 287 (343)
T cd07851 208 ELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD 287 (343)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChh
Confidence 99999999975432211100000000000 00 000000000000000 011257789999999999999
Q ss_pred CCCCHHHHHHH
Q 010432 425 ARPLMSEVVEA 435 (511)
Q Consensus 425 ~RPs~~eil~~ 435 (511)
+|||+.+|+++
T Consensus 288 ~Rpt~~ell~h 298 (343)
T cd07851 288 KRITAAEALAH 298 (343)
T ss_pred hCCCHHHHhcC
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.75 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=212.4
Q ss_pred hHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcce
Q 010432 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVK 199 (511)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~ 199 (511)
++.+...+..|++.+.||.|.+|.||+++.+. +++.+|||++...... .++...|.+||+.+ +|||++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~ 80 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVAT 80 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcce
Confidence 33344456789999999999999999999876 6778999998766433 35677899999888 7999999
Q ss_pred EeeEEEe-----CCeEEEEEEccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 200 LIGYCIE-----DDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 200 l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
+||+|.. ++.+|||||||.+|+.-+++.. .+..+.|..+..|++.++.||.+||.+. +||||||-.|||++
T Consensus 81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT 157 (953)
T KOG0587|consen 81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLT 157 (953)
T ss_pred EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEe
Confidence 9999874 5789999999999999998863 2567899999999999999999999988 99999999999999
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----CCCCcccc
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSD 348 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~D 348 (511)
.++.|||+|||++..+..... ...+.+||+.|||||++.. ..|+..+|
T Consensus 158 -------------------------~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D 210 (953)
T KOG0587|consen 158 -------------------------ENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSD 210 (953)
T ss_pred -------------------------ccCcEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccc
Confidence 488899999999987755332 2445789999999999963 35788999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhcccccccccc-CCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 349 VYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI-DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 349 IwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
+||||++..||.-|.+|+.+..+.- .++.+. +|.....-+..+++++.++|..||..|-.+||
T Consensus 211 ~WsLGITaIEladG~PPl~DmHPmr----------------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP 274 (953)
T KOG0587|consen 211 LWSLGITAIEMAEGAPPLCDMHPMR----------------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRP 274 (953)
T ss_pred hhhccceeehhcCCCCCccCcchhh----------------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCc
Confidence 9999999999999999997654321 111111 22223334667889999999999999999999
Q ss_pred CHHHHHHH
Q 010432 428 LMSEVVEA 435 (511)
Q Consensus 428 s~~eil~~ 435 (511)
++.+++++
T Consensus 275 ~~~~ll~h 282 (953)
T KOG0587|consen 275 STEELLKH 282 (953)
T ss_pred chhhhccC
Confidence 99999874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=291.45 Aligned_cols=220 Identities=24% Similarity=0.255 Sum_probs=177.7
Q ss_pred CCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEEEccCC
Q 010432 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219 (511)
Q Consensus 140 G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~ 219 (511)
|.||.||++++.. +++.||+|.+.... .+.+|...+....||||+++++++...+..++||||+++
T Consensus 4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8899999999876 67899999997653 234555666667899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccc
Q 010432 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299 (511)
Q Consensus 220 g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (511)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .
T Consensus 70 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~-------------------------~ 120 (237)
T cd05576 70 GKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLD-------------------------D 120 (237)
T ss_pred CCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEc-------------------------C
Confidence 9999998654 36899999999999999999999988 99999999999998 4
Q ss_pred cCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 010432 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 379 (511)
Q Consensus 300 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~ 379 (511)
++.++|+|||++...... .....++..|+|||++.+..++.++||||+||++|||++|..||......
T Consensus 121 ~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------- 188 (237)
T cd05576 121 RGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------- 188 (237)
T ss_pred CCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------
Confidence 677999999988765432 12245677899999998888999999999999999999999887532110
Q ss_pred hhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 380 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
... .. ...++...+..+.+||.+||+.||++||++
T Consensus 189 -----~~~------~~----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 189 -----INT------HT----TLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -----ccc------cc----ccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 000 00 001112235678999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.87 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=210.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..+++.+..||-||||.|=++..... ...+|+|++++... ...+.+..|-+||..++.|.||+||-.|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 45677778899999999999887642 22589999987643 2345678899999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+..++|++||-|-||.|...|..+ +.++...+..++..+++|++|||+++ ||+|||||+|+||+
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd----------- 554 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLD----------- 554 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeec-----------
Confidence 9999999999999999999999655 47889999999999999999999999 99999999999999
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||.|||+|+....+..+ .++|||+.|.|||++.+...+.++|.||||+++|||++|.+
T Consensus 555 --------------~~Gy~KLVDFGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 555 --------------NRGYLKLVDFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred --------------cCCceEEeehhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence 4888999999999998877654 45899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 436 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~L 436 (511)
||.+.++....+++-.... .-.++......+.+||++++..+|.+|.. +.+|-.|-
T Consensus 618 PFs~~dpmktYn~ILkGid----------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 618 PFSGVDPMKTYNLILKGID----------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred CCCCCchHHHHHHHHhhhh----------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 9998776554443321111 11233444677899999999999999975 55565544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.10 Aligned_cols=240 Identities=31% Similarity=0.393 Sum_probs=194.2
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv 213 (511)
||.|+||.||++.+.. ++..||+|++...... ....+..|+.++++++|+||+++++.+..++..++|
T Consensus 1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6999999999998865 5779999999765432 234688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~ 293 (511)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~-------------------- 127 (250)
T cd05123 72 LEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLD-------------------- 127 (250)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEc--------------------
Confidence 9999999999999654 36899999999999999999999988 99999999999998
Q ss_pred cccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 010432 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 373 (511)
Q Consensus 294 ~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~ 373 (511)
.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 128 -----~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-- 198 (250)
T cd05123 128 -----ADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-- 198 (250)
T ss_pred -----CCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--
Confidence 467899999999987654321 12335688999999999888889999999999999999999999965432
Q ss_pred chhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 010432 374 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM---SEVVE 434 (511)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~---~eil~ 434 (511)
........ .. ...++...+..+.+++.+||..||++||++ .++++
T Consensus 199 -~~~~~~~~---~~------------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 199 -KEIYEKIL---KD------------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred -HHHHHHHh---cC------------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 11111110 00 111222225778999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.39 Aligned_cols=246 Identities=25% Similarity=0.315 Sum_probs=193.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.-|..++.||-|+||.|.+++-.+ |...||.|.|.+.+...+ ..+..|.+||...+.+.||+||..|.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred cceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 458888999999999999997655 677999999987654322 34678999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.+.+|+||+|++|||+..+|.+.+ -|++..++.++.++..|+++.|..| +|||||||+|||||
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILID------------ 763 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILID------------ 763 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEc------------
Confidence 9999999999999999999997664 6899999999999999999999999 99999999999999
Q ss_pred eeeccccccccccccCceeeecCCCcccCC---------CCCc-------------------------------ceeeee
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGP---------EGDK-------------------------------THVSTR 325 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~---------~~~~-------------------------------~~~~~~ 325 (511)
.+++|||+||||+.-+. .++. ......
T Consensus 764 -------------rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahs 830 (1034)
T KOG0608|consen 764 -------------RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHS 830 (1034)
T ss_pred -------------cCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhh
Confidence 48889999999986321 0000 000113
Q ss_pred ccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCH
Q 010432 326 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI 405 (511)
Q Consensus 326 ~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (511)
.+||+.|+|||++....|+..+|+||.|||||||+.|+.||....+.+....+. .+...++-... .
T Consensus 831 lvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~----------nw~~~l~~~~~----~ 896 (1034)
T KOG0608|consen 831 LVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVI----------NWRNFLHIPYQ----G 896 (1034)
T ss_pred hcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeee----------ehhhccccccc----c
Confidence 679999999999999999999999999999999999999998776654322111 11111221122 2
Q ss_pred HHHHHHHHHHHHhcccCCCCCC
Q 010432 406 KGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 406 ~~~~~~~~Li~~cl~~dP~~RP 427 (511)
+.+.++.+||.+++ -+++.|.
T Consensus 897 ~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 897 NLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred ccCHHHHHHHHHHh-cChhhhh
Confidence 33566777777755 3677776
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=286.22 Aligned_cols=292 Identities=20% Similarity=0.247 Sum_probs=207.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-----C---CCcce
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----H---LNLVK 199 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----H---~nIv~ 199 (511)
..+|.+.++||.|.|++||+|++.. ..+.||+|+.+... ...+..+.|+++|++++ | .+||+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred CceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 3789999999999999999999987 56699999997542 22355788999999883 3 36999
Q ss_pred EeeEEEe----CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecc
Q 010432 200 LIGYCIE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 200 l~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~ 274 (511)
|++.|.. +.++|||+|++ |-+|..+|... ...++...+..|++||+.||.|||... +|||-||||+|||+..
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCS 223 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeec
Confidence 9999975 56899999999 77999988754 457999999999999999999999864 4999999999999973
Q ss_pred ccccc---------------------cCC---------------------------------------------------
Q 010432 275 VRAEN---------------------YGK--------------------------------------------------- 282 (511)
Q Consensus 275 ~~~~~---------------------~~~--------------------------------------------------- 282 (511)
..... ...
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence 20000 000
Q ss_pred ------ccee-eeccc----------------cc-----------------------------c----------c-----
Q 010432 283 ------FGFC-IYYGL----------------FF-----------------------------N----------N----- 295 (511)
Q Consensus 283 ------~~~~-~~~~~----------------~~-----------------------------~----------~----- 295 (511)
.+.+ ....+ .. + .
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence 0000 00000 00 0 0
Q ss_pred --cccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 010432 296 --MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 373 (511)
Q Consensus 296 --~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~ 373 (511)
.-..+.++||+|||-|+..... .+.-..|..|+|||++.+..|++.+||||++|++|||+||...|.......
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~ 458 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGEN 458 (590)
T ss_pred CCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCC
Confidence 0112456899999999975432 334567899999999999999999999999999999999999997644332
Q ss_pred c----hhHHHhh--h---------------hhhccccccccccCCcc---------CCCCCHHHHHHHHHHHHHhcccCC
Q 010432 374 E----HNLVEWA--R---------------PHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 374 ~----~~~~~~~--~---------------~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
. ..+..+. . ..+.....+..+-.-.. .-.++.+...++.+++.-||+.+|
T Consensus 459 Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 459 YSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred CCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence 1 1111110 0 01111111111111000 113566778899999999999999
Q ss_pred CCCCCHHHHHHHhc
Q 010432 424 KARPLMSEVVEALK 437 (511)
Q Consensus 424 ~~RPs~~eil~~L~ 437 (511)
++||||.+++++-.
T Consensus 539 eKR~tA~~cl~hPw 552 (590)
T KOG1290|consen 539 EKRPTAAQCLKHPW 552 (590)
T ss_pred cccccHHHHhcCcc
Confidence 99999999998643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.13 Aligned_cols=268 Identities=21% Similarity=0.266 Sum_probs=172.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeE---
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY--- 203 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~--- 203 (511)
..++|++.++||+|+||.||+|++..+.. ..+..||||++..... .+.+..| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45789999999999999999999876211 1267999999864321 1222222 1222223333332222
Q ss_pred ---EEeCCeEEEEEEccCCCCHHHHHhhCCCCC-------------------CHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 010432 204 ---CIEDDQRLLVYEFMPRGSLENHLFRRSLPL-------------------PWSIRMKIALGAAKGLAFLHEEAERPVI 261 (511)
Q Consensus 204 ---~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l-------------------~~~~~~~i~~qi~~gL~yLH~~~~~~ii 261 (511)
...+...+|||||+.+++|.+++....... ....+..++.||+.||+|||+++ ||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii 277 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV 277 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 234667899999999999999986543211 12345679999999999999988 99
Q ss_pred ecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC
Q 010432 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 341 (511)
Q Consensus 262 HrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~ 341 (511)
||||||+|||++. +++.+||+|||+|+........ ......||+.|||||++...
T Consensus 278 HRDLKP~NILl~~------------------------~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~ 332 (566)
T PLN03225 278 HRDVKPQNIIFSE------------------------GSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMS 332 (566)
T ss_pred eCcCCHHHEEEeC------------------------CCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhcc
Confidence 9999999999984 3567999999999865443222 23346789999999966422
Q ss_pred ----------------------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCcc
Q 010432 342 ----------------------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 399 (511)
Q Consensus 342 ----------------------~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (511)
.++.++||||||||||||+++..++... ...+.......-.....+...+.+..
T Consensus 333 ~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~ 408 (566)
T PLN03225 333 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRA 408 (566)
T ss_pred CCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhcccc
Confidence 2445679999999999999977665421 00110000000000000011111110
Q ss_pred CCC----C--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 400 EGH----F--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 400 ~~~----~--~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
... + .........+||.+||+.||.+|||+.+++++
T Consensus 409 ~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 409 SPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred chhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 000 0 00012345689999999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.34 Aligned_cols=277 Identities=19% Similarity=0.259 Sum_probs=186.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCC-------ccCCCCcEEEEEEecCCCcccHHH--------------HHHH
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHKE--------------WLAE 185 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~-------~~~~~~~~vAvK~~~~~~~~~~~~--------------~~~E 185 (511)
..++|++.++||+|+||.||+|.+...+... .....++.||||+++.......++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999764322111 122356789999997654322222 3447
Q ss_pred HHHHhCCCCCCc-----ceEeeEEEe--------CCeEEEEEEccCCCCHHHHHhhCC----------------------
Q 010432 186 VNFLGDLVHLNL-----VKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRS---------------------- 230 (511)
Q Consensus 186 ~~il~~l~H~nI-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~---------------------- 230 (511)
+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 677777753 356899999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCC
Q 010432 231 -LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309 (511)
Q Consensus 231 -~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG 309 (511)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++ .+..+||+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~-------------------------~~~~~kL~DFG 354 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVT-------------------------VDGQVKIIDFG 354 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEEC-------------------------CCCcEEEEeCc
Confidence 12456778899999999999999988 99999999999998 36789999999
Q ss_pred CcccCCCCCcceeeeeccccccccCCcccccCC--------------------CC--ccccchhHHHHHHHHHhCCC-CC
Q 010432 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--------------------LT--SRSDVYSFGVVLLEMLTGRR-SM 366 (511)
Q Consensus 310 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--------------------~~--~~~DIwSlGvil~elltg~~-pf 366 (511)
+++......... .....+|+.|+|||++.... |+ .+.||||+|||||+|++|.. ||
T Consensus 355 la~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 355 AAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred CccccccCCccC-ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 997654322211 11234588999999875322 12 24799999999999999875 66
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHhc
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP---KARPLMSEVVEALK 437 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP---~~RPs~~eil~~L~ 437 (511)
........ .+.. ...... .+.......+.-......+...++|+.+||..+| .+|+|+.|+|+|-.
T Consensus 434 ~~~~~f~~-~~~~-~~~~~~---~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 434 ANIRLFNT-ELRQ-YDNDLN---RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred cchhhhhh-HHhh-ccchHH---HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 43211110 0000 000000 0000000001111112335788999999999876 68999999998654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=281.30 Aligned_cols=269 Identities=26% Similarity=0.352 Sum_probs=217.6
Q ss_pred hHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcce
Q 010432 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~ 199 (511)
..++.+...++++..++-+|.||.||.|.+++.+.. ...+.|-+|.++....+ ....++.|.-.|..+.|||+..
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~----n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY----NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCc----chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence 355666777899999999999999999988764332 23456788888765433 3356889999999999999999
Q ss_pred EeeEEEeC-CeEEEEEEccCCCCHHHHHhh-----C--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 200 LIGYCIED-DQRLLVYEFMPRGSLENHLFR-----R--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 200 l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~-----~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
+.+++.++ +..++++.++..|+|..||.. . ...+...+...++.|++.||+|||.++ |||.||..+|++
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv 428 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV 428 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence 99998764 567888999999999999972 1 234666778889999999999999999 999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchh
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwS 351 (511)
|+ +..++||+|=.+++.+-..+..........+..||+||.+....|+.++||||
T Consensus 429 Id-------------------------d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs 483 (563)
T KOG1024|consen 429 ID-------------------------DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS 483 (563)
T ss_pred eh-------------------------hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence 99 57889999999999887766655444455678999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 352 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 352 lGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
|||+||||+| |+.|+...++..+... +....+-..+.++++++..+|.-||..+|++||+++
T Consensus 484 fGVllWELmtlg~~PyaeIDPfEm~~y-----------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~ 546 (563)
T KOG1024|consen 484 FGVLLWELMTLGKLPYAEIDPFEMEHY-----------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFS 546 (563)
T ss_pred HHHHHHHHHhcCCCCccccCHHHHHHH-----------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHH
Confidence 9999999998 8889876655433221 112223334456789999999999999999999999
Q ss_pred HHHHHhcC
Q 010432 431 EVVEALKP 438 (511)
Q Consensus 431 eil~~L~~ 438 (511)
+++..|.+
T Consensus 547 Qlv~cLse 554 (563)
T KOG1024|consen 547 QLVICLSE 554 (563)
T ss_pred HHHHHHHH
Confidence 99998854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=270.94 Aligned_cols=239 Identities=31% Similarity=0.425 Sum_probs=192.5
Q ss_pred CCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEEEccCC
Q 010432 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219 (511)
Q Consensus 141 ~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~ 219 (511)
+||.||+|.+.. +++.||+|++....... .+.+.+|+..+++++|+||+++++++......+++|||+.+
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 589999999865 57799999998765544 57889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccc
Q 010432 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299 (511)
Q Consensus 220 g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (511)
++|.+++.... .+++..+..++.+++.+|.|||..+ |+|+||+|+||+++ +
T Consensus 72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~-------------------------~ 122 (244)
T smart00220 72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLD-------------------------E 122 (244)
T ss_pred CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEEC-------------------------C
Confidence 99999986543 3889999999999999999999988 99999999999998 3
Q ss_pred cCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 010432 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 379 (511)
Q Consensus 300 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~ 379 (511)
++.++|+|||.+....... ......|+..|++||.+.+..++.++||||||+++|+|++|..||..... ......
T Consensus 123 ~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~ 197 (244)
T smart00220 123 DGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFK 197 (244)
T ss_pred CCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHH
Confidence 6789999999998765532 12335688999999999888899999999999999999999999965311 111111
Q ss_pred hhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 380 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
....... . . .......+..+.+++.+||..+|++||++.++++
T Consensus 198 ~~~~~~~---~---~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 198 KIGKPKP---P---F------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHhccCC---C---C------ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1110000 0 0 0000003467899999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.46 Aligned_cols=250 Identities=27% Similarity=0.362 Sum_probs=189.0
Q ss_pred CCCCccccCCCc-eEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCCe
Q 010432 132 RPESLLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 132 ~~~~~lG~G~fg-~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 209 (511)
...+++|.|+.| .||+|.+ .|+.||||++-... ..-..+|+..|+.- +|||||++|+.-.+..+
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-----------e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF 577 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-----------EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQF 577 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-----------CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence 334578999988 4899988 46799999986543 23456899999888 69999999999888999
Q ss_pred EEEEEEccCCCCHHHHHhhCCCCC---CHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLPL---PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~l---~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.||.+|+| ..+|.+++......+ .....+.++.|++.||++||+.+ ||||||||.||||+.+...
T Consensus 578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~-------- 645 (903)
T KOG1027|consen 578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSAD-------- 645 (903)
T ss_pred EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCC--------
Confidence 99999999 569999997631111 11345678899999999999998 9999999999999864321
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC-CC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RR 364 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg-~~ 364 (511)
....++|+|||+++.+..+.... ......||-+|+|||++....-+.++||||||||+|+.++| ..
T Consensus 646 ------------~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~H 713 (903)
T KOG1027|consen 646 ------------GTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSH 713 (903)
T ss_pred ------------cceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCcc
Confidence 24689999999999876654332 23446799999999999988888899999999999999997 89
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||...-.... ..+.....+..+. . ..+ .++.+||.+|++++|..||+|.+|+.|-
T Consensus 714 pFGd~~~R~~--------NIl~~~~~L~~L~-----~--~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 714 PFGDSLERQA--------NILTGNYTLVHLE-----P--LPD--CEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred CCCchHHhhh--------hhhcCccceeeec-----c--Cch--HHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 9965321110 0111111111111 0 011 1789999999999999999999999753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=289.66 Aligned_cols=269 Identities=23% Similarity=0.294 Sum_probs=207.7
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC------CCCcc
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV------HLNLV 198 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~------H~nIv 198 (511)
+....+|.+....|+|-|++|.+|.+.. .|..||||+|..+... .+.=+.|++||++|+ --|++
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 4556789999999999999999998876 5669999999876432 244578999999995 34789
Q ss_pred eEeeEEEeCCeEEEEEEccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
+|+-.|...+++|||+|-+ .-+|.+.|..- +..|....+..|+.|+..||..|-.++ |+|.||||+|||+..
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE-- 571 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE-- 571 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc--
Confidence 9999999999999999998 56999999753 456888899999999999999999988 999999999999985
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil 356 (511)
....+||||||.|........+ -..-+..|.|||++.|.+|+...|+||.||+|
T Consensus 572 ----------------------~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctL 625 (752)
T KOG0670|consen 572 ----------------------SKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTL 625 (752)
T ss_pred ----------------------CcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceee
Confidence 4567999999999887664422 23446789999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhh---------------hhcccccc----------------ccccCC------cc
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARP---------------HLGERRRF----------------YRLIDP------RL 399 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~---------------~~~~~~~~----------------~~~~~~------~~ 399 (511)
|||.||+..|.+...+.+..+.--+.. ++.....| ...+.| .+
T Consensus 626 YElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l 705 (752)
T KOG0670|consen 626 YELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSEL 705 (752)
T ss_pred EEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHH
Confidence 999999999998766544332211111 11111010 111111 00
Q ss_pred CC--CCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 400 EG--HFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 400 ~~--~~~---~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.+ .++ ......+.+|+.+||..||++|.|..+.|.+
T Consensus 706 ~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 706 IAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred hccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 00 112 2234678899999999999999999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=273.77 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=200.6
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+.+..+.||.|+||+||.+.+.. .|+.||+|.+..- .....+.+.+|+.+|..++|.|++..++...-.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPR---------dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp 124 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPR---------SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA 124 (449)
T ss_pred cCCCCCcccccceeEEEeccCCC---------CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence 45667889999999999987654 6889999998653 223446789999999999999999998876543
Q ss_pred C-----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 208 ~-----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
. .+|+|+|++ ..||...|.. ...++...+.-+++||++||.|||+.+ |+||||||.|+|+++
T Consensus 125 h~dfFqEiYV~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNS-------- 191 (449)
T KOG0664|consen 125 NPSFFQELYVLTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNS-------- 191 (449)
T ss_pred CchHHHHHHHHHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEecc--------
Confidence 2 457889998 5588887754 357888888999999999999999999 999999999999984
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHh
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ellt 361 (511)
+..+||||||+|+........+ .+..+-|-.|+|||++++ ..|+.++||||.|||+.||+.
T Consensus 192 -----------------NCvLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 192 -----------------NCILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred -----------------CceEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh
Confidence 7889999999999866544433 444567899999999986 479999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhh--c------cccccccccCCccC-CC--------CCHHHHHHHHHHHHHhcccCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHL--G------ERRRFYRLIDPRLE-GH--------FSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~-~~--------~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
++..|....+....+++.-....- . +..+. .+++...+ .. -+.....+...++..+|..||+
T Consensus 254 RrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~-H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d 332 (449)
T KOG0664|consen 254 RKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN-HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD 332 (449)
T ss_pred hhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH-HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence 999998877665544432221100 0 00000 00110000 00 0112234567899999999999
Q ss_pred CCCCHHHHHHHhc
Q 010432 425 ARPLMSEVVEALK 437 (511)
Q Consensus 425 ~RPs~~eil~~L~ 437 (511)
+|.+..+.+.++.
T Consensus 333 kris~~~A~~~~~ 345 (449)
T KOG0664|consen 333 KRISVEEALQHRY 345 (449)
T ss_pred ccccHhhhccccc
Confidence 9999999887764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=256.10 Aligned_cols=203 Identities=27% Similarity=0.363 Sum_probs=168.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
+..+....+..||+|+||.|-+-++.. +|...|+|.+...-. +..++.++|+++..+. .+|.+|++||.
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 334455556679999999999988876 688999999976532 3446788999987665 79999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
.......||.||.| .-+|..+.. ..+..+++..+-+|+..++.||.|||++-+ |||||+||+||||+.
T Consensus 114 ~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~------ 184 (282)
T KOG0984|consen 114 LFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINY------ 184 (282)
T ss_pred hhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEcc------
Confidence 98888999999999 457776653 457789999999999999999999998653 999999999999994
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc----cCCCCccccchhHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~----~~~~~~~~DIwSlGvil 356 (511)
++++||||||++-.+.+.-. .+-..|.-.|||||.+. ...|+-++||||||+++
T Consensus 185 -------------------~GqVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItm 242 (282)
T KOG0984|consen 185 -------------------DGQVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITM 242 (282)
T ss_pred -------------------CCcEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhh
Confidence 88999999999987655322 23346888999999885 34799999999999999
Q ss_pred HHHHhCCCCCCC
Q 010432 357 LEMLTGRRSMDK 368 (511)
Q Consensus 357 ~elltg~~pf~~ 368 (511)
.||.+++.||..
T Consensus 243 iElA~lr~PY~~ 254 (282)
T KOG0984|consen 243 IEMAILRFPYES 254 (282)
T ss_pred hhhhhccccccc
Confidence 999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=257.92 Aligned_cols=261 Identities=19% Similarity=0.262 Sum_probs=199.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~ 206 (511)
.++|++.+++|+|-|+.||.|.... +.+.++||+++.-. .+.+.+|+.||..|. |||||+|++...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 4689999999999999999998765 56689999998643 356889999999996 9999999999877
Q ss_pred CC--eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 207 DD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 207 ~~--~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.. ...||+||+.+.+...+. ..+....+..++.+++.||.|+|+.| |+|||+||.|++|+.
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh---------- 167 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDH---------- 167 (338)
T ss_pred ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeech----------
Confidence 53 456999999998877665 35777888999999999999999999 999999999999996
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~ 363 (511)
....++|+|+|+|.....+....+ .+.+..|--||++.. ..|+..-|+|||||+|..|+..+
T Consensus 168 --------------~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk 230 (338)
T KOG0668|consen 168 --------------ELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 230 (338)
T ss_pred --------------hhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence 466799999999998877655433 456778899998864 57899999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhh-------------hccccccccccCCccCCC--------CCHHHHHHHHHHHHHhcccC
Q 010432 364 RSMDKNRPNGEHNLVEWARPH-------------LGERRRFYRLIDPRLEGH--------FSIKGAQKAAQLAAHCLSRD 422 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~Li~~cl~~d 422 (511)
.||.....+.. +++..+... +.-...+..++....+.. -..-.++++.+|+.++|.+|
T Consensus 231 epFFhG~dN~D-QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYD 309 (338)
T KOG0668|consen 231 EPFFHGHDNYD-QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYD 309 (338)
T ss_pred CcccCCCCCHH-HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhc
Confidence 99976654432 222222110 000111111111100000 00011478899999999999
Q ss_pred CCCCCCHHHHHHH
Q 010432 423 PKARPLMSEVVEA 435 (511)
Q Consensus 423 P~~RPs~~eil~~ 435 (511)
-.+|+|+.|.+.+
T Consensus 310 HqeRlTakEam~H 322 (338)
T KOG0668|consen 310 HQERLTAKEAMAH 322 (338)
T ss_pred cccccchHHHhcC
Confidence 9999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=262.23 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=195.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.+|.-+..+|.|.- .|-.|.+.- +++.||+|.+.... ....++..+|...+..+.|+||++++.+|.-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v---------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQV---------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhh---------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 36677778888887 666665543 67799999886542 2334567899999999999999999999864
Q ss_pred C------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
. ...|+||||+ .++|.+.+. ..++-.....|+.|++.|+.|||+.+ |+||||||+||++.
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~------- 152 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVN------- 152 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceec-------
Confidence 3 3568999999 569999886 35777888999999999999999999 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.+..+||.|||+|+..... ...+..+.|..|.|||++.+..|...+||||+|||+.||+
T Consensus 153 ------------------~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 153 ------------------SDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELI 211 (369)
T ss_pred ------------------chhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHh
Confidence 4788999999999875443 2345578899999999999988999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHH----------------Hhhhhhhcccc-----ccccccCCc-cCC--CCCHHHHHHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLV----------------EWARPHLGERR-----RFYRLIDPR-LEG--HFSIKGAQKAAQLAA 416 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~----------------~~~~~~~~~~~-----~~~~~~~~~-~~~--~~~~~~~~~~~~Li~ 416 (511)
+|...|.+....+.-..+ ..++....... .+.+.+... +.. ..+......+.+|+.
T Consensus 212 ~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~ 291 (369)
T KOG0665|consen 212 LGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLS 291 (369)
T ss_pred hceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHH
Confidence 999999864332211111 11111110000 111111110 000 011122467889999
Q ss_pred HhcccCCCCCCCHHHHHHHh
Q 010432 417 HCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 417 ~cl~~dP~~RPs~~eil~~L 436 (511)
+||..||++|.+++++|+|-
T Consensus 292 ~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 292 KMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HhhccChhhcccHHHHhcCC
Confidence 99999999999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=277.95 Aligned_cols=198 Identities=24% Similarity=0.339 Sum_probs=170.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH--------HHHHHHHHHHhCCC---CCCc
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--------KEWLAEVNFLGDLV---HLNL 197 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~--------~~~~~E~~il~~l~---H~nI 197 (511)
.+|..++.||+|+||.|++|.++. ....|+||.+.+...-.. -.+-.|+.||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 469999999999999999999986 355899999987643210 12345999999997 9999
Q ss_pred ceEeeEEEeCCeEEEEEEcc-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 198 VKLIGYCIEDDQRLLVYEFM-PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 198 v~l~~~~~~~~~~~lv~E~~-~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
++++++|.+++++||+||-. ++-+|+++|..+ ..+++..+..|+.||+.|+++||+++ |||||||-+|+.++.
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~-- 705 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDS-- 705 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEec--
Confidence 99999999999999999986 445899999544 47899999999999999999999999 999999999999994
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVV 355 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvi 355 (511)
++-+||+|||.|.....+.. ..++||..|.|||++.+.+| +..-|||++|++
T Consensus 706 -----------------------~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgil 758 (772)
T KOG1152|consen 706 -----------------------NGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGIL 758 (772)
T ss_pred -----------------------CCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhhe
Confidence 77899999999988766543 34789999999999999888 667899999999
Q ss_pred HHHHHhCCCCCCC
Q 010432 356 LLEMLTGRRSMDK 368 (511)
Q Consensus 356 l~elltg~~pf~~ 368 (511)
||.++....||+.
T Consensus 759 lytivykenpyyn 771 (772)
T KOG1152|consen 759 LYTIVYKENPYYN 771 (772)
T ss_pred eeEEEeccCCCcC
Confidence 9999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-34 Score=286.88 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=205.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
..+|+++..+|.|+||.||||+++. +++..|||+++........-..+|+-+++..+|+|||.|+|.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 4689999999999999999999876 7889999999988766666677899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+.+|++||||.+|+|.+..+ -..++++.++....+..+.||+|||+.+ =+|||||-.|||++
T Consensus 85 dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanillt-------------- 146 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLT-------------- 146 (829)
T ss_pred cCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeec--------------
Confidence 99999999999999988664 3457889999999999999999999999 89999999999999
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+.+.+|++|||.+-....... ....+.||+.|||||+.. .+.|+..+|||++|+...|+-.-++
T Consensus 147 -----------d~gDvklaDfgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqp 213 (829)
T KOG0576|consen 147 -----------DEGDVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQP 213 (829)
T ss_pred -----------ccCceeecccCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCC
Confidence 578899999999977654322 233578999999999863 6789999999999999999998888
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
|.....+.....+. ....+ -.+.+. -...+++-+-+|++.||..+|++||++..+|.
T Consensus 214 plfdlhpmr~l~Lm--TkS~~---------qpp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 214 PLFDLHPMRALFLM--TKSGF---------QPPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccccchHHHHHHh--hccCC---------CCCccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 87544332111111 00000 011111 12344677889999999999999999988765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=242.63 Aligned_cols=213 Identities=36% Similarity=0.568 Sum_probs=182.8
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E 215 (511)
||+|++|.||++.... +++.+++|++...... ....+.+|+.+++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999998864 4779999999876543 23568899999999999999999999999899999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccc
Q 010432 216 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295 (511)
Q Consensus 216 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~ 295 (511)
|+.+++|.+++......+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~--------------------- 127 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDS--------------------- 127 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeC---------------------
Confidence 99989999998765356889999999999999999999998 999999999999982
Q ss_pred cccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 010432 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 374 (511)
Q Consensus 296 ~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~ 374 (511)
.+..++|+|||.+........ ......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 128 ---~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------- 187 (215)
T cd00180 128 ---DNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------- 187 (215)
T ss_pred ---CCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------
Confidence 157799999999987654321 12224578899999998876 888999999999999998
Q ss_pred hhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 375 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..+.+++.+||+.||.+||++.+++++|
T Consensus 188 ----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=248.81 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=188.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEee-EEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIG-YCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~-~~~ 205 (511)
.+.|.+.+.||+|.||.+.+|+++. +...+++|.+.... ....+|.+|...--.| .|.||+.-|+ .|+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 3578899999999999999999987 56799999997653 3357899999876666 5899998876 466
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+.++++|||++.|+|..-+.. ..+-+.....++.|+++||.|+|+++ +||||||.+||||-..
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~---------- 157 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDA---------- 157 (378)
T ss_pred cCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecC----------
Confidence 77888899999999999988754 35778888999999999999999999 9999999999999642
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc---C--CCCccccchhHHHHHHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---G--HLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~--~~~~~~DIwSlGvil~ell 360 (511)
+..+|||||||+.+..+..-.. ..-+..|.+||+... . ...+.+|||.||+|+|.++
T Consensus 158 -------------df~rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl 219 (378)
T KOG1345|consen 158 -------------DFYRVKLCDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL 219 (378)
T ss_pred -------------CccEEEeeecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence 3568999999999876543221 234667999997753 2 3467899999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
||++||......+ .....|..... -..+.++..|. .+++.+..+.++-|..+|++|--..++
T Consensus 220 tG~~PWQka~~~d-~~Y~~~~~w~~--------rk~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 220 TGKFPWQKASIMD-KPYWEWEQWLK--------RKNPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred cCCCcchhhhccC-chHHHHHHHhc--------ccCccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHH
Confidence 9999998443222 11222211111 11111221111 235778899999999999999433333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=260.86 Aligned_cols=273 Identities=25% Similarity=0.327 Sum_probs=201.2
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEe
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~ 201 (511)
.+....+.|.++++||+|.|++||++.+... ....+.||+|.+..... ...+..|++.|..+ -+.||+++.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~ 101 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLN 101 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcch
Confidence 3445567899999999999999999988752 22577999999976543 35688999999999 699999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++..++..++||||++.-+..+++. .++...+..+++.++.||.++|.+| ||||||||.|+|.+.
T Consensus 102 ~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~------- 167 (418)
T KOG1167|consen 102 GCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNR------- 167 (418)
T ss_pred hhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCcccccccc-------
Confidence 99999999999999999988888873 4678899999999999999999999 999999999999985
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCC-----------------C-----------------CC--------c
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP-----------------E-----------------GD--------K 319 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~-----------------~-----------------~~--------~ 319 (511)
....-.|+|||+|.... . .. .
T Consensus 168 -----------------~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r 230 (418)
T KOG1167|consen 168 -----------------RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGR 230 (418)
T ss_pred -----------------ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCc
Confidence 45667899999997210 0 00 0
Q ss_pred ceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhh----------hhhccc
Q 010432 320 THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----------PHLGER 388 (511)
Q Consensus 320 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~----------~~~~~~ 388 (511)
........||++|+|||++... .-++++||||.|||++-+++++.||........ .+.+.+. ..+...
T Consensus 231 ~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~ 309 (418)
T KOG1167|consen 231 PSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGR 309 (418)
T ss_pred cceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCc
Confidence 0011135799999999999754 568899999999999999999999975433211 1111100 000000
Q ss_pred ------cc---------cccccC--Cc-------c-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 389 ------RR---------FYRLID--PR-------L-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 389 ------~~---------~~~~~~--~~-------~-~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.. -++.++ .. . ........+..+.+|+.+||..||.+|.|+++.|.+
T Consensus 310 ~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 310 ILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 000110 00 0 011112234578999999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=240.38 Aligned_cols=200 Identities=33% Similarity=0.418 Sum_probs=172.2
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCe
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
|.+.+.||.|++|.||++.+.. ++..||+|.+...... ....+.+|+..+.+++|+||+++++++...+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5667889999999999998865 5679999999876554 45678899999999999999999999999899
Q ss_pred EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeec
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~ 289 (511)
.++++||+++++|.+++......+++..+..++.+++.+|.|||.++ ++|+||+|.||+++
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~---------------- 132 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLG---------------- 132 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc----------------
Confidence 99999999999999998654433889999999999999999999988 99999999999998
Q ss_pred cccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccc-ccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 290 ~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~-~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
.+..++|+|||++......... ......++..|++||++ ....++.++|||+||+++|||++|+.||..
T Consensus 133 ---------~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 133 ---------MDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---------CCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3678999999999876553210 12235678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=294.94 Aligned_cols=217 Identities=19% Similarity=0.243 Sum_probs=158.0
Q ss_pred CCCC-CCcceEeeEE-------EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 010432 191 DLVH-LNLVKLIGYC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (511)
Q Consensus 191 ~l~H-~nIv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH 262 (511)
.++| .||++++++| .....++++|||+ +++|.++|......+++..++.|+.||+.||.|||+++ |||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4456 5888888887 2334567888988 67999999765667999999999999999999999998 999
Q ss_pred cccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCc--------------ceeeeeccc
Q 010432 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK--------------THVSTRVMG 328 (511)
Q Consensus 263 rDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~G 328 (511)
|||||+||||+..+..++.+|+.+..... ..+..+||+|||+++....... .......+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGS------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccc------cccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 99999999998777777777776543211 1356799999999975321100 001122468
Q ss_pred cccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHH
Q 010432 329 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA 408 (511)
Q Consensus 329 t~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (511)
|+.|||||++.+..|+.++|||||||+||||++|..|+..... ....... ....+.. ....
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~---------~~~~~~~-----~~~~ 238 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRH---------RVLPPQI-----LLNW 238 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHH---------hhcChhh-----hhcC
Confidence 9999999999999999999999999999999999888652210 0000000 0111110 0112
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 409 QKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 409 ~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..+..++.+||+.||.+||++.+|+++-
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 4467899999999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=215.68 Aligned_cols=166 Identities=25% Similarity=0.255 Sum_probs=125.4
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccc
Q 010432 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299 (511)
Q Consensus 220 g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (511)
|+|.+++..+...+++..++.|+.||+.||.|||+++ ||+|||++ .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~-------------------------~ 46 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLT-------------------------W 46 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEc-------------------------C
Confidence 7899999876677999999999999999999999865 99999998 4
Q ss_pred cCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 010432 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 379 (511)
Q Consensus 300 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~ 379 (511)
++.+|+ ||+++...... ..||+.|||||++.+..|+.++|||||||++|||++|+.||....... ....
T Consensus 47 ~~~~~~--fG~~~~~~~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~ 115 (176)
T smart00750 47 DGLLKL--DGSVAFKTPEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILE 115 (176)
T ss_pred ccceee--ccceEeecccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHH
Confidence 677888 99998754321 258999999999999999999999999999999999999996543211 1111
Q ss_pred hhhhhhccccccccccCCccCCCCCHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 380 WARPHLGERRRFYRLIDPRLEGHFSIKGAQ--KAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
........ ..+. .......... .+.+++.+||+.||.+||++.++++++..
T Consensus 116 ~~~~~~~~-------~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 116 ILLNGMPA-------DDPR-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhcc-------CCcc-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11100000 0000 0001112233 68999999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=225.32 Aligned_cols=265 Identities=23% Similarity=0.228 Sum_probs=196.4
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC----CCcceEeeEE-
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH----LNLVKLIGYC- 204 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H----~nIv~l~~~~- 204 (511)
+|.+.++||+|+||.||+|.....+ ...+|+|............+..|+.+|..+.. .++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 7999999999999999999886521 34789998876533322357789999988863 5889999988
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
..+...||||+.+ |.+|.++..... ..++..+++.|+.|++.+|++||+.| +|||||||+|++++....
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~------ 160 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSR------ 160 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCC------
Confidence 4778899999999 889999875444 67999999999999999999999999 999999999999985210
Q ss_pred ceeeeccccccccccccCceeeecCCCcc--cCCCCCcc---ee---eeeccccccccCCcccccCCCCccccchhHHHH
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAK--DGPEGDKT---HV---STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~--~~~~~~~~---~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi 355 (511)
.+...+.|.|||+++ ........ .. .....||..|+++.+..+...+.+.|+||++.+
T Consensus 161 --------------~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~ 226 (322)
T KOG1164|consen 161 --------------SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYM 226 (322)
T ss_pred --------------cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHH
Confidence 012569999999999 32221110 00 123569999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.||+.|..||................... .... +....+..+.+++..+-..+...+|....+...
T Consensus 227 l~el~~g~LPW~~~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 227 LLELLKGSLPWEALEMTDLKSKFEKDPRKL--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHHhcCCCCCccccccchHHHHHHHhhhh--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 999999999996544322211111100000 0000 111124566677777777899999999999888
Q ss_pred hcCC
Q 010432 436 LKPL 439 (511)
Q Consensus 436 L~~l 439 (511)
|...
T Consensus 294 l~~~ 297 (322)
T KOG1164|consen 294 LKDV 297 (322)
T ss_pred HHHH
Confidence 6544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=229.77 Aligned_cols=177 Identities=18% Similarity=0.151 Sum_probs=132.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhCCCCCCcce-
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVK- 199 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~H~nIv~- 199 (511)
....+|.+.+.||+|+||+||+|.+... ++..||||++..... .....+.+|+++|++|+|+|||.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 4456899999999999999999987641 466789998753311 12345889999999999999985
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc-CCCcEEecccccc
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDAVRAE 278 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDL-Kp~NILl~~~~~~ 278 (511)
++++ +..|||||||+|++|.. +.. .. ...++.|++.||.|||+++ |+|||| ||+|||++
T Consensus 87 l~~~----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~----- 146 (365)
T PRK09188 87 LLAT----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMG----- 146 (365)
T ss_pred EEEc----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEc-----
Confidence 4432 45799999999999963 211 11 1467889999999999998 999999 99999997
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCccee------eeeccccccccCCcccccC------CCCcc
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHV------STRVMGTYGYAAPEYVMTG------HLTSR 346 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~------~~~~~ 346 (511)
.++.+||+|||+|+.......... .+...+++.|+|||++... ..+..
T Consensus 147 --------------------~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~ 206 (365)
T PRK09188 147 --------------------PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLP 206 (365)
T ss_pred --------------------CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccc
Confidence 366799999999997654321111 1346789999999998632 22344
Q ss_pred ccch
Q 010432 347 SDVY 350 (511)
Q Consensus 347 ~DIw 350 (511)
.|-|
T Consensus 207 ~dgW 210 (365)
T PRK09188 207 SRIW 210 (365)
T ss_pred cCcE
Confidence 6666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=215.62 Aligned_cols=259 Identities=32% Similarity=0.420 Sum_probs=196.4
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCC-CcceEeeEEEe
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHL-NLVKLIGYCIE 206 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~-nIv~l~~~~~~ 206 (511)
|.+...||.|+||.||++.+. ..+|+|.+....... ...+.+|+.++..+.|+ +|+++++++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 667788999999999999875 379999997664432 56789999999999988 79999999977
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
....+++++|+.+++|.+++.... ..+.......++.|++.+|.|+|..+ ++||||||+|||++.
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~---------- 136 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDR---------- 136 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecC----------
Confidence 777899999999999997775443 26889999999999999999999999 999999999999984
Q ss_pred eeeeccccccccccccC-ceeeecCCCcccCCCCCcce----eeeeccccccccCCccccc---CCCCccccchhHHHHH
Q 010432 285 FCIYYGLFFNNMLFQDY-NAKLSDFGLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVL 356 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~-~~kl~DFGla~~~~~~~~~~----~~~~~~Gt~~y~aPE~~~~---~~~~~~~DIwSlGvil 356 (511)
.. .++++|||+++......... ......||..|+|||.+.+ ..++...|+||+|+++
T Consensus 137 ---------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~ 201 (384)
T COG0515 137 ---------------DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201 (384)
T ss_pred ---------------CCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence 44 69999999998654433221 2345789999999999987 5788999999999999
Q ss_pred HHHHhCCCCCCCCCCC-CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLTGRRSMDKNRPN-GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+++++|..||...... ............... .................+.+++..|+..+|..|.+..+....
T Consensus 202 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 202 YELLTGLPPFEGEKNSSATSQTLKIILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhCCCCCCCCCccccHHHHHHHHHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 9999999997654321 011111111111000 000000000001223578899999999999999998877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=209.34 Aligned_cols=209 Identities=21% Similarity=0.278 Sum_probs=176.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~ 207 (511)
-+|++.++||+|+||+.|.|+..- +++.||||.-...... -++..|.+..+.| ..+.|..+|.+..++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecccccc---------cCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 479999999999999999998876 5779999976544321 3566788877777 568999999888888
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
-+-.||||++ |.+|++++.-.+..++..++..++.|++.-++|+|++. +|+|||||+|+||+.++..
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k--------- 163 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTK--------- 163 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCC---------
Confidence 8889999999 88999998777888999999999999999999999999 9999999999999965432
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcce-----eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
+...|.|+|||+|+...+..... ......||.+||+-....+..-+.+-|+=|||-+++..|-|
T Consensus 164 -----------~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRG 232 (449)
T KOG1165|consen 164 -----------DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 232 (449)
T ss_pred -----------CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccC
Confidence 35668999999999876644322 22346799999999988899999999999999999999999
Q ss_pred CCCCCCCCCC
Q 010432 363 RRSMDKNRPN 372 (511)
Q Consensus 363 ~~pf~~~~~~ 372 (511)
..||.+....
T Consensus 233 sLPWQGLKA~ 242 (449)
T KOG1165|consen 233 SLPWQGLKAD 242 (449)
T ss_pred CCccccccCc
Confidence 9999876544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=202.57 Aligned_cols=264 Identities=20% Similarity=0.212 Sum_probs=200.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC-CCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~ 205 (511)
...+|.++++||.|+||.+|.|.... .|..||||+-..... ..++..|..+.+.|+| ..|..+..|..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---------~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---------SGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---------CCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 35689999999999999999998876 688999998765532 2457789999999965 56778888888
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+..+-.|||+++ |.+|++++.-....++..+++-++-|++.-++|+|.++ +|||||||+|+|.+-..
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgr--------- 148 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGR--------- 148 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeecccc---------
Confidence 888999999999 88999988766678999999999999999999999998 99999999999998422
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
....+.|+|||+|+...+.... .......||..|.+-....+..-+.+-|+=|+|.+|..+.
T Consensus 149 -------------h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfn 215 (341)
T KOG1163|consen 149 -------------HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFN 215 (341)
T ss_pred -------------ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeee
Confidence 2456899999999976543221 1233468999999988777777888999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
-|..||.+.......+..+.+....- ....+.+ - ..++.++.-.+.-|-..--++-|...-+-+.+.
T Consensus 216 rG~LPWQglka~tk~QKyEkI~EkK~--s~~ie~L----C----~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 216 RGSLPWQGLKAATKKQKYEKISEKKM--STPIEVL----C----KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred cCCCcccccchhhHHHHHHHHHHhhc--CCCHHHH----h----CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 99999998765543332222211100 0000111 1 122456777888888888888887666555444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-26 Score=241.99 Aligned_cols=255 Identities=19% Similarity=0.227 Sum_probs=185.9
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCC--CcccH----HHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGH----KEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~----~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
....++|.|++|.|+.+...... ..++.|..... ..... ..+..|+.+-..|.|+||+..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~---------~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDL---------KSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecCCC---------ccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 45568999999988887765422 23333332210 11111 12556888888999999988887777
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.....-+||||++ ||..++... ..+....+..++.|++.||.|||+.| |.|||||++|+|+.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~------------ 454 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVT------------ 454 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEe------------
Confidence 66666666999999 999998654 46788888999999999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCcccccCCCCc-cccchhHHHHHHHHHhC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~-~~DIwSlGvil~elltg 362 (511)
.++.+||+|||.+......... .....++|+..|+|||++.+..|.+ .+||||.|+++..|++|
T Consensus 455 -------------~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~ 521 (601)
T KOG0590|consen 455 -------------ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG 521 (601)
T ss_pred -------------cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence 4778999999999876544433 4556689999999999999999976 58999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
+.||.......... ... .......+.. -........+...+.+|.+||+.||.+|.|+.+|++
T Consensus 522 ~~~Wk~a~~~~~~~-~~~------~~~~~~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 522 RFPWKVAKKSDNSF-KTN------NYSDQRNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred CCccccccccccch-hhh------cccccccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99997543332210 000 0000000000 001111233567789999999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-26 Score=206.88 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=189.9
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
..++.+|.+...|..|+|+++ |..+++|+++...... .++|..|.-.|+-+.||||+.+++.|....
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-----------gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-----------GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred hhhhhhhccCCCccccccccc-----------CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 344557899999999999996 4467788887654332 257889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
++.++..||+.|+|+..|+... ..++..++.+++.+|++|++|||+.. +-|.---|....++|+
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmid-------------- 325 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMID-------------- 325 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEec--------------
Confidence 9999999999999999997653 34678889999999999999999976 3244456888999998
Q ss_pred eccccccccccccCceeee--cCCCcccCCCCCcceeeeeccccccccCCcccccCCCC---ccccchhHHHHHHHHHhC
Q 010432 288 YYGLFFNNMLFQDYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~---~~~DIwSlGvil~elltg 362 (511)
++...+|+ |--++... ....-.+.||+||.+...+-+ .++|+|||.++||||.|.
T Consensus 326 -----------edltarismad~kfsfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tr 385 (448)
T KOG0195|consen 326 -----------EDLTARISMADTKFSFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTR 385 (448)
T ss_pred -----------chhhhheecccceeeeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcc
Confidence 35555553 32222111 011236889999999866543 479999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
..||....+..... .+.-..++..+++..+..+.+||.-|+..||.+||.+..|+-.|+++.
T Consensus 386 evpfadlspmecgm----------------kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 386 EVPFADLSPMECGM----------------KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCchhhhh----------------hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99998765543211 122223444555566788899999999999999999999999888753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=223.09 Aligned_cols=171 Identities=25% Similarity=0.407 Sum_probs=126.6
Q ss_pred EEEEEccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 211 LLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
||.|++|...+|.+||.++ ....++...+.++.|++.|++| ++ .+||||||.||++.
T Consensus 332 yI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~--------------- 390 (516)
T KOG1033|consen 332 YIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFS--------------- 390 (516)
T ss_pred hhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccc---------------
Confidence 7899999999999999643 3456788889999999999999 66 99999999999987
Q ss_pred ccccccccccccCceeeecCCCcccCCCCC----cceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~ 363 (511)
++..+||.|||+........ .....+..+||..||+||++.+..|+.++||||||+||+||+. =.
T Consensus 391 ----------~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~ 460 (516)
T KOG1033|consen 391 ----------DDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFS 460 (516)
T ss_pred ----------cchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhc
Confidence 46789999999998765544 1223455789999999999999999999999999999999997 22
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
..|... ..+..+-+..+...+. ...+.-..|+.++|...|.+||++.+.
T Consensus 461 T~~er~-------------------~t~~d~r~g~ip~~~~-~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 461 TQFERI-------------------ATLTDIRDGIIPPEFL-QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cHHHHH-------------------HhhhhhhcCCCChHHh-hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 222100 0000111111111111 112345689999999999999955443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-24 Score=197.46 Aligned_cols=172 Identities=9% Similarity=0.077 Sum_probs=133.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHH---------HHHHHHHHhCCCCCC
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGDLVHLN 196 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~---------~~~E~~il~~l~H~n 196 (511)
...++|+++++||.|+||.||++.. ++..||||++.......... +.+|+..+.++.|++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 4568999999999999999999644 24479999997654332222 578999999999999
Q ss_pred cceEeeEEEeC--------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 010432 197 LVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (511)
Q Consensus 197 Iv~l~~~~~~~--------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~ 268 (511)
|..+.+++... ...+|||||++|.+|.++. .++. ....+|+.+|..||..+ |+||||||+
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~ 164 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHKG 164 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCChH
Confidence 99999886643 3578999999999998874 2222 24568999999999999 999999999
Q ss_pred cEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCcccc
Q 010432 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 348 (511)
Q Consensus 269 NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~D 348 (511)
|||++ +++ ++|+|||........... ..++....|+.++|
T Consensus 165 Nili~-------------------------~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~d 204 (232)
T PRK10359 165 NFIVS-------------------------KNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNE 204 (232)
T ss_pred HEEEe-------------------------CCC-EEEEECCCcccccchhhH--------------HHHHHHhHhccccc
Confidence 99998 355 999999998765332111 01345667788999
Q ss_pred chhHHHHHHHHH
Q 010432 349 VYSFGVVLLEML 360 (511)
Q Consensus 349 IwSlGvil~ell 360 (511)
||+||+++..+.
T Consensus 205 i~~lg~~~~~~~ 216 (232)
T PRK10359 205 IKDLGYYLLIYK 216 (232)
T ss_pred ccceeEeehHHH
Confidence 999999887665
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-24 Score=219.58 Aligned_cols=229 Identities=28% Similarity=0.348 Sum_probs=182.9
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhCCC-CCCcceEeeEEEeCCeEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 212 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~l 212 (511)
.+|+|+||.|++++-... ...|..||+|++++...... .....|..++..++ ||.+|+++..++.+...++
T Consensus 1 vlg~g~~gkvfLvrk~~g------~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGG------ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhcc------ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 379999999998754321 22578899999986543221 13456888898886 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
+++|..+|+|...+.... .+.+.....+...++.+++++|..+ |+|||+|++||+++
T Consensus 75 ~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld------------------- 131 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLL------------------- 131 (612)
T ss_pred hhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeec-------------------
Confidence 999999999998885543 4666677777888999999999999 99999999999999
Q ss_pred ccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~ 372 (511)
.++++++.|||+++..-.... .|||..|||||++. .....+|+||||++++||+||..||..
T Consensus 132 ------~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---- 193 (612)
T KOG0603|consen 132 ------LEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---- 193 (612)
T ss_pred ------ccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----
Confidence 488999999999997655332 28999999999887 677899999999999999999999975
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
+.... ++. ....++...+..+.+++..++..+|.+|.-.
T Consensus 194 ---~~~~~-------------Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 ---DTMKR-------------ILK--AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ---HHHHH-------------Hhh--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11111 110 1223455667888999999999999999754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=188.29 Aligned_cols=140 Identities=17% Similarity=0.163 Sum_probs=107.6
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--c-------H-----------------HHHHHHHH
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--G-------H-----------------KEWLAEVN 187 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~-------~-----------------~~~~~E~~ 187 (511)
...||+|+||.||+|.+. +|+.||||+++..... . . ....+|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 468999999999999874 4779999999764221 0 0 11235999
Q ss_pred HHhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecccC
Q 010432 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRDFK 266 (511)
Q Consensus 188 il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~~iiHrDLK 266 (511)
+|.++.|+++.....+.. . ..+|||||+++++|...+.. ...++...+..++.|++.+|.|| |+.+ |||||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlk 145 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLS 145 (190)
T ss_pred HHHHHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999998877644333222 2 23899999988877655333 34788999999999999999999 6888 9999999
Q ss_pred CCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCC
Q 010432 267 TSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315 (511)
Q Consensus 267 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~ 315 (511)
|+|||++ ++.++|+|||+|....
T Consensus 146 P~NIli~--------------------------~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 146 EYNLLYH--------------------------DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HHHEEEE--------------------------CCcEEEEEccccccCC
Confidence 9999997 3569999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=194.65 Aligned_cols=267 Identities=19% Similarity=0.246 Sum_probs=176.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCc-c----------C---------------CCCcEEEEEEecCCCcc-cH
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPV-K----------P---------------GTGLTVAVKTLNHDGLQ-GH 179 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~-~----------~---------------~~~~~vAvK~~~~~~~~-~~ 179 (511)
..++|++.+.||+|..+.||.|+...++.... . + ....+.|||.+-.-... ..
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 44679999999999999999998875321100 0 0 01235677766432211 11
Q ss_pred HH----HHHHH------H--------HHhC--------CCCCCcceEeeEEEeC--------------------------
Q 010432 180 KE----WLAEV------N--------FLGD--------LVHLNLVKLIGYCIED-------------------------- 207 (511)
Q Consensus 180 ~~----~~~E~------~--------il~~--------l~H~nIv~l~~~~~~~-------------------------- 207 (511)
.. +-+|. . ..+. -.|||||+++++|.+.
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 11 11221 0 1111 2599999999987642
Q ss_pred -CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
..+|+||.-.+ .+|.+++..+ ..+.....-++.|+++|+.|||.++ |.|||||.+||||.-.++
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD--------- 379 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDD--------- 379 (598)
T ss_pred CceEEEehhcch-hhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCC---------
Confidence 14689998874 4999999654 3456667778899999999999999 999999999999975322
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCC----cceeeeeccccccccCCcccccCC-----C-CccccchhHHHHH
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGH-----L-TSRSDVYSFGVVL 356 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~----~~~~~~~~~Gt~~y~aPE~~~~~~-----~-~~~~DIwSlGvil 356 (511)
.-..+.|+|||++-...... .........|....||||+....+ . -.|+|.|+.|.+.
T Consensus 380 ------------~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Gala 447 (598)
T KOG4158|consen 380 ------------EIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALA 447 (598)
T ss_pred ------------CCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhH
Confidence 23568999999985433211 111122346888999999876322 1 2489999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||+++...||+........ ...+.+.--|. .+..+++.+++|+..+|+.||.+|++..-..+.|
T Consensus 448 YEIfg~~NPFY~rGem~L~------------~r~Yqe~qLPa----lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 448 YEIFGRSNPFYKRGEMLLD------------TRTYQESQLPA----LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhccCCcccccchheec------------hhhhhhhhCCC----CcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 9999999999874322110 00111111122 2334457789999999999999999865554443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=179.36 Aligned_cols=141 Identities=17% Similarity=0.151 Sum_probs=109.4
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---------------------c-----HHHHHHHHH
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---------------------G-----HKEWLAEVN 187 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---------------------~-----~~~~~~E~~ 187 (511)
...||+|+||.||+|.+. +|+.||||+++..... . ...+.+|..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 568999999999999864 4779999999865311 0 112357899
Q ss_pred HHhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccC
Q 010432 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFK 266 (511)
Q Consensus 188 il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLK 266 (511)
.+.++.|++|.....+.... .+|||||++|+++...+.. ...++......++.|++.+|.+||+ .+ |+|||||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred HHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 99999999875544443332 4899999988765443222 2457788899999999999999999 88 9999999
Q ss_pred CCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 267 TSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 267 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
|+|||++ ++.++|+|||++.....
T Consensus 146 P~NIll~--------------------------~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH--------------------------DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE--------------------------CCCEEEEEcccceecCC
Confidence 9999997 45699999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=179.50 Aligned_cols=141 Identities=18% Similarity=0.210 Sum_probs=108.4
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-----CCCCcceEeeEEEe
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-----VHLNLVKLIGYCIE 206 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-----~H~nIv~l~~~~~~ 206 (511)
.-.++||+|+||.||. +.. ++.. +||++........+.+.+|+.+++.| +||||++++|++.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 3456899999999995 443 3334 69998765444556789999999999 67999999999988
Q ss_pred CC---eEE-EEEEc--cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 207 DD---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL-AFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 207 ~~---~~~-lv~E~--~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
+. .++ +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++ ||||||||+|||++....
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~-- 143 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISE-- 143 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCC--
Confidence 63 434 78999 5579999999542 35555 35677888888 9999999 999999999999974221
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcc
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~ 312 (511)
.+..++|+||+.+.
T Consensus 144 -------------------~~~~~~LiDg~G~~ 157 (210)
T PRK10345 144 -------------------SEVIPVVCDNIGES 157 (210)
T ss_pred -------------------CCCcEEEEECCCCc
Confidence 24579999955443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=216.86 Aligned_cols=252 Identities=23% Similarity=0.246 Sum_probs=177.9
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHH---HHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHK---EWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~---~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
+|...+.||.+.|=+|.+|++++ |. |+||++-+.. ....+ +.+.|++ ...++|||.+.+.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 56667889999999999998865 44 8999986543 23333 3445555 55669999999988777
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+...|||=+|.. -+|++.|..+. .+...+.+.|+.||+.||.-+|..+ |+|+|||.+||||++
T Consensus 92 t~kAAylvRqyvk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTS----------- 155 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITS----------- 155 (1431)
T ss_pred hhHHHHHHHHHHh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEee-----------
Confidence 7777889999994 49999986543 4667778889999999999999999 999999999999995
Q ss_pred eeeccccccccccccCceeeecCCCcccCCC--CC---cceeeeeccccccccCCcccccC----------C-CCccccc
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE--GD---KTHVSTRVMGTYGYAAPEYVMTG----------H-LTSRSDV 349 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~--~~---~~~~~~~~~Gt~~y~aPE~~~~~----------~-~~~~~DI 349 (511)
-..+.|+||..-+...- ++ ......+...-..|+|||.+... . .+++-||
T Consensus 156 --------------WNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDI 221 (1431)
T KOG1240|consen 156 --------------WNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDI 221 (1431)
T ss_pred --------------echhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhh
Confidence 44578899877664321 11 11111112223479999987531 2 6778999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
||+||+++||++ |++||.- .++..+-...........+.+ +...++.|+..|++.||.+|.+
T Consensus 222 FS~GCViaELf~Eg~PlF~L------SQL~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlS 284 (1431)
T KOG1240|consen 222 FSAGCVIAELFLEGRPLFTL------SQLLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLS 284 (1431)
T ss_pred hhhhHHHHHHHhcCCCcccH------HHHHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccC
Confidence 999999999998 5788752 122222111000000011111 1235789999999999999999
Q ss_pred HHHHHHHhcCCC
Q 010432 429 MSEVVEALKPLP 440 (511)
Q Consensus 429 ~~eil~~L~~l~ 440 (511)
+++.|+.-..+.
T Consensus 285 AedyL~~yrG~~ 296 (1431)
T KOG1240|consen 285 AEDYLQKYRGLV 296 (1431)
T ss_pred HHHHHHhhhccc
Confidence 999998755543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=177.74 Aligned_cols=188 Identities=18% Similarity=0.084 Sum_probs=138.4
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc----HHHHHHHHHHHhCCC-CCCcceEeeEEEe
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~E~~il~~l~-H~nIv~l~~~~~~ 206 (511)
.+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++|. |++|++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 3456899999999997754 35678888776554311 124778999999995 5889999886
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc-CCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDL-Kp~NILl~~~~~~~~~~~~~ 285 (511)
+..+++|||+.|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||+|||++
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~------------ 126 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQ------------ 126 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEc------------
Confidence 346999999999998754311 11357789999999999999 999999 79999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc---ee--------eeeccccccccCCcccccC-CCC-ccccchhH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT---HV--------STRVMGTYGYAAPEYVMTG-HLT-SRSDVYSF 352 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~---~~--------~~~~~Gt~~y~aPE~~~~~-~~~-~~~DIwSl 352 (511)
.++.++|+|||+|......... .. ..-...++.|++|+.-.-. ..+ ...++++.
T Consensus 127 -------------~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~ 193 (218)
T PRK12274 127 -------------EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFAT 193 (218)
T ss_pred -------------CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHh
Confidence 3677999999999865443210 00 0012357778888744321 233 56799999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 010432 353 GVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~ 370 (511)
|+.+|.++|++.++....
T Consensus 194 g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 194 GKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHhccCCccccC
Confidence 999999999998876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-22 Score=214.10 Aligned_cols=209 Identities=26% Similarity=0.380 Sum_probs=147.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.+|..+++|..|+||.||.++++. +.+.+|+| +++... +++- ||.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~---------trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccc---------cccchhhc-ccccch-----hhhc--cccccCCccee----------
Confidence 578899999999999999999876 67789994 443321 1111 33333333333
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
||-...+.. .++++... +.+++|||+.+ |+|||+||+|.||..
T Consensus 136 -----------gDc~tllk~-~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~-------------- 178 (1205)
T KOG0606|consen 136 -----------GDCATLLKN-IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITS-------------- 178 (1205)
T ss_pred -----------chhhhhccc-CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeee--------------
Confidence 565555532 23444333 67899999988 999999999999995
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcce-------------eeeeccccccccCCcccccCCCCccccchhHHHH
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi 355 (511)
-+++|+.|||+++......... ....++||+.|+|||++....|+..+|+|++|+|
T Consensus 179 -----------mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiI 247 (1205)
T KOG0606|consen 179 -----------MGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGII 247 (1205)
T ss_pred -----------cccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHH
Confidence 6789999999998542211110 1224699999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
+||.+.|+.||.+..+..... .+ +.+...+.+- ......++++++.++|+.+|..|-
T Consensus 248 lyeFLVgcvpffGdtpeelfg---~v---isd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 248 LYEFLVGCVPFFGDTPEELFG---QV---ISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHheeeeeccCCCHHHHHh---hh---hhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 999999999999875542211 11 1111111111 112257889999999999999996
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=198.48 Aligned_cols=218 Identities=25% Similarity=0.400 Sum_probs=165.6
Q ss_pred HhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EecccCC
Q 010432 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV-IYRDFKT 267 (511)
Q Consensus 189 l~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~i-iHrDLKp 267 (511)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.....++++|+.||.|||.-- | .|+.|++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 46789999999999999999999999999999999999887788999999999999999999999854 4 9999999
Q ss_pred CcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC---C--
Q 010432 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---H-- 342 (511)
Q Consensus 268 ~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~-- 342 (511)
.|++++. ...+||+|||+.................-..-|.|||.+... .
T Consensus 78 ~nClvd~-------------------------~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~ 132 (484)
T KOG1023|consen 78 SNCLVDS-------------------------RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLE 132 (484)
T ss_pred ccceeee-------------------------eEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccc
Confidence 9999994 788999999999876431111111122234679999998753 1
Q ss_pred --CCccccchhHHHHHHHHHhCCCCCCCCCCCCc-hhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhc
Q 010432 343 --LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419 (511)
Q Consensus 343 --~~~~~DIwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl 419 (511)
.+.+.||||||++++|+++...||........ ..++..+.. .......|.+.... +..+.+..++..||
T Consensus 133 ~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw 204 (484)
T KOG1023|consen 133 SALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCW 204 (484)
T ss_pred ccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhc
Confidence 46679999999999999999999986433322 223322221 00111222221111 33457899999999
Q ss_pred ccCCCCCCCHHHHHHHhcCCCCC
Q 010432 420 SRDPKARPLMSEVVEALKPLPNL 442 (511)
Q Consensus 420 ~~dP~~RPs~~eil~~L~~l~~~ 442 (511)
..+|.+||++..|-..++.+...
T Consensus 205 ~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 205 EEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccChhhCccHHHHHhhhhhhccc
Confidence 99999999999999888776553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=184.34 Aligned_cols=231 Identities=22% Similarity=0.285 Sum_probs=146.9
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCC----------CCc
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVH----------LNL 197 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H----------~nI 197 (511)
+.....||.|+|+.||.+++.. |++.+|||++..... ...+++.+|.-....+.+ -.+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred EEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 4455689999999999999976 789999999864432 223456666544444322 112
Q ss_pred ceEeeEE---------EeCC--------eEEEEEEccCCCCHHHHHh---hCCC---CCCHHHHHHHHHHHHHHHHHHhc
Q 010432 198 VKLIGYC---------IEDD--------QRLLVYEFMPRGSLENHLF---RRSL---PLPWSIRMKIALGAAKGLAFLHE 254 (511)
Q Consensus 198 v~l~~~~---------~~~~--------~~~lv~E~~~~g~L~~~l~---~~~~---~l~~~~~~~i~~qi~~gL~yLH~ 254 (511)
+--++.. .... ..+++|+-+ .+||.+++. .... .+....++.+..|++..+++||+
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 2112211 1111 236788877 568888753 2221 23345556777999999999999
Q ss_pred CCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccC
Q 010432 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 334 (511)
Q Consensus 255 ~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~a 334 (511)
.| |||+||||+|+|++ .++.++|+||+.....+... .. ...+..|.+
T Consensus 164 ~G---lVHgdi~~~nfll~-------------------------~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~P 210 (288)
T PF14531_consen 164 YG---LVHGDIKPENFLLD-------------------------QDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTP 210 (288)
T ss_dssp TT---EEEST-SGGGEEE--------------------------TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-
T ss_pred cc---eEecccceeeEEEc-------------------------CCCCEEEcChHHHeecCcee----ec-cCCCcccCC
Confidence 99 99999999999999 58899999999887654311 11 234678999
Q ss_pred Cccccc--------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHH
Q 010432 335 PEYVMT--------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406 (511)
Q Consensus 335 PE~~~~--------~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (511)
||.... -.++.+.|.|+||+++|.|++|..||....+...... . -.... +
T Consensus 211 Pe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------------~---------f~~C~-~ 268 (288)
T PF14531_consen 211 PELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------------D---------FSRCR-D 268 (288)
T ss_dssp HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------------G---------GTTSS--
T ss_pred hhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------------c---------chhcC-C
Confidence 997643 2578899999999999999999999975432211100 0 11222 4
Q ss_pred HHHHHHHHHHHhcccCCCCC
Q 010432 407 GAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 407 ~~~~~~~Li~~cl~~dP~~R 426 (511)
.++.++.||..+|++||.+|
T Consensus 269 ~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 269 MPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --HHHHHHHHHHT-SSGGGS
T ss_pred cCHHHHHHHHHHccCCcccC
Confidence 57889999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-21 Score=207.83 Aligned_cols=207 Identities=19% Similarity=0.210 Sum_probs=161.3
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC---CCCcce
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVK 199 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~ 199 (511)
+.++....|.+.+.||+|+||.||+|...+ |+.||||+-+....- +|.-=.+++.+|+ -+-|..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMH 758 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHH
Confidence 334556788999999999999999998754 779999988765431 1211223344443 234566
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
+..++.-.+.-+||+||.+.|+|.+++. ....+++..++.+..|++.-|++||..+ |||+||||+|+||...-...
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~ 834 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICAD 834 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCC
Confidence 6666666677789999999999999996 4557899999999999999999999999 99999999999998532211
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
. +...++|+|||.+..+.--.........++|-.+-.+|+..|.+|+..+|.|.|..+++-|
T Consensus 835 ~------------------~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~m 896 (974)
T KOG1166|consen 835 S------------------DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVM 896 (974)
T ss_pred C------------------cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHH
Confidence 0 2556899999999865433222334557889999999999999999999999999999999
Q ss_pred HhCCC
Q 010432 360 LTGRR 364 (511)
Q Consensus 360 ltg~~ 364 (511)
|.|+.
T Consensus 897 LFG~y 901 (974)
T KOG1166|consen 897 LFGKY 901 (974)
T ss_pred HHHHH
Confidence 99864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=165.37 Aligned_cols=134 Identities=18% Similarity=0.260 Sum_probs=111.2
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--------HHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
+.||+|++|.||+|.+ .|..|+||+........ ...+.+|+.++..+.|++|+....++..
T Consensus 2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 5799999999999986 35579999876433211 1357789999999999998877777777
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||++|++|.+++.... . .+..++.+++.+|.+||..+ ++|+||+|.|||++
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~------------- 129 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS------------- 129 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-------------
Confidence 788899999999999999885422 2 77889999999999999998 99999999999997
Q ss_pred eeccccccccccccCceeeecCCCccc
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
+..++|+|||++..
T Consensus 130 -------------~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 -------------GGKIYLIDFGLAEF 143 (211)
T ss_pred -------------CCCEEEEECCcccC
Confidence 44589999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=168.48 Aligned_cols=145 Identities=18% Similarity=0.160 Sum_probs=109.5
Q ss_pred CCCCCCccccCCCceEEEEE-EcCCCCCCccCCCCcEEEEEEecCCCcc------------------------cHHHHHH
Q 010432 130 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------------GHKEWLA 184 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~-~~~~~~~~~~~~~~~~vAvK~~~~~~~~------------------------~~~~~~~ 184 (511)
-|.+.+.||+|+||.||+|. +.. +|+.||||+++..... ....+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 58889999999999999998 433 5789999999754311 0122568
Q ss_pred HHHHHhCCCCCC--cceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 010432 185 EVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (511)
Q Consensus 185 E~~il~~l~H~n--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH 262 (511)
|+.++.++.+.. +.+++++ . ..+|||||+.+++|..++... ..+.......++.||+.+|.|||.++. |+|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH 172 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGE--LVH 172 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCC--EEe
Confidence 999999997533 3444442 2 358999999988887654332 345566678899999999999998653 999
Q ss_pred cccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 263 rDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
|||||+|||++ +..++|+|||++.....
T Consensus 173 ~Dikp~NIli~--------------------------~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 173 GDLSEYNILVH--------------------------DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCChhhEEEE--------------------------CCCEEEEEChhhhccCC
Confidence 99999999997 34699999999876433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-19 Score=163.50 Aligned_cols=131 Identities=21% Similarity=0.317 Sum_probs=105.3
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.||+|+||.||+|.+ .+..|++|........ ...++.+|++++..+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999985 3568999986543211 124567899999999988766555556667
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||++|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|+|||++
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-------------- 124 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-------------- 124 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE--------------
Confidence 778999999999999988744211 78899999999999998 99999999999997
Q ss_pred eccccccccccccCceeeecCCCcccC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
+..++|+|||++...
T Consensus 125 ------------~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 125 ------------DDKLYLIDFGLGKYS 139 (199)
T ss_pred ------------CCcEEEEECCCCcCC
Confidence 456999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=185.51 Aligned_cols=137 Identities=23% Similarity=0.293 Sum_probs=110.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cc------cHHHHHHHHHHHhCCCCCCcceE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQ------GHKEWLAEVNFLGDLVHLNLVKL 200 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~------~~~~~~~E~~il~~l~H~nIv~l 200 (511)
..|...++||+|+||+||+|.+.. ..+++|+..... .. ..+.+.+|++++..++|++|+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 455678899999999999998743 234444332111 11 12457899999999999999988
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+.++......++||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||++
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl~------- 462 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIVR------- 462 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEEE-------
Confidence 888877778899999999999999884 34678999999999999998 99999999999994
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccC
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
+..++|+|||+++..
T Consensus 463 -------------------~~~~~liDFGla~~~ 477 (535)
T PRK09605 463 -------------------DDRLYLIDFGLGKYS 477 (535)
T ss_pred -------------------CCcEEEEeCcccccC
Confidence 557999999999763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=158.10 Aligned_cols=138 Identities=17% Similarity=0.076 Sum_probs=107.3
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc----------------------cHHHHHHHHH
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVN 187 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~E~~ 187 (511)
.|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 4788899999999999999764 4779999987653210 0113567899
Q ss_pred HHhCCCCCC--cceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 010432 188 FLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (511)
Q Consensus 188 il~~l~H~n--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDL 265 (511)
++.++.|.+ +...++ ....++||||+++++|..+... .....++.+++.++.++|..+ |+||||
T Consensus 86 ~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 86 ALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 999998774 444443 2346899999999998765421 234678899999999999988 999999
Q ss_pred CCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 266 KTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 266 Kp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
||+|||++ +++.++|+|||++.....
T Consensus 152 ~p~Nill~-------------------------~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVD-------------------------DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEc-------------------------CCCcEEEEECCccccCCC
Confidence 99999998 477899999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.6e-19 Score=190.11 Aligned_cols=256 Identities=24% Similarity=0.283 Sum_probs=190.6
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCC-CCCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~ 206 (511)
.|.+.+.||+|+|+.|-......+ ....+|+|.+.... .........|..+-..+. |.|++++++...+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 466677799999999988766432 34577888776553 111233345787777786 9999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 207 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l-~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+..+++++|..+|++...+ .......+...+-.++.|+..+|.|+| ..+ +.||||||+|.+++.
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~---------- 159 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDE---------- 159 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhcc----------
Confidence 99999999999999999988 443335667777889999999999999 877 999999999999984
Q ss_pred eeeeccccccccccccC-ceeeecCCCcccCCC-CCcceeeeeccc-cccccCCcccccC-CCCccccchhHHHHHHHHH
Q 010432 285 FCIYYGLFFNNMLFQDY-NAKLSDFGLAKDGPE-GDKTHVSTRVMG-TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~-~~kl~DFGla~~~~~-~~~~~~~~~~~G-t~~y~aPE~~~~~-~~~~~~DIwSlGvil~ell 360 (511)
.+ .+|++|||+|..... ..........+| ++.|+|||...+. -.....|+||.|+++.-++
T Consensus 160 ---------------s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~ 224 (601)
T KOG0590|consen 160 ---------------SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML 224 (601)
T ss_pred ---------------CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc
Confidence 44 799999999998766 444444555788 9999999988875 4467899999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
+|..|+......... ...|... .. ...............+++.+++..+|..|.+.+++..
T Consensus 225 ~g~~p~~~~~~~~~~-~~~~~~~----~~--------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 225 TGELPWDFPSRKDGR-YSSWKSN----KG--------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cCCCCcccccccccc-ceeeccc----cc--------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 999999754332210 0001000 00 0001111122456788999999999999999888754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=142.87 Aligned_cols=136 Identities=22% Similarity=0.150 Sum_probs=112.1
Q ss_pred CCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC--CCcceEeeEEEeCCeE
Q 010432 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDDQR 210 (511)
Q Consensus 133 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~~~~ 210 (511)
+.+.||.|.++.||++... +..++||....... ...+.+|+.++..+.| .++++++++....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4567999999999999873 35799999876543 4568899999999976 5899999988877889
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
+++|||++++.+..+ +......++.+++.+|.+||.....+++|+||+|+|||++
T Consensus 69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----------------- 123 (155)
T cd05120 69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----------------- 123 (155)
T ss_pred EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-----------------
Confidence 999999988777643 4556677899999999999986444599999999999998
Q ss_pred ccccccccccCceeeecCCCcccC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
+...++++|||+++..
T Consensus 124 --------~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 124 --------DGKILGIIDWEYAGYG 139 (155)
T ss_pred --------CCcEEEEEecccccCC
Confidence 3567999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=145.28 Aligned_cols=138 Identities=20% Similarity=0.155 Sum_probs=96.1
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHH----------------------HHHHHHHH
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKE----------------------WLAEVNFL 189 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~----------------------~~~E~~il 189 (511)
.+.||+|+||+||+|.+. +++.||||++....... ... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 467999999999999864 36799999987543211 111 13466666
Q ss_pred hCCCCCC--cceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccC
Q 010432 190 GDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFK 266 (511)
Q Consensus 190 ~~l~H~n--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLK 266 (511)
.++.+.. +.+.+++ ...++||||++++.+........ ... ..+..++.+++.++.++|. .+ |+|||||
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~ 142 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG---LVHGDLS 142 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCC
Confidence 6664432 4444443 24589999999854432111110 011 5577899999999999999 88 9999999
Q ss_pred CCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 267 TSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 267 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
|+|||++ +..++|+|||.+.....
T Consensus 143 p~Nili~--------------------------~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 143 EYNILVD--------------------------DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hhhEEEE--------------------------CCcEEEEECcccccccC
Confidence 9999997 45689999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.8e-16 Score=148.57 Aligned_cols=135 Identities=22% Similarity=0.244 Sum_probs=102.6
Q ss_pred Cccc-cCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhCCCCCCc--c
Q 010432 135 SLLG-EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLVHLNL--V 198 (511)
Q Consensus 135 ~~lG-~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~E~~il~~l~H~nI--v 198 (511)
..|| .||.|+||.+... +..++||++..... .....+.+|+.++.+|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 3687 8999999998763 55789998854221 112457889999999998875 6
Q ss_pred eEeeEEEeCC----eEEEEEEccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 199 KLIGYCIEDD----QRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 199 ~l~~~~~~~~----~~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
..+++..... ..+|||||++| .+|.+++... .++.. .+.+|+.+|.+||++| |+||||||+|||++
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~ 176 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLD 176 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEc
Confidence 7777654322 23599999997 6899887542 34443 3568999999999999 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccC
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
. +..++|+|||.+...
T Consensus 177 ~-------------------------~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 177 P-------------------------DGKFWLIDFDRGELR 192 (239)
T ss_pred C-------------------------CCCEEEEECCCcccC
Confidence 3 557999999998763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.9e-16 Score=162.02 Aligned_cols=254 Identities=25% Similarity=0.288 Sum_probs=187.9
Q ss_pred HhcCCCCCCcccc--CCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCC-CCCCcceEe
Q 010432 127 ATRNFRPESLLGE--GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLI 201 (511)
Q Consensus 127 ~~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l-~H~nIv~l~ 201 (511)
....|.+.+.+|. |.+|.||.+.... ...+..+|+|.-+.... .....=++|+....++ .|+|.|+.+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccC
Confidence 3456778888999 9999999998722 12577899998443221 2223335677777777 599999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
..+...+..|+-+|+| +.+|..+.......++...++.++.+... ||.++|+.. |+|-|+||+||++..
T Consensus 185 ~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~--- 257 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTS--- 257 (524)
T ss_pred cccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccc---
Confidence 9999999999999999 67999988777667888888888888888 999999988 999999999999984
Q ss_pred cccCCcceeeecccccccccccc-CceeeecCCCcccCCCCCcce---eeeeccccccccCCcccccCCCCccccchhHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQD-YNAKLSDFGLAKDGPEGDKTH---VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~-~~~kl~DFGla~~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlG 353 (511)
+ ...+++|||+........... ..-+..|...|++||++ .+.++...|||+||
T Consensus 258 ----------------------~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ 314 (524)
T KOG0601|consen 258 ----------------------DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLG 314 (524)
T ss_pred ----------------------ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchh
Confidence 4 678999999998876654222 12233678899999965 56789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 354 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
.++.+..++..++...-... |. ++-...+..++...-+..+..++..|++.+|..|+++..+.
T Consensus 315 ev~l~~~l~~~~~~~g~~~~------W~-----------~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSS------WS-----------QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred hhhHhhHhhcccccCCCCCC------cc-----------ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 99999999877664331111 10 00000011112112234555699999999999999988876
Q ss_pred H
Q 010432 434 E 434 (511)
Q Consensus 434 ~ 434 (511)
.
T Consensus 378 ~ 378 (524)
T KOG0601|consen 378 A 378 (524)
T ss_pred c
Confidence 5
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=6e-14 Score=145.55 Aligned_cols=141 Identities=20% Similarity=0.152 Sum_probs=96.3
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH-----------------------------------
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH----------------------------------- 179 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~----------------------------------- 179 (511)
+.||.|++|.||+|+.+ +|+.||||+.+.......
T Consensus 123 ~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 192 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK 192 (437)
T ss_pred cceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence 67999999999999986 478999999875421100
Q ss_pred -----HHHHHHHHHHhCC----CCCCcceEeeEEE-eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-H
Q 010432 180 -----KEWLAEVNFLGDL----VHLNLVKLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK-G 248 (511)
Q Consensus 180 -----~~~~~E~~il~~l----~H~nIv~l~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~-g 248 (511)
-+|.+|+..+.++ .|.+-|.+-.++. .....+|||||++|++|.++......... ...++.+++. .
T Consensus 193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~ 269 (437)
T TIGR01982 193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSF 269 (437)
T ss_pred HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHH
Confidence 0134455555544 2322233222222 23457899999999999887643222222 3345555555 4
Q ss_pred HHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 249 L~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
+..+|..| ++|+|+||.||+++ +++.++|+|||++.....
T Consensus 270 l~ql~~~g---~~H~D~hPgNilv~-------------------------~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 270 LNQVLRDG---FFHADLHPGNIFVL-------------------------KDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHhCC---ceeCCCCcccEEEC-------------------------CCCcEEEEeCCCeeECCH
Confidence 67889888 99999999999997 477899999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4e-14 Score=134.27 Aligned_cols=204 Identities=24% Similarity=0.301 Sum_probs=136.8
Q ss_pred HHHhCCCCCCcceEeeEEEeC-----CeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 010432 187 NFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 258 (511)
Q Consensus 187 ~il~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ 258 (511)
.-|-++.|.|||+++.||.+. ....++.||+..|+|..+|++. ...+......+|+.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445566899999999999764 3467899999999999999742 345777888899999999999999987 8
Q ss_pred CeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCC--cceeeeeccccccccCCc
Q 010432 259 PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPE 336 (511)
Q Consensus 259 ~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~Gt~~y~aPE 336 (511)
+|||++|..+-|++.. ++-+||.----........ .........|-++|.|||
T Consensus 198 piihgnlTc~tifiq~-------------------------ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~ 252 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQH-------------------------NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPE 252 (458)
T ss_pred ccccCCcchhheeecC-------------------------CceEEecccCccccchhhhhhhHhhhhccccCCccccCC
Confidence 8999999999999983 5556653211100000000 000011234678899999
Q ss_pred ccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHH
Q 010432 337 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 416 (511)
Q Consensus 337 ~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~ 416 (511)
.=.....+.++|||+||....||..+..--........ ...... ..+..+-+ ..-+.++.
T Consensus 253 sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~--~ee~ia------~~i~~len------------~lqr~~i~ 312 (458)
T KOG1266|consen 253 SGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVE--VEENIA------NVIIGLEN------------GLQRGSIT 312 (458)
T ss_pred cCcccccccchhhhhhhHHHHHHHHheeccCCCcceee--hhhhhh------hheeeccC------------ccccCcCc
Confidence 76666778899999999999999887642211100000 000000 00000000 11246889
Q ss_pred HhcccCCCCCCCHHHHHHHh
Q 010432 417 HCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 417 ~cl~~dP~~RPs~~eil~~L 436 (511)
+|++..|..||+|.+++.+.
T Consensus 313 kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 313 KCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred ccccCCCCCCcchhhhhcCc
Confidence 99999999999999988754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4e-14 Score=145.14 Aligned_cols=250 Identities=21% Similarity=0.158 Sum_probs=179.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHH--HHHHHHHHhCC-CCCCcceEee
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDL-VHLNLVKLIG 202 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~--~~~E~~il~~l-~H~nIv~l~~ 202 (511)
....+|..+..||.|.|+.|+.+..+. .++..|++|.+.+.......+ -+.|+.+...+ .|.++++++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~--------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRP--------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecC--------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence 345678999999999999999987442 256689999987765443322 24677766666 6899999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
.|...+..|+-.|||+++++...+. -...+.+...+.+..|++.++.++|+.. ++|+|+||+||++..
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~-------- 401 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISN-------- 401 (524)
T ss_pred CccccccccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeecc--------
Confidence 8988888899999999998877662 2235677788899999999999999988 999999999999984
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeecccccccc--CCcccccCCCCccccchhHHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA--APEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~--aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
+.+..++.|||++..+.-. .....++-+++ +++......+..++|++|||.-+.|.+
T Consensus 402 ----------------~~~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~ 460 (524)
T KOG0601|consen 402 ----------------DGFFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAI 460 (524)
T ss_pred ----------------chhhhhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccc
Confidence 1266899999998753221 11123344455 555555678899999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
++...-..... | ..+....+ ...+.. ..++..+.+.++..++..||.+.++..+.+
T Consensus 461 ~~~~ls~~~~~--------~-----------~~i~~~~~-p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 461 TGSPLSESGVQ--------S-----------LTIRSGDT-PNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cCcccCccccc--------c-----------eeeecccc-cCCCch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 98653321100 0 01111000 011111 266788999999999999999988876554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.2e-13 Score=119.45 Aligned_cols=131 Identities=19% Similarity=0.063 Sum_probs=95.4
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcc-eEeeEEEeCCeEEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLL 212 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv-~l~~~~~~~~~~~l 212 (511)
++.|+.|.++.||+++. .+..|++|+...... ....+.+|+.++..+.+.+++ +++.+. ....++
T Consensus 3 ~~~l~~G~~~~vy~~~~-----------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEE-----------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 35689999999999986 356899998865432 123457899999988655544 455443 334589
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
||||++|.++.... . ....++.+++.+|+.||..+ ...++|+|++|.|||++
T Consensus 69 v~e~i~G~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----------------- 122 (170)
T cd05151 69 ITEFIEGSELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----------------- 122 (170)
T ss_pred EEEecCCCcccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-----------------
Confidence 99999998876430 1 11345678999999999876 22359999999999997
Q ss_pred ccccccccccCceeeecCCCccc
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
+..++|+|||.+..
T Consensus 123 ---------~~~~~liDf~~a~~ 136 (170)
T cd05151 123 ---------DGRLWLIDWEYAGM 136 (170)
T ss_pred ---------CCeEEEEecccccC
Confidence 34589999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.3e-13 Score=140.93 Aligned_cols=147 Identities=16% Similarity=0.125 Sum_probs=92.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------------------------c----
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------G---- 178 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------------------------~---- 178 (511)
..|+. +.||.|++|.||+|+++. +|+.||||+++..... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 45666 789999999999999875 5889999999754210 0
Q ss_pred ----HH------HHHHHHHHHhCCC----CCCcceEeeEEEe-CCeEEEEEEccCCCCHHHHH--hhCCC---CCCHHHH
Q 010432 179 ----HK------EWLAEVNFLGDLV----HLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSIR 238 (511)
Q Consensus 179 ----~~------~~~~E~~il~~l~----H~nIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l--~~~~~---~l~~~~~ 238 (511)
.+ ++.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.|.++- ...+. .+....+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 01 1333444443332 3333333333322 34568999999999998743 22221 1222223
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 239 ~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
..++.|+ +..| ++|+|+||.||+++..+. .++.++++|||++.....
T Consensus 270 ~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~---------------------~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQV-------FRDG---FFHADMHPGNIFVSYDPP---------------------ENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------HhCC---eeeCCCChHHeEEecCCC---------------------CCCeEEEEecceEEECCH
Confidence 3344444 3456 999999999999984211 134899999999987644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-13 Score=148.50 Aligned_cols=248 Identities=21% Similarity=0.212 Sum_probs=169.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
+.|.+.+-+-+|.|+.++.+.-.. +|...++|+....... ..+....+-.++-...||.++....-+.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~---------sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAG---------SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccceecccccCCCCcccccCCccc---------cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence 345666778899999998875432 5556666665443211 1122333444444445677776665556
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.....+|||+|+.+++|...|+... ..+.+....+...+..+++|||... ++|||++|.|+|+..
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~----------- 939 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAY----------- 939 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcc-----------
Confidence 6778899999999999999886544 4555566667778889999999977 899999999999984
Q ss_pred eeeccccccccccccCceeeecCCCcccCCC-----------------------------CCcceeeeeccccccccCCc
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE-----------------------------GDKTHVSTRVMGTYGYAAPE 336 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~-----------------------------~~~~~~~~~~~Gt~~y~aPE 336 (511)
+++.+++|||+...... ...........||+.|.+||
T Consensus 940 --------------~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe 1005 (1205)
T KOG0606|consen 940 --------------DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPE 1005 (1205)
T ss_pred --------------cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCc
Confidence 56666777663321100 00001123467999999999
Q ss_pred ccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCcc-CCCCCHHHHHHHHHHH
Q 010432 337 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL-EGHFSIKGAQKAAQLA 415 (511)
Q Consensus 337 ~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~Li 415 (511)
.+.+......+|+|++|++++|.++|.+||....+.... ..++.... ...-+...+..+.+++
T Consensus 1006 ~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~ 1069 (1205)
T KOG0606|consen 1006 ILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLI 1069 (1205)
T ss_pred ccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhh
Confidence 999999999999999999999999999999865443211 01111100 1111223356788999
Q ss_pred HHhcccCCCCCCCHH
Q 010432 416 AHCLSRDPKARPLMS 430 (511)
Q Consensus 416 ~~cl~~dP~~RPs~~ 430 (511)
.+.+..+|.+|-.+.
T Consensus 1070 ~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1070 NRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhccCchhccCcc
Confidence 999999999998765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-11 Score=112.61 Aligned_cols=146 Identities=14% Similarity=0.101 Sum_probs=100.3
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--c-------------------c-HHHH----HHHHH
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--Q-------------------G-HKEW----LAEVN 187 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~-------------------~-~~~~----~~E~~ 187 (511)
...||.|--+.||.|....... ....+..+|||+.+.... + . ...+ .+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 3579999999999997532100 011356899999864210 0 0 1112 37999
Q ss_pred HHhCCCC--CCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecc
Q 010432 188 FLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRD 264 (511)
Q Consensus 188 il~~l~H--~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~~iiHrD 264 (511)
.|.++.. -++.+.+++ ...+|||||+.++.+..-..+ ...++......+..+++.+|..| |..+ |||+|
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999843 466677764 356899999965444221111 12345556677889999999999 8888 99999
Q ss_pred cCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 265 FKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 265 LKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
|++.|||+. ++.+.|+|||.+.....
T Consensus 151 Ls~~NIL~~--------------------------~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH--------------------------DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE--------------------------CCcEEEEECCCceeCCC
Confidence 999999996 45699999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.4e-11 Score=122.93 Aligned_cols=164 Identities=16% Similarity=0.184 Sum_probs=122.2
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHH
Q 010432 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241 (511)
Q Consensus 162 ~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i 241 (511)
++.+|.|...+...........+-++-|+.|+||||++|++.+..++..|||+|-+ -.|..++.+.. ...+...
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~~G 109 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVCLG 109 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHHHH
Confidence 67789999887765432344677889999999999999999999999999999998 36777775432 4556667
Q ss_pred HHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce
Q 010432 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH 321 (511)
Q Consensus 242 ~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~ 321 (511)
+.||+.||.|||..+. ++|++|.-+-|+++ ..+..||++|-++.........
T Consensus 110 l~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn-------------------------~~GeWkLggle~v~~~~~~~~~- 161 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCN--LVHGNVCKDSVFVN-------------------------ESGEWKLGGLELVSKASGFNAP- 161 (690)
T ss_pred HHHHHHHHHHHhccCC--eeeccEeeeeEEEc-------------------------CCCcEEEeeeEEEeccccCCcc-
Confidence 8899999999985442 99999999999998 4788999999887654332210
Q ss_pred eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 322 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 322 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.....--..|..|+.+.... -..|.|-|||+++|++.|
T Consensus 162 -~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 -AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 00011122456666443222 457999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.8e-11 Score=104.87 Aligned_cols=131 Identities=22% Similarity=0.281 Sum_probs=97.1
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..|++|+-+.+|.+.+. |..+++|.=...... ..++..+|+.+|.++.--.|..-+=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 36889999999999663 445667754332211 12346789999998864444433334556
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+...|+|||++|-.|.+.+... ...++..|-.-+.-||..+ |||+||.++||++.
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~------------- 126 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILS------------- 126 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEe-------------
Confidence 77788999999988888888543 2456667777788899999 99999999999997
Q ss_pred eeccccccccccccCceeeecCCCccc
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
...+.++||||+..
T Consensus 127 -------------~~~i~~IDfGLg~~ 140 (204)
T COG3642 127 -------------GGRIYFIDFGLGEF 140 (204)
T ss_pred -------------CCcEEEEECCcccc
Confidence 44599999999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.1e-11 Score=104.60 Aligned_cols=145 Identities=20% Similarity=0.194 Sum_probs=105.5
Q ss_pred CCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 133 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.+.+|-+|+-+.|+++.+ .|+.+.||.-..... -...+..+|+++|.++.--.|.--.=++
T Consensus 11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 566899999999999987 467778875432221 1124578899999998654544333355
Q ss_pred EeCCeEEEEEEccCC-CCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 205 IEDDQRLLVYEFMPR-GSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~-g~L~~~l~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
.+...-+|+|||++| .++.+++...... ........++.+|-..+.-||.++ |||+||..+||||..++
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~------ 150 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDG------ 150 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCC------
Confidence 666667899999966 3788888643222 223333678889999999999999 99999999999998643
Q ss_pred cceeeeccccccccccccCceeeecCCCccc
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
....+.|+|||++..
T Consensus 151 ----------------~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 151 ----------------NQITPILIDFGLSSV 165 (229)
T ss_pred ----------------CcCceEEEeecchhc
Confidence 244568999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.8e-10 Score=108.72 Aligned_cols=144 Identities=19% Similarity=0.222 Sum_probs=106.1
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCC--CCcceEeeEEEeC---C
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVH--LNLVKLIGYCIED---D 208 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~---~ 208 (511)
+.||.|.++.||++...+ |..|++|....... .....+.+|+.++..+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 568999999999997632 46899999865432 123467899999999965 4467777776553 2
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------- 256 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-------------------------------- 256 (511)
..++||||++|.+|.+.+.. ..++......++.+++.+|.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 56899999999888765521 24667777778888888888888521
Q ss_pred ---------------------CCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCccc
Q 010432 257 ---------------------ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 257 ---------------------~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
...++|+|+.|.|||++.. .+..+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-----------------------~~~~~~iID~e~~~~ 206 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-----------------------EPRVVAVLDWELATL 206 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-----------------------CCcEEEEEecccccc
Confidence 2347999999999999831 034578999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.7e-09 Score=106.07 Aligned_cols=168 Identities=20% Similarity=0.264 Sum_probs=125.3
Q ss_pred CCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe----CCeEEEEEEc
Q 010432 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEF 216 (511)
Q Consensus 141 ~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~~lv~E~ 216 (511)
--.+.|+++... +|..|++|+++............-+++++++.|.|||+|..+|.. +..++||++|
T Consensus 288 ~~~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDY 358 (655)
T KOG3741|consen 288 FSITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDY 358 (655)
T ss_pred ccceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEec
Confidence 345788998876 577899999965443333333456788999999999999998873 4578999999
Q ss_pred cCC-CCHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 217 MPR-GSLENHLFRR--------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 217 ~~~-g~L~~~l~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
.++ ++|.++.... +...++..++.++.|+..||.++|+.| +.-+-|.|.+||++.
T Consensus 359 yP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G------- 428 (655)
T KOG3741|consen 359 YPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTG------- 428 (655)
T ss_pred CCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeC-------
Confidence 876 5787765321 234778999999999999999999999 888999999999983
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
+.+++|+..|+......... |-+.. -.+-|.=.||.+++-|.|
T Consensus 429 ------------------~~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt 471 (655)
T KOG3741|consen 429 ------------------KMRIRISGCGIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALAT 471 (655)
T ss_pred ------------------cceEEEecccceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhh
Confidence 55788877766554433220 11111 135688899999999999
Q ss_pred CCC
Q 010432 362 GRR 364 (511)
Q Consensus 362 g~~ 364 (511)
|..
T Consensus 472 ~~~ 474 (655)
T KOG3741|consen 472 GTE 474 (655)
T ss_pred ccc
Confidence 854
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.6e-08 Score=97.92 Aligned_cols=146 Identities=14% Similarity=0.036 Sum_probs=98.4
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-----------cHHHHHHHHHHHhCCCCC--CcceEee
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFLGDLVHL--NLVKLIG 202 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~il~~l~H~--nIv~l~~ 202 (511)
.+-.-....|++..+ .|+.|.||........ ....+.+|...+.+|... .....++
T Consensus 29 ~v~~~~~rrvvr~~~-----------~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa 97 (268)
T PRK15123 29 VFRELEGRRTLRFEL-----------AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVA 97 (268)
T ss_pred EEecCCCceEEEEEE-----------CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeE
Confidence 333333344666655 3668999977543311 011377899988888433 3344455
Q ss_pred EEEe-----CCeEEEEEEccCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccc
Q 010432 203 YCIE-----DDQRLLVYEFMPRG-SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 203 ~~~~-----~~~~~lv~E~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 275 (511)
+... ...-+||||++++. +|.+++... ....+......++.+++..+.-||..| |+|+||++.|||++..
T Consensus 98 ~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 98 FGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLP 174 (268)
T ss_pred EEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEecc
Confidence 5543 23468999999875 798887532 234556677789999999999999999 9999999999999731
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCccc
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
... ..++..+.|+||+.++.
T Consensus 175 ~~~------------------~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPG------------------REEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccC------------------CCCCceEEEEECCcccc
Confidence 000 00256799999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.4e-08 Score=92.85 Aligned_cols=126 Identities=22% Similarity=0.204 Sum_probs=78.9
Q ss_pred eEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc----------------------c----HHHHHHHHHHHhCCCCC--
Q 010432 144 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------G----HKEWLAEVNFLGDLVHL-- 195 (511)
Q Consensus 144 ~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----------------------~----~~~~~~E~~il~~l~H~-- 195 (511)
.||.|... .|..+|||+.+..... . .....+|++.|.++..-
T Consensus 1 ~Vy~~~~~----------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv 70 (188)
T PF01163_consen 1 DVYHAIDP----------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGV 70 (188)
T ss_dssp EEEEEEEC----------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-
T ss_pred CEEEEECC----------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCc
Confidence 38888764 3679999998643110 0 12356799999999765
Q ss_pred CcceEeeEEEeCCeEEEEEEccC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecccCCCcEEe
Q 010432 196 NLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 196 nIv~l~~~~~~~~~~~lv~E~~~--~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~y-LH~~~~~~iiHrDLKp~NILl 272 (511)
++.+.+++. ..+|||||+. |..|..+. .. .+.......++.+++..+.. +|..| |||+||.+.|||+
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~--~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv 140 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DV--DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILV 140 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHH-HC--GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEE
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHH-hc--cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEe
Confidence 566666542 3479999997 54444332 21 11133455677778775655 57888 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCC
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~ 315 (511)
+ +..+.|+|||.+....
T Consensus 141 ~--------------------------~~~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 141 D--------------------------DGKVYIIDFGQAVDSS 157 (188)
T ss_dssp E--------------------------TTCEEE--GTTEEETT
T ss_pred e--------------------------cceEEEEecCcceecC
Confidence 8 3479999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.7e-07 Score=89.67 Aligned_cols=259 Identities=17% Similarity=0.176 Sum_probs=152.2
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEE------
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC------ 204 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~------ 204 (511)
.....||+|+-+.+|-.--- + ..+.|+.......... +-+..|... .||-+..=+.+=
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-----------~-d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-----------R-DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCCccccCCccceeeecchh-----------h-chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhC
Confidence 45567999999999954211 1 2345777655433222 223334444 566443311111
Q ss_pred EeCC-eEEEEEEccCCCC-HHHHHh----hC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 205 IEDD-QRLLVYEFMPRGS-LENHLF----RR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 205 ~~~~-~~~lv~E~~~~g~-L~~~l~----~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
-+.. ..-++|..+.+-. +..++. ++ .....|...++.++.++.+.+-||.+| .+-+|+.++|+|++
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVs---- 151 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVS---- 151 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeee----
Confidence 1122 2567888886642 223332 11 234689999999999999999999999 88899999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSF 352 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSl 352 (511)
++..+.|.|--.-....++. .....+|...|.+||.-. +-.-+...|.|.|
T Consensus 152 ---------------------d~~~V~LVdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGL 207 (637)
T COG4248 152 ---------------------DDSKVVLVDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGL 207 (637)
T ss_pred ---------------------cCceEEEEcccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhH
Confidence 47778887632222111111 122357899999999654 2344667999999
Q ss_pred HHHHHHHHhC-CCCCCCCCCCCch-----hHHHhhhhhhccccccccccCCccCCCCCH-HHHHHHHHHHHHhccc--CC
Q 010432 353 GVVLLEMLTG-RRSMDKNRPNGEH-----NLVEWARPHLGERRRFYRLIDPRLEGHFSI-KGAQKAAQLAAHCLSR--DP 423 (511)
Q Consensus 353 Gvil~elltg-~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~cl~~--dP 423 (511)
||++++|+.| +.||.+....... .-+............. ....+ ....+. -.++.+..|..+|+.. ++
T Consensus 208 avLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~-g~~p~--P~~~P~~~Lpp~vqAlF~qaF~~~~~~ 284 (637)
T COG4248 208 AVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRR-GLKPP--PRSIPLSMLPPDVQALFQQAFTESGVA 284 (637)
T ss_pred HHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccC-CCCCC--CCCCChhhcCHHHHHHHHHHhcccCCC
Confidence 9999999987 9999864322110 0000000000000000 00000 111121 1246778888899865 35
Q ss_pred CCCCCHHHHHHHhcCC
Q 010432 424 KARPLMSEVVEALKPL 439 (511)
Q Consensus 424 ~~RPs~~eil~~L~~l 439 (511)
.-|||++.-+..|..+
T Consensus 285 ~~RP~a~aW~aAl~al 300 (637)
T COG4248 285 TPRPTAKAWVAALDAL 300 (637)
T ss_pred CCCCCHHHHHHHHHHH
Confidence 6899998877776554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-07 Score=86.69 Aligned_cols=127 Identities=22% Similarity=0.170 Sum_probs=90.4
Q ss_pred CCcEEEEEEecCCCc-------ccHHHHHHHHHHHhCCC--CCCcceEeeEEEeC----CeEEEEEEccCCC-CHHHHHh
Q 010432 162 TGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLV--HLNLVKLIGYCIED----DQRLLVYEFMPRG-SLENHLF 227 (511)
Q Consensus 162 ~~~~vAvK~~~~~~~-------~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~----~~~~lv~E~~~~g-~L~~~l~ 227 (511)
.++.|-+|.+..... -......+|...+..|. .-.+.+.+++.... ...+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 345666765432211 12235778888887774 33455666666542 2348999999874 7999886
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeec
Q 010432 228 RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307 (511)
Q Consensus 228 ~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 307 (511)
.... .+......++.+++..+.-||.+| |+|+||++.|||+.... ....+.|+|
T Consensus 111 ~~~~-~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~----------------------~~~~~~lID 164 (206)
T PF06293_consen 111 QWEQ-LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDD----------------------GQYRFYLID 164 (206)
T ss_pred hhcc-cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCC----------------------CceeEEEEc
Confidence 5322 566677889999999999999999 99999999999998522 134789999
Q ss_pred CCCcccC
Q 010432 308 FGLAKDG 314 (511)
Q Consensus 308 FGla~~~ 314 (511)
|+.++..
T Consensus 165 ld~~~~~ 171 (206)
T PF06293_consen 165 LDRMRFR 171 (206)
T ss_pred chhceeC
Confidence 9988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.4e-09 Score=110.61 Aligned_cols=186 Identities=17% Similarity=0.101 Sum_probs=133.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCC-cceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~ 208 (511)
.+...+-+++|++++++|.+... +. ....+.+... ....-++++|.+++||| .+..++-+..++
T Consensus 243 ws~~fh~fvK~altknpKkRpta---------ek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTA---------EK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED 307 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCCh---------hh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence 34444568999999999987543 12 2225555432 33445888999999999 778888777888
Q ss_pred eEEEEEEccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..+++|++|.+| +-..........+...+...+.+.-+++|+|||+.. =+||| |||..
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s-------------- 366 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGS-------------- 366 (829)
T ss_pred ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----ccccc--------------
Confidence 999999999877 222111111122333444566677788999999854 38999 88876
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
....|..||+....+.... ..+...+|+.|+|||+.....+....|+|++|+--.+|.-|-+|-
T Consensus 367 ------------~~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 367 ------------EEEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ------------ccccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4668999999998776543 234467999999999999999999999999998777777776654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.1e-08 Score=103.65 Aligned_cols=150 Identities=22% Similarity=0.309 Sum_probs=100.9
Q ss_pred HHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCccee-
Q 010432 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHV- 322 (511)
Q Consensus 244 qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~- 322 (511)
+++.||.|+|..- .+||+.|.|++|.++. .+..||+.|+.+...........
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na-------------------------~~~wkl~Gf~f~v~~~~~~~~p~~ 159 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNA-------------------------NGDWKLAGFSFCVNANGPTEYPFS 159 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeecc-------------------------CcceeeccchhhhccCCCCccccc
Confidence 4559999999753 4999999999999984 66789999988765443221100
Q ss_pred ------eeeccccccccCCcccccCCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCchhHHHhhhhhhcccccccccc
Q 010432 323 ------STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 395 (511)
Q Consensus 323 ------~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (511)
..-..-...|.|||++.+...+.++|+||+||++|-+. .|+..+............ ...
T Consensus 160 ~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~ 225 (700)
T KOG2137|consen 160 EYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNL 225 (700)
T ss_pred cCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcc
Confidence 00112356899999999888899999999999999999 555555433221111000 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 396 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
+..-...++...+.++++-+.+++..++.-||++..+..
T Consensus 226 ~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 226 LNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 000111222344678999999999999999997766653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.2e-06 Score=78.97 Aligned_cols=140 Identities=17% Similarity=0.103 Sum_probs=99.7
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC------cccHHHHHHHHHHHhCCCCC--CcceEeeEEEe--
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG------LQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIE-- 206 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~il~~l~H~--nIv~l~~~~~~-- 206 (511)
-|+||.+-|++..+. |..|-+|.-.... ......|.+|+..|.+|..- .+.+...+...
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~ 94 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKI 94 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeecc
Confidence 478999999997763 4467788765221 12346799999999988532 24444422211
Q ss_pred --CCeEEEEEEccCC-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 207 --DDQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 207 --~~~~~lv~E~~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
.-..+||+|-+.+ -+|.+++.... .+.+......++.+|+..|.-||+.+ +.|+|+-+.|||++..
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~------- 164 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTE------- 164 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCC-------
Confidence 1235799998754 48988885432 24567777899999999999999999 9999999999999731
Q ss_pred cceeeeccccccccccccCceeeecCCCccc
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
+...++++||--++.
T Consensus 165 ----------------g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 165 ----------------GKAEAGFLDLEKSRR 179 (216)
T ss_pred ----------------CCeeEEEEEhhccch
Confidence 133599999977664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=9.8e-07 Score=83.31 Aligned_cols=136 Identities=18% Similarity=0.093 Sum_probs=93.1
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc----------------------cHHHHHHHHHH
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVNF 188 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~E~~i 188 (511)
..+...||-|--+.||.|... .|..+|||.=+..... ......+|.++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 456678999999999999875 3779999965432110 11235689999
Q ss_pred HhCCCCC--CcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccC
Q 010432 189 LGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (511)
Q Consensus 189 l~~l~H~--nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLK 266 (511)
|.+|.-. .+.+-+++ +...+||||++|-.|...- +.....-.++..|+.-+.-+-..| |||+|+.
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G---iVHGDlS 229 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG---IVHGDLS 229 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence 9999544 56666553 4568999999886655321 122333344444444444444556 9999999
Q ss_pred CCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccC
Q 010432 267 TSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 267 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
+-|||++ +++.+.++||--+...
T Consensus 230 efNIlV~-------------------------~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVT-------------------------EDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEe-------------------------cCCCEEEEeCcccccC
Confidence 9999999 5778999999766543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.8e-07 Score=93.35 Aligned_cols=142 Identities=17% Similarity=0.146 Sum_probs=90.2
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--------------------------H----H----
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------------------H----K---- 180 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--------------------------~----~---- 180 (511)
+.|+.++-|.||+|+++ +|+.||||+.+.+-... . +
T Consensus 131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 57999999999999987 48899999987542110 0 0
Q ss_pred ------HHHHHHHHHhCCC-----CCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH
Q 010432 181 ------EWLAEVNFLGDLV-----HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249 (511)
Q Consensus 181 ------~~~~E~~il~~l~-----H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL 249 (511)
++.+|..-+.++. .++|.--.=|+.-.....|+|||++|-.+.+....+...++...+.....++. +
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--L 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--H
Confidence 1334555444442 23322111122334567899999999888887533334455333333222222 2
Q ss_pred HHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 250 ~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
..+-..| ++|.|..|.||++.. ++.+.+.|||+......
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~-------------------------~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRS-------------------------DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcC---ccccCCCccceEEec-------------------------CCcEEEEcCcceecCCH
Confidence 2222345 999999999999994 78899999999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.8e-06 Score=79.62 Aligned_cols=72 Identities=17% Similarity=0.137 Sum_probs=53.3
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCC--cceEeeEEEeCCeEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIEDDQRLL 212 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~n--Iv~l~~~~~~~~~~~l 212 (511)
..||.|..+.||+.. +..+++|...... ......+|.++++.+..-. +.+.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 468999999999841 3357788876533 2345788999998885433 4677777777777889
Q ss_pred EEEccCCCC
Q 010432 213 VYEFMPRGS 221 (511)
Q Consensus 213 v~E~~~~g~ 221 (511)
|||+++|.+
T Consensus 72 v~e~i~G~~ 80 (226)
T TIGR02172 72 IYELIVGKR 80 (226)
T ss_pred eeeecCCcc
Confidence 999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.5e-06 Score=77.29 Aligned_cols=139 Identities=12% Similarity=0.081 Sum_probs=92.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHH---------HHHHHHHhCCC---
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---------LAEVNFLGDLV--- 193 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~---------~~E~~il~~l~--- 193 (511)
....+|.+.+++-......|.+-.. .|..+++|..+.......+.| .+++..+.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g 96 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG 96 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence 4457888888888888777877655 467899998876543222221 23444333332
Q ss_pred CCCcceEeeEEEe-----CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 010432 194 HLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (511)
Q Consensus 194 H~nIv~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~ 268 (511)
-..++.++.+... ....+|||||++|-.|.++.. ++. .++..|+.+|.-||..| ++|+|..|.
T Consensus 97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpg 164 (229)
T PF06176_consen 97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPG 164 (229)
T ss_pred ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcC
Confidence 2233333333322 234569999999988876541 222 24456778899999999 999999999
Q ss_pred cEEeccccccccCCcceeeeccccccccccccCceeeecCCCccc
Q 010432 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 269 NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
|+++. +..++++||+..+.
T Consensus 165 NFlv~--------------------------~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 165 NFLVS--------------------------NNGIRIIDTQGKRM 183 (229)
T ss_pred cEEEE--------------------------CCcEEEEECccccc
Confidence 99997 45599999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.7e-06 Score=77.45 Aligned_cols=153 Identities=19% Similarity=0.165 Sum_probs=97.4
Q ss_pred cChHHHHHHhcCCCCCCc---cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-----------------
Q 010432 119 FTFNDLKLATRNFRPESL---LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----------------- 178 (511)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~---lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~----------------- 178 (511)
.+...+.....+..+... |..|--+.||+|... .+..||||+++......
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~ 104 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSR 104 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCC
Confidence 444445555555555554 556666789998753 36799999997543211
Q ss_pred --HHH-----HHHHHHHHhCCC--CCCcceEeeEEEeCCeEEEEEEccCCCCH-HHHHhhCCCCCCHHHHHHHHHHHHHH
Q 010432 179 --HKE-----WLAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLPWSIRMKIALGAAKG 248 (511)
Q Consensus 179 --~~~-----~~~E~~il~~l~--H~nIv~l~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~l~~~~~~~i~~qi~~g 248 (511)
.++ ...|+.-|.++. +-.+.+-+++. .-.|||||+...-+ .-.| ....+.......+..+++..
T Consensus 105 ~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 105 SNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEY 178 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHH
Confidence 011 235777777763 44444555443 24799999943210 0011 11223333567778888888
Q ss_pred HHHHhc-CCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 249 LAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 249 L~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
+.-|-. .+ +||+||..=|||+. ++.+.|+|||-|....+
T Consensus 179 ~~~l~~~a~---LVHgDLSEyNiL~~--------------------------~~~p~iID~~QaV~~~h 218 (268)
T COG1718 179 MRRLYKEAG---LVHGDLSEYNILVH--------------------------DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred HHHHHHhcC---cccccchhhheEEE--------------------------CCeEEEEECccccccCC
Confidence 887766 56 99999999999997 66799999999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.6e-06 Score=75.73 Aligned_cols=115 Identities=28% Similarity=0.393 Sum_probs=82.0
Q ss_pred cCCCCCCccccCCC-ceEEEEEEcCCCCCCccCCCCcEEEEEEecC---CC-------cc-----------cHHHHHHHH
Q 010432 129 RNFRPESLLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---DG-------LQ-----------GHKEWLAEV 186 (511)
Q Consensus 129 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~---~~-------~~-----------~~~~~~~E~ 186 (511)
.+++.++.||.|.- |.||+++. .|+.||||++.. .. .. ....|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 68889999999999 99999988 477999999432 10 00 012377888
Q ss_pred HHHhCCC---CCCc--ceEeeEEEeC------------------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHH
Q 010432 187 NFLGDLV---HLNL--VKLIGYCIED------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243 (511)
Q Consensus 187 ~il~~l~---H~nI--v~l~~~~~~~------------------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~ 243 (511)
+...+|+ +.++ |+.+||..-. ..+.||.||.+... .+. ..-+.
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~ 171 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIP 171 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHH
Confidence 8887774 4566 9999987432 12357888775533 122 22345
Q ss_pred HHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 244 GAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 244 qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
+|.+-|..+|..+ |+-+|+|+.|..
T Consensus 172 ~~~~dl~~~~k~g---I~~~Dv~~~ny~ 196 (207)
T PF13095_consen 172 QMLRDLKILHKLG---IVPRDVKPRNYR 196 (207)
T ss_pred HHHHHHHHHHHCC---eeeccCcccccc
Confidence 6777888999999 999999999985
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=7e-06 Score=86.01 Aligned_cols=144 Identities=16% Similarity=0.093 Sum_probs=90.9
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-------------------------------HH---
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------------------------------HK--- 180 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-------------------------------~~--- 180 (511)
+.||.-+.|.||+|+.+. |+.||||+-+..-... .+
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 579999999999999874 7899999876542110 00
Q ss_pred ---HHHHHHHHHhC----CCCCC------cceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH
Q 010432 181 ---EWLAEVNFLGD----LVHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247 (511)
Q Consensus 181 ---~~~~E~~il~~----l~H~n------Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~ 247 (511)
+|.+|++-..+ +.|-+ |.++|- .-.....|+||||+|..+.+.-.-....++...+...+.++..
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL 314 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH
Confidence 13344433322 23444 333332 2234678999999998766654323334555544444444332
Q ss_pred HHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 248 gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
-+-+. .| ++|+|=.|.|||+...+. .+..+.+-|||+......
T Consensus 315 ~qIf~--~G---ffHaDPHPGNilv~~~~~---------------------~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFK--TG---FFHADPHPGNILVRPNPE---------------------GDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHh--cC---CccCCCCCCcEEEecCCC---------------------CCccEEEEcccccccccH
Confidence 22233 35 999999999999985321 367899999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.3e-05 Score=75.28 Aligned_cols=74 Identities=19% Similarity=0.142 Sum_probs=52.0
Q ss_pred cccCCC-ceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEeCCeEEEEE
Q 010432 137 LGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVY 214 (511)
Q Consensus 137 lG~G~f-g~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv~ 214 (511)
|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++...++..++||
T Consensus 6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 444555 789998542 3468888876543 234668999888873 445667888777666789999
Q ss_pred EccCCCCHHH
Q 010432 215 EFMPRGSLEN 224 (511)
Q Consensus 215 E~~~~g~L~~ 224 (511)
|+++|.+|..
T Consensus 72 e~i~G~~l~~ 81 (244)
T cd05150 72 SAVPGVPAAA 81 (244)
T ss_pred EeeCCccHhH
Confidence 9999877654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.7e-05 Score=71.83 Aligned_cols=121 Identities=17% Similarity=0.220 Sum_probs=85.0
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC----------------cccHHHHHHHHHHHhCCC----
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------------LQGHKEWLAEVNFLGDLV---- 193 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~E~~il~~l~---- 193 (511)
...||+|+.-.||.--. .....||++.... .....+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~HP~------------dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD------------DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEECCC------------CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 45799999999996321 2256789987765 122345666776665555
Q ss_pred --CCCcceEeeEEEeCCeEEEEEEccCC--C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 010432 194 --HLNLVKLIGYCIEDDQRLLVYEFMPR--G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (511)
Q Consensus 194 --H~nIv~l~~~~~~~~~~~lv~E~~~~--g----~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDL 265 (511)
+.+|.+++|+..++...-+|+|.+.+ | +|.+++... .++. .....+. .-..||-.++ |+.+||
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl 144 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALD---EFKRYLLDHH---IVIRDL 144 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHH---HHHHHHHHcC---CeecCC
Confidence 88999999999999888999998643 2 688888433 3444 3333333 3345666767 999999
Q ss_pred CCCcEEeccc
Q 010432 266 KTSNILLDAV 275 (511)
Q Consensus 266 Kp~NILl~~~ 275 (511)
+|.||++...
T Consensus 145 ~~~NIv~~~~ 154 (199)
T PF10707_consen 145 NPHNIVVQRR 154 (199)
T ss_pred CcccEEEEec
Confidence 9999999864
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=2e-05 Score=74.59 Aligned_cols=77 Identities=14% Similarity=0.220 Sum_probs=54.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCC--CcceEeeEEEe---CCe
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIE---DDQ 209 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~--nIv~l~~~~~~---~~~ 209 (511)
+.|+.|..+.||+..... ..+++|..... .....+.+|+.+++.|... .+.+++.+... ...
T Consensus 3 ~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred ccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 568999999999998642 48999997654 3345677898888887433 35677765433 345
Q ss_pred EEEEEEccCCCCHHH
Q 010432 210 RLLVYEFMPRGSLEN 224 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~ 224 (511)
.+++|++++|..+..
T Consensus 70 ~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEEESSEEHHH
T ss_pred ceEEEEEeccccccc
Confidence 789999999887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.1e-05 Score=71.09 Aligned_cols=101 Identities=29% Similarity=0.274 Sum_probs=78.9
Q ss_pred HHHHHHhCCCC-CCcceEeeEEEeCCeEEEEEEccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 010432 184 AEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 260 (511)
Q Consensus 184 ~E~~il~~l~H-~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~i 260 (511)
.|.-+|..+.+ +++.+++|+| ..++|.||...+++..... ..-...+|..+.+|+.+++..+.+|+..-...+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888888866 6999999998 2478999997765542100 111256899999999999999999987544458
Q ss_pred EecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCccc
Q 010432 261 IYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 261 iHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
.-.|++++|+-++ +++.+|++|...+..
T Consensus 84 ~lcDv~~~nfgv~-------------------------~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVN-------------------------DDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEe-------------------------CCCcEEEEechhcch
Confidence 8899999999998 477899999887754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.1e-05 Score=66.89 Aligned_cols=129 Identities=19% Similarity=0.192 Sum_probs=87.2
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcc-eEeeEEEeCCe
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQ 209 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv-~l~~~~~~~~~ 209 (511)
.++.+.||+|.+|.||+|.+. |..+|+|+-+.+.. ...+..|+++|..+.-.++. ++|.|. .
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~ 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----E 86 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----h
Confidence 344567999999999999984 56899998876643 35688999999999776664 444443 2
Q ss_pred EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC--CcEEeccccccccCCcceee
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT--SNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp--~NILl~~~~~~~~~~~~~~~ 287 (511)
.++.|||+.|-.|.++-.. .+..... .+++.---|-..| |-|..|.- .||++.
T Consensus 87 ~~i~me~i~G~~L~~~~~~----~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~-------------- 141 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIG----GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVN-------------- 141 (201)
T ss_pred hhhhhhhhcCcchhhhhhc----ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEec--------------
Confidence 3566999988788776531 1222222 3333323333445 88887764 466664
Q ss_pred eccccccccccccCceeeecCCCccc
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
+..+.|+||--|+.
T Consensus 142 ------------~~~~~iIDFd~At~ 155 (201)
T COG2112 142 ------------DRDVYIIDFDSATF 155 (201)
T ss_pred ------------CCcEEEEEccchhh
Confidence 44799999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00013 Score=82.42 Aligned_cols=81 Identities=17% Similarity=0.209 Sum_probs=56.7
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCC-CCCc--ceEeeEEEeC--
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNL--VKLIGYCIED-- 207 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-H~nI--v~l~~~~~~~-- 207 (511)
++.|+.|.+..+|+......+ ....+++|+...... .....+.+|+++|+.|. |.+| .+++.+|.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 457899999999998764311 113577887654322 23356889999999995 6654 7888877654
Q ss_pred -CeEEEEEEccCCCC
Q 010432 208 -DQRLLVYEFMPRGS 221 (511)
Q Consensus 208 -~~~~lv~E~~~~g~ 221 (511)
+..|+||||++|-.
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 45789999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0001 Score=70.33 Aligned_cols=73 Identities=15% Similarity=0.136 Sum_probs=45.4
Q ss_pred CccccCCCc-eEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCC---CcceEeeEEEeC---
Q 010432 135 SLLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCIED--- 207 (511)
Q Consensus 135 ~~lG~G~fg-~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~---nIv~l~~~~~~~--- 207 (511)
+.|+.|+.. .||+.. ..+++|...... ....+.+|+++|..|... .+.++++.....
T Consensus 3 ~~~~~gG~~n~vy~~~--------------~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~ 66 (235)
T cd05155 3 EPVDSGGTDNATFRLG--------------DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY 66 (235)
T ss_pred eeccCCCcccceEEcC--------------CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence 467877776 599751 246778755422 234688899999877531 344445443322
Q ss_pred CeEEEEEEccCCCCHH
Q 010432 208 DQRLLVYEFMPRGSLE 223 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~ 223 (511)
...+++|++++|.++.
T Consensus 67 ~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 67 PWPWSVYRWLEGETAT 82 (235)
T ss_pred CcceEEEEeecCCCCC
Confidence 2348899999886653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00028 Score=69.83 Aligned_cols=77 Identities=12% Similarity=0.060 Sum_probs=55.1
Q ss_pred CCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC---CCcceEeeEEEe---
Q 010432 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCIE--- 206 (511)
Q Consensus 133 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H---~nIv~l~~~~~~--- 206 (511)
-.+.||.|..+.||+....+ + .+.+|..+... ....+..|...|+.|.- ..+.++++++..
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ----------G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred eeeecCCccceeEEEEEcCC----------C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34579999999999986422 2 46777754311 22468899999988843 467888887754
Q ss_pred CCeEEEEEEccCCCCH
Q 010432 207 DDQRLLVYEFMPRGSL 222 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L 222 (511)
.+..+||||+++++++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 3568999999988754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.83 E-value=5.5e-05 Score=84.04 Aligned_cols=198 Identities=20% Similarity=0.201 Sum_probs=131.0
Q ss_pred HHHHHHHhCCCCCCcceEeeEEEeCCeE----EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 010432 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 258 (511)
Q Consensus 183 ~~E~~il~~l~H~nIv~l~~~~~~~~~~----~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ 258 (511)
..|...+.++.|+|++.++.|....... .+..|+|..-++...+.. -..++....+.+..++..||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~-- 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS-- 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence 3467778888999999999987764332 244588888888887743 457888999999999999999999864
Q ss_pred CeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeee--cCCCcccCCCCCcceeeeeccccccccCCc
Q 010432 259 PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336 (511)
Q Consensus 259 ~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE 336 (511)
..|.-|-.+-..-. .......+.++ ||+.++......... ...-+..|.++|
T Consensus 307 -l~~v~L~~s~~~~~----------------------~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e 360 (1351)
T KOG1035|consen 307 -LEHVVLSASSSKES----------------------TVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADE 360 (1351)
T ss_pred -cceeEEeccccccc----------------------ccCccceeecchhhhcccccCCCcccch---hhcCcccccccc
Confidence 44433332211110 00124445555 888888766543321 123455678888
Q ss_pred ccccCCCCcc--ccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHH
Q 010432 337 YVMTGHLTSR--SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 414 (511)
Q Consensus 337 ~~~~~~~~~~--~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 414 (511)
......+..+ .|+|.+|..+..+..|..+-..... ...+++ ..+ .....++
T Consensus 361 ~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-------------------~~~~l~----~~~----~~~~~d~ 413 (1351)
T KOG1035|consen 361 DLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-------------------PVSLLD----VLS----TSELLDA 413 (1351)
T ss_pred ccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-------------------hhhhhc----ccc----chhhhhh
Confidence 7776665554 7999999999999987654321100 000111 000 1146788
Q ss_pred HHHhcccCCCCCCCHHHHHHHh
Q 010432 415 AAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 415 i~~cl~~dP~~RPs~~eil~~L 436 (511)
..+|+..++++|+++.+++.+.
T Consensus 414 ~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 414 LPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhcchhhhhccchhhhhhch
Confidence 9999999999999999998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00086 Score=66.29 Aligned_cols=75 Identities=11% Similarity=0.002 Sum_probs=48.6
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCC--CcceEeeE------EE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGY------CI 205 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~--nIv~l~~~------~~ 205 (511)
++.|..|....+|+.... +..+++|+.... .......|+.++..|.+. .+.+++.. ..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 456778888899987642 336889987642 234566788888777432 24444431 22
Q ss_pred eCCeEEEEEEccCCCCH
Q 010432 206 EDDQRLLVYEFMPRGSL 222 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L 222 (511)
.++..++|++|++|..+
T Consensus 85 ~~~~~~~l~~~i~G~~~ 101 (296)
T cd05153 85 LAGKPAALVEFLAGEHL 101 (296)
T ss_pred eCCceEEEEEeCCCCCC
Confidence 34567899999988664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0013 Score=62.58 Aligned_cols=75 Identities=20% Similarity=0.112 Sum_probs=46.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC-CCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~~~~~~lv 213 (511)
+.|..|-...||+.....+ .+..|++|+....... .-...+|+.++..+.. .-..++++.+. + .+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEE
Confidence 4577788889999864310 1357889977543221 1123478888888843 33445554432 2 479
Q ss_pred EEccCCCCH
Q 010432 214 YEFMPRGSL 222 (511)
Q Consensus 214 ~E~~~~g~L 222 (511)
|||++|-+|
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00099 Score=64.42 Aligned_cols=72 Identities=17% Similarity=0.089 Sum_probs=45.1
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCc-ceEeeEEEeCCeEEEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVY 214 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lv~ 214 (511)
.+..|-...+|+... .+..+++|+.......-.-...+|..+++.+....+ .+++... . -++||
T Consensus 3 ~~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 355688889998863 355788887654322110134678899988854333 3444433 2 36899
Q ss_pred EccCCCCH
Q 010432 215 EFMPRGSL 222 (511)
Q Consensus 215 E~~~~g~L 222 (511)
||++|..+
T Consensus 68 e~i~G~~~ 75 (256)
T TIGR02721 68 EWLEGEVI 75 (256)
T ss_pred EeccCccc
Confidence 99988654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0064 Score=62.31 Aligned_cols=76 Identities=20% Similarity=0.133 Sum_probs=52.7
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCC------C-cccHHHHHHHHHHHhCCC---CCCcceEeeEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGDLV---HLNLVKLIGYC 204 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~------~-~~~~~~~~~E~~il~~l~---H~nIv~l~~~~ 204 (511)
+.||.|.+..||++.... .++.|+||.-... . ....+++..|.+.|..+. -.++.+++.+
T Consensus 32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 468999999999998753 2247999985321 1 123456777888888762 3457777776
Q ss_pred EeCCeEEEEEEccCCCC
Q 010432 205 IEDDQRLLVYEFMPRGS 221 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~ 221 (511)
+.+..++||||+++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 4456789999997643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0075 Score=60.29 Aligned_cols=74 Identities=8% Similarity=-0.001 Sum_probs=42.8
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC--CCcceEee------EEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIG------YCI 205 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~------~~~ 205 (511)
.+.|+.|....+|+..... | .+++|++... ....+..|+.++..|.. -.+.+.+. +..
T Consensus 27 ~~~l~~G~~n~~y~v~t~~----------g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~ 92 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ----------G-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGE 92 (319)
T ss_pred cchhccccccceEEEEeCC----------C-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeee
Confidence 3457778778999886432 3 6889987621 12334445555555521 12333332 122
Q ss_pred eCCeEEEEEEccCCCC
Q 010432 206 EDDQRLLVYEFMPRGS 221 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~ 221 (511)
..+..+++|||++|..
T Consensus 93 ~~g~~~~l~~~l~G~~ 108 (319)
T PRK05231 93 LAGKPAAIVTFLEGKW 108 (319)
T ss_pred eCCEEEEEEEecCCCC
Confidence 3556789999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0034 Score=62.50 Aligned_cols=75 Identities=12% Similarity=-0.001 Sum_probs=45.4
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCC--CcceEeeE------EE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGY------CI 205 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~--nIv~l~~~------~~ 205 (511)
++.|+.|....||+.... .| .+++|+..... .......|++++..|... .+.+++.. ..
T Consensus 27 i~~~~~G~~n~~y~v~t~----------~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD----------VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ccccCCccccceEEEEeC----------CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 456777877899988642 23 57789875432 123455677777766322 23444331 11
Q ss_pred eCCeEEEEEEccCCCC
Q 010432 206 EDDQRLLVYEFMPRGS 221 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~ 221 (511)
..+..+++|||++|..
T Consensus 94 ~~g~~~~l~e~i~G~~ 109 (307)
T TIGR00938 94 LAGKPACLVEFLQGLS 109 (307)
T ss_pred cCCeEEEEEEeCCCCC
Confidence 2456789999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=2.7e-05 Score=88.21 Aligned_cols=158 Identities=15% Similarity=0.007 Sum_probs=114.0
Q ss_pred HHHHHHHHhCCCCCCcceEeeEEEe--CCeEEEEEEccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCC
Q 010432 182 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEA 256 (511)
Q Consensus 182 ~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~ 256 (511)
.+.|.+.++...|++++..+.-... ....+.+++||.+|++.+.|.+.. ..+....+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4456666777889998877654432 345689999999999999986432 23333444444444466666666432
Q ss_pred --CCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccC
Q 010432 257 --ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 334 (511)
Q Consensus 257 --~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~a 334 (511)
..-.+|++||+-|.+|.. +..+|++++|+.+...... .......+++.|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVt-------------------------ny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~ 1408 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVT-------------------------NYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVL 1408 (2724)
T ss_pred cCCccchhhhhhhhccceec-------------------------CCcccccccccccccCchH--hhhhhhhCCHHHHH
Confidence 233689999999999984 7779999999999432211 12334578889999
Q ss_pred CcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 335 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 335 PE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
|++...-.++.++|+|..|+-+|++.-|..+|
T Consensus 1409 qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1409 QLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99888888999999999999999999887766
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0019 Score=64.01 Aligned_cols=144 Identities=16% Similarity=0.106 Sum_probs=91.5
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--cc--------------------HHH----HHHH
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QG--------------------HKE----WLAE 185 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~--------------------~~~----~~~E 185 (511)
.+..+|..|--+.||.|.-. .|..+|||+++..-+ .+ ++. ...|
T Consensus 147 ~inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE 216 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE 216 (520)
T ss_pred ecccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence 34457889999999998654 477899999874311 00 011 2357
Q ss_pred HHHHhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 010432 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (511)
Q Consensus 186 ~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDL 265 (511)
++-|.+|+...|..---... ....|||+|+ |.+=.-.-.-+...++...+..+-.|++.-|.-|-..+ ++||.||
T Consensus 217 ~RNLkRl~~aGIP~PePIlL--k~hVLVM~Fl-Grdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL 291 (520)
T KOG2270|consen 217 MRNLKRLNNAGIPCPEPILL--KNHVLVMEFL-GRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL 291 (520)
T ss_pred HHHHHHHHhcCCCCCCceee--ecceEeeeec-cCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence 77787775444321111111 1247999999 43311110112234666677777778888887775543 2999999
Q ss_pred CCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCC
Q 010432 266 KTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316 (511)
Q Consensus 266 Kp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~ 316 (511)
.-=|+|+- ++.+.|+|-+-+.....
T Consensus 292 SEfN~Lyh--------------------------dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 292 SEFNLLYH--------------------------DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred hhhhheEE--------------------------CCEEEEEEccccccCCC
Confidence 99999986 78899999888765433
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0041 Score=61.65 Aligned_cols=81 Identities=20% Similarity=0.184 Sum_probs=48.7
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCc-ceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lv 213 (511)
+.|..|-...||+........ .+..+..|++|+...... ......+|+.++..+....+ .++++++. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~---~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDA---LSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCccc---ccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 345667777899887532110 122357899999765432 22345678888888743333 45565553 2 368
Q ss_pred EEccCCCCHH
Q 010432 214 YEFMPRGSLE 223 (511)
Q Consensus 214 ~E~~~~g~L~ 223 (511)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0015 Score=67.23 Aligned_cols=49 Identities=24% Similarity=0.342 Sum_probs=38.8
Q ss_pred HHHHHHHHHHhCCCCCCcceEeeEEEeC-CeEEEEEEccCCCCHHHHHhhC
Q 010432 180 KEWLAEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRR 229 (511)
Q Consensus 180 ~~~~~E~~il~~l~H~nIv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~ 229 (511)
.+++-...+++.+.|+|...++++.... ....+|||++ +-+|++.+..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 4556677889999999999999877653 3467899999 67999988654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.014 Score=59.00 Aligned_cols=79 Identities=16% Similarity=0.039 Sum_probs=48.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcc-eEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv-~l~~~~~~~~~~~lv 213 (511)
..|-.|-.-.+|++....... ..++.|++|+........ -...+|+.+++.+...++. ++++.+..+ .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~-----~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEG-----NLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCCC-----CCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 345557788999987543111 134689999886543221 1235788888888544443 556655322 58
Q ss_pred EEccCCCCHH
Q 010432 214 YEFMPRGSLE 223 (511)
Q Consensus 214 ~E~~~~g~L~ 223 (511)
+||+++.+|.
T Consensus 112 ~efi~g~~l~ 121 (344)
T PLN02236 112 EEFIHARTLS 121 (344)
T ss_pred EEeeCCCCCC
Confidence 9999776653
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.015 Score=57.49 Aligned_cols=57 Identities=16% Similarity=0.281 Sum_probs=36.2
Q ss_pred CcEEEEEEecC--CCcccHHHHHHHHHHHhCCCC--CCcceEeeEEEeCC--eEEEEEEccCCC
Q 010432 163 GLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDD--QRLLVYEFMPRG 220 (511)
Q Consensus 163 ~~~vAvK~~~~--~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~~--~~~lv~E~~~~g 220 (511)
++.+++. ... ..........+|+.+|+.+.- .-+...+++|..+. ..|.||+|++|.
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 5678887 332 122233456678888887743 23445667776655 669999999883
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0027 Score=61.93 Aligned_cols=136 Identities=17% Similarity=0.086 Sum_probs=88.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc----------------------cHHHHHHHHH
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVN 187 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~E~~ 187 (511)
-+.+.+.||-|--+.||.+-+.. |...++|.-+..... ++-...+|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 36788899999999999997753 678888854321100 0112457888
Q ss_pred HHhCCC-CC-CcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 010432 188 FLGDLV-HL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (511)
Q Consensus 188 il~~l~-H~-nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDL 265 (511)
.|+.|. |- -+.+.++ .+..++|||++.|-.|.+.-+- .+...+. ..+..-+--|-.+| +||+|.
T Consensus 163 fmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly---~~lm~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV----EDPPTLY---DDLMGLIVRLANHG---LIHGDF 228 (465)
T ss_pred HHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec----CChHHHH---HHHHHHHHHHHHcC---ceeccc
Confidence 888883 32 2344444 3457899999988887764321 1222222 22222333455567 999999
Q ss_pred CCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccC
Q 010432 266 KTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 266 Kp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
.-=||++. ++..++++||--....
T Consensus 229 NEFNimv~-------------------------dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 229 NEFNIMVK-------------------------DDDKIVVIDFPQMVST 252 (465)
T ss_pred chheeEEe-------------------------cCCCEEEeechHhhcc
Confidence 99999998 4778999999665443
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.012 Score=59.27 Aligned_cols=133 Identities=17% Similarity=0.176 Sum_probs=75.1
Q ss_pred CccccCCCceEEEEEEcC------CCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeE----
Q 010432 135 SLLGEGGFGCVFKGWIEE------NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY---- 203 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~------~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~---- 203 (511)
..||.|+-+.||+|..+. ++...+.+.+.+.||||+...+... .+.+.+.||.-. +-+|+|.-+.|
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~---~ir~Dl~Il~f~Akl~~~vP~l~wL~l~ 271 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEK---QIRLDLGILGFGAKLINNVPDLSWLSLP 271 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHH---HHHHHHHHHhhhhhhhhhcCccccccCc
Confidence 479999999999998763 2222234556788999999865422 122222222211 00111110000
Q ss_pred -----------------------------E-------------EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHH
Q 010432 204 -----------------------------C-------------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241 (511)
Q Consensus 204 -----------------------------~-------------~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i 241 (511)
| .-.....|+-+|..|-++..++.... .+++...++
T Consensus 272 ~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkv 349 (565)
T KOG1236|consen 272 LEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKS--QPEALVKKV 349 (565)
T ss_pred chHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhccc--ChHHHHHHH
Confidence 0 00112356667888888888885443 344555555
Q ss_pred HHHHHHHHHHH-hcCCCCCeEecccCCCcEEeccc
Q 010432 242 ALGAAKGLAFL-HEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 242 ~~qi~~gL~yL-H~~~~~~iiHrDLKp~NILl~~~ 275 (511)
+.--+.||.-+ --.+ ++|.|+.|.||++...
T Consensus 350 a~lg~~AllkMl~vDN---FvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 350 AKLGVNALLKMLIVDN---FVHADLHPGNVLIRFN 381 (565)
T ss_pred HHHHHHHHHHHHHhhc---ceecccCCCcEEEEec
Confidence 54444554322 2234 9999999999999753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.1 Score=51.72 Aligned_cols=64 Identities=14% Similarity=0.102 Sum_probs=37.6
Q ss_pred eEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCC--CcceEeeE------EEeCCeEEEEEE
Q 010432 144 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGY------CIEDDQRLLVYE 215 (511)
Q Consensus 144 ~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~--nIv~l~~~------~~~~~~~~lv~E 215 (511)
.||+.... +..+++|++... ...+..|+.++..|... .+++++.. ...++..++|+|
T Consensus 11 ~v~~v~t~-----------~g~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~ 75 (313)
T TIGR02906 11 NVYKVETD-----------SGNKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTE 75 (313)
T ss_pred cEEEEEeC-----------CCCeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEeh
Confidence 48887642 225889988532 23445566666666322 33444322 223567899999
Q ss_pred ccCCCCH
Q 010432 216 FMPRGSL 222 (511)
Q Consensus 216 ~~~~g~L 222 (511)
|++|..+
T Consensus 76 ~i~G~~~ 82 (313)
T TIGR02906 76 WIEGREC 82 (313)
T ss_pred hccCcCC
Confidence 9988543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.11 Score=52.21 Aligned_cols=80 Identities=15% Similarity=0.088 Sum_probs=49.2
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCC------C-cccHHHHHHHHHHHhCCC--CC-CcceEeeEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGDLV--HL-NLVKLIGYCI 205 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~------~-~~~~~~~~~E~~il~~l~--H~-nIv~l~~~~~ 205 (511)
.||.|....||++.... .++.|+||.-... . ....++...|..+|+... -| .+.++|.+
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-- 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-- 70 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--
Confidence 47999999999998632 2357999974311 1 122345556778876652 23 45556543
Q ss_pred eCCeEEEEEEccCCC-CHHHHH
Q 010432 206 EDDQRLLVYEFMPRG-SLENHL 226 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g-~L~~~l 226 (511)
+++...+|||+++.. .|.+.|
T Consensus 71 D~e~~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 71 DTEMAVTVMEDLSHHKIARKGL 92 (370)
T ss_pred ccccceehHhhCccchHHHHHH
Confidence 455667999999553 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.099 Score=51.12 Aligned_cols=29 Identities=14% Similarity=0.074 Sum_probs=19.8
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhCCC
Q 010432 163 GLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 193 (511)
Q Consensus 163 ~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~ 193 (511)
|..+++|.-+... ....+.+|+++|+.|.
T Consensus 35 g~~~VlR~p~~~~--~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 35 GVPWVLRIPRRPD--VSERAAAEKRVLALVR 63 (276)
T ss_pred CCeEEEEecCCHH--HHHHHHHHHHHHHHHH
Confidence 5678888765322 2345788999998884
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.17 Score=51.97 Aligned_cols=73 Identities=10% Similarity=0.021 Sum_probs=48.5
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhCCC---CCCcceEeeE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLV---HLNLVKLIGY 203 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~il~~l~---H~nIv~l~~~ 203 (511)
.+.||-|....||+.... +..|+||.-..... -...+-..|+..|+.+. ..++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 456899999999998752 23588987652111 12233445677776553 3578888887
Q ss_pred EEeCCeEEEEEEccCC
Q 010432 204 CIEDDQRLLVYEFMPR 219 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~ 219 (511)
+. +..+++|||+++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 75 456889999976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.11 Score=51.00 Aligned_cols=73 Identities=22% Similarity=0.273 Sum_probs=45.8
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC---CCCCcceEeeEEEeCCeE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL---VHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~~~~ 210 (511)
.+.|+-|....+|+... .+..+.||+-.... ...|..|..-|+.| .--.+.+.+++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT-----------DGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEET-----------TS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEEC-----------CCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 34688899999998762 46689999887322 24567788877777 344577888888777778
Q ss_pred EEEEEccCCC
Q 010432 211 LLVYEFMPRG 220 (511)
Q Consensus 211 ~lv~E~~~~g 220 (511)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.11 Score=52.22 Aligned_cols=76 Identities=17% Similarity=0.234 Sum_probs=45.4
Q ss_pred ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCc-ceEeeEEEeCCeEEEEE
Q 010432 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVY 214 (511)
Q Consensus 136 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lv~ 214 (511)
.|..|=.-.+|+....... ..+..|++|+....... .-.-.+|..+++.+..-++ .++++++. +. +|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 21 RISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred EeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence 4544777789988654211 02347889987654321 1123478888888865444 35666552 22 589
Q ss_pred EccCCCCH
Q 010432 215 EFMPRGSL 222 (511)
Q Consensus 215 E~~~~g~L 222 (511)
+|+++-.|
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 99977654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.12 Score=52.84 Aligned_cols=75 Identities=19% Similarity=0.208 Sum_probs=48.7
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCC-----C-cccHHHHHHHHHHHhCCC--CC-CcceEeeEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-----G-LQGHKEWLAEVNFLGDLV--HL-NLVKLIGYC 204 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~-----~-~~~~~~~~~E~~il~~l~--H~-nIv~l~~~~ 204 (511)
.+.||-|.-..||++.+.. .+..|+||.-... . .-..++...|.++|+.+. -| .+.++|.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 4578999999999998732 1347888864321 1 123455667888887662 23 45566643
Q ss_pred EeCCeEEEEEEccCC
Q 010432 205 IEDDQRLLVYEFMPR 219 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~ 219 (511)
+.+...+|||+++.
T Consensus 104 -D~e~~~~vMEdL~~ 117 (409)
T PRK12396 104 -DSVMNCCVMEDLSD 117 (409)
T ss_pred -CcHHhhHHHHhCcc
Confidence 45556789999854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.14 Score=47.62 Aligned_cols=136 Identities=15% Similarity=0.108 Sum_probs=80.4
Q ss_pred EEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHH
Q 010432 166 VAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244 (511)
Q Consensus 166 vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~q 244 (511)
..+|.+..-... ...-|..+.++++++. .|++|..- ..-.+-+++|+|..... .. ..++..
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~----~N~i~a 149 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NF----SNFITA 149 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------ch----hHHHHH
Confidence 445655543332 3345678899998874 57777731 23345599999943211 11 111111
Q ss_pred HHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeee
Q 010432 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVST 324 (511)
Q Consensus 245 i~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~ 324 (511)
=+.+|.-.|+.. .+.+|+|..|+||+-+ ..+.+||.|=+.--.
T Consensus 150 gi~~L~~fH~~~-~~~lHGD~np~NiM~D-------------------------~~G~lKlVDP~~Ll~----------- 192 (308)
T PF07387_consen 150 GIKDLMDFHSEN-QHCLHGDCNPDNIMCD-------------------------KFGYLKLVDPVCLLE----------- 192 (308)
T ss_pred hHHHHHHhhccC-CCeecCCCChhheeec-------------------------CCCCEEecChhhhhh-----------
Confidence 136678889654 4599999999999998 477899998554321
Q ss_pred eccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 325 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 325 ~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.+..|.--| ....+.++.+-+|=.-++++...
T Consensus 193 ---~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 193 ---NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred ---heeeEEeee---ccccChHHHHHHHHHHHHHHHHH
Confidence 112233211 22346667776776666666653
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.46 Score=47.21 Aligned_cols=32 Identities=16% Similarity=0.187 Sum_probs=26.2
Q ss_pred CCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccC
Q 010432 258 RPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 258 ~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
..++|+|+.+.|||++ ++..+.|+||-.+...
T Consensus 196 ~~lcHgD~~~~Nvl~~-------------------------~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYD-------------------------ETRGGYFINFEKASFA 227 (309)
T ss_pred eeeeCCCCcHHhEEEc-------------------------CCCCEEEEEhhhcccC
Confidence 3599999999999997 3556889999887653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.068 Score=49.89 Aligned_cols=54 Identities=20% Similarity=0.156 Sum_probs=30.7
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCc-ceEeeEEEeCCeEEEEEEccCCCCH
Q 010432 164 LTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVYEFMPRGSL 222 (511)
Q Consensus 164 ~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lv~E~~~~g~L 222 (511)
+.|+|++..... ...-....|..+++.+...++ .++++++ .+ .+|.||+++.+|
T Consensus 3 ~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~--~~--g~v~e~i~g~~l 57 (211)
T PF01633_consen 3 EKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFF--EN--GRVEEFIEGRTL 57 (211)
T ss_dssp SEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEE--TT--EEEEE--SSEE-
T ss_pred CEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEc--CC--CcEEEEeccccc
Confidence 478899887662 223345678888888754444 4555544 22 257799966543
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.11 Score=51.84 Aligned_cols=73 Identities=19% Similarity=0.179 Sum_probs=55.4
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
.+.|++|++. |+.|.- + ....+++++.++++.+.-++-+..+ .+.=||||.-.||||+
T Consensus 299 ~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-------------- 356 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-------------- 356 (488)
T ss_pred eEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee--------------
Confidence 4567888876 656542 1 2345788889998887776666553 4589999999999997
Q ss_pred eccccccccccccCceeeecCCCcccC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
++.|.|+||-+++.-
T Consensus 357 ------------~GnvtLIDfklsRl~ 371 (488)
T COG5072 357 ------------EGNVTLIDFKLSRLS 371 (488)
T ss_pred ------------cCceEEEEeeeeecc
Confidence 788999999999953
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.66 E-value=1.6 Score=43.64 Aligned_cols=71 Identities=17% Similarity=0.122 Sum_probs=41.5
Q ss_pred CCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC--CCcceEe---e--EEEeCCeEEE
Q 010432 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLI---G--YCIEDDQRLL 212 (511)
Q Consensus 140 G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~---~--~~~~~~~~~l 212 (511)
+.-..||+.... .+..+++|+.+... .....+..|+.++..|.- -.++... | +...++..+.
T Consensus 36 s~eN~vy~v~~~----------~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~ 104 (325)
T PRK11768 36 SYENRVYQFGDE----------DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFA 104 (325)
T ss_pred cccceEEEEecC----------CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEE
Confidence 344578888653 35579999876432 233556678777776631 1122211 1 2223566788
Q ss_pred EEEccCCCC
Q 010432 213 VYEFMPRGS 221 (511)
Q Consensus 213 v~E~~~~g~ 221 (511)
|+++++|..
T Consensus 105 l~~~~~G~~ 113 (325)
T PRK11768 105 LFPRRGGRA 113 (325)
T ss_pred EEeeeCCCC
Confidence 999997753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.76 E-value=1.6 Score=50.77 Aligned_cols=77 Identities=19% Similarity=0.214 Sum_probs=42.7
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-------CCCCcceEe-e----
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-------VHLNLVKLI-G---- 202 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-------~H~nIv~l~-~---- 202 (511)
+.|+ |..-.+|+.... +|..+++|+.+.... ......|..+|..| .-|.+++-. |
T Consensus 31 ~~L~-s~~d~nf~v~~~----------~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~ 97 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTD----------DGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLA 97 (1013)
T ss_pred eecC-CcCCceEEEEeC----------CCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEE
Confidence 3564 456788887643 366899999986532 22333455555544 223333321 1
Q ss_pred EEEe-CC--eEEEEEEccCCCCHHH
Q 010432 203 YCIE-DD--QRLLVYEFMPRGSLEN 224 (511)
Q Consensus 203 ~~~~-~~--~~~lv~E~~~~g~L~~ 224 (511)
.... ++ ..+-+|+|++|..|.+
T Consensus 98 ~v~~~~G~~~~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 98 SAQDPDGEPRLLRLLSWLPGTPLAE 122 (1013)
T ss_pred EeecCCCceEEEEEEeccCCCcHHh
Confidence 1111 12 4677899999876654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=92.62 E-value=1.4 Score=41.36 Aligned_cols=58 Identities=26% Similarity=0.322 Sum_probs=40.4
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhCC---CCCCcceEeeEEEeCCeEEEEEEccCCCCHH
Q 010432 163 GLTVAVKTLNHDGLQGHKEWLAEVNFLGDL---VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 223 (511)
Q Consensus 163 ~~~vAvK~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~ 223 (511)
...|-||+-... ....|..|+.-|..| +--++.+++.+-...++.||||||++-|.+.
T Consensus 39 ~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 39 TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 346777764432 124466777666655 4456778888888889999999999886654
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.31 E-value=0.17 Score=49.74 Aligned_cols=72 Identities=18% Similarity=0.049 Sum_probs=40.9
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCcceeeecccccccc-ccccCceeeecCCCccc
Q 010432 236 SIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM-LFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 236 ~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~kl~DFGla~~ 313 (511)
+-++.++.||+.-.-.+-. .+....+|-||||+|||+-.......-.++- ... ..+...++|.||-+++.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~--------~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKD--------ATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECC--------eEEEeccchhhhhcccCHHHH
Confidence 4456778888654423322 2223489999999999996532211101000 011 11345678999999886
Q ss_pred CC
Q 010432 314 GP 315 (511)
Q Consensus 314 ~~ 315 (511)
..
T Consensus 351 ~~ 352 (444)
T PHA03111 351 AN 352 (444)
T ss_pred cc
Confidence 43
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.09 E-value=0.98 Score=46.33 Aligned_cols=81 Identities=14% Similarity=0.065 Sum_probs=44.8
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcc-eEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv-~l~~~~~~~~~~~lv 213 (511)
+.|..|-...+|++........ .-..+.|+++...... ...-+-.+|+.+++.|...++. ++++.+. -++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~---~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKD---RYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCC---ccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 3555588889999976432100 0001224444432211 1111224789999999655554 5555553 2689
Q ss_pred EEccCCCCHH
Q 010432 214 YEFMPRGSLE 223 (511)
Q Consensus 214 ~E~~~~g~L~ 223 (511)
.||++|-+|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999887653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 511 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 511 | |||
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 0.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-179 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-155 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-81 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-60 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-59 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-58 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-58 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-56 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-55 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-53 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-52 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 8e-52 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-51 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-51 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-50 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-50 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-49 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-37 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-37 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 9e-37 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-36 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-35 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-35 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-35 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-34 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-33 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-33 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-33 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-32 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-32 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-32 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-32 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-32 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-32 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-32 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-32 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-31 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-31 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-31 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-31 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-31 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-31 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-31 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-31 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 8e-31 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 9e-31 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-30 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-30 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-30 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-30 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-30 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-30 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-30 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 7e-30 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 8e-30 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 8e-30 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-30 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-29 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-29 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-29 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-29 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-29 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-29 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-29 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-29 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-29 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-29 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 9e-29 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-28 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-28 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-28 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-28 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-28 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-28 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-27 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-27 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-27 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-27 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-27 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-27 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-27 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-26 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-26 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-26 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-26 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-26 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-25 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-25 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-25 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-25 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-25 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-25 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-25 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-25 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-24 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-23 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-23 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-23 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-23 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-23 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 8e-23 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-22 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-22 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-22 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-22 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 9e-22 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-21 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-21 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 8e-21 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-20 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-20 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-20 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-20 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-19 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-19 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-19 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-19 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-19 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 8e-19 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-19 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-18 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-18 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-18 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-18 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-18 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-18 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-18 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-18 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 7e-18 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-18 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 9e-18 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-17 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-17 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-17 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-17 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-17 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-17 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-17 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 7e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-16 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-16 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-16 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-16 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 6e-16 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-16 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 7e-16 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 8e-16 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-16 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-15 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-15 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-15 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-15 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-15 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-15 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-15 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-15 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 6e-15 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 7e-15 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 7e-15 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-14 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-14 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-14 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-14 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-14 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-14 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-14 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-14 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-14 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-14 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-13 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-13 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-13 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-13 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-13 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-13 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-13 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-13 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-12 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-12 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-12 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-12 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-12 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-12 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 6e-12 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 7e-12 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 8e-12 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-12 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 8e-12 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-11 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-11 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-11 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-11 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-11 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-11 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-07 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-10 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-10 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-10 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 8e-10 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-09 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-09 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-08 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-08 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 4e-08 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 7e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-07 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 7e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-07 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 7e-06 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 8e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-06 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-05 |
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 524 bits (1351), Expect = 0.0
Identities = 110/346 (31%), Positives = 172/346 (49%), Gaps = 56/346 (16%)
Query: 107 EEELKVAS-RLRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVK 159
+ L+V+ R F+F +LK T NF + +GEGGFG V+KG++
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT------ 55
Query: 160 PGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215
TVAVK L + + +++ E+ + H NLV+L+G+ + D LVY
Sbjct: 56 -----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 216 FMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273
+MP GSL + L + PL W +R KIA GAA G+ FLHE I+RD K++NILLD
Sbjct: 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167
Query: 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 333
+ AK+SDFGLA+ + +T +++R++GT Y
Sbjct: 168 E-------------------------AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 334 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 393
APE + G +T +SD+YSFGVVLLE++TG ++D++R L++ E +
Sbjct: 203 APEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIED 259
Query: 394 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
ID ++ + +A+ CL RP + +V + L+ +
Sbjct: 260 YIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 505 bits (1304), Expect = e-179
Identities = 116/357 (32%), Positives = 182/357 (50%), Gaps = 42/357 (11%)
Query: 93 TTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEE 152
+ + +NS L V + DL+ AT NF + L+G G FG V+KG + +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 153 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212
G VA+K + QG +E+ E+ L H +LV LIG+C E ++ +L
Sbjct: 63 ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112
Query: 213 VYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269
+Y++M G+L+ HL+ ++ + W R++I +GAA+GL +LH +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169
Query: 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 329
ILLD +++ K++DFG++K G E D+TH+ST V GT
Sbjct: 170 ILLD-------------------------ENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 330 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 389
GY PEY + G LT +SDVYSFGVVL E+L R ++ ++ P NL EWA
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNG 263
Query: 390 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 446
+ +++DP L + +K A CL+ + RP M +V+ L+ L++
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 444 bits (1145), Expect = e-155
Identities = 119/329 (36%), Positives = 187/329 (56%), Gaps = 43/329 (13%)
Query: 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
+L++F+ +L++A+ NF +++LG GGFG V+KG + +GT VAVK L +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65
Query: 175 GLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 230
QG + ++ EV + VH NL++L G+C+ +RLLVY +M GS+ + L R
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290
PL W R +IALG+A+GLA+LH+ + +I+RD K +NILLD
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE---------------- 169
Query: 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350
++ A + DFGLAK D THV+T V GT G+ APEY+ TG + ++DV+
Sbjct: 170 ---------EFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 219
Query: 351 SFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA 408
+GV+LLE++TG+R+ D R + L++W + L + ++ L+D L+G++ +
Sbjct: 220 GYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEV 278
Query: 409 QKAAQLAAHCLSRDPKARPLMSEVVEALK 437
++ Q+A C P RP MSEVV L+
Sbjct: 279 EQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 4e-81
Identities = 77/373 (20%), Positives = 129/373 (34%), Gaps = 75/373 (20%)
Query: 96 NAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
+ +S ++ +L + + + G FGCV+K +
Sbjct: 2 GHHHHHHSSGVD-----------LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---- 46
Query: 156 APVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLGDLVHLNLVKLIGYCIEDD----Q 209
VAVK +Q + W E V L + H N+++ IG
Sbjct: 47 -------NEYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96
Query: 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER-------PVIY 262
L+ F +GSL + L + W+ IA A+GLA+LHE+ + +
Sbjct: 97 LWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHV 322
RD K+ N+LL + A ++DFGLA G
Sbjct: 155 RDIKSKNVLLKN-------------------------NLTACIADFGLALKFEAGKSAGD 189
Query: 323 STRVMGTYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 377
+ +GT Y APE + R D+Y+ G+VL E+ + + D
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 378 VE--WARPHLGERRRF--YRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEV 432
E P L + + ++ P L ++ G + C D +AR V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 433 VEALKPLPNLKDM 445
E + + L ++
Sbjct: 310 GERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-60
Identities = 69/357 (19%), Positives = 121/357 (33%), Gaps = 79/357 (22%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQ 177
++ L N + L+G G +G V+KG E VAVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER------------PVAVKVFS---FA 47
Query: 178 GHKEWLAEVN--FLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS 230
+ ++ E N + + H N+ + I + LLV E+ P GSL +L +
Sbjct: 48 NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT 107
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAER------PVIYRDFKTSNILLDAVRAENYGKFG 284
W ++A +GLA+LH E R + +RD + N+L+
Sbjct: 108 --SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN---------- 155
Query: 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAK------DGPEGDKTHVSTRVMGTYGYAAPEYV 338
D +SDFGL+ G++ + + +GT Y APE +
Sbjct: 156 ---------------DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200
Query: 339 M-------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL----VEWARPHLGE 387
+ D+Y+ G++ E+ + E+ + P +
Sbjct: 201 EGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED 260
Query: 388 RRRF-----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
+ R P S+ + + C +D +AR E + L
Sbjct: 261 MQVLVSREKQRPKFPEAWKENSL-AVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-59
Identities = 81/333 (24%), Positives = 138/333 (41%), Gaps = 77/333 (23%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 179
N+++ E +G+GGFG V KG + ++ + VA+K+L +G
Sbjct: 18 DNEIEY-------EKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGET 61
Query: 180 ------KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+E+ EV + +L H N+VKL G +V EF+P G L + L ++ P+
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPI 119
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293
WS+++++ L A G+ ++ + P+++RD ++ NI L
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQ-------------------- 158
Query: 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVY 350
+ AK++DFGL++ H + ++G + + APE + T ++D Y
Sbjct: 159 SLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTY 212
Query: 351 SFGVVLLEMLTGRRSMDKNRP----NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406
SF ++L +LTG P + G R PRL
Sbjct: 213 SFAMILYTILTGE------GPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL------- 259
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
+ C S DPK RP S +V+ L L
Sbjct: 260 -----RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-58
Identities = 86/326 (26%), Positives = 131/326 (40%), Gaps = 67/326 (20%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
F +L L +G GGFG V++ W G VAVK HD +
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDI 46
Query: 180 ----KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
+ E L H N++ L G C+++ LV EF G L L + +P
Sbjct: 47 SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPP 104
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
I + A+ A+G+ +LH+EA P+I+RD K+SNIL+ N
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ-----------------KVEN 147
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
+ K++DFGLA+ E +T + G Y + APE + + SDV+S+GV+
Sbjct: 148 GDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVL 203
Query: 356 LLEMLTGRRSMDKNRP-NGEHNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
L E+LTG P G L V + A+
Sbjct: 204 LWELLTGE------VPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF------------AK 245
Query: 414 LAAHCLSRDPKARPLMSEVVEALKPL 439
L C + DP +RP + +++ L +
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-58
Identities = 77/325 (23%), Positives = 124/325 (38%), Gaps = 76/325 (23%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ ++++ +G G FG V K W VA+K + + +
Sbjct: 7 YKEIEVEEV-------VGRGAFGVVCKAKW------------RAKDVAIKQIESESER-- 45
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSI 237
K ++ E+ L + H N+VKL G C+ LV E+ GSL N H +
Sbjct: 46 KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
M L ++G+A+LH + +I+RD K N+LL A
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA----------------------- 140
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357
K+ DFG A D T G+ + APE + + + DV+S+G++L
Sbjct: 141 -GGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 358 EMLTGRRSMDKNRPNGEHNLVEWARP---HLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 414
E++T R +P E + H G R + + + L
Sbjct: 195 EVITRR------KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI------------ESL 236
Query: 415 AAHCLSRDPKARPLMSEVVEALKPL 439
C S+DP RP M E+V+ + L
Sbjct: 237 MTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-56
Identities = 82/326 (25%), Positives = 135/326 (41%), Gaps = 72/326 (22%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ DL + + +G G FG V + W +G+ VAVK L
Sbjct: 36 WCDLNIKEK-------IGAGSFGTVHRAEW---HGS---------DVAVKILMEQDFHAE 76
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPW 235
E+L EV + L H N+V +G + +V E++ RGSL L + L
Sbjct: 77 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
R+ +A AKG+ +LH P+++R+ K+ N+L+D
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVD---------------------- 173
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
+ Y K+ DFGL++ + S GT + APE + +SDVYSFGV+
Sbjct: 174 ---KKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 356 LLEMLTGRRSMDKNRPNGEHNLVE--WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
L E+ T + +P G N + A +R R ++P++ A
Sbjct: 229 LWELATLQ------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV------------AA 270
Query: 414 LAAHCLSRDPKARPLMSEVVEALKPL 439
+ C + +P RP + +++ L+PL
Sbjct: 271 IIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-55
Identities = 73/334 (21%), Positives = 120/334 (35%), Gaps = 81/334 (24%)
Query: 129 RNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
R FRP L LG+G FG K TG + +K L + + +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTF 54
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L EV + L H N++K IG +D + + E++ G+L + PWS R+ A
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
A G+A+LH +I+RD + N L+ ++ N
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVR-------------------------ENKN 146
Query: 303 AKLSDFGLAK------------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350
++DFGLA+ + V+G + APE + + DV+
Sbjct: 147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206
Query: 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL-----IDPRLEGHFSI 405
SFG+VL E++ + P+ +++ R F P
Sbjct: 207 SFGIVLCEIIGRVNA----DPDYLPRTMDFGLNV----RGFLDRYCPPNCPPSF------ 252
Query: 406 KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
+ C DP+ RP ++ L+ L
Sbjct: 253 ------FPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 62/376 (16%), Positives = 123/376 (32%), Gaps = 94/376 (25%)
Query: 98 ESNSSTSKLEEELKVASRLRKFT------FNDLKLATRNFRPESLLGEGGFGCVFKG-WI 150
E N S + AS+ F F L++ +G+G FG V+ G W
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHGRW- 54
Query: 151 EENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208
+G VA++ ++ + K + EV H N+V +G C+
Sbjct: 55 --HGE----------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
++ +L + + + L + +IA KG+ +LH + ++++D K+
Sbjct: 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSK 159
Query: 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK---DGPEGDKTHVSTR 325
N+ D + ++DFGL G +
Sbjct: 160 NVFYD--------------------------NGKVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 326 VMGTYGYAAPEYVMTG---------HLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNG 373
G + APE + + SDV++ G + E+ ++
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--- 250
Query: 374 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433
+ W + ++ I + C + + + RP ++++
Sbjct: 251 ----IIWQ------MGTGMKPNLSQIGMGKEIS------DILLFCWAFEQEERPTFTKLM 294
Query: 434 EALKPLPNLKDMASSS 449
+ L+ LP K S
Sbjct: 295 DMLEKLP--KRNRRLS 308
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-52
Identities = 67/337 (19%), Positives = 116/337 (34%), Gaps = 95/337 (28%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
F L T+ L E G ++KG W G + VK L
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTR 49
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFR-RSLPLP 234
+++ E L H N++ ++G C + +MP GSL N L + +
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294
S +K AL A+G+AFLH E + + ++++D
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMID--------------------- 147
Query: 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVY 350
+D A++S + + S M + APE + +D++
Sbjct: 148 ----EDMTARISMADVKF-------SFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMW 195
Query: 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--------RPHLGERRRFYRLIDPRLEGH 402
SF V+L E++T P + + +E RP + I P +
Sbjct: 196 SFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLRPTIPPG------ISPHV--- 240
Query: 403 FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
++L C++ DP RP +V L+ +
Sbjct: 241 ---------SKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-52
Identities = 75/326 (23%), Positives = 128/326 (39%), Gaps = 67/326 (20%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ + R +G G FG V+KG W +G VAVK LN
Sbjct: 23 DGQITVGQR-------IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQ 62
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+ + EV L H+N++ +GY Q +V ++ SL +HL
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ IA A+G+ +LH + +I+RD K++NI L
Sbjct: 122 LIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLH------------------------ 154
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE---YVMTGHLTSRSDVYSFGV 354
+D K+ DFGLA + +H ++ G+ + APE + + +SDVY+FG+
Sbjct: 155 -EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213
Query: 355 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 414
VL E++TG+ P N + +G ++ + ++ +L
Sbjct: 214 VLYELMTGQ------LPYSNINNRDQIIEMVGRGSL--SPDLSKVRSNCP----KRMKRL 261
Query: 415 AAHCLSRDPKARPLMSEVVEALKPLP 440
A CL + RP ++ ++ L
Sbjct: 262 MAECLKKKRDERPSFPRILAEIEELA 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-50
Identities = 68/338 (20%), Positives = 120/338 (35%), Gaps = 70/338 (20%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLG 190
+G+G +G V+ G W E VAVK W E+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGE------------KVAVKVFFT---TEEASWFRETEIYQTV 86
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ H N++ I I+ Q L+ ++ GSL ++L +S L +K+A +
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
GL LH E + +RD K+ NIL+ ++
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-------------------------KNG 179
Query: 302 NAKLSDFGLA--KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSF 352
++D GLA + +GT Y PE V+ L +D+YSF
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSF 238
Query: 353 GVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRF--YRLIDPRLEGHFSIKGA 408
G++L E+ R + ++ + + P + R + + P +S
Sbjct: 239 GLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDEC 297
Query: 409 QKA-AQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 445
+ +L C + +P +R V + L + +D+
Sbjct: 298 LRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-50
Identities = 71/336 (21%), Positives = 114/336 (33%), Gaps = 78/336 (23%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 190
+G+G +G V++G W G VAVK + + K W E +
Sbjct: 13 LECVGKGRYGEVWRGSW---QGE---------NVAVKIFSS---RDEKSWFRETELYNTV 57
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N++ I + Q L+ + GSL ++L + L ++I L A
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
GLA LH E + +RD K+ NIL+ +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK-------------------------NG 150
Query: 302 NAKLSDFGLA--KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSF 352
++D GLA + +GT Y APE V+ + R D+++F
Sbjct: 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAF 209
Query: 353 GVVLLEMLTGRRSMDKNRP--------NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHF 403
G+VL E+ S E R + ++ R I R
Sbjct: 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ--RPNIPNRWFSD- 266
Query: 404 SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
A+L C ++P AR + + L +
Sbjct: 267 --PTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 1e-49
Identities = 73/342 (21%), Positives = 124/342 (36%), Gaps = 78/342 (22%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 190
+ +G+G FG V++G W E VAVK + + + W E +
Sbjct: 47 QESIGKGRFGEVWRGKWRGE------------EVAVKIFS---SREERSWFREAEIYQTV 91
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N++ I +D+ Q LV ++ GSL ++L + +K+AL A
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTA 149
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
GLA LH E + +RD K+ NIL+ ++
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------------------------KNG 184
Query: 302 NAKLSDFGLA--KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSF 352
++D GLA D +GT Y APE V+ + R+D+Y+
Sbjct: 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAM 243
Query: 353 GVVLLEMLTGRRSMDKNRP--------NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHF 403
G+V E+ + VE R + E++ R I R +
Sbjct: 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL--RPNIPNRWQSCE 301
Query: 404 SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 445
+++ A++ C + AR + + L L + +
Sbjct: 302 ALR---VMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 71/305 (23%), Positives = 113/305 (37%), Gaps = 56/305 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FG VF G + + T VAVK+ ++L E L H
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
+ I+RD N L+ + K+SDFG++++
Sbjct: 231 -SKCCIHRDLAARNCLVT-------------------------EKNVLKISDFGMSREEA 264
Query: 316 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 374
+G + APE + G +S SDV+SFG++L E + S N N +
Sbjct: 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324
Query: 375 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
VE + RL P E +L C + +P RP S + +
Sbjct: 325 REFVE----------KGGRL--PCPELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
Query: 435 ALKPL 439
L+ +
Sbjct: 368 ELQSI 372
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 88/327 (26%), Positives = 122/327 (37%), Gaps = 69/327 (21%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 187
R + LGEG FG V + P GTG VAVK L D G Q W E++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H +++K G C + LV E++P GSL ++L R S+ L + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQI 143
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
+G+A+LH + I+RD N+LLD D K+
Sbjct: 144 CEGMAYLHA---QHYIHRDLAARNVLLD-------------------------NDRLVKI 175
Query: 306 SDFGLAKDGPEGDKTHVST-------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
DFGLAK PEG + + APE + SDV+SFGV L E
Sbjct: 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWY------APECLKEYKFYYASDVWSFGVTLYE 229
Query: 359 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF----YRLIDPR---LEGHFSIKGAQK 410
+LT S E + + + RL P E +
Sbjct: 230 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVY-------- 281
Query: 411 AAQLAAHCLSRDPKARPLMSEVVEALK 437
L +C + RP ++ LK
Sbjct: 282 --HLMKNCWETEASFRPTFENLIPILK 306
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-37
Identities = 54/233 (23%), Positives = 88/233 (37%), Gaps = 36/233 (15%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+G F +FKG V +K L+ + + + + L H
Sbjct: 16 LGQGTFTKIFKGVR---REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
+LV G C+ D+ +LV EF+ GSL+ +L + + + W + + A A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL- 129
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
E +I+ + NILL G F KLSD G++
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFI-----------------KLSDPGISIT 170
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRR 364
D + PE + +L +D +SFG L E+ + G +
Sbjct: 171 VLPKDILQERIPWV------PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-36
Identities = 82/331 (24%), Positives = 121/331 (36%), Gaps = 72/331 (21%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + S LG+G FG V + P+ TG VAVK L H G +++ E+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L +VK G ++ LV E++P G L + L R L S + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
KG+ +L R ++RD NIL++ + + K+
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVE-------------------------SEAHVKI 168
Query: 306 SDFGLAKDGPEGDKTHVST-------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
+DFGLAK P +V APE + + +SDV+SFGVVL E
Sbjct: 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWY------APESLSDNIFSRQSDVWSFGVVLYE 222
Query: 359 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF----YRLIDPRLEG-----HFSIKGA 408
+ T +S + E P L RL P H
Sbjct: 223 LFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL--PAPPACPAEVH------ 274
Query: 409 QKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
+L C + P+ RP S + L L
Sbjct: 275 ----ELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 74/330 (22%), Positives = 121/330 (36%), Gaps = 69/330 (20%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
KG+ +L + I+RD T NIL++ + K+
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVE-------------------------NENRVKI 155
Query: 306 SDFGLAKDGPEGDKTHVST-------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
DFGL K P+ + APE + + SDV+SFGVVL E
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWY------APESLTESKFSVASDVWSFGVVLYE 209
Query: 359 MLTGRRSMDKNRPNGEHNL-----VEWARPHLGER-RRFYRLIDPRL---EGHFSIKGAQ 409
+ T + + HL E + RL P E +
Sbjct: 210 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY------- 262
Query: 410 KAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
+ C + + RP ++ + +
Sbjct: 263 ---MIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
KG+ +L + I+RD T NIL++ + K+
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVE-------------------------NENRVKI 186
Query: 306 SDFGLAKDGPEGDKTHVST-------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
DFGL K P+ + + APE + + SDV+SFGVVL E
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWY------APESLTESKFSVASDVWSFGVVLYE 240
Query: 359 MLT 361
+ T
Sbjct: 241 LFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 79/329 (24%), Positives = 118/329 (35%), Gaps = 67/329 (20%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 187
R + LGEG FG V + P TG VAVK+L + G + E+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L +L H N+VK G C ED L+ EF+P GSL+ +L + + ++K A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
KG+ +L R ++RD N+L++ ++ K+
Sbjct: 136 CKGMDYL---GSRQYVHRDLAARNVLVE-------------------------SEHQVKI 167
Query: 306 SDFGLAKDGPEGDKTHVST-------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
DFGL K + + APE +M SDV+SFGV L E
Sbjct: 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWY------APECLMQSKFYIASDVWSFGVTLHE 221
Query: 359 MLT-GRRSMDKNRPNGEHNLV---EWARPHLGER-RRFYRLIDPR---LEGHFSIKGAQK 410
+LT + + L + RL P E +
Sbjct: 222 LLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY-------- 273
Query: 411 AAQLAAHCLSRDPKARPLMSEVVEALKPL 439
QL C P R ++E + L
Sbjct: 274 --QLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 59/254 (23%), Positives = 106/254 (41%), Gaps = 45/254 (17%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLN 172
+ LR + K LG G FG V+KG WI E + VA+K L
Sbjct: 7 ALLRILKETEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELR 53
Query: 173 HD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 231
+ +KE L E + + + ++ +L+G C+ L+ + MP G L +++
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
+ + + AKG+ +L +R +++RD N+L+
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKT----------------- 152
Query: 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351
+ K++DFGLAK +K + + + A E ++ T +SDV+S
Sbjct: 153 --------PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 204
Query: 352 FGVVLLEMLT-GRR 364
+GV + E++T G +
Sbjct: 205 YGVTVWELMTFGSK 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 58/243 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVH 194
LGEG FG V +G + GT L VAVKT+ D + +E+L+E + D H
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 195 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IALG 244
N+++L+G CIE + +++ FM G L +L + R P I ++ +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
A G+ +L + R ++RD N +L D
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLR-------------------------DDMTVC 187
Query: 305 LSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
++DFGL+K GD + ++ + A E + TS+SDV++FGV + E
Sbjct: 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWE 241
Query: 359 MLT 361
+ T
Sbjct: 242 IAT 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 54/241 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 33 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAA 246
++V+L+G + L++ E M RG L+++L P S +++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
G+A+L ++RD N ++ +D+ K+
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVA-------------------------EDFTVKIG 180
Query: 307 DFGLAKDGPEGDKTHVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
DFG+ +D E D + M +PE + G T+ SDV+SFGVVL E+
Sbjct: 181 DFGMTRDIYETDYYRKGGKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 361 T 361
T
Sbjct: 235 T 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 62/245 (25%), Positives = 104/245 (42%), Gaps = 43/245 (17%)
Query: 128 TRNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 180
R F+ L LG G FG V KG WI E + + V +K + G Q +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQ 60
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ +G L H ++V+L+G C LV +++P GSL +H+ + L + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ AKG+ +L E +++R+ N+LL
Sbjct: 120 WGVQIAKGMYYL---EEHGMVHRNLAARNVLLK-------------------------SP 151
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
+++DFG+A P DK + + + A E + G T +SDV+S+GV + E++
Sbjct: 152 SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
Query: 361 T-GRR 364
T G
Sbjct: 212 TFGAE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 46/233 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FGCV+ G T G + AVK+LN + ++L E + D H
Sbjct: 33 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 196 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N++ L+G C+ + L+V +M G L N + + + L AKG+ +L
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
A + ++RD N +LD + + K++DFGLA+D
Sbjct: 145 -ASKKFVHRDLAARNCMLD-------------------------EKFTVKVADFGLARDM 178
Query: 315 PEGDKTHVSTRVMG------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+ + V + A E + T T++SDV+SFGV+L E++T
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
LG G FG V+KG WI E + VA+K L + +KE L E + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++ +L+G C+ L+ + MP G L +++ + + + AKG+ +L
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
+R +++RD N+L+ + K++DFGLAK
Sbjct: 134 -EDRRLVHRDLAARNVLVK-------------------------TPQHVKITDFGLAKLL 167
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+K + + + A E ++ T +SDV+S+GV + E++T G +
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 66/305 (21%), Positives = 108/305 (35%), Gaps = 61/305 (20%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
R + + +G G F V+KG E T + VA L L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 187 NFLGDLVHLNLVKLIGYCI---EDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N+V+ + + +++ E M G+L+ +L +R + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWC 135
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
KGL FLH P+I+RD K NI + G G +
Sbjct: 136 RQILKGLQFLHTR-TPPIIHRDLKCDNIFIT-------GPTG-----------------S 170
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
K+ D GLA + + V+GT + APE + DVY+FG+ +LEM T
Sbjct: 171 VKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMAT- 224
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422
E+ E RR + + + ++ C+ ++
Sbjct: 225 ----------SEYPYSECQNAAQIYRRVTSGVKPASFDKVAI----PEVKEIIEGCIRQN 270
Query: 423 PKARP 427
R
Sbjct: 271 KDERY 275
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 64/245 (26%), Positives = 91/245 (37%), Gaps = 58/245 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 49 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------MKIA 242
+V+ G C E L+V+E+M G L L + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
A G+ +L A ++RD T N L+ Q
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVG-------------------------QGLV 196
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
K+ DFG+++D D V R M PE ++ T+ SDV+SFGVVL
Sbjct: 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVL 250
Query: 357 LEMLT 361
E+ T
Sbjct: 251 WEIFT 255
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 69/300 (23%), Positives = 115/300 (38%), Gaps = 55/300 (18%)
Query: 79 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPE---- 134
S I +TS + S + + +L A ++
Sbjct: 30 GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89
Query: 135 -----SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNF 188
++G G FGCV+ G T G + AVK+LN + ++L E
Sbjct: 90 IVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 189 LGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ D H N++ L+G C+ + L+V +M G L N + + + L AK
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
G+ FL A + ++RD N +LD + + K++D
Sbjct: 204 GMKFL---ASKKFVHRDLAARNCMLD-------------------------EKFTVKVAD 235
Query: 308 FGLAKDGPEGDKTHVSTRVMG------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
FGLA+D + + V + A E + T T++SDV+SFGV+L E++T
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 50/235 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V+ G + + A+K+L+ +Q + +L E + L H
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 196 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFL 252
N++ LIG + + ++ +M G L + +R+ + I L A+G+ +L
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
AE+ ++RD N +LD + + K++DFGLA+
Sbjct: 141 ---AEQKFVHRDLAARNCMLD-------------------------ESFTVKVADFGLAR 172
Query: 313 DGPEGDKTHVSTRVMG------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
D + + V T A E + T T++SDV+SFGV+L E+LT
Sbjct: 173 DILDREYYSVQQHRHARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 59/244 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVH 194
LG+G FG V + + G+ + VAVK L D + +E+L E + + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 195 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IAL 243
++ KL+G + + +++ FM G L L R P+++ ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
A G+ +L + R I+RD N +L +D
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLA-------------------------EDMTV 176
Query: 304 KLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357
++DFGL++ GD + ++++ + A E + T SDV++FGV +
Sbjct: 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMW 230
Query: 358 EMLT 361
E++T
Sbjct: 231 EIMT 234
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 66/246 (26%), Positives = 95/246 (38%), Gaps = 59/246 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E +P K VAVK L L K++ E L +L H +
Sbjct: 23 LGEGAFGKVFLA--ECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------MKI 241
+VK G C + D ++V+E+M G L L + + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
A A G+ +L A + ++RD T N L+ +
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVG-------------------------ANL 170
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
K+ DFG+++D D V M PE +M T+ SDV+SFGV+
Sbjct: 171 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVI 224
Query: 356 LLEMLT 361
L E+ T
Sbjct: 225 LWEIFT 230
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 37/234 (15%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G G V G + G V VA+K L + + ++L+E + +G
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G ++V E+M GSL+ L + + G G+ +L
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
++ ++RD N+L+D + K+SDFGL++
Sbjct: 168 ---SDLGYVHRDLAARNVLVD-------------------------SNLVCKVSDFGLSR 199
Query: 313 D-GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ D + +T + APE + +S SDV+SFGVV+ E+L G R
Sbjct: 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 58/240 (24%), Positives = 96/240 (40%), Gaps = 51/240 (21%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 191
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 67 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
L E+ ++RD N+LL + AK+SDFGL+
Sbjct: 126 L---EEKNFVHRDLAARNVLLV-------------------------NRHYAKISDFGLS 157
Query: 312 KDGPEGDKTHVSTRVMGTYG------YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
K D + + + APE + +SRSDV+S+GV + E L+ G++
Sbjct: 158 KALGADDSYYTARS-----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 74/330 (22%), Positives = 135/330 (40%), Gaps = 66/330 (20%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G +G V++G W LTVAVKTL D ++ +E+L E + ++ H
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
NLV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
++ I+R+ N L+ +++ K++DFGL++
Sbjct: 335 -EKKNFIHRNLAARNCLVG-------------------------ENHLVKVADFGLSRL- 367
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 374
GD + APE + + +SDV++FGV+L E+ T S +
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
Query: 375 -HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEV 432
+ L+E + YR+ P G + +L C +P RP +E+
Sbjct: 428 VYELLE----------KDYRMERPE--------GCPEKVYELMRACWQWNPSDRPSFAEI 469
Query: 433 VEALKPLPNLKDMASSSYYFQTMQAERIGS 462
+A + + SS + + G+
Sbjct: 470 HQAFETMFQ----ESSISDEVEKELGKRGT 495
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 67/310 (21%), Positives = 95/310 (30%), Gaps = 68/310 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVN 187
+F+ S LG G +G VFK G AVK G + LAEV
Sbjct: 58 SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 188 FLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ H V+L E L E SL+ H LP +
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
LA LH + +++ D K +NI L KL
Sbjct: 168 LALAHLHS---QGLVHLDVKPANIFLG-------------------------PRGRCKLG 199
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
DFGL + V G Y APE + + + +DV+S G+ +LE+
Sbjct: 200 DFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNME-- 253
Query: 367 DKNRPNGEHNLVEWARPHLGERRR--FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
PH GE + + P S + + L DPK
Sbjct: 254 ---------------LPHGGEGWQQLRQGYLPPEFTAGLS----SELRSVLVMMLEPDPK 294
Query: 425 ARPLMSEVVE 434
R ++
Sbjct: 295 LRATAEALLA 304
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 63/233 (27%), Positives = 93/233 (39%), Gaps = 38/233 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 38 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPWSIRMKIALGAAKG 248
N+V+ IG ++ R ++ E M G L++ L R + P L + +A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+L E I+RD N LL AK+ DF
Sbjct: 153 CQYL---EENHFIHRDIAARNCLL----------------------TCPGPGRVAKIGDF 187
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
G+A+D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 62/233 (26%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 79 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIR--MKIALGAAKG 248
N+V+ IG ++ R ++ E M G L++ L R + P ++ + +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+L E I+RD N LL AK+ DF
Sbjct: 194 CQYL---EENHFIHRDIAARNCLL----------------------TCPGPGRVAKIGDF 228
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
G+A+D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 50/238 (21%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVH 194
+G G FG V+KG +G V VA+KTL + ++L E +G H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+++L G + +++ E+M G+L+ L + + + G A G+ +L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA--- 311
A ++RD NIL++ + K+SDFGL+
Sbjct: 164 -ANMNYVHRDLAARNILVN-------------------------SNLVCKVSDFGLSRVL 197
Query: 312 KDGPEGDKTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+D PE T ++ APE + TS SDV+SFG+V+ E++T G R
Sbjct: 198 EDDPEATYTTSGGKIPIRWT------APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 66/238 (27%), Positives = 99/238 (41%), Gaps = 50/238 (21%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 192
LG+G FG V +G W +G ++VAVK L D L + +++ EVN + L
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLA 250
H NL++L G + +V E P GSL + L + L R A+ A+G+
Sbjct: 79 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+L + I+RD N+LL K+ DFGL
Sbjct: 136 YL---ESKRFIHRDLAARNLLL-------------------------ATRDLVKIGDFGL 167
Query: 311 AKDGPEGDKTHVSTRVMGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ P+ D +V + + APE + T + SD + FGV L EM T G+
Sbjct: 168 MRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 53/235 (22%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W G V AVK + +G E+ E + L H
Sbjct: 16 LGSGQFGVVKLGKW---KGQYDV--------AVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LVK G C ++ +V E++ G L N+L + L + M +G+AFL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
I+RD N L+D +D K+SDFG+ +
Sbjct: 121 --ESHQFIHRDLAARNCLVD-------------------------RDLCVKVSDFGMTRY 153
Query: 314 GPEGDKTHVSTRVMGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ +GT ++APE +S+SDV++FG+++ E+ + G+
Sbjct: 154 VLDDQ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 63/254 (24%), Positives = 100/254 (39%), Gaps = 61/254 (24%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGL--QG 178
L L + LG G FG V KG + + V AVK L ++
Sbjct: 16 KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTV--------AVKILKNEANDPAL 61
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSI 237
E LAE N + L + +V++IG C E + +LV E G L +L R + I
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ + G+ +L E ++RD N+LL
Sbjct: 121 EL--VHQVSMGMKYL---EESNFVHRDLAARNVLLV------------------------ 151
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG------YAAPEYVMTGHLTSRSDVYS 351
+ AK+SDFGL+K + + + + APE + +S+SDV+S
Sbjct: 152 -TQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWS 205
Query: 352 FGVVLLEMLT-GRR 364
FGV++ E + G++
Sbjct: 206 FGVLMWEAFSYGQK 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 61/270 (22%), Positives = 103/270 (38%), Gaps = 67/270 (24%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
+L++ + + ++ LGE FG V+KG G AP + VA+KTL
Sbjct: 1 GKLKEISLSAVRF-------MEELGEDRFGKVYKG--HLFGPAPGEQTQ--AVAIKTLKD 49
Query: 174 D-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
+E+ E L H N+V L+G +D +++ + G L L RS
Sbjct: 50 KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 233 LPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277
+ + A G+ +L + V+++D T N+L+
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVY---- 162
Query: 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYG 331
N K+SD GL ++ D K ++ + M
Sbjct: 163 ---------------------DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM---- 197
Query: 332 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
APE +M G + SD++S+GVVL E+ +
Sbjct: 198 --APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 57/237 (24%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W V A+KT+ +G ++++ E + L H
Sbjct: 16 IGSGQFGLVHLGYW---LNKDKV--------AIKTI-REGAMSEEDFIEEAEVMMKLSHP 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LV+L G C+E LV EFM G L ++L R + M L +G+A+L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
E VI+RD N L+ ++ K+SDFG+ +
Sbjct: 121 --EEACVIHRDLAARNCLVG-------------------------ENQVIKVSDFGMTRF 153
Query: 314 GPEGD-KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ + T+ +PE +S+SDV+SFGV++ E+ + G+
Sbjct: 154 VLDDQYTSSTGTKFPVKWA------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 64/248 (25%), Positives = 102/248 (41%), Gaps = 59/248 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 239
N++ L+G C +D ++ E+ +G+L +L R P +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
A+G+ +L A + I+RD N+L+
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE------------------------- 192
Query: 300 DYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFG 353
+ K++DFGLA+D D K + R+ M APE + T +SDV+SFG
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFG 246
Query: 354 VVLLEMLT 361
V++ E+ T
Sbjct: 247 VLMWEIFT 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 52/237 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG FG V++G G + VAVKT D +K ++++E + +L H
Sbjct: 20 LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
++VKLIG E+ ++ E P G L ++L + SL + + +L K +A+L
Sbjct: 74 HIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL- 129
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
++RD NIL+ KL DFGL++
Sbjct: 130 --ESINCVHRDIAVRNILVA-------------------------SPECVKLGDFGLSRY 162
Query: 314 GPEGDKTHVST-----RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ D S + M +PE + T+ SDV+ F V + E+L+ G++
Sbjct: 163 IEDEDYYKASVTRLPIKWM------SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 75/330 (22%), Positives = 124/330 (37%), Gaps = 74/330 (22%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ + T +AES+SS + +++ +RL +
Sbjct: 7 HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66
Query: 130 N----------FRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
F + L LGEG FG V E G KP +TVAVK L D
Sbjct: 67 EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDD 124
Query: 175 -GLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
+ + ++E+ + + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 233 LPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277
+ A+G+ +L A + I+RD N+L+
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE--- 238
Query: 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYG 331
+ K++DFGLA+D D K + R+ M
Sbjct: 239 ----------------------NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM---- 272
Query: 332 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
APE + T +SDV+SFGV++ E+ T
Sbjct: 273 --APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 49/240 (20%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL 192
+ ++G G FG V G ++ + VA+KTL + +++L E + +G
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEIS------VAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G + ++V E+M GSL++ L + + + G A G+ +L
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA- 311
++ ++RD NIL++ + K+SDFGL
Sbjct: 164 ---SDMGYVHRDLAARNILIN-------------------------SNLVCKVSDFGLGR 195
Query: 312 --KDGPEGDKTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+D PE T ++ +PE + TS SDV+S+G+VL E+++ G R
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWT------SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 53/235 (22%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W G V A+K + +G E++ E + +L H
Sbjct: 32 LGTGQFGVVKYGKW---RGQYDV--------AIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LV+L G C + ++ E+M G L N+L R + M + + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYL- 136
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
+ ++RD N L++ K+SDFGL++
Sbjct: 137 --ESKQFLHRDLAARNCLVN-------------------------DQGVVKVSDFGLSRY 169
Query: 314 GPEGDKTHVSTRVMGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ + T +G+ ++ PE +M +S+SD+++FGV++ E+ + G+
Sbjct: 170 VLDDE----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 61/250 (24%), Positives = 103/250 (41%), Gaps = 65/250 (26%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
+ ++GEG FG V K I+ K G + A+K + H+++ E+ L L
Sbjct: 30 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 193 V-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------------- 238
H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 141
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
+ A A+G+ +L +++ I+RD NIL+
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVG---------------------- 176
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYS 351
++Y AK++DFGL++ K R+ M A E + T+ SDV+S
Sbjct: 177 ---ENYVAKIADFGLSRGQEVYVKKT-MGRLPVRWM------AIESLNYSVYTTNSDVWS 226
Query: 352 FGVVLLEMLT 361
+GV+L E+++
Sbjct: 227 YGVLLWEIVS 236
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 75/391 (19%), Positives = 123/391 (31%), Gaps = 76/391 (19%)
Query: 73 SKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFR 132
S S + A+ + ++ S + E + + K + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
+ +G G FG V + TG AVK + L+ + E+ L
Sbjct: 62 HQPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVR---LEVFRV--EELVACAGL 107
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
+V L G E + E + GSL L ++ LP + A +GL +L
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
H +++ D K N+LL + G A L DFG A
Sbjct: 167 HTRR---ILHGDVKADNVLLS-----SDGS-------------------RAALCDFGHAL 199
Query: 313 ---DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
G + GT + APE VM ++ D++S ++L ML G
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGC----- 253
Query: 369 NRPNGEHNLVEWARPHLGERRRFYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423
P W ++ + + AQ L ++P
Sbjct: 254 -HP--------WT--QYFRGPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEP 298
Query: 424 KARP----LMSEVVEALKPLPNLKDMASSSY 450
R L +V +AL+ + LK Y
Sbjct: 299 VHRASAMELRRKVGKALQEVGGLKSPWKGEY 329
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-30
Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 45/237 (18%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 191
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 451
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
L E+ ++R+ N+LL + AK+SDFGL+
Sbjct: 452 L---EEKNFVHRNLAARNVLLV-------------------------NRHYAKISDFGLS 483
Query: 312 KDGPEGDKTHVSTRVMGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
K D + + + APE + +SRSDV+S+GV + E L+ G++
Sbjct: 484 KALGADDSYYTARS--AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 63/255 (24%), Positives = 101/255 (39%), Gaps = 68/255 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+GEG FG VF+ G P +P T VAVK L + ++ E + + +
Sbjct: 55 IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 238
N+VKL+G C L++E+M G L L S S+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 239 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292
+ IA A G+A+L +ER ++RD T N L+
Sbjct: 171 LSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVG------------------- 208
Query: 293 FNNMLFQDYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSR 346
++ K++DFGL+++ D K + + M PE + T+
Sbjct: 209 ------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTE 256
Query: 347 SDVYSFGVVLLEMLT 361
SDV+++GVVL E+ +
Sbjct: 257 SDVWAYGVVLWEIFS 271
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 71/341 (20%), Positives = 112/341 (32%), Gaps = 75/341 (21%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKE 181
+ + +++ LGEGGF V V+ G A+K + Q +E
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDL----------VEGLHDGHFYALKRILCHEQQDREE 72
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSL---PLP 234
E + H N+++L+ YC+ + L+ F RG+L N + R L
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294
+ + LG +GL +H + +RD K +NILL
Sbjct: 133 EDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLG--------------------- 168
Query: 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-------GTYGYAAPEYVMT---GHLT 344
+ L D G + + T Y APE +
Sbjct: 169 ----DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224
Query: 345 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 404
R+DV+S G VL M+ G D G+ L + + P S
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-------LAVQNQLSIPQSP----RHS 273
Query: 405 IKGAQKAAQLAAHCLSRDPKARP----LMSEVVEALKPLPN 441
QL ++ DP RP L+S++ P P
Sbjct: 274 ----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 79/310 (25%), Positives = 124/310 (40%), Gaps = 64/310 (20%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
E LG+G FG V+ G W NGT V A+KTL G + +L E + L
Sbjct: 189 EVKLGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKL 236
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 251
H LV+L E+ +V E+M +GSL + L L + +A A G+A+
Sbjct: 237 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
+ ++RD + +NIL+ ++ K++DFGLA
Sbjct: 296 V---ERMNYVHRDLRAANILVG-------------------------ENLVCKVADFGLA 327
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 371
+ E ++ + APE + G T +SDV+SFG++L E+ T R
Sbjct: 328 RL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386
Query: 372 NGE-HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLM 429
N E + VE R YR+ P ++ L C ++P+ RP
Sbjct: 387 NREVLDQVE----------RGYRMPCPP--------ECPESLHDLMCQCWRKEPEERPTF 428
Query: 430 SEVVEALKPL 439
+ L+
Sbjct: 429 EYLQAFLEDY 438
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 73/334 (21%), Positives = 113/334 (33%), Gaps = 83/334 (24%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+F+ L+G GGFG VFK G T +K + ++ + + EV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNNEKAER----EVKA 57
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL----------------LVYEFMPRGSLENHL-FRRSL 231
L L H+N+V G D + EF +G+LE + RR
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
L + +++ KG+ ++H + +I RD K SNI L
Sbjct: 118 KLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLV------------------ 156
Query: 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351
K+ DFGL TR GT Y +PE + + D+Y+
Sbjct: 157 -------DTKQVKIGDFGLVT---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYA 206
Query: 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA 411
G++L E+L F L D + F +K
Sbjct: 207 LGLILAELLHVCD-----TAFETSKF-------------FTDLRDGIISDIFD----KKE 244
Query: 412 AQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 445
L LS+ P+ RP SE++ L +
Sbjct: 245 KTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 66/248 (26%), Positives = 102/248 (41%), Gaps = 59/248 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK--- 240
N++ L+G C +D ++ E+ +G+L +L + S + K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 241 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
A A+G+ +L A + I+RD N+L+
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTE------------------------- 226
Query: 300 DYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFG 353
D K++DFGLA+D D K + R+ M APE + T +SDV+SFG
Sbjct: 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFG 280
Query: 354 VVLLEMLT 361
V+L E+ T
Sbjct: 281 VLLWEIFT 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 64/338 (18%), Positives = 113/338 (33%), Gaps = 94/338 (27%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+F ++LG+G FG V K A+K + H + L+EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRL-------------LVYEFMPRGSLENHLFRRSLPLP 234
L L H +V+ +E + + E+ G+L + + +L
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 235 ----WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290
W + +I L+++H + +I+RD K NI +D
Sbjct: 115 RDEYWRLFRQILEA----LSYIHS---QGIIHRDLKPMNIFID----------------- 150
Query: 291 LFFNNMLFQDYNAKLSDFGLAK-------------DGPEGDKTHVSTRVMGTYGYAAPEY 337
+ N K+ DFGLAK G ++++ + GT Y A E
Sbjct: 151 --------ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE- 200
Query: 338 VM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHLGERRRFYRL 394
V+ TGH + D+YS G++ EM+ + V +
Sbjct: 201 VLDGTGHYNEKIDMYSLGIIFFEMIYP--------FSTGMERVNILKKLRSVSIE----- 247
Query: 395 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432
P + + + ++ + DP RP +
Sbjct: 248 FPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGARTL 281
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 59/237 (24%), Positives = 91/237 (38%), Gaps = 52/237 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
+GEG FG V +G L VA+KT + + ++L E + H
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
++VKLIG E+ ++ E G L + L + SL L I A + LA+L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
+ ++RD N+L+ + KL DFGL++
Sbjct: 133 --ESKRFVHRDIAARNVLVS-------------------------SNDCVKLGDFGLSRY 165
Query: 314 GPEGDKTHVST-----RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ S + M APE + TS SDV+ FGV + E+L G +
Sbjct: 166 MEDSTYYKASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 62/311 (19%), Positives = 114/311 (36%), Gaps = 50/311 (16%)
Query: 64 VSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFND 123
V+G + + + + R P+ +++ S++ + ++ + T+
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDY-AEIIDEEDTYTM 379
Query: 124 LKLATRNFRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQ 177
+ E + +GEG FG V +G + VA+KT +
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDS 433
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+++L E + H ++VKLIG E+ ++ E G L + L R L +
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ A + LA+L + ++RD N+L+
Sbjct: 493 LILYAYQLSTALAYL---ESKRFVHRDIAARNVLVS------------------------ 525
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLTSRSDVYSFGV 354
+ KL DFGL++ + S + APE + TS SDV+ FGV
Sbjct: 526 -SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINFRRFTSASDVWMFGV 580
Query: 355 VLLEMLT-GRR 364
+ E+L G +
Sbjct: 581 CMWEILMHGVK 591
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 59/236 (25%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 29 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
++RD N+L+ +D AK+SDFGL K+
Sbjct: 134 --EGNNFVHRDLAARNVLVS-------------------------EDNVAKVSDFGLTKE 166
Query: 314 GPEGDKTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
T + ++ APE + +++SDV+SFG++L E+ + GR
Sbjct: 167 A---SSTQDTGKLPVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 51/235 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL + +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 256 AERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315
++ I+RD N L+ +++ K++DFGL++
Sbjct: 128 EKKNFIHRDLAARNCLVG-------------------------ENHLVKVADFGLSRLMT 162
Query: 316 EGD-KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
H + APE + + +SDV++FGV+L E+ T G
Sbjct: 163 GDTYTAHAGAKFPIKWT------APESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 51/232 (21%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313
++RD N+L+ +D AK+SDFGL K+
Sbjct: 306 --EGNNFVHRDLAARNVLVS-------------------------EDNVAKVSDFGLTKE 338
Query: 314 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
T + ++ + APE + +++SDV+SFG++L E+ + GR
Sbjct: 339 A---SSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 69/346 (19%), Positives = 119/346 (34%), Gaps = 83/346 (23%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S +T + S + + E +LG+G +G V+ G
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYD------------------ENGDRVVLGKGTYGIVYAG- 41
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209
+ +A+K + + + E+ L H N+V+ +G E+
Sbjct: 42 --------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93
Query: 210 RLLVYEFMPRGSLENHLFRRSLPLPWS---IRMKIALGAAKGLAFLHEEAERPVIYRDFK 266
+ E +P GSL L + PL + I +GL +LH+ +++RD K
Sbjct: 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQ---IVHRDIK 149
Query: 267 TSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRV 326
N+L++ G K+SDFG +K + +
Sbjct: 150 GDNVLINT-------YSGVL-----------------KISDFGTSKRLAGINPCTET--F 183
Query: 327 MGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 383
GT Y APE + G+ +D++S G ++EM TG+ P + L E
Sbjct: 184 TGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK------PPF--YELGEPQAA 234
Query: 384 --HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
+G + + P + S +A C DP R
Sbjct: 235 MFKVGMFK-----VHPEIPESMS----AEAKAFILKCFEPDPDKRA 271
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 47/232 (20%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G + NG V AVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYY---NGHTKV--------AVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
LV+L ++ ++ E+M GSL + L + L + + +A A+G+AF+
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
ER I+RD + +NIL+ + K++DFGLA+
Sbjct: 126 -EERNYIHRDLRAANILVS-------------------------DTLSCKIADFGLARLI 159
Query: 315 PEGD-KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ + + + APE + G T +SDV+SFG++L E++T GR
Sbjct: 160 EDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 66/373 (17%), Positives = 124/373 (33%), Gaps = 64/373 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
+ +GEG FG G +K +N + KE EV
Sbjct: 25 KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREV 74
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGA 245
L ++ H N+V+ E+ +V ++ G L + ++ + + +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
L +H +R +++RD K+ NI L +D +L
Sbjct: 135 CLALKHVH---DRKILHRDIKSQNIFLT-------------------------KDGTVQL 166
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365
DFG+A+ + GT Y +PE ++SD+++ G VL E+ T + +
Sbjct: 167 GDFGIARVL-NSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
Query: 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425
+ + P + H+S L + R+P+
Sbjct: 225 FEAGSMKNLVLKIISGSF-------------PPVSLHYS----YDLRSLVSQLFKRNPRD 267
Query: 426 RPLMSEVVE---ALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ 482
RP ++ ++E K + + F + GS P + S+S
Sbjct: 268 RPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPA 327
Query: 483 RSLSIPNGSYASP 495
+ ++ P Y P
Sbjct: 328 QKITKPAAKYGIP 340
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 78/307 (25%), Positives = 122/307 (39%), Gaps = 64/307 (20%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+G FG V+ G W NGT V A+KTL G + +L E + L H
Sbjct: 275 LGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKLRHE 322
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
LV+L E+ +V E+M +GSL + L L + +A A G+A++
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379
Query: 255 EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314
++RD + +NIL+ + K++DFGLA+
Sbjct: 380 -ERMNYVHRDLRAANILVGE-------------------------NLVCKVADFGLARL- 412
Query: 315 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 374
E ++ + APE + G T +SDV+SFG++L E+ T R N E
Sbjct: 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 472
Query: 375 -HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEV 432
+ VE R YR+ P ++ L C ++P+ RP +
Sbjct: 473 VLDQVE----------RGYRMPCPP--------ECPESLHDLMCQCWRKEPEERPTFEYL 514
Query: 433 VEALKPL 439
L+
Sbjct: 515 QAFLEDY 521
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 71/317 (22%), Positives = 115/317 (36%), Gaps = 75/317 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
NFR E +G G F V++ G+ VA+K + L K + E+
Sbjct: 33 NFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIAL 243
+ L L H N++K IED++ +V E G L + ++ +P K +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
L +H R V++RD K +N+ +
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFIT-------------------------ATGVV 175
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
KL D GL + T + V GT Y +PE + +SD++S G +L EM +
Sbjct: 176 KLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLI--------DPRLEGHFSIKGAQKAAQLA 415
P G++ Y L P H+S ++ QL
Sbjct: 234 ------------------SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS----EELRQLV 271
Query: 416 AHCLSRDPKARPLMSEV 432
C++ DP+ RP ++ V
Sbjct: 272 NMCINPDPEKRPDVTYV 288
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 68/256 (26%), Positives = 100/256 (39%), Gaps = 70/256 (27%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V K T TVAVK L + ++ L+E N L + H
Sbjct: 31 LGEGEFGKVVKA--TAFHLKGRAGYT--TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 238
+++KL G C +D LL+ E+ GSL L R S +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 239 -------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
+ A ++G+ +L AE +++RD NIL+
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAE----------------- 185
Query: 292 FFNNMLFQDYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTS 345
K+SDFGL++D E D R+ M A E + T+
Sbjct: 186 --------GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTT 231
Query: 346 RSDVYSFGVVLLEMLT 361
+SDV+SFGV+L E++T
Sbjct: 232 QSDVWSFGVLLWEIVT 247
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 65/334 (19%), Positives = 110/334 (32%), Gaps = 89/334 (26%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+F P LG GGFG VF+ A+K + + +E + EV
Sbjct: 6 DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 189 LGDLVHLNLVKLIGYCIEDD---------QRLLVY---EFMPRGSLENHLFRR--SLPLP 234
L L H +V+ +E + ++ +Y + + +L++ + R
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294
S+ + I L A+ + FLH + +++RD K SNI
Sbjct: 117 RSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFT--------------------- 152
Query: 295 NMLFQDYNAKLSDFGLAK----------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 344
D K+ DFGL T +GT Y +PE + +
Sbjct: 153 ----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208
Query: 345 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID----PRLE 400
+ D++S G++L E+L + + ER R + P L
Sbjct: 209 HKVDIFSLGLILFELLY--------PFSTQM-----------ERVRTLTDVRNLKFPPLF 249
Query: 401 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
+ LS P RP ++E
Sbjct: 250 TQKY----PCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 49/304 (16%), Positives = 89/304 (29%), Gaps = 31/304 (10%)
Query: 68 STHYESKSTNDTSRDQPA----AAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFND 123
S S T D +I + ++ SS E ++ T +
Sbjct: 2 SPQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT--E 59
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
+L ++ LLGEG F V++ + K +K
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEA--TQGDLNDAK--NKQKFVLKVQKPANPWEFYIGT 115
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRM 239
+ L + +K + + +LV E G+L N + +P + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
A+ + +H+ +I+ D K N +L E +
Sbjct: 176 SFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQD--------------DEDDL 218
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
L D G + D K + T T G+ E + + D + + M
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278
Query: 360 LTGR 363
L G
Sbjct: 279 LFGT 282
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 67/234 (28%), Positives = 103/234 (44%), Gaps = 45/234 (19%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
E LG G FG V+ + N V AVKT+ G + +LAE N + L
Sbjct: 193 EKKLGAGQFGEVWMATY---NKHTKV--------AVKTM-KPGSMSVEAFLAEANVMKTL 240
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAF 251
H LVKL ++ ++ EFM +GSL + L P + + A+G+AF
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
+ +R I+RD + +NIL+ A K++DFGLA
Sbjct: 300 I---EQRNYIHRDLRAANILVSA-------------------------SLVCKIADFGLA 331
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364
+ E ++ + APE + G T +SDV+SFG++L+E++T GR
Sbjct: 332 RV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 62/308 (20%), Positives = 100/308 (32%), Gaps = 53/308 (17%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAE 185
T F +G G FG VFK VK G A+K G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 186 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 241
V L H ++V+ EDD L+ E+ GSL + + +R + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
L +GL ++H +++ D K SNI + N ++
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEE------GDEDDWASNKV 171
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEM 359
K+ D G V G + A E + HL +D+++ + ++
Sbjct: 172 MFKIGDLGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLPK-ADIFALALTVVCA 224
Query: 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419
P +W G PR+ S Q+ +L +
Sbjct: 225 AGAEPL-----PRNGD---QWHEIRQGRL--------PRIPQVLS----QEFTELLKVMI 264
Query: 420 SRDPKARP 427
DP+ RP
Sbjct: 265 HPDPERRP 272
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 74/320 (23%), Positives = 113/320 (35%), Gaps = 74/320 (23%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWLA---- 184
++ LG GG V+ T L VA+K + + +E L
Sbjct: 13 YKIVDKLGGGGMSTVYLAE-----------DTILNIKVAIKAI-FIPPREKEETLKRFER 60
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV+ L H N+V +I EDD LV E++ +L ++ PL +
Sbjct: 61 EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQ 119
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
G+ H+ +++RD K NIL+D + K
Sbjct: 120 ILDGIKHAHD---MRIVHRDIKPQNILID-------------------------SNKTLK 151
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
+ DFG+AK E T + V+GT Y +PE +D+YS G+VL EML G
Sbjct: 152 IFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE- 209
Query: 365 SMDKNRP-NGEHNLVEWARPHLGE-----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418
P NGE V A H+ + + I L +
Sbjct: 210 -----PPFNGE-TAVSIAIKHIQDSVPNVTTDVRKDIPQSLS------------NVILRA 251
Query: 419 LSRDPKARPL-MSEVVEALK 437
+D R + E+ + L
Sbjct: 252 TEKDKANRYKTIQEMKDDLS 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 62/246 (25%), Positives = 93/246 (37%), Gaps = 59/246 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + G VAVK L + ++E+ + L H
Sbjct: 54 LGAGAFGKVVEA--TAFGLGKEDAVL--KVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKI 241
N+V L+G C L++ E+ G L N L R+S L +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
+ A+G+AFL A + I+RD N+LL +
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLT-------------------------NGH 201
Query: 302 NAKLSDFGLAKDGPEGDKTHVST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
AK+ DFGLA+D V + M APE + T +SDV+S+G++
Sbjct: 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGIL 255
Query: 356 LLEMLT 361
L E+ +
Sbjct: 256 LWEIFS 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 65/250 (26%), Positives = 95/250 (38%), Gaps = 64/250 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + + G TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQVIEA--DAFGIDKTATCR--TVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 195 LNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 238
LN+V L+G C + +++ EF G+L +L R +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ + AKG+ FL A R I+RD NILL
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE----------------------- 183
Query: 298 FQDYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYS 351
K+ DFGLA+D + R+ M APE + T +SDV+S
Sbjct: 184 --KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWS 235
Query: 352 FGVVLLEMLT 361
FGV+L E+ +
Sbjct: 236 FGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 65/250 (26%), Positives = 91/250 (36%), Gaps = 63/250 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + G TVAVK L L + ++E+ L L H
Sbjct: 31 LGAGAFGKVVEA--TAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 238
+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ + AKG+AFL A + I+RD NILL
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTH----------------------- 180
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVST------RVMGTYGYAAPEYVMTGHLTSRSDVYS 351
K+ DFGLA+D V + M APE + T SDV+S
Sbjct: 181 --GRITKICDFGLARDIKNDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWS 232
Query: 352 FGVVLLEMLT 361
+G+ L E+ +
Sbjct: 233 YGIFLWELFS 242
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 68/380 (17%), Positives = 124/380 (32%), Gaps = 80/380 (21%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ S+ R ++ + +++ +S + R
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-----R 56
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +G GG VF+ V A+K +N + Q + E+
Sbjct: 57 IYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 188 FLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
+L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 107 YLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKN 163
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
+ + +H+ +++ D K +N L+ + ML K
Sbjct: 164 MLEAVHTIHQHG---IVHSDLKPANFLIV--------------------DGML------K 194
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------TGHLTSRSDVYSFG 353
L DFG+A + V +G Y PE + ++ +SDV+S G
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254
Query: 354 VVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 412
+L M G+ P N + + + +IDP E F +
Sbjct: 255 CILYYMTYGK------TPFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQ 298
Query: 413 QLAAHCLSRDPKARPLMSEV 432
+ CL RDPK R + E+
Sbjct: 299 DVLKCCLKRDPKQRISIPEL 318
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 9e-27
Identities = 70/323 (21%), Positives = 106/323 (32%), Gaps = 62/323 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+ + LG GGFG V + + TG VA+K + ++E W E+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 189 LGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFR--RSLPLPWSIR 238
+ L H N+V + D + LL E+ G L +L + L
Sbjct: 66 MKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ + L +LHE +I+RD K NI+L
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGP---------------------- 158
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358
Q K+ D G AK+ +G+ V GT Y APE + T D +SFG + E
Sbjct: 159 QRLIHKIIDLGYAKELDQGELCT--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 215
Query: 359 MLTGRR---------SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQ 409
+TG R + + G + L P H S A
Sbjct: 216 CITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAG 272
Query: 410 KAAQLAAHCLSRDPKARPLMSEV 432
K + L + R +
Sbjct: 273 KLERWLQCMLMWHQRQRGTDPQN 295
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 68/320 (21%), Positives = 105/320 (32%), Gaps = 66/320 (20%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 186
+R L+G GG G V++ VA+K + + L + E
Sbjct: 36 YRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREA 85
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
G L ++V + + D Q + + L L RR PL + I
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIG 144
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
L H +RD K NIL+ A D A L
Sbjct: 145 SALDAAHA---AGATHRDVKPENILVSA-------------------------DDFAYLV 176
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
DFG+A + T + +GT Y APE H T R+D+Y+ VL E LTG
Sbjct: 177 DFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS--- 232
Query: 367 DKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425
P G+ + H+ + + P + + A ++++P+
Sbjct: 233 ---PPYQGDQ--LSVMGAHINQAIPRPSTVRPGI--------PVAFDAVIARGMAKNPED 279
Query: 426 RP-----LMSEVVEALKPLP 440
R L + AL
Sbjct: 280 RYVTCGDLSAAAHAALATAD 299
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 65/333 (19%), Positives = 113/333 (33%), Gaps = 75/333 (22%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
F + + R + +G GG VF+ V A+K +N +
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEA 65
Query: 177 QGH--KEWLAEVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 231
+ E+ +L L + ++L Y DQ + +V E L + L ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK- 122
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
+ R + + +H+ +++ D K +N L+
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV------------------ 161
Query: 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------T 340
+ ML KL DFG+A + V +GT Y PE +
Sbjct: 162 --DGML------KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 213
Query: 341 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRL 399
++ +SDV+S G +L M G+ P N + + + +IDP
Sbjct: 214 SKISPKSDVWSLGCILYYMTYGKT------PFQQIINQIS----------KLHAIIDPNH 257
Query: 400 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432
E F + + CL RDPK R + E+
Sbjct: 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/255 (22%), Positives = 89/255 (34%), Gaps = 68/255 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V G + VAVK L + ++E+ + L H
Sbjct: 53 LGSGAFGKVMNA--TAYGISKTGVSI--QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 238
N+V L+G C L++E+ G L N+L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 239 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292
+ A AKG+ FL + ++RD N+L+
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTH------------------ 207
Query: 293 FNNMLFQDYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSR 346
K+ DFGLA+D + R+ M APE + G T +
Sbjct: 208 -------GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIK 254
Query: 347 SDVYSFGVVLLEMLT 361
SDV+S+G++L E+ +
Sbjct: 255 SDVWSYGILLWEIFS 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 65/359 (18%), Positives = 106/359 (29%), Gaps = 68/359 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 195 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 249
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
L E +++R+ K NI+ KL+DFG
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQS---------------------VYKLTDFG 161
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS--------DVYSFGVVLLEMLT 361
A++ + ++ + GT Y P+ L D++S GV T
Sbjct: 162 AARELEDDEQFV--SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 362 GRR-------------SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA 408
G M K + + + D + S
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQ 276
Query: 409 QKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 467
+ A+ L D + + + + + + Q M A +I
Sbjct: 277 VLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIH--VFSLQQMTAHKIYIHSYNT 333
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 61/309 (19%), Positives = 103/309 (33%), Gaps = 58/309 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F P+ +LG G G + + VAVK + + EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 190 GDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ H N+++ + + + E +L+ ++ ++ + + G
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
LA LH +++RD K NIL+ A K A +SDF
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIK--------------------AMISDF 167
Query: 309 GLAK--DGPEGDKTHVSTRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGR 363
GL K + S GT G+ APE + + T D++S G V +++
Sbjct: 168 GLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG 226
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423
P G+ + L E H A +L ++ DP
Sbjct: 227 S-----HPFGKSLQRQ-----ANILLGACSLDCLHPEKHED----VIARELIEKMIAMDP 272
Query: 424 KARPLMSEV 432
+ RP V
Sbjct: 273 QKRPSAKHV 281
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 61/318 (19%), Positives = 97/318 (30%), Gaps = 66/318 (20%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 195 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 249
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
L E +++R+ K NI+ KL+DFG
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQS---------------------VYKLTDFG 161
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--------TSRSDVYSFGVVLLEMLT 361
A++ + ++ + GT Y P+ L + D++S GV T
Sbjct: 162 AARELEDDEQFV--SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 362 GRR-------------SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA 408
G M K + + + D + S
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQ 276
Query: 409 QKAAQLAAHCLSRDPKAR 426
+ A+ L D +
Sbjct: 277 VLLTPVLANILEADQEKC 294
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 59/314 (18%), Positives = 104/314 (33%), Gaps = 78/314 (24%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 189
+ + + GG G ++ G V +K L H G + +AE FL
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVN--------GRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
++VH ++V++ + D+ +V E++ SL+ + LP+ +I L
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEAIA--YLLE 190
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
L++LH ++Y D K NI+L + K
Sbjct: 191 ILPALSYLHS---IGLVYNDLKPENIMLTEEQL--------------------------K 221
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
L D G + GT G+ APE ++ T +D+Y+ G L +
Sbjct: 222 LIDLGAVSR-----INSFGY-LYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
+ + +G P L + RL+ + DP+
Sbjct: 275 TRNGRYVDGLPEDD----PVLKTYDSYGRLL--------------------RRAIDPDPR 310
Query: 425 ARPL-MSEVVEALK 437
R E+ L
Sbjct: 311 QRFTTAEEMSAQLT 324
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 44/406 (10%), Positives = 84/406 (20%), Gaps = 89/406 (21%)
Query: 83 QPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGF 142
+ +I + ++ + + L R + L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 143 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVK 199
VF A+K E L+ + +
Sbjct: 76 SVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 200 LIGYC-----------------------IEDDQRLLVYEFMPR--------GSLENHLFR 228
+D MP S + ++
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288
+ + A L + +++ F N+ +
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIM--------------- 228
Query: 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSR 346
D L D G + S+ YA E++ T
Sbjct: 229 ----------PDGRLMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHA 273
Query: 347 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 406
+ + G+ + + P + W RP L +
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKG---SWKRPSLRVPGTDS--LAFGSCTPLP-- 326
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVE--ALKPLPNLKDMASSSY 450
L L+ D + R L E +E L N + S+
Sbjct: 327 --DFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTG 370
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 67/372 (18%), Positives = 126/372 (33%), Gaps = 79/372 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+G GG VF+ A+K +N + + E+ +L L
Sbjct: 16 QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 194 HLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+ ++L Y DQ + +V E L + L ++ + R + +
Sbjct: 66 QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 122
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+H+ +++ D K +N L+ + ML KL DFG+
Sbjct: 123 TIHQHG---IVHSDLKPANFLIV--------------------DGML------KLIDFGI 153
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEM 359
A + V +GT Y PE + ++ +SDV+S G +L M
Sbjct: 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
Query: 360 LTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418
G+ P N + + + +IDP E F + + C
Sbjct: 214 TYGKT------PFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCC 257
Query: 419 LSRDPKARPLMSEVVE----ALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQG 474
L RDPK R + E++ ++ P + ++ + + + +G + A+
Sbjct: 258 LKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKT 317
Query: 475 GSLSRNGQRSLS 486
+G S +
Sbjct: 318 LYEHYSGGESHN 329
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 49/353 (13%), Positives = 92/353 (26%), Gaps = 110/353 (31%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------------- 174
R ++LG+ + +E TG + V
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 175 ---------GLQGHKEWLAEVNFL--GDLVHLNLVKLIGYCIEDDQRLLV---YEFMPRG 220
G++ K+ + F+ DLV K + D++ + V + PR
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 221 SLENHLFRRSL--------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272
F L L R+++ L + LA LH +++ + +I+L
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVL 244
Query: 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 332
D L+ F +G S G+
Sbjct: 245 DQ-------------------------RGGVFLTGFEHLV--RDGA----SAVSPIGRGF 273
Query: 333 AAPEYVM----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 382
A PE +T D ++ G+ + + PN + + +
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------LPNTDDAALGGSE 327
Query: 383 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435
+ P+ L L + R L + +E
Sbjct: 328 WIFRSCKNI-----PQP-----------VRALLEGFLRYPKEDRLLPLQAMET 364
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 59/315 (18%), Positives = 108/315 (34%), Gaps = 62/315 (19%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
++ +G G +G K + G + K L++ + + ++EV
Sbjct: 6 EDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEV 56
Query: 187 NFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 241
N L +L H N+V+ + L +V E+ G L + + + L +++
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 242 ALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
L H + V++RD K +N+ LD
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-------------------------G 151
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
N KL DFGLA+ D + T V GT Y +PE + +SD++S G +L E+
Sbjct: 152 KQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209
Query: 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419
+ + R+ +S + ++ L
Sbjct: 210 CALMPPFTAFSQKELAGKIREGKF-------------RRIPYRYS----DELNEIITRML 252
Query: 420 SRDPKARPLMSEVVE 434
+ RP + E++E
Sbjct: 253 NLKDYHRPSVEEILE 267
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 45/267 (16%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLK---LATRNFRPESLLGEGGFGCVFKGWIEENGTAP 157
+LE + + RL F K L +F S LG G G VFK +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP----- 56
Query: 158 VKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
+GL +A K ++ + + + E+ L + +V G D + + E
Sbjct: 57 ----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276
M GSL+ + +++ +P I K+++ KGL +L E+ +++RD K SNIL+++
Sbjct: 113 MDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 169
Query: 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336
KL DFG++ + + ++ V GT Y +PE
Sbjct: 170 -------------------------EIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPE 200
Query: 337 YVMTGHLTSRSDVYSFGVVLLEMLTGR 363
+ H + +SD++S G+ L+EM GR
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 51/420 (12%), Positives = 105/420 (25%), Gaps = 120/420 (28%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFN------- 122
H+ S + P VI ++N T+ + S + +N
Sbjct: 5 HHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRV 64
Query: 123 --DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---- 176
+L R ++LG+ + TG + V
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSN 115
Query: 177 ------------------------QGHKEWLAEVNFLGDLVHLNLVKLIGYC--IEDDQR 210
+ H ++ + + D ++++ + R
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 211 LLVYEFMP-----RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265
+Y M G + L R+++ L + LA LH +++
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL 232
Query: 266 KTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTR 325
+ +I+LD Q L+ F +G +
Sbjct: 233 RPVDIVLD-------------------------QRGGVFLTGFEHLV--RDGARV----V 261
Query: 326 VMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 374
+ G+ PE +T D ++ G+V+ + P +
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD------LPITK 315
Query: 375 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
+ + R + Q L L + R L + +E
Sbjct: 316 DAALGGSEWIF------------RSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 68/332 (20%), Positives = 115/332 (34%), Gaps = 74/332 (22%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWL 183
L+ R + +LG GG V VAVK L L +
Sbjct: 10 LSDR-YELGEILGFGGMSEVHLAR-----------DLRDHRDVAVKVL-RADLARDPSFY 56
Query: 184 A----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPW 235
E L H +V + + +V E++ +L + + P+
Sbjct: 57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTP 115
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
+++ A + L F H+ +I+RD K +NI++
Sbjct: 116 KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMIS---------------------- 150
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 354
K+ DFG+A+ + + T V+GT Y +PE + +RSDVYS G
Sbjct: 151 ---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 355 VLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
VL E+LTG P G+ + V A H+ E L +
Sbjct: 208 VLYEVLTGE------PPFTGD-SPVSVAYQHVREDPIPPSARHEGL--------SADLDA 252
Query: 414 LAAHCLSRDPKARP-----LMSEVVEALKPLP 440
+ L+++P+ R + +++V P
Sbjct: 253 VVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 80/360 (22%), Positives = 121/360 (33%), Gaps = 79/360 (21%)
Query: 84 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 143
PA A + + + ++ L + R + LG+GGF
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFA 55
Query: 144 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKL 200
F+ T A K + L + E++ L H ++V
Sbjct: 56 KCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 201 IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259
G+ ED+ + +V E R SL RR R G +LH
Sbjct: 107 HGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---NR 161
Query: 260 VIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA-KDGPEGD 318
VI+RD K N+ L+ D K+ DFGLA K +G+
Sbjct: 162 VIHRDLKLGNLFLNE-------------------------DLEVKIGDFGLATKVEYDGE 196
Query: 319 KTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 377
+ V GT Y APE V++ S DV+S G ++ +L G+ P L
Sbjct: 197 RKKVLC---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCL 246
Query: 378 VEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
E Y I + + H + AA L L DP ARP ++E++
Sbjct: 247 KE-----------TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 291
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 86/347 (24%), Positives = 117/347 (33%), Gaps = 66/347 (19%)
Query: 31 DEVEVEEEEETGCWVKLRFFGSCISSRSKVDSSVSGTSTHYESKSTNDTSR--DQPAAAV 88
E EV +++ + G ++ + TN T R P +
Sbjct: 88 AEYEVTPDDKR------KACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDL 141
Query: 89 ISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDL---KLATRNFRPESLLGEGGFGCV 145
T E S + + L R + L + FR +LG+GGFG V
Sbjct: 142 FQELTRLTHE-YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200
Query: 146 FKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIG 202
A TG A K L ++ K L E L + +V L
Sbjct: 201 C---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IALGAAKGLAFLHEEA 256
Y E L LV M G L+ H++ R I G L LH E
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRER 306
Query: 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPE 316
++YRD K NILLD + ++SD GLA PE
Sbjct: 307 ---IVYRDLKPENILLDD-------------------------HGHIRISDLGLAVHVPE 338
Query: 317 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
G RV GT GY APE V T D ++ G +L EM+ G+
Sbjct: 339 GQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 71/328 (21%), Positives = 108/328 (32%), Gaps = 77/328 (23%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
E +LG G G V G VAVK + + L E+ L
Sbjct: 17 VVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRML---IDFCDIALMEIKLLT 63
Query: 191 DLV-HLNLVKLIGYCIEDDQRL--LVYEFMPRGSL-----ENHLFRRSLPLPWSIRMKIA 242
+ H N+++ YC E R + E +L ++ +L L
Sbjct: 64 ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 243 L-GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
L A G+A LH +I+RD K NIL+ ++
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTAD------------QQTGAENL 165
Query: 302 NAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPE-------YVMTGHLTSRSDVYS 351
+SDFGL K G +T+++ GT G+ APE LT D++S
Sbjct: 166 RILISDFGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 352 FGVVLLEMLTG-------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 404
G V +L+ + S + N G +L E H +
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLH---------------DRSLI 269
Query: 405 IKGAQKAAQLAAHCLSRDPKARPLMSEV 432
+A L + + DP RP +V
Sbjct: 270 ----AEATDLISQMIDHDPLKRPTAMKV 293
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 75/321 (23%), Positives = 111/321 (34%), Gaps = 85/321 (26%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAE 185
R + LG+GGF F+ T A K + L + E
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM----- 239
++ L H ++V G+ ED+ + +V E R SL RR +
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEA 117
Query: 240 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
G +LH VI+RD K N+ L+
Sbjct: 118 RYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNE------------------------ 150
Query: 299 QDYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVL 356
D K+ DFGLA K +G++ V GT Y APE V++ S DV+S G ++
Sbjct: 151 -DLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 205
Query: 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQ 413
+L G+ P L E Y I + + H + AA
Sbjct: 206 YTLLVGK------PPFETSCLKE-----------TYLRIKKNEYSIPKHIN----PVAAS 244
Query: 414 LAAHCLSRDPKARPLMSEVVE 434
L L DP ARP ++E++
Sbjct: 245 LIQKMLQTDPTARPTINELLN 265
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 44/256 (17%), Positives = 86/256 (33%), Gaps = 74/256 (28%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------------ 184
L +G F + E++ A+K L+ +++
Sbjct: 39 LNQGKFNKIILC--EKDNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 185 -----EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-------FRRSL 231
E+ + D+ + + G I + + ++YE+M S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
+P + I +++H E+ + +RD K SNIL+D
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDK----------------- 187
Query: 292 FFNNMLFQDYNAKLSDFGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYVMTGHLT---SRS 347
+ KLSDFG ++ + K GTY + PE + + ++
Sbjct: 188 --------NGRVKLSDFGESEYMVDKKIKG-----SRGTYEFMPPE-FFSNESSYNGAKV 233
Query: 348 DVYSFGVVLLEMLTGR 363
D++S G+ L M
Sbjct: 234 DIWSLGICLYVMFYNV 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 67/306 (21%), Positives = 112/306 (36%), Gaps = 71/306 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 192
LG+G FG V+ + + +A+K L L+ + EV L
Sbjct: 16 PLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+++L GY D R+ L+ E+ P G++ L ++ A L++
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
H + VI+RD K N+LL + K++DFG +
Sbjct: 125 CHS---KRVIHRDIKPENLLLGS-------------------------AGELKIADFGWS 156
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 371
P + GT Y PE + + D++S GV+ E L G+ P
Sbjct: 157 VHAP-SSRRTDLC---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PP 206
Query: 372 NGEHNLVEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428
+ E Y+ I + + +GA+ L + L +P RP+
Sbjct: 207 FEANTYQE-----------TYKRISRVEFTFPDFVT-EGARD---LISRLLKHNPSQRPM 251
Query: 429 MSEVVE 434
+ EV+E
Sbjct: 252 LREVLE 257
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 69/254 (27%), Positives = 91/254 (35%), Gaps = 63/254 (24%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
+ F +LG GGFG VF A TG A K LN L+ K +
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPW 235
+ E L + +V L Y E L LV M G + H++ P
Sbjct: 232 AMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP- 289
Query: 236 SIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290
R I G L LH+ +IYRD K N+LLD
Sbjct: 290 --RAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDD---------------- 324
Query: 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DV 349
D N ++SD GLA + G GT G+ APE ++ G S D
Sbjct: 325 ---------DGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDY 372
Query: 350 YSFGVVLLEMLTGR 363
++ GV L EM+ R
Sbjct: 373 FALGVTLYEMIAAR 386
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 59/240 (24%), Positives = 94/240 (39%), Gaps = 48/240 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 186
+F+ +LLG+G F V++ TGL VA+K ++ + EV
Sbjct: 12 DFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H ++++L Y ED + LV E G + +L R P +
Sbjct: 63 KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
G+ +LH +++RD SN+LL + N K+
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTR-------------------------NMNIKI 153
Query: 306 SDFGLA-KDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 363
+DFGLA + +K + GT Y +PE + H SDV+S G + +L GR
Sbjct: 154 ADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-22
Identities = 69/278 (24%), Positives = 100/278 (35%), Gaps = 70/278 (25%)
Query: 100 NSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK 159
S + K T ND F ++G GGFG V+ K
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMND-------FSVHRIIGRGGFGEVY---------GCRK 210
Query: 160 PGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLN---LVKLIGYCIEDDQRL-L 212
TG A+K L+ ++ + L E L + + +V + Y +L
Sbjct: 211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSF 269
Query: 213 VYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFK 266
+ + M G L HL + M+ I LG L +H V+YRD K
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHMHNRF---VVYRDLK 319
Query: 267 TSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRV 326
+NILLD + ++SD GLA D + K H V
Sbjct: 320 PANILLDE-------------------------HGHVRISDLGLACDFSK-KKPH--ASV 351
Query: 327 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
GT+GY APE + G S D +S G +L ++L G
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 69/373 (18%), Positives = 129/373 (34%), Gaps = 89/373 (23%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW 182
++L R +L EGGF V++ + G+G A+K L + + ++
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 183 LAEVNFLGDLV-HLNLVKLIGYCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--P 232
+ EV F+ L H N+V+ + L+ + +G L L + P
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292
L +KI + + +H + P+I+RD K N+LL
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSN------------------ 173
Query: 293 FNNMLFQDYNAKLSDFGLA---KDGPEGDKTHVSTRVM-------GTYGYAAPEYV-MTG 341
KL DFG A P+ + ++ T Y PE + +
Sbjct: 174 -------QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226
Query: 342 HL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 399
+ + D+++ G +L + + P + + I +
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQ------HPFEDGAKLR---------------I---V 262
Query: 400 EGHFSI----KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM 455
G +SI L L +P+ R ++EVV L+ + +++ S + +
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELL 322
Query: 456 -QAERIGSSPNTR 467
Q GS+ +R
Sbjct: 323 EQNGGYGSATLSR 335
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 54/232 (23%), Positives = 83/232 (35%), Gaps = 47/232 (20%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLA-EVNFLGDL 192
LG+G FG V+ + +A+K L L+ L E+ L
Sbjct: 21 PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N++++ Y D +R+ L+ EF PRG L L ++ A L +
Sbjct: 72 RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 129
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
HE R VI+RD K N+L+ K++DFG +
Sbjct: 130 CHE---RKVIHRDIKPENLLMGY-------------------------KGELKIADFGWS 161
Query: 312 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
P + GT Y PE + + D++ GV+ E L G
Sbjct: 162 VHAP-SLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 63/321 (19%), Positives = 108/321 (33%), Gaps = 80/321 (24%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEW 182
+++ + P LG G +G V K +G +AVK + Q K
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRL 52
Query: 183 LAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIR 238
L +++ + + V G + + E M SL+ + + +P I
Sbjct: 53 LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
KIA+ K L LH + VI+RD K SN+L++
Sbjct: 112 GKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLIN------------------------- 144
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGV 354
K+ DFG++ G Y APE + + +SD++S G+
Sbjct: 145 ALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 201
Query: 355 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID-------PRL-EGHFSIK 406
++E+ R W P ++ + P+L FS
Sbjct: 202 TMIELAILR-----------FPYDSWGTP--------FQQLKQVVEEPSPQLPADKFS-- 240
Query: 407 GAQKAAQLAAHCLSRDPKARP 427
+ + CL ++ K RP
Sbjct: 241 --AEFVDFTSQCLKKNSKERP 259
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 61/265 (23%), Positives = 101/265 (38%), Gaps = 44/265 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + K T TVAVK L H+ ++E+ L + H
Sbjct: 30 LGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 195 LNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFL 252
LN+V L+G C + L+V EF G+L +L +R+ +P+ + + +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYG----------------------KFGFCIYYG 290
+ +R + S+ V ++ + F + G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 291 LFF--------------NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336
+ F N +L + K+ DFGLA+D + + APE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 337 YVMTGHLTSRSDVYSFGVVLLEMLT 361
+ T +SDV+SFGV+L E+ +
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 74/340 (21%), Positives = 123/340 (36%), Gaps = 101/340 (29%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL 189
F +G+G FG VFKG + T VA+K ++ + + E + E+ L
Sbjct: 24 FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAA 246
+ K G ++D + ++ E++ GS + L L IA
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREIL 129
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
KGL +LH E I+RD K +N+LL KL+
Sbjct: 130 KGLDYLHSEK---KIHRDIKAANVLLSE-------------------------HGEVKLA 161
Query: 307 DFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
DFG+A G T + +GT + APE + S++D++S G+ +E+ G
Sbjct: 162 DFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
Query: 364 ---------RSM---DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA 411
+ + KN P P LEG++S +
Sbjct: 217 PPHSELHPMKVLFLIPKNNP-------------------------PTLEGNYS----KPL 247
Query: 412 AQLAAHCLSRDPKARPLMSE------VVEALKPLPNLKDM 445
+ CL+++P RP E ++ K L ++
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 61/268 (22%), Positives = 93/268 (34%), Gaps = 72/268 (26%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKT 170
V F+ F +G+G FG V V K T A+K
Sbjct: 5 VFDENEDVNFDH-------FEILRAIGKGSFGKVCI----------VQKNDTKKMYAMKY 47
Query: 171 LNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL 226
+N E E+ + L H LV L Y +D++ + +V + + G L HL
Sbjct: 48 MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL 106
Query: 227 FR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280
+ +K + + L +L + +I+RD K NILLD
Sbjct: 107 QQNVHFKEE---TVKLFICELVMA----LDYLQN---QRIIHRDMKPDNILLDE------ 150
Query: 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 339
+ ++DF +A P + T + GT Y APE
Sbjct: 151 -------------------HGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSS 188
Query: 340 ---TGHLTSRSDVYSFGVVLLEMLTGRR 364
G+ + D +S GV E+L GRR
Sbjct: 189 RKGAGY-SFAVDWWSLGVTAYELLRGRR 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 70/274 (25%), Positives = 107/274 (39%), Gaps = 64/274 (23%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160
S ++ V K + F +LG+G FG VF +++
Sbjct: 3 GSIKEIAITHHVKEGHEKADPSQ-------FELLKVLGQGSFGKVFL--VKKISG----S 49
Query: 161 GTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFM 217
A+K L L+ E + L ++ H +VKL Y + + +L L+ +F+
Sbjct: 50 DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFL 108
Query: 218 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
G L L + +K +AL L LH +IYRD K NIL
Sbjct: 109 RGGDLFTRLSKEVMFTEE---DVKFYLAELALA----LDHLHS---LGIIYRDLKPENIL 158
Query: 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTY 330
LD + + KL+DFGL+K+ + +K GT
Sbjct: 159 LDE-------------------------EGHIKLTDFGLSKESIDHEKK---AYSFCGTV 190
Query: 331 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
Y APE V+ ++S D +SFGV++ EMLTG
Sbjct: 191 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 76/338 (22%), Positives = 120/338 (35%), Gaps = 72/338 (21%)
Query: 99 SNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 158
S+ S+ K L + + + NDL+ +G G G V+K +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLEN-------LGEMGSGTCGQVWKMRFRK------ 48
Query: 159 KPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEF 216
TG +AVK + G + +K L +++ + +V+ G I + + E
Sbjct: 49 ---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276
M E R P+P I K+ + K L +L E+ VI+RD K SNILLD
Sbjct: 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDE-- 160
Query: 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336
KL DFG++ R G Y APE
Sbjct: 161 -----------------------RGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPE 194
Query: 337 YVMTGHL-----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERR 389
+ R+DV+S G+ L+E+ TG+ + + E +++ P L
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG-- 252
Query: 390 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
FS CL++D + RP
Sbjct: 253 ----------HMGFS----GDFQSFVKDCLTKDHRKRP 276
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 77/300 (25%), Positives = 114/300 (38%), Gaps = 59/300 (19%)
Query: 72 ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNF 131
E + T D + + + ++ E E+ +A + T N+ F
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-------F 150
Query: 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNF 188
LLG+G FG V + TG A+K L + + E L E
Sbjct: 151 EYLKLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGA 245
L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEI 257
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
L +LH +E+ V+YRD K N++LD D + K+
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDK-------------------------DGHIKI 290
Query: 306 SDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
+DFGL K+G + T + GT Y APE V+ + R+ D + GVV+ EM+ GR
Sbjct: 291 TDFGLCKEGIKDGAT---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 78/378 (20%), Positives = 121/378 (32%), Gaps = 92/378 (24%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
+ + AA S+ E + + K +
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN------ 55
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----LAE 185
F +LG G +G VF + + TG A+K L + + E
Sbjct: 56 -FELLKVLGTGAYGKVFL--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 186 VNFLGDLVHLN-LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-- 240
L + LV L Y + + +L L+ +++ G L HL + ++
Sbjct: 109 RQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIY 164
Query: 241 ---IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
I L L LH+ +IYRD K NILLD+
Sbjct: 165 VGEIVLA----LEHLHK---LGIIYRDIKLENILLDS----------------------- 194
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGV 354
+ + L+DFGL+K+ + GT Y AP+ V +GH + D +S GV
Sbjct: 195 --NGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGV 250
Query: 355 VLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFYRLI---DPRLEGHFSIKGA 408
++ E+LTG + E R I +P S
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAE----------------ISRRILKSEPPYPQEMS---- 290
Query: 409 QKAAQLAAHCLSRDPKAR 426
A L L +DPK R
Sbjct: 291 ALAKDLIQRLLMKDPKKR 308
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 55/280 (19%), Positives = 97/280 (34%), Gaps = 64/280 (22%)
Query: 95 SNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 154
A + + + + RK D F+ +LGEG F V
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLA------ 49
Query: 155 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211
+ T A+K L + + E + + L H VKL + +DD++L
Sbjct: 50 ---RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKL 105
Query: 212 -LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRD 264
+ G L ++ + S + I L +LH + +I+RD
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLHG---KGIIHRD 155
Query: 265 FKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVST 324
K NILL+ D + +++DFG AK K +
Sbjct: 156 LKPENILLNE-------------------------DMHIQITDFGTAKVLSPESKQARAN 190
Query: 325 RVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 363
+GT Y +PE + SD+++ G ++ +++ G
Sbjct: 191 SFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 84/318 (26%), Positives = 116/318 (36%), Gaps = 87/318 (27%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 239
+ E L + H L L Y + RL V E+ G L HL R R R
Sbjct: 52 TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RA 107
Query: 240 K-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294
+ I L +LH R V+YRD K N++LD
Sbjct: 108 RFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDK-------------------- 140
Query: 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSF 352
D + K++DFGL K+G T + GT Y APE V+ + R+ D +
Sbjct: 141 -----DGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGL 191
Query: 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-RRRFYRLI---DPRLEGHFSIKGA 408
GVV+ EM+ G R P + R + LI + R S
Sbjct: 192 GVVMYEMMCG-------RL-----------PFYNQDHERLFELILMEEIRFPRTLS---- 229
Query: 409 QKAAQLAAHCLSRDPKAR 426
+A L A L +DPK R
Sbjct: 230 PEAKSLLAGLLKKDPKQR 247
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 70/326 (21%), Positives = 105/326 (32%), Gaps = 84/326 (25%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKE 181
+ + +G G +G V K + +G +AVK + + K+
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQ 66
Query: 182 WLAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWS 236
L +++ + +V+ G + + E M S + +P
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM 296
I KI L K L L E +I+RD K SNILLD
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDR---------------------- 161
Query: 297 LFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL----TSRSDVYSF 352
N KL DFG++ + + TR G Y APE + RSDV+S
Sbjct: 162 ---SGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSL 215
Query: 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID-------PRL----EG 401
G+ L E+ TGR K + + P+L E
Sbjct: 216 GITLYELATGRFPYPKWNS-------------------VFDQLTQVVKGDPPQLSNSEER 256
Query: 402 HFSIKGAQKAAQLAAHCLSRDPKARP 427
FS CL++D RP
Sbjct: 257 EFS----PSFINFVNLCLTKDESKRP 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 59/282 (20%), Positives = 97/282 (34%), Gaps = 63/282 (22%)
Query: 102 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
S+L ++ VA L+ +++L +F ++G G F V
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--------- 79
Query: 157 PV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 211
V TG A+K +N + E + E + L + + +L + +D+ L
Sbjct: 80 -VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLY 137
Query: 212 LVYEFMPRGSLENHLFR--RSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTS 268
LV E+ G L L + +P + R +A + A + +H ++RD K
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHR---LGYVHRDIKPD 191
Query: 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMG 328
NILLD G +L+DFG V G
Sbjct: 192 NILLDR--------CGHI-----------------RLADFGSCLKLRADGTVRSLVAV-G 225
Query: 329 TYGYAAPEYVMTGHLTSRSDVY-------SFGVVLLEMLTGR 363
T Y +PE + + Y + GV EM G+
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 69/308 (22%), Positives = 113/308 (36%), Gaps = 72/308 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ + + N+V + + D+ +V E++ GSL + + + I + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVCRECLQ 127
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
L FLH VI+RD K+ NILL D + KL+D
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGM-------------------------DGSVKLTD 159
Query: 308 FGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
FG A+ PE K T V GT + APE V + D++S G++ +EM+ G
Sbjct: 160 FGFCAQITPEQSKRS--TMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG---- 212
Query: 367 DKNRPNGEHNLVEWARPHLGER--RRFYRLID---PRLEG--HFSIKGAQKAAQLAAHCL 419
P P+L E R Y + P L+ S CL
Sbjct: 213 ---EP-----------PYLNENPLRALYLIATNGTPELQNPEKLS----AIFRDFLNRCL 254
Query: 420 SRDPKARP 427
D + R
Sbjct: 255 EMDVEKRG 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 52/331 (15%), Positives = 103/331 (31%), Gaps = 71/331 (21%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
+ R + + L G F W+E + + + ++ +
Sbjct: 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106
Query: 183 LA--EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------ 234
++ + N V + + + + +L++ + RR
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294
I ++IA + FLH + +++RD K SNI
Sbjct: 167 LHIFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFT--------------------- 198
Query: 295 NMLFQDYNAKLSDFGLAKD----------GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 344
D K+ DFGL T +GT Y +PE + + +
Sbjct: 199 ----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254
Query: 345 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI-DPRLEGHF 403
+ D++S G++L E+L + ER R + + + F
Sbjct: 255 HKVDIFSLGLILFELLYSFSTQM-------------------ERVRIITDVRNLKFPLLF 295
Query: 404 SIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
+ K + + LS P RP ++++E
Sbjct: 296 TQK-YPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 66/270 (24%), Positives = 101/270 (37%), Gaps = 66/270 (24%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E V K F +LG+GG+G VF+ + + TG
Sbjct: 2 SSETSVNRGPEKIRPEC-------FELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIF 48
Query: 167 AVKTLNHDGLQGHK---EW-LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
A+K L + + AE N L ++ H +V LI Y + +L L+ E++ G
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGE 107
Query: 222 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275
L L R I++ L LH++ +IYRD K NI+L+
Sbjct: 108 LFMQLEREGIFMED---TACFYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNH- 156
Query: 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAA 334
+ KL+DFGL K+ T GT Y A
Sbjct: 157 ------------------------QGHVKLTDFGLCKESIHDGTV---THTFCGTIEYMA 189
Query: 335 PEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
PE ++ +R+ D +S G ++ +MLTG
Sbjct: 190 PE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 74/347 (21%), Positives = 126/347 (36%), Gaps = 79/347 (22%)
Query: 96 NAESNSSTSKLEEELKVASRLRKFTFND-LKLATRNFRPESL------LGEGGFGCVFKG 148
+ S+ E + + F L++ P L +GEG G V
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 149 WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208
+ +G VAVK ++ Q + EV + D H N+V++ + +
Sbjct: 65 ---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
+ ++ EF+ G+L + + + L + + LA+LH + VI+RD K+
Sbjct: 116 ELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170
Query: 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL-AKDGPEGDKTHVSTRVM 327
+ILL D KLSDFG A+ + K + V
Sbjct: 171 SILLTL-------------------------DGRVKLSDFGFCAQISKDVPKRK--SLV- 202
Query: 328 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 387
GT + APE + + D++S G++++EM+ G P P+ +
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP-----------PYFSD 244
Query: 388 R--RRFYRLID---PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 427
+ RL D P+L+ S L RDP+ R
Sbjct: 245 SPVQAMKRLRDSPPPKLKNSHKVS----PVLRDFLERMLVRDPQERA 287
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 66/311 (21%), Positives = 110/311 (35%), Gaps = 81/311 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G +G V T + A+K + + + + L EV L L H
Sbjct: 45 LGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 248
N++KL + ED + LV E G L + + R ++ +K L
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSG--- 148
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+ +LH+ +++RD K N+LL++ +D K+ DF
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKE----------------------KDALIKIVDF 183
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
GL+ K +GT Y APE V+ + DV+S GV+L +L G
Sbjct: 184 GLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY----- 234
Query: 369 NRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSR 421
P G+ + + R + +G ++ + A L L
Sbjct: 235 -PPFGGQTD------------QEILRKV---EKGKYTFDSPEWKNVSEGAKDLIKQMLQF 278
Query: 422 DPKARPLMSEV 432
D + R +
Sbjct: 279 DSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 82/312 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
LG+G FG V TG AVK ++ ++ + L EV L L
Sbjct: 34 LGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAK 247
H N++KL + ED LV E G L + + R +S ++ L
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSG-- 138
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
+ ++H+ +++RD K N+LL++ +D N ++ D
Sbjct: 139 -ITYMHK---NKIVHRDLKPENLLLESKS----------------------KDANIRIID 172
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367
FGL+ K +GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 173 FGLSTHFEASKKMK---DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC---- 224
Query: 368 KNRPNGEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLS 420
P G + + +G ++ + + A L L+
Sbjct: 225 --------------PPFNGANEYDILKKV---EKGKYTFELPQWKKVSESAKDLIRKMLT 267
Query: 421 RDPKARPLMSEV 432
P R +
Sbjct: 268 YVPSMRISARDA 279
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 66/322 (20%), Positives = 109/322 (33%), Gaps = 92/322 (28%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------------HDGLQGHKEWLA 184
LG G +G V + A+K + + ++ E +
Sbjct: 44 LGSGAYGEVLLC---------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 185 -EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 238
E++ L L H N++KL ED + LV EF G L + R +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAAN 150
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
MK L + +LH + +++RD K NILL+
Sbjct: 151 IMKQILSG---ICYLH---KHNIVHRDIKPENILLENKN--------------------- 183
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357
N K+ DFGL+ + K +GT Y APE V+ + DV+S GV++
Sbjct: 184 -SLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMY 238
Query: 358 EMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QK 410
+L G P G+++ + + + +G + +
Sbjct: 239 ILLCGY------PPFGGQND------------QDIIKKV---EKGKYYFDFNDWKNISDE 277
Query: 411 AAQLAAHCLSRDPKARPLMSEV 432
A +L L+ D R E
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEA 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 63/314 (20%), Positives = 110/314 (35%), Gaps = 83/314 (26%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
+ LG+G FG V+K TG A K + + ++++ E+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
H +VKL+G D + ++ EF P G+++ + L + + L
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
FLH + +I+RD K N+L+ + + +L+DFG+
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTL-------------------------EGDIRLADFGV 163
Query: 311 AKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLT-----SRSDVYSFGVVLLEMLTG 362
+ + +GT + APE VM + ++D++S G+ L+EM
Sbjct: 164 S-----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGE---RRRFYRLID----PRLE--GHFSIKGAQKAAQ 413
P PH R I P L +S +
Sbjct: 219 -------EP-----------PHHELNPMRVLL--KIAKSDPPTLLTPSKWS----VEFRD 254
Query: 414 LAAHCLSRDPKARP 427
L ++P+ RP
Sbjct: 255 FLKIALDKNPETRP 268
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 68/309 (22%), Positives = 113/309 (36%), Gaps = 74/309 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
F LGEG +G V+K +E TG VA+K + + +E + E++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ ++VK G ++ +V E+ GS+ + + R+ L I K
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
GL +LH I+RD K NILL+ + +AKL+D
Sbjct: 137 GLEYLHFMR---KIHRDIKAGNILLNT-------------------------EGHAKLAD 168
Query: 308 FGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
FG+ + K + V+GT + APE + +D++S G+ +EM G
Sbjct: 169 FGVAGQLTDTMAKRNT---VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG---- 221
Query: 367 DKNRPNGEHNLVEWARPHLGER--RRFYRLID----PRLEG--HFSIKGAQKAAQLAAHC 418
+P P+ R + +I P +S C
Sbjct: 222 ---KP-----------PYADIHPMRAIF-MIPTNPPPTFRKPELWS----DNFTDFVKQC 262
Query: 419 LSRDPKARP 427
L + P+ R
Sbjct: 263 LVKSPEQRA 271
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 84/368 (22%), Positives = 131/368 (35%), Gaps = 85/368 (23%)
Query: 79 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLG 138
+ TT N + EE K A R+ L ++F ++G
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 139 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-H 194
G + V T A++ + + + ++ E + H
Sbjct: 62 RGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAK 247
LV L C + + RL V E++ G L H+ R R LP + I+L
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA--- 165
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
L +LHE R +IYRD K N+LLD+ G KL+D
Sbjct: 166 -LNYLHE---RGIIYRDLKLDNVLLDS--------EGHI-----------------KLTD 196
Query: 308 FGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR-- 363
+G+ K+G T T GT Y APE ++ G S D ++ GV++ EM+ GR
Sbjct: 197 YGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
Query: 364 --RSMDKNRPNGEHNLVEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHC 418
+ P+ +++I R+ S KAA +
Sbjct: 253 FDIVGSSDNPDQN------------TEDYLFQVILEKQIRIPRSLS----VKAASVLKSF 296
Query: 419 LSRDPKAR 426
L++DPK R
Sbjct: 297 LNKDPKER 304
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 64/281 (22%), Positives = 95/281 (33%), Gaps = 61/281 (21%)
Query: 101 SSTSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
+ S L E + L ++L +F ++G G FG V
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV-------- 92
Query: 156 APV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211
V A+K LN + E + E + L + + L Y +DD L
Sbjct: 93 --VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNL 149
Query: 212 -LVYEFMPRGSLENHL--FRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKT 267
LV ++ G L L F LP + R +A + A + +H+ ++RD K
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQ---LHYVHRDIKP 203
Query: 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM 327
NIL+D G +L+DFG E S V
Sbjct: 204 DNILMDM--------NGHI-----------------RLADFGSCLKLMEDGTVQSSVAV- 237
Query: 328 GTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGR 363
GT Y +PE + D +S GV + EML G
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 67/277 (24%), Positives = 106/277 (38%), Gaps = 58/277 (20%)
Query: 102 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
L + + + L ++ DL++ ++ ++G G FG V
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--------- 87
Query: 157 PVKP-GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 211
V+ T A+K L+ + + + E + + +V+L Y +DD+ L
Sbjct: 88 -VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLY 145
Query: 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTSNI 270
+V E+MP G L N + +P W+ R A + A L +H I+RD K N+
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNM 199
Query: 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 330
LLD K G KL+DFG + T V GT
Sbjct: 200 LLD--------KSGHL-----------------KLADFGTCMKMNKEGMVRCDTAV-GTP 233
Query: 331 GYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTGR 363
Y +PE + + G+ D +S GV L EML G
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 58/236 (24%), Positives = 90/236 (38%), Gaps = 55/236 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G VFK + TG VA+K L E+ L
Sbjct: 11 IGEGSYGVVFKCRNRD---------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H NLV L+ + LV+E+ ++ + L R +P + I + + F
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
H + I+RD K NIL+ ++++ KL DFG A
Sbjct: 118 CH---KHNCIHRDVKPENILITK-------------------HSVI------KLCDFGFA 149
Query: 312 KD--GPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
+ GP V+TR Y +PE ++ DV++ G V E+L+G
Sbjct: 150 RLLTGPSDYYDDEVATR-----WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 82/376 (21%), Positives = 129/376 (34%), Gaps = 97/376 (25%)
Query: 97 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESL------LGEGGFGCVFKGWI 150
N + + R D+ PE L +G G FG V+
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-- 73
Query: 151 EENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIED 207
VA+K +++ G Q +++W + EV FL L H N ++ G + +
Sbjct: 74 -------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126
Query: 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267
LV E+ GS + L PL + GA +GLA+LH +I+RD K
Sbjct: 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKA 182
Query: 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTR-- 325
NILL + KL DFG A + ++
Sbjct: 183 GNILLS-------------------------EPGLVKLGDFGSA--------SIMAPANS 209
Query: 326 VMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 382
+GT + APE ++ G + DV+S G+ +E+ +P
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-------KP----------- 251
Query: 383 PHLGE---RRRFYRLID----PRLE-GHFSIKGAQKAAQLAAHCLSRDPKARP-----LM 429
P + I P L+ GH+S + CL + P+ RP L
Sbjct: 252 PLFNMNAMSALY--HIAQNESPALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 305
Query: 430 SEVVEALKPLPNLKDM 445
V +P + D+
Sbjct: 306 HRFVLRERPPTVIMDL 321
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 68/313 (21%), Positives = 109/313 (34%), Gaps = 85/313 (27%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 248
N++KL ED +V E G L + + +R +S +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSG--- 133
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA--KLS 306
+ ++H+ +++RD K NILL++ ++ + K+
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLES------------------------KEKDCDIKII 166
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
DFGL+ + K +GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 167 DFGLSTCFQQNTKMK---DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT--- 219
Query: 367 DKNRPNGEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCL 419
P G+ + + G ++ A L L
Sbjct: 220 ---------------PPFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 420 SRDPKARPLMSEV 432
+ P R ++
Sbjct: 262 TFHPSLRITATQC 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 67/320 (20%), Positives = 113/320 (35%), Gaps = 77/320 (24%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
++ + ++G G V VA+K +N + Q + L E+
Sbjct: 16 DYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IAL 243
+ H N+V + D+ LV + + GS+ + + + IA
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 244 ---GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+GL +LH+ I+RD K NILL +D
Sbjct: 126 ILREVLEGLEYLHKNG---QIHRDVKAGNILLG-------------------------ED 157
Query: 301 YNAKLSDFGL-AKDGPEGDKTHVSTR--VMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVL 356
+ +++DFG+ A GD T R +GT + APE + ++D++SFG+
Sbjct: 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217
Query: 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI----DPRLEGHFSIKGAQKA- 411
+E+ TG K P + L P LE K K
Sbjct: 218 IELATGAAPYHKYPPM-----------------KVLMLTLQNDPPSLETGVQDKEMLKKY 260
Query: 412 ----AQLAAHCLSRDPKARP 427
++ + CL +DP+ RP
Sbjct: 261 GKSFRKMISLCLQKDPEKRP 280
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 67/274 (24%), Positives = 100/274 (36%), Gaps = 69/274 (25%)
Query: 103 TSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 162
T+ + + D F +LG+G FG V + GT
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVMLS---------ERKGT 44
Query: 163 GLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFM 217
AVK L D + + + E L L +L C + RL V E++
Sbjct: 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYV 103
Query: 218 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
G L H+ + P IA+G L FL + +IYRD K N++
Sbjct: 104 NGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVM 153
Query: 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTY 330
LD+ G K++DFG+ K+ T T+ GT
Sbjct: 154 LDSE--------GHI-----------------KIADFGMCKENIWDGVT---TKTFCGTP 185
Query: 331 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
Y APE ++ +S D ++FGV+L EML G+
Sbjct: 186 DYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 74/287 (25%), Positives = 102/287 (35%), Gaps = 69/287 (24%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
NA + ++ S +D F ++G+G FG V
Sbjct: 6 QEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKVLLA- 57
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCI 205
+ AVK L + KE ++E N L V H LV L +
Sbjct: 58 --------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSF 108
Query: 206 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAER 258
+ +L V +++ G L HL R R P R + IA L +LH
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----LGYLHS---L 158
Query: 259 PVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD 318
++YRD K NILLD+ G L+DFGL K+ E +
Sbjct: 159 NIVYRDLKPENILLDS--------QGHI-----------------VLTDFGLCKENIEHN 193
Query: 319 KTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
T T GT Y APE V+ R+ D + G VL EML G
Sbjct: 194 ST---TSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 72/270 (26%), Positives = 98/270 (36%), Gaps = 69/270 (25%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E + S K D F +LG+G FG VF T
Sbjct: 2 ELNKERPSLQIKLKIED-------FILHKMLGKGSFGKVFLA---------EFKKTNQFF 45
Query: 167 AVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
A+K L D + + + E L H L + + + L V E++ G
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGD 104
Query: 222 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275
L H+ L R I LG L FLH + ++YRD K NILLD
Sbjct: 105 LMYHIQSCHKFDLS---RATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDK- 153
Query: 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAA 334
G K++DFG+ K+ GD T GT Y A
Sbjct: 154 -------DGHI-----------------KIADFGMCKENMLGDAK---TNTFCGTPDYIA 186
Query: 335 PEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
PE ++ G + S D +SFGV+L EML G+
Sbjct: 187 PE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 2e-17
Identities = 72/306 (23%), Positives = 110/306 (35%), Gaps = 55/306 (17%)
Query: 68 STHYESKSTNDTSRDQPAAAVI-SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKL 126
+ E + N + + A+ T EE+ N ++
Sbjct: 279 LSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRM 338
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 183
+F +LG+G FG V + GT AVK L D + + +
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTM 389
Query: 184 AEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 240
E L L +L C + RL V E++ G L H+ + P
Sbjct: 390 VEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAV 445
Query: 241 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
A A GL FL + +IYRD K N++LD+ G
Sbjct: 446 FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSE--------GHI------------- 481
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLL 357
K++DFG+ K+ T T+ GT Y APE ++ +S D ++FGV+L
Sbjct: 482 ----KIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLY 533
Query: 358 EMLTGR 363
EML G+
Sbjct: 534 EMLAGQ 539
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 78/320 (24%), Positives = 122/320 (38%), Gaps = 81/320 (25%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
L ++F ++G G + V T A+K + + + ++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDW 55
Query: 183 -LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 238
E + H LV L C + + RL V E++ G L H+ R R LP + R
Sbjct: 56 VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-R 113
Query: 239 M---KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
+I+L L +LHE R +IYRD K N+LLD+ G
Sbjct: 114 FYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDS--------EGHI--------- 149
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFG 353
KL+D+G+ K+G T T GT Y APE ++ G S D ++ G
Sbjct: 150 --------KLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALG 197
Query: 354 VVLLEMLTGR----RSMDKNRPNGEHNLVEWARPHLGERRRFYRLI---DPRLEGHFSIK 406
V++ EM+ GR + P+ +++I R+ S
Sbjct: 198 VLMFEMMAGRSPFDIVGSSDNPDQN------------TEDYLFQVILEKQIRIPRSLS-- 243
Query: 407 GAQKAAQLAAHCLSRDPKAR 426
KAA + L++DPK R
Sbjct: 244 --VKAASVLKSFLNKDPKER 261
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 62/280 (22%), Positives = 97/280 (34%), Gaps = 81/280 (28%)
Query: 114 SRLRKFTFNDLKLATRNFRPESL---------LGEGGFGCVFKGWIEENGTAPVKPGTGL 164
SR + F F DL + ++ P++L LG G G V + T
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCK 161
Query: 165 TVAVKTLNHDGLQGHKEWLA--------EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
VA++ ++ A E+ L L H ++K+ + + + +V E
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFK 266
M G E LF + + L + +LHE +I+RD K
Sbjct: 221 MEGG--E--LFDK-------VVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 266
Query: 267 TSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRV 326
N+LL + +D K++DFG +K E T
Sbjct: 267 PENVLLSSQE----------------------EDCLIKITDFGHSKILGETSLM--RTLC 302
Query: 327 MGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTG 362
GT Y APE V+ D +S GV+L L+G
Sbjct: 303 -GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 73/325 (22%), Positives = 113/325 (34%), Gaps = 71/325 (21%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 193
E +LGEG V + T AVK + EV L
Sbjct: 18 EDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 194 -HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAA 246
H N+++LI + E++ R LV+E M GS+ +H+ +R ++ ++ A
Sbjct: 69 GHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASA- 123
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
L FLH + + +RD K NIL + Q K+
Sbjct: 124 --LDFLH---NKGIAHRDLKPENILCEHPN----------------------QVSPVKIC 156
Query: 307 DFGLAKD-GPEGDKTHVSTRVM----GTYGYAAPEYVMTGHLTSRS-----DVYSFGVVL 356
DF L GD + +ST + G+ Y APE V + D++S GV+L
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
Query: 357 LEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------Q 409
+L+G P G L + EG +
Sbjct: 217 YILLSGY------PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC 270
Query: 410 KAAQLAAHCLSRDPKARPLMSEVVE 434
A L + L RD K R ++V++
Sbjct: 271 AAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 58/243 (23%), Positives = 92/243 (37%), Gaps = 55/243 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LA 184
+ L+GEG +G V K ++ TG VA+K + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFL---ESDDDKMVKKIAMR 73
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E+ L L H NLV L+ C + + LV+EF+ ++ + L L + + K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
G+ F H +I+RD K NIL+ + ++ K
Sbjct: 133 IINGIGFCH---SHNIIHRDIKPENILVSQ-------------------SGVV------K 164
Query: 305 LSDFGLAKD--GPEGDKTH-VSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 360
L DFG A+ P V+TR Y APE ++ DV++ G ++ EM
Sbjct: 165 LCDFGFARTLAAPGEVYDDEVATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
Query: 361 TGR 363
G
Sbjct: 220 MGE 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 56/335 (16%), Positives = 91/335 (27%), Gaps = 89/335 (26%)
Query: 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHL 195
G V TG V V+ +N + E++ H
Sbjct: 36 GFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFL 252
N+V I D++ +V FM GS + L + + IA G K L ++
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIAYILQGVLKALDYI 144
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG-LA 311
H ++R K S+IL+ D LS
Sbjct: 145 HHMG---YVHRSVKASHILISV-------------------------DGKVYLSGLRSNL 176
Query: 312 KDGPEGDKTHV----STRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGR- 363
G + V + + +PE V+ +L ++SD+YS G+ E+ G
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 364 -------------------------------RSMDKNRPNGEHNLVEWARPHLGERRRFY 392
+ ++ + + R
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295
Query: 393 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
FS CL R+P ARP
Sbjct: 296 DSPSHPYHRTFS----PHFHHFVEQCLQRNPDARP 326
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 65/285 (22%), Positives = 107/285 (37%), Gaps = 62/285 (21%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
++ S + + K + T + F LG G FG V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59
Query: 150 IEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCI 205
VK +G A+K L+ + K+ L E L + LVKL +
Sbjct: 60 --------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSF 110
Query: 206 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---KIALGAAKGLAFLHEEAERPV 260
+D+ L +V E++ G + +HL R P + R +I L +LH +
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT----FEYLHS---LDL 162
Query: 261 IYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT 320
IYRD K N+L+D G+ +++DFG AK T
Sbjct: 163 IYRDLKPENLLIDQ--------QGYI-----------------QVTDFGFAKRVKGRTWT 197
Query: 321 HVSTRVMGTYGYAAPEYVMT-GHLTSRS-DVYSFGVVLLEMLTGR 363
+ GT APE +++ G+ +++ D ++ GV++ EM G
Sbjct: 198 -----LCGTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGY 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 75/424 (17%), Positives = 137/424 (32%), Gaps = 97/424 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K ++ A+K + G+ E+ L +L H N
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 197 LVKLIGYCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPWSIRMKIALGAAK 247
++ L + D+++ L++++ ++ H ++ + LP + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
G+ +LH V++RD K +NIL+ G+ K++D
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMG-EGPERGRV--------------------KIAD 175
Query: 308 FGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
G A+ + P + V+ T+ Y APE ++ G H T D+++ G + E+LT
Sbjct: 176 MGFARLFNSPLKPLADLDPVVV-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233
Query: 364 -----RSMDKNRPNGEH--------------NLVEW-----------ARPHLGERRRFYR 393
R D N H +W
Sbjct: 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 293
Query: 394 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK-------PLPNLKDMA 446
+ +E H + KA L L+ DP R +A++ PLP A
Sbjct: 294 SLIKYMEKHKVKPDS-KAFHLLQKLLTMDPIKRITSE---QAMQDPYFLEDPLPTSDVFA 349
Query: 447 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPK 506
+ + P+ + + Q N P + H
Sbjct: 350 GCQIPYP-KREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPG-------NQDSSHTQGP 401
Query: 507 PNGK 510
P K
Sbjct: 402 PLKK 405
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 72/275 (26%), Positives = 100/275 (36%), Gaps = 69/275 (25%)
Query: 102 STSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 161
S E + + ++ F +LG+G FG V
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVMLA---------RVKE 46
Query: 162 TGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEF 216
TG AVK L D + + + E L H L +L C + RL V EF
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEF 105
Query: 217 MPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNI 270
+ G L H+ + R R + I L FLH+ + +IYRD K N+
Sbjct: 106 VNGGDLMFHIQKSRRFDEA---RARFYAAEIISA----LMFLHD---KGIIYRDLKLDNV 155
Query: 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 329
LLD G C KL+DFG+ K+G T T GT
Sbjct: 156 LLDHE--------GHC-----------------KLADFGMCKEGICNGVT---TATFCGT 187
Query: 330 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
Y APE ++ L + D ++ GV+L EML G
Sbjct: 188 PDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 65/323 (20%), Positives = 112/323 (34%), Gaps = 62/323 (19%)
Query: 55 SSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVAS 114
SS + + + S + S A V S+ + S + + +
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 115 RLRKFTFNDLKLATRNFR------PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
F + +LG G FG V K + TGL +A
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAA 119
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL----- 222
K + G++ +E E++ + L H NL++L E + LV E++ G L
Sbjct: 120 KIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRII 178
Query: 223 -ENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279
E++ ++ MK G+ +H+ +++ D K NIL
Sbjct: 179 DESYNLTELDTILF-----MKQICE---GIRHMHQ---MYILHLDLKPENILCVNR---- 223
Query: 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 339
K+ DFGLA+ +K V GT + APE V
Sbjct: 224 -------------------DAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVN 261
Query: 340 TGHLTSRSDVYSFGVVLLEMLTG 362
++ +D++S GV+ +L+G
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 63/252 (25%), Positives = 106/252 (42%), Gaps = 66/252 (26%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW- 182
K + ++F+ LG G FG V ++ G A+K L + + K+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVE 51
Query: 183 --LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 238
E L + H ++++ +D Q++ ++ +++ G L + L + + P P
Sbjct: 52 HTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---V 107
Query: 239 MK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293
K + L L +LH + +IYRD K NILLD
Sbjct: 108 AKFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDK------------------- 141
Query: 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRS-DVYS 351
+ + K++DFG AK P+ T + GT Y APE V T + ++S D +S
Sbjct: 142 ------NGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTKPY--NKSIDWWS 188
Query: 352 FGVVLLEMLTGR 363
FG+++ EML G
Sbjct: 189 FGILIYEMLAGY 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 51/236 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LGEG +G V+K T TVA+K + L+ +E + EV+ L +
Sbjct: 42 LGEGTYGEVYKAIDTV---------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKE 89
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+++L + + L++E+ L+ ++ ++ + + G+ F
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNF 147
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
H R ++RD K N+LL A K+ DFGLA
Sbjct: 148 CHS---RRCLHRDLKPQNLLLSVSDASETP--------------------VLKIGDFGLA 184
Query: 312 KD--GPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
+ P TH ++ T Y PE ++ G H ++ D++S + EML
Sbjct: 185 RAFGIPIRQFTH---EII-TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 70/296 (23%), Positives = 115/296 (38%), Gaps = 60/296 (20%)
Query: 81 RDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEG 140
R A +A + S+ ++ KV + + + ++ ++G G
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65
Query: 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 200
FG V++ + + +G VA+K + LQ + E+ + L H N+V+L
Sbjct: 66 SFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 201 IGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
Y +D+ L LV +++P + H R LP + LA+
Sbjct: 113 R-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
+H + +RD K N+LLD +L KL DFG A
Sbjct: 172 IH---SFGICHRDIKPQNLLLDPD------------------TAVL------KLCDFGSA 204
Query: 312 KDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
K G+ + +R Y Y APE ++ G TS DV+S G VL E+L G+
Sbjct: 205 KQLVRGEPNVSYICSR----Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 81/348 (23%), Positives = 120/348 (34%), Gaps = 101/348 (29%)
Query: 113 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 172
A L + + L+ F L+G G +G V+KG + TG A+K ++
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMD 58
Query: 173 HDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGSLE-- 223
G +E E+N L H N+ G DDQ LV EF GS+
Sbjct: 59 VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 224 -NHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279
+ +L W IA +GL+ LH+ VI+RD K N+LL
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT------ 163
Query: 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPE 336
++ KL DFG++ R +GT + APE
Sbjct: 164 -------------------ENAEVKLVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPE 199
Query: 337 YVMTGHLT-----SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE---R 388
+ +SD++S G+ +EM G P P R
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEG-------AP-----------PLCDMHPMR 241
Query: 389 RRFYRLID----PRLEG-HFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431
F LI PRL+ +S +K CL ++ RP +
Sbjct: 242 ALF--LIPRNPAPRLKSKKWS----KKFQSFIESCLVKNHSQRPATEQ 283
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 63/249 (25%), Positives = 100/249 (40%), Gaps = 54/249 (21%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
F+ E + G+G FG V G + TG++VA+K + D ++E L +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRFRNRE-LQIMQ 71
Query: 188 FLGDLVHLNLVKLI------GYCIEDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIR 238
L L H N+V+L G D L +V E++P + +RR + P +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ + LH + V +RD K N+L++ + L
Sbjct: 132 KVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEA------------------DGTL- 171
Query: 299 QDYNAKLSDFGLAKD-GPEGDKTH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGV 354
KL DFG AK P + +R Y Y APE ++ G H T+ D++S G
Sbjct: 172 -----KLCDFGSAKKLSPSEPNVAYICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGC 220
Query: 355 VLLEMLTGR 363
+ EM+ G
Sbjct: 221 IFAEMMLGE 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 74/321 (23%), Positives = 118/321 (36%), Gaps = 88/321 (27%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----E 185
N+R +G+G F V TG VA+K ++ L L E
Sbjct: 16 NYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFRE 64
Query: 186 VNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
V + L H N+VKL + IE ++ L L+ E+ G + ++L RMK
Sbjct: 65 VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEKE 115
Query: 244 GAAK------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+K + + H+ + +++RD K N+LLDA
Sbjct: 116 ARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDA----------------------- 149
Query: 298 FQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVV 355
D N K++DFG + + G K G YAAPE + G DV+S GV+
Sbjct: 150 --DMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE-LFQGKKYDGPEVDVWSLGVI 203
Query: 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQ 413
L +++G D NL E + L G + I +
Sbjct: 204 LYTLVSGSLPFD------GQNLKE-----------LRERV---LRGKYRIPFYMSTDCEN 243
Query: 414 LAAHCLSRDPKARPLMSEVVE 434
L L +P R + ++++
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMK 264
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 72/314 (22%), Positives = 109/314 (34%), Gaps = 85/314 (27%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
LG G FG V + +GL +KT+N D Q E + E+ L L H
Sbjct: 30 LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----------MKIALG 244
N++K+ ED + +V E G E L R + + MK +
Sbjct: 81 NIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
A LA+ H + V+++D K NIL K
Sbjct: 136 A---LAYFHS---QHVVHKDLKPENILFQDTS----------------------PHSPIK 167
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
+ DFGLA+ + + GT Y APE V +T + D++S GVV+ +LTG
Sbjct: 168 IIDFGLAELFKSDEH--STNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC- 222
Query: 365 SMDKNRPNGEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA-----QKAAQLAAHC 418
P G + + +A L
Sbjct: 223 -----------------LPFTGTSLEEVQQKA---TYKEPNYAVECRPLTPQAVDLLKQM 262
Query: 419 LSRDPKARPLMSEV 432
L++DP+ RP ++V
Sbjct: 263 LTKDPERRPSAAQV 276
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 60/310 (19%), Positives = 99/310 (31%), Gaps = 51/310 (16%)
Query: 62 SSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSN-AESNSSTSKLEEELKVASRLRKFT 120
+ G S E + D+ T + V +++
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 121 FNDLKLATRNFRP----ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
+++ + LG G FG V + + TG A K +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHE 195
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
+ E+ + L H LV L +D++ +++YEFM G E LF +
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNK 251
Query: 237 IRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292
+ A+ + GL +H E ++ D K NI+ R
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKR---------------- 292
Query: 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352
KL DFGL V GT +AAPE + +D++S
Sbjct: 293 -------SNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 353 GVVLLEMLTG 362
GV+ +L+G
Sbjct: 343 GVLSYILLSG 352
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 70/317 (22%), Positives = 104/317 (32%), Gaps = 95/317 (29%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V V+ GT + A K + ++ + E+ + L H N
Sbjct: 17 IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKIA 242
+++L ED+ + LV E G E LF R + MK
Sbjct: 68 IIRLYET-FEDNTDIYLVMELCTGG--E--LFER-------VVHKRVFRESDAARIMKDV 115
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
L A +A+ H+ V +RD K N L D
Sbjct: 116 LSA---VAYCHK---LNVAHRDLKPENFLFLTDS----------------------PDSP 147
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
KL DFGLA G + T+V GT Y +P+ V+ G D +S GV++ +L G
Sbjct: 148 LKLIDFGLAARFKPGKM--MRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLA 415
P I EG F+ +A L
Sbjct: 204 Y------------------PPFSAPTDSEVMLKI---REGTFTFPEKDWLNVSPQAESLI 242
Query: 416 AHCLSRDPKARPLMSEV 432
L++ PK R +
Sbjct: 243 RRLLTKSPKQRITSLQA 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 56/236 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K + G T A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
H +R V++RD K N+L++ G K++DFGLA
Sbjct: 116 CH---DRRVLHRDLKPQNLLIN-----REG--------------------ELKIADFGLA 147
Query: 312 KD--GPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
+ P TH ++ T Y AP+ V+ G ++ D++S G + EM+ G
Sbjct: 148 RAFGIPVRKYTH---EIV-TLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 69/317 (21%), Positives = 108/317 (34%), Gaps = 81/317 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+G+G F V + + TG AVK ++ E +
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SIRMKIALG 244
L H ++V+L+ D L +V+EFM L + +R+ S M+ L
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
A L + H + +I+RD K +LL A + K
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLL-ASKEN---------------------SAPVK 173
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
L FG+A E RV GT + APE V+ + DV+ GV+L +L+G
Sbjct: 174 LGGFGVAIQLGESGLV-AGGRV-GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC 230
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQ------KAAQLAAH 417
P G + R + I ++G + + Q A L
Sbjct: 231 ------------------LPFYGTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRR 269
Query: 418 CLSRDPKARPLMSEVVE 434
L DP R + E +
Sbjct: 270 MLMLDPAERITVYEALN 286
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 56/243 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 184
+ LGEG + V+KG + T VA+K + + H+E +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
+GLA+ H + V++RD K N+L++ G K
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLIN-----ERG--------------------ELK 140
Query: 305 LSDFGLA--KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEML 360
L+DFGLA K P + V+ T Y P+ ++ G +++ D++ G + EM
Sbjct: 141 LADFGLARAKSIPTKTYDN---EVV-TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMA 195
Query: 361 TGR 363
TGR
Sbjct: 196 TGR 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 61/237 (25%), Positives = 93/237 (39%), Gaps = 55/237 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G VFK E T VA+K + L E L E+ L +
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+V+L D + LV+EF + L+ + + L I KGL F
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
H R V++RD K N+L++ G KL++FGLA
Sbjct: 117 CH---SRNVLHRDLKPQNLLIN-----RNG--------------------ELKLANFGLA 148
Query: 312 KD--GPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRR 364
+ P + V+ T Y P+ V+ G ++ D++S G + E+ R
Sbjct: 149 RAFGIPVRCYSA---EVV-TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 63/236 (26%), Positives = 99/236 (41%), Gaps = 56/236 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K K G VA+K + L E + E++ L +
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+V LI + LV+EFM + L+ L L S +G+A
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
H + +++RD K N+L++ + G KL+DFGLA
Sbjct: 135 CH---QHRILHRDLKPQNLLIN-----SDG--------------------ALKLADFGLA 166
Query: 312 KD--GPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
+ P TH V+ T Y AP+ V+ G ++ D++S G + EM+TG+
Sbjct: 167 RAFGIPVRSYTH---EVV-TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 64/287 (22%), Positives = 112/287 (39%), Gaps = 62/287 (21%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S T ++ + + L++ KV L + + ++G G FG VF+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAK 60
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI---- 205
+ E+ VA+K + LQ + E+ + + H N+V L
Sbjct: 61 LVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLK-AFFYSNG 105
Query: 206 --EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 260
+D+ L LV E++P H + +P + + LA++H +
Sbjct: 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGI 162
Query: 261 IYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK- 319
+RD K N+LLD + +L KL DFG AK G+
Sbjct: 163 CHRDIKPQNLLLDPP------------------SGVL------KLIDFGSAKILIAGEPN 198
Query: 320 TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
+ +R Y Y APE ++ G + T+ D++S G V+ E++ G+
Sbjct: 199 VSYICSR----Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 56/248 (22%), Positives = 85/248 (34%), Gaps = 72/248 (29%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 188
LG G G V + T VA+K ++ A E+
Sbjct: 18 LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---A 245
L L H ++K+ + + + +V E M G E LF + + L
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLKEATC 116
Query: 246 AK-------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ +LHE +I+RD K N+LL +
Sbjct: 117 KLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQE---------------------- 151
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR----SDVYSFGV 354
+D K++DFG +K E T GT Y APE V+ T+ D +S GV
Sbjct: 152 EDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGV 207
Query: 355 VLLEMLTG 362
+L L+G
Sbjct: 208 ILFICLSG 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 72/321 (22%), Positives = 109/321 (33%), Gaps = 97/321 (30%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MK 240
N++KL ED +V E G E LF I +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRFSEHDAARIIK 128
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ ++H+ +++RD K NILL++ +D
Sbjct: 129 QVFSG---ITYMHK---HNIVHRDLKPENILLESKE----------------------KD 160
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
+ K+ DFGL+ + K R+ GT Y APE V+ G + DV+S GV+L +L
Sbjct: 161 CDIKIIDFGLSTCFQQNTKM--KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILL 216
Query: 361 TGRRSMDKNRPNGEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQ 413
+G P G+ + + G ++ A
Sbjct: 217 SGT------------------PPFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKD 255
Query: 414 LAAHCLSRDPKARPLMSEVVE 434
L L+ P R ++ +E
Sbjct: 256 LIRKMLTFHPSLRITATQCLE 276
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 66/236 (27%), Positives = 96/236 (40%), Gaps = 52/236 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LGEG F V+K + T VA+K + K+ L E+ L +
Sbjct: 18 LGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N++ L+ LV++FM LE + SL L S L +GL +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
LH + +++RD K +N+LLD N +L KL+DFGLA
Sbjct: 128 LH---QHWILHRDLKPNNLLLDE-------------------NGVL------KLADFGLA 159
Query: 312 K--DGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 363
K P TH V TR Y APE + + D+++ G +L E+L
Sbjct: 160 KSFGSPNRAYTHQVVTR-----WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 52/281 (18%), Positives = 94/281 (33%), Gaps = 50/281 (17%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRP----ESLLGEGGFGCV 145
+ + + +K+ +++ + LG G FG V
Sbjct: 8 HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVV 67
Query: 146 FKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205
+ V+ TG K +N E++ + L H L+ L
Sbjct: 68 HRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-F 117
Query: 206 EDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFLHEEAERPVI 261
ED + L+ EF+ G L + + + M+ A GL +HE ++
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHE---HSIV 171
Query: 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH 321
+ D K NI+ + + + K+ DFGLA +
Sbjct: 172 HLDIKPENIMCETKK-----------------------ASSVKIIDFGLATKLNPDEIVK 208
Query: 322 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
V T +AAPE V + +D+++ GV+ +L+G
Sbjct: 209 V---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 67/338 (19%), Positives = 113/338 (33%), Gaps = 83/338 (24%)
Query: 55 SSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVAS 114
R + + + + + ++ + N + K E L S
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 115 RLRKFTFNDLKLA---TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ D A + + P+ ++G G V + V TG AVK +
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIM 127
Query: 172 NHDGLQGHKEWLA--------EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
+ E L E + L + H +++ LI E + LV++ M +G
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG- 185
Query: 222 LENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNIL 271
E LF + K+AL ++FLH +++RD K NIL
Sbjct: 186 -E--LFDY-------LTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENIL 232
Query: 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 331
LD + +LSDFG + G+K GT G
Sbjct: 233 LD-------------------------DNMQIRLSDFGFSCHLEPGEKL--RELC-GTPG 264
Query: 332 YAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 362
Y APE ++ + D+++ GV+L +L G
Sbjct: 265 YLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 59/240 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LG G + V+KG + TG+ VA+K + D +E + E++ + +
Sbjct: 13 LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMKIALGAAK 247
L H N+V+L +++ LV+EFM + +++ + L ++ +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
GLAF H E +++RD K N+L++ G KL D
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLIN-----KRG--------------------QLKLGD 151
Query: 308 FGLA--KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
FGLA P + V+ T Y AP+ V+ G ++ D++S G +L EM+TG+
Sbjct: 152 FGLARAFGIPVNTFSS---EVV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 54/241 (22%), Positives = 83/241 (34%), Gaps = 67/241 (27%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG G F VF + TG A+K + E+ L + H
Sbjct: 16 VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------AAK- 247
N+V L E LV + + G E LF R I + G A+
Sbjct: 67 NIVTLEDI-YESTTHYYLVMQLVSGG--E--LFDR-------I---LERGVYTEKDASLV 111
Query: 248 ------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
+ +LHE +++RD K N+L ++
Sbjct: 112 IQQVLSAVKYLHE---NGIVHRDLKPENLLYLT----------------------PEENS 146
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
++DFGL+K G + + GT GY APE + + D +S GV+ +L
Sbjct: 147 KIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
Query: 362 G 362
G
Sbjct: 203 G 203
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 56/242 (23%), Positives = 90/242 (37%), Gaps = 57/242 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNFLGD 191
LLGEG +G V + E T AVK L L+ A E+ L
Sbjct: 12 LLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 192 LVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLE--NHLFRRSLPLPWSIRMKIALGAAK 247
L H N+++L+ E+ Q++ +V E+ G E + + + P+ + L
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL--ID 120
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
GL +LH + ++++D K N+LL K+S
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTT-------------------------GGTLKISA 152
Query: 308 FGLA---KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLT 361
G+A D S G+ + PE + G T + D++S GV L + T
Sbjct: 153 LGVAEALHPFAADDTCRTSQ---GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITT 208
Query: 362 GR 363
G
Sbjct: 209 GL 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 55/278 (19%), Positives = 90/278 (32%), Gaps = 89/278 (32%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
+G+G +G V ++ T A+K +N + ++ EV +
Sbjct: 34 IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------ 244
L H N+ +L ED+Q + LV E G L + L M +
Sbjct: 85 LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 245 --------------------------AAK-------GLAFLHEEAERPVIYRDFKTSNIL 271
+ L +LH + + +RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK---DGPEGDKTHVSTRVMG 328
+ + KL DFGL+K G+ ++T+ G
Sbjct: 201 FSTN-----------------------KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-G 236
Query: 329 TYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGR 363
T + APE V+ S + D +S GV+L +L G
Sbjct: 237 TPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 60/239 (25%), Positives = 86/239 (35%), Gaps = 58/239 (24%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 247
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 248 -GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
G+ +LH + +RD K N+LLD N K+S
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDE-------------------------RDNLKIS 147
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 363
DFGLA ++ + ++ GT Y APE ++ DV+S G+VL ML G
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 67/366 (18%), Positives = 112/366 (30%), Gaps = 103/366 (28%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S+ S+ + K+A K ++ LLG GGFG V+ G
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES------QYQVGPLLGSGGFGSVYSG- 62
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLGDLVHL--NLVKLI 201
++ L VA+K + D + E EV L + +++L+
Sbjct: 63 --------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 202 GYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLH 253
+ E L+ E P L + + R ++ L + + H
Sbjct: 115 DW-FERPDSFVLILERPEPVQDLFDFITERG-------ALQEELARSFFWQVLEAVRHCH 166
Query: 254 EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA-- 311
V++RD K NIL+D KL DFG
Sbjct: 167 N---CGVLHRDIKDENILIDL------------------------NRGELKLIDFGSGAL 199
Query: 312 -KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDK 368
KD GT Y+ PE++ H + V+S G++L +M+ G +
Sbjct: 200 LKDTVY--TDFD-----GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFE- 250
Query: 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428
+ ++ + S + L CL+ P RP
Sbjct: 251 ----HDEEIIRGQ----------VFF--RQ---RVS----SECQHLIRWCLALRPSDRPT 287
Query: 429 MSEVVE 434
E+
Sbjct: 288 FEEIQN 293
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 74/317 (23%), Positives = 115/317 (36%), Gaps = 91/317 (28%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 192
LG G FG V G TG VAVK LN ++ E+ L
Sbjct: 18 TLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 193 VHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK--- 247
H +++KL Y I +V E++ G L +++ + R++
Sbjct: 69 RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEMEARRLFQQ 119
Query: 248 ---GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
+ + H V++RD K N+LLDA NAK
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDA-------------------------HMNAK 151
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTG 362
++DFGL+ +G+ S G+ YAAPE V++G L D++S GV+L +L G
Sbjct: 152 IADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAH 417
D + ++ ++ I G F I + L H
Sbjct: 208 TLPFD------DEHV-----------PTLFKKI---RGGVFYIPEYLNRSVAT---LLMH 244
Query: 418 CLSRDPKARPLMSEVVE 434
L DP R + ++ E
Sbjct: 245 MLQVDPLKRATIKDIRE 261
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 37/322 (11%), Positives = 78/322 (24%), Gaps = 93/322 (28%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
R +R G ++ VA+ ++ G+ +E
Sbjct: 29 ANGR-YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQET 78
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L+ L + + +++ L+V E++ GSL+ + P P ++
Sbjct: 79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAM 135
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
A H V S + + D +
Sbjct: 136 QSLAAAADAAHR---AGVALSIDHPSRVRVSI-------------------------DGD 167
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
L+ + D+ G L +L
Sbjct: 168 VVLAYPA----------------------TMPDA-------NPQDDIRGIGASLYALLVN 198
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGER----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418
R + + G + + A + R I ++ +AA
Sbjct: 199 RWPLPE---AGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS------------AVAARS 243
Query: 419 LSRDPKARPLMSEVVEALKPLP 440
+ D R S ++ ++
Sbjct: 244 VQGDGGIRSA-STLLNLMQQAT 264
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 68/311 (21%), Positives = 109/311 (35%), Gaps = 72/311 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHL 195
LGEG F K V + AVK ++ ++ E+ L H
Sbjct: 19 LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 249
N+VKL D LV E + G L + ++ +S M+ + A +
Sbjct: 67 NIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSA---V 119
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+ +H+ V++RD K N+L + K+ DFG
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDEN----------------------DNLEIKIIDFG 154
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
A+ P ++ + T T YAAPE + D++S GV+L ML+G+
Sbjct: 155 FARLKPPDNQP-LKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------ 206
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDP 423
P + ++ +G FS +G Q+A L L+ DP
Sbjct: 207 VPF-------QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDP 259
Query: 424 KARPLMSEVVE 434
R MS +
Sbjct: 260 NKRLKMSGLRY 270
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 60/239 (25%), Positives = 86/239 (35%), Gaps = 58/239 (24%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 247
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 248 -GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
G+ +LH + +RD K N+LLD N K+S
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDE-------------------------RDNLKIS 147
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 363
DFGLA ++ + ++ GT Y APE ++ DV+S G+VL ML G
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 53/239 (22%), Positives = 89/239 (37%), Gaps = 57/239 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + + EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
G+ +LH + + + D K NI+ + +
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIM---------------------LLDKNIPIPHI 158
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
KL DFGLA + +G + + GT + APE V L +D++S GV+ +L+G
Sbjct: 159 KLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 59/251 (23%), Positives = 97/251 (38%), Gaps = 68/251 (27%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 185
+ N+ + LG+G F V + V TGL A K +N L ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG- 244
L H N+V+L E+ LV++ + G E LF I +A
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFED-------I---VAREF 101
Query: 245 -----AAK-------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292
A+ +A+ H +++R+ K N+LL + +A+
Sbjct: 102 YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLAS-KAK-------------- 143
Query: 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYS 351
KL+DFGLA + + + H GT GY +PE V+ + D+++
Sbjct: 144 -------GAAVKLADFGLAIEVNDSEAWH--GFA-GTPGYLSPE-VLKKDPYSKPVDIWA 192
Query: 352 FGVVLLEMLTG 362
GV+L +L G
Sbjct: 193 CGVILYILLVG 203
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 68/391 (17%), Positives = 116/391 (29%), Gaps = 102/391 (26%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 184
+ S LG G FG V+ V V VK + + +
Sbjct: 25 KYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 185 ---EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRM 239
E+ L + H N++K++ E+ LV E G L + R R+
Sbjct: 76 VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RL 127
Query: 240 KIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293
L + + +L + +I+RD K NI++
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAE------------------- 165
Query: 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYS 351
D+ KL DFG A G + GT Y APE V+ G+ +++S
Sbjct: 166 ------DFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE-VLMGNPYRGPELEMWS 215
Query: 352 FGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQ 409
GV L ++ + P S +
Sbjct: 216 LGVTLYTLVFEENPFCELEETVEAA-----------------IHP--PY---LVS----K 249
Query: 410 KAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 467
+ L + L P+ R + ++V + NL D Y ++ + S
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLAD-----YTWEEVFRVNKPESGVLS 304
Query: 468 NGIRAQGGSLSRNGQRSLSIPNGSYASPYHH 498
G + ++ + G +HH
Sbjct: 305 AASLEMGNRSLSDVAQAQELCGGEGHHHHHH 335
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 60/263 (22%), Positives = 97/263 (36%), Gaps = 81/263 (30%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--------HDGLQGH 179
N+ P+ +LG G V + + T AVK ++ + +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 180 KEWLA-EVNFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 236
+E EV+ L + H N+++L E + LV++ M +G E LF
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDY------- 114
Query: 237 IRMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286
+ K+ L K + LH+ +++RD K NILLD
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLD------------- 158
Query: 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 346
D N KL+DFG + G+K GT Y APE ++ +
Sbjct: 159 ------------DDMNIKLTDFGFSCQLDPGEKL--REVC-GTPSYLAPE-IIECSMNDN 202
Query: 347 S-------DVYSFGVVLLEMLTG 362
D++S GV++ +L G
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 53/239 (22%), Positives = 90/239 (37%), Gaps = 57/239 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
G+ +LH + + + D K NI+ + +
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIM---------------------LLDKNIPIPHI 158
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
KL DFGLA + +G + + GT + APE V L +D++S GV+ +L+G
Sbjct: 159 KLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 58/260 (22%), Positives = 102/260 (39%), Gaps = 52/260 (20%)
Query: 111 KVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT 170
+ R +F N + N+ + LG+G F V + V TGL A K
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKI 61
Query: 171 LNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF 227
+N L ++ E L H N+V+L I+++ LV++ + G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV 120
Query: 228 RRSLPLPWSIR-----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282
R +S ++ L + +A+ H +++R+ K N+LL +
Sbjct: 121 ARE---FYSEADASHCIQQILES---IAYCH---SNGIVHRNLKPENLLLASKA------ 165
Query: 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 342
+ KL+DFGLA + + + H GT GY +PE +
Sbjct: 166 ----------------KGAAVKLADFGLAIEVNDSEAWH--GFA-GTPGYLSPEVLKKDP 206
Query: 343 LTSRSDVYSFGVVLLEMLTG 362
+ D+++ GV+L +L G
Sbjct: 207 YSKPVDIWACGVILYILLVG 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 67/329 (20%), Positives = 106/329 (32%), Gaps = 101/329 (30%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------HDGLQGHKEWL 183
+R LLG+GGFG VF G + L VA+K + L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 184 AEVNFL----GDLVHLNLVKLIGYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSI 237
EV L H +++L+ + E + LV E +P L +++ +
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG------- 134
Query: 238 RMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
+ + H R V++RD K NIL+D
Sbjct: 135 PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDL----------------- 174
Query: 292 FFNNMLFQDYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS- 347
+ AKL DFG D P GT Y+ PE++ +
Sbjct: 175 -------RRGCAKLIDFGSGALLHDEPY--TDFD-----GTRVYSPPEWISRHQYHALPA 220
Query: 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 407
V+S G++L +M+ G P ++ I LE
Sbjct: 221 TVWSLGILLYDMVCGD------------------IPFERDQE-----I---LEAELHFPA 254
Query: 408 --AQKAAQLAAHCLSRDPKARPLMSEVVE 434
+ L CL+ P +RP + E++
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 57/239 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 13 LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEA----TQFLKQIL 118
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
G+ +LH + + + D K NI+L +
Sbjct: 119 D---GVHYLHS---KRIAHFDLKPENIMLLDKNVP---------------------NPRI 151
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
KL DFG+A G++ + GT + APE V L +D++S GV+ +L+G
Sbjct: 152 KLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 74/320 (23%), Positives = 117/320 (36%), Gaps = 85/320 (26%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
++ LG G FG V G TG VAVK LN ++ E+
Sbjct: 17 HYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 187 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
L H +++KL Y I + +V E++ G L +++ + R+
Sbjct: 68 QNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEKES 118
Query: 245 AAK------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
G+ + H V++RD K N+LLDA
Sbjct: 119 RRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDA------------------------ 151
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVL 356
NAK++DFGL+ +G+ S G+ YAAPE V++G L D++S GV+L
Sbjct: 152 -HMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLYAGPEVDIWSSGVIL 206
Query: 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQL 414
+L G D + ++ ++ I +G F L
Sbjct: 207 YALLCGTLPFD------DDHV-----------PTLFKKI---CDGIFYTPQYLNPSVISL 246
Query: 415 AAHCLSRDPKARPLMSEVVE 434
H L DP R + ++ E
Sbjct: 247 LKHMLQVDPMKRATIKDIRE 266
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 61/318 (19%), Positives = 103/318 (32%), Gaps = 85/318 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
+LG G G V + TG A+K L + EV+
Sbjct: 36 VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81
Query: 195 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALG 244
++V ++ E+ L++ E M G L + + R ++ R M+
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGT 139
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA- 303
A + FLH + +RD K N+L ++ +A
Sbjct: 140 A---IQFLHS---HNIAHRDVKPENLLY------------------------TSKEKDAV 169
Query: 304 -KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
KL+DFG AK+ + + T T Y APE + D++S GV++ +L G
Sbjct: 170 LKLTDFGFAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAA 416
++ R I G + + A QL
Sbjct: 226 FPPF-------------YSNTGQAISPGMKRRI---RLGQYGFPNPEWSEVSEDAKQLIR 269
Query: 417 HCLSRDPKARPLMSEVVE 434
L DP R +++ +
Sbjct: 270 LLLKTDPTERLTITQFMN 287
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 51/239 (21%), Positives = 86/239 (35%), Gaps = 57/239 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 70 EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEA----TEFLKQIL 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
+ +LH + + D K NI+ +
Sbjct: 125 NG---VYYLHS---LQIAHFDLKPENIM---------------------LLDRNVPKPRI 157
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
K+ DFGLA G++ + GT + APE V L +D++S GV+ +L+G
Sbjct: 158 KIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 64/315 (20%), Positives = 103/315 (32%), Gaps = 84/315 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 195
+G G + + + T + AVK ++ E E+ L H
Sbjct: 30 IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 249
N++ L +D + + +V E M G L + + R+ +S R + +
Sbjct: 77 NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKT---V 129
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LH + V++RD K SNIL + N ++ DFG
Sbjct: 130 EYLHA---QGVVHRDLKPSNILY-VDESGNPESI--------------------RICDFG 165
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG----RRS 365
AK + + T T + APE + + D++S GV+L MLTG
Sbjct: 166 FAKQLRAENGL-LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223
Query: 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCL 419
D I G FS+ G A L + L
Sbjct: 224 PDDTPE------------------EILARI---GSGKFSLSGGYWNSVSDTAKDLVSKML 262
Query: 420 SRDPKARPLMSEVVE 434
DP R + V+
Sbjct: 263 HVDPHQRLTAALVLR 277
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 60/244 (24%), Positives = 94/244 (38%), Gaps = 63/244 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G VFK +N G VA+K + +Q +E + EV L
Sbjct: 19 IGEGAYGKVFKARDLKN--------GGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 192 L---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 240
L H N+V+L + + +L LV+E + L+ +P
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ +GL FLH V++RD K NIL+ + G
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVT-----SSG------------------- 157
Query: 301 YNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
KL+DFGLA+ + T V+ T Y APE ++ + D++S G + EM
Sbjct: 158 -QIKLADFGLARIYSFQMALTS---VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212
Query: 360 LTGR 363
+
Sbjct: 213 FRRK 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 65/385 (16%), Positives = 120/385 (31%), Gaps = 83/385 (21%)
Query: 67 TSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKL 126
+++ +S + P + A+ + + V S L+ +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 186
+LG G G V + T A+K L + EV
Sbjct: 62 --DYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREV 105
Query: 187 NFLGDLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-- 238
++V+++ E+ L+V E + G L + + R ++ R
Sbjct: 106 ELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREA 163
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
MK A + +LH + +RD K N+L + R
Sbjct: 164 SEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKR------------------- 198
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
+ KL+DFG AK+ + ++T T Y APE + D++S GV+
Sbjct: 199 ---PNAILKLTDFGFAKETTSHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
Query: 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------Q 409
+ +L G P ++ L I G + +
Sbjct: 253 MYILLCGY------PPF-------YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSE 296
Query: 410 KAAQLAAHCLSRDPKARPLMSEVVE 434
+ L + L +P R ++E +
Sbjct: 297 EVKMLIRNLLKTEPTQRMTITEFMN 321
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 49/237 (20%), Positives = 85/237 (35%), Gaps = 55/237 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G F V + + TG A K L E L E+ L
Sbjct: 37 LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 195 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW--------SIRMKIALGA 245
++ L + +L+ E+ G E +F LP +K L
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE- 142
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
G+ +LH + +++ D K NILL ++ + K+
Sbjct: 143 --GVYYLH---QNNIVHLDLKPQNILLSSIY----------------------PLGDIKI 175
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
DFG+++ + +MGT Y APE + +T+ +D+++ G++ +LT
Sbjct: 176 VDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 63/250 (25%), Positives = 97/250 (38%), Gaps = 71/250 (28%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 25 IGQGTFGEVFKARHRK---------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72
Query: 192 LVHLNLVKLIGYCIEDDQRL--------LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV++F G L N L + +L + M+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-MQ 131
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ L GL ++H +++RD K +N+L+ G
Sbjct: 132 MLL---NGLYYIHR---NKILHRDMKAANVLIT-----RDG------------------- 161
Query: 301 YNAKLSDFGLA------KDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFG 353
KL+DFGLA K+ T+ RV+ T Y PE ++ D++ G
Sbjct: 162 -VLKLADFGLARAFSLAKNSQPNRYTN---RVV-TLWYRPPELLLGERDYGPPIDLWGAG 216
Query: 354 VVLLEMLTGR 363
++ EM T
Sbjct: 217 CIMAEMWTRS 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 71/323 (21%), Positives = 116/323 (35%), Gaps = 92/323 (28%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
+ LGEG FG V T VA+K ++ L+ + E+
Sbjct: 10 PYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 187 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
++L L H +++KL Y I + +V E+ G L +++ + RM G
Sbjct: 61 SYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK-------RMTEDEG 110
Query: 245 AAK------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ + H +++RD K N+LLD
Sbjct: 111 RRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDD------------------------ 143
Query: 299 QDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVL 356
+ N K++DFGL+ +G+ S G+ YAAPE V+ G L DV+S G+VL
Sbjct: 144 -NLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVL 198
Query: 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI-----KGAQKA 411
ML GR D + + ++ + + + GAQ
Sbjct: 199 YVMLVGRLPFD------DEFI-----------PNLFKKV---NSCVYVMPDFLSPGAQS- 237
Query: 412 AQLAAHCLSRDPKARPLMSEVVE 434
L + DP R + E+
Sbjct: 238 --LIRRMIVADPMQRITIQEIRR 258
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 8e-12
Identities = 43/230 (18%), Positives = 80/230 (34%), Gaps = 47/230 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V + V+ + T K + G E++ L H N
Sbjct: 13 LGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFL 252
++ L E + L +++EF+ + + + L + + L FL
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFL 118
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
H + + D + NI+ R K+ +FG A+
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRR-----------------------SSTIKIIEFGQAR 152
Query: 313 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
GD + + Y APE +++ +D++S G ++ +L+G
Sbjct: 153 QLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 48/243 (19%), Positives = 86/243 (35%), Gaps = 58/243 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ LG G + VF+ N V VK L K+ E+ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKIL 84
Query: 190 GDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIR--MKIALG 244
+L N++ L + R F + N F++ + IR M L
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL- 140
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
K L + H +++RD K N+++D + +
Sbjct: 141 --KALDYCHS---MGIMHRDVKPHNVMIDH------------------------EHRKLR 171
Query: 305 LSDFGLAKDG-PEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLT 361
L D+GLA+ P + V++R + PE ++ + S D++S G +L M+
Sbjct: 172 LIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 362 GRR 364
+
Sbjct: 227 RKE 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 52/247 (21%), Positives = 89/247 (36%), Gaps = 67/247 (27%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF-------- 188
+G G +G V+K +G VA+K++ + +
Sbjct: 17 IGVGAYGTVYKARDPH---------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64
Query: 189 ---LGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSI 237
L H N+V+L+ + + ++ LV+E + R L+ LP
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAET 121
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ +GL FLH +++RD K NIL+ + G
Sbjct: 122 IKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVT-----SGG---------------- 157
Query: 298 FQDYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
KL+DFGLA+ + T V+ T Y APE ++ + D++S G +
Sbjct: 158 ----TVKLADFGLARIYSYQMALTP---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIF 209
Query: 357 LEMLTGR 363
EM +
Sbjct: 210 AEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 53/282 (18%), Positives = 98/282 (34%), Gaps = 94/282 (33%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQGHKEWLAEV 186
++ + LG G FG V + + E +G A+K L + E+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP-----RYKNREL 51
Query: 187 NFLGDLVHLNLVKLIGY-------------------------------------CIEDDQ 209
+ + L H+N++KL+ Y ++
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 210 RL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFLHEEAERPVIYRDF 265
L ++ E++P + R +P + I + + + F+H + +RD
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDI 167
Query: 266 KTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK-TH-VS 323
K N+L+++ +D KL DFG AK + +
Sbjct: 168 KPQNLLVNS------------------------KDNTLKLCDFGSAKKLIPSEPSVAYIC 203
Query: 324 TRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 363
+R + Y APE +M G T D++S G V E++ G+
Sbjct: 204 SR----F-YRAPE-LMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 81/385 (21%), Positives = 122/385 (31%), Gaps = 103/385 (26%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ S D + S ++ A + T+ L + + + +D
Sbjct: 4 HHHHSSGVDLGTENLYF---QSMSSVTASAAPGTASLVPDYWIDGS-NRDALSDF----- 54
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
F ES LG G V++ + GT A+K L K E+ L
Sbjct: 55 -FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVRTEIGVL 102
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---- 244
L H N++KL E + LV E + G L F R I + G
Sbjct: 103 LRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------I---VEKGYYSE 147
Query: 245 --AAK-------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
AA +A+LHE +++RD K N+L A A
Sbjct: 148 RDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLY-ATPAP----------------- 186
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
D K++DFGL+K V GT GY APE + D++S G++
Sbjct: 187 ----DAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239
Query: 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------Q 409
+L G P ER + L +
Sbjct: 240 TYILLCGF------------------EPFYDERGD-QFMFRRILNCEYYFISPWWDEVSL 280
Query: 410 KAAQLAAHCLSRDPKARPLMSEVVE 434
A L + DPK R + ++
Sbjct: 281 NAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 42/278 (15%), Positives = 80/278 (28%), Gaps = 63/278 (22%)
Query: 212 LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270
+V+E + L + + LP KI +GL +LH + +I+ D K NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 271 LL------------------------DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
LL + A + + + K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
D G A + + TR Y + E ++ + +D++S + E+ TG
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293
Query: 367 DKNRPNGEHN-------------------LVEWARPHL-----GERRRFYRLIDPRLEG- 401
+ + +V G+ + +L L
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 402 -----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
+S + A L P+ R +E +
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 56/235 (23%), Positives = 92/235 (39%), Gaps = 53/235 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G F V + VK G A +N L H++ E L H
Sbjct: 19 LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 248
N+V+L I ++ L+++ + G L + R +S ++ L A
Sbjct: 70 PNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEA--- 122
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+ H+ V++R+ K N+LL A + + KL+DF
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLL-ASKLK---------------------GAAVKLADF 157
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 362
GLA + EG++ GT GY +PE V+ D+++ GV+L +L G
Sbjct: 158 GLAIE-VEGEQQAWFGFA-GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 66/320 (20%), Positives = 99/320 (30%), Gaps = 81/320 (25%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
+ +G G FG T VAVK + E + E+
Sbjct: 21 RYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIIN 69
Query: 189 LGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N+V+ I L ++ E+ G L + R
Sbjct: 70 HRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG-------RFSEDEARF 120
Query: 247 K------GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
G+++ H + +RD K N LLD A
Sbjct: 121 FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAP---------------------- 155
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLE 358
K+ DFG +K + + V GT Y APE V+ +DV+S GV L
Sbjct: 156 -RLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYV 210
Query: 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418
ML G + P + R+ + I L +SI + + H
Sbjct: 211 MLVGAYPFE--DPEEPRDY-----------RKTIQRI---LSVKYSIPDDIRISPECCHL 254
Query: 419 LSR----DPKARPLMSEVVE 434
+SR DP R + E+
Sbjct: 255 ISRIFVADPATRISIPEIKT 274
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 52/247 (21%), Positives = 87/247 (35%), Gaps = 58/247 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ ++ +G G G V VA+K L+ K E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ + + H N++ L+ +E+ Q + LV E M + + + L RM
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL---DHERM 166
Query: 240 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
L G+ LH +I+RD K SNI++ +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKS------------------------ 199
Query: 299 QDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
D K+ DFGLA+ +V TR Y APE ++ D++S G ++
Sbjct: 200 -DCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIM 253
Query: 357 LEMLTGR 363
EM+ +
Sbjct: 254 GEMVRHK 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 9e-11
Identities = 59/364 (16%), Positives = 119/364 (32%), Gaps = 75/364 (20%)
Query: 79 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFT---FNDLKLATRNFRPE- 134
T+R + +S+ TT++ + + L + +V S L K+ DL P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 135 -SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 191
S++ E + W N K T + ++ L + + L+ V F
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCD---KLTTIIESSLNVLEPAEYRKMFDRLS-V-FPPS 384
Query: 192 LVHLN---LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
H+ L + I+ D ++V + +E ++ +P SI +++ +
Sbjct: 385 -AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP-SIYLEL-KVKLEN 441
Query: 249 LAFLHEEA-ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG-------------LFFN 294
LH + I + F + +++ + Y F + G LF
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPP--YLDQY----FYSHIGHHLKNIEHPERMTLF-- 493
Query: 295 NMLFQDYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351
M+F D+ K+ A + G + ++ Y ++ Y
Sbjct: 494 RMVFLDFRFLEQKIRHDSTAWNAS-GSILNTLQQLK-FYK---------PYICDNDPKYE 542
Query: 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL--EGHFSIKGAQ 409
++ ++ P E NL+ ++ L+ L E + A
Sbjct: 543 ------RLV---NAILDFLPKIEENLI---------CSKYTDLLRIALMAEDEAIFEEAH 584
Query: 410 KAAQ 413
K Q
Sbjct: 585 KQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 1e-07
Identities = 44/288 (15%), Positives = 86/288 (29%), Gaps = 94/288 (32%)
Query: 25 KKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK-VDSSVSG----------TSTHYES 73
K++++ + ++ LR F + +S + + V V + E
Sbjct: 47 SKEEIDHIIMSKDAVSG----TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102
Query: 74 KSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRP 133
+ QP+ + N + ++ + V SRL+ + L+ A RP
Sbjct: 103 R--------QPSMMTRMYIEQRDRLYNDN--QVFAKYNV-SRLQPYL--KLRQALLELRP 149
Query: 134 ESLL---GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE----WLAEV 186
+ G G G K W VA+ +Q + WL
Sbjct: 150 AKNVLIDGVLGSG---KTW----------------VALDVCLSYKVQCKMDFKIFWLN-- 188
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRG-SLENHLFRRSLPLPWSIRMK 240
+ C + L L+Y+ P S +H L +
Sbjct: 189 --------------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS----- 229
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR-AENYGKFGF-C 286
+ E R + + ++ ++L V+ A+ + F C
Sbjct: 230 -----------IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 56/267 (20%), Positives = 95/267 (35%), Gaps = 65/267 (24%)
Query: 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 175
+ F+ + LG GG G VF V VA+K +
Sbjct: 2 MNIHGFD----LGSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTD 48
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLI-------------GYCIEDDQRL-LVYEFMPRGS 221
Q K L E+ + L H N+VK+ + + + +V E+M
Sbjct: 49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM---- 104
Query: 222 LENHLFR--RSLPLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278
E L PL + +GL ++H A V++RD K +N+ ++
Sbjct: 105 -ETDLANVLEQGPLL-EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINT---- 155
Query: 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEY 337
+D K+ DFGLA+ P + + T Y +P
Sbjct: 156 --------------------EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
Query: 338 VMT-GHLTSRSDVYSFGVVLLEMLTGR 363
+++ + T D+++ G + EMLTG+
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 50/263 (19%), Positives = 89/263 (33%), Gaps = 80/263 (30%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----------- 184
+G+G +G V A+K L+ L +
Sbjct: 20 EIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 185 ---------------EVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENH 225
E+ L L H N+VKL + +D +V+E + +G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 226 LFRRSLPLPWSIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283
+ L + + G + +LH + +I+RD K SN+L+
Sbjct: 129 PTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGE--------- 172
Query: 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 343
D + K++DFG++ + +G +S V GT + APE +
Sbjct: 173 ----------------DGHIKIADFGVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRK 214
Query: 344 T---SRSDVYSFGVVLLEMLTGR 363
DV++ GV L + G+
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 55/256 (21%), Positives = 89/256 (34%), Gaps = 65/256 (25%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----- 182
+ + + G +G V G+ VA+K + + G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 183 ------LAEVNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 231
L E+ L H N++ L + + +L LV E M L + + +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129
Query: 232 PLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290
+ ++ GL LHE A V++RD NILL
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLAD---------------- 169
Query: 291 LFFNNMLFQDYNAKLSDFGLA-KDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRS 347
+ + + DF LA +D + +KT +V+ R Y APE VM T
Sbjct: 170 ---------NNDITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLV 215
Query: 348 DVYSFGVVLLEMLTGR 363
D++S G V+ EM +
Sbjct: 216 DMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 55/247 (22%), Positives = 89/247 (36%), Gaps = 58/247 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ ++ +G G G V VA+K L+ K E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ + + H N++ L+ +E+ Q + +V E M +L + + L RM
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQMEL---DHERM 129
Query: 240 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
L G+ LH +I+RD K SNI++ +
Sbjct: 130 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKS------------------------ 162
Query: 299 QDYNAKLSDFGLA-KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
D K+ DFGLA G T +V TR Y APE ++ D++S G ++
Sbjct: 163 -DCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIM 216
Query: 357 LEMLTGR 363
EM+ G
Sbjct: 217 GEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 56/257 (21%), Positives = 97/257 (37%), Gaps = 79/257 (30%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ + + +G G +G V + +G VA+K L+ K E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ L + H N++ L+ + + LV FM + L + + +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK-------IMGL 121
Query: 240 KIA-----------LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288
K + L KGL ++H A V++RD K N+ ++
Sbjct: 122 KFSEEKIQYLVYQML---KGLKYIHS-AG--VVHRDLKPGNLAVNE-------------- 161
Query: 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSR 346
D K+ DFGLA+ + + T V TR + Y APE +++ H
Sbjct: 162 -----------DCELKILDFGLAR-HADAEMTGYVVTR----W-YRAPEVILSWMHYNQT 204
Query: 347 SDVYSFGVVLLEMLTGR 363
D++S G ++ EMLTG+
Sbjct: 205 VDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 60/248 (24%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
++ S +G G +G V + + TGL VAVK L+ + K E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 237
+ L + H N++ L+ +E+ + LV M L + L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ +GL ++H A+ +I+RD K SN+ ++
Sbjct: 134 VQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNE----------------------- 167
Query: 298 FQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 355
D K+ DFGLA+ + T +V+TR Y APE ++ H D++S G +
Sbjct: 168 --DCELKILDFGLAR-HTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCI 219
Query: 356 LLEMLTGR 363
+ E+LTGR
Sbjct: 220 MAELLTGR 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 47/266 (17%), Positives = 87/266 (32%), Gaps = 66/266 (24%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
LG G F V+ N T VA+K + D + E+ L +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74
Query: 195 LNLVKLIG----YCIEDDQRLLVYEFMPRGSLENHLF------RRSL----------PLP 234
+ K + + +LL + F +G H+ +L +P
Sbjct: 75 ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFN 294
+I+ GL ++H +I+ D K N+L++ V +
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE--------------- 172
Query: 295 NMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 354
K++D G A E + TR Y +PE ++ +D++S
Sbjct: 173 ----NLIQIKIADLGNACWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTAC 223
Query: 355 VLLEMLTGR-----RSMDKNRPNGEH 375
++ E++TG + +H
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 56/247 (22%), Positives = 86/247 (34%), Gaps = 51/247 (20%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 193
+G+G FG V +N AVK + N + E + L +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNIKKY--TRSAKIEADILKKIQ 89
Query: 194 HL-----NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 236
+ N+VK G C+ E L +YE + + +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN---GFHIE 137
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM 296
+ K L +L + + + + D K NILLD E + G
Sbjct: 138 DIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 297 LFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVV 355
+ KL DFG A + + ++TR Y APE V+ S D++SFG V
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCV 248
Query: 356 LLEMLTG 362
L E+ TG
Sbjct: 249 LAELYTG 255
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 58/248 (23%), Positives = 92/248 (37%), Gaps = 60/248 (24%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+R +G G +G V V TG VA+K L K E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 237
+ L + H N++ L+ ++D LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNML 297
+ KGL ++H A +I+RD K N+ ++
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNE----------------------- 163
Query: 298 FQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 355
D K+ DFGLA+ + + T +V TR Y APE ++ T D++S G +
Sbjct: 164 --DCELKILDFGLAR-QADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCI 215
Query: 356 LLEMLTGR 363
+ EM+TG+
Sbjct: 216 MAEMITGK 223
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 43/263 (16%), Positives = 77/263 (29%), Gaps = 67/263 (25%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------LQG 178
R ++ +S G +++ + ++K DG
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGY-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPW 235
+ + L L + +G+ +D R LV +P SL+ S
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVL 156
Query: 236 SIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293
S R ++A L FLH E ++ + NI +
Sbjct: 157 SERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV-----------------DPED 196
Query: 294 NNMLFQDYNAKLSDFGLAK---DGPEGDKTHVSTR------VMGTYGYAAPEYVMTGHL- 343
+ + L+ +G A HV+ G + + M H
Sbjct: 197 QSQVT------LAGYGFAFRYCP----SGKHVAYVEGSRSPHEGDLEFIS----MDLHKG 242
Query: 344 ---TSRSDVYSFGVVLLEMLTGR 363
+ RSD+ S G +L+ L G
Sbjct: 243 CGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 60/250 (24%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ S +GEG +G V + VA+K ++ + + L E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA---------YDNLNKVRVAIKKISPFEHQTYCQRTLREI 76
Query: 187 NFLGDLVHLNLVKLIG----YCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 239
L H N++ + IE + + +V + M E L++ ++ L + +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHI 130
Query: 240 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
L +GL ++H A V++RD K SN+LL+
Sbjct: 131 CYFLYQIL---RGLKYIHS-AN--VLHRDLKPSNLLLNT--------------------- 163
Query: 296 MLFQDYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFG 353
+ K+ DFGLA+ P+ D T T + T Y APE ++ T D++S G
Sbjct: 164 ----TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219
Query: 354 VVLLEMLTGR 363
+L EML+ R
Sbjct: 220 CILAEMLSNR 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 51/300 (17%), Positives = 96/300 (32%), Gaps = 70/300 (23%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
+S+ L E+ V + ++ +G+GGFGC++
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAA-------AWKVGLPIGQGGFGCIYLAD 55
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGDLVHLNLVKLIG-- 202
+ + G+ VK D E A+ + + +K +G
Sbjct: 56 MNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111
Query: 203 ---YCIEDDQRLLVYEF--MPR--GSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
D+ Y F M R L+ ++ + ++ ++L L ++
Sbjct: 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRFSRK-TVLQ-LSLRILDILEYI 168
Query: 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312
H E ++ D K SN+LL + ++ L D+GLA
Sbjct: 169 H---EHEYVHGDIKASNLLL-----------------NYKNPDQVY------LVDYGLAY 202
Query: 313 D-GPEGDKTHVSTR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 363
PEG + GT + + + H + R D+ G +++ LTG
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 62/265 (23%), Positives = 86/265 (32%), Gaps = 59/265 (22%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
D L R + LGEG FG V + VA+K + N
Sbjct: 10 VCRIGDW-LQER-YEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY 59
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ E+N L + V + + CI E LL +EF
Sbjct: 60 --REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-- 111
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278
L+ + F+ P P +A L FLHE + + D K NIL E
Sbjct: 112 ---LKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE 162
Query: 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 338
N + +++DFG A E T V+TR Y PE V
Sbjct: 163 TLYNEHKSCEEKSVKNTSI------RVADFGSATFDHEHHTTIVATRH-----YRPPE-V 210
Query: 339 MTGHL-TSRSDVYSFGVVLLEMLTG 362
+ DV+S G +L E G
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 65/265 (24%), Positives = 97/265 (36%), Gaps = 59/265 (22%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
D+ L+ R + LGEG FG V + + G G VAVK + N D
Sbjct: 5 ICQSGDV-LSAR-YEIVDTLGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRY 54
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ +E+ L L V+++ + CI E LL Y+F
Sbjct: 55 --CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-- 106
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278
++ + F P K+A K + FLH + + D K NIL
Sbjct: 107 ---IKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILF------ 151
Query: 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 338
+ + + + + K+ DFG A E T VSTR Y APE V
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPE-V 205
Query: 339 MTGHL-TSRSDVYSFGVVLLEMLTG 362
+ + DV+S G +L+E G
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 56/257 (21%), Positives = 96/257 (37%), Gaps = 67/257 (26%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ +F+ +SLLGEG +G V TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA---------THKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 187 NFLGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 239
L H N++ + E+ + ++ E M + L R + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHI 114
Query: 240 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
+ L + + LH + VI+RD K SN+L+++
Sbjct: 115 QYFIYQTL---RAVKVLHG-SN--VIHRDLKPSNLLINS--------------------- 147
Query: 296 MLFQDYNAKLSDFGLA----KDGPEGDKTHVSTRVMGTY----GYAAPEYVMTGHL-TSR 346
+ + K+ DFGLA + + + M + Y APE ++T +
Sbjct: 148 ----NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA 203
Query: 347 SDVYSFGVVLLEMLTGR 363
DV+S G +L E+ R
Sbjct: 204 MDVWSCGCILAELFLRR 220
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 54/250 (21%), Positives = 91/250 (36%), Gaps = 61/250 (24%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 187
+++ +GEG FG +F+G VA+K D Q E+
Sbjct: 11 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 244
G + + + E +LV + + SLE L R + ++ M A
Sbjct: 62 LAG---CTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQ 114
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
+ +H E+ ++YRD K N L+ ++N NM++
Sbjct: 115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKN--------------ANMIY------ 151
Query: 305 LSDFGLAK---DGPEGDKTHVSTR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFG 353
+ DFG+ K D K H+ R + GT Y + + HL + R D+ + G
Sbjct: 152 VVDFGMVKFYRDP--VTKQHIPYREKKNLSGTARYMS----INTHLGREQSRRDDLEALG 205
Query: 354 VVLLEMLTGR 363
V + L G
Sbjct: 206 HVFMYFLRGS 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 54/248 (21%), Positives = 90/248 (36%), Gaps = 73/248 (29%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 193
++G+G FG V K + + VA+K + N H++ E+ L L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEKRF--HRQAAEEIRILEHLR 151
Query: 194 HL------NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPW 235
N++ ++ C+ E LL +YE + + + LP
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF------QGFSLP- 200
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
+R K A + L LH+ +I+ D K NILL
Sbjct: 201 LVR-KFAHSILQCLDALHKNR---IIHCDLKPENILL----------------------- 233
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
K+ DFG + + T++ +R Y APE ++ D++S G +
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCI 288
Query: 356 LLEMLTGR 363
L E+LTG
Sbjct: 289 LAELLTGY 296
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 53/340 (15%), Positives = 98/340 (28%), Gaps = 103/340 (30%)
Query: 85 AAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLAT-----RNFRPESLLGE 139
A + S + S S+ E + + K T + + + + L+G
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGDLVH 194
G +G V + VA+K + E+ L L H
Sbjct: 64 GSYGHVCEA---------YDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNH 111
Query: 195 LNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--- 246
++VK+ I +E L +V E ++ + R + L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK-------LFRTPVYLTELHIK 159
Query: 247 -------KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
G+ ++H A +++RD K +N L++
Sbjct: 160 TLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQ------------------------- 191
Query: 300 DYNAKLSDFGLA---------KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-------- 342
D + K+ DFGLA ++ + +TGH
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 343 ----LTSRS-----DVYSFGVVLLEMLTGRRSMDKNRPNG 373
L + DV+S G + E+L + +
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 57/266 (21%), Positives = 92/266 (34%), Gaps = 75/266 (28%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
+ R + +SL+G+G FG V K + VA+K + N
Sbjct: 45 IVKNGEK-WMDR-YEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKKAF 93
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ EV L + +V L + C+ E +L +Y+
Sbjct: 94 --LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-- 145
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278
L N FR + ++ K A L FL +I+ D K NILL
Sbjct: 146 ---LRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILL-----C 193
Query: 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 338
N + K+ DFG + + ++ +R Y +PE V
Sbjct: 194 NPKRSAI------------------KIVDFGSSCQLGQRIYQYIQSRF-----YRSPE-V 229
Query: 339 MTGHLTSRS-DVYSFGVVLLEMLTGR 363
+ G + D++S G +L+EM TG
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 56/249 (22%), Positives = 86/249 (34%), Gaps = 59/249 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
NFR +G G FG + G T VA+K E F
Sbjct: 10 NFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQLHL--EYRFY 58
Query: 190 GDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
L + ++ + +V E + SLE LF R+ L ++ M IA+
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQL 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
+ ++H + +IYRD K N L+ G N + +
Sbjct: 115 ISRMEYVH---SKNLIYRDVKPENFLI-----------------GRPGNKTQQVIH---I 151
Query: 306 SDFGLAK---DGPEGDKTHVSTR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGV 354
DF LAK D K H+ R + GT Y + + HL + R D+ + G
Sbjct: 152 IDFALAKEYIDP--ETKKHIPYREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGH 205
Query: 355 VLLEMLTGR 363
+ + L G
Sbjct: 206 MFMYFLRGS 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 54/283 (19%), Positives = 91/283 (32%), Gaps = 87/283 (30%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
N+ + L+G G +G V+ T VA+K +N + L K L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA---------YDKNTEKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ L L +++L I DD +V E ++ L + +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK-------LFKTP 123
Query: 241 IALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290
I L G F+HE + +I+RD K +N LL+
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQ---------------- 164
Query: 291 LFFNNMLFQDYNAKLSDFGLA----KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 346
D + K+ DFGLA + + + +T H+ +R
Sbjct: 165 ---------DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR 215
Query: 347 -----------------SDVYSFGVVLLEMLTGRRSMDKNRPN 372
D++S G + E+L +S + N
Sbjct: 216 WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 56/247 (22%), Positives = 87/247 (35%), Gaps = 57/247 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+R +G G FG ++ G G VA+K H + E
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKIY 58
Query: 190 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
+ + + E D ++V E + SLE LF R L ++ + +A
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
+ ++H + I+RD K N L+ GK G +Y +
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMG------LGKKGNLVY----------------I 149
Query: 306 SDFGLAKD-GPEGDKTHVSTR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVL 356
DFGLAK H+ R + GT YA+ + HL + R D+ S G VL
Sbjct: 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVL 205
Query: 357 LEMLTGR 363
+ G
Sbjct: 206 MYFNLGS 212
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 56/264 (21%), Positives = 101/264 (38%), Gaps = 71/264 (26%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
R + LG+G +G V+K + TG VAVK + + E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 186 VNFLGDL-VHLNLVKLIGYCI-EDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRMK 240
+ L +L H N+V L+ ++D+ + LV+++M E L R+ L + +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQ 112
Query: 241 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
+ K + +LH +++RD K SNILL+A
Sbjct: 113 YVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNA------------------------- 144
Query: 300 DYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH------------LT 344
+ + K++DFGL+ + + T + + ++T + L
Sbjct: 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204
Query: 345 SRS-----DVYSFGVVLLEMLTGR 363
S D++S G +L E+L G+
Sbjct: 205 STKYTKGIDMWSLGCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 8e-06
Identities = 46/292 (15%), Positives = 75/292 (25%), Gaps = 80/292 (27%)
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ S+ F+ L T + +GEG FG VF+ VA+K
Sbjct: 2 MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIK 49
Query: 170 TLNHDGLQGH--------KEWLAEVNFLGDLVHL---------NLVKLIGYCI------- 205
+ +G +E L E+ +L L + L
Sbjct: 50 IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109
Query: 206 -----------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+DDQ +V EF G + + + I
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSIL 167
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN--YGKFGFCIYYGLFFNNMLFQD 300
LA +RD N+LL + Y G
Sbjct: 168 HQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC-------G 218
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352
+ D+ L++ V + E + TG + D+Y
Sbjct: 219 LQVSIIDYTLSRL------ERDGIVVF--CDVSMDEDLFTGDGDYQFDIYRL 262
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 42/261 (16%), Positives = 83/261 (31%), Gaps = 66/261 (25%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 183
+ +G GGFG ++ + VK + E +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 184 AEVNFLGDLVHLNLVKLIG-----YC-----IEDDQRLLVYEFMPR--GSLENHLFRRSL 231
A+ + + + + +G R +V M R L+ + ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNG 146
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
S +++ + L ++H E ++ D K +N+LL G
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLL-----------------GY 186
Query: 292 FFNNMLFQDYNAKLSDFGLAKD-GPEGDKTHVSTRV----MGTYGYAAPEYVMTGHL--- 343
+ ++ L+D+GL+ P G+ GT + + + H
Sbjct: 187 KNPDQVY------LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVA 236
Query: 344 -TSRSDVYSFGVVLLEMLTGR 363
+ RSDV G +L L G+
Sbjct: 237 LSRRSDVEILGYCMLRWLCGK 257
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 56/325 (17%), Positives = 95/325 (29%), Gaps = 121/325 (37%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 195
LG G G V + T A+K L + EV
Sbjct: 26 LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71
Query: 196 NLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG-----A 245
++V+++ E+ L+V E + G E LF R I+ + A
Sbjct: 72 HIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSR-------IQDRGDQAFTEREA 119
Query: 246 A-------KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLF 298
+ + + +LH + +RD K N+L +
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTS------------------------ 152
Query: 299 QDYNA--KLSDFGLAKDGPEGDKTHVSTRVMGT-YGYAAPEYVMTGHLTSRSDVYSFGVV 355
+ NA KL+DFG A E G Y + D++S GV+
Sbjct: 153 KRPNAILKLTDFGFA---KE---------TTGEKYDKSC-------------DMWSLGVI 187
Query: 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------Q 409
+ +L G P ++ L I G + +
Sbjct: 188 MYILLCGY------PPF-------YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSE 231
Query: 410 KAAQLAAHCLSRDPKARPLMSEVVE 434
+ L + L +P R ++E +
Sbjct: 232 EVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 60/247 (24%), Positives = 90/247 (36%), Gaps = 57/247 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
FR +G G FG ++ G + VA+K N H + L E
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVK--TKHPQLLYESKIY 56
Query: 190 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
L + + + +E D +LV + + SLE LF R L L ++ M +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLK-TVLM-LADQM 112
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
+ F+H + ++RD K N L+ R N +
Sbjct: 113 INRVEFVH---SKSFLHRDIKPDNFLMGLGRRAN----------------------QVYI 147
Query: 306 SDFGLAKD-GPEGDKTHVSTR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVL 356
DFGLAK H+ R + GT YA+ + HL + R D+ S G VL
Sbjct: 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVL 203
Query: 357 LEMLTGR 363
+ L G
Sbjct: 204 MYFLRGS 210
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 511 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.37 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.97 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.88 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.81 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.61 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.64 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.91 | |
| 2khx_A | 85 | Ribonuclease 3; drosha, RNA binding domain, hydrol | 80.29 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-61 Score=472.15 Aligned_cols=262 Identities=30% Similarity=0.443 Sum_probs=213.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|.+.+.||+|+||+||+|++.... ...++..||||+++.......++|.+|+++|++|+|||||+++|+|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcc----cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 57888899999999999999986421 12357899999998766555678999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 209 QRLLVYEFMPRGSLENHLFRR------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
.+|||||||++|+|.++|... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~--- 162 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVG--- 162 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC---
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEEC---
Confidence 999999999999999999653 246999999999999999999999988 99999999999998
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHH
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil 356 (511)
.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+|
T Consensus 163 ----------------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 163 ----------------------ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220 (299)
T ss_dssp ----------------------GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ----------------------CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 4788999999999876554433333345799999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|||+| |+.||.+.... .+...+... . ....+..+++++.+||.+||+.||++||||.+|++.
T Consensus 221 ~Ellt~G~~Pf~~~~~~---~~~~~i~~~----~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~ 283 (299)
T 4asz_A 221 WEIFTYGKQPWYQLSNN---EVIECITQG----R----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTL 283 (299)
T ss_dssp HHHHTTTCCTTTTSCHH---HHHHHHHHT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCCCCHH---HHHHHHHcC----C----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999 89999764321 222111110 0 111223346789999999999999999999999998
Q ss_pred hcCC
Q 010432 436 LKPL 439 (511)
Q Consensus 436 L~~l 439 (511)
|+.+
T Consensus 284 L~~~ 287 (299)
T 4asz_A 284 LQNL 287 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8755
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=473.81 Aligned_cols=263 Identities=28% Similarity=0.435 Sum_probs=207.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|.+.++||+|+||+||+|+++.. ....++..||||+++.......++|.+|+++|++|+|||||+++|+|.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4677788999999999999998641 112367899999998766555678999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecc
Q 010432 209 QRLLVYEFMPRGSLENHLFRR--------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~ 274 (511)
.+|||||||++|+|.++|... ..++++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~- 192 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG- 192 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE-
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC-
Confidence 999999999999999999653 235899999999999999999999988 99999999999998
Q ss_pred ccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHH
Q 010432 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 354 (511)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGv 354 (511)
+++.+||+|||+|+...........+..+||+.|||||++.+..|+.++|||||||
T Consensus 193 ------------------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 193 ------------------------QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248 (329)
T ss_dssp ------------------------TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ------------------------CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHH
Confidence 47889999999999776554444455678999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 355 VLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 355 il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
+||||+| |+.||...... .+...+.. .. ....+..+++++.+||.+||+.||++||||.||+
T Consensus 249 vl~Ellt~G~~Pf~~~~~~---~~~~~i~~----g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 311 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNT---EAIDCITQ----GR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVH 311 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHH---HHHHHHHH----TC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred HHHHHHcCCCCCCCCCCHH---HHHHHHHc----CC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 9999999 89999764321 12211111 00 1112233467899999999999999999999999
Q ss_pred HHhcCCC
Q 010432 434 EALKPLP 440 (511)
Q Consensus 434 ~~L~~l~ 440 (511)
++|+.+.
T Consensus 312 ~~L~~l~ 318 (329)
T 4aoj_A 312 ARLQALA 318 (329)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=476.16 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=204.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||+||+|+++. +|+.||||++...... ..+.+.+|+.+|++|+|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 589999999999999999999876 6889999999866433 24568999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++.+|||||||+||+|.++|..+ ...+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~------------ 159 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLT------------ 159 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEEC------------
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEEC------------
Confidence 99999999999999999999754 445789999999999999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+|+....... ..+..+||+.|||||++.+..|+.++||||||||||||++|+.|
T Consensus 160 -------------~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~P 224 (350)
T 4b9d_A 160 -------------KDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224 (350)
T ss_dssp -------------TTCCEEECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------CCCCEEEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 478899999999997643211 23346899999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|.+.... .+...+ .... . + ..+...+.++.+||.+||+.||.+|||+.|++++
T Consensus 225 F~~~~~~---~~~~~i---~~~~------~-~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 225 FEAGSMK---NLVLKI---ISGS------F-P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCSSHH---HHHHHH---HHTC------C-C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCcCHH---HHHHHH---HcCC------C-C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9764321 111111 1100 0 1 1122335789999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-60 Score=470.66 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=211.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+.|+++++||+|+||+||+|+++. +|+.||||++........+.+.+|+.+|++|+|||||+++++|.++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3579999999999999999999876 7889999999766555556788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+.+|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~-------------- 204 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLT-------------- 204 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC--------------
T ss_pred CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEC--------------
Confidence 999999999999999999865 36899999999999999999999999 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||+|+....... ..+..+||+.|||||++.+..|+.++||||||||||||++|+.||.
T Consensus 205 -----------~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 205 -----------HDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp -----------TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----------CCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 478899999999987654322 2345789999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.... .....+.... .+.+ ......++++.+||.+||+.||++|||+.|++++
T Consensus 272 ~~~~~---~~~~~i~~~~----------~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 272 NEPPL---KAMKMIRDNL----------PPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp TSCHH---HHHHHHHHSS----------CCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CcCHH---HHHHHHHcCC----------CCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 64321 1111111110 0111 1112335789999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-60 Score=464.99 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=204.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.++||+|+||+||+|+++. .||||+++.... ...+.|.+|+.+|++|+|||||++++++
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34678889999999999999998643 699999975433 2345799999999999999999999988
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+ +.++||||||++|+|.++|......+++..++.|+.|||.||+|||+++ ||||||||+||||+
T Consensus 102 ~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~----------- 166 (307)
T 3omv_A 102 TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLH----------- 166 (307)
T ss_dssp CS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEE-----------
T ss_pred EC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEEC-----------
Confidence 54 5689999999999999999877778999999999999999999999988 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc---CCCCccccchhHHHHHHHHHh
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DIwSlGvil~ellt 361 (511)
+++.+||+|||+|+..............+||+.|||||++.+ ..|+.++|||||||+||||+|
T Consensus 167 --------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt 232 (307)
T 3omv_A 167 --------------EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232 (307)
T ss_dssp --------------TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred --------------CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH
Confidence 478899999999987654333333455789999999999864 469999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|+.||.+..... .+...+... ...+.+ ...+..++..+.+||.+||+.||++||||.+|+++|+.+
T Consensus 233 g~~Pf~~~~~~~--~~~~~~~~~---------~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 233 GELPYSHINNRD--QIIFMVGRG---------YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SSCTTTTCCCHH--HHHHHHHTT---------CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCChHH--HHHHHHhcC---------CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 999997643321 111111100 011111 122334567899999999999999999999999998755
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-60 Score=466.77 Aligned_cols=265 Identities=26% Similarity=0.371 Sum_probs=213.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++++++.||+|+||+||+|++.... ...+++.||||+++.... ...++|.+|+.+|++|+|||||+++|+|.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 35667789999999999999985311 112578999999976533 3356799999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
+.++||||||++|+|.++|..+ ...+++..++.|+.|||.||+|||+++ ||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence 9999999999999999999643 135899999999999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
+ +++.+||+|||+|+...........+..+||+.|||||++.+..|+.++|||||
T Consensus 179 ~-------------------------~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf 233 (308)
T 4gt4_A 179 Y-------------------------DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233 (308)
T ss_dssp C-------------------------GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred C-------------------------CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence 9 478899999999987654433333445689999999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 353 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 353 Gvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
||+||||+| |+.||.+... ..+...+.. . .....+..++..+.+||.+||+.||.+||||.+
T Consensus 234 Gvvl~El~t~g~~Pf~~~~~---~~~~~~i~~----~----------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~e 296 (308)
T 4gt4_A 234 GVVLWEVFSYGLQPYCGYSN---QDVVEMIRN----R----------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD 296 (308)
T ss_dssp HHHHHHHHTTTCCTTTTCCH---HHHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----C----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999998 8999976532 122222111 0 011123345678999999999999999999999
Q ss_pred HHHHhcCCCCC
Q 010432 432 VVEALKPLPNL 442 (511)
Q Consensus 432 il~~L~~l~~~ 442 (511)
|++.|+.+.++
T Consensus 297 i~~~L~a~~nl 307 (308)
T 4gt4_A 297 IHSRLRAWGNL 307 (308)
T ss_dssp HHHHHHTSCC-
T ss_pred HHHHHHhccCC
Confidence 99999876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=463.29 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=210.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|+++++||+|+||+||+|+++. +|+.||||++.+.. ....+.+.+|+++|++|+|||||++++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 469999999999999999999876 78899999997542 233467899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~------------ 166 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLN------------ 166 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEc------------
Confidence 999999999999999999999654 47999999999999999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+|+..............+||+.|||||++.+..|+.++||||||||||||++|+.|
T Consensus 167 -------------~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~P 233 (311)
T 4aw0_A 167 -------------EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233 (311)
T ss_dssp -------------TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 4788999999999987554433344567999999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
|.+.... .+...+. ... . .++...++++.+||.+||+.||.+|||+.|++.
T Consensus 234 F~~~~~~---~~~~~i~---~~~--------~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 234 FRAGNEG---LIFAKII---KLE--------Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp SCCSSHH---HHHHHHH---HTC--------C----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCCCCHH---HHHHHHH---cCC--------C----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 9764321 1111111 110 1 112223577899999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=477.97 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=212.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+.|++++.||+|+||+||+|+++. +|+.||||++........+.+.+|+.+|++|+|||||+++++|.++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 3579999999999999999999876 7889999999877666667789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+.+|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~-------------- 281 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLT-------------- 281 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEEC--------------
T ss_pred CEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEc--------------
Confidence 999999999999999999865 35899999999999999999999999 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||+|+....... .....+||+.|||||++.+..|+.++||||||||||||++|+.||.
T Consensus 282 -----------~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 282 -----------HDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp -----------TTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----------CCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 478899999999987654322 2345789999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.... .....+... ..+.+ ......+.++.+||.+||+.||.+|||+.|++++
T Consensus 349 ~~~~~---~~~~~i~~~----------~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 349 NEPPL---KAMKMIRDN----------LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TSCHH---HHHHHHHHS----------CCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CcCHH---HHHHHHHcC----------CCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 64322 111111111 01111 1111235788999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=459.68 Aligned_cols=253 Identities=24% Similarity=0.246 Sum_probs=206.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+.|++.++||+|+||+||+|+++. +|+.||||+++..... .+|+.+|++|+|||||++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467888899999999999999876 7889999999865432 47999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
.+|||||||+||+|.++|.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~-------------- 185 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS-------------- 185 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECT--------------
T ss_pred EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeC--------------
Confidence 999999999999999999654 47999999999999999999999998 999999999999984
Q ss_pred ccccccccccccC-ceeeecCCCcccCCCCCcc---eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 289 YGLFFNNMLFQDY-NAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 289 ~~~~~~~~~~~~~-~~kl~DFGla~~~~~~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
++ .+||+|||+|+........ .....++||+.|||||++.+..|+.++||||||||||||++|+.
T Consensus 186 -----------~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 186 -----------DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp -----------TSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -----------CCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 44 6999999999876543221 11234689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||.+.........+.. ....+ ..++...++.+.+||.+||+.||.+|||+.||+++|...
T Consensus 255 Pf~~~~~~~~~~~i~~------~~~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 255 PWTQYFRGPLCLKIAS------EPPPI---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp SSTTTCCSCCHHHHHH------SCCGG---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHc------CCCCc---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 9987654432221111 10000 112223457889999999999999999999999987643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=450.97 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=199.8
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe---
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE--- 206 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~--- 206 (511)
++.++||+|+||+||+|++.. ++..||||++...... ..+.|.+|+.+|++|+|||||+++++|..
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred EeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 556689999999999999876 6889999999754332 34568999999999999999999999875
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++.+|||||||++|+|.++|.+. ..+++..+..|+.||+.||+|||+++ ++||||||||+||||+.
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~----------- 166 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITG----------- 166 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESS-----------
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEEC-----------
Confidence 35689999999999999999654 47999999999999999999999976 56999999999999973
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.|
T Consensus 167 -------------~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~P 228 (290)
T 3fpq_A 167 -------------PTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 228 (290)
T ss_dssp -------------TTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred -------------CCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence 3678999999999865432 2345789999999998864 699999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|...... ..+...+... .....++...++++.+||.+||+.||++|||+.|++++
T Consensus 229 f~~~~~~--~~~~~~i~~~-------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 229 YSECQNA--AQIYRRVTSG-------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTTCSSH--HHHHHHHTTT-------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCcH--HHHHHHHHcC-------------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9754321 1111111110 00011111224678999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=441.19 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=193.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||+||+|+++. +|+.||||+++.... .....+.+|+.+|++|+|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 589999999999999999999865 688999999976533 23457899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++.+||||||| +|+|.+++.++ ..+++..+..++.||+.||+|||+++ ||||||||+||||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~------------ 146 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLD------------ 146 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEEC------------
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEEC------------
Confidence 999999999999 78999999765 47999999999999999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+|+...... .....+||+.|||||++.+..| +.++|||||||+||||++|+.
T Consensus 147 -------------~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~ 210 (275)
T 3hyh_A 147 -------------EHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210 (275)
T ss_dssp -------------TTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------CCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCC
Confidence 47889999999998765432 2345789999999999998876 579999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||.+... ..+...+. ... .. ++...++++.+||.+||+.||++|||+.|++++
T Consensus 211 PF~~~~~---~~~~~~i~---~~~--------~~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 211 PFDDESI---PVLFKNIS---NGV--------YT----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SSCCSSH---HHHHHHHH---HTC--------CC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCCH---HHHHHHHH---cCC--------CC----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 9975422 11111111 100 01 112235778999999999999999999999984
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=462.73 Aligned_cols=271 Identities=27% Similarity=0.370 Sum_probs=219.3
Q ss_pred hHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCC-CCcc
Q 010432 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVH-LNLV 198 (511)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H-~nIv 198 (511)
.+.+++..++|++.+.||+|+||+||+|++...+. ..+++.||||+++..... ..+.|.+|+.+|.++.| ||||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 34555667899999999999999999999865322 124678999999865443 34568999999999965 8999
Q ss_pred eEeeEEEeC-CeEEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 010432 199 KLIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (511)
Q Consensus 199 ~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH 262 (511)
+++|+|... +.++||||||++|+|.++|... ...+++..++.|+.|||.||+|||+++ |||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 999999764 5689999999999999999643 234889999999999999999999998 999
Q ss_pred cccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC
Q 010432 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 342 (511)
Q Consensus 263 rDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~ 342 (511)
|||||+||||+ +++.+||+|||+|+...........+..+||+.|||||++.+..
T Consensus 209 RDLK~~NILl~-------------------------~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~ 263 (353)
T 4ase_A 209 RDLAARNILLS-------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 263 (353)
T ss_dssp SCCSGGGEEEC-------------------------GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred CccCccceeeC-------------------------CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC
Confidence 99999999998 47889999999999876655444455678999999999999999
Q ss_pred CCccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccc
Q 010432 343 LTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 421 (511)
Q Consensus 343 ~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~ 421 (511)
|+.++|||||||+||||+| |+.||.+..... .+...+.. . .....+..+++++.+||.+||+.
T Consensus 264 y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~~~~~i~~----g----------~~~~~p~~~~~~~~~li~~c~~~ 327 (353)
T 4ase_A 264 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE----G----------TRMRAPDYTTPEMYQTMLDCWHG 327 (353)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHH----T----------CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--HHHHHHHc----C----------CCCCCCccCCHHHHHHHHHHcCc
Confidence 9999999999999999998 899997654321 11111111 0 11112223457899999999999
Q ss_pred CCCCCCCHHHHHHHhcCC
Q 010432 422 DPKARPLMSEVVEALKPL 439 (511)
Q Consensus 422 dP~~RPs~~eil~~L~~l 439 (511)
||.+||||.+|+++|+.+
T Consensus 328 dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 328 EPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SGGGSCCHHHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHHHH
Confidence 999999999999999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-58 Score=450.25 Aligned_cols=251 Identities=27% Similarity=0.341 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||+||+|++..+. .+++.||||+++..... ....+.+|+.+|++|+|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGS------DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSST------TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCC------CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 47999999999999999999885432 26889999999764322 22467899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+|||++
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~------------- 160 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLD------------- 160 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEEC-------------
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEc-------------
Confidence 99999999999999999999654 47999999999999999999999999 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||
T Consensus 161 ------------~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF 226 (304)
T 3ubd_A 161 ------------EEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226 (304)
T ss_dssp ------------TTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ------------CCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCC
Confidence 478899999999987544322 234578999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVE 434 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~-----~eil~ 434 (511)
.+.... .+...+. ... . .++...++++.+||.+||+.||.+|||+ +|+++
T Consensus 227 ~~~~~~---~~~~~i~---~~~--------~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 227 QGKDRK---ETMTMIL---KAK--------L----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCSSHH---HHHHHHH---HCC--------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCcCHH---HHHHHHH---cCC--------C----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 764321 1111111 110 0 1122235788999999999999999985 45554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=440.11 Aligned_cols=265 Identities=26% Similarity=0.362 Sum_probs=198.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHH--HHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~--~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|.+.++||+|+||+||+|++ +|+.||||+++... ...+. .|+.++.+++|||||++++++..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~ 68 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 4577888999999999999987 46799999997542 23333 45666678899999999999987
Q ss_pred CC----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecccCCCcEEeccccc
Q 010432 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 207 ~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~iiHrDLKp~NILl~~~~~ 277 (511)
++ .+|||||||++|+|.++|... .+++..++.|+.|++.||+|||++. .++||||||||+||||+
T Consensus 69 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~---- 142 (303)
T 3hmm_A 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---- 142 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC----
T ss_pred cCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC----
Confidence 54 579999999999999999754 5899999999999999999999871 23499999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccC------CCCccccc
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDV 349 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~------~~~~~~DI 349 (511)
.++.+||+|||+|+......... .....+||+.|||||++.+. .|+.++||
T Consensus 143 ---------------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DV 201 (303)
T 3hmm_A 143 ---------------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201 (303)
T ss_dssp ---------------------TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred ---------------------CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhh
Confidence 47889999999998754433221 22346899999999998754 47889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCch---------hHHHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHHHHHhc
Q 010432 350 YSFGVVLLEMLTGRRSMDKNRPNGEH---------NLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCL 419 (511)
Q Consensus 350 wSlGvil~elltg~~pf~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Li~~cl 419 (511)
|||||+||||+||..||......... ......... .....++.+... ...+.+..+.+||.+||
T Consensus 202 wS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl 275 (303)
T 3hmm_A 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMAKIMRECW 275 (303)
T ss_dssp HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTC
T ss_pred hhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHH------hcccCCCCCCccccchHHHHHHHHHHHHHc
Confidence 99999999999998887543221100 000000000 001112222221 12356678999999999
Q ss_pred ccCCCCCCCHHHHHHHhcCCC
Q 010432 420 SRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 420 ~~dP~~RPs~~eil~~L~~l~ 440 (511)
+.||++||||.+|++.|+.+.
T Consensus 276 ~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 276 YANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999997654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=435.10 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=189.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++++.||+|+||+||+|+++. +|+.||||+++..... ..+.+.+|+.+|++|+|||||+++++|.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 74 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 74 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred chhCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3569999999999999999999876 6889999999765432 33568999999999999999999999876
Q ss_pred CC------------eEEEEEEccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 207 DD------------QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 207 ~~------------~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
.+ .+|||||||++|+|.+++..+.. ..++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl 151 (299)
T 4g31_A 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFF 151 (299)
T ss_dssp EC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEE
Confidence 44 37899999999999999975432 3456778899999999999999999 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc----------eeeeeccccccccCCcccccCC
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGH 342 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~Gt~~y~aPE~~~~~~ 342 (511)
+ .++.+||+|||+|+........ ...+..+||+.|||||++.+..
T Consensus 152 ~-------------------------~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 152 T-------------------------MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp C-------------------------TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred C-------------------------CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 8 4778999999999876543221 1123468999999999999999
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccC
Q 010432 343 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422 (511)
Q Consensus 343 ~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~d 422 (511)
|+.++||||||||||||++ ||.... ........ +....+. ......++.+.+||.+||+.|
T Consensus 207 y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~~~~~----------~~~~~~p-~~~~~~~~~~~~li~~~L~~d 267 (299)
T 4g31_A 207 YSHKVDIFSLGLILFELLY---PFSTQM-----ERVRTLTD----------VRNLKFP-PLFTQKYPCEYVMVQDMLSPS 267 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHHH----------HHTTCCC-HHHHHHCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHHHHHH----------HhcCCCC-CCCcccCHHHHHHHHHHcCCC
Confidence 9999999999999999996 775311 11110000 0000000 011223456789999999999
Q ss_pred CCCCCCHHHHHHH
Q 010432 423 PKARPLMSEVVEA 435 (511)
Q Consensus 423 P~~RPs~~eil~~ 435 (511)
|.+|||+.||+++
T Consensus 268 P~~Rps~~eil~h 280 (299)
T 4g31_A 268 PMERPEAINIIEN 280 (299)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=438.47 Aligned_cols=268 Identities=23% Similarity=0.303 Sum_probs=203.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||+||+|+++. +|+.||||+++..... ..+.+++|+.+|++|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 579999999999999999999876 7889999999765432 23568899999999999999999998764
Q ss_pred ------CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 ------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
.+.+|||||||. |+|.+++.. ...+++..+..|+.||+.||.|||+++ ||||||||+|||++
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~------- 192 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVN------- 192 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC-------
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccC-------
Confidence 357899999995 789999965 457999999999999999999999999 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCc--ceeeeeccccccccCCcccccC-CCCccccchhHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLL 357 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~ 357 (511)
.++.+||+|||+|+....... ....+..+||+.|||||++.+. .|+.++||||+|||||
T Consensus 193 ------------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ 254 (398)
T 4b99_A 193 ------------------ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG 254 (398)
T ss_dssp ------------------TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ------------------CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHH
Confidence 478899999999987643221 1123457899999999998875 5699999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhhhccc----------cccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCC
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPHLGER----------RRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~---~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
||++|++||.+.........+.......... ........+..... .....+.++.+||.+||+.||.
T Consensus 255 ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 334 (398)
T 4b99_A 255 EMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS 334 (398)
T ss_dssp HHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence 9999999998754332222211111000000 00000000000000 0011246789999999999999
Q ss_pred CCCCHHHHHHH
Q 010432 425 ARPLMSEVVEA 435 (511)
Q Consensus 425 ~RPs~~eil~~ 435 (511)
+|||+.|+|+|
T Consensus 335 ~R~ta~e~L~H 345 (398)
T 4b99_A 335 ARISAAAALRH 345 (398)
T ss_dssp TSCCHHHHTTS
T ss_pred HCcCHHHHhcC
Confidence 99999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=428.16 Aligned_cols=205 Identities=25% Similarity=0.325 Sum_probs=173.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
..++|++.++||+|+||+||+|+++.+ ..+++.||||++.... ...++.+|+++|+.+ +|||||++++++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 457899999999999999999987532 1267899999987543 345688999999998 6999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.+++|||||||++|+|.+++. .+++..+..++.||+.||+|||+++ ||||||||+||||+.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~----------- 152 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNR----------- 152 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEET-----------
T ss_pred ECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeC-----------
Confidence 9999999999999999999983 5899999999999999999999999 999999999999984
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc--------------------------eeeeeccccccccCCcccc
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--------------------------HVSTRVMGTYGYAAPEYVM 339 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--------------------------~~~~~~~Gt~~y~aPE~~~ 339 (511)
+.+.+||+|||+|+........ ...+..+||+.|||||++.
T Consensus 153 -------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 219 (361)
T 4f9c_A 153 -------------RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT 219 (361)
T ss_dssp -------------TTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT
T ss_pred -------------CCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 2468999999999865432110 1123457999999999998
Q ss_pred cC-CCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 340 TG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 340 ~~-~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
+. .|+.++||||+|||+|||++|+.||....
T Consensus 220 ~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 220 KCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 75 58999999999999999999999997543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=451.48 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=214.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++++.||+|+||+||+|+++. +|+.||||++........+.+.+|+.+|+.|+|||||+|+++|.++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 4689999999999999999999876 7889999999876655566789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+.+|||||||+||+|.++|......+++..+..|+.||+.||+|||+++ ||||||||+||||+..
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~------------ 291 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK------------ 291 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSS------------
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCC------------
Confidence 9999999999999999999766678999999999999999999999999 9999999999999841
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
..+.+||+|||+|+....... ....+||+.|||||++.+..|+.++||||||||||||++|+.||.
T Consensus 292 -----------~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 292 -----------RSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp -----------SCCCEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred -----------CCCCEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 246799999999998765432 344689999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+..... ....+.. ... .+........++++.+||.+||+.||.+|||+.|+++|
T Consensus 358 ~~~~~~---~~~~i~~---~~~--------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 358 GENDDE---TLRNVKS---CDW--------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSSHHH---HHHHHHT---TCC--------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcCHHH---HHHHHHh---CCC--------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 653221 1111110 000 00111111235778999999999999999999999996
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=445.75 Aligned_cols=251 Identities=26% Similarity=0.348 Sum_probs=203.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHH---HHHHHHhCCCCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWL---AEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~---~E~~il~~l~H~nIv~l~ 201 (511)
.++|+++++||+|+||+||+|+++. +|+.||||++++... .....+. .++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 4689999999999999999999876 788999999975321 1122233 346777889999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
++|.+.+.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld-------- 326 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLD-------- 326 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEEC--------
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEe--------
Confidence 9999999999999999999999999654 47999999999999999999999999 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ell 360 (511)
.++++||+|||+|+...... ....+||+.|||||++.. ..|+.++||||||||||||+
T Consensus 327 -----------------~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmL 385 (689)
T 3v5w_A 327 -----------------EHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385 (689)
T ss_dssp -----------------TTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 48899999999998765432 234689999999999974 58999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
+|+.||.+........+..... .. ...++...++++.+||.+||+.||.+|++ +.||++|
T Consensus 386 tG~~PF~~~~~~~~~~i~~~i~---~~------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 386 RGHSPFRQHKTKDKHEIDRMTL---TM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HSSCTTCGGGCCCHHHHHHHHH---HC------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred hCCCCCCCCChHHHHHHHHhhc---CC------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 9999997654333222211111 11 01122233578999999999999999998 6777764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=401.33 Aligned_cols=283 Identities=40% Similarity=0.696 Sum_probs=237.0
Q ss_pred cChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcc
Q 010432 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV 198 (511)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv 198 (511)
+.+.++....++|++.+.||+|+||.||+|++. ++..||||++........+.+.+|+.+|+.++||||+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 98 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLV 98 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEe
Confidence 344445556789999999999999999999864 4679999999877656667899999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 275 (511)
++++++...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~-- 173 (321)
T 2qkw_B 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLD-- 173 (321)
T ss_dssp CEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEEC--
T ss_pred eEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEEC--
Confidence 99999999999999999999999999986543 35899999999999999999999998 99999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHH
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi 355 (511)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+
T Consensus 174 -----------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 230 (321)
T 2qkw_B 174 -----------------------ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230 (321)
T ss_dssp -----------------------TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHH
T ss_pred -----------------------CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHH
Confidence 477899999999987554333333344579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|||++|+.||....+........|..... ....+...+++.+........+..+.+|+.+||+.||.+|||+.+|+++
T Consensus 231 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 231 LFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999998776665555555443322 2233445566666677788889999999999999999999999999999
Q ss_pred hcCCC
Q 010432 436 LKPLP 440 (511)
Q Consensus 436 L~~l~ 440 (511)
|+.+.
T Consensus 310 L~~~l 314 (321)
T 2qkw_B 310 LEYAL 314 (321)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=385.12 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=210.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||+||+|.+.. +++.||||++........+.+.+|+.++++++||||+++++++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 34689999999999999999998765 678999999986655566778999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++|||||++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~------------- 150 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG------------- 150 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-------------
T ss_pred CCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEC-------------
Confidence 99999999999999999999654 5899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 151 ------------~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 216 (297)
T 3fxz_A 151 ------------MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (297)
T ss_dssp ------------TTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------CCCCEEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4778999999999876543322 33467999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
........ ....... . .+ ....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 217 ~~~~~~~~--~~~~~~~---~--------~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 217 LNENPLRA--LYLIATN---G--------TP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp TTSCHHHH--HHHHHHH---C--------SC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHH--HHHHHhC---C--------CC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 75432111 0000000 0 00 011122335678999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=389.96 Aligned_cols=288 Identities=40% Similarity=0.731 Sum_probs=233.8
Q ss_pred ccccChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCC
Q 010432 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVH 194 (511)
Q Consensus 116 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H 194 (511)
...+++.++....++|++.+.||+|+||.||+|++. ++..||||++...... ....+.+|+.++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h 86 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH 86 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCC
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccC
Confidence 456888999999999999999999999999999753 4678999999765422 22368899999999999
Q ss_pred CCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 195 ~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
|||+++++++...+..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||++..++|+||||||+|||
T Consensus 87 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp TTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred CCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 999999999999999999999999999999997542 34899999999999999999999982122999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchh
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwS 351 (511)
++ +++.+||+|||+++........ ......||+.|+|||++.+..++.++||||
T Consensus 167 ~~-------------------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 220 (326)
T 3uim_A 167 LD-------------------------EEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 220 (326)
T ss_dssp EC-------------------------TTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHH
T ss_pred EC-------------------------CCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchh
Confidence 98 4778999999999876543322 234456999999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC--CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 352 FGVVLLEMLTGRRSMDKNR--PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 352 lGvil~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
|||++|||++|+.||.... .........+..... .........+..+...+....+..+.+|+.+||+.||.+|||+
T Consensus 221 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 299 (326)
T 3uim_A 221 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299 (326)
T ss_dssp HHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH
T ss_pred HHHHHHHHHhCCCcccccccccccchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH
Confidence 9999999999999996211 111222333333322 2233445556666777788889999999999999999999999
Q ss_pred HHHHHHhcCCC
Q 010432 430 SEVVEALKPLP 440 (511)
Q Consensus 430 ~eil~~L~~l~ 440 (511)
.+|+++|+...
T Consensus 300 ~ell~~L~~~~ 310 (326)
T 3uim_A 300 SEVVRMLEGDG 310 (326)
T ss_dssp HHHHHHHHTSS
T ss_pred HHHHHHhcCcc
Confidence 99999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.86 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=212.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|.+.++||+|+||+||+|++.. ++..||+|++........+.+.+|+.+|++++||||+++++++.++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 3578899999999999999999876 6779999999766555567799999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++|||||++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~-------------- 142 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVR-------------- 142 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEC--------------
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEEC--------------
Confidence 9999999999999999999876778999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcce------------eeeeccccccccCCcccccCCCCccccchhHHHH
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi 355 (511)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||+
T Consensus 143 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 211 (310)
T 3s95_A 143 -----------ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211 (310)
T ss_dssp -----------TTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred -----------CCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHH
Confidence 47789999999998764432211 0114579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|||++|..||............ ......+.. .+..++..+.+|+.+||+.||.+|||+.+|++.
T Consensus 212 l~el~~g~~~~~~~~~~~~~~~~-----------~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~ 276 (310)
T 3s95_A 212 LCEIIGRVNADPDYLPRTMDFGL-----------NVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276 (310)
T ss_dssp HHHHHHTCCSSTTTSCBCTTSSB-----------CHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCcchhhhHHHHhh-----------hhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999998754332211000 000000000 111223568899999999999999999999999
Q ss_pred hcCCC
Q 010432 436 LKPLP 440 (511)
Q Consensus 436 L~~l~ 440 (511)
|+.+.
T Consensus 277 L~~l~ 281 (310)
T 3s95_A 277 LETLR 281 (310)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98663
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=396.62 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=213.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|++..... ....++..||||+++..... ..+.+.+|+.+|+++ +|||||++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34689999999999999999998753211 11235678999999865432 335689999999999 899999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
...+.+|||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999997543 24789999999999999999999998 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
|||+ .++.+||+|||+++...............||+.|+|||++.+..|+.++||
T Consensus 234 Ill~-------------------------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv 288 (370)
T 2psq_A 234 VLVT-------------------------ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288 (370)
T ss_dssp EEEC-------------------------TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHH
T ss_pred EEEC-------------------------CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHH
Confidence 9998 477899999999987654333222334567899999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||||++|||++ |..||....... +...... ......+..++..+.+||.+||+.||.+||+
T Consensus 289 wslG~il~ellt~g~~p~~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt 351 (370)
T 2psq_A 289 WSFGVLMWEIFTLGGSPYPGIPVEE---LFKLLKE--------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPT 351 (370)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHT--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 999999999999 999997643221 1111110 0011122234578999999999999999999
Q ss_pred HHHHHHHhcCC
Q 010432 429 MSEVVEALKPL 439 (511)
Q Consensus 429 ~~eil~~L~~l 439 (511)
+.+|++.|+.+
T Consensus 352 ~~ell~~L~~i 362 (370)
T 2psq_A 352 FKQLVEDLDRI 362 (370)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=391.44 Aligned_cols=271 Identities=27% Similarity=0.336 Sum_probs=207.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.++||+|+||+||+|++. ++.||||++..... ....+.+|+.+|++++|||||++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 3468999999999999999999873 57999999975432 22346679999999999999999999987
Q ss_pred CC----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCeEecccCCCcEEe
Q 010432 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE----------AERPVIYRDFKTSNILL 272 (511)
Q Consensus 207 ~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------~~~~iiHrDLKp~NILl 272 (511)
.. .+++|||||++|+|.+++... .+++..++.++.||+.||.|||+. + |+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill 164 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLL 164 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEE
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEE
Confidence 44 469999999999999999653 589999999999999999999998 7 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----CCCCccc
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRS 347 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~ 347 (511)
+ .++.+||+|||+++...............||+.|+|||++.+ ..++.++
T Consensus 165 ~-------------------------~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 219 (322)
T 3soc_A 165 K-------------------------NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219 (322)
T ss_dssp C-------------------------TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHH
T ss_pred C-------------------------CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccc
Confidence 8 477899999999986554333222334579999999999876 3567789
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhcccccc-----ccccCCccCCC-CCHHHHHHHHHHHHHhccc
Q 010432 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF-----YRLIDPRLEGH-FSIKGAQKAAQLAAHCLSR 421 (511)
Q Consensus 348 DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~Li~~cl~~ 421 (511)
|||||||++|||++|+.||.+................. ....+ .....+.+... .....+..+.+||.+||+.
T Consensus 220 DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (322)
T 3soc_A 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298 (322)
T ss_dssp HHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCS
T ss_pred hhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC-chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccC
Confidence 99999999999999999998754433222211110000 00000 00111111111 1224567799999999999
Q ss_pred CCCCCCCHHHHHHHhcCCC
Q 010432 422 DPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 422 dP~~RPs~~eil~~L~~l~ 440 (511)
||.+|||+.+|++.|+.+.
T Consensus 299 dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 299 DAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SGGGSCCHHHHHHHHHHHH
T ss_pred ChhhCcCHHHHHHHHHHHH
Confidence 9999999999999998664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=387.19 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=207.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|++.. +|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4589999999999999999999865 688999999976532 23456889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~------------ 148 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLD------------ 148 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC------------
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEc------------
Confidence 999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCC-ccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++....... ....+||+.|+|||++.+..+. .++|||||||++|||++|+.
T Consensus 149 -------------~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 212 (328)
T 3fe3_A 149 -------------ADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212 (328)
T ss_dssp -------------TTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSC
T ss_pred -------------CCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 477899999999986554332 2346899999999999888775 79999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||.+.... .+..... .... .++...+..+.+|+.+||+.||.+|||+.+++++-
T Consensus 213 pf~~~~~~---~~~~~i~---~~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 213 PFDGQNLK---ELRERVL---RGKY------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp SSCCSSHH---HHHHHHH---HCCC------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred CCCCCCHH---HHHHHHH---hCCC------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 99764321 1111111 0000 11112356789999999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=384.98 Aligned_cols=251 Identities=30% Similarity=0.364 Sum_probs=207.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++++.||+|+||+||+|+++. +|+.||||+++... ......+.+|+.+|+.++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 3579999999999999999999875 68899999997542 23345688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..|||||||++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~----------- 139 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLD----------- 139 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC-----------
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEEC-----------
Confidence 9999999999999999999998654 46899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus 140 --------------~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 203 (337)
T 1o6l_A 140 --------------KDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp --------------TTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCC
Confidence 478899999999986433222 1334689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 436 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~L 436 (511)
||...... .+.... ..... .++...+..+.+||.+||+.||.+|| ++.+|+++-
T Consensus 204 Pf~~~~~~---~~~~~i---~~~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 204 PFYNQDHE---RLFELI---LMEEI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp SSCCSSHH---HHHHHH---HHCCC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCCCCCHH---HHHHHH---HcCCC------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 99754321 111111 11100 11222357889999999999999999 899998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=387.97 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=211.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||.||+|++...+. .+..||||+++.... ...+.+.+|+.+|++++||||+++++++..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4678999999999999999999875332 456799999986533 234568999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..+||||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~------------- 185 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVD------------- 185 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEC-------------
Confidence 99999999999999999999776678999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 186 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 186 ------------SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp ------------TTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ------------CCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 4778999999999876543222 12223457889999999999999999999999999999999 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
||...... .+...... ......+..++..+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 254 p~~~~~~~---~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 254 PYWNMTNR---DVISSVEE--------------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp TTTTSCHH---HHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccCCHH---HHHHHHHc--------------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99754321 11111110 0011122234578999999999999999999999999998663
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=389.64 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=208.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhCCCCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~ 201 (511)
.++|++.+.||+|+||.||+|+++. +|..||||+++..... ..+.+.+|+.+|++++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 4679999999999999999999875 6889999999765432 246789999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++.+.+..+||||||++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~---- 153 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNI---- 153 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTS----
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCC----
Confidence 999999999999999999999999965 347999999999999999999999998 999999999999974210
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
....+||+|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 154 -----------------~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~ 213 (361)
T 2yab_A 154 -----------------PIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (361)
T ss_dssp -----------------SSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -----------------CccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh
Confidence 123799999999987655322 234679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|..||.+.... .....+.. .... +...+....+..+.+||.+||..||.+|||+.+++++-
T Consensus 214 g~~Pf~~~~~~---~~~~~i~~---~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 214 GASPFLGDTKQ---ETLANITA---VSYD--------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp SCCSSCCSSHH---HHHHHHHT---TCCC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred CCCCCCCCCHH---HHHHHHHh---cCCC--------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 99999764321 11111100 0000 00000011246789999999999999999999999853
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=382.78 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=202.4
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
+..++|++.+.||+|+||+||+|++ ++..||||++....... .+.+.+|+.+|++++||||++++++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3456899999999999999999986 36789999997664332 3568899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+...+..++|||||++|+|.+++..... .+++..++.++.||+.||+|||+++ ++|+||||||+|||++
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~-------- 173 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVD-------- 173 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEEC--------
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEe--------
Confidence 9999999999999999999999965432 3899999999999999999999976 4599999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 174 -----------------~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 234 (309)
T 3p86_A 174 -----------------KKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234 (309)
T ss_dssp -----------------TTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred -----------------CCCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHh
Confidence 477899999999986543221 1234679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|+.||....... ........ .. ...++...+..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 235 g~~Pf~~~~~~~---~~~~~~~~---------~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 235 LQQPWGNLNPAQ---VVAAVGFK---------CK----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCCTTTTSCHHH---HHHHHHHS---------CC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHH---HHHHHHhc---------CC----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999997543211 11111000 00 111222335778999999999999999999999999976643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=379.45 Aligned_cols=256 Identities=18% Similarity=0.242 Sum_probs=209.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 4689999999999999999999875 68899999997553 2345688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~------------ 138 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTR------------ 138 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSS------------
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccC------------
Confidence 9999999999999999999766667999999999999999999999998 9999999999999841
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 139 -----------~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 139 -----------RSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp -----------SCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred -----------CCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 257899999999988755432 334679999999999998889999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..... ....... .....+. .... ...+..+.+||.+||+.||.+|||+.+++++-
T Consensus 205 ~~~~~---~~~~~i~---~~~~~~~----~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 205 AETNQ---QIIENIM---NAEYTFD----EEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CSSHH---HHHHHHH---HTCCCCC----HHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCHH---HHHHHHH---cCCCCCC----hhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 64321 1111111 0000000 0000 01246789999999999999999999999854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=397.11 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=211.1
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
....++|.+.+.||+|+||.||+|++.. ++..||||+++..... ....|.+|+.+|++++|||||+++++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445789999999999999999999875 5779999999765322 22357899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+...+..+||||||++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~---------- 247 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVT---------- 247 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEc----------
Confidence 99989999999999999999999766667999999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-C
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 362 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g 362 (511)
.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 248 ---------------~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g 312 (377)
T 3cbl_A 248 ---------------EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLG 312 (377)
T ss_dssp ---------------TTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTS
T ss_pred ---------------CCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 477899999999987544321111112346788999999998999999999999999999998 9
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
..||...... ........ . .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 313 ~~p~~~~~~~---~~~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 313 ASPYPNLSNQ---QTREFVEK----G----------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCSSTTSCHH---HHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHH---HHHHHHHc----C----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 9999754321 11111110 0 01111222356789999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=383.13 Aligned_cols=257 Identities=25% Similarity=0.329 Sum_probs=206.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||+||+|++.. +++.||||++...... ..+.+.+|+.+++.++|||||++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4689999999999999999999875 6779999999755432 23568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..+||||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~------------- 139 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLD------------- 139 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------
T ss_pred CCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEe-------------
Confidence 9999999999999999999854 346999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.|
T Consensus 140 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 207 (323)
T 3tki_A 140 ------------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (323)
T ss_dssp ------------TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 477899999999986544333333345689999999999987776 7899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
|........ ....+... .. ........+..+.+||.+||+.||.+|||+.|++++-.
T Consensus 208 f~~~~~~~~-~~~~~~~~-----~~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 208 WDQPSDSCQ-EYSDWKEK-----KT---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp CSSSCTTSH-HHHHHHTT-----CT---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCCCchHHH-HHHHHhcc-----cc---------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 976543221 11111110 00 00001123467889999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=386.32 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=206.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++++.||+|+||.||+|++.. +++.||||++.... ......+.+|+.+|+.++|||||++++++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3579999999999999999999876 67899999996532 22346788999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+.+..|+|||||.+|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~----------- 149 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLD----------- 149 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-----------
T ss_pred EeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEC-----------
Confidence 999999999999999999999965 457999999999999999999999999 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc---CCCCccccchhHHHHHHHHHh
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+++....... ....+||+.|+|||++.. ..|+.++|||||||++|||++
T Consensus 150 --------------~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt 212 (384)
T 4fr4_A 150 --------------EHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212 (384)
T ss_dssp --------------TTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH
T ss_pred --------------CCCCEEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh
Confidence 478899999999987654332 344689999999999863 468999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVE 434 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-~~eil~ 434 (511)
|+.||..........+....... ...++...+..+.+||.+||+.||.+||+ +.+|++
T Consensus 213 G~~Pf~~~~~~~~~~~~~~~~~~---------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 213 GRRPYHIRSSTSSKEIVHTFETT---------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SSCSSCCCTTSCHHHHHHHHHHC---------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCCCCCCCccHHHHHHHHhhc---------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 99999865444333222221110 01112223578899999999999999998 777765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=371.97 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=204.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||+||+|++.. +++.||||++...... ....+.+|+.+|++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 578999999999999999999876 6789999999765432 23568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..+||||||. |+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~------------- 135 (292)
T 3o0g_A 73 DKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLIN------------- 135 (292)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-------------
T ss_pred CCEEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc-------------
Confidence 999999999996 5777777666678999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC-CCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 136 ------------~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p 201 (292)
T 3o0g_A 136 ------------RNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp ------------TTSCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred ------------CCCCEEEeecccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCC
Confidence 4778999999999876433222 23457899999999998765 89999999999999999999888
Q ss_pred CCCCCCCCchhHHHhhhhhhcc--cc---ccccccC---------CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGE--RR---RFYRLID---------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~---------~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
|...... ............. .. ......+ ...........+..+.+||.+||+.||.+|||+.|
T Consensus 202 ~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 279 (292)
T 3o0g_A 202 LFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp SCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CcCCCCH--HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence 6543221 1111111110000 00 0000000 00001111234578899999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
++++
T Consensus 280 ~l~h 283 (292)
T 3o0g_A 280 ALQH 283 (292)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=374.16 Aligned_cols=275 Identities=22% Similarity=0.251 Sum_probs=212.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||+||+|++.. +++.||||++..... ...+.+.+|+.+|++++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 3579999999999999999999876 678999999975432 334678899999999999999999999987
Q ss_pred CC--eEEEEEEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 207 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 207 ~~--~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
.+ ..+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+.....
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~----- 150 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED----- 150 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTT-----
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCC-----
Confidence 55 7899999999999999997532 34899999999999999999999998 999999999999832110
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc--------cCCCCccccchhHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TGHLTSRSDVYSFGV 354 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--------~~~~~~~~DIwSlGv 354 (511)
.+..+||+|||+++....... .....||+.|+|||++. +..++.++|||||||
T Consensus 151 ----------------~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 211 (319)
T 4euu_A 151 ----------------GQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211 (319)
T ss_dssp ----------------SCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHH
T ss_pred ----------------CCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHH
Confidence 356799999999987655432 23457999999999886 578899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCc-hhHHHhhhhhhcc-c-ccccc-------c-cCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 355 VLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGE-R-RRFYR-------L-IDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 355 il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~-~-~~~~~-------~-~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
++|||++|+.||........ ............. . ..+.. . -.......+....+..+.+||.+||+.||
T Consensus 212 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 291 (319)
T 4euu_A 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (319)
T ss_dssp HHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCCh
Confidence 99999999999975433221 1111111111000 0 00000 0 01111234567788899999999999999
Q ss_pred CCCCCHHHHHHHhcC
Q 010432 424 KARPLMSEVVEALKP 438 (511)
Q Consensus 424 ~~RPs~~eil~~L~~ 438 (511)
.+|||+.|++++...
T Consensus 292 ~~R~s~~ell~h~~d 306 (319)
T 4euu_A 292 EKCWGFDQFFAETSD 306 (319)
T ss_dssp TTSCCHHHHHHHHHH
T ss_pred hhhccHHHhhhccHH
Confidence 999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=374.95 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=207.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||.||+|++.. ++..||||++....... .+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 4689999999999999999999865 67799999996543322 35688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..++..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~----------- 145 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILID----------- 145 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC-----------
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC-----------
Confidence 9999999999999999999999654 47899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 146 --------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 210 (294)
T 4eqm_A 146 --------------SNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210 (294)
T ss_dssp --------------TTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 4778999999999876543222 2234579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCCCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNLK 443 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-s~~eil~~L~~l~~~~ 443 (511)
||........ ... ...... +..........+..+.+||.+||+.||.+|| ++.++++.|+.+....
T Consensus 211 pf~~~~~~~~--~~~----~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 211 PFNGETAVSI--AIK----HIQDSV-------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp SSCSSCHHHH--HHH----HHSSCC-------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCCCCChHHH--HHH----HhhccC-------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 9975432110 000 000000 0000111122357789999999999999999 8999999998775543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=388.58 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=201.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCC-CCCCcceEee
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~H~nIv~l~~ 202 (511)
..++|+++++||+|+||+||+|+++. +++.||||+++... ......+.+|..+|..+ +|||||++++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 91 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence 34789999999999999999999876 67899999997542 12335678999999988 7999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++.+.+.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~--------- 158 (353)
T 3txo_A 92 CFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLD--------- 158 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC---------
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEEC---------
Confidence 999999999999999999999999654 46999999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 159 ----------------~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 220 (353)
T 3txo_A 159 ----------------HEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220 (353)
T ss_dssp ----------------TTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHS
T ss_pred ----------------CCCCEEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhC
Confidence 478899999999986433222 23446899999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~------~eil~~ 435 (511)
+.||...... .+...+ .... ..++...+..+.+||.+||+.||.+||++ .+|+++
T Consensus 221 ~~Pf~~~~~~---~~~~~i---~~~~------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 221 HAPFEAENED---DLFEAI---LNDE------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp SCSSCCSSHH---HHHHHH---HHCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCCCCCCHH---HHHHHH---HcCC------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 9999764321 111111 1110 01112235678999999999999999998 677764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=392.11 Aligned_cols=273 Identities=27% Similarity=0.383 Sum_probs=216.7
Q ss_pred cChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCC
Q 010432 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLN 196 (511)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~n 196 (511)
+....+....++|++.+.||+|+||.||+|++.... ...+++.||||+++..... ..+.+.+|+.+|.++ +|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 344555566789999999999999999999875321 1236789999999865432 235689999999999 8999
Q ss_pred cceEeeEEEeCC-eEEEEEEccCCCCHHHHHhhCCC--------------------------------------------
Q 010432 197 LVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-------------------------------------------- 231 (511)
Q Consensus 197 Iv~l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~-------------------------------------------- 231 (511)
||++++++...+ ..++|||||++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999999998754 48999999999999999975421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 232 ---------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 232 ---------------------~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
.+++..++.++.||+.||.|||+++ ||||||||+|||++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~----------------- 227 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS----------------- 227 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC-----------------
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEc-----------------
Confidence 1889999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 369 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~ 369 (511)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 228 --------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 228 --------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp --------GGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred --------CCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 377899999999987655444444455678999999999999999999999999999999998 99999765
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
..... +....... .....+...+..+.+|+.+||+.||.+|||+.+|+++|+.+
T Consensus 300 ~~~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 300 KIDEE--FCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCSHH--HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHH--HHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 43211 11111100 01111122346789999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=375.05 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=206.7
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeE
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 210 (511)
|...+.||+|+||.||+|++.. +|+.||||++........+.+.+|+.+|++++||||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 6667789999999999999865 5789999999877666667899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecc
Q 010432 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290 (511)
Q Consensus 211 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~ 290 (511)
++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~----------------- 175 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT----------------- 175 (321)
T ss_dssp EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-----------------
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC-----------------
Confidence 999999999999999854 46899999999999999999999998 99999999999998
Q ss_pred ccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 010432 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370 (511)
Q Consensus 291 ~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~ 370 (511)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 176 --------~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 176 --------LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp --------TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --------CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4778999999999876543221 234679999999999999999999999999999999999999997543
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
.. ......... ..+.+. .....+..+.+||.+||+.||.+|||+.+++++.
T Consensus 246 ~~---~~~~~~~~~----------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 246 PV---QAMKRLRDS----------PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HH---HHHHHHHHS----------SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HH---HHHHHHhcC----------CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 21 111111110 001010 1112346789999999999999999999999854
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=389.00 Aligned_cols=257 Identities=20% Similarity=0.277 Sum_probs=211.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||.||+|.+.. +++.||+|++..........+.+|+.+|++++|||||++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 3679999999999999999999875 6789999999876544456788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...+||||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~------------ 185 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETK------------ 185 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESST------------
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecC------------
Confidence 9999999999999999999766667999999999999999999999998 9999999999999731
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
..+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 186 -----------~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 186 -----------KASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp -----------TCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred -----------CCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 246799999999987654332 233579999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..... ........ ... .+........+..+.+||.+||+.||.+|||+.+++++-
T Consensus 252 ~~~~~---~~~~~i~~---~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 252 GEDDL---ETLQNVKR---CDW--------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp CSSHH---HHHHHHHH---CCC--------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCCHH---HHHHHHHh---CCC--------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 64321 11111100 000 001111122357889999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=390.37 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=204.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
.++|+++++||+|+||+||+|+++. +++.||||+++...... ...+.+|..+|.++ +|||||+++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 4579999999999999999999876 68899999998653222 23578899999887 89999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+.+.+.+|||||||++|+|..++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~---------- 187 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLD---------- 187 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC----------
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEC----------
Confidence 99999999999999999999998654 46999999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 188 ---------------~~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~ 250 (396)
T 4dc2_A 188 ---------------SEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250 (396)
T ss_dssp ---------------TTSCEEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------CCCCEEEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 478899999999986433222 234578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCc--hhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 010432 364 RSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~------~eil~~ 435 (511)
.||........ ........... ... ...++...+..+.+||.+||+.||.+||++ .+|+++
T Consensus 251 ~Pf~~~~~~~~~~~~~~~~~~~~i---------~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 251 SPFDIVGSSDNPDQNTEDYLFQVI---------LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CSSTTTTC------CCHHHHHHHH---------HHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCCcccccccccchhhHHHHHHHH---------hcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 99975322111 00000000000 000 011222335788999999999999999986 566654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=376.90 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=203.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|+++++||+|+||+||+|++. +++.||||++...... ....+.+|+.+|++++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 368999999999999999999874 3679999999755322 2356889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..+||||||+ |+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~------------ 153 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLIN------------ 153 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC------------
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEEC------------
Confidence 9999999999996 5899888777677999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 154 -------------~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (311)
T 3niz_A 154 -------------SDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218 (311)
T ss_dssp -------------TTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------CCCCEEEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence 4778999999999876533221 334578999999999876 568999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhh-----cccccc-------ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHL-----GERRRF-------YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~-----~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
||...........+....... ...... ................+.++.+||.+||+.||.+|||+.|+
T Consensus 219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 998765443322111110000 000000 00000000000011224678999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 299 l~h 301 (311)
T 3niz_A 299 MNH 301 (311)
T ss_dssp HTS
T ss_pred hcC
Confidence 974
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=368.38 Aligned_cols=261 Identities=29% Similarity=0.539 Sum_probs=207.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccH-------HHHHHHHHHHhCCCCCCcceE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-------KEWLAEVNFLGDLVHLNLVKL 200 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-------~~~~~E~~il~~l~H~nIv~l 200 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++........ +.+.+|+.++++++||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 3679999999999999999999875 577999999976543221 568899999999999999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
++++.+.. ++||||+++|+|.+++......+++..++.++.||+.||+|||+++ ++|+||||||+|||++..+..
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~-- 163 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDEN-- 163 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTT--
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCC--
Confidence 99986554 7999999999999999877778999999999999999999999976 559999999999999842110
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc--cCCCCccccchhHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DIwSlGvil~e 358 (511)
....+||+|||+++..... .....||+.|+|||++. ...++.++|||||||++||
T Consensus 164 ------------------~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~ 220 (287)
T 4f0f_A 164 ------------------APVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220 (287)
T ss_dssp ------------------CSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHH
T ss_pred ------------------CceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHH
Confidence 1334999999999864432 33467999999999984 5567899999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
|++|+.||............ .... ......++...+..+.+||.+||+.||.+|||+.+|++.|+.
T Consensus 221 l~~g~~pf~~~~~~~~~~~~-~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 221 ILTGEGPFDEYSYGKIKFIN-MIRE-------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHSSCTTTTCCCCHHHHHH-HHHH-------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHcCCCCCccccccHHHHHH-HHhc-------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 99999999765432211111 1100 011112222345789999999999999999999999999976
Q ss_pred C
Q 010432 439 L 439 (511)
Q Consensus 439 l 439 (511)
+
T Consensus 287 l 287 (287)
T 4f0f_A 287 L 287 (287)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=393.68 Aligned_cols=259 Identities=21% Similarity=0.264 Sum_probs=209.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|.+.. +|+.||+|++...... ....+.+|+.+|++++|||||++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 45689999999999999999999876 6889999999876533 234688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+++..|||||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++...
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~-------- 147 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKL-------- 147 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSS--------
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccC--------
Confidence 9999999999999999999999765 46999999999999999999999998 99999999999998421
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+++.+||+|||+++........ .....||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 148 --------------~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~ 211 (444)
T 3soa_A 148 --------------KGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211 (444)
T ss_dssp --------------TTCCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 2567999999999876543322 234689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||...... .+...... ... .. ........++.+.+||.+||+.||.+|||+.+++++-
T Consensus 212 Pf~~~~~~---~~~~~i~~---~~~---~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 212 PFWDEDQH---RLYQQIKA---GAY---DF-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp SCCCSSHH---HHHHHHHH---TCC---CC-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred CCCCccHH---HHHHHHHh---CCC---CC-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 99754321 11111111 000 00 0111112357789999999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=379.34 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=207.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhCCCCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~ 201 (511)
.++|++.+.||+|+||.||+|++.. +|..||||++...... ..+.+.+|+.+|++++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3568999999999999999999875 6789999999765332 356789999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++...+..++|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++..+.
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~---- 152 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNV---- 152 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSS----
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCC----
Confidence 999999999999999999999999954 357999999999999999999999998 999999999999984211
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
....+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 153 -----------------~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 212 (326)
T 2y0a_A 153 -----------------PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212 (326)
T ss_dssp -----------------SSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH
Confidence 123799999999987654322 234579999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|..||...... ........ .... +........+..+.+||.+||+.||.+|||+.+++++-
T Consensus 213 g~~pf~~~~~~---~~~~~~~~---~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 213 GASPFLGDTKQ---ETLANVSA---VNYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp SCCSSCCSSHH---HHHHHHHH---TCCC--------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CcCCCCCCCHH---HHHHHHHh---cCCC--------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 99999754321 11111100 0000 00000011246789999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=393.55 Aligned_cols=267 Identities=26% Similarity=0.376 Sum_probs=209.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++++.||+|+||+||+|++.... ...++..||||+++.... .....+.+|+.+|++++|||||++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 467899999999999999999975321 123678999999975432 233568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
....+||||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+||||+..+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~---- 218 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPG---- 218 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSS----
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCC----
Confidence 999999999999999999997532 35899999999999999999999998 99999999999998422
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.+..+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+
T Consensus 219 ------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ell 280 (367)
T 3l9p_A 219 ------------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280 (367)
T ss_dssp ------------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ------------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 24569999999997532221111223456899999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 361 T-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 361 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
+ |..||...... .+....... .....+..++..+.+||.+||+.||.+||++.+|+++|+.+
T Consensus 281 t~g~~pf~~~~~~---~~~~~i~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 281 SLGYMPYPSKSNQ---EVLEFVTSG--------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTSCCSSTTCCHH---HHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHH---HHHHHHHcC--------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 8 99999754321 111111110 00111222356789999999999999999999999999765
Q ss_pred C
Q 010432 440 P 440 (511)
Q Consensus 440 ~ 440 (511)
.
T Consensus 344 ~ 344 (367)
T 3l9p_A 344 T 344 (367)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=371.15 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=209.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||.||+|++.. +..||||++..... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4678999999999999999998853 56899999986543 346789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~-------------- 140 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVG-------------- 140 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC--------------
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEc--------------
Confidence 9999999999999999999776677999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 141 -----------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~ 208 (269)
T 4hcu_A 141 -----------ENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 208 (269)
T ss_dssp -----------GGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred -----------CCCCEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCC
Confidence 3678999999999865432211 1223457889999999999999999999999999999999 99999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
...... ......... . ....+...+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 209 ~~~~~~---~~~~~~~~~----------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 209 ENRSNS---EVVEDISTG----------F----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TTCCHH---HHHHHHHTT----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHhcC----------c----cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 754321 111111100 0 1111112256789999999999999999999999999765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=380.96 Aligned_cols=257 Identities=24% Similarity=0.313 Sum_probs=205.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhCCCCCCcceEee
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
.++|++.+.||+|+||+||+|+++. +++.||||++.... ....+.+.+|+.+|+.++|||||++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3579999999999999999999876 67899999986421 123567899999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
++..++..|||||||++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~--- 167 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKE--- 167 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSS---
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCC---
Confidence 999999999999999999999887542 345899999999999999999999998 99999999999998421
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
....+||+|||+++....... .....+||+.|+|||++.+..|+.++||||||||+|||
T Consensus 168 -------------------~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 226 (351)
T 3c0i_A 168 -------------------NSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFIL 226 (351)
T ss_dssp -------------------TTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred -------------------CCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHH
Confidence 234599999999987655332 13346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
++|+.||.... ..+..... ..... ..+.... ..+..+.+||.+||+.||.+|||+.+++++
T Consensus 227 l~g~~pf~~~~----~~~~~~i~---~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 227 LSGCLPFYGTK----ERLFEGII---KGKYK----MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHSSCSSCSSH----HHHHHHHH---HTCCC----CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHCCCCCCCcH----HHHHHHHH---cCCCC----CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 99999997532 11111110 00000 0000001 124678999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=384.64 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=208.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|.+.. ++..||||++...... ..+.+.+|+.+|++|+|||||++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35679999999999999999999875 6789999999865433 235688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+.+..|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++...
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~-------- 165 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKA-------- 165 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSS--------
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCC--------
Confidence 9999999999999999999998654 46899999999999999999999998 99999999999998421
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
++..+||+|||+++....... .....||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 166 --------------~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 228 (362)
T 2bdw_A 166 --------------KGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228 (362)
T ss_dssp --------------TTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 245699999999987654332 234679999999999999899999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||..... ..+....... ... . ........+..+.+||.+||+.||.+||++.+++++
T Consensus 229 Pf~~~~~---~~~~~~i~~~---~~~---~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 229 PFWDEDQ---HRLYAQIKAG---AYD---Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp SSCCSSH---HHHHHHHHHT---CCC---C-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCH---HHHHHHHHhC---CCC---C-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9975432 1111111110 000 0 000011235678999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=383.26 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||+||+|++..++.. ....||+|.+.... ....+.+.+|+.+|++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 35789999999999999999998653221 23357899886543 2345679999999999999999999999987
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+. .++||||+.+|+|.+++......+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~------------- 151 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK------------- 151 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE-------------
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEEC-------------
Confidence 65 78999999999999999887778999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 152 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 152 ------------TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp ------------ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ------------CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence 477899999999987654443333344567899999999999999999999999999999999 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
|........ ...... ......+..++..+.+|+.+||+.||.+||++.+|+++|+.+.
T Consensus 220 ~~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 220 YDGIPASEI---SSILEK--------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTTCCGGGH---HHHHHT--------------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ccCCCHHHH---HHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 976543221 111110 0011112223567899999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=368.09 Aligned_cols=281 Identities=37% Similarity=0.617 Sum_probs=224.7
Q ss_pred ccccChHHHHHHhcCCCCC------CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC----cccHHHHHHH
Q 010432 116 LRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAE 185 (511)
Q Consensus 116 ~~~~~~~~~~~~~~~y~~~------~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E 185 (511)
...+++.++...+++|... +.||+|+||.||+|++ ++..||||++.... ....+.+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence 4567888888888888777 8999999999999985 35689999997542 1224578899
Q ss_pred HHHHhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 010432 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 263 (511)
Q Consensus 186 ~~il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHr 263 (511)
+.++++++||||+++++++...+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 157 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR 157 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence 99999999999999999999999999999999999999998632 346899999999999999999999998 9999
Q ss_pred ccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC
Q 010432 264 DFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 343 (511)
Q Consensus 264 DLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~ 343 (511)
||||+|||++ .++.+||+|||+++...............||+.|+|||++.+ .+
T Consensus 158 dlkp~Nili~-------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 211 (307)
T 2nru_A 158 DIKSANILLD-------------------------EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EI 211 (307)
T ss_dssp CCCGGGEEEC-------------------------TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EE
T ss_pred CCCHHHEEEc-------------------------CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CC
Confidence 9999999998 477899999999987655433333344679999999998764 58
Q ss_pred CccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 344 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 344 ~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
+.++|||||||++|+|++|..||........... +..........+...+++.+ ...+...+..+.+|+.+||+.||
T Consensus 212 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p 288 (307)
T 2nru_A 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD--IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKK 288 (307)
T ss_dssp CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH--HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSST
T ss_pred CccchhHHHHHHHHHHHHCCCCcccCcchHHHHH--HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCc
Confidence 9999999999999999999999986544322111 11111111112222333322 33456778899999999999999
Q ss_pred CCCCCHHHHHHHhcCC
Q 010432 424 KARPLMSEVVEALKPL 439 (511)
Q Consensus 424 ~~RPs~~eil~~L~~l 439 (511)
.+||++.+|+++|+.+
T Consensus 289 ~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 289 NKRPDIKKVQQLLQEM 304 (307)
T ss_dssp TTSCCHHHHHHHHHHH
T ss_pred ccCcCHHHHHHHHHHH
Confidence 9999999999999765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=389.63 Aligned_cols=262 Identities=24% Similarity=0.416 Sum_probs=200.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+|++.+.||+|+||.||+|++.... .++..||||+++.... ...+.|.+|+.+|++++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPS------KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTT------SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCC------CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 358999999999999999999876322 1567899999976532 234578999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..+||||||++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~------------- 181 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILIN------------- 181 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC-------------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEc-------------
Confidence 99999999999999999999876667999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.
T Consensus 182 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~ 249 (373)
T 2qol_A 182 ------------SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249 (373)
T ss_dssp ------------TTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred ------------CCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCC
Confidence 47789999999998765432211 1122346788999999999999999999999999999998 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
||...... .+....... .....+..++..+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 250 P~~~~~~~---~~~~~i~~~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 250 PYWEMSNQ---DVIKAVDEG--------------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp TTTTCCHH---HHHHHHHTT--------------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHH---HHHHHHHcC--------------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 99754321 111111110 011112233577899999999999999999999999998763
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=383.75 Aligned_cols=251 Identities=28% Similarity=0.423 Sum_probs=205.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCC-CCCCcceEe
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~H~nIv~l~ 201 (511)
...++|++.++||+|+||.||+|+++. +++.||||+++... ......+.+|..+|..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 456789999999999999999999875 68899999997542 12345678899999876 999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++.+.+..|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~-------- 152 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLD-------- 152 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC--------
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEEC--------
Confidence 9999999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+++........ ....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 153 -----------------~~g~vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 213 (345)
T 1xjd_A 153 -----------------KDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213 (345)
T ss_dssp -----------------TTSCEEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCEEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc
Confidence 4778999999999865432221 345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 434 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~-eil~ 434 (511)
|+.||...... .+...+.. . .+. ++...+..+.+||.+||+.||.+||++. +|++
T Consensus 214 g~~Pf~~~~~~---~~~~~i~~---~--------~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 214 GQSPFHGQDEE---ELFHSIRM---D--------NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp SSCSSCCSSHH---HHHHHHHH---C--------CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCCCCCHH---HHHHHHHh---C--------CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 99999754321 11111110 0 011 1122357789999999999999999997 6654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=368.33 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=212.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.++.+++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 34689999999999999999998753 56799999986543 34678999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
....++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~------------- 138 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVD------------- 138 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEEC-------------
T ss_pred CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEEC-------------
Confidence 99999999999999999999776667999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 139 ------------~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 205 (268)
T 3sxs_A 139 ------------RDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205 (268)
T ss_dssp ------------TTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCT
T ss_pred ------------CCCCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCC
Confidence 4778999999999876554322 2233457788999999998899999999999999999999 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|....... ...... ... .. ..+...+..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 206 ~~~~~~~~---~~~~~~----~~~---~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 206 YDLYTNSE---VVLKVS----QGH---RL-------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTTSCHHH---HHHHHH----TTC---CC-------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ccccChHH---HHHHHH----cCC---CC-------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 97543211 111100 000 00 0111124678999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=375.15 Aligned_cols=247 Identities=27% Similarity=0.374 Sum_probs=205.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++++.||+|+||.||+|++.. +|+.||||+++... ....+.+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 3579999999999999999999875 67899999997542 23345678999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+.+..|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~----------- 140 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLD----------- 140 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEEC-----------
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEc-----------
Confidence 9999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 141 --------------~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 201 (318)
T 1fot_A 141 --------------KNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201 (318)
T ss_dssp --------------TTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 4788999999999875432 234679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
||...... .... ....... .++...+..+.+||.+||+.||.+|| ++.+|+++
T Consensus 202 pf~~~~~~---~~~~---~i~~~~~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 202 PFYDSNTM---KTYE---KILNAEL------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TTCCSSHH---HHHH---HHHHCCC------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCHH---HHHH---HHHhCCC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 99754321 1111 1111100 11122356789999999999999999 88888864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=379.71 Aligned_cols=275 Identities=24% Similarity=0.356 Sum_probs=208.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
.++|++++.||+|+||+||+|++... ...+++.||||++........+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTT-----CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecc-----cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46899999999999999999986431 123688999999987655555678999999999999999999999865
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
....++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~------------ 148 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVE------------ 148 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE------------
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEc------------
Confidence 35689999999999999999876667999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|||++|..
T Consensus 149 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 215 (295)
T 3ugc_A 149 -------------NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215 (295)
T ss_dssp -------------ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTC
T ss_pred -------------CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccc
Confidence 4778999999999876543221 12233467888999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccc---cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGER---RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||..... ............. ......+........+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 216 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 216 KSKSPPA----EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp TTCSHHH----HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCChH----HHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 9864211 0000000000000 000001111111122334467899999999999999999999999998765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=396.30 Aligned_cols=264 Identities=20% Similarity=0.244 Sum_probs=211.4
Q ss_pred hHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCc
Q 010432 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 197 (511)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nI 197 (511)
+.++....++|+++++||+|+||+||+|+++. +++.||||+++.... .....+.+|+.+|..++||||
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I 136 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE
Confidence 44555667899999999999999999999876 678999999975321 112237889999999999999
Q ss_pred ceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 198 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
|+++++|.+.+.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+
T Consensus 137 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~---- 209 (437)
T 4aw2_A 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMD---- 209 (437)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC----
T ss_pred EEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEc----
Confidence 99999999999999999999999999999775668999999999999999999999998 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSF 352 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSl 352 (511)
.++.+||+|||+|+........ .....+||+.|||||++. ...|+.++|||||
T Consensus 210 ---------------------~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl 267 (437)
T 4aw2_A 210 ---------------------MNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267 (437)
T ss_dssp ---------------------TTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred ---------------------CCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence 4788999999999876543322 233468999999999987 5679999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHH
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMS 430 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~--RPs~~ 430 (511)
||++|||++|+.||........ ...+. .... ...-+... ...+..+.+||.+||..+|++ ||++.
T Consensus 268 Gvil~elltG~~Pf~~~~~~~~---~~~i~---~~~~---~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~ 334 (437)
T 4aw2_A 268 GVCMYEMLYGETPFYAESLVET---YGKIM---NHKE---RFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIE 334 (437)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHH---HHHHH---THHH---HCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTH
T ss_pred HHHHHHHHhCCCCCCCCChhHH---HHhhh---hccc---cccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHH
Confidence 9999999999999976432211 11110 0000 00001100 113577899999999988888 99999
Q ss_pred HHHHH
Q 010432 431 EVVEA 435 (511)
Q Consensus 431 eil~~ 435 (511)
||+++
T Consensus 335 eil~H 339 (437)
T 4aw2_A 335 DFKKH 339 (437)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=374.44 Aligned_cols=266 Identities=18% Similarity=0.173 Sum_probs=210.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+.++++| +|+||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 3679999999999999999999865 6889999999765332 3578999999999 99999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..+|||||+ +++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+|||++..+..
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~-------- 144 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNK-------- 144 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGT--------
T ss_pred CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCC--------
Confidence 99999999999 99999999876668999999999999999999999998 9999999999999852210
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcce-----eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
....+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 145 ------------~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 212 (330)
T 2izr_A 145 ------------TQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLR 212 (330)
T ss_dssp ------------CTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ------------CCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhc
Confidence 12239999999998754432211 1234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|+.||...................... ..... . ...+ .+.+|+..||+.||.+||++.+|++.|+.+
T Consensus 213 g~~Pf~~~~~~~~~~~~~~i~~~~~~~--~~~~~----~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 213 GSLPWQGLKADTLKERYQKIGDTKRAT--PIEVL----C----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SSCTTTTCCCSSHHHHHHHHHHHHHHS--CHHHH----T----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCCCccccccccHHHHHHHHHhhhccC--CHHHH----h----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 999998765443322222211100000 00000 0 0113 789999999999999999999999988754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=389.81 Aligned_cols=268 Identities=26% Similarity=0.373 Sum_probs=215.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|.+.+.||+|+||.||+|++...+. .....+..||||+++..... ....+.+|+++++++ +|||||++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34689999999999999999999754221 11224578999999765432 235688999999999 999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
..++..+||||||++|+|.+++.... ..+++..++.|+.||+.||.|||+++ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 99999999999999999999997643 35899999999999999999999998 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
|||+ .++.+||+|||+++...............||+.|+|||++.+..++.++||
T Consensus 222 Ill~-------------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 276 (382)
T 3tt0_A 222 VLVT-------------------------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276 (382)
T ss_dssp EEEC-------------------------TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHH
T ss_pred EEEc-------------------------CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHH
Confidence 9998 477899999999987655433333344568899999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||||++|||++ |..||...... .+....... .....+..++..+.+||.+||+.||.+||+
T Consensus 277 wslG~il~ellt~g~~p~~~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 339 (382)
T 3tt0_A 277 WSFGVLLWEIFTLGGSPYPGVPVE---ELFKLLKEG--------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPT 339 (382)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHTT--------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC--------------CCCCCCccCCHHHHHHHHHHcCCChhhCcC
Confidence 999999999999 99999754321 111111110 011111223577899999999999999999
Q ss_pred HHHHHHHhcCCCC
Q 010432 429 MSEVVEALKPLPN 441 (511)
Q Consensus 429 ~~eil~~L~~l~~ 441 (511)
+.+|+++|+.+..
T Consensus 340 ~~ell~~L~~~~~ 352 (382)
T 3tt0_A 340 FKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=374.42 Aligned_cols=268 Identities=25% Similarity=0.354 Sum_probs=190.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++++.||+|+||.||+|++.. +|+.||||+++.... .....+.+|+.+|++++|||||++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 3579999999999999999998765 678999999976543 233678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
++..+||||||+ |+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~-------- 142 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLIN-------- 142 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC--------
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEc--------
Confidence 999999999997 6999988643 245899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ell 360 (511)
.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 143 -----------------~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 203 (317)
T 2pmi_A 143 -----------------KRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203 (317)
T ss_dssp -----------------TTCCEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 4778999999999876433221 234578999999999876 46899999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhh-----hcc---ccccccccCCc--------cCCCCCHHHHHHHHHHHHHhcccCCC
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPH-----LGE---RRRFYRLIDPR--------LEGHFSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~-----~~~---~~~~~~~~~~~--------~~~~~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
+|+.||...........+...... +.. ...+...+... +........+..+.+||.+||+.||.
T Consensus 204 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 283 (317)
T 2pmi_A 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283 (317)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGG
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcc
Confidence 999999765432111111000000 000 00000000000 00001112346789999999999999
Q ss_pred CCCCHHHHHHH
Q 010432 425 ARPLMSEVVEA 435 (511)
Q Consensus 425 ~RPs~~eil~~ 435 (511)
+|||+.+++++
T Consensus 284 ~Rpt~~e~l~h 294 (317)
T 2pmi_A 284 MRLSAKQALHH 294 (317)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=371.26 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=197.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------------------------cHHH
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKE 181 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~ 181 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 3579999999999999999999865 6789999999765321 1245
Q ss_pred HHHHHHHHhCCCCCCcceEeeEEEe--CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 010432 182 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259 (511)
Q Consensus 182 ~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 259 (511)
+.+|+.+|++++||||+++++++.. .+..+|||||+++|+|.+++. ...+++..++.++.||+.||+|||+++
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 8899999999999999999999987 568899999999999988653 346899999999999999999999998
Q ss_pred eEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc
Q 010432 260 VIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 339 (511)
Q Consensus 260 iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~ 339 (511)
|+||||||+|||++ .++.+||+|||+++....... ......||+.|+|||++.
T Consensus 158 ivH~Dlkp~Nil~~-------------------------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~ 210 (298)
T 2zv2_A 158 IIHRDIKPSNLLVG-------------------------EDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLS 210 (298)
T ss_dssp EECCCCCGGGEEEC-------------------------TTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCC
T ss_pred eeccCCCHHHEEEC-------------------------CCCCEEEecCCCccccccccc--cccCCcCCccccChhhhc
Confidence 99999999999998 477899999999987654332 233467999999999987
Q ss_pred cCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHH
Q 010432 340 TGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 416 (511)
Q Consensus 340 ~~~---~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~ 416 (511)
+.. ++.++|||||||++|||++|+.||...... .+...... .... . + .....+..+.+||.
T Consensus 211 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~---~~~~---~--~-----~~~~~~~~l~~li~ 274 (298)
T 2zv2_A 211 ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM---CLHSKIKS---QALE---F--P-----DQPDIAEDLKDLIT 274 (298)
T ss_dssp TTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---CCCC---C--C-----SSSCCCHHHHHHHH
T ss_pred cCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH---HHHHHHhc---ccCC---C--C-----CccccCHHHHHHHH
Confidence 655 478899999999999999999999754211 11111110 0000 0 0 01122467899999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 010432 417 HCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 417 ~cl~~dP~~RPs~~eil~~ 435 (511)
+||+.||.+||++.+|+++
T Consensus 275 ~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 275 RMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHTCSCTTTSCCHHHHTTC
T ss_pred HHhhcChhhCCCHHHHhcC
Confidence 9999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=381.95 Aligned_cols=267 Identities=25% Similarity=0.373 Sum_probs=213.2
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
...++|++.+.||+|+||.||+|++..... ..++..||||+++..... ....+.+|+.+|++++||||+++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCC----CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345789999999999999999999864211 124679999999865432 245688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ii 261 (511)
...+..+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 99999999999999999999997532 56899999999999999999999998 99
Q ss_pred ecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC
Q 010432 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 341 (511)
Q Consensus 262 HrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~ 341 (511)
||||||+|||++ .++.+||+|||+++...............||+.|+|||++.+.
T Consensus 197 H~Dlkp~NIl~~-------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 197 HRDLATRNCLVG-------------------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp CSCCSGGGEEEC-------------------------GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred cCCCCcceEEEC-------------------------CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence 999999999998 4778999999999865433222223345789999999999999
Q ss_pred CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 010432 342 HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 420 (511)
Q Consensus 342 ~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~ 420 (511)
.++.++|||||||++|||++ |..||...... .+...... .. ....+...+..+.+||.+||+
T Consensus 252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~~----~~----------~~~~~~~~~~~l~~li~~~l~ 314 (343)
T 1luf_A 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---EVIYYVRD----GN----------ILACPENCPLELYNLMRLCWS 314 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHT----TC----------CCCCCTTCCHHHHHHHHHHTC
T ss_pred CcCcccccHHHHHHHHHHHhcCCCcCCCCChH---HHHHHHhC----CC----------cCCCCCCCCHHHHHHHHHHcc
Confidence 99999999999999999999 99999754321 11111110 00 001122335678999999999
Q ss_pred cCCCCCCCHHHHHHHhcCCCC
Q 010432 421 RDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 421 ~dP~~RPs~~eil~~L~~l~~ 441 (511)
.||.+||++.+|++.|+.+..
T Consensus 315 ~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 315 KLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcccCCCHHHHHHHHHHHHh
Confidence 999999999999999987754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=370.60 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=199.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++|++.+.||+|+||.||+|++...+. .+..||||++...... ..+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~- 85 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence 34689999999999999999999865322 4668999999765332 345688999999999999999999987
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~------------ 150 (281)
T 1mp8_A 86 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVS------------ 150 (281)
T ss_dssp CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE------------
T ss_pred ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEEC------------
Confidence 456789999999999999999877667999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 151 -------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~ 216 (281)
T 1mp8_A 151 -------------SNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216 (281)
T ss_dssp -------------ETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred -------------CCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCC
Confidence 3678999999999876543222 1233467889999999998999999999999999999997 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||....... ........ . ....+...+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 217 pf~~~~~~~---~~~~i~~~----~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 217 PFQGVKNND---VIGRIENG----E----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp TTTTCCGGG---HHHHHHTT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHH---HHHHHHcC----C----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 997654321 11111100 0 0111223357889999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=381.50 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=205.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
..++|++.+.||+|+||.||+|+++. +++.||||++...... +.+|+++|.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 34679999999999999999999875 6889999999765432 34688888887 7999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++..|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+.....
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~-------- 154 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESG-------- 154 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSC--------
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCC--------
Confidence 999999999999999999999654 46999999999999999999999998 999999999999863110
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
....+||+|||+++........ ....+||+.|+|||++.+..|+.++|||||||++|||++|..|
T Consensus 155 -------------~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 219 (342)
T 2qr7_A 155 -------------NPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219 (342)
T ss_dssp -------------SGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------CcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCC
Confidence 1346999999999876443221 3346799999999999888899999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|..........+....... .. .+........+..+.+||.+||+.||.+||++.+++++
T Consensus 220 f~~~~~~~~~~~~~~i~~~---~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 220 FANGPDDTPEEILARIGSG---KF--------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp SCSSTTSCHHHHHHHHHHC---CC--------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCcCCHHHHHHHHccC---Cc--------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9764333222222211110 00 01111122335788999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=397.83 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=215.3
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.+...+|++.+.||+|+||.||+|++.. ++..||||+++.... ..+.|.+|+.+|++++|||||++++++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3445678999999999999999999875 577999999986543 357899999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
...+..+||||||++|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~---------- 352 (495)
T 1opk_A 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVG---------- 352 (495)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------
T ss_pred ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEC----------
Confidence 9999999999999999999999754 346899999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-C
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 362 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g 362 (511)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+||||++ |
T Consensus 353 ---------------~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g 416 (495)
T 1opk_A 353 ---------------ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 416 (495)
T ss_dssp ---------------GGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred ---------------CCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCC
Confidence 477899999999987654322 12223456789999999999999999999999999999999 9
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
..||....... +...... ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 417 ~~p~~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 417 MSPYPGIDLSQ---VYELLEK--------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCSSTTCCGGG---HHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHH---HHHHHHc--------------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 99997653221 1111110 11112223345789999999999999999999999999988753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=378.92 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=203.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
.++|++++.||+|+||.||+|+++. +++.||||+++...... ...+.+|+.+|.++ +|||||+++++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 3579999999999999999999875 68899999998654322 34578899999988 89999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+.+.+..|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~---------- 144 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLD---------- 144 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC----------
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEC----------
Confidence 99999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 145 ---------------~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 207 (345)
T 3a8x_A 145 ---------------SEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207 (345)
T ss_dssp ---------------TTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------CCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCC
Confidence 478899999999986433222 134468999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCch--hHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 010432 364 RSMDKNRPNGEH--NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~------~eil~~ 435 (511)
.||......... .......... ... ...++...+..+.+||.+||+.||.+||++ .+|+++
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~i---------~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 208 SPFDIVGSSDNPDQNTEDYLFQVI---------LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CTTTTTTC-------CHHHHHHHH---------HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCcCCcccccccccccHHHHHHHH---------HcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 999753221100 0000000000 000 001122335778999999999999999996 566553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=378.32 Aligned_cols=247 Identities=25% Similarity=0.305 Sum_probs=205.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++++.||+|+||.||+|++.. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4689999999999999999999875 67899999996542 23346788999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+.+..|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~----------- 175 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLID----------- 175 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-----------
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEEC-----------
Confidence 9999999999999999999999654 46899999999999999999999999 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 176 --------------~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (350)
T 1rdq_E 176 --------------QQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236 (350)
T ss_dssp --------------TTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCC
Confidence 4778999999999876442 234679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
||...... .+...+ .... . .++...+..+.+||.+||+.||.+||+ +.+|+++
T Consensus 237 Pf~~~~~~---~~~~~i---~~~~--------~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 237 PFFADQPI---QIYEKI---VSGK--------V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SSCCSSHH---HHHHHH---HHCC--------C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCHH---HHHHHH---HcCC--------C----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 99754321 111111 1000 0 112223577899999999999999998 7888764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=382.08 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=207.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||+||+|++..++.. ....||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35789999999999999999998763321 233588888864432 22345778999999999999999999886
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..++||||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~------------- 149 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLK------------- 149 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEES-------------
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEEC-------------
Confidence 45689999999999999999766567899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 150 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 150 ------------SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp ------------SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ------------CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 477899999999998765444433455678899999999999999999999999999999999 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|...........+. .. . ....+..++..+.+||.+||+.||.+||++.+|+++|+.+..
T Consensus 218 ~~~~~~~~~~~~~~---~~----~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 218 YAGLRLAEVPDLLE---KG----E----------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTSCTTHHHHHHH---TT----C----------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ccccCHHHHHHHHH---cC----C----------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 98654332211111 00 0 000111123457799999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=379.50 Aligned_cols=257 Identities=21% Similarity=0.259 Sum_probs=196.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++++.||+|+||+||+|++.. +++.||||++...... .+.+.+|+.+++.++|||||++++++...
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 3579999999999999999999876 6789999999765433 35688999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..+||||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~------------ 152 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGS------------ 152 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSS------------
T ss_pred CEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCC------------
Confidence 9999999999999999998654 36999999999999999999999998 9999999999999841
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCcc-ccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~-~DIwSlGvil~elltg~~pf 366 (511)
....+||+|||+++....... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 153 -----------~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf 218 (361)
T 3uc3_A 153 -----------PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218 (361)
T ss_dssp -----------SSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----------CCceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCC
Confidence 133599999999985433221 234579999999999988887665 89999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
.......... .......... .........+..+.+||.+||+.||.+|||+.+++++-
T Consensus 219 ~~~~~~~~~~--~~~~~~~~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 219 EDPEEPRDYR--KTIQRILSVK----------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp C----CCCHH--HHHHHHHTTC----------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCCccHHHHH--HHHHHHhcCC----------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 7654322211 1111111000 00000111246789999999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=392.56 Aligned_cols=263 Identities=21% Similarity=0.239 Sum_probs=208.7
Q ss_pred hHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCc
Q 010432 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 197 (511)
Q Consensus 121 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nI 197 (511)
+.+.....++|+++++||+|+||.||+|+++. +|+.||||++++... .....+.+|+.+|..++||||
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I 123 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe
Confidence 34445567899999999999999999999875 688999999975321 112347889999999999999
Q ss_pred ceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 198 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
+++++++.+.+.+|||||||++|+|.+++.+....+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 124 v~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld---- 196 (412)
T 2vd5_A 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLD---- 196 (412)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC----
T ss_pred eeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeec----
Confidence 99999999999999999999999999999766567999999999999999999999998 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-------cCCCCccccch
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVY 350 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-------~~~~~~~~DIw 350 (511)
.++.+||+|||+++........ .....+||+.|+|||++. ...|+.++|||
T Consensus 197 ---------------------~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~Diw 254 (412)
T 2vd5_A 197 ---------------------RCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254 (412)
T ss_dssp ---------------------TTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHH
T ss_pred ---------------------CCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhh
Confidence 4788999999999876543321 223468999999999987 35789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC---C
Q 010432 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---P 427 (511)
Q Consensus 351 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R---P 427 (511)
||||++|||++|+.||........ ...+.. ... ....+.+ ....+.++.+||.+||. +|.+| |
T Consensus 255 SlGvilyelltG~~Pf~~~~~~~~---~~~i~~---~~~---~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~ 320 (412)
T 2vd5_A 255 ALGVFAYEMFYGQTPFYADSTAET---YGKIVH---YKE---HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRG 320 (412)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHH---HHHHHT---HHH---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTT
T ss_pred HHhHHHHHHHhCCCCCCCCCHHHH---HHHHHh---ccc---CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 999999999999999976432211 111100 000 0000111 11235788999999999 99998 5
Q ss_pred CHHHHHHH
Q 010432 428 LMSEVVEA 435 (511)
Q Consensus 428 s~~eil~~ 435 (511)
++.+|+++
T Consensus 321 ~~~ei~~H 328 (412)
T 2vd5_A 321 GAGDFRTH 328 (412)
T ss_dssp THHHHHTS
T ss_pred CHHHHhcC
Confidence 89999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=374.93 Aligned_cols=264 Identities=27% Similarity=0.391 Sum_probs=213.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++|.+.+.||+|+||.||+|.+.... ...++..||||++..... ...+.+.+|+.+|++++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred chhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 4578999999999999999999875321 112567999999976532 23356889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH 262 (511)
..+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 9999999999999999999997542 23889999999999999999999998 999
Q ss_pred cccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC
Q 010432 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 342 (511)
Q Consensus 263 rDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~ 342 (511)
|||||+|||++ .++.+||+|||+++...............||+.|+|||++.+..
T Consensus 174 ~dikp~NIli~-------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 174 RDLAARNILVA-------------------------EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp CCCSGGGEEEE-------------------------TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred cccchheEEEc-------------------------CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence 99999999998 47789999999998765544333333456789999999999999
Q ss_pred CCccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccc
Q 010432 343 LTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 421 (511)
Q Consensus 343 ~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~ 421 (511)
++.++|||||||++|||++ |..||........ ....... .....+...+..+.+|+.+||+.
T Consensus 229 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~ 291 (314)
T 2ivs_A 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL---FNLLKTG--------------HRMERPDNCSEEMYRLMLQCWKQ 291 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHhhcC--------------CcCCCCccCCHHHHHHHHHHccC
Confidence 9999999999999999999 9999976543221 1111100 01111223357889999999999
Q ss_pred CCCCCCCHHHHHHHhcCC
Q 010432 422 DPKARPLMSEVVEALKPL 439 (511)
Q Consensus 422 dP~~RPs~~eil~~L~~l 439 (511)
||.+||++.+|+++|+.+
T Consensus 292 dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 292 EPDKRPVFADISKDLEKM 309 (314)
T ss_dssp SGGGSCCHHHHHHHHHHH
T ss_pred ChhhCcCHHHHHHHHHHH
Confidence 999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=379.31 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=205.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCC-CCCCcceEee
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~H~nIv~l~~ 202 (511)
..++|+++++||+|+||.||+|+++. +++.||||+++... ....+.+.+|..+|..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 45689999999999999999999875 67899999997542 22345688999999988 8999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++.+.+..|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~--------- 155 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLD--------- 155 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC---------
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEc---------
Confidence 999999999999999999999999654 36899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 156 ----------------~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 217 (353)
T 2i0e_A 156 ----------------SEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217 (353)
T ss_dssp ----------------TTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred ----------------CCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcC
Confidence 478899999999986433222 13346899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
+.||...... .+...+ .... ..++...+..+.+||.+||+.||.+||+ +.+|+++
T Consensus 218 ~~Pf~~~~~~---~~~~~i---~~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 218 QAPFEGEDED---ELFQSI---MEHN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp SCSSCCSSHH---HHHHHH---HHCC------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCCCCHH---HHHHHH---HhCC------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999754321 111111 1110 0112223578899999999999999995 4667654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=391.02 Aligned_cols=261 Identities=23% Similarity=0.276 Sum_probs=208.7
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcc
Q 010432 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLV 198 (511)
Q Consensus 122 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv 198 (511)
.++....++|+++++||+|+||+||+|+++. +++.||||+++.... .....+.+|+.+|+.++|||||
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv 132 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBC
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence 3444556899999999999999999999876 678999999965211 1123478999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
+++++|.+++.+|||||||++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+
T Consensus 133 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~----- 202 (410)
T 3v8s_A 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLD----- 202 (410)
T ss_dssp CEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-----
T ss_pred eEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeEC-----
Confidence 9999999999999999999999999998653 5899999999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC----CCccccchhHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGV 354 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DIwSlGv 354 (511)
.++.+||+|||+|+........ .....+||+.|+|||++.+.. |+.++|||||||
T Consensus 203 --------------------~~g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGv 261 (410)
T 3v8s_A 203 --------------------KSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 261 (410)
T ss_dssp --------------------TTSCEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHH
T ss_pred --------------------CCCCEEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchH
Confidence 4788999999999876543321 233578999999999998665 889999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHH
Q 010432 355 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEV 432 (511)
Q Consensus 355 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~--RPs~~ei 432 (511)
+||||++|+.||........ ...+.. .... ..-+ .....+..+.+||.+||+.+|.+ ||++.||
T Consensus 262 ilyell~G~~Pf~~~~~~~~---~~~i~~---~~~~---~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei 327 (410)
T 3v8s_A 262 FLYEMLVGDTPFYADSLVGT---YSKIMN---HKNS---LTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEI 327 (410)
T ss_dssp HHHHHHHSSCTTCCSSHHHH---HHHHHT---HHHH---CCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHH
T ss_pred HHHHHHhCCCCCCCCChhhH---HHHHHh---cccc---ccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHH
Confidence 99999999999976432211 111100 0000 0000 00112477899999999999988 9999999
Q ss_pred HHHh
Q 010432 433 VEAL 436 (511)
Q Consensus 433 l~~L 436 (511)
+++-
T Consensus 328 ~~Hp 331 (410)
T 3v8s_A 328 KRHL 331 (410)
T ss_dssp HTSG
T ss_pred hcCc
Confidence 9864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=383.53 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=200.4
Q ss_pred CCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEE
Q 010432 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (511)
Q Consensus 133 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 212 (511)
..++||+|+||.||+|++.. +|..||||+++.......+.+.+|+.+|++|+|||||++++++...+..+|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp EEEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 35679999999999999875 678999999987665556779999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+...
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~----------------- 223 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNR----------------- 223 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEET-----------------
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecC-----------------
Confidence 99999999999999776667999999999999999999999998 9999999999999521
Q ss_pred ccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~ 372 (511)
.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 224 ------~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 294 (373)
T 2x4f_A 224 ------DAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294 (373)
T ss_dssp ------TTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ------CCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 356799999999987654332 22357999999999999899999999999999999999999999764321
Q ss_pred CchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 373 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
. .+..... .... . ........+..+.+||.+||+.||.+||++.+++++
T Consensus 295 ~--~~~~i~~----~~~~---~-----~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 295 E--TLNNILA----CRWD---L-----EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp H--HHHHHHH----TCCC---S-----CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred H--HHHHHHh----ccCC---C-----ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 1111111 0000 0 000001224678999999999999999999999984
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=375.09 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=197.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++|++.+.||+|+||.||+|+++. +|+.||||+++..... ..+.+.+|+.+|++++|||||+++++|.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 74 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 74 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34679999999999999999999875 6789999999765432 3467899999999999999999999986
Q ss_pred eCC---------------------------------------------------------eEEEEEEccCCCCHHHHHhh
Q 010432 206 EDD---------------------------------------------------------QRLLVYEFMPRGSLENHLFR 228 (511)
Q Consensus 206 ~~~---------------------------------------------------------~~~lv~E~~~~g~L~~~l~~ 228 (511)
+.. ..++|||||++|+|.+++..
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 154 (332)
T 3qd2_B 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154 (332)
T ss_dssp ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence 643 37999999999999999975
Q ss_pred CC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeee
Q 010432 229 RS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306 (511)
Q Consensus 229 ~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 306 (511)
.. ...++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+
T Consensus 155 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~-------------------------~~~~~kL~ 206 (332)
T 3qd2_B 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFT-------------------------MDDVVKVG 206 (332)
T ss_dssp CCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC-------------------------TTCCEEEC
T ss_pred ccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEe-------------------------CCCCEEEe
Confidence 43 23566678999999999999999998 99999999999998 47789999
Q ss_pred cCCCcccCCCCCcc----------eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchh
Q 010432 307 DFGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 376 (511)
Q Consensus 307 DFGla~~~~~~~~~----------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~ 376 (511)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+... ..
T Consensus 207 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~ 281 (332)
T 3qd2_B 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VR 281 (332)
T ss_dssp CCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HH
T ss_pred ecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HH
Confidence 99999876553211 1123357999999999999999999999999999999999987664210 00
Q ss_pred HHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 377 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...... ... ........++.+.+||.+||+.||.+||++.+++++
T Consensus 282 ~~~~~~-------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 282 IITDVR-------------NLK-FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHH-------------TTC-CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHhh-------------ccC-CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 000000 000 001112334677899999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=373.19 Aligned_cols=247 Identities=26% Similarity=0.265 Sum_probs=196.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
.++|++.++||+|+||+||+|++.. +++.||||++...... ....+..|+..+.++ +|+|||+++++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 4679999999999999999999875 5789999998764332 223456666666555 999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+++..+|||||| +++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+|||++
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~----------- 191 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLG----------- 191 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-----------
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEC-----------
Confidence 9999999999999 77999999877778999999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|||++|..
T Consensus 192 --------------~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~ 253 (311)
T 3p1a_A 192 --------------PRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME 253 (311)
T ss_dssp --------------GGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCC
T ss_pred --------------CCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCC
Confidence 477899999999987654322 234569999999998875 79999999999999999999977
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||.... ..... . .......+....+..+.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~-----~~~~~-~-------------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 254 LPHGGE-----GWQQL-R-------------QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CCSSHH-----HHHHH-T-------------TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCcc-----HHHHH-h-------------ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 764321 11000 0 0000001111224778999999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=369.05 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=200.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||.||+|++. +++.||||++...... ....+.+|+.+|++++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 47899999999999999999873 4779999999765322 23678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||+. ++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~------------- 134 (288)
T 1ob3_A 72 KKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLIN------------- 134 (288)
T ss_dssp SSCEEEEEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC-------------
T ss_pred CCeEEEEEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc-------------
Confidence 999999999996 4999999776678999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 135 ------------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (288)
T 1ob3_A 135 ------------REGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (288)
T ss_dssp ------------TTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------CCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 477899999999986543221 1233578999999999876 4689999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhcc-----cccccc--ccCCcc-------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGE-----RRRFYR--LIDPRL-------EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~-----~~~~~~--~~~~~~-------~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
|........ +..... .... ...... ..++.+ ...+....+..+.+||.+||+.||.+|||+.+
T Consensus 201 f~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 277 (288)
T 1ob3_A 201 FPGVSEADQ--LMRIFR-ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (288)
T ss_dssp CCCSSHHHH--HHHHHH-HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCHHHH--HHHHHH-HHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 976432211 111110 0000 000000 000000 00111223577899999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
++++
T Consensus 278 ~l~h 281 (288)
T 1ob3_A 278 ALEH 281 (288)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=379.79 Aligned_cols=267 Identities=25% Similarity=0.378 Sum_probs=212.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|++.... ...++..||||++..... ...+.+.+|+.+|.++ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4578999999999999999999974311 123577899999975432 2346789999999999 999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH 262 (511)
...+..+||||||++|+|.+++..... .+++..++.++.||+.||.|||+++ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999999999999999999999975432 3789999999999999999999998 999
Q ss_pred cccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC
Q 010432 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 342 (511)
Q Consensus 263 rDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~ 342 (511)
|||||+|||++ .++.+||+|||+++...............||+.|+|||++.+..
T Consensus 196 ~Dikp~NIll~-------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 250 (344)
T 1rjb_A 196 RDLAARNVLVT-------------------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250 (344)
T ss_dssp TTCSGGGEEEE-------------------------TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred CCCChhhEEEc-------------------------CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC
Confidence 99999999998 47789999999998765544333344467889999999999999
Q ss_pred CCccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccc
Q 010432 343 LTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 421 (511)
Q Consensus 343 ~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~ 421 (511)
++.++|||||||++|||++ |..||....... .+...... ......+...+..+.+||.+||+.
T Consensus 251 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~ 314 (344)
T 1rjb_A 251 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA--NFYKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAF 314 (344)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CChhHhHHHHHHHHHHHHcCCCCCcccCCcHH--HHHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCC
Confidence 9999999999999999998 999997654321 11111111 011111222357899999999999
Q ss_pred CCCCCCCHHHHHHHhcCCCC
Q 010432 422 DPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 422 dP~~RPs~~eil~~L~~l~~ 441 (511)
||.+||++.+|+++|+.+..
T Consensus 315 dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 315 DSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp SGGGSCCHHHHHHHHHHHC-
T ss_pred CchhCcCHHHHHHHHHHHHH
Confidence 99999999999999986543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=365.23 Aligned_cols=268 Identities=17% Similarity=0.157 Sum_probs=213.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+.++..+ +|+||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCCcc--HHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 4679999999999999999999865 6789999999754322 3578899999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
....++||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++..+..
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~-------- 145 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSK-------- 145 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSST--------
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCC--------
Confidence 99999999999 99999999876667999999999999999999999998 9999999999999842210
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
....+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 146 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 213 (298)
T 1csn_A 146 ------------NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 213 (298)
T ss_dssp ------------TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ------------CCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc
Confidence 2345999999999876543221 11234679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
|+.||..................... ..... +.. ..+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 214 g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 214 GSLPWQGLKAATNKQKYERIGEKKQS-TPLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp SSCTTSSCCSCCHHHHHHHHHHHHHH-SCHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCcchhhccccHHHHHHHHhhccC-ccHHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 99999875543332222211111000 00000 011 12467899999999999999999999999998664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=378.55 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=204.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|.+.+.||+|+||.||+|++.. +++.||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3689999999999999999999865 67899999996432 12235688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..++||||+ +|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~----------- 142 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLD----------- 142 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEEC-----------
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEc-----------
Confidence 9999999999999 78999988654 46999999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~ 363 (511)
+++.+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+
T Consensus 143 --------------~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 205 (336)
T 3h4j_B 143 --------------DNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205 (336)
T ss_dssp --------------TTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS
T ss_pred --------------CCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC
Confidence 477899999999987654332 234579999999999988776 68999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
.||......... ..+... ...++...+..+.+||.+||+.||.+|||+.+|+++-
T Consensus 206 ~Pf~~~~~~~~~-----------------~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 206 LPFDDEFIPNLF-----------------KKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp CSSBCSSSTTCB-----------------CCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CCCCCccHHHHH-----------------HHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 999754322110 000000 0111222357789999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=375.18 Aligned_cols=263 Identities=23% Similarity=0.359 Sum_probs=204.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|+++++||+|+||.||+|++...+.. ....||+|.+.... ......+.+|+.+|++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 36799999999999999999998763321 12357888886543 3345778999999999999999999999987
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+. .++||||+.+|+|.+++......+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~------------- 151 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK------------- 151 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE-------------
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEc-------------
Confidence 65 78999999999999999877778999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 152 ------------~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 219 (327)
T 3lzb_A 152 ------------TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp ------------ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ------------CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence 367899999999987655433333344567889999999999999999999999999999999 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|........ ...... ......+...+..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 220 ~~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 220 YDGIPASEI---SSILEK--------------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTTCCGGGH---HHHHHT--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCHHHH---HHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 976543221 111110 00111122235678999999999999999999999999987643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.16 Aligned_cols=270 Identities=24% Similarity=0.341 Sum_probs=208.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|.+.+.||+|+||.||+|++...+... ...+..||+|++........+.+.+|+.+|++++||||+++++++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYG--QLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGG--CEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccc--cccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 467899999999999999999987532100 001257999999776555667899999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.......+
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~------ 155 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG------ 155 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT------
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc------
Confidence 9999999999999999999876656999999999999999999999998 9999999999999853321111
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+...+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+
T Consensus 156 -----------~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 156 -----------NPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp -----------BCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -----------ccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 1234999999999765432 23468999999999987 77999999999999999999965555
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 443 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 443 (511)
...... ....... ..... +.. ..+..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 219 ~~~~~~--~~~~~~~----~~~~~--------~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 219 LSALDS--QRKLQFY----EDRHQ--------LPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TTTSCH--HHHHHHH----HTTCC--------CCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ccccch--HHHHHHh----hccCC--------CCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 432211 1111100 00000 011 11345789999999999999999999999999886543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.48 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=197.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCC--CCcceEeeE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVH--LNLVKLIGY 203 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H--~nIv~l~~~ 203 (511)
.++|++++.||+|+||.||+|.+. ++..||||++...... ..+.+.+|+.+|.+++| +||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 467999999999999999999864 4678999999765433 23568899999999976 999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+..++..+||||+ .+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~---------- 142 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV---------- 142 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE----------
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE----------
Confidence 9999999999995 588999999764 47899999999999999999999998 99999999999996
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----------CCCCccccchhH
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSF 352 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DIwSl 352 (511)
++.+||+|||+++..............+||+.|+|||++.+ ..++.++|||||
T Consensus 143 ----------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 143 ----------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp ----------------TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred ----------------CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 55699999999987755443333445689999999999865 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
||++|||++|+.||...... .... ...+++.....++...+..+.+||.+||+.||.+|||+.++
T Consensus 207 G~il~ell~g~~pf~~~~~~-----~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~ 271 (343)
T 3dbq_A 207 GCILYYMTYGKTPFQQIINQ-----ISKL----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271 (343)
T ss_dssp HHHHHHHHHSSCTTTTCCSH-----HHHH----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHHHhCCCcchhhhhH-----HHHH----------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99999999999999753221 0000 11111111222222234678999999999999999999999
Q ss_pred HHHh
Q 010432 433 VEAL 436 (511)
Q Consensus 433 l~~L 436 (511)
+++.
T Consensus 272 l~hp 275 (343)
T 3dbq_A 272 LAHP 275 (343)
T ss_dssp HTSH
T ss_pred HhCc
Confidence 9864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=364.27 Aligned_cols=262 Identities=29% Similarity=0.467 Sum_probs=197.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc----cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.++|++.+.||+|+||.||+|++ ++..||||+++..... ..+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 35789999999999999999987 3668999999764322 23568899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+..++..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++..+|+||||||+|||++.....
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~----- 147 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN----- 147 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS-----
T ss_pred EecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc-----
Confidence 9999999999999999999999853 478999999999999999999999875558999999999999842110
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
....++.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 148 ------------~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 148 ------------GDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp ------------SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCC
T ss_pred ------------ccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 00025679999999998654432 22357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.||....... .... ..........+...+..+.+|+.+||+.||.+|||+.+++++|+.+
T Consensus 212 ~p~~~~~~~~---~~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 212 VPFRGIDGLA---VAYG-------------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CTTTTSCHHH---HHHH-------------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCHHH---HHHh-------------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 9997543211 0000 0000111112223357899999999999999999999999999754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=376.16 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=193.4
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
...++|++.+.||+|+||.||+|++...+. ....||||+++.... ...+.+.+|+.++++++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 345789999999999999999998765221 224899999976532 334678999999999999999999999
Q ss_pred EEeCCeE------EEEEEccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 204 CIEDDQR------LLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 204 ~~~~~~~------~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
+...... ++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEE
Confidence 9877655 9999999999999998632 225899999999999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
+ +++.+||+|||+++...............||+.|+|||++.+..++.++|||||
T Consensus 171 ~-------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (323)
T 3qup_A 171 A-------------------------EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225 (323)
T ss_dssp C-------------------------TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred c-------------------------CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhH
Confidence 8 477899999999987655443333344567889999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 353 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 353 Gvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
||++|||++ |..||........ ....... .....+...+..+.+|+.+||+.||.+|||+.+
T Consensus 226 G~il~ell~~g~~p~~~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 288 (323)
T 3qup_A 226 GVTMWEIMTRGQTPYAGIENAEI---YNYLIGG--------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288 (323)
T ss_dssp HHHHHHHHTTSCCTTTTCCGGGH---HHHHHTT--------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCccccChHHH---HHHHhcC--------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999 9999976543211 1111000 001112223567899999999999999999999
Q ss_pred HHHHhcCCC
Q 010432 432 VVEALKPLP 440 (511)
Q Consensus 432 il~~L~~l~ 440 (511)
+++.|+.+.
T Consensus 289 l~~~l~~~l 297 (323)
T 3qup_A 289 LRMELENIL 297 (323)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=383.40 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=197.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCC--CCCcceEeeEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLV--HLNLVKLIGYC 204 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~--H~nIv~l~~~~ 204 (511)
.+|++++.||+|+||.||+|.+. .++.||||++...... ....+.+|+.+|.+|. |+|||++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 56999999999999999999864 3678999999765432 3356889999999996 59999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..++.+||||| +.+++|.+++.... .+++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~----------- 189 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV----------- 189 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-----------
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-----------
Confidence 99999999999 55889999997654 7889999999999999999999998 99999999999996
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----------CCCCccccchhHH
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFG 353 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DIwSlG 353 (511)
++.+||+|||+++..............+||+.|+|||++.+ ..|+.++||||||
T Consensus 190 ---------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG 254 (390)
T 2zmd_A 190 ---------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254 (390)
T ss_dssp ---------------SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH
T ss_pred ---------------CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH
Confidence 46799999999987654433323345689999999999865 4689999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 354 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
||||||++|+.||...... ..... .++++.....++...+..+.+||.+||+.||.+||++.+|+
T Consensus 255 vil~ell~G~~Pf~~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 255 CILYYMTYGKTPFQQIINQ-----ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp HHHHHHHHSSCTTTTCCCH-----HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHCCCcchhhhHH-----HHHHH----------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 9999999999999753221 00111 11111111112222246789999999999999999999999
Q ss_pred HHh
Q 010432 434 EAL 436 (511)
Q Consensus 434 ~~L 436 (511)
++.
T Consensus 320 ~hp 322 (390)
T 2zmd_A 320 AHP 322 (390)
T ss_dssp TSH
T ss_pred hCc
Confidence 764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=390.18 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=205.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||.||+|.+. +..||||+++... ..+.|.+|+.+|++++|||||++++++..
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 4568899999999999999999873 5689999998654 34679999999999999999999999887
Q ss_pred CC-eEEEEEEccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 207 DD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 207 ~~-~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+ ..+||||||++|+|.+++..... .+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~----------- 323 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVS----------- 323 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC-----------
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEC-----------
Confidence 65 78999999999999999976543 4799999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~ 363 (511)
.++.+||+|||+++...... ....+|+.|+|||++.+..++.++|||||||+||||++ |+
T Consensus 324 --------------~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 384 (450)
T 1k9a_A 324 --------------EDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384 (450)
T ss_dssp --------------TTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred --------------CCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 47789999999998653321 22367899999999999999999999999999999998 99
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.||......... ..... ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 385 ~P~~~~~~~~~~---~~i~~--------------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 385 VPYPRIPLKDVV---PRVEK--------------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CSSTTSCTTTHH---HHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHH---HHHHc--------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 999765433211 11110 011112233457899999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=369.02 Aligned_cols=256 Identities=21% Similarity=0.362 Sum_probs=206.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.++.+++|+||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3468999999999999999999875 366899999986543 34678999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~------------- 154 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVN------------- 154 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEEC-------------
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEc-------------
Confidence 99999999999999999999765567999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 155 ------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p 221 (283)
T 3gen_A 155 ------------DQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221 (283)
T ss_dssp ------------TTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ------------CCCCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 4778999999999865432211 1223457889999999998999999999999999999998 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|...... ........ .. ....+...+..+.+|+.+||+.||.+|||+.+++++|..+
T Consensus 222 ~~~~~~~---~~~~~~~~----------~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 222 YERFTNS---ETAEHIAQ----------GL----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp TTTSCHH---HHHHHHHT----------TC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccChh---HHHHHHhc----------cc----CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 9754321 11111110 00 0111112246789999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=368.14 Aligned_cols=261 Identities=26% Similarity=0.379 Sum_probs=200.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhC--CCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 46899999999999999999987 4678999999654 23456667777665 89999999999876
Q ss_pred eC----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecccCCCcEEec
Q 010432 206 ED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 206 ~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~~iiHrDLKp~NILl~ 273 (511)
.. ...++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +++ |+||||||+|||++
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVK 147 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEEC
T ss_pred cccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEc
Confidence 52 458899999999999999943 46899999999999999999999 777 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccC------CCCc
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTS 345 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~------~~~~ 345 (511)
.++.+||+|||+++......... ......||+.|+|||++.+. .++.
T Consensus 148 -------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 202 (301)
T 3q4u_A 148 -------------------------KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK 202 (301)
T ss_dssp -------------------------TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHH
T ss_pred -------------------------CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCc
Confidence 47789999999997654432221 12234799999999999876 5667
Q ss_pred cccchhHHHHHHHHHhC----------CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccC-CCCCHHHHHHHHHH
Q 010432 346 RSDVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE-GHFSIKGAQKAAQL 414 (511)
Q Consensus 346 ~~DIwSlGvil~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L 414 (511)
++|||||||++|||++| ..||............ ... .... ....+.+. ..+....+..+.+|
T Consensus 203 ~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~-~~~-~~~~-----~~~~~~~~~~~~~~~~~~~l~~l 275 (301)
T 3q4u_A 203 RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED-MRK-VVCV-----DQQRPNIPNRWFSDPTLTSLAKL 275 (301)
T ss_dssp HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH-HHH-HHTT-----SCCCCCCCGGGGGSHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh-hhH-HHhc-----cCCCCCCChhhccCccHHHHHHH
Confidence 99999999999999999 8888654333221110 000 0000 00011111 11233567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 415 AAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 415 i~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|.+||+.||.+|||+.+|++.|+.+
T Consensus 276 i~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 276 MKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhcChhhCCCHHHHHHHHhcc
Confidence 9999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=382.73 Aligned_cols=257 Identities=26% Similarity=0.328 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHH-HhCCCCCCcceEeeEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNF-LGDLVHLNLVKLIGYC 204 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~i-l~~l~H~nIv~l~~~~ 204 (511)
++|+++++||+|+||.||+|+++. +++.||||+++..... ....+.+|..+ ++.++|||||++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 579999999999999999999876 6789999999765432 23456778777 5778999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+.+.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~----------- 173 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLD----------- 173 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC-----------
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEC-----------
Confidence 9999999999999999999999654 46889999999999999999999999 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 174 --------------~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 237 (373)
T 2r5t_A 174 --------------SQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237 (373)
T ss_dssp --------------TTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 478899999999986433221 1344689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 443 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~ 443 (511)
||...... .+... ...... . ++...+..+.+||.+||+.||.+||++.+.++.+...+.+.
T Consensus 238 Pf~~~~~~---~~~~~---i~~~~~--------~----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 238 PFYSRNTA---EMYDN---ILNKPL--------Q----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp TTCCSBHH---HHHHH---HHHSCC--------C----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred CCCCCCHH---HHHHH---HHhccc--------C----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 99754321 11111 111100 1 11123467899999999999999999865555554444443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=380.51 Aligned_cols=299 Identities=22% Similarity=0.216 Sum_probs=213.0
Q ss_pred cccChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC---
Q 010432 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--- 193 (511)
Q Consensus 117 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--- 193 (511)
..+++.+.....++|+++++||+|+||+||+|++.. +++.||||+++... .....+..|+.+++.+.
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~ 92 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDD 92 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCS
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccC
Confidence 345666666677899999999999999999999875 67799999997532 22355778999999986
Q ss_pred --CCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcE
Q 010432 194 --HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (511)
Q Consensus 194 --H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NI 270 (511)
|||||++++++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+||
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 168 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENI 168 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccE
Confidence 999999999999999999999999 999999997653 45899999999999999999999998 99999999999
Q ss_pred EeccccccccCCcceeeec-cccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 271 LLDAVRAENYGKFGFCIYY-GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||+........ ....... +.........+..+||+|||+++...... ....||+.|+|||++.+..++.++||
T Consensus 169 ll~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di 242 (360)
T 3llt_A 169 LLDDPYFEKSL-ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDM 242 (360)
T ss_dssp EESCTTCCEEE-EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred EEccccccccc-cchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccch
Confidence 99742100000 0000000 00000000136789999999998754422 33579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhcccc-------cccccc-CC----ccCCCCC-------------
Q 010432 350 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-------RFYRLI-DP----RLEGHFS------------- 404 (511)
Q Consensus 350 wSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~----~~~~~~~------------- 404 (511)
|||||++|||++|+.||...........+........... ...... .. .......
T Consensus 243 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 322 (360)
T 3llt_A 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322 (360)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence 9999999999999999976543221111111110000000 000000 00 0000000
Q ss_pred ---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 405 ---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 405 ---~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
....+.+.+||.+||+.||.+|||+.|++++
T Consensus 323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0012567899999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=381.26 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=196.0
Q ss_pred hcCCCCC-CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHh-CCCCCCcceEeeEEE
Q 010432 128 TRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG-DLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~-~l~H~nIv~l~~~~~ 205 (511)
.++|.+. ++||+|+||+||+|++.. +++.||||++... ..+.+|+.++. .++||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3567776 689999999999999876 6789999999643 46778998874 458999999999987
Q ss_pred e----CCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 206 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
. ...+|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++ ||||||||+|||++...
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~---- 198 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR---- 198 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSS----
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCC----
Confidence 6 567899999999999999997643 46999999999999999999999998 99999999999998421
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.++.+||+|||+++....... ....+||+.|+|||++.+..|+.++||||||||||||+
T Consensus 199 ------------------~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 257 (400)
T 1nxk_A 199 ------------------PNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_dssp ------------------TTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH
T ss_pred ------------------CCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH
Confidence 267899999999987543221 33467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchh-HHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 361 TGRRSMDKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+|+.||.......... ....... .. .. +........+..+.+||.+||+.||.+|||+.+|+++-
T Consensus 258 ~g~~pf~~~~~~~~~~~~~~~i~~---~~---~~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 258 CGYPPFYSNHGLAISPGMKTRIRM---GQ---YE-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HSSCSCCCCTTCSSCCSHHHHHHH---TC---CC-----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hCCCCCCCCccccccHHHHHHHHc---Cc---cc-----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 9999997654332110 1111110 00 00 00001112357789999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=365.22 Aligned_cols=261 Identities=27% Similarity=0.471 Sum_probs=196.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.++||+|+||.||+|++.. .||||+++..... ..+.+.+|+.+|++++||||+++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 45689999999999999999998643 6999999765432 235688999999999999999999965
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.....++|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~----------- 154 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLH----------- 154 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE-----------
T ss_pred -cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEEC-----------
Confidence 556789999999999999999777778999999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHh
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+++...............||+.|+|||++. +..++.++|||||||++|||++
T Consensus 155 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 220 (289)
T 3og7_A 155 --------------EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220 (289)
T ss_dssp --------------TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH
T ss_pred --------------CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH
Confidence 47789999999998654432222334467999999999986 6678999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
|+.||....... .+....... ...+. .......++..+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 221 g~~p~~~~~~~~--~~~~~~~~~---------~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 221 GQLPYSNINNRD--QIIEMVGRG---------SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SSCTTSSCCCHH--HHHHHHHHT---------SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCccccchHH--HHHHHhccc---------ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 999997643221 111111110 00000 01112233578999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=372.36 Aligned_cols=265 Identities=26% Similarity=0.392 Sum_probs=214.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|++... ....++..||||+++.... ...+.+.+|+.+|.++ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 456899999999999999999986431 1123678999999986543 2345688999999999 999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp 267 (511)
..++..++|||||++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 999999999999999999999975432 4899999999999999999999998 99999999
Q ss_pred CcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccc
Q 010432 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 347 (511)
Q Consensus 268 ~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~ 347 (511)
+|||++ .++.+||+|||+++...............||+.|+|||++.+..++.++
T Consensus 174 ~Nil~~-------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 228 (313)
T 1t46_A 174 RNILLT-------------------------HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (313)
T ss_dssp GGEEEE-------------------------TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred ceEEEc-------------------------CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHH
Confidence 999998 4778999999999987665444334445688999999999999999999
Q ss_pred cchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 348 DVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 348 DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
|||||||++|||++ |+.||........ ........ . ....+...+..+.+|+.+||+.||.+|
T Consensus 229 Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~----------~----~~~~~~~~~~~l~~li~~~l~~dp~~R 292 (313)
T 1t46_A 229 DVWSYGIFLWELFSLGSSPYPGMPVDSK--FYKMIKEG----------F----RMLSPEHAPAEMYDIMKTCWDADPLKR 292 (313)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHH--HHHHHHHT----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHHHhCCCCCCCcccchhH--HHHHhccC----------C----CCCCcccCCHHHHHHHHHHcCCCchhC
Confidence 99999999999999 9999976543211 11111100 0 011112235778999999999999999
Q ss_pred CCHHHHHHHhcCC
Q 010432 427 PLMSEVVEALKPL 439 (511)
Q Consensus 427 Ps~~eil~~L~~l 439 (511)
||+.+|+++|+.+
T Consensus 293 ps~~ell~~L~~~ 305 (313)
T 1t46_A 293 PTFKQIVQLIEKQ 305 (313)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=390.83 Aligned_cols=250 Identities=29% Similarity=0.366 Sum_probs=197.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|+++++||+|+||.||+|++.. +|+.||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 4679999999999999999999876 68899999997532 22234678899999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
...+.++||||||++|+|.+++... ..+++..+..++.||+.||+|||+ ++ ||||||||+||||+
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~---------- 283 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLD---------- 283 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEEC----------
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEEC----------
Confidence 9999999999999999999998654 478999999999999999999998 88 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|+
T Consensus 284 ---------------~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 346 (446)
T 4ejn_A 284 ---------------KDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346 (446)
T ss_dssp ---------------SSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------CCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCC
Confidence 477899999999986443222 234468999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
.||...... .+.... ..... .++...+..+.+||.+||+.||.+|| ++.+++++
T Consensus 347 ~Pf~~~~~~---~~~~~i---~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 347 LPFYNQDHE---KLFELI---LMEEI------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CSSCCSSHH---HHHHHH---HHCCC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCHH---HHHHHH---HhCCC------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 999754321 111111 11100 11122357789999999999999999 99999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=389.72 Aligned_cols=268 Identities=22% Similarity=0.302 Sum_probs=186.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|+++++||+|+||+||+|++.. +++.||||++..... ...+.+.+|+.+|++|+|||||++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp TTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 689999999999999999999876 678999999975432 233568899999999999999999999854
Q ss_pred C-----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 207 ~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
. ..+||||||+ +|+|.+++.. ...+++..+..|+.||+.||.|||+++ ||||||||+||||+
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~-------- 190 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVN-------- 190 (458)
T ss_dssp SCTTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC--------
T ss_pred CCcccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEEC--------
Confidence 3 5689999998 6799998854 457999999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcc-------------------------eeeeeccccccccCCc
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-------------------------HVSTRVMGTYGYAAPE 336 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-------------------------~~~~~~~Gt~~y~aPE 336 (511)
.++.+||+|||+|+........ ...+..+||+.|+|||
T Consensus 191 -----------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 253 (458)
T 3rp9_A 191 -----------------QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253 (458)
T ss_dssp -----------------TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred -----------------CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence 4778999999999876432110 1234468999999999
Q ss_pred ccc-cCCCCccccchhHHHHHHHHHh-----------CCCCCCCCCCCCc-----------------hhHHHhhhhhhcc
Q 010432 337 YVM-TGHLTSRSDVYSFGVVLLEMLT-----------GRRSMDKNRPNGE-----------------HNLVEWARPHLGE 387 (511)
Q Consensus 337 ~~~-~~~~~~~~DIwSlGvil~ellt-----------g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~ 387 (511)
++. +..|+.++||||||||||||++ |+++|.+...... ......+...++.
T Consensus 254 ~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~ 333 (458)
T 3rp9_A 254 LILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333 (458)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCC
T ss_pred HhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCC
Confidence 864 6679999999999999999999 6666655331100 0000000000000
Q ss_pred c-------------cccccccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 388 R-------------RRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 388 ~-------------~~~~~~~~~~~~---~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
. ..+......... .......+..+.+||.+||+.||.+|||+.|++++
T Consensus 334 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 334 PSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000000000 00011235788999999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=371.87 Aligned_cols=253 Identities=27% Similarity=0.367 Sum_probs=196.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.++|++.+.||+|+||.||+|++.... .+++.||||+++.... .....+.+|+.+|++++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGA------NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSST------TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccC------CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 357999999999999999999885321 2688999999986532 223457789999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+...+..|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~---------- 155 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLN---------- 155 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEEC----------
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEEC----------
Confidence 99999999999999999999999654 46889999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 156 ---------------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 218 (327)
T 3a62_A 156 ---------------HQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218 (327)
T ss_dssp ---------------TTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------CCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCC
Confidence 477899999999986433221 123467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
.||...... ...... .... . .++...+..+.+||.+||+.||.+|| ++.+++++
T Consensus 219 ~pf~~~~~~---~~~~~i---~~~~--------~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 219 PPFTGENRK---KTIDKI---LKCK--------L----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CSCCCSSHH---HHHHHH---HHTC--------C----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCCCCCHH---HHHHHH---HhCC--------C----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 999754321 111111 1000 0 11122357789999999999999999 77888875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=394.59 Aligned_cols=260 Identities=26% Similarity=0.399 Sum_probs=210.7
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
+.+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++|||||+++++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 34456789999999999999999998853 5689999998654 345789999999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+. .+..+||||||++|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~--------- 318 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS--------- 318 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEEC---------
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEC---------
Confidence 86 66789999999999999999643 236889999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT- 361 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt- 361 (511)
.++.+||+|||+++....... .......+|+.|+|||++....++.++|||||||+||||++
T Consensus 319 ----------------~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~ 381 (454)
T 1qcf_A 319 ----------------ASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381 (454)
T ss_dssp ----------------TTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ----------------CCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhC
Confidence 477899999999987543211 11223457889999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|+.||.+.... .+....... .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 382 g~~P~~~~~~~---~~~~~i~~~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 382 GRIPYPGMSNP---EVIRALERG--------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp SCCSSTTCCHH---HHHHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCCHH---HHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 99999754321 111111100 0111122345789999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=375.63 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=192.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||.||+|++.. +++.||||+++... ..+.+.+|+.+|++++||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 34679999999999999999999875 57799999998653 23567889999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..+|||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++...
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~---------- 185 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPA---------- 185 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSS----------
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCC----------
Confidence 99999999999999999999654 46899999999999999999999998 99999999999997321
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 186 ------------~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 250 (349)
T 2w4o_A 186 ------------PDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250 (349)
T ss_dssp ------------TTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------CCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 36789999999998754322 123467999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
....... .+..... .... . .........+..+.+||.+||+.||.+|||+.+++++-
T Consensus 251 ~~~~~~~--~~~~~i~---~~~~---~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 251 YDERGDQ--FMFRRIL---NCEY---Y-----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp CCTTCHH--HHHHHHH---TTCC---C-----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CCCcccH--HHHHHHH---hCCC---c-----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 7543211 1111110 0000 0 01111122356789999999999999999999999854
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=367.65 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=214.8
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEee
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
++....++|++.+.||+|+||.||+|.+.. ++..||||++.... ...+.+.+|+.++++++||||+++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 334456789999999999999999999876 57799999997653 33467899999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
++...+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~-------- 145 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVG-------- 145 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEEC--------
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEc--------
Confidence 999999999999999999999999763 345899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 146 -----------------~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 146 -----------------ENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207 (288)
T ss_dssp -----------------GGGCEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -----------------CCCCEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 4678999999999876543322 2334567889999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 362 -GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 362 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|..||........ ...... ......+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 208 ~g~~p~~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 208 YGMSPYPGIDLSQV---YELLEK--------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp TSCCSSTTCCGGGH---HHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHH---HHHHhc--------------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 9999976533211 111110 011111223357889999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=372.02 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=181.5
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEeCCeEEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 212 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~l 212 (511)
.+.||+|+||.||+|.+.. +++.||||++... ....+.+|+.+|+.+. ||||+++++++.+....||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 3789999999999999875 6789999999753 2356789999999997 9999999999999999999
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~---------------- 143 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDEN---------------- 143 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC------------------
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCC----------------
Confidence 99999999999999764 47999999999999999999999998 99999999999997421
Q ss_pred ccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 372 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~ 372 (511)
....+||+|||+++........ ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus 144 ------~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 215 (325)
T 3kn6_A 144 ------DNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215 (325)
T ss_dssp --------CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----
T ss_pred ------CcccEEEeccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 2347999999999865543222 33457899999999999999999999999999999999999999764332
Q ss_pred Cch-hHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 373 GEH-NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 373 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
... ............. ..+........+..+.+||.+||+.||.+|||+.+++++
T Consensus 216 ~~~~~~~~~~~~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 216 LTCTSAVEIMKKIKKGD--------FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --CCCHHHHHHHHTTTC--------CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccccHHHHHHHHHcCC--------CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 110 0011110000000 000100011235789999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=375.59 Aligned_cols=277 Identities=27% Similarity=0.351 Sum_probs=214.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEE--
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-- 205 (511)
.++|++.+.||+|+||.||+|++... ...++..||||++........+.+.+|+.+|++++|+||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPL-----GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTT-----SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccC-----CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 36799999999999999999986431 12368899999998776555567899999999999999999999987
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.....+||||||++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~------------ 161 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVE------------ 161 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE------------
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEEC------------
Confidence 456789999999999999999765557999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 162 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~ 228 (327)
T 3lxl_A 162 -------------SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228 (327)
T ss_dssp -------------ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred -------------CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 47789999999998765433221 2233568899999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhh--hhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 365 SMDKNRPNGEHNLVEWAR--PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
||...... ...... ............+........+...+..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus 229 p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 229 KSCSPSAE----FLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp GGGSHHHH----HHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred CCccccch----hhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 98642110 000000 00000000111111111222233446789999999999999999999999999987743
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=375.34 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=203.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
+.|++.+.||+|+||.||+|++.. +++.||||++....... ...+.+|+.+|++++|||||++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458899999999999999999865 67899999997654322 246889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..+||||||. |+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~------------ 188 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLS------------ 188 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE------------
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEC------------
Confidence 9999999999996 6898888766668999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHhC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.+||+|||+++..... ....||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 189 -------------~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g 249 (348)
T 1u5q_A 189 -------------EPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249 (348)
T ss_dssp -------------TTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred -------------CCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 4778999999999876432 2357999999999985 56789999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
+.||....... .+... ... ..+.+ .....+..+.+||.+||+.||.+|||+.+++++..
T Consensus 250 ~~p~~~~~~~~--~~~~~----~~~-------~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 250 KPPLFNMNAMS--ALYHI----AQN-------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp SCTTTTSCHHH--HHHHH----HHS-------CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCCCCCChHH--HHHHH----Hhc-------CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 99997543211 11100 000 00001 11123567899999999999999999999997643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=393.50 Aligned_cols=254 Identities=30% Similarity=0.434 Sum_probs=209.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
..++|++.++||+|+||.||+|+++. +|+.||||++.... ......+.+|+.+|++++|||||+++++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 34679999999999999999999875 68899999996532 2234568899999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+.+.+.+|||||||+||+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld--------- 320 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLD--------- 320 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC---------
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEe---------
Confidence 999999999999999999999987543 35899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.+||+|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 321 ----------------~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG 381 (576)
T 2acx_A 321 ----------------DHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381 (576)
T ss_dssp ----------------TTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHS
T ss_pred ----------------CCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence 478899999999987654332 2346899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchh-HHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 363 RRSMDKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
+.||.......... +...... . ...++...+..+.+||.+||+.||.+|| ++.||+++
T Consensus 382 ~~PF~~~~~~~~~~~i~~~i~~-----------~----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 382 QSPFQQRKKKIKREEVERLVKE-----------V----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp SCSSSCSSSCCCHHHHHHHHHH-----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred CCCCcccccchhHHHHHHHhhc-----------c----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 99998654322111 1111110 0 1111223357899999999999999999 78888875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=379.09 Aligned_cols=269 Identities=19% Similarity=0.223 Sum_probs=204.7
Q ss_pred hcCCCCCCccccC--CCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 128 TRNFRPESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 128 ~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.++|+++++||+| +||.||+|++.. +++.||||++...... ....+.+|+.+|+.++|||||+++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 4679999999999 999999999875 6789999999765332 23567889999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+..++..+||||||++|+|.+++... ...+++..+..++.||+.||+|||+++ ||||||||+||||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~--------- 162 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILIS--------- 162 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC---------
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc---------
Confidence 99999999999999999999999754 356899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCccccc--CCCCccccchhHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVV 355 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvi 355 (511)
.++.+||+|||++......... .......||+.|+|||++.+ ..|+.++|||||||+
T Consensus 163 ----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 163 ----------------VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226 (389)
T ss_dssp ----------------TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHH
T ss_pred ----------------CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHH
Confidence 4778999999998654321111 01122479999999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc--------cc-------------ccccc---------CCccCCCCCH
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--------RR-------------FYRLI---------DPRLEGHFSI 405 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~-------------~~~~~---------~~~~~~~~~~ 405 (511)
+|||++|+.||.+....... ........... .. ..... .......+..
T Consensus 227 l~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHH--HHC-------------------------------------------------------
T ss_pred HHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccc
Confidence 99999999999765433221 11100000000 00 00000 0000001222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 406 KGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 406 ~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..+..+.+||.+||+.||.+|||+.+++++
T Consensus 305 ~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 305 TFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 345779999999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=368.09 Aligned_cols=267 Identities=25% Similarity=0.304 Sum_probs=200.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhCCC---CCCcc
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLV---HLNLV 198 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~---H~nIv 198 (511)
..++|++.+.||+|+||+||+|++.. +++.||||++..... .....+.+|+.+++++. ||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 46789999999999999999998765 678999999974321 12246678888877764 99999
Q ss_pred eEeeEEEeCC-----eEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 199 KLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 199 ~l~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
++++++.... ..++||||+. |+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~ 153 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILV 153 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 9999998765 5799999995 69999997543 34899999999999999999999999 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
+ .++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||
T Consensus 154 ~-------------------------~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (308)
T 3g33_A 154 T-------------------------SGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSV 205 (308)
T ss_dssp C-------------------------TTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred c-------------------------CCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHH
Confidence 8 477899999999987644322 234679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccc---cccCCccCC-------CCCHHHHHHHHHHHHHhcccC
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY---RLIDPRLEG-------HFSIKGAQKAAQLAAHCLSRD 422 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-------~~~~~~~~~~~~Li~~cl~~d 422 (511)
||++|||++|+.||...........+...... .....+. ......+.. ......+..+.+||.+||+.|
T Consensus 206 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 284 (308)
T 3g33_A 206 GCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN 284 (308)
T ss_dssp HHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCC
Confidence 99999999999999765432211111000000 0000000 000000000 001123477899999999999
Q ss_pred CCCCCCHHHHHHH
Q 010432 423 PKARPLMSEVVEA 435 (511)
Q Consensus 423 P~~RPs~~eil~~ 435 (511)
|.+|||+.+++++
T Consensus 285 P~~R~t~~e~l~h 297 (308)
T 3g33_A 285 PHKRISAFRALQH 297 (308)
T ss_dssp TTTSCCHHHHHTS
T ss_pred CccCCCHHHHhcC
Confidence 9999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=364.28 Aligned_cols=271 Identities=25% Similarity=0.269 Sum_probs=200.5
Q ss_pred hcCCCCC-CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 128 TRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
.+.|++. ++||+|+||.||+|++.. +++.||||++..........+.+|+.+|.++ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3568775 789999999999998765 6789999999876655567899999999885 7999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+.+..++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~--------- 148 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPN--------- 148 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSS---------
T ss_pred eCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCC---------
Confidence 999999999999999999999654 46899999999999999999999998 99999999999998421
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCccccc-----CCCCccccchhHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVV 355 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DIwSlGvi 355 (511)
....+||+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 149 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 215 (316)
T 2ac3_A 149 -------------QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215 (316)
T ss_dssp -------------SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHH
T ss_pred -------------CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHH
Confidence 1234999999999865422111 11223569999999999875 568899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI----KGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
+|||++|+.||.................... ...+..+.... ..++. ..+..+.+||.+||+.||.+|||+.+
T Consensus 216 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 216 LYILLSGYPPFVGRCGSDCGWDRGEACPACQ-NMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp HHHHHHSSCSCCCCCCSCSCC----CCHHHH-HHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHCCCCCcccccccccccccccchhHH-HHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 9999999999986543321000000000000 00000000000 00111 12467899999999999999999999
Q ss_pred HHHHh
Q 010432 432 VVEAL 436 (511)
Q Consensus 432 il~~L 436 (511)
++++-
T Consensus 293 ~l~hp 297 (316)
T 2ac3_A 293 VLQHP 297 (316)
T ss_dssp HHHST
T ss_pred HhcCh
Confidence 99853
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=375.85 Aligned_cols=275 Identities=18% Similarity=0.230 Sum_probs=207.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-----------HHHHHHHHHHHhCCCCCC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFLGDLVHLN 196 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-----------~~~~~~E~~il~~l~H~n 196 (511)
.++|++.++||+|+||.||+|.+..+.. ...++.||||++....... ...+.+|+..+..++|+|
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSES----VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSC----CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccc----cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 4589999999999999999999875322 1146789999997654211 123456777788899999
Q ss_pred cceEeeEEEeC----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 197 LVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 197 Iv~l~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
|+++++++... ...+|||||| +++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99999998774 4589999999 99999999877678999999999999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCccc
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRS 347 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~ 347 (511)
+.. .++.+||+|||+++........ .......||+.|+|||++.+..++.++
T Consensus 186 ~~~-----------------------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 242 (364)
T 3op5_A 186 NYK-----------------------NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG 242 (364)
T ss_dssp ESS-----------------------CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHH
T ss_pred ecC-----------------------CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchh
Confidence 731 2678999999999765432111 011235699999999999999999999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 348 DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
|||||||+||||++|+.||........ .......... ..+..++++.+.. ...+..+.+|+..||+.||.+||
T Consensus 243 Di~slG~~l~el~~g~~Pf~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP 315 (364)
T 3op5_A 243 DLEILGYCMIQWLTGHLPWEDNLKDPK--YVRDSKIRYR--ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKP 315 (364)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCHH--HHHHHHHHHH--HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCC
T ss_pred hHHHHHHHHHHHHhCCCCccccccCHH--HHHHHHHHhh--hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999985432211 1111111110 1111111111110 11246789999999999999999
Q ss_pred CHHHHHHHhcCCC
Q 010432 428 LMSEVVEALKPLP 440 (511)
Q Consensus 428 s~~eil~~L~~l~ 440 (511)
++.+|++.|+.+.
T Consensus 316 ~~~~l~~~l~~~~ 328 (364)
T 3op5_A 316 LYENLRDILLQGL 328 (364)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999987653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=369.62 Aligned_cols=274 Identities=28% Similarity=0.398 Sum_probs=209.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+.|++.+.||+|+||.||+|++.... ..+++.||||++..... .....+.+|+.+|++++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTS-----SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEcccc-----CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 46888999999999999999864321 23788999999975432 3346789999999999999999999999876
Q ss_pred --CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 208 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
...++||||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~------------ 160 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVE------------ 160 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE------------
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEc------------
Confidence 6689999999999999999766667999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|||++|..
T Consensus 161 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 161 -------------SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp -------------ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred -------------CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccC
Confidence 3778999999999876554322 22334578999999999999999999999999999999999998
Q ss_pred CCCCCCCCCchhHHHhhhhhhc--cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLG--ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|+.... ............ ....+...+........+...+..+.+||.+||+.||.+|||+.++++.|+.+
T Consensus 228 p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 228 SDSSPM----ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp GGGSHH----HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchh----hHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 864211 000000000000 00000011111111122333457899999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=382.34 Aligned_cols=268 Identities=23% Similarity=0.322 Sum_probs=193.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCC-CCCcceEeeE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HLNLVKLIGY 203 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~-H~nIv~l~~~ 203 (511)
..++|++++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+|.++. |||||+++++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~ 77 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV 77 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence 45789999999999999999999876 678999999965422 23356789999999997 9999999999
Q ss_pred EEeCC--eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 204 CIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 204 ~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+...+ .+|||||||. |+|..++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~-------- 143 (388)
T 3oz6_A 78 LRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLN-------- 143 (388)
T ss_dssp EECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC--------
T ss_pred EecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEc--------
Confidence 98654 6899999996 699999865 36889999999999999999999999 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCC-------------------cceeeeeccccccccCCccccc-C
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD-------------------KTHVSTRVMGTYGYAAPEYVMT-G 341 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~-------------------~~~~~~~~~Gt~~y~aPE~~~~-~ 341 (511)
.++.+||+|||+|+...... .....+..+||+.|+|||++.+ .
T Consensus 144 -----------------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 206 (388)
T 3oz6_A 144 -----------------AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST 206 (388)
T ss_dssp -----------------TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCC
T ss_pred -----------------CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCC
Confidence 47789999999998653211 1112344689999999999986 6
Q ss_pred CCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhcccccccccc------------------CCccCCCC
Q 010432 342 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI------------------DPRLEGHF 403 (511)
Q Consensus 342 ~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~ 403 (511)
.|+.++||||||||||||++|+.||.+.........+..... .+....+..+. .......+
T Consensus 207 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (388)
T 3oz6_A 207 KYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285 (388)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCH
T ss_pred CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhC
Confidence 799999999999999999999999986543221111100000 00000000000 00000000
Q ss_pred ------------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 404 ------------SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 404 ------------~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
....+..+.+||.+||+.||.+|||+.|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 00224678999999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=385.13 Aligned_cols=249 Identities=27% Similarity=0.345 Sum_probs=205.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|.+.+.||+|+||.||+|++.. +|+.||||++..... .....+.+|+.+|+.++||||+++++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3679999999999999999999875 688999999975421 2345688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..+||||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~----------- 150 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLD----------- 150 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEC-----------
T ss_pred EECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEe-----------
Confidence 999999999999999999999964 357999999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+++....... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+
T Consensus 151 --------------~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 213 (476)
T 2y94_A 151 --------------AHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213 (476)
T ss_dssp --------------TTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred --------------cCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCC
Confidence 477899999999987654332 234679999999999988766 68999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.||...... .+...+.. . .. ..+...+..+.+||.+||+.||.+|||+.+|+++
T Consensus 214 ~Pf~~~~~~---~~~~~i~~---~----------~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 214 LPFDDDHVP---TLFKKICD---G----------IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CSSCCSSSH---HHHHHHHT---T----------CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCCCHH---HHHHHHhc---C----------Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 999754321 11111110 0 00 0111224678999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=373.36 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=212.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|++..... ....++..||||+++.... .....+.+|+.+|+++ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 35689999999999999999999864211 1123578999999986543 2345688999999999 999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 99999999999999999999997543 24889999999999999999999998 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ .++.+||+|||+++...............||+.|+|||++.+..++.++||
T Consensus 188 Ill~-------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 242 (334)
T 2pvf_A 188 VLVT-------------------------ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242 (334)
T ss_dssp EEEC-------------------------TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred EEEc-------------------------CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHH
Confidence 9998 477899999999987665443333334567899999999998899999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||||++|||++ |..||...... .+....... . ....+...+..+.+||.+||+.||.+||+
T Consensus 243 ~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~----------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps 305 (334)
T 2pvf_A 243 WSFGVLMWEIFTLGGSPYPGIPVE---ELFKLLKEG----------H----RMDKPANCTNELYMMMRDCWHAVPSQRPT 305 (334)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHHT----------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCcCcCCHH---HHHHHHhcC----------C----CCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999 99999754321 111111100 0 01112223567899999999999999999
Q ss_pred HHHHHHHhcCCC
Q 010432 429 MSEVVEALKPLP 440 (511)
Q Consensus 429 ~~eil~~L~~l~ 440 (511)
+.+|++.|+.+.
T Consensus 306 ~~ell~~L~~l~ 317 (334)
T 2pvf_A 306 FKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999998763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=365.47 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=200.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||+||+|++.. +|+.||||++....... .+.+.+|+.++++++||||+++++++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 579999999999999999999876 67899999997654322 3557899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++|||||++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~------------- 136 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILIT------------- 136 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-------------
T ss_pred CCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEc-------------
Confidence 9999999999999999888754 456999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 137 ------------~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 202 (311)
T 4agu_A 137 ------------KHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202 (311)
T ss_dssp ------------TTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------CCCCEEEeeCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 4778999999999876543221 234579999999999876 6789999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhh--------hccccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPH--------LGERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|...........+...... ......+.....+......+ ...+..+.+||.+||+.||.+|||+.++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 282 (311)
T 4agu_A 203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282 (311)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH
Confidence 9765432221111110000 00000000000000000000 1235678999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 283 l~h 285 (311)
T 4agu_A 283 LHH 285 (311)
T ss_dssp HTS
T ss_pred hcC
Confidence 975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=369.02 Aligned_cols=266 Identities=27% Similarity=0.426 Sum_probs=200.6
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceE
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKL 200 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l 200 (511)
++....++|.+.+.||+|+||.||+|++.... .++..||||+++..... ..+.+.+|+.++++++||||+++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQED------GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTT------SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccC------CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence 33445678999999999999999999886532 25678999999765432 23568899999999999999999
Q ss_pred eeEEEeCC-----eEEEEEEccCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcE
Q 010432 201 IGYCIEDD-----QRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (511)
Q Consensus 201 ~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NI 270 (511)
++++...+ ..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NI 178 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNC 178 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGE
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceE
Confidence 99998754 35999999999999999853 2356899999999999999999999998 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccch
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIw 350 (511)
|++ .++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus 179 li~-------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 233 (313)
T 3brb_A 179 MLR-------------------------DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 233 (313)
T ss_dssp EEC-------------------------TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred EEc-------------------------CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence 998 4778999999999876544332223345678999999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 351 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 351 SlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
||||++|||++ |..||....... ........ . ....+...+..+.+||.+||+.||.+||++
T Consensus 234 slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~----------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 296 (313)
T 3brb_A 234 AFGVTMWEIATRGMTPYPGVQNHE---MYDYLLHG----------H----RLKQPEDCLDELYEIMYSCWRTDPLDRPTF 296 (313)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTT----------C----CCCCBTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred HHHHHHHHHHhcCCCCCccCCHHH---HHHHHHcC----------C----CCCCCccccHHHHHHHHHHcCCChhhCcCH
Confidence 99999999999 889997643321 11111100 0 011112234678999999999999999999
Q ss_pred HHHHHHhcCC
Q 010432 430 SEVVEALKPL 439 (511)
Q Consensus 430 ~eil~~L~~l 439 (511)
.+|+++|+.+
T Consensus 297 ~~l~~~L~~l 306 (313)
T 3brb_A 297 SVLRLQLEKL 306 (313)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=379.75 Aligned_cols=278 Identities=22% Similarity=0.250 Sum_probs=213.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||+||+|++.. +++.||||++..... ...+.+.+|+.+|++++||||+++++++..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 3579999999999999999999876 678999999975432 334678899999999999999999999987
Q ss_pred CC--eEEEEEEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 207 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 207 ~~--~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
.+ ..+||||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+.....
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~----- 150 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED----- 150 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTT-----
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCC-----
Confidence 55 7899999999999999996532 34899999999999999999999998 999999999999832110
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc--------CCCCccccchhHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVYSFGV 354 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--------~~~~~~~DIwSlGv 354 (511)
.+..+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||
T Consensus 151 ----------------~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~ 211 (396)
T 4eut_A 151 ----------------GQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211 (396)
T ss_dssp ----------------SCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHH
T ss_pred ----------------CceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHH
Confidence 356799999999987654322 233579999999999865 56788999999999
Q ss_pred HHHHHHhCCCCCCCCCCCC-chhHHHhhhhhhcc-c-ccccc-------c-cCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 355 VLLEMLTGRRSMDKNRPNG-EHNLVEWARPHLGE-R-RRFYR-------L-IDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 355 il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~-~-~~~~~-------~-~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
++|||++|+.||....... .............. . ..... . -.......+....+..+.+|+.+||+.||
T Consensus 212 il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP 291 (396)
T 4eut_A 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (396)
T ss_dssp HHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccCh
Confidence 9999999999997543321 11111111110000 0 00000 0 01111234557788899999999999999
Q ss_pred CCCCCHHHHHHHhcCCCC
Q 010432 424 KARPLMSEVVEALKPLPN 441 (511)
Q Consensus 424 ~~RPs~~eil~~L~~l~~ 441 (511)
++||++.++++.++.+..
T Consensus 292 ~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 292 EKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTSCCHHHHHHHHHHHHT
T ss_pred hhhccHHHHHHHHHHHhh
Confidence 999999999998876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=367.83 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=207.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhCCCCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~ 201 (511)
.++|++.+.||+|+||.||+|++.. +|+.||||++...... ..+.+.+|+.+|++++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 4579999999999999999999875 6789999999765432 356789999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~---- 153 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNI---- 153 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTS----
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCC----
Confidence 999999999999999999999999965 457899999999999999999999998 999999999999984210
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
....+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 154 -----------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 213 (321)
T 2a2a_A 154 -----------------PIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (321)
T ss_dssp -----------------SSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -----------------CcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH
Confidence 112799999999987654322 234579999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|..||...... ........ .... .++.+. ...+..+.+||.+||+.||.+|||+.+++++-
T Consensus 214 g~~pf~~~~~~---~~~~~i~~---~~~~----~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 214 GASPFLGDTKQ---ETLANITS---VSYD----FDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp SCCSSCCSSHH---HHHHHHHT---TCCC----CCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred CCCCCCCCCHH---HHHHHHHh---cccc----cChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 99999754321 11111100 0000 000000 11246789999999999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=386.03 Aligned_cols=265 Identities=23% Similarity=0.259 Sum_probs=197.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|+++++||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 4689999999999999999999876 68899999997642 223456889999999999999999999996
Q ss_pred eC------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
.. ...|||||||.+ +|.+.+.. .+++..+..++.||+.||+|||+++ ||||||||+||||+
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~------ 198 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK------ 198 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC------
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEe------
Confidence 54 457999999965 67777643 4889999999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++...... ..+..+||+.|+|||++.+..|+.++||||||||||||
T Consensus 199 -------------------~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 256 (464)
T 3ttj_A 199 -------------------SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256 (464)
T ss_dssp -------------------TTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred -------------------CCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHH
Confidence 47789999999998765432 23446899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhh----------------hhcccc-----ccccccCCccCCC---CCHHHHHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARP----------------HLGERR-----RFYRLIDPRLEGH---FSIKGAQKAAQLA 415 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~----------------~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~Li 415 (511)
++|+.||.+.........+..... ...... .+.......+... .....+..+.+||
T Consensus 257 l~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 336 (464)
T 3ttj_A 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336 (464)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHH
Confidence 999999976542211111100000 000000 0000000000000 0112267799999
Q ss_pred HHhcccCCCCCCCHHHHHHHh
Q 010432 416 AHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 416 ~~cl~~dP~~RPs~~eil~~L 436 (511)
.+||+.||.+|||+.|++++-
T Consensus 337 ~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 337 SKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHHSCSSTTTSCCHHHHHTST
T ss_pred HHHcCCChhhCCCHHHHhcCh
Confidence 999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=368.59 Aligned_cols=246 Identities=23% Similarity=0.291 Sum_probs=204.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhCCCCCCcc
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLV 198 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~H~nIv 198 (511)
..++|++.+.||+|+||.||+|++.. +++.||||++...... ....+.+|+.+|++++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 35689999999999999999999876 6789999999865421 123467899999999999999
Q ss_pred eEeeEEEeCCeEEEEEEccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
++++++...+..++||||+.+| +|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~---- 164 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIA---- 164 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEc----
Confidence 9999999999999999999777 999998544 46999999999999999999999998 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVL 356 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil 356 (511)
.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++
T Consensus 165 ---------------------~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (335)
T 3dls_A 165 ---------------------EDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220 (335)
T ss_dssp ---------------------TTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHH
T ss_pred ---------------------CCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHH
Confidence 477899999999987655432 234679999999999988877 8899999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|||++|+.||...... . ..... .+...+..+.+||.+||+.||.+|||+.+|+++-
T Consensus 221 ~el~~g~~pf~~~~~~------------~------~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 221 YTLVFEENPFCELEET------------V------EAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp HHHHHSSCSCSSGGGG------------T------TTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred HHHHhCCCchhhHHHH------------H------hhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 9999999999642110 0 00000 0111246789999999999999999999999964
Q ss_pred c
Q 010432 437 K 437 (511)
Q Consensus 437 ~ 437 (511)
.
T Consensus 277 ~ 277 (335)
T 3dls_A 277 W 277 (335)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=363.78 Aligned_cols=260 Identities=26% Similarity=0.363 Sum_probs=206.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++|++.+.||+|+||.||+|++.... .++..||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTT------CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCC------CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3467999999999999999999876432 2456799999986532 23467889999999999999999999876
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+ +..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~------------ 147 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVA------------ 147 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEE------------
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEC------------
Confidence 4 4578999999999999999876667999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 148 -------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~ 213 (281)
T 3cc6_A 148 -------------SPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213 (281)
T ss_dssp -------------ETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -------------CCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCC
Confidence 3678999999999876543222 1233567889999999998999999999999999999998 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||........ ....... . ....+...++.+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 214 p~~~~~~~~~---~~~~~~~----~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 214 PFFWLENKDV---IGVLEKG----D----------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp TTTTSCGGGH---HHHHHHT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccCChHHH---HHHHhcC----C----------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 9975433221 1111100 0 0011112346789999999999999999999999999765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=373.63 Aligned_cols=270 Identities=26% Similarity=0.407 Sum_probs=213.0
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEe
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~ 201 (511)
++....++|++.+.||+|+||.||+|++... ....++..||||++..... .....+.+|+.+|++++||||++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 3344567899999999999999999987521 0112467899999976533 2334688999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
+++...+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999986421 45789999999999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
+ .++.+||+|||+++...............||+.|+|||++.+..++.++|||||
T Consensus 172 ~-------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 172 A-------------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp C-------------------------TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred c-------------------------CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 8 477899999999986544332222233467899999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 353 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 353 Gvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
||++|||++ |..||...... ........ .. ....+...+..+.+||.+||+.||.+|||+.+
T Consensus 227 G~il~el~~~g~~p~~~~~~~---~~~~~~~~----~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 289 (322)
T 1p4o_A 227 GVVLWEIATLAEQPYQGLSNE---QVLRFVME----GG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE 289 (322)
T ss_dssp HHHHHHHHHTSCCTTTTSCHH---HHHHHHHT----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhcCCCccccCCHH---HHHHHHHc----CC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 999999999 89999754221 11111110 00 00111223567899999999999999999999
Q ss_pred HHHHhcCCCC
Q 010432 432 VVEALKPLPN 441 (511)
Q Consensus 432 il~~L~~l~~ 441 (511)
++++|+.+..
T Consensus 290 ~l~~L~~~~~ 299 (322)
T 1p4o_A 290 IISSIKEEME 299 (322)
T ss_dssp HHHHHGGGSC
T ss_pred HHHHHHHhhc
Confidence 9999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=370.92 Aligned_cols=272 Identities=27% Similarity=0.376 Sum_probs=215.4
Q ss_pred ChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCc
Q 010432 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNL 197 (511)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nI 197 (511)
....+....++|++.+.||+|+||.||+|++.... ...+++.||||++...... ..+.+.+|+.+|.++ +||||
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 34445556789999999999999999999875311 1236789999999865432 335688999999999 79999
Q ss_pred ceEeeEEEeCC-eEEEEEEccCCCCHHHHHhhCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 010432 198 VKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (511)
Q Consensus 198 v~l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~qi~~gL~yLH~~~~~~ii 261 (511)
+++++++...+ ..++|||||++|+|.+++..... .+++..++.++.||+.||.|||+++ |+
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~ 170 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 170 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 99999987754 58999999999999999975432 2789999999999999999999998 99
Q ss_pred ecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC
Q 010432 262 YRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 341 (511)
Q Consensus 262 HrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~ 341 (511)
||||||+|||++ .++.+||+|||+++...............||+.|+|||++.+.
T Consensus 171 H~dikp~Nil~~-------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 225 (316)
T 2xir_A 171 HRDLAARNILLS-------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 225 (316)
T ss_dssp CSCCSGGGEEEC-------------------------GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred cccCccceEEEC-------------------------CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc
Confidence 999999999998 3678999999999876554443334446789999999999999
Q ss_pred CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 010432 342 HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 420 (511)
Q Consensus 342 ~~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~ 420 (511)
.++.++|||||||++|||++ |..||....... .+....... . ....+...+..+.+|+.+||+
T Consensus 226 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~----------~----~~~~~~~~~~~l~~li~~~l~ 289 (316)
T 2xir_A 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEG----------T----RMRAPDYTTPEMYQTMLDCWH 289 (316)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHHHHHT----------C----CCCCCTTCCHHHHHHHHHHTC
T ss_pred cccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHHHhccC----------c----cCCCCCCCCHHHHHHHHHHcC
Confidence 99999999999999999998 999997654321 111111100 0 001111234678999999999
Q ss_pred cCCCCCCCHHHHHHHhcCC
Q 010432 421 RDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 421 ~dP~~RPs~~eil~~L~~l 439 (511)
.||.+|||+.+|+++|+.+
T Consensus 290 ~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 290 GEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SSGGGSCCHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHH
Confidence 9999999999999999755
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=367.08 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=194.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++....... ...+.+|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 4689999999999999999999865 67899999998754333 24688999999999999999999998
Q ss_pred EeCC----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 205 IEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 205 ~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
.... ..|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~------- 150 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMIS------- 150 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-------
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEc-------
Confidence 7654 349999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 151 ------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 151 ------------------ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212 (311)
T ss_dssp ------------------TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------------CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence 4778999999999876543221 122335799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
++|+.||....... ................ ....+..+.+||.+||+.||.+||++.+++.
T Consensus 213 l~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 213 LTGEPPFTGDSPVS------VAYQHVREDPIPPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHSSCSCCCSSHHH------HHHHHHHCCCCCHHHH--------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HhCCCCCCCCChHH------HHHHHhcCCCCCcccc--------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 99999997543211 1011110000000000 0112467899999999999999997766654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=374.85 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=211.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|.+...+. ......||||++..... ...+.+.+|+.+|+++ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGK----EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSS----SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCc----ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34689999999999999999999865322 11345899999976543 2345688999999999 899999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEE
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NIL 271 (511)
...+..++|||||++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 9999999999999999999998642 345799999999999999999999998 999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchh
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwS 351 (511)
++ .++.+||+|||+++...............||+.|+|||++.+..++.++||||
T Consensus 197 ~~-------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 251 (333)
T 2i1m_A 197 LT-------------------------NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251 (333)
T ss_dssp EE-------------------------GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHH
T ss_pred EC-------------------------CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHH
Confidence 98 46789999999998765443333334456889999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 352 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 352 lGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
|||++|||++ |..||........ ........ .....+...+..+.+||.+||+.||.+|||+.
T Consensus 252 lG~il~el~t~g~~p~~~~~~~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 315 (333)
T 2i1m_A 252 YGILLWEIFSLGLNPYPGILVNSK--FYKLVKDG--------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ 315 (333)
T ss_dssp HHHHHHHHTTTSCCSSTTCCSSHH--HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHcCCCCCCcccchhHH--HHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence 9999999998 9999976533211 11111110 00111112246789999999999999999999
Q ss_pred HHHHHhcCC
Q 010432 431 EVVEALKPL 439 (511)
Q Consensus 431 eil~~L~~l 439 (511)
+|++.|+.+
T Consensus 316 ~l~~~L~~~ 324 (333)
T 2i1m_A 316 QICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=359.58 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=202.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|++. +..||||++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 357899999999999999999873 568999999865432 2356899999999999999999999998
Q ss_pred eC--CeEEEEEEccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 206 ED--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 206 ~~--~~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
.. +..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ .+|+||||||+|||++
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~--------- 147 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMID--------- 147 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEEC---------
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEc---------
Confidence 76 788999999999999999976433 5899999999999999999999876 5599999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCc---cccchhHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEM 359 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~---~~DIwSlGvil~el 359 (511)
.++.++|+|||++...... ...||+.|+|||++.+..++. ++|||||||++|||
T Consensus 148 ----------------~~~~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 204 (271)
T 3kmu_A 148 ----------------EDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL 204 (271)
T ss_dssp ----------------TTSCEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHH
T ss_pred ----------------CCcceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHH
Confidence 4677888888777653322 246899999999998765554 79999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
++|+.||....... .... ... .......+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 205 ~~g~~p~~~~~~~~---~~~~---~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 205 VTREVPFADLSNME---IGMK---VAL----------EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHCSCTTTTSCHHH---HHHH---HHH----------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCccccChHH---HHHH---HHh----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 99999997543211 1000 000 0011112223357799999999999999999999999999765
Q ss_pred C
Q 010432 440 P 440 (511)
Q Consensus 440 ~ 440 (511)
.
T Consensus 269 ~ 269 (271)
T 3kmu_A 269 Q 269 (271)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=371.50 Aligned_cols=263 Identities=24% Similarity=0.407 Sum_probs=204.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+|.+.++||+|+||.||+|++...+. ..+..||||+++..... ....+.+|+.++++++||||+++++++..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3578888999999999999998865221 12457999999865332 23468899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..+|||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~------------- 181 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVN------------- 181 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC-------------
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEEC-------------
Confidence 99999999999999999999877678999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 182 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 182 ------------SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp ------------TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ------------CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 47789999999998765432211 1222456889999999999999999999999999999999 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
||...... .+...... . .....+...+..+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 250 pf~~~~~~---~~~~~~~~----~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 250 PYWELSNH---EVMKAIND----G----------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp TTTTCCHH---HHHHHHHT----T----------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcccCCHH---HHHHHHHC----C----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99654321 11111110 0 001112233577899999999999999999999999997654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=371.18 Aligned_cols=270 Identities=22% Similarity=0.296 Sum_probs=196.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|+++++||+|+||+||+|++.. +++.||||+++...... ...+.+|+.+|++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3579999999999999999999875 68899999997654322 345789999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.++..+||||||. |+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++..+..
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~------- 171 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDAS------- 171 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----------
T ss_pred cCCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCC-------
Confidence 9999999999996 5999999654 36899999999999999999999998 9999999999999642210
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~ 364 (511)
+...+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 172 -------------~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 172 -------------ETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp --------------CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------ccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 356799999999986543222 12345789999999999874 58999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhh-hccccc---------ccccc----CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 365 SMDKNRPNGEHNLVEWARPH-LGERRR---------FYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~-~~~~~~---------~~~~~----~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
||........ +....... ...... +.... ...+...+....+..+.+||.+||+.||.+|||+.
T Consensus 237 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 314 (329)
T 3gbz_A 237 LFPGDSEIDQ--LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314 (329)
T ss_dssp SSCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcCCCCHHHH--HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHH
Confidence 9976432211 11111000 000000 00000 00000000111346789999999999999999999
Q ss_pred HHHHH
Q 010432 431 EVVEA 435 (511)
Q Consensus 431 eil~~ 435 (511)
|++++
T Consensus 315 e~l~h 319 (329)
T 3gbz_A 315 NALEH 319 (329)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=357.31 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=205.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||.||+|.+.. ++..||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4579999999999999999999875 6779999999876555667899999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~----------- 143 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDS----------- 143 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSS-----------
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCC-----------
Confidence 9999999999999999988654 46899999999999999999999998 99999999999994211
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.+..+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.
T Consensus 144 -----------~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 144 -----------PDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp -----------TTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred -----------CCCcEEEEecccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCC
Confidence 467899999999987654332 233579999999998765 48999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..... ........ ..... ........+..+.+||.+||+.||.+||++.+++++
T Consensus 209 ~~~~~---~~~~~~~~---~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 209 APTDS---EVMLKIRE---GTFTF--------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CSSHH---HHHHHHHH---CCCCC--------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCHH---HHHHHHHh---CCCCC--------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 54321 11111100 00000 000000124678999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=360.25 Aligned_cols=254 Identities=26% Similarity=0.338 Sum_probs=199.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|.+.+.||+|+||.||+|++.. ++..||||++..... ...+.+.+|+.+|++++||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 568889999999999999999875 677999999976532 3456789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 208 DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...++|||||++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++...
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~-------- 161 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTS-------- 161 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSS--------
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCC--------
Confidence 999999999999999998853 2467999999999999999999999998 99999999999996311
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++....... .....||+.|+|||++. ..++.++|||||||++|||++|+.
T Consensus 162 --------------~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~ 223 (285)
T 3is5_A 162 --------------PHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCL 223 (285)
T ss_dssp --------------TTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCC
Confidence 356799999999987544322 23467999999999875 578999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||...... ........ .... .... ....++.+.+||.+||+.||.+|||+.||+++
T Consensus 224 pf~~~~~~---~~~~~~~~---~~~~--------~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 224 PFTGTSLE---EVQQKATY---KEPN--------YAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp SSCCSSHH---HHHHHHHH---CCCC--------CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCCCCCHH---HHHhhhcc---CCcc--------cccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99754321 11111100 0000 0000 00124678899999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=358.42 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=185.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 579999999999999999999865 678999999964321 22356889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~------------ 146 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLT------------ 146 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEEC------------
T ss_pred cCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc------------
Confidence 999999999999999999999876678999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 147 -------------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (278)
T 3cok_A 147 -------------RNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211 (278)
T ss_dssp -------------TTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred -------------CCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 4778999999999876533221 2235799999999999988999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|.......... ...... ...+...+..+.+||.+||+.||.+||++.+++++
T Consensus 212 ~~~~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 212 FDTDTVKNTLN----------------KVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SCCCSCC---------------------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCChhHHHHHH----------------HHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 97643221100 000000 01112234678999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.38 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=208.3
Q ss_pred hcCCCCCC-ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|.+.+ .||+|+||.||+|.+... .++..||||+++.... ...+.+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 35677776 899999999999987532 2477899999987533 2345688999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~------------ 144 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLV------------ 144 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE------------
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEc------------
Confidence 556789999999999999999766667999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~ 363 (511)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 145 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 211 (287)
T 1u59_A 145 -------------NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211 (287)
T ss_dssp -------------ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred -------------CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 37789999999998765433221 1223457899999999998899999999999999999998 99
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.||....... +....... ....++...+..+.+||.+||+.||.+||++.+|+++|+.+
T Consensus 212 ~p~~~~~~~~---~~~~i~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 212 KPYKKMKGPE---VMAFIEQG--------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CTTTTCCTHH---HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccCCHHH---HHHHHhcC--------------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9997643321 11111100 01112223457899999999999999999999999999765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=356.97 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=206.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 4679999999999999999999875 577999999975432 334678899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~------------- 139 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLD------------- 139 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------
T ss_pred CCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEc-------------
Confidence 9999999999999999999854 346899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|||++|+.|
T Consensus 140 ------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 207 (276)
T 2yex_A 140 ------------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (276)
T ss_dssp ------------TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred ------------cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 477899999999986543332222344679999999999987765 7899999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|........ ....+... .. .. ......+..+.+||.+||+.||.+|||+.+|+++
T Consensus 208 ~~~~~~~~~-~~~~~~~~-----~~---~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 208 WDQPSDSCQ-EYSDWKEK-----KT---YL------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp CSCSCTTSH-HHHHHHTT-----CT---TS------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCchHHH-HHHHhhhc-----cc---cc------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 976543221 11111110 00 00 0011234678899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=388.59 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=206.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.++||+|+||.||+|+++. +|+.||||++..... .....+.+|+.+|++++|||||++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4689999999999999999999875 688999999975421 2345688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
...+.+|||||||+||+|.+++... ...+++..++.++.||+.||.|||+++ ||||||||+||||+
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~-------- 323 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD-------- 323 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC--------
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEe--------
Confidence 9999999999999999999998653 346899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+++........ ....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 324 -----------------~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt 384 (543)
T 3c4z_A 324 -----------------DDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384 (543)
T ss_dssp -----------------TTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh
Confidence 4788999999999876543321 234589999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCc-hhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 010432 362 GRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVE 434 (511)
Q Consensus 362 g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~-----~eil~ 434 (511)
|+.||........ ..+.... .... ..++...+..+.+||.+||+.||.+||++ .+|++
T Consensus 385 G~~PF~~~~~~~~~~~~~~~i---~~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 385 ARGPFRARGEKVENKELKQRV---LEQA------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp SSCSSCCTTCCCCHHHHHHHH---HHCC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCCCCCCccchhHHHHHHHH---hhcc------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 9999986543221 1111111 1100 11122335788999999999999999975 55654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=371.22 Aligned_cols=272 Identities=18% Similarity=0.202 Sum_probs=201.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-----------cHHHHHHHHHHHhCCCCCC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFLGDLVHLN 196 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~il~~l~H~n 196 (511)
.++|++.+.||+|+||.||+|++...+. ++..||||++...... ....+.+|+.++..++|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 3679999999999999999999875322 4678999999865421 1134678899999999999
Q ss_pred cceEeeEEEe----CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 197 LVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 197 Iv~l~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
|+++++++.. ....||||||| +++|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||+
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 184 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence 9999999988 77899999999 999999986544 7999999999999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCccc
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRS 347 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~ 347 (511)
+.. ....+||+|||+++........ .......||+.|+|||++.+..++.++
T Consensus 185 ~~~-----------------------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 241 (345)
T 2v62_A 185 GYK-----------------------NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRS 241 (345)
T ss_dssp ESS-----------------------STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHH
T ss_pred ccC-----------------------CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchh
Confidence 841 1238999999999865432111 011345799999999999999999999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccc-cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR-FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 348 DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
|||||||++|||++|+.||......... .............. +..... ....+..+.+||.+||+.||.+|
T Consensus 242 Di~slG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~R 313 (345)
T 2v62_A 242 DVEILGYCMLRWLCGKLPWEQNLKDPVA-VQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEK 313 (345)
T ss_dssp HHHHHHHHHHHHHHSSCTTGGGTTCHHH-HHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCC
T ss_pred hHHHHHHHHHHHHhCCCCccccccccHH-HHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccC
Confidence 9999999999999999999643222111 11110000000000 000000 00124689999999999999999
Q ss_pred CCHHHHHHHhcCCCC
Q 010432 427 PLMSEVVEALKPLPN 441 (511)
Q Consensus 427 Ps~~eil~~L~~l~~ 441 (511)
|++.+|++.|+.+..
T Consensus 314 ps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 314 PNYQALKKILNPHGI 328 (345)
T ss_dssp CCHHHHHHHHCTTCC
T ss_pred CCHHHHHHHHhccCC
Confidence 999999999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=359.72 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=209.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4678899999999999999998853 56899999987643 346789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~-------------- 138 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVG-------------- 138 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEEC--------------
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEC--------------
Confidence 9999999999999999999877667999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 139 -----------~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (267)
T 3t9t_A 139 -----------ENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206 (267)
T ss_dssp -----------GGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred -----------CCCCEEEcccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCC
Confidence 367899999999986543211 11223467889999999998999999999999999999999 89999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
...... ......... . ....+...+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 207 ~~~~~~---~~~~~i~~~----------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 207 ENRSNS---EVVEDISTG----------F----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TTCCHH---HHHHHHHTT----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHhcC----------C----cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 754321 111111100 0 0011112356789999999999999999999999999755
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=364.99 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=202.3
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC--CCCCcceEee
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL--VHLNLVKLIG 202 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l--~H~nIv~l~~ 202 (511)
....++|++.+.||+|+||.||+|++ +++.||||++.... ...+.+|.+++..+ +||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-----------RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-----------CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 34557899999999999999999987 36799999996432 34556677777665 9999999999
Q ss_pred EEEeC----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCCeEecccCCCcE
Q 010432 203 YCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE--------AERPVIYRDFKTSNI 270 (511)
Q Consensus 203 ~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~~~~iiHrDLKp~NI 270 (511)
++... ...++|||||++|+|.+++... .+++..++.++.||+.||.|||++ + ||||||||+||
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Ni 173 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNI 173 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGE
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHE
Confidence 99887 7899999999999999999654 689999999999999999999988 6 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccCCCCcc--
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSR-- 346 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~-- 346 (511)
|++ .++.+||+|||+++......... ......||+.|+|||++.+..++..
T Consensus 174 ll~-------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 228 (337)
T 3mdy_A 174 LVK-------------------------KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228 (337)
T ss_dssp EEC-------------------------TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTH
T ss_pred EEC-------------------------CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCcccc
Confidence 998 47789999999997654432211 1123579999999999987766655
Q ss_pred ----ccchhHHHHHHHHHhC----------CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCC-CCHHHHHHH
Q 010432 347 ----SDVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKA 411 (511)
Q Consensus 347 ----~DIwSlGvil~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 411 (511)
+|||||||++|||++| ..||.......... ... ..... .....+.+... ....++..+
T Consensus 229 ~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~-~~~-~~~~~-----~~~~~~~~~~~~~~~~~~~~l 301 (337)
T 3mdy_A 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY-EDM-REIVC-----IKKLRPSFPNRWSSDECLRQM 301 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-HHH-HHHHT-----TSCCCCCCCGGGGGSHHHHHH
T ss_pred CccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch-hhh-HHHHh-----hhccCccccccchhhHHHHHH
Confidence 9999999999999999 56665432221110 000 00000 00111111111 123667889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 010432 412 AQLAAHCLSRDPKARPLMSEVVEALKPLPNL 442 (511)
Q Consensus 412 ~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~ 442 (511)
.+||.+||+.||.+|||+.+|+++|+.+...
T Consensus 302 ~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 302 GKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=386.17 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=205.0
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.|.+|+.+|++++||||+++++++
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~ 248 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV 248 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3445678999999999999999999863 45799999986543 356799999999999999999999998
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
.. +..+||||||++|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~---------- 314 (452)
T 1fmk_A 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVG---------- 314 (452)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC----------
T ss_pred cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEC----------
Confidence 65 6789999999999999999643 346899999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-C
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 362 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g 362 (511)
.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||+||||++ |
T Consensus 315 ---------------~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 378 (452)
T 1fmk_A 315 ---------------ENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378 (452)
T ss_dssp ---------------GGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred ---------------CCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCC
Confidence 4778999999999876543221 2233457889999999999999999999999999999999 9
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
+.||.+.... ......... .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 379 ~~P~~~~~~~---~~~~~i~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 379 RVPYPGMVNR---EVLDQVERG--------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCSSTTCCHH---HHHHHHHTT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCHH---HHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 9999754321 111111100 0111222345788999999999999999999999999988754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=372.91 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=197.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++++.||+|+||.||+|++.. +++.||||++....... ...+.+|+.+|++++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 578999999999999999999875 67799999997543221 12356799999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..+|||||+. |+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~-------------- 134 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLIN-------------- 134 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEEC--------------
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEEC--------------
Confidence 99999999996 6999999877777999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 135 -----------~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 201 (324)
T 3mtl_A 135 -----------ERGELKLADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201 (324)
T ss_dssp -----------TTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----------CCCCEEEccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4778999999999865433221 234578999999999876 57899999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccc---------cCCccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRL---------IDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~----~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
.+.........+....... ....+... ..+..... .....+..+.+||.+||+.||.+|||+.|++
T Consensus 202 ~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 202 PGSTVEEQLHFIFRILGTP-TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CCSSHHHHHHHHHHHHCCC-CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCHHHHHHHHHHHhCCC-ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 7654322111111100000 00000000 00000000 0112246789999999999999999999998
Q ss_pred HH
Q 010432 434 EA 435 (511)
Q Consensus 434 ~~ 435 (511)
++
T Consensus 281 ~h 282 (324)
T 3mtl_A 281 KH 282 (324)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=377.72 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=197.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhCCCCCCc
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNL 197 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~H~nI 197 (511)
...++|.+.+.||+|+||.||+|.+.. +++.||||++...... ....+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 456789999999999999999999876 6789999999754211 11247899999999999999
Q ss_pred ceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 198 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
|++++++. .+..+||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~- 276 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQE- 276 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSS-
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCC-
Confidence 99999975 55689999999999999988544 57999999999999999999999998 99999999999997422
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc---CCCCccccchhHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGV 354 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DIwSlGv 354 (511)
++..+||+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||
T Consensus 277 ---------------------~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~ 332 (419)
T 3i6u_A 277 ---------------------EDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332 (419)
T ss_dssp ---------------------SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHH
T ss_pred ---------------------CcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHH
Confidence 24569999999999765432 2334679999999999863 67889999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 355 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 355 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
++|||++|+.||........ +........ .. .. +... ...+..+.+||.+||+.||.+||++.++++
T Consensus 333 il~~lltg~~pf~~~~~~~~--~~~~i~~~~---~~---~~-~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 333 ILFICLSGYPPFSEHRTQVS--LKDQITSGK---YN---FI-PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHHHSSCSSCCCSSSCC--HHHHHHTTC---CC---CC-HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCcchHH--HHHHHhcCC---CC---CC-chhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 99999999999976433211 111111000 00 00 0000 112467899999999999999999999998
Q ss_pred Hh
Q 010432 435 AL 436 (511)
Q Consensus 435 ~L 436 (511)
+-
T Consensus 400 hp 401 (419)
T 3i6u_A 400 HP 401 (419)
T ss_dssp SG
T ss_pred Cc
Confidence 53
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=358.30 Aligned_cols=266 Identities=20% Similarity=0.231 Sum_probs=205.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEE-E
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-I 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~-~ 205 (511)
..++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+.+++.++|++++..+.++ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 34789999999999999999999865 6789999987654322 3478899999999988877766655 6
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..++||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++...
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~--------- 142 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK--------- 142 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGG---------
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccC---------
Confidence 678889999999 99999999866668999999999999999999999998 99999999999994211
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
+++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 143 -------------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 4hgt_A 143 -------------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp -------------GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred -------------CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHh
Confidence 4678999999999876543221 1123467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhh-hccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPH-LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
+|+.||.................. .... ... +.. ..+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 210 LGSLPWQGLKAATKRQKYERISEKKMSTP---IEV----LCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HSSCTTSSCCCSSSSSHHHHHHHHHHHSC---HHH----HTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred cCCCCCcccchhhhhhhhhhhhcccccch---hhh----hhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 999999875544332222211110 0000 000 001 1246789999999999999999999999999765
Q ss_pred C
Q 010432 440 P 440 (511)
Q Consensus 440 ~ 440 (511)
.
T Consensus 279 ~ 279 (296)
T 4hgt_A 279 F 279 (296)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=357.85 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=206.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 4689999999999999999999876 6779999999765332 2356789999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
..+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~--------- 142 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKA--------- 142 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSS---------
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCC---------
Confidence 999999999999999999988654 46899999999999999999999998 99999999999998422
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
....+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 143 -------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (284)
T 3kk8_A 143 -------------KGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206 (284)
T ss_dssp -------------TTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------CCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 245599999999987654332 2335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|...... ........ ... .. ........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 207 f~~~~~~---~~~~~~~~---~~~---~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 207 FWDEDQH---RLYAQIKA---GAY---DY-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp SCCSSHH---HHHHHHHH---TCC---CC-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCchh---HHHHHHHh---ccc---cC-----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 9754321 11111110 000 00 000111234678999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=372.00 Aligned_cols=262 Identities=22% Similarity=0.253 Sum_probs=200.3
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhCCCCCCcce
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVK 199 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~H~nIv~ 199 (511)
....++|++.+.||+|+||.||+|++.. ++..||||++.... ....+.+.+|+.+|++++|||||+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 92 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3456789999999999999999999865 67799999986532 233467899999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHhhC---------------------------------------CCCCCHHHHHH
Q 010432 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------------------------------SLPLPWSIRMK 240 (511)
Q Consensus 200 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~ 240 (511)
+++++.+.+..+||||||++|+|.+++... ...+++..++.
T Consensus 93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 999999999999999999999999988410 11235677888
Q ss_pred HHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCC--
Q 010432 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGD-- 318 (511)
Q Consensus 241 i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~-- 318 (511)
++.||+.||+|||+++ |+||||||+|||++.. ....+||+|||+++......
T Consensus 173 i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~-----------------------~~~~~kl~Dfg~a~~~~~~~~~ 226 (345)
T 3hko_A 173 IMRQIFSALHYLHNQG---ICHRDIKPENFLFSTN-----------------------KSFEIKLVDFGLSKEFYKLNNG 226 (345)
T ss_dssp HHHHHHHHHHHHHHTT---EECCCCCGGGEEESCS-----------------------SSCCEEECCCTTCEEGGGTTCC
T ss_pred HHHHHHHHHHHHHHCC---ccccCCChhhEEEecC-----------------------CCceEEEeeccccccccccCcc
Confidence 9999999999999998 9999999999999741 13379999999998643211
Q ss_pred cceeeeeccccccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccC
Q 010432 319 KTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 396 (511)
Q Consensus 319 ~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (511)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .... ....... .
T Consensus 227 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~---~~~~~~~---~-- 295 (345)
T 3hko_A 227 EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD---TISQ---VLNKKLC---F-- 295 (345)
T ss_dssp --------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCCCC---T--
T ss_pred ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH---HHHH---HHhcccc---c--
Confidence 1112334679999999999875 678999999999999999999999997543211 1111 1111000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 397 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 397 ~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
........+..+.+||.+||+.||.+||++.+++++
T Consensus 296 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 296 ---ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp ---TSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred ---CCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000011235678999999999999999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=376.72 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=197.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
..|.+.++||+|+||.||+|++..... .+..||||.++.... ...+.+.+|+.+|++++|||||++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 357778899999999999998864211 245799999975432 334678999999999999999999998754
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~------------- 226 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLD------------- 226 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC-------------
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEEC-------------
Confidence 45789999999999999999876677899999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~ 363 (511)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 227 ------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~ 294 (373)
T 3c1x_A 227 ------------EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294 (373)
T ss_dssp ------------TTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ------------CCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcC
Confidence 4778999999999865443211 11233567889999999999999999999999999999999 67
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
+||.......... .... .. .. ..+..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 295 ~p~~~~~~~~~~~---~~~~----~~---~~-------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 295 PPYPDVNTFDITV---YLLQ----GR---RL-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CSCTTSCSSCHHH---HHHT----TC---CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHH---HHHc----CC---CC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 7776544332211 1110 00 00 11112356789999999999999999999999999765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=368.34 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=203.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcE--EEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
++|++.+.||+|+||.||+|++.. ++.. ||||.+..... ...+.+.+|+.+|+++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 578999999999999999999875 4554 49999875432 2335688999999999 999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
...+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 172 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 172 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence 99999999999999999999996543 46899999999999999999999998 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ .++.+||+|||+++...... ......+|+.|+|||++.+..++.++||
T Consensus 173 Il~~-------------------------~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di 224 (327)
T 1fvr_A 173 ILVG-------------------------ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDV 224 (327)
T ss_dssp EEEC-------------------------GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHH
T ss_pred EEEc-------------------------CCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcc
Confidence 9998 36789999999998543211 1223457889999999998899999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||||++|||++ |+.||...... .+..... .. .....+...+..+.+||.+||+.||.+||+
T Consensus 225 ~slG~il~ellt~g~~pf~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 287 (327)
T 1fvr_A 225 WSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP----QG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPS 287 (327)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHH---HHHHHGG----GT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred hHHHHHHHHHHcCCCCCCCCCcHH---HHHHHhh----cC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 999999999998 99999754321 1111110 00 011112233577899999999999999999
Q ss_pred HHHHHHHhcCCC
Q 010432 429 MSEVVEALKPLP 440 (511)
Q Consensus 429 ~~eil~~L~~l~ 440 (511)
+.+++++|+.+.
T Consensus 288 ~~ell~~L~~~~ 299 (327)
T 1fvr_A 288 FAQILVSLNRML 299 (327)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999997654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=361.94 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=204.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|.+.+.||+|+||.||+|++.. +|+.||||++..........+.+|+.++++++||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 4578999999999999999999875 6789999999866544446788999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~----------- 143 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPE----------- 143 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSS-----------
T ss_pred CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCC-----------
Confidence 9999999999999999998654 36899999999999999999999998 99999999999994211
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
+++.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 144 -----------~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 144 -----------ENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp -----------TTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----------CCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 46789999999998654322 223569999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..... .+...... ... . .........+..+.+||.+||+.||.+||++.+++++
T Consensus 209 ~~~~~---~~~~~i~~---~~~---~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 209 EETES---KLFEKIKE---GYY---E-----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TSCHH---HHHHHHHH---CCC---C-----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHH---HHHHHHHc---CCC---C-----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 54321 11111110 000 0 0111112235778999999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=367.72 Aligned_cols=269 Identities=24% Similarity=0.319 Sum_probs=203.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||.||+|++.. +|+.||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 579999999999999999999875 6789999998655332 23568899999999999999999999987
Q ss_pred --------CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 207 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 207 --------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
.+..+||||||. |+|.+.+......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~----- 158 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLIT----- 158 (351)
T ss_dssp C--------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-----
T ss_pred cccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEc-----
Confidence 346899999996 5888888776667999999999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCc--ceeeeeccccccccCCccccc-CCCCccccchhHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 355 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvi 355 (511)
.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 --------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 218 (351)
T 3mi9_A 159 --------------------RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218 (351)
T ss_dssp --------------------TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred --------------------CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHH
Confidence 477899999999986543211 112234678999999999876 568999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc-------cccccccCCccCCCCCH--H-----HHHHHHHHHHHhccc
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-------RRFYRLIDPRLEGHFSI--K-----GAQKAAQLAAHCLSR 421 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~--~-----~~~~~~~Li~~cl~~ 421 (511)
+|||++|+.||.+.........+.......... ................. . .++.+.+||.+||+.
T Consensus 219 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 298 (351)
T 3mi9_A 219 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298 (351)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence 999999999998654322211111111100000 00000000000000000 0 135688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 010432 422 DPKARPLMSEVVEA 435 (511)
Q Consensus 422 dP~~RPs~~eil~~ 435 (511)
||.+|||+.|++++
T Consensus 299 dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 299 DPAQRIDSDDALNH 312 (351)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhCC
Confidence 99999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=356.89 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=201.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||.||+|++.. ++..||||++..... .....+.+|+.++++++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 4679999999999999999999876 577999999965321 2235688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~----------- 143 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLG----------- 143 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEEC-----------
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEc-----------
Confidence 9999999999999999999998654 46899999999999999999999988 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 144 --------------~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 205 (279)
T 3fdn_A 144 --------------SAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205 (279)
T ss_dssp --------------TTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCC
Confidence 47789999999997654332 234579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||....... ....... .. ..++...+..+.+||.+||+.||.+||++.+|+++
T Consensus 206 p~~~~~~~~---~~~~~~~-----------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 206 PFEANTYQE---TYKRISR-----------VE----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTCCSSHHH---HHHHHHH-----------TC----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCcHHH---HHHHHHh-----------CC----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 997543211 1111000 00 01112234678999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=378.24 Aligned_cols=200 Identities=29% Similarity=0.398 Sum_probs=166.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.++||+|+||.||+|++.. +++.||||++..... ...+.+.+|+.+|++++|+|||++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3689999999999999999999876 688999999976432 23357889999999999999999999997
Q ss_pred eC-----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
.. ...||||||+. |+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~------- 163 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLN------- 163 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC-------
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEEC-------
Confidence 76 57899999995 699999854 457999999999999999999999999 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcc--------------------eeeeeccccccccCCccc-c
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--------------------HVSTRVMGTYGYAAPEYV-M 339 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--------------------~~~~~~~Gt~~y~aPE~~-~ 339 (511)
.++.+||+|||+|+........ ...+..+||+.|+|||++ .
T Consensus 164 ------------------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 164 ------------------QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp ------------------TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT
T ss_pred ------------------CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 4778999999999876543211 113457899999999986 4
Q ss_pred cCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 340 TGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 340 ~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
...|+.++||||||||||||++|..||
T Consensus 226 ~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 226 QENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCCCcccccchHHHHHHHHHhccccc
Confidence 567999999999999999999854444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=394.99 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=203.0
Q ss_pred CCCCCC-ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 130 NFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++.+.+ .||+|+||.||+|.++..+ ++..||||+++.... ...+.+.+|+.+|++++|||||++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSS-------CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCC-------CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 344444 7999999999999886421 466899999986533 345789999999999999999999999976
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..+||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~-------------- 470 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLV-------------- 470 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE--------------
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEc--------------
Confidence 5689999999999999999776677999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||+||||++ |+.|
T Consensus 471 -----------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~P 539 (613)
T 2ozo_A 471 -----------NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539 (613)
T ss_dssp -----------ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred -----------CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 4778999999999876543221 11222346789999999999999999999999999999998 9999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|....... +...+.. . ....++..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 540 f~~~~~~~---~~~~i~~----~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 540 YKKMKGPE---VMAFIEQ----G----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TTTCCSHH---HHHHHHT----T----------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHH---HHHHHHc----C----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 97654321 1111111 0 01112233457899999999999999999999999998753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=366.14 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=204.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++........+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 4689999999999999999999865 678999999976555555678999999999999999999999873
Q ss_pred ---CCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 ---DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ---~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
....++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~------- 168 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLG------- 168 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC-------
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc-------
Confidence 3478899999999999999865 3567999999999999999999999998 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcce-------eeeeccccccccCCcccccCC---CCccccch
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSRSDVY 350 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~---~~~~~DIw 350 (511)
.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++|||
T Consensus 169 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~ 230 (317)
T 2buj_A 169 ------------------DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVW 230 (317)
T ss_dssp ------------------TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHH
T ss_pred ------------------CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHH
Confidence 47789999999987643211000 011245799999999987554 78999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 351 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
||||++|||++|+.||........ ....... . ..........+..+.+||.+||+.||.+||++.
T Consensus 231 slG~il~el~~g~~p~~~~~~~~~-~~~~~~~----~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 295 (317)
T 2buj_A 231 SLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQ----N----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295 (317)
T ss_dssp HHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHH----C----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHhCCCChhhhhcccc-hhhHHhh----c----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHH
Confidence 999999999999999953111000 0000000 0 000011122356799999999999999999999
Q ss_pred HHHHHhcCCCC
Q 010432 431 EVVEALKPLPN 441 (511)
Q Consensus 431 eil~~L~~l~~ 441 (511)
+|+++|+.+..
T Consensus 296 ~ll~~L~~~~~ 306 (317)
T 2buj_A 296 LLLSQLEALQP 306 (317)
T ss_dssp HHHHHHHHTCC
T ss_pred HHHHHhhhcCC
Confidence 99999987753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=385.99 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=204.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.++||+|+||+||+|++.. +++.||||++.... ......+.+|+.+|++++|||||++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 4579999999999999999999875 67899999996432 233467899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.....++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~--------- 158 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKE--------- 158 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSS---------
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCC---------
Confidence 999999999999999999988654 46899999999999999999999998 99999999999997422
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.+..+||+|||+++....... ....+||+.|+|||++.+ .|+.++||||||||+|+|++|..|
T Consensus 159 -------------~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 221 (486)
T 3mwu_A 159 -------------KDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221 (486)
T ss_dssp -------------TTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------CCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 356799999999987644322 234579999999998875 599999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|.+.... .+...... .... .........+..+.+||.+||+.||.+|||+.+++++
T Consensus 222 f~~~~~~---~~~~~i~~---~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 222 FYGKNEY---DILKRVET---GKYA--------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCCSSHH---HHHHHHHH---TCCC--------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCHH---HHHHHHHh---CCCC--------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9764321 11111110 0000 0000011235778999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=370.67 Aligned_cols=267 Identities=26% Similarity=0.380 Sum_probs=204.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|++.... ...++..||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 467999999999999999999864311 112678999999975432 234568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
.+..+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~---- 177 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPG---- 177 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSS----
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCC----
Confidence 999999999999999999997543 35889999999999999999999998 99999999999998422
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
++..+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+
T Consensus 178 ------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 239 (327)
T 2yfx_A 178 ------------------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239 (327)
T ss_dssp ------------------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ------------------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 24569999999997543332222233456899999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 361 T-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 361 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
+ |..||...... ......... . ....+...+..+.+||.+||+.||.+||++.+|+++|+.+
T Consensus 240 t~g~~p~~~~~~~---~~~~~~~~~----~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 240 SLGYMPYPSKSNQ---EVLEFVTSG----G----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTSCCSSTTCCHH---HHHHHHHTT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCcCHH---HHHHHHhcC----C----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 8 99999754321 111111100 0 0111122356789999999999999999999999999765
Q ss_pred C
Q 010432 440 P 440 (511)
Q Consensus 440 ~ 440 (511)
.
T Consensus 303 ~ 303 (327)
T 2yfx_A 303 T 303 (327)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=361.76 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=205.4
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.|.+.++||+|+||+||+|++..... ++..||+|++..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 56667899999999999999865322 355899999976443 23457889999999999999999999998766
Q ss_pred eE-EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 209 QR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 209 ~~-~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
.. ++||||+.+|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~-------------- 158 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLD-------------- 158 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC--------------
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc--------------
Confidence 55 9999999999999999876778999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~ 227 (298)
T 3pls_A 159 -----------ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227 (298)
T ss_dssp -----------TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred -----------CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCC
Confidence 4778999999999865442211 112335689999999999999999999999999999999996655
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|...... ..+........ ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 228 ~~~~~~~--~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 228 PYRHIDP--FDLTHFLAQGR--------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp TTTTSCG--GGHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCH--HHHHHHhhcCC--------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5432221 11111111100 0111122346789999999999999999999999999765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=359.09 Aligned_cols=265 Identities=20% Similarity=0.228 Sum_probs=209.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEE-Ee
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-IE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~-~~ 206 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+.+++.++|++++..+.++ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 4689999999999999999999865 6789999998765433 4588999999999988877666555 56
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||+ +++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++...
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~---------- 142 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK---------- 142 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGG----------
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCC----------
Confidence 78889999999 99999999766668999999999999999999999998 99999999999995211
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcce-----eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
+++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 143 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 3uzp_A 143 ------------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp ------------GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ------------CCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh
Confidence 36789999999998765433211 1234679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhh-hhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARP-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
|+.||................. ..... .. .+.. ..+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 211 GSLPWQGLKAATKRQKYERISEKKMSTP---IE----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHHHHSC---HH----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCCCcCchhhhhhhhhhcccccCCc---hH----HHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 9999987544332222211111 00000 00 0011 12467899999999999999999999999998664
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=386.19 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=201.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++++.||+|+||+||+|++.. ++..||||++..... .....+.+|+.+|+.++|||||++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3579999999999999999999876 678999999976532 23467899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.....|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~--------- 173 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKE--------- 173 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS---------
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCC---------
Confidence 999999999999999999988654 46899999999999999999999998 99999999999997422
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.+..+||+|||+++....... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..|
T Consensus 174 -------------~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~p 236 (494)
T 3lij_A 174 -------------KDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236 (494)
T ss_dssp -------------TTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------CCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCC
Confidence 255699999999987654322 33467999999999875 5799999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|...... .+...+.. ... ....+. ....+..+.+||.+||+.||.+|||+.+++++
T Consensus 237 f~~~~~~---~~~~~i~~---~~~---~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 237 FGGQTDQ---EILRKVEK---GKY---TFDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SCCSSHH---HHHHHHHH---TCC---CCCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCHH---HHHHHHHh---CCC---CCCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 9764321 11111110 000 000000 01224678999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=361.87 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=203.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+|++.++||+|+||+||+|++..... ....||||.+..... ...+.+.+|+.++++++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 3578889999999999999999764322 345799999986433 234568899999999999999999998654
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~------------ 162 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLD------------ 162 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC------------
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEC------------
Confidence 56789999999999999999776677899999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-C
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 362 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g 362 (511)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 163 -------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~ 229 (298)
T 3f66_A 163 -------------EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 229 (298)
T ss_dssp -------------TTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -------------CCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 4778999999999876543221 12334568899999999999999999999999999999999 5
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.+||......... ...... . ....+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 230 ~~~~~~~~~~~~~---~~~~~~----------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 230 APPYPDVNTFDIT---VYLLQG----------R----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp CCSSTTSCTTTHH---HHHHTT----------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHH---HHHhcC----------C----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5566544332211 111000 0 0001112246789999999999999999999999999765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=370.17 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=189.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~ 206 (511)
..+|++.++||+|+||.||+|++.. +++.||||++..........+.+|+.++.++. ||||+++++++..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 4579999999999999999999875 67899999997665555567899999999995 9999999999953
Q ss_pred --------CCeEEEEEEccCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 207 --------DDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 207 --------~~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||||+|||++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~--- 172 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLS--- 172 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEEC---
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEEC---
Confidence 345789999995 799998864 3457999999999999999999999875 4599999999999998
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce----------eeeeccccccccCCccc---ccCCC
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYV---MTGHL 343 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~----------~~~~~~Gt~~y~aPE~~---~~~~~ 343 (511)
.++.+||+|||+++......... ......||+.|+|||++ .+..+
T Consensus 173 ----------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 230 (337)
T 3ll6_A 173 ----------------------NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230 (337)
T ss_dssp ----------------------TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCS
T ss_pred ----------------------CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC
Confidence 47789999999998765432211 11135699999999998 56678
Q ss_pred CccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 344 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 344 ~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
+.++|||||||++|||++|+.||........ .. . ..........+..+.+||.+||+.||
T Consensus 231 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~----~----------~~~~~~~~~~~~~~~~li~~~l~~~p 290 (337)
T 3ll6_A 231 GEKQDIWALGCILYLLCFRQHPFEDGAKLRI------VN----G----------KYSIPPHDTQYTVFHSLIRAMLQVNP 290 (337)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCCC--------------------------------CCCCTTCCSSGGGHHHHHHHSCSSG
T ss_pred ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh------hc----C----------cccCCcccccchHHHHHHHHHccCCh
Confidence 9999999999999999999999965322110 00 0 00000011112457899999999999
Q ss_pred CCCCCHHHHHHHhcCCCC
Q 010432 424 KARPLMSEVVEALKPLPN 441 (511)
Q Consensus 424 ~~RPs~~eil~~L~~l~~ 441 (511)
.+||++.+++++|+.+..
T Consensus 291 ~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 291 EERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999987644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=367.02 Aligned_cols=272 Identities=31% Similarity=0.427 Sum_probs=208.0
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe--C
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--D 207 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~ 207 (511)
|++++.||+|+||+||+|.+... ...+++.||||+++.... .....+.+|+.+|++++||||+++++++.+ .
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPT-----NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSC-----C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HhhhheecCCCCeEEEEEEEccC-----CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 48899999999999999977542 223788999999986543 224568899999999999999999999988 4
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
...++||||+++|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~-------------- 168 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLD-------------- 168 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------
T ss_pred ceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEc--------------
Confidence 6789999999999999999654 4899999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 169 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 237 (318)
T 3lxp_A 169 -----------NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237 (318)
T ss_dssp -----------TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred -----------CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence 4778999999999877654322 1233456889999999999999999999999999999999999998
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
....... .....+..... ....+...+........+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 238 ~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 238 QSPPTKF-LELIGIAQGQM-TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp GSHHHHH-HHHHCSCCHHH-HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchhh-hhhhcccccch-hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 6421100 00000000000 00001111111112222334467899999999999999999999999999765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=375.89 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=199.0
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
....++|++.+.||+|+||+||+|++.. +|+.||||++...... ..+|+.+|+.++|||||++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhhee
Confidence 3456789999999999999999999876 6789999999765322 34799999999999999999998
Q ss_pred Ee--------------------------------------CCeEEEEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHH
Q 010432 205 IE--------------------------------------DDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIAL 243 (511)
Q Consensus 205 ~~--------------------------------------~~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~ 243 (511)
.. ....++|||||+ |+|.+.+. .....+++..+..++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 54 334889999997 58877765 3456799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceee
Q 010432 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVS 323 (511)
Q Consensus 244 qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~ 323 (511)
||+.||.|||+++ |+||||||+|||++. +++.+||+|||+++....... .
T Consensus 149 qi~~aL~~LH~~g---i~H~Dikp~Nil~~~------------------------~~~~~kl~Dfg~a~~~~~~~~---~ 198 (383)
T 3eb0_A 149 QLFRAVGFIHSLG---ICHRDIKPQNLLVNS------------------------KDNTLKLCDFGSAKKLIPSEP---S 198 (383)
T ss_dssp HHHHHHHHHHTTT---EECSCCCGGGEEEET------------------------TTTEEEECCCTTCEECCTTSC---C
T ss_pred HHHHHHHHHHHCc---CccCccCHHHEEEcC------------------------CCCcEEEEECCCCcccCCCCC---C
Confidence 9999999999998 999999999999973 367899999999987644332 2
Q ss_pred eeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhc-cc-------c-----
Q 010432 324 TRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER-------R----- 389 (511)
Q Consensus 324 ~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~-------~----- 389 (511)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...... +......... .. .
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~ 276 (383)
T 3eb0_A 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEV 276 (383)
T ss_dssp CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--C
T ss_pred cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccc
Confidence 335789999999998865 589999999999999999999999986532211 1111110000 00 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 390 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.+.......+...++...+..+.+||.+||+.||.+|||+.|++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 277 RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000111111222345779999999999999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=360.15 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=197.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 579999999999999999999865 577999999976432 23356889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
..+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~--------- 170 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFIT--------- 170 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC---------
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEc---------
Confidence 99999999999999999999863 3456899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 171 ----------------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 232 (310)
T 2wqm_A 171 ----------------ATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232 (310)
T ss_dssp ----------------TTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred ----------------CCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 477899999999987544322 12335789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
+.||....... ..+...... .. .........+..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 233 ~~p~~~~~~~~-~~~~~~~~~-----~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 233 QSPFYGDKMNL-YSLCKKIEQ-----CD--------YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp SCTTC---CCH-HHHHHHHHT-----TC--------SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccchhH-HHHHHHhhc-----cc--------CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 99997543221 111111100 00 0000011235678999999999999999999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=367.30 Aligned_cols=268 Identities=17% Similarity=0.137 Sum_probs=205.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC---CCCcceEee
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIG 202 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~ 202 (511)
...++|.+.++||+|+||+||+|.+.... ...+++.||||++.... ..++.+|+.++..++ |+||+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 34578999999999999999999643211 11268899999997653 456788888888886 999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
++...+..+||||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.....
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 99999999999999999999999964 3457999999999999999999999998 9999999999999841100
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
... .-..++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++||
T Consensus 212 ~~~--------------~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 277 (365)
T 3e7e_A 212 QDD--------------EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277 (365)
T ss_dssp C--------------------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHH
T ss_pred ccc--------------cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHH
Confidence 000 000267899999999976543233334455789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhc
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALK 437 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-s~~eil~~L~ 437 (511)
|++|+.||....... ...... +... ...+.+.+++..||+.+|.+|+ ++.++.+.|+
T Consensus 278 lltg~~pf~~~~~~~---------------~~~~~~----~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 278 MLFGTYMKVKNEGGE---------------CKPEGL----FRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp HHHSSCCCEEEETTE---------------EEECSC----CTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred HHhCCCccccCCCCc---------------eeechh----cccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 999999995432110 000011 1111 1256788999999999999995 7788877776
Q ss_pred CC
Q 010432 438 PL 439 (511)
Q Consensus 438 ~l 439 (511)
.+
T Consensus 336 ~~ 337 (365)
T 3e7e_A 336 KV 337 (365)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=369.32 Aligned_cols=267 Identities=25% Similarity=0.333 Sum_probs=200.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-----HHHHHHHHHHHhCCCCCCcceEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~ 201 (511)
..++|++.+.||+|+||.||+|++.. +|+.||||++....... ...+.+|+.++++++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 45789999999999999999998865 67899999997543221 23578999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++...+..++||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~-------- 146 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLD-------- 146 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC--------
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEc--------
Confidence 999999999999999965 899998776667899999999999999999999999 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~ell 360 (511)
.++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 147 -----------------~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 207 (346)
T 1ua2_A 147 -----------------ENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207 (346)
T ss_dssp -----------------TTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCEEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHH
Confidence 4778999999999876543221 3346799999999998754 5899999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhcc--cc---ccccccCC---ccCCCCC-----HHHHHHHHHHHHHhcccCCCCCC
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGE--RR---RFYRLIDP---RLEGHFS-----IKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~---~~~~~~~-----~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
+|.+||.+...... +..... .... .. ......+. ......+ ...+..+.+||.+||+.||.+||
T Consensus 208 ~g~~~~~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 284 (346)
T 1ua2_A 208 LRVPFLPGDSDLDQ--LTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284 (346)
T ss_dssp HSSCSSCCSSHHHH--HHHHHH-HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred HCCCCCCCCCHHHH--HHHHHH-HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC
Confidence 99999976532211 111111 0000 00 00000000 0000001 12347899999999999999999
Q ss_pred CHHHHHHHh
Q 010432 428 LMSEVVEAL 436 (511)
Q Consensus 428 s~~eil~~L 436 (511)
|+.|++++-
T Consensus 285 t~~ell~h~ 293 (346)
T 1ua2_A 285 TATQALKMK 293 (346)
T ss_dssp CHHHHHTSG
T ss_pred CHHHHhcCh
Confidence 999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=367.13 Aligned_cols=267 Identities=26% Similarity=0.399 Sum_probs=200.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++.+.||+|+||.||+|++.. +++.||||++....... .+.+.+|+.++++++||||+++++++..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 579999999999999999999876 67899999997654332 3457899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~------------- 158 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVS------------- 158 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC-------------
T ss_pred CCEEEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEc-------------
Confidence 9999999999998888877643 447999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 159 ------------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (331)
T 4aaa_A 159 ------------QSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224 (331)
T ss_dssp ------------TTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------CCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCC
Confidence 477899999999987544322 12345799999999998865 789999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhh--------hhccccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 366 MDKNRPNGEHNLVEWARP--------HLGERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|...........+..... .+.....+.....+.+....+ ...+..+.+||.+||+.||.+|||+.++
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 304 (331)
T 4aaa_A 225 FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304 (331)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred CCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence 976533211111000000 000000000111111111111 1235789999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 305 l~h 307 (331)
T 4aaa_A 305 LHH 307 (331)
T ss_dssp GGS
T ss_pred hcC
Confidence 874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=361.35 Aligned_cols=259 Identities=27% Similarity=0.370 Sum_probs=204.5
Q ss_pred HhcCCCCCC-ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 127 ATRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 127 ~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
..++|.+.+ .||+|+||.||+|.+... .++..||||+++..... ..+.+.+|+.+++.++||||++++++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 346788888 999999999999976431 25779999999765432 24578999999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+ ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~---------- 151 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLV---------- 151 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE----------
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEe----------
Confidence 9 567789999999999999999764 46899999999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT- 361 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt- 361 (511)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 216 (291)
T 1xbb_A 152 ---------------TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 216 (291)
T ss_dssp ---------------ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred ---------------CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhc
Confidence 36789999999998765443321 1223457789999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|+.||...... .+....... .....+...+..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 217 g~~p~~~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 217 GQKPYRGMKGS---EVTAMLEKG--------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TCCSSTTCCHH---HHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHH---HHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999764321 111111100 01111223357899999999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=365.40 Aligned_cols=267 Identities=19% Similarity=0.251 Sum_probs=209.6
Q ss_pred ccChHHHHHHhcCCCCC-CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCC-C
Q 010432 118 KFTFNDLKLATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-V 193 (511)
Q Consensus 118 ~~~~~~~~~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l-~ 193 (511)
.+.+.......+.|.+. +.||+|+||.||+|++.. +++.||||++..... .....+.+|+.++..+ .
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~ 87 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC
Confidence 34555666777788887 889999999999999876 678999999976432 3356789999999999 5
Q ss_pred CCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEe
Q 010432 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 194 H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl 272 (511)
||||+++++++...+..++|||||++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 88 ~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~ 164 (327)
T 3lm5_A 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILL 164 (327)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEE
Confidence 699999999999999999999999999999998543 356899999999999999999999998 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
+... .++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||
T Consensus 165 ~~~~----------------------~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 219 (327)
T 3lm5_A 165 SSIY----------------------PLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNI 219 (327)
T ss_dssp SCBT----------------------TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ecCC----------------------CCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHH
Confidence 8421 257899999999987654322 233579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
||++|||++|+.||........ ...... . ............+..+.+||.+||+.||.+|||+.++
T Consensus 220 G~il~~ll~g~~pf~~~~~~~~---~~~i~~---~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l 285 (327)
T 3lm5_A 220 GIIAYMLLTHTSPFVGEDNQET---YLNISQ---V--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285 (327)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH---HHHHHH---T--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhCCCCCCCCCchHH---HHHHHh---c--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999999999999975432111 100000 0 0001111112235778999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 286 l~h 288 (327)
T 3lm5_A 286 LSH 288 (327)
T ss_dssp TTC
T ss_pred hCC
Confidence 875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.76 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=200.1
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 209 (511)
+|....+||+|+||.||+|++.. ++..||||++........+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 45556689999999999999865 677999999987665555778999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 210 RLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~------------- 157 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINT------------- 157 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET-------------
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEEC-------------
Confidence 999999999999999997653 34678889999999999999999998 999999999999983
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC--CCccccchhHHHHHHHHHhCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 158 -----------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (295)
T 2clq_A 158 -----------YSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224 (295)
T ss_dssp -----------TTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred -----------CCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 267899999999987644221 123457999999999987643 88999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|........ ........ ...+ .++...+..+.+||.+||+.||.+||++.+++++
T Consensus 225 f~~~~~~~~---~~~~~~~~--------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 225 FYELGEPQA---AMFKVGMF--------KVHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp TGGGSSHHH---HHHHHHHH--------CCCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccCCCchhH---HHHhhccc--------cccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 964321110 00000000 0111 1222335778999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=357.44 Aligned_cols=266 Identities=20% Similarity=0.217 Sum_probs=201.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCC-CCCCcceEeeE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l-~H~nIv~l~~~ 203 (511)
..++|++.+.||+|+||.||+|++.. +++.||||++...... ....+.+|+.++..+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 34679999999999999999999875 5789999999865332 345688999999999 99999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++..+....
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcc
Confidence 99999999999999999999999653 256899999999999999999999998 999999999999985332111
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~el 359 (511)
..... ...........+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|||
T Consensus 157 ~~~~~------~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 224 (289)
T 1x8b_A 157 ASEEG------DEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCA 224 (289)
T ss_dssp -------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHH
T ss_pred ccccc------ccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHH
Confidence 00000 000000135579999999998765432 23589999999999765 667899999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
++|.+++.... ....... ...+.+. ...+..+.+||.+||+.||.+|||+.+++++-
T Consensus 225 ~~~~~~~~~~~-----~~~~~~~-----------~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 225 AGAEPLPRNGD-----QWHEIRQ-----------GRLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp TTCCCCCSSSH-----HHHHHHT-----------TCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred hcCCCCCcchh-----HHHHHHc-----------CCCCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 99998764321 1111100 0001111 12346789999999999999999999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=361.36 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=194.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++.+.||+|+||.||+|++. ++.||||++.... ..+.+.+|+.+|++++||||+++++++. +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 57889999999999999999873 5689999997542 3467899999999999999999999876 4
Q ss_pred eEEEEEEccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+..+|+||||||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~------------ 140 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA------------ 140 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET------------
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC------------
Confidence 47999999999999999975432 4788999999999999999999932223999999999999983
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+...+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 141 ------------~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 203 (307)
T 2eva_A 141 ------------GGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203 (307)
T ss_dssp ------------TTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred ------------CCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 2234899999999865432 22346999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
......... .. +... . ...+.+. ...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 204 ~~~~~~~~~-~~-~~~~-~--------~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 204 DEIGGPAFR-IM-WAVH-N--------GTRPPLI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TTTCSSHHH-HH-HHHH-T--------TCCCCCB----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred hhhCccHHH-HH-HHHh-c--------CCCCCcc----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 754322111 10 1000 0 0011111 123467899999999999999999999999997654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.30 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=210.5
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
+.+..++|++.++||+|+||.||+|.+.. +..||||+++.... ..+.|.+|+.+|++|+|+|||+++++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~ 330 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV 330 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34456788999999999999999999863 45799999986543 35679999999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
+.+ +..+||||||.+|+|.++|... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~--------- 397 (535)
T 2h8h_A 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVG--------- 397 (535)
T ss_dssp ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC---------
T ss_pred Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEc---------
Confidence 865 6789999999999999999643 346899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT- 361 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt- 361 (511)
+++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||+||||++
T Consensus 398 ----------------~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~ 460 (535)
T 2h8h_A 398 ----------------ENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460 (535)
T ss_dssp ----------------GGGCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ----------------CCCcEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 467899999999987653211 11223457889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|+.||.+.... .+...+.. . .....+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 461 g~~P~~~~~~~---~~~~~i~~----~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 461 GRVPYPGMVNR---EVLDQVER----G----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TCCSSTTCCHH---HHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCCHH---HHHHHHHc----C----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 99999754321 11111110 0 0111122345788999999999999999999999999988754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.48 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=207.8
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEee
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
++.+..++|++.+.||+|+||.||+|.+. .+..||||++..... ..+.+.+|+.+|++++||||+++++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYA 75 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEE
Confidence 33445678999999999999999999875 356899999976543 3567899999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
++. .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 76 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~-------- 143 (279)
T 1qpc_A 76 VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVS-------- 143 (279)
T ss_dssp EEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred EEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEc--------
Confidence 876 456899999999999999986432 26899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
+++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 144 -----------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 205 (279)
T 1qpc_A 144 -----------------DTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (279)
T ss_dssp -----------------TTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred -----------------CCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHh
Confidence 4778999999999876543221 1223457889999999998899999999999999999999
Q ss_pred -CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 362 -GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 362 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|+.||...... ......... .....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 206 ~g~~p~~~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 206 HGRIPYPGMTNP---EVIQNLERG--------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp TTCCSSTTCCHH---HHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccCHH---HHHHHHhcc--------------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 99999754321 111111100 00111122357889999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=355.29 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=203.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhCCCCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~H~nIv~l~ 201 (511)
.++|++.+.||+|+||.||+|++.. +++.||||+++..... ..+.+.+|+.+|++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 3578999999999999999999875 6789999999765322 356789999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..+.
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~---- 146 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNV---- 146 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSS----
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCC----
Confidence 9999999999999999999999999653 46899999999999999999999998 999999999999984211
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
....+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 147 -----------------~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 206 (283)
T 3bhy_A 147 -----------------PNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206 (283)
T ss_dssp -----------------SSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH
Confidence 134799999999987654322 233579999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|..||...... ........ .... .........+..+.+|+.+||+.||.+||++.+++++
T Consensus 207 g~~p~~~~~~~---~~~~~~~~---~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 207 GASPFLGETKQ---ETLTNISA---VNYD--------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp SSCTTCCSSHH---HHHHHHHT---TCCC--------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCCCCCCcchH---HHHHHhHh---cccC--------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 99999754321 11111000 0000 0000001124678999999999999999999999974
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=363.86 Aligned_cols=275 Identities=24% Similarity=0.350 Sum_probs=210.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++++.||+|+||.||+|++... ...+++.||||++........+.+.+|+.+|++++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTT-----SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEeccc-----cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 35788999999999999999986421 1236889999999876555556789999999999999999999998764
Q ss_pred C--eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 208 D--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 208 ~--~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+ ..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~------------ 179 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVE------------ 179 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEE------------
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEc------------
Confidence 3 789999999999999999877667999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|||++|..
T Consensus 180 -------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~ 246 (326)
T 2w1i_A 180 -------------NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246 (326)
T ss_dssp -------------ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred -------------CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence 37789999999998765543221 1223467888999999998899999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhcc---ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGE---RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||..... ............ ...+...+........+..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 247 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 247 KSKSPPA----EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp GGGSHHH----HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHH----HHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 8853210 000000000000 0000011111111112233457899999999999999999999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=377.23 Aligned_cols=262 Identities=26% Similarity=0.356 Sum_probs=196.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC-
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 207 (511)
.+|++.++||+|+||.||+|++.. +|+.||||++..... .+.+|+++|++|+|||||++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 468889999999999999999875 678999999975432 234799999999999999999988642
Q ss_pred -----CeEEEEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 208 -----DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 208 -----~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
..++|||||+++ +|.+++. .....+++..++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~----- 191 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDP----- 191 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEET-----
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeC-----
Confidence 236799999965 6766654 34567999999999999999999999998 999999999999984
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~e 358 (511)
+...+||+|||+++....... .....||+.|+|||++.+. .|+.++|||||||||||
T Consensus 192 -------------------~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 249 (420)
T 1j1b_A 192 -------------------DTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249 (420)
T ss_dssp -------------------TTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred -------------------CCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHH
Confidence 245689999999987644332 2335789999999998765 79999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhh-------hcc-ccccccccCCccCC-----CCCHHHHHHHHHHHHHhcccCCCC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPH-------LGE-RRRFYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKA 425 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~-------~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~Li~~cl~~dP~~ 425 (511)
|++|+.||.+.... ..+....... +.. ...+....-+.+.. .+....+.++.+||.+||+.||.+
T Consensus 250 ll~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 250 LLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp HHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhH
Confidence 99999999865322 1121111100 000 00000000011100 012223578999999999999999
Q ss_pred CCCHHHHHHHh
Q 010432 426 RPLMSEVVEAL 436 (511)
Q Consensus 426 RPs~~eil~~L 436 (511)
||++.|++++-
T Consensus 328 R~t~~e~l~hp 338 (420)
T 1j1b_A 328 RLTPLEACAHS 338 (420)
T ss_dssp SCCHHHHHTSG
T ss_pred CCCHHHHhCCH
Confidence 99999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=396.79 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=206.2
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCC-CCCCcceEe
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~H~nIv~l~ 201 (511)
...++|+++++||+|+||.||+|+++. +++.||||+++... ....+.+..|..+|..+ +|+||++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 345789999999999999999999876 67899999997532 12335678999999988 799999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++.+.+.+||||||+++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~-------- 476 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLD-------- 476 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEEC--------
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEc--------
Confidence 9999999999999999999999999754 46999999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+|+....... .....+||+.|||||++.+..|+.++||||||||||||++
T Consensus 477 -----------------~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt 537 (674)
T 3pfq_A 477 -----------------SEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537 (674)
T ss_dssp -----------------SSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc
Confidence 478899999999986433222 2345789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~-----~eil~~ 435 (511)
|+.||.+.... .+...+ .... ..++...+.++.+||.+||+.||.+||++ .+|+++
T Consensus 538 G~~Pf~~~~~~---~~~~~i---~~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 538 GQAPFEGEDED---ELFQSI---MEHN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SSCSSCCSSHH---HHHHHH---HSSC------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCCCCCCCCHH---HHHHHH---HhCC------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999764321 111111 1110 11222345789999999999999999997 666653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=385.86 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=206.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.++||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|++++|||||++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4579999999999999999999875 678999999976532 3456789999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++...
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~-------- 163 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKS-------- 163 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSS--------
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCC--------
Confidence 9999999999999999999998654 46999999999999999999999998 99999999999996321
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..
T Consensus 164 --------------~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 225 (484)
T 3nyv_A 164 --------------KDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225 (484)
T ss_dssp --------------TTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCC
Confidence 367899999999987654332 234579999999998865 79999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||...... .+...+.. .... .........+..+.+||.+||+.||.+|||+.+++++
T Consensus 226 pf~~~~~~---~~~~~i~~---~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 226 PFNGANEY---DILKKVEK---GKYT--------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SSCCSSHH---HHHHHHHH---CCCC--------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCHH---HHHHHHHc---CCCC--------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 99764321 11111110 0000 0000111235778999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=369.78 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=196.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++++.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 3679999999999999999999865 6889999999654322 2356889999999999999999999997
Q ss_pred eCC------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
... ..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~------ 162 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVN------ 162 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC------
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEc------
Confidence 653 469999999 8899999865 46899999999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++..... .+..+||+.|+|||++.+ ..++.++||||||||+||
T Consensus 163 -------------------~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 218 (367)
T 1cm8_A 163 -------------------EDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218 (367)
T ss_dssp -------------------TTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred -------------------CCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHH
Confidence 4778999999999875432 234578999999999887 689999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhc--------c--cccccc----ccCCccCCCCCHHHHHHHHHHHHHhcccCCC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLG--------E--RRRFYR----LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~----~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
|++|+.||.+.........+........ . ...+.. .....+. ......+..+.+||.+||+.||.
T Consensus 219 ll~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~ 297 (367)
T 1cm8_A 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAE 297 (367)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChh
Confidence 9999999986532211111100000000 0 000000 0000000 11122357889999999999999
Q ss_pred CCCCHHHHHHH
Q 010432 425 ARPLMSEVVEA 435 (511)
Q Consensus 425 ~RPs~~eil~~ 435 (511)
+|||+.+++++
T Consensus 298 ~R~t~~e~l~h 308 (367)
T 1cm8_A 298 QRVTAGEALAH 308 (367)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=358.12 Aligned_cols=249 Identities=28% Similarity=0.423 Sum_probs=204.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
...+|++.+.||+|+||.||+|++.. +++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 45679999999999999999999875 57799999998654 356789999999999999999998864
Q ss_pred ----------------CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 207 ----------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 207 ----------------~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
....++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~N 152 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSN 152 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHH
Confidence 34579999999999999999753 357899999999999999999999998 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ +++.+||+|||++........ .....||+.|+|||++.+..++.++||
T Consensus 153 il~~-------------------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (284)
T 2a19_B 153 IFLV-------------------------DTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDL 204 (284)
T ss_dssp EEEE-------------------------ETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHH
T ss_pred EEEc-------------------------CCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhh
Confidence 9998 477899999999987654322 233569999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 350 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 350 wSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
|||||++|||++|..||... ..... .+....+... .+..+.+||.+||+.||.+||++
T Consensus 205 ~slG~il~~l~~~~~~~~~~-----~~~~~-------------~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~ 262 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFET-----SKFFT-------------DLRDGIISDI----FDKKEKTLLQKLLSKKPEDRPNT 262 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHH-----HHHHH-------------HHHTTCCCTT----SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHHhcCCcchhH-----HHHHH-------------Hhhccccccc----CCHHHHHHHHHHccCChhhCcCH
Confidence 99999999999999887421 00000 0011111112 24678899999999999999999
Q ss_pred HHHHHHhcCCCC
Q 010432 430 SEVVEALKPLPN 441 (511)
Q Consensus 430 ~eil~~L~~l~~ 441 (511)
.+++++|+.+..
T Consensus 263 ~e~l~~l~~~~~ 274 (284)
T 2a19_B 263 SEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHHHTC
T ss_pred HHHHHHHHHHhh
Confidence 999999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=357.20 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=202.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 45689999999999999999999865 67899999997653 23678999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~------------- 159 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLN------------- 159 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC-------------
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEEC-------------
Confidence 99999999999999999999755668999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 160 ------------~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 225 (314)
T 3com_A 160 ------------TEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225 (314)
T ss_dssp ------------TTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------CCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 477899999999987544321 123457999999999999989999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...... ........ . ..+. ...+...+..+.+||.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~---~~~~~~~~---~-------~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 226 ADIHPM---RAIFMIPT---N-------PPPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp TTSCHH---HHHHHHHH---S-------CCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCChH---HHHHHHhc---C-------CCcc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 754321 11000000 0 0000 01112235678999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=360.59 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=201.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|++.. +++.||||+++... .+.+.+|+.+|+++. ||||+++++++..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 3679999999999999999999876 67799999997543 467889999999997 9999999999988
Q ss_pred --CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 207 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 207 --~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
....++||||+.+++|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~---------- 165 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDH---------- 165 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET----------
T ss_pred CCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcC----------
Confidence 667899999999999999884 4889999999999999999999998 999999999999984
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~ 363 (511)
+...+||+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 166 --------------~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 228 (330)
T 3nsz_A 166 --------------EHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228 (330)
T ss_dssp --------------TTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred --------------CCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCC
Confidence 234799999999987654332 233578999999999876 67899999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhcc--------------cccccccc--------CCccCCCCCHHHHHHHHHHHHHhccc
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGE--------------RRRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSR 421 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~--------~~~~~~~~~~~~~~~~~~Li~~cl~~ 421 (511)
.||........ .+..... .... ...+.... ............+..+.+||.+||+.
T Consensus 229 ~p~~~~~~~~~-~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 306 (330)
T 3nsz_A 229 EPFFHGHDNYD-QLVRIAK-VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306 (330)
T ss_dssp SSSSCCSSHHH-HHHHHHH-HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCS
T ss_pred CCcccCCchHH-HHHHHHH-hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcC
Confidence 99965432211 1111000 0000 00000000 00001111122357899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 010432 422 DPKARPLMSEVVEA 435 (511)
Q Consensus 422 dP~~RPs~~eil~~ 435 (511)
||.+|||+.+++++
T Consensus 307 dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 307 DHQSRLTAREAMEH 320 (330)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=372.81 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=204.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|++.. ++..||+|++...... ....+.+|+.+|++++||||+++++++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 4689999999999999999999875 6789999999865332 23568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++..+||||||++|+|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+|||++
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~------------ 166 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVN------------ 166 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEEC------------
T ss_pred CCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEEC------------
Confidence 99999999999999999999654 3689999999999999999999985 7 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 167 -------------~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 229 (360)
T 3eqc_A 167 -------------SRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229 (360)
T ss_dssp -------------TTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCC
T ss_pred -------------CCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 4778999999999754221 12335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhh-hh---------------------cccccc----ccccCCccCCCCCHHHHHHHHHHHHHhc
Q 010432 366 MDKNRPNGEHNLVEWARP-HL---------------------GERRRF----YRLIDPRLEGHFSIKGAQKAAQLAAHCL 419 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~-~~---------------------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~Li~~cl 419 (511)
|................. .. ...... ..+.............+..+.+||.+||
T Consensus 230 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 309 (360)
T 3eqc_A 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 309 (360)
T ss_dssp SSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHh
Confidence 975432111100000000 00 000000 0000000000111123567899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 010432 420 SRDPKARPLMSEVVEA 435 (511)
Q Consensus 420 ~~dP~~RPs~~eil~~ 435 (511)
+.||.+|||+.+++++
T Consensus 310 ~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 310 IKNPAERADLKQLMVH 325 (360)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred hcChhhCCCHHHHhhC
Confidence 9999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=384.40 Aligned_cols=257 Identities=24% Similarity=0.318 Sum_probs=203.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhCCC
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLV 193 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~E~~il~~l~ 193 (511)
..++|+++++||+|+||+||+|++.. ++..||||++..... ...+.+.+|+.+|++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 35689999999999999999999876 678999999976432 22456889999999999
Q ss_pred CCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 194 H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
|||||++++++.+....+||||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE 180 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence 999999999999999999999999999999998654 46999999999999999999999998 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlG 353 (511)
..+ ....+||+|||+++....... ....+||+.|+|||++. ..|+.++||||||
T Consensus 181 ~~~----------------------~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG 234 (504)
T 3q5i_A 181 NKN----------------------SLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCG 234 (504)
T ss_dssp STT----------------------CCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHH
T ss_pred cCC----------------------CCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHH
Confidence 421 134699999999987654322 23457999999999876 5699999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 354 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
|++|+|++|..||.+.... .+...+.. ....+ +.... ...+..+.+||.+||+.||.+|||+.+++
T Consensus 235 ~il~~ll~g~~pf~~~~~~---~~~~~i~~---~~~~~----~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l 300 (504)
T 3q5i_A 235 VIMYILLCGYPPFGGQNDQ---DIIKKVEK---GKYYF----DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEAL 300 (504)
T ss_dssp HHHHHHHHSSCSSCCSSHH---HHHHHHHH---CCCCC----CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHhCCCCCCCCCHH---HHHHHHHc---CCCCC----Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9999999999999764321 11111110 00000 00000 11246789999999999999999999999
Q ss_pred HHh
Q 010432 434 EAL 436 (511)
Q Consensus 434 ~~L 436 (511)
++-
T Consensus 301 ~h~ 303 (504)
T 3q5i_A 301 NSR 303 (504)
T ss_dssp TSH
T ss_pred cCH
Confidence 753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=353.81 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=200.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..|.+.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.+|++++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 347788899999999999998875 6779999999754332 33568899999999999999999999875
Q ss_pred ----CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 207 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 207 ----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
....++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ .+|+||||||+|||++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~-------- 166 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITG-------- 166 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESS--------
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEEC--------
Confidence 45689999999999999999654 46899999999999999999999876 45999999999999973
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
+++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|
T Consensus 167 ----------------~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g 225 (290)
T 1t4h_A 167 ----------------PTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATS 225 (290)
T ss_dssp ----------------TTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHS
T ss_pred ----------------CCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhC
Confidence 36789999999998654432 23457999999999876 5699999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.||...... .......... . ....++...++.+.+||.+||+.||.+|||+.+|+++
T Consensus 226 ~~pf~~~~~~--~~~~~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 226 EYPYSECQNA--AQIYRRVTSG----V---------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp SCTTTTCSSH--HHHHHHHTTT----C---------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCcCcH--HHHHHHHhcc----C---------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 9999754321 1111111100 0 0001111123678999999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=355.25 Aligned_cols=260 Identities=23% Similarity=0.255 Sum_probs=199.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++....... .+.+.+|+.++++++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 4689999999999999999999865 57899999997653322 35688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..++..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~----------- 168 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVS----------- 168 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC-----------
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEc-----------
Confidence 9999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 169 --------------~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (309)
T 2h34_A 169 --------------ADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233 (309)
T ss_dssp --------------TTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCC
Confidence 4678999999999876543221 1234579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPN 441 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-s~~eil~~L~~l~~ 441 (511)
||...... .+... ....... ........+..+.+||.+||+.||.+|| ++.++++.|+.+..
T Consensus 234 pf~~~~~~---~~~~~----~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 234 PYQGDQLS---VMGAH----INQAIPR--------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp SSCSCHHH---HHHHH----HHSCCCC--------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CCCCchHH---HHHHH----hccCCCC--------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 99754211 11111 1000000 0011122346789999999999999999 99999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=357.18 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=206.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+.|++.+.||+|+||.||+|++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 568899999999999999998865 678999999976543 3456789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~-------------- 153 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLS-------------- 153 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC--------------
T ss_pred CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEEC--------------
Confidence 999999999999999999854 46899999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 154 -----------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 154 -----------EHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp -----------TTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----------CCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 477899999999987644321 1234579999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
..... ........ ...+.+.. ..+..+.+||.+||+.||.+|||+.+|+++.
T Consensus 221 ~~~~~---~~~~~~~~----------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 221 ELHPM---KVLFLIPK----------NNPPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp TSCHH---HHHHHHHH----------SCCCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CcCHH---HHHHHhhc----------CCCCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 54221 11111100 01111122 2246789999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=370.08 Aligned_cols=260 Identities=27% Similarity=0.337 Sum_probs=204.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhCC-CCCCcceEee
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l-~H~nIv~l~~ 202 (511)
.++|++.++||+|+||.||+|++.... .+++.||||+++.... ...+.+.+|+.+|.++ +||||+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccC------CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 357999999999999999999985321 2688999999975421 2234567899999999 7999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++...+..+||||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~--------- 193 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLD--------- 193 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC---------
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC---------
Confidence 999999999999999999999999654 36899999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc--CCCCccccchhHHHHHHHHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil~ell 360 (511)
.++.+||+|||+++........ .....+||+.|+|||++.+ ..++.++|||||||+||||+
T Consensus 194 ----------------~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell 256 (355)
T 1vzo_A 194 ----------------SNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256 (355)
T ss_dssp ----------------TTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred ----------------CCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 4778999999999865432221 2234679999999999985 35789999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
+|+.||........... ........ .+ .++...+..+.+||.+||+.||.+|| ++.+++++
T Consensus 257 ~g~~pf~~~~~~~~~~~--~~~~~~~~--------~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 257 TGASPFTVDGEKNSQAE--ISRRILKS--------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HSSCTTSCTTSCCCHHH--HHHHHHHC--------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HCCCCCccCCccchHHH--HHHHHhcc--------CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 99999975443222111 11111100 01 11222356789999999999999999 99999886
Q ss_pred hc
Q 010432 436 LK 437 (511)
Q Consensus 436 L~ 437 (511)
..
T Consensus 323 ~~ 324 (355)
T 1vzo_A 323 LF 324 (355)
T ss_dssp GG
T ss_pred cc
Confidence 53
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.67 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=205.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|.+.+.||+|+||.||+|++.. +++.||+|++..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4679999999999999999999876 677999999975432 2345688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+.+..++|||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~----------- 175 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLN----------- 175 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC-----------
T ss_pred ecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEc-----------
Confidence 9999999999999999999988654 46899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 176 --------------~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 239 (335)
T 2owb_A 176 --------------EDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239 (335)
T ss_dssp --------------TTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcC
Confidence 4778999999999876433221 234579999999999999899999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||...... ...... .... ..+ +...+..+.+||.+||+.||.+||++.+++++
T Consensus 240 pf~~~~~~---~~~~~~---~~~~--------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 240 PFETSCLK---ETYLRI---KKNE--------YSI----PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TTCCSSHH---HHHHHH---HHTC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCCCCHH---HHHHHH---hcCC--------CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99754211 111000 0000 011 11224678899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=375.11 Aligned_cols=265 Identities=22% Similarity=0.245 Sum_probs=209.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC-CCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||.||+|++.. +++.||||++...... ..+.+|+.+++.|.| ++|+.+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4689999999999999999999865 6789999998765432 357899999999977 556667777778
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..+|||||| +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+...
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~---------- 140 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR---------- 140 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGG----------
T ss_pred CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCC----------
Confidence 88999999999 99999999866678999999999999999999999998 99999999999995211
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||||||||++
T Consensus 141 ------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt 208 (483)
T 3sv0_A 141 ------------RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR 208 (483)
T ss_dssp ------------GTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ------------CCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 3778999999999876543321 11224679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|+.||..................... .....+ .. .++.++.+||..||+.||.+||++.+|++.|+.+
T Consensus 209 G~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~~l-----~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 209 GSLPWQGLKAGTKKQKYEKISEKKVA-TSIEAL-----CR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp SSCTTSSCCCSSHHHHHHHHHHHHHH-SCHHHH-----HT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCCCCccccchhHHHHHHHHhhcccc-ccHHHH-----hc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 99999876554333322221111000 000000 01 1246789999999999999999999999988765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=377.44 Aligned_cols=242 Identities=18% Similarity=0.203 Sum_probs=189.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHH---HHHhCCCCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEV---NFLGDLVHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~---~il~~l~H~nIv~l~ 201 (511)
.++|++.+.||+|+||.||+|++.. +|+.||||++.... ....+.+.+|+ .+|++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 4678999999999999999999765 67899999997542 23346788999 556666899999998
Q ss_pred -------eEEEeCC-----------------eEEEEEEccCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHH
Q 010432 202 -------GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSL------PLPWSIRMKIALGAAKGLAF 251 (511)
Q Consensus 202 -------~~~~~~~-----------------~~~lv~E~~~~g~L~~~l~~~~~------~l~~~~~~~i~~qi~~gL~y 251 (511)
+++...+ ..||||||| +|+|.+++..... .+++..++.|+.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 6666543 278999999 6899999975321 23357888899999999999
Q ss_pred HhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeecccccc
Q 010432 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 331 (511)
Q Consensus 252 LH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~ 331 (511)
||+++ ||||||||+||||+ .++.+||+|||+++.... .....+| +.
T Consensus 222 LH~~~---ivHrDikp~NIll~-------------------------~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~ 267 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLD-------------------------QRGGVFLTGFEHLVRDGA-----RVVSSVS-RG 267 (377)
T ss_dssp HHHTT---EECSCCCGGGEEEC-------------------------TTCCEEECCGGGCEETTC-----EEECCCC-TT
T ss_pred HHhCC---eecCCCCHHHEEEc-------------------------CCCCEEEEechhheecCC-----cccCCCC-cC
Confidence 99998 99999999999998 477899999999986433 2344678 99
Q ss_pred ccCCcccccC-----------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccC
Q 010432 332 YAAPEYVMTG-----------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 400 (511)
Q Consensus 332 y~aPE~~~~~-----------~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (511)
|+|||++.+. .|+.++|||||||+||||++|+.||.......... .+... .
T Consensus 268 y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~~--~ 329 (377)
T 3byv_A 268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE----------------WIFRS--C 329 (377)
T ss_dssp CCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG----------------GGGSS--C
T ss_pred ccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh----------------hhhhh--c
Confidence 9999999877 89999999999999999999999997543221110 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 401 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 401 ~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
. ..+..+.+||.+||+.||.+||++.+++++
T Consensus 330 ~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 330 K----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred c----CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 1 124678999999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=361.27 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=201.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..++|++.+.||+|+||.||+|++.. ++..||+|++..........+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 34689999999999999999999875 677999999987666666789999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~------------- 151 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMT------------- 151 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC-------------
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEC-------------
Confidence 99999999999999999998766667999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHHHh
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 152 ------------~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 217 (302)
T 2j7t_A 152 ------------LEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ 217 (302)
T ss_dssp ------------TTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH
T ss_pred ------------CCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc
Confidence 47789999999975421110 0122357899999999883 6678999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|..||....... ....... .. .+ ....+...+..+.+||.+||+.||.+|||+.+|+++
T Consensus 218 g~~p~~~~~~~~--~~~~~~~----~~-------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 218 IEPPHHELNPMR--VLLKIAK----SD-------PP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SSCTTTTSCHHH--HHHHHHH----SC-------CC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred CCCCCccCCHHH--HHHHHhc----cC-------Cc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 999997543211 0110000 00 00 001112235678999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=352.89 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=204.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||.||+|++.. ++..||||++.... ......+.+|+.++++++||||+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 3579999999999999999999865 57799999996432 12245688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~----------- 148 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMG----------- 148 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEEC-----------
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEc-----------
Confidence 9999999999999999999999654 36899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 149 --------------~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (284)
T 2vgo_A 149 --------------YKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210 (284)
T ss_dssp --------------TTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCC
Confidence 47789999999997654322 233579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||...... ..... ... .+. .++...+..+.+||.+||+.||.+||++.+++++
T Consensus 211 pf~~~~~~---~~~~~---~~~--------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 211 PFDSPSHT---ETHRR---IVN--------VDL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TTCCSSHH---HHHHH---HHT--------TCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCCCCHh---HHHHH---Hhc--------ccc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 99754221 11100 000 001 1112234678999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=356.86 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=196.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||.||+|++ +|..||||+++... ..+.+.+|+.++++++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 46899999999999999999987 36799999997653 346789999999999999999999987654
Q ss_pred -CeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 208 -DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 208 -~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~------------ 151 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVS------------ 151 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC------------
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEe------------
Confidence 47899999999999999996543 23789999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 152 -------------~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 213 (278)
T 1byg_A 152 -------------EDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213 (278)
T ss_dssp -------------TTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred -------------CCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCC
Confidence 47789999999998654322 22467899999999999999999999999999999998 999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||...... ........ ......+...+..+.+||.+||+.||.+||++.++++.|+.+
T Consensus 214 p~~~~~~~---~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 214 PYPRIPLK---DVVPRVEK--------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp SCTTSCGG---GHHHHHTT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHH---HHHHHHhc--------------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 99754321 11111110 011112223357889999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=370.94 Aligned_cols=253 Identities=14% Similarity=0.039 Sum_probs=183.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHH---HHHhCCCCCCcceEe-
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEV---NFLGDLVHLNLVKLI- 201 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~---~il~~l~H~nIv~l~- 201 (511)
.+|.+.+.||+|+||.||+|++.. +++.||||++...... ....+.+|+ .+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 458889999999999999999875 6789999999876532 234566774 55556 799988755
Q ss_pred ------eEEEeC-----------------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHH
Q 010432 202 ------GYCIED-----------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------MKIALGAAKGLAFL 252 (511)
Q Consensus 202 ------~~~~~~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~------~~i~~qi~~gL~yL 252 (511)
+++... ...|||||||+ |+|.+++......+++..+ +.++.||+.||+||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 455433 33799999998 8999999765445566666 77889999999999
Q ss_pred hcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccc
Q 010432 253 HEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 332 (511)
Q Consensus 253 H~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y 332 (511)
|+++ ||||||||+||||+ .++.+||+|||+++..... .....||+.|
T Consensus 211 H~~~---ivHrDikp~NIll~-------------------------~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y 257 (371)
T 3q60_A 211 QSKG---LVHGHFTPDNLFIM-------------------------PDGRLMLGDVSALWKVGTR-----GPASSVPVTY 257 (371)
T ss_dssp HHTT---EEETTCSGGGEEEC-------------------------TTSCEEECCGGGEEETTCE-----EEGGGSCGGG
T ss_pred HHCC---CccCcCCHHHEEEC-------------------------CCCCEEEEecceeeecCCC-----ccCccCCcCC
Confidence 9998 99999999999998 4778999999999876431 2245678999
Q ss_pred cCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHH
Q 010432 333 AAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 410 (511)
Q Consensus 333 ~aPE~~~~--~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (511)
+|||++.+ ..|+.++|||||||+||||++|+.||........... .. ..........+........+..
T Consensus 258 ~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~ 328 (371)
T 3q60_A 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW---KR------PSLRVPGTDSLAFGSCTPLPDF 328 (371)
T ss_dssp CCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC---CB------CCTTSCCCCSCCCTTSSCCCHH
T ss_pred cChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccch---hh------hhhhhccccccchhhccCCCHH
Confidence 99999987 6899999999999999999999999986543211100 00 0000000011111111233578
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 010432 411 AAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 411 ~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
+.+||.+||+.||.+|||+.++++
T Consensus 329 ~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 329 VKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=354.72 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|.+.+.||+|+||.||+|++.. +++.||+|++..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4678999999999999999999875 677999999976432 2235688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~----------- 149 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLN----------- 149 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC-----------
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEc-----------
Confidence 9999999999999999999988654 46899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 150 --------------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 213 (294)
T 2rku_A 150 --------------EDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213 (294)
T ss_dssp --------------TTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 4778999999999876432221 233579999999999998899999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||...... ...... .... . .++...+..+.+|+.+||+.||.+||++.+++++
T Consensus 214 p~~~~~~~---~~~~~~---~~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 214 PFETSCLK---ETYLRI---KKNE--------Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTCCSSHH---HHHHHH---HTTC--------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCCCCHH---HHHHHH---hhcc--------C----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 99754321 111000 0000 0 1111234678999999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=376.31 Aligned_cols=199 Identities=22% Similarity=0.338 Sum_probs=171.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC------CCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL------VHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l------~H~nIv~l~ 201 (511)
..+|+++++||+|+||.||+|++.. +++.||||++.... .....+.+|+.+++.+ .|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 3579999999999999999999875 67899999997642 2234577888888776 577999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+++...+..+|||||+. ++|.+++.... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~------ 235 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQ------ 235 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESS------
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcc------
Confidence 99999999999999995 69999987653 45899999999999999999999998 999999999999984
Q ss_pred CCcceeeeccccccccccccCc--eeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
++. +||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||+|||
T Consensus 236 -------------------~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 291 (429)
T 3kvw_A 236 -------------------QGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAE 291 (429)
T ss_dssp -------------------TTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHH
T ss_pred -------------------CCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHH
Confidence 433 999999999865432 223579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 010432 359 MLTGRRSMDKNR 370 (511)
Q Consensus 359 lltg~~pf~~~~ 370 (511)
|++|..||.+..
T Consensus 292 lltG~~pf~~~~ 303 (429)
T 3kvw_A 292 LLTGYPLLPGED 303 (429)
T ss_dssp HHHSSCSSCCSS
T ss_pred HHhCCCCCCCCC
Confidence 999999997654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=358.51 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=199.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||.||+|++.... +.+..||||+++.... ...+.+.+|+.++++++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 357999999999999999999875421 1234799999976532 2345788999999999999999999998
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.... .++||||+++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~----------- 155 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLA----------- 155 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEE-----------
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEc-----------
Confidence 7655 88999999999999999766567899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-C
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 362 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g 362 (511)
.++.+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|||++ |
T Consensus 156 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 221 (291)
T 1u46_A 156 --------------TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221 (291)
T ss_dssp --------------ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTS
T ss_pred --------------CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 36789999999998765543221 2233568889999999998899999999999999999999 9
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
+.||...... ....... ... .....+...+..+.+||.+||+.||.+||++.++++.|+.+.
T Consensus 222 ~~p~~~~~~~---~~~~~~~---~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 222 QEPWIGLNGS---QILHKID---KEG----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCTTTTCCHH---HHHHHHH---TSC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCcccCCHH---HHHHHHH---ccC----------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 9999754321 1111110 000 001111223578999999999999999999999999997654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=356.66 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=203.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|++.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3579999999999999999999875 6789999999865432 2356889999999999999999999886
Q ss_pred e--CCeEEEEEEccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCcEEecccccc
Q 010432 206 E--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 206 ~--~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~iiHrDLKp~NILl~~~~~~ 278 (511)
. ....++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ ..+|+||||||+|||++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~----- 150 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----- 150 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-----
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-----
Confidence 5 56889999999999999998642 345899999999999999999999865 23499999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 151 --------------------~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 208 (279)
T 2w5a_A 151 --------------------GKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208 (279)
T ss_dssp --------------------SSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHH
T ss_pred --------------------CCCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHH
Confidence 4778999999999876543221 223578999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
|++|+.||..... ..+....... ..+ .++...+..+.+||.+||+.||.+||++.+|++++..
T Consensus 209 l~~g~~p~~~~~~---~~~~~~i~~~----------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 209 LCALMPPFTAFSQ---KELAGKIREG----------KFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHSSCSSCCSSH---HHHHHHHHHT----------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHCCCCCcccCH---HHHHHHHhhc----------ccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 9999999975432 1111111100 000 1112235788999999999999999999999987753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=370.53 Aligned_cols=289 Identities=19% Similarity=0.210 Sum_probs=206.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC--------CCCcce
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--------HLNLVK 199 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--------H~nIv~ 199 (511)
.++|++.++||+|+||+||+|++.. +++.||||+++... ...+.+.+|+.+|+.++ |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 4689999999999999999998875 67899999997542 23456889999999885 788999
Q ss_pred EeeEEE----eCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEec
Q 010432 200 LIGYCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLD 273 (511)
Q Consensus 200 l~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~ 273 (511)
+++++. .....||||||+ +++|.+++... ...+++..++.|+.||+.||.|||++ + ||||||||+||||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~ 181 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence 999987 456789999999 66777776554 35699999999999999999999998 8 99999999999998
Q ss_pred cccccc---------cCCcceee---------------eccccccccccccCceeeecCCCcccCCCCCcceeeeecccc
Q 010432 274 AVRAEN---------YGKFGFCI---------------YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 329 (511)
Q Consensus 274 ~~~~~~---------~~~~~~~~---------------~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt 329 (511)
..+... +...+... ...............+||+|||+++..... .....||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt 256 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT 256 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence 543100 00000000 000000000012357999999999876432 2335799
Q ss_pred ccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHH---hhhhhhccc------------------
Q 010432 330 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE---WARPHLGER------------------ 388 (511)
Q Consensus 330 ~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~---~~~~~~~~~------------------ 388 (511)
+.|+|||++.+..++.++|||||||+||||++|+.||............. .........
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 99999999999999999999999999999999999998655433211111 110000000
Q ss_pred cccccccCCc---------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 389 RRFYRLIDPR---------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 389 ~~~~~~~~~~---------~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..+..+.+.. -....+...+..+.+||.+||+.||.+|||+.+|+++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000000000 0112356677889999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=361.24 Aligned_cols=269 Identities=23% Similarity=0.360 Sum_probs=196.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHH--hCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL--GDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il--~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.+++ ..++|+||+++++++.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 46899999999999999999976 46799999997542 34455555554 4589999999998665
Q ss_pred e-----CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCCeEecccCCCcEE
Q 010432 206 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE---------AERPVIYRDFKTSNIL 271 (511)
Q Consensus 206 ~-----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------~~~~iiHrDLKp~NIL 271 (511)
. ....+||||||++|+|.+++... ..++..++.++.||+.||.|||++ + ||||||||+|||
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil 152 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL 152 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence 3 23578999999999999999654 358899999999999999999998 7 999999999999
Q ss_pred eccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCc------ceeeeeccccccccCCccccc-----
Q 010432 272 LDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMT----- 340 (511)
Q Consensus 272 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~Gt~~y~aPE~~~~----- 340 (511)
|+ .++.+||+|||+++....... ........||+.|+|||++.+
T Consensus 153 l~-------------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (336)
T 3g2f_A 153 VK-------------------------NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207 (336)
T ss_dssp EC-------------------------TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG
T ss_pred Ec-------------------------CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc
Confidence 98 477899999999987543221 111234579999999999876
Q ss_pred --CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchh-HHHhhhhhhcccccc-----ccccCCccCCCC--CHHHHHH
Q 010432 341 --GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRF-----YRLIDPRLEGHF--SIKGAQK 410 (511)
Q Consensus 341 --~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~ 410 (511)
..++.++|||||||++|||++|..||.......... ..............+ .....+.+.... ....+..
T Consensus 208 ~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
T 3g2f_A 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287 (336)
T ss_dssp GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHH
T ss_pred cccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHH
Confidence 456789999999999999999987775433221110 000000000000000 000111111111 2345778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 411 AAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 411 ~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 999999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=359.37 Aligned_cols=264 Identities=24% Similarity=0.366 Sum_probs=187.2
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
...++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 445789999999999999999998765 577999999875432 2345688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
...+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~---- 155 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLG---- 155 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC----
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEc----
Confidence 999999999999999999999863 2456899999999999999999999998 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc---eeeeeccccccccCCccccc-CCCCccccchhHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFG 353 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~---~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlG 353 (511)
.++.+||+|||++......... .......||+.|+|||++.+ ..++.++||||||
T Consensus 156 ---------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 214 (303)
T 2vwi_A 156 ---------------------EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214 (303)
T ss_dssp ---------------------TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred ---------------------CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence 4778999999999765432211 11233579999999999875 5789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccc-cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY-RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 354 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|++|||++|+.||......... ...... ...... ...++... ...+..+.+||.+||+.||.+||++.++
T Consensus 215 ~il~~l~~g~~pf~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~l 285 (303)
T 2vwi_A 215 ITAIELATGAAPYHKYPPMKVL--MLTLQN---DPPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAEL 285 (303)
T ss_dssp HHHHHHHHSSCTTTTSCGGGHH--HHHHTS---SCCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHHHHhCCCCCccCchhhHH--HHHhcc---CCCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999999999999765432111 100000 000000 00011111 1224678999999999999999999999
Q ss_pred HHH
Q 010432 433 VEA 435 (511)
Q Consensus 433 l~~ 435 (511)
+++
T Consensus 286 l~h 288 (303)
T 2vwi_A 286 LRH 288 (303)
T ss_dssp HTS
T ss_pred hhC
Confidence 975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=354.33 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=187.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHH-HHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKE-WLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~-~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|++.. +++.||||+++...... ... +.++...++.++||||+++++++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~ 75 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 75 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence 34689999999999999999999865 67899999997653322 222 44455568889999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEecccccccc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
..++..++||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~------- 144 (290)
T 3fme_A 76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLIN------- 144 (290)
T ss_dssp ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEEC-------
T ss_pred eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEEC-------
Confidence 99999999999996 588877753 456799999999999999999999997 8 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccc----ccCCCCccccchhHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~----~~~~~~~~~DIwSlGvil 356 (511)
.++.+||+|||+++....... .....||+.|+|||++ .+..++.++|||||||++
T Consensus 145 ------------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 203 (290)
T 3fme_A 145 ------------------ALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203 (290)
T ss_dssp ------------------TTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHH
T ss_pred ------------------CCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHH
Confidence 467899999999987654322 2234799999999996 466789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|||++|+.||....... ..+..... . .. ........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 204 ~~l~~g~~p~~~~~~~~-~~~~~~~~----~-------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 204 IELAILRFPYDSWGTPF-QQLKQVVE----E-------PS---PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHHTSCSSCCCSCHH-HHHHHHHH----S-------CC---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCccccCchH-HHHHHHhc----c-------CC---CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 99999999997532211 11111100 0 00 000111235678999999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=362.79 Aligned_cols=257 Identities=28% Similarity=0.401 Sum_probs=198.7
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEe
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~ 201 (511)
.+....++|++.+.||+|+||.||+|++.. +++.||||++..... ....+.+|+.+++++ +||||++++
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeee
Confidence 333456789999999999999999999865 577999999976543 346788999999999 899999999
Q ss_pred eEEEe------CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecc
Q 010432 202 GYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 202 ~~~~~------~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~ 274 (511)
+++.. .+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~- 163 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT- 163 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC-
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEc-
Confidence 99987 46789999999999999999754 356899999999999999999999998 99999999999998
Q ss_pred ccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccc
Q 010432 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDV 349 (511)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DI 349 (511)
.++.+||+|||++........ ......||+.|+|||++. +..++.++||
T Consensus 164 ------------------------~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 217 (326)
T 2x7f_A 164 ------------------------ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 217 (326)
T ss_dssp ------------------------TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHH
T ss_pred ------------------------CCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchH
Confidence 477899999999987543221 123357999999999987 5678999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 350 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 350 wSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
|||||++|+|++|..||....... ...... .. ..+.+ .....+..+.+||.+||+.||.+||++
T Consensus 218 ~slG~il~~l~~g~~p~~~~~~~~---~~~~~~---~~-------~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~ 281 (326)
T 2x7f_A 218 WSLGITAIEMAEGAPPLCDMHPMR---ALFLIP---RN-------PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPAT 281 (326)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH---HS-------CCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHHHHHHHHHhCCCCCCCCcHHH---HHHHhh---cC-------ccccC---CccccCHHHHHHHHHHhccChhhCCCH
Confidence 999999999999999996543211 100000 00 00000 111224678999999999999999999
Q ss_pred HHHHHH
Q 010432 430 SEVVEA 435 (511)
Q Consensus 430 ~eil~~ 435 (511)
.+++++
T Consensus 282 ~~ll~h 287 (326)
T 2x7f_A 282 EQLMKH 287 (326)
T ss_dssp HHHHTS
T ss_pred HHHhhC
Confidence 999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.23 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=206.0
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhCC-C
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDL-V 193 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l-~ 193 (511)
......++|++.+.||+|+||.||+|++.. +|+.||||++...... ..+.+.+|+.+++++ +
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 158 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 334556789999999999999999999865 6789999999765321 124578899999999 8
Q ss_pred CCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 194 H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
||||+++++++......+|||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 159 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLD 234 (365)
T ss_dssp CTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred CCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc------CCCCccc
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRS 347 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~ 347 (511)
.++.+||+|||++........ .....||+.|+|||++.+ ..++.++
T Consensus 235 -------------------------~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 286 (365)
T 2y7j_A 235 -------------------------DNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEV 286 (365)
T ss_dssp -------------------------TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTH
T ss_pred -------------------------CCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchh
Confidence 477899999999987654332 234679999999998863 3688999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 348 DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
|||||||++|||++|+.||...... ........ .... ...+. .. ..+..+.+||.+||+.||.+||
T Consensus 287 Di~slG~il~ell~g~~pf~~~~~~---~~~~~i~~---~~~~---~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rp 352 (365)
T 2y7j_A 287 DLWACGVILFTLLAGSPPFWHRRQI---LMLRMIME---GQYQ---FSSPE-WD----DRSSTVKDLISRLLQVDPEARL 352 (365)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---TCCC---CCHHH-HS----SSCHHHHHHHHHHSCSSTTTSC
T ss_pred hHHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh---CCCC---CCCcc-cc----cCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999999999754221 11111110 0000 00000 00 1246789999999999999999
Q ss_pred CHHHHHHH
Q 010432 428 LMSEVVEA 435 (511)
Q Consensus 428 s~~eil~~ 435 (511)
++.+++++
T Consensus 353 s~~ell~h 360 (365)
T 2y7j_A 353 TAEQALQH 360 (365)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=391.08 Aligned_cols=250 Identities=27% Similarity=0.375 Sum_probs=197.6
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 212 (511)
+.||+|+||.||+|.+... .+++.||||+++.... ...+.+.+|+.+|++|+|||||++++++.. +..+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 3799999999999977532 2567999999976432 234679999999999999999999999864 56889
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
|||||++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 447 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~------------------- 503 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLV------------------- 503 (635)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE-------------------
T ss_pred EEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEe-------------------
Confidence 99999999999999654 47899999999999999999999998 99999999999998
Q ss_pred ccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 370 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~ 370 (511)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++ |+.||.+..
T Consensus 504 ------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 504 ------TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp ------ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ------CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3778999999999876543321 22333467899999999999999999999999999999998 999997643
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
.. .+...+.. ......+..++..+.+||.+||+.||.+||++.+|++.|+.
T Consensus 578 ~~---~~~~~i~~--------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 578 GS---EVTAMLEK--------------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp HH---HHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HH---HHHHHHHc--------------CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 21 11111110 01111222345789999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=350.82 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=198.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.++|++.+.||+|+||.||+|.+.. ++..||||+++... ......+.+|+.++++++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 4689999999999999999998765 67899999997542 1234678899999999999999999999
Q ss_pred EE--eCCeEEEEEEccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 204 CI--EDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 204 ~~--~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+. .....++|||||.++ |.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~------- 143 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLT------- 143 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEc-------
Confidence 85 345789999999776 7777754 3456899999999999999999999998 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC--CCccccchhHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLE 358 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||++................||+.|+|||++.+.. ++.++|||||||++||
T Consensus 144 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 205 (305)
T 2wtk_C 144 ------------------TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYN 205 (305)
T ss_dssp ------------------TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHH
T ss_pred ------------------CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHH
Confidence 47789999999998765433332334567999999999987644 4789999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|++|+.||...... ....... ... ..+ +...+..+.+||.+||+.||.+||++.+++++
T Consensus 206 l~~g~~p~~~~~~~---~~~~~i~---~~~--------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 206 ITTGLYPFEGDNIY---KLFENIG---KGS--------YAI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHSSCSCCCSSHH---HHHHHHH---HCC--------CCC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHhCCCCCCCchHH---HHHHHHh---cCC--------CCC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999754211 1111110 000 011 11234678999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=347.47 Aligned_cols=249 Identities=27% Similarity=0.338 Sum_probs=196.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 4689999999999999999999865 57899999996532 22345788999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~----------- 145 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLD----------- 145 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEEC-----------
T ss_pred ecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEEC-----------
Confidence 9999999999999999999999654 36899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|+
T Consensus 146 --------------~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 208 (276)
T 2h6d_A 146 --------------AHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208 (276)
T ss_dssp --------------TTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSS
T ss_pred --------------CCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCC
Confidence 477899999999987654322 233578999999999987765 68999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.||..... ..+...... .. .. .+...+..+.+||.+||+.||.+|||+.+|+++
T Consensus 209 ~p~~~~~~---~~~~~~~~~---~~--------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 209 LPFDDEHV---PTLFKKIRG---GV--------FY----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CSSCCSSH---HHHHHHHHH---CC--------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCCcH---HHHHHHhhc---Cc--------cc----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 99975321 111111110 00 00 111224678999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=363.47 Aligned_cols=263 Identities=22% Similarity=0.270 Sum_probs=193.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++++.||+|+||.||+|.+.. +++.||||++...... ....+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 3689999999999999999999865 6789999999764322 2356889999999999999999999997
Q ss_pred eCC------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
..+ ..++|||||. |+|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~------ 161 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK------ 161 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC------
T ss_pred cccccccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEc------
Confidence 654 7899999996 58888884 35889999999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 -------------------~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 219 (371)
T 2xrw_A 162 -------------------SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219 (371)
T ss_dssp -------------------TTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred -------------------CCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence 47789999999998754322 12346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhh------------------hhccccc-----cccccCCccCCC---CCHHHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARP------------------HLGERRR-----FYRLIDPRLEGH---FSIKGAQKAAQ 413 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~------------------~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~ 413 (511)
++|+.||.+...... +...... ....... +........... .....+..+.+
T Consensus 220 ~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (371)
T 2xrw_A 220 IKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297 (371)
T ss_dssp HHSSCSSCCSSHHHH--HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHH
Confidence 999999976432111 0000000 0000000 000000000000 11233678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHh
Q 010432 414 LAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 414 Li~~cl~~dP~~RPs~~eil~~L 436 (511)
||.+||+.||.+|||+.+++++-
T Consensus 298 li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 298 LLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHCcCChhhCCCHHHHhCCc
Confidence 99999999999999999999853
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=367.03 Aligned_cols=271 Identities=23% Similarity=0.306 Sum_probs=199.4
Q ss_pred ChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-----------HHHHHHHHHH
Q 010432 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNF 188 (511)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-----------~~~~~~E~~i 188 (511)
.+.++....++|++.+.||+|+||.||+|.+. .|..||||++....... .+.+.+|+.+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 82 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence 34566777899999999999999999999864 37799999996532211 2578899999
Q ss_pred HhCCCCCCcceEeeEEEeC-----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 010432 189 LGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 263 (511)
Q Consensus 189 l~~l~H~nIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHr 263 (511)
|++++||||+++++++... ...|+||||+. |+|.+++......+++..+..++.||+.||.|||+++ |+||
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 158 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHR 158 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEec
Confidence 9999999999999998653 36899999996 6999998776668999999999999999999999998 9999
Q ss_pred ccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CC
Q 010432 264 DFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GH 342 (511)
Q Consensus 264 DLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~ 342 (511)
||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+ ..
T Consensus 159 Dlkp~NIl~~-------------------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~ 210 (362)
T 3pg1_A 159 DLHPGNILLA-------------------------DNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKG 210 (362)
T ss_dssp CCCGGGEEEC-------------------------TTCCEEECCTTC------------------CGGGCCHHHHTTCTT
T ss_pred CCChHHEEEc-------------------------CCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCC
Confidence 9999999998 477899999999986443322 234578999999999876 67
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc----------cccccccCCcc---C----CCCCH
Q 010432 343 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER----------RRFYRLIDPRL---E----GHFSI 405 (511)
Q Consensus 343 ~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~---~----~~~~~ 405 (511)
++.++|||||||++|+|++|+.||.......... ......... ......+...+ . .....
T Consensus 211 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T 3pg1_A 211 FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN---KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287 (362)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHST
T ss_pred CCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCC
Confidence 8999999999999999999999997643221111 100000000 00000000000 0 00111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 406 KGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 406 ~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..+..+.+||.+||+.||.+|||+.+++++
T Consensus 288 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 288 TADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 224678999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=356.27 Aligned_cols=257 Identities=26% Similarity=0.340 Sum_probs=199.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhCCCCCCcc
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNLV 198 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~H~nIv 198 (511)
..++|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|++++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 34679999999999999999999875 678999999975432 1123478999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
++++++..++ .++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~-- 151 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQE-- 151 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSS--
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCC--
Confidence 9999987655 8999999999999999854 357899999999999999999999998 99999999999998421
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc---cCCCCccccchhHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVV 355 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvi 355 (511)
.+..+||+|||+++....... .....||+.|+|||++. ...++.++|||||||+
T Consensus 152 --------------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 208 (322)
T 2ycf_A 152 --------------------EDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208 (322)
T ss_dssp --------------------SSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHH
T ss_pred --------------------CCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHH
Confidence 244699999999987654321 22357999999999874 5678999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+|+|++|..||........ +....... ...+ .+... ...+..+.+||.+||+.||.+||++.+++++
T Consensus 209 l~~l~~g~~pf~~~~~~~~--~~~~~~~~---~~~~----~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 209 LFICLSGYPPFSEHRTQVS--LKDQITSG---KYNF----IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHHSSCSSCSTTCSSC--HHHHHHHT---CCCC----CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCCCCCcccchHHH--HHHHHHhC---cccc----Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 9999999999976543221 11111100 0000 00000 1124678999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=355.77 Aligned_cols=265 Identities=26% Similarity=0.393 Sum_probs=205.9
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhC--CCCCCcceEee
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIG 202 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~ 202 (511)
....++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|++++.. ++||||+++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 34557899999999999999999987 3679999999643 24567889998887 79999999999
Q ss_pred EEEeCC----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecccCCCcE
Q 010432 203 YCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNI 270 (511)
Q Consensus 203 ~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~~iiHrDLKp~NI 270 (511)
++.... ..++||||+++|+|.+++... .+++..++.++.||+.||.||| +++ |+||||||+||
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 998876 789999999999999999653 6899999999999999999999 777 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccC------C
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------H 342 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~------~ 342 (511)
|++ .++.+||+|||+++......... ......||+.|+|||++.+. .
T Consensus 179 ll~-------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 233 (342)
T 1b6c_B 179 LVK-------------------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233 (342)
T ss_dssp EEC-------------------------TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHH
T ss_pred EEC-------------------------CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccc
Confidence 998 47789999999998654433221 12345799999999998765 3
Q ss_pred CCccccchhHHHHHHHHHhC----------CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCC-CCHHHHHHH
Q 010432 343 LTSRSDVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKA 411 (511)
Q Consensus 343 ~~~~~DIwSlGvil~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 411 (511)
++.++|||||||++|||++| ..||......... ...+...... ....+.+... .....+..+
T Consensus 234 ~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l 306 (342)
T 1b6c_B 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVCE------QKLRPNIPNRWQSCEALRVM 306 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHHHHHTT------SCCCCCCCGGGGTSHHHHHH
T ss_pred cCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc-HHHHHHHHHH------HHhCCCCcccccchhHHHHH
Confidence 44789999999999999999 7788654332111 1111110000 0111111111 123567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 412 AQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 412 ~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus 307 ~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 307 AKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999999999998664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=366.35 Aligned_cols=271 Identities=18% Similarity=0.224 Sum_probs=204.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcce--------
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK-------- 199 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~-------- 199 (511)
.++|++.+.||+|+||.||+|++..+.... ....++.||||++... ..+.+|+.++++++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~-~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCD-SGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCcccc-ccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 368999999999999999999987521100 0013679999999755 35789999999999999988
Q ss_pred -------EeeEEEe-CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcE
Q 010432 200 -------LIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (511)
Q Consensus 200 -------l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NI 270 (511)
+++++.. +...+|||||| +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 78889999999 99999999764 357999999999999999999999998 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccC--ceeeecCCCcccCCCCCcce-----eeeeccccccccCCcccccCCC
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDY--NAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHL 343 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~ 343 (511)
|++. ++ .+||+|||+++......... ......||+.|+|||++.+..+
T Consensus 191 l~~~-------------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 245 (352)
T 2jii_A 191 FVDP-------------------------EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP 245 (352)
T ss_dssp EEET-------------------------TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC
T ss_pred EEcC-------------------------CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC
Confidence 9984 44 79999999998654322110 1123579999999999999999
Q ss_pred CccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 344 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 344 ~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
+.++|||||||+||||++|+.||....... ..+............ .+...... ....+..+.+||.+||+.||
T Consensus 246 ~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 246 SRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMKQKQKFVDKPG---PFVGPCGH---WIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHSCC---CEECTTSC---EECCCHHHHHHHHHHHTCCT
T ss_pred CchhhHHHHHHHHHHHHhCCCCcccCCcCH-HHHHHHHHhccCChh---hhhhhccc---cCCCcHHHHHHHHHHHhCCh
Confidence 999999999999999999999997653221 111111111111111 11110000 01124778999999999999
Q ss_pred CCCCCHHHHHHHhcCCC
Q 010432 424 KARPLMSEVVEALKPLP 440 (511)
Q Consensus 424 ~~RPs~~eil~~L~~l~ 440 (511)
.+||++.+|++.|+.+.
T Consensus 319 ~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 319 EEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TCCCCHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHH
Confidence 99999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=368.61 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=184.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3689999999999999999998865 688999999976432 23356889999999999999999999987
Q ss_pred eC------CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
.. ...++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~------ 166 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN------ 166 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC------
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEEC------
Confidence 54 5679999999 7899998854 46899999999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++..... .+...||+.|+|||++.+ ..++.++|||||||++||
T Consensus 167 -------------------~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 222 (367)
T 2fst_X 167 -------------------EDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222 (367)
T ss_dssp -------------------TTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHH
T ss_pred -------------------CCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHH
Confidence 4778999999999875432 234679999999999886 689999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhh--------hcc--ccccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPH--------LGE--RRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKA 425 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~Li~~cl~~dP~~ 425 (511)
|++|+.||.+.........+...... ... ...+...+.......+ ....+..+.+||.+||+.||.+
T Consensus 223 ll~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~ 302 (367)
T 2fst_X 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302 (367)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCccc
Confidence 99999999765432111111100000 000 0000000000000000 0112467899999999999999
Q ss_pred CCCHHHHHHH
Q 010432 426 RPLMSEVVEA 435 (511)
Q Consensus 426 RPs~~eil~~ 435 (511)
|||+.+++++
T Consensus 303 R~t~~e~L~h 312 (367)
T 2fst_X 303 RITAAQALAH 312 (367)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhcC
Confidence 9999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=366.34 Aligned_cols=275 Identities=21% Similarity=0.317 Sum_probs=186.6
Q ss_pred cCCCC-CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 129 RNFRP-ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 129 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
+.|++ .++||+|+||+||+|+++.. .++..||||++..... ...+.+|+.+|++|+|||||++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 34665 45899999999999997642 1477899999976533 2568899999999999999999999965
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
....+|||||+. |+|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+||||...+.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSST
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCC
Confidence 678999999995 5888887521 224899999999999999999999999 999999999999953111
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccC-CCCccccchhHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVV 355 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvi 355 (511)
.++.+||+|||+++........ ......+||+.|+|||++.+. .++.++||||||||
T Consensus 167 ---------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i 225 (405)
T 3rgf_A 167 ---------------------ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 225 (405)
T ss_dssp ---------------------TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHH
T ss_pred ---------------------CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHH
Confidence 4678999999999876542211 123346899999999999874 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCc------hhHHHhhhhhhcc--ccccccc------------cCCccCCCCC---------HH
Q 010432 356 LLEMLTGRRSMDKNRPNGE------HNLVEWARPHLGE--RRRFYRL------------IDPRLEGHFS---------IK 406 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~------~~~~~~~~~~~~~--~~~~~~~------------~~~~~~~~~~---------~~ 406 (511)
||||++|+.||........ ..........++. ...+..+ .......... ..
T Consensus 226 l~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (405)
T 3rgf_A 226 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305 (405)
T ss_dssp HHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCC
T ss_pred HHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCC
Confidence 9999999999976543210 0111111000000 0000000 0000000000 00
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 407 ~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
.+..+.+||.+||+.||.+|||+.|++++-.
T Consensus 306 ~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp TTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 1456889999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=357.49 Aligned_cols=268 Identities=27% Similarity=0.367 Sum_probs=190.5
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
....++|++.+.||+|+||.||+|++.. ++..||||++...... ...+.+|+..+..++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~ 88 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYF 88 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhh
Confidence 3456789999999999999999999875 6789999998665322 24567888889999999999999999
Q ss_pred EeCCe-------EEEEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeEecccCCCcEEe
Q 010432 205 IEDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH--EEAERPVIYRDFKTSNILL 272 (511)
Q Consensus 205 ~~~~~-------~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~~~~iiHrDLKp~NILl 272 (511)
..... .++||||+.+ +|...+. .....+++..+..++.||+.||.||| +++ |+||||||+|||+
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll 164 (360)
T 3e3p_A 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLV 164 (360)
T ss_dssp EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEE
T ss_pred hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEE
Confidence 76433 7899999965 6655443 34567899999999999999999999 877 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchh
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYS 351 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwS 351 (511)
+. .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||
T Consensus 165 ~~------------------------~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 217 (360)
T 3e3p_A 165 NE------------------------ADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWS 217 (360)
T ss_dssp ET------------------------TTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred eC------------------------CCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHH
Confidence 83 267899999999987654332 2345789999999998765 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCC----------------ccCCCCCHHHHHHHHHHH
Q 010432 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP----------------RLEGHFSIKGAQKAAQLA 415 (511)
Q Consensus 352 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~Li 415 (511)
|||++|||++|+.||........ +.................+++ ..........+..+.+||
T Consensus 218 lG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (360)
T 3e3p_A 218 VGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295 (360)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHHHHHHhCCCCcCCCChHHH--HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHH
Confidence 99999999999999986532211 111111000000000000000 000111222467899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 010432 416 AHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 416 ~~cl~~dP~~RPs~~eil~~ 435 (511)
.+||+.||.+|||+.+++++
T Consensus 296 ~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 296 SALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhccCccccCCHHHHhcC
Confidence 99999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.05 Aligned_cols=269 Identities=23% Similarity=0.291 Sum_probs=202.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
..+|++++.||+|+||.||+|++.. ++..||||++...... ....+.+|+.+|.+++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 3589999999999999999999865 6789999999754332 23568899999999999999999999976
Q ss_pred C-----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 207 ~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
. ...++||||+. |+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~-------- 162 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN-------- 162 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC--------
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEEC--------
Confidence 4 36899999995 6999998653 5899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCccccc-CCCCccccchhHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 163 -----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 225 (364)
T 3qyz_A 163 -----------------TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225 (364)
T ss_dssp -----------------TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHH
T ss_pred -----------------CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHH
Confidence 4778999999999876432211 11234579999999998764 5589999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhcc----------cccc-ccccCCccC--CCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGE----------RRRF-YRLIDPRLE--GHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~-~~~~~~~~~--~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
++|+.||.+.........+......... ...+ ......... .......+..+.+||.+||+.||.+|
T Consensus 226 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 305 (364)
T 3qyz_A 226 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305 (364)
T ss_dssp HHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999765433322111100000000 0000 000000000 00001224678999999999999999
Q ss_pred CCHHHHHHHh
Q 010432 427 PLMSEVVEAL 436 (511)
Q Consensus 427 Ps~~eil~~L 436 (511)
||+.+++++-
T Consensus 306 ~t~~e~l~hp 315 (364)
T 3qyz_A 306 IEVEQALAHP 315 (364)
T ss_dssp CCHHHHHTSG
T ss_pred CCHHHHhcCc
Confidence 9999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=351.28 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=195.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++.... .....+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 4679999999999999999999865 57899999996532 233568899999999999999999998865
Q ss_pred ------------CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecc
Q 010432 207 ------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 207 ------------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~ 274 (511)
....++||||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~- 150 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFID- 150 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC-
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEc-
Confidence 35678999999999999999876667888999999999999999999998 99999999999998
Q ss_pred ccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCc------------ceeeeeccccccccCCcccccC-
Q 010432 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG- 341 (511)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~aPE~~~~~- 341 (511)
.++.+||+|||+++....... ........||+.|+|||++.+.
T Consensus 151 ------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (303)
T 1zy4_A 151 ------------------------ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206 (303)
T ss_dssp ------------------------TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCS
T ss_pred ------------------------CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC
Confidence 477899999999987543210 1112345799999999998764
Q ss_pred CCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccc
Q 010432 342 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 421 (511)
Q Consensus 342 ~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~ 421 (511)
.++.++|||||||++|||++ ||.... .......... .....+...++...+..+.+||.+||+.
T Consensus 207 ~~~~~~Di~slG~il~~l~~---p~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~ 270 (303)
T 1zy4_A 207 HYNEKIDMYSLGIIFFEMIY---PFSTGM-----ERVNILKKLR--------SVSIEFPPDFDDNKMKVEKKIIRLLIDH 270 (303)
T ss_dssp CCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHHHHH--------STTCCCCTTCCTTTSHHHHHHHHHHTCS
T ss_pred CCcchhhHHHHHHHHHHHHh---ccCCch-----hHHHHHHhcc--------ccccccCccccccchHHHHHHHHHHHhc
Confidence 78999999999999999998 553210 1111111000 0111122233334456789999999999
Q ss_pred CCCCCCCHHHHHHHh
Q 010432 422 DPKARPLMSEVVEAL 436 (511)
Q Consensus 422 dP~~RPs~~eil~~L 436 (511)
||.+|||+.+++++-
T Consensus 271 dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 271 DPNKRPGARTLLNSG 285 (303)
T ss_dssp SGGGSCCHHHHHHSS
T ss_pred CcccCcCHHHHhCCC
Confidence 999999999999854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=357.95 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=198.9
Q ss_pred cChHHHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCC--C
Q 010432 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLV--H 194 (511)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~--H 194 (511)
+.+..+....++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.++.+++ |
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 87 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGC
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccC
Confidence 333444455678999999999999999999864 3678999999765432 3356889999999997 5
Q ss_pred CCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecc
Q 010432 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 195 ~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~ 274 (511)
+||+++++++...+..++||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 88 ~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~- 161 (313)
T 3cek_A 88 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV- 161 (313)
T ss_dssp TTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-
T ss_pred CceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-
Confidence 999999999999999999999 5588999999764 47899999999999999999999998 99999999999996
Q ss_pred ccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-----------CCC
Q 010432 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHL 343 (511)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----------~~~ 343 (511)
++.+||+|||+++...............||+.|+|||++.+ ..+
T Consensus 162 -------------------------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 216 (313)
T 3cek_A 162 -------------------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216 (313)
T ss_dssp -------------------------TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CC
T ss_pred -------------------------CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccC
Confidence 46799999999987654433222334579999999999875 478
Q ss_pred CccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 344 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 344 ~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
+.++|||||||++|||++|+.||....... .... ..+++.....++...+..+.+||.+||+.||
T Consensus 217 ~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred CchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHH----------HHHhcccccCCcccchHHHHHHHHHHccCCc
Confidence 899999999999999999999997542210 0000 1111111111222224678999999999999
Q ss_pred CCCCCHHHHHHHh
Q 010432 424 KARPLMSEVVEAL 436 (511)
Q Consensus 424 ~~RPs~~eil~~L 436 (511)
.+||++.+++++.
T Consensus 282 ~~Rps~~ell~h~ 294 (313)
T 3cek_A 282 KQRISIPELLAHP 294 (313)
T ss_dssp TTSCCHHHHHTSH
T ss_pred ccCcCHHHHhcCc
Confidence 9999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=350.04 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=204.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---------ccHHHHHHHHHHHhCCC-CCC
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHKEWLAEVNFLGDLV-HLN 196 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~~E~~il~~l~-H~n 196 (511)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+|+++. |||
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 34689999999999999999999875 678999999976531 11245789999999995 999
Q ss_pred cceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccc
Q 010432 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276 (511)
Q Consensus 197 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 276 (511)
|+++++++......++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~--- 158 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD--- 158 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEc---
Confidence 999999999999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred ccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc------cCCCCccccch
Q 010432 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVY 350 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~~~~DIw 350 (511)
.++.+||+|||++........ .....||+.|+|||++. ...++.++|||
T Consensus 159 ----------------------~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~ 213 (298)
T 1phk_A 159 ----------------------DDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213 (298)
T ss_dssp ----------------------TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred ----------------------CCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccH
Confidence 477899999999987654332 23457999999999885 45688999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 351 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
||||++|||++|+.||...... ....... .... .. ........+..+.+||.+||+.||.+||++.
T Consensus 214 slG~~l~~l~~g~~p~~~~~~~---~~~~~~~---~~~~---~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (298)
T 1phk_A 214 STGVIMYTLLAGSPPFWHRKQM---LMLRMIM---SGNY---QF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279 (298)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HTCC---CC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred hHHHHHHHHHHCCCCCcCccHH---HHHHHHh---cCCc---cc-----CcccccccCHHHHHHHHHHccCCcccCCCHH
Confidence 9999999999999999754221 1111110 0000 00 0001112357789999999999999999999
Q ss_pred HHHHH
Q 010432 431 EVVEA 435 (511)
Q Consensus 431 eil~~ 435 (511)
+++++
T Consensus 280 ~ll~h 284 (298)
T 1phk_A 280 EALAH 284 (298)
T ss_dssp HHTTS
T ss_pred HHHhC
Confidence 99873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=361.29 Aligned_cols=261 Identities=20% Similarity=0.336 Sum_probs=201.8
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEee
Q 010432 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 125 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
.+..++|++.+.||+|+||.||+|++.. .||||+++.... ...+.+.+|+.++++++|+||+++++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 96 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 3445789999999999999999998753 599999975432 22345778999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++...+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~--------- 164 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD--------- 164 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---------
T ss_pred EEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe---------
Confidence 999999999999999999999999776667999999999999999999999998 99999999999997
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCc---ceeeeeccccccccCCccccc---------CCCCccccch
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT---------GHLTSRSDVY 350 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~---~~~~~~~~Gt~~y~aPE~~~~---------~~~~~~~DIw 350 (511)
++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||
T Consensus 165 -----------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~ 227 (319)
T 2y4i_B 165 -----------------NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227 (319)
T ss_dssp -------------------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHH
T ss_pred -----------------CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHH
Confidence 45799999999876432111 111223469999999999864 4578999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 010432 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430 (511)
Q Consensus 351 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ 430 (511)
||||++|||++|+.||...... ......... ..+... ....+..+.+|+.+||+.||.+|||+.
T Consensus 228 slG~il~el~~g~~p~~~~~~~---~~~~~~~~~----------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ 291 (319)
T 2y4i_B 228 ALGTIWYELHAREWPFKTQPAE---AIIWQMGTG----------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFT 291 (319)
T ss_dssp HHHHHHHHHHHSSCSSSSCCHH---HHHHHHHTT----------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHH---HHHHHhccC----------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 9999999999999999754321 111111000 001010 011235688999999999999999999
Q ss_pred HHHHHhcCCCCC
Q 010432 431 EVVEALKPLPNL 442 (511)
Q Consensus 431 eil~~L~~l~~~ 442 (511)
+|++.|+.+...
T Consensus 292 ~l~~~l~~l~~~ 303 (319)
T 2y4i_B 292 KLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHTTC---
T ss_pred HHHHHHHHHHHh
Confidence 999999988654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=388.86 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=208.6
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEee
Q 010432 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
.....++|++.+.||+|+||.||+|.+...+. .+..||||+++..... ..+.+.+|+.+|++++|||||++++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 458 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 33445789999999999999999999865322 4678999998764332 2357899999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++. ++..++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 459 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~--------- 525 (656)
T 2j0j_A 459 VIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVS--------- 525 (656)
T ss_dssp EEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE---------
T ss_pred EEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEe---------
Confidence 984 56689999999999999999877667999999999999999999999998 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT- 361 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt- 361 (511)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 526 ----------------~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~ 588 (656)
T 2j0j_A 526 ----------------SNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 588 (656)
T ss_dssp ----------------ETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ----------------CCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHc
Confidence 3778999999999876543322 2233567899999999998999999999999999999997
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|..||.+.... ......... . ....+..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 589 g~~Pf~~~~~~---~~~~~i~~~----------~----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 589 GVKPFQGVKNN---DVIGRIENG----------E----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp SCCTTTTCCHH---HHHHHHHHT----------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHH---HHHHHHHcC----------C----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999754321 111111100 0 0111223357889999999999999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=352.68 Aligned_cols=269 Identities=23% Similarity=0.309 Sum_probs=195.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEE--
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-- 205 (511)
.++|++.+.||+|+||.||+|.+.. +++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 3689999999999999999999875 67899999998765555567899999999999999999999873
Q ss_pred ------------eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 206 ------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 206 ------------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
.....++||||+. |+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 3467899999996 699999854 46899999999999999999999998 99999999999997
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCccccc-CCCCccccchh
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYS 351 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwS 351 (511)
. ++..+||+|||+++........ .......||..|+|||++.+ ..++.++||||
T Consensus 155 ~------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 210 (320)
T 2i6l_A 155 T------------------------EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210 (320)
T ss_dssp T------------------------TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHH
T ss_pred C------------------------CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHh
Confidence 3 3568999999999876432111 11233568999999998875 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhc--cccccccc---------cCCcc-CCCCCHHHHHHHHHHHHHhc
Q 010432 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--ERRRFYRL---------IDPRL-EGHFSIKGAQKAAQLAAHCL 419 (511)
Q Consensus 352 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~-~~~~~~~~~~~~~~Li~~cl 419 (511)
|||++|||++|+.||...........+........ ....+... ..+.. ........+..+.+||.+||
T Consensus 211 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (320)
T 2i6l_A 211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL 290 (320)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTS
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHc
Confidence 99999999999999986542211111000000000 00000000 00000 00001123577899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 010432 420 SRDPKARPLMSEVVEA 435 (511)
Q Consensus 420 ~~dP~~RPs~~eil~~ 435 (511)
+.||.+|||+.+++++
T Consensus 291 ~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 291 TFSPMDRLTAEEALSH 306 (320)
T ss_dssp CSSGGGSCCHHHHHTS
T ss_pred CCCccccCCHHHHhCC
Confidence 9999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=369.69 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=193.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
.+|++.++||+|+||+||+|++.. +..||+|++...... ..+|+.+|+.++|||||++++++....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~----------~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC----------CCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 468999999999999999999864 334888888654322 237999999999999999999996543
Q ss_pred ------eEEEEEEccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 209 ------QRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 209 ------~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
..++|||||++ +|...+. .....+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 106 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~----- 176 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDP----- 176 (394)
T ss_dssp SSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEET-----
T ss_pred CCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcC-----
Confidence 37899999976 4444332 23557999999999999999999999998 999999999999973
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++....... .....||+.|+|||++.+. .|+.++|||||||++||
T Consensus 177 -------------------~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 234 (394)
T 4e7w_A 177 -------------------PSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234 (394)
T ss_dssp -------------------TTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred -------------------CCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence 367899999999987644332 2345789999999998765 58999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhc-c-------ccccc-----cccCCccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLG-E-------RRRFY-----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~-~-------~~~~~-----~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~ 425 (511)
|++|+.||.+..... .+......... . ...+. ......+...+....+..+.+||.+||+.||.+
T Consensus 235 ll~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (394)
T 4e7w_A 235 LMQGQPLFPGESGID--QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312 (394)
T ss_dssp HHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhh
Confidence 999999998653221 11111110000 0 00000 000000001112223578999999999999999
Q ss_pred CCCHHHHHHH
Q 010432 426 RPLMSEVVEA 435 (511)
Q Consensus 426 RPs~~eil~~ 435 (511)
|||+.+++++
T Consensus 313 R~t~~e~l~h 322 (394)
T 4e7w_A 313 RLTAIEALCH 322 (394)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.79 Aligned_cols=284 Identities=21% Similarity=0.272 Sum_probs=205.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCC------CcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL------NLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~------nIv~l~ 201 (511)
.++|++.+.||+|+||.||+|.+.. .+++.||||+++... ...+.+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 4689999999999999999998742 157899999997542 2235678899999888665 499999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+++...+..+|||||+ +++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.......
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccc
Confidence 9999999999999999 889999997654 46899999999999999999999998 999999999999985221000
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.. ...........+..+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 160 ~~------~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 228 (339)
T 1z57_A 160 YN------PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228 (339)
T ss_dssp EC----------CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred cC------CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH
Confidence 00 00000000012567999999999875432 22357999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhcc-------cccc------------------ccccCCc-cCCCCCHHHHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGE-------RRRF------------------YRLIDPR-LEGHFSIKGAQKAAQL 414 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~------------------~~~~~~~-~~~~~~~~~~~~~~~L 414 (511)
+|..||..................... .... .....+. .........++.+.+|
T Consensus 229 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 308 (339)
T 1z57_A 229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308 (339)
T ss_dssp HSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHH
Confidence 999999765332211111111100000 0000 0000000 0011233557889999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 010432 415 AAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 415 i~~cl~~dP~~RPs~~eil~~ 435 (511)
|.+||+.||.+|||+.||+++
T Consensus 309 i~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 309 IQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHhCcCcccccCHHHHhcC
Confidence 999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.25 Aligned_cols=256 Identities=23% Similarity=0.276 Sum_probs=176.6
Q ss_pred hcCCCCCC-ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHH-HHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV-NFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~-~il~~l~H~nIv~l~~~~~ 205 (511)
.++|.+.+ +||+|+||.||+|++.. +++.||||++... ....+|+ ..++.+.||||+++++++.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHh
Confidence 46788855 69999999999999876 6789999999753 2223333 3456779999999999987
Q ss_pred e----CCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 206 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
. ....+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~---- 165 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKE---- 165 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS----
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecC----
Confidence 6 455899999999999999997653 46999999999999999999999998 99999999999998422
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.+..+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 166 ------------------~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 223 (336)
T 3fhr_A 166 ------------------KDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 223 (336)
T ss_dssp ------------------TTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHH
T ss_pred ------------------CCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHH
Confidence 25569999999998654322 23357899999999998889999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
+|..||............. . . .......+........+..+.+||.+||+.||.+|||+.+++++-
T Consensus 224 ~g~~pf~~~~~~~~~~~~~--~-~-------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 224 CGFPPFYSNTGQAISPGMK--R-R-------IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp HSSCCC-------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HCCCCCCCccchhhhhhHH--H-h-------hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 9999997543321100000 0 0 000000011111122357889999999999999999999999853
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=358.93 Aligned_cols=263 Identities=19% Similarity=0.264 Sum_probs=203.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-----------------HHHHHHHHHHHh
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------HKEWLAEVNFLG 190 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-----------------~~~~~~E~~il~ 190 (511)
.++|++.+.||+|+||.||+|++ +++.||||++....... ...+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999987 36799999997532211 167899999999
Q ss_pred CCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEe
Q 010432 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 262 (511)
Q Consensus 191 ~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH 262 (511)
+++||||+++++++...+..++||||+++|+|.++ +... ...+++..++.++.||+.||.|||+ ++ |+|
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H 175 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH 175 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence 99999999999999999999999999999999998 5432 4679999999999999999999998 88 999
Q ss_pred cccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-
Q 010432 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG- 341 (511)
Q Consensus 263 rDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~- 341 (511)
|||||+|||++ .++.+||+|||++...... ......||+.|+|||++.+.
T Consensus 176 ~dl~p~Nil~~-------------------------~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 226 (348)
T 2pml_X 176 RDVKPSNILMD-------------------------KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNES 226 (348)
T ss_dssp CCCCGGGEEEC-------------------------TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCC
T ss_pred cCCChHhEEEc-------------------------CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCC
Confidence 99999999998 4778999999999876443 23446799999999999877
Q ss_pred CCCc-cccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhcccc-ccccccCCcc---CCCCCHHHHHHHHHHHH
Q 010432 342 HLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-RFYRLIDPRL---EGHFSIKGAQKAAQLAA 416 (511)
Q Consensus 342 ~~~~-~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~Li~ 416 (511)
.++. ++|||||||++|||++|+.||...... ............... .......+.. ........+..+.+||.
T Consensus 227 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 304 (348)
T 2pml_X 227 SYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK 304 (348)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHH
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHH
Confidence 6766 999999999999999999999765431 111111111000000 0000000000 00001223578899999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 010432 417 HCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 417 ~cl~~dP~~RPs~~eil~~ 435 (511)
+||+.||.+||++.+++++
T Consensus 305 ~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 305 LFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHCCSSGGGSCCHHHHHTS
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=357.81 Aligned_cols=204 Identities=24% Similarity=0.286 Sum_probs=172.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CC-----CcceE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL-----NLVKL 200 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~-----nIv~l 200 (511)
..++|++.++||+|+||+||+|++.. +++.||||+++... .....+.+|+.++..+. |+ +|+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 45789999999999999999999875 67899999997542 22355778888888874 44 49999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
++++...+..+|||||+. |+|.+++.... ..+++..+..++.||+.||.|||.+. .+||||||||+||||+..
T Consensus 122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~---- 195 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNP---- 195 (382)
T ss_dssp EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESST----
T ss_pred eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecC----
Confidence 999999999999999995 69999997653 46899999999999999999999532 239999999999999631
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||
T Consensus 196 -------------------~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 251 (382)
T 2vx3_A 196 -------------------KRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251 (382)
T ss_dssp -------------------TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -------------------CCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHH
Confidence 3567999999999876442 2235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 010432 360 LTGRRSMDKNR 370 (511)
Q Consensus 360 ltg~~pf~~~~ 370 (511)
++|+.||....
T Consensus 252 ltg~~pf~~~~ 262 (382)
T 2vx3_A 252 HTGEPLFSGAN 262 (382)
T ss_dssp HHSSCSSCCSS
T ss_pred HhCCCCCCCCC
Confidence 99999998654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=351.57 Aligned_cols=255 Identities=27% Similarity=0.353 Sum_probs=180.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHH-HHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVN-FLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~-il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 4689999999999999999999865 6789999999865432 2345666666 778889999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEecccccccc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
..+..++||||+. |+|.+++.. ....+++..+..++.|++.||.|||++ + |+||||||+|||++
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~------- 160 (327)
T 3aln_A 92 REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLD------- 160 (327)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEE-------
T ss_pred eCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEc-------
Confidence 9999999999996 488877752 245789999999999999999999998 8 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccc----ccCCCCccccchhHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVL 356 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~----~~~~~~~~~DIwSlGvil 356 (511)
.++.+||+|||+++....... .....||+.|+|||++ .+..++.++|||||||++
T Consensus 161 ------------------~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 219 (327)
T 3aln_A 161 ------------------RSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219 (327)
T ss_dssp ------------------TTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHH
T ss_pred ------------------CCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence 477899999999987644321 2234799999999998 456789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|||++|+.||....... ..... ......+.+........+..+.+||.+||+.||.+||++.+|+++
T Consensus 220 ~~l~~g~~pf~~~~~~~-----~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 220 YELATGRFPYPKWNSVF-----DQLTQ-------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp HHHHHSCCCSSCC------------CC-------CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchHH-----HHHHH-------HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 99999999997532210 00000 000011111111112235789999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=346.49 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=204.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
..++|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 45689999999999999999999865 577999999965432 3456789999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~-------- 158 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKE-------- 158 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSS--------
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCC--------
Confidence 9999999999999999999988654 36899999999999999999999998 99999999999997421
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.+..+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 159 --------------~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~ 220 (287)
T 2wei_A 159 --------------KDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220 (287)
T ss_dssp --------------TTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCC
Confidence 245799999999987544322 223468999999998765 58999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||...... ........ .... ...+ .....+..+.+||.+||+.||.+|||+.+++++
T Consensus 221 p~~~~~~~---~~~~~~~~---~~~~---~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 221 PFYGKNEY---DILKRVET---GKYA---FDLP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp SSCCSSHH---HHHHHHHH---CCCC---CCSG-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCCHH---HHHHHHHc---CCCC---CCch-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 99764321 11111110 0000 0000 001224678999999999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=356.35 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=197.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++....... ...+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 3689999999999999999999876 68899999997654322 356889999999999999999999998
Q ss_pred eCCeE------EEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 EDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~~~------~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
..+.. ++||||+. ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~------ 178 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVN------ 178 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC------
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEEC------
Confidence 76654 99999996 68888773 34899999999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++||
T Consensus 179 -------------------~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (371)
T 4exu_A 179 -------------------EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 234 (371)
T ss_dssp -------------------TTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred -------------------CCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHH
Confidence 4778999999999865432 234678999999999887 789999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccc------------cccccCCccCCC---CCHHHHHHHHHHHHHhcccCC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRR------------FYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~---~~~~~~~~~~~Li~~cl~~dP 423 (511)
|++|+.||........ +............. +...+....... .....+..+.+||.+||+.||
T Consensus 235 l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (371)
T 4exu_A 235 MLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 312 (371)
T ss_dssp HHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCT
T ss_pred HHhCCCCCCCCChHHH--HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCCh
Confidence 9999999976432211 11110000000000 000000000000 011225788999999999999
Q ss_pred CCCCCHHHHHHH
Q 010432 424 KARPLMSEVVEA 435 (511)
Q Consensus 424 ~~RPs~~eil~~ 435 (511)
.+|||+.+++++
T Consensus 313 ~~Rpt~~ell~h 324 (371)
T 4exu_A 313 DKRLTAAQALTH 324 (371)
T ss_dssp TTSCCHHHHHTS
T ss_pred hhcCCHHHHhcC
Confidence 999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=360.52 Aligned_cols=270 Identities=21% Similarity=0.261 Sum_probs=202.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-----------CCC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLN 196 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----------H~n 196 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++.... .....+.+|+.+++++. |+|
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3589999999999999999999865 67899999997542 22356788999999886 899
Q ss_pred cceEeeEEEeCC----eEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcE
Q 010432 197 LVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNI 270 (511)
Q Consensus 197 Iv~l~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NI 270 (511)
|+++++++...+ ..++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ + |+||||||+||
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI 163 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV 163 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence 999999988654 789999999 89999999753 34699999999999999999999997 8 99999999999
Q ss_pred EeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccch
Q 010432 271 LLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350 (511)
Q Consensus 271 Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIw 350 (511)
||+..+.. .....+||+|||+++..... .....||+.|+|||++.+..++.++|||
T Consensus 164 ll~~~~~~-------------------~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 219 (373)
T 1q8y_A 164 LMEIVDSP-------------------ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIW 219 (373)
T ss_dssp EEEEEETT-------------------TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHH
T ss_pred EEeccCCC-------------------cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHH
Confidence 99642210 02457999999999876442 2235799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCch---hHHHhhhhhhccc-----------------cccccccCC----------ccC
Q 010432 351 SFGVVLLEMLTGRRSMDKNRPNGEH---NLVEWARPHLGER-----------------RRFYRLIDP----------RLE 400 (511)
Q Consensus 351 SlGvil~elltg~~pf~~~~~~~~~---~~~~~~~~~~~~~-----------------~~~~~~~~~----------~~~ 400 (511)
||||+||||++|+.||......... ............. ......+.. ...
T Consensus 220 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (373)
T 1q8y_A 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 299 (373)
T ss_dssp HHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc
Confidence 9999999999999999765422111 0000000000000 000000000 001
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 401 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 401 ~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
..++...+..+.+||.+||+.||.+|||+.+|+++
T Consensus 300 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 300 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred ccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 13456778899999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=359.21 Aligned_cols=268 Identities=24% Similarity=0.289 Sum_probs=199.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|++.. +|+.||||++...... ....+.+|+.+|++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 4689999999999999999999875 6889999999754322 23467899999999999999999998875
Q ss_pred C-----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 207 ~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
. ...++||||+. |+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~-------- 146 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLIN-------- 146 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC--------
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEc--------
Confidence 4 67899999996 699999865 36899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcce--------eeeeccccccccCCccccc-CCCCccccchhH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSF 352 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSl 352 (511)
.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||
T Consensus 147 -----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 209 (353)
T 2b9h_A 147 -----------------SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209 (353)
T ss_dssp -----------------TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred -----------------CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence 47789999999998764322111 1123578999999998764 778999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhcccc-----------ccccccCCccCC---CCCHHHHHHHHHHHHHh
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-----------RFYRLIDPRLEG---HFSIKGAQKAAQLAAHC 418 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~---~~~~~~~~~~~~Li~~c 418 (511)
||++|||++|+.||.+.........+........... .....+...... ......+..+.+||.+|
T Consensus 210 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (353)
T 2b9h_A 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM 289 (353)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHh
Confidence 9999999999999976532111110000000000000 000000000000 00012356789999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 010432 419 LSRDPKARPLMSEVVEA 435 (511)
Q Consensus 419 l~~dP~~RPs~~eil~~ 435 (511)
|+.||.+|||+.+++++
T Consensus 290 L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 290 LVFDPAKRITAKEALEH 306 (353)
T ss_dssp SCSSGGGSCCHHHHHTS
T ss_pred cCcCcccCCCHHHHhcC
Confidence 99999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=352.53 Aligned_cols=284 Identities=20% Similarity=0.238 Sum_probs=204.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCC------cceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN------LVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~n------Iv~l~ 201 (511)
.++|++.+.||+|+||.||+|.+... .+..||||+++... .....+.+|+.+++++.|++ |+.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 46899999999999999999998652 23689999997542 23356788999999987665 99999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..+....
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccc
Confidence 9999999999999999 677877776543 56999999999999999999999998 999999999999953211000
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
... ..........+..+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 165 ~~~------~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 233 (355)
T 2eu9_A 165 YNE------HKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233 (355)
T ss_dssp ECC------C-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccc------cccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence 000 00000000146789999999998754422 3357999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhcc-------cccc------------------ccccCC-ccCCCCCHHHHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGE-------RRRF------------------YRLIDP-RLEGHFSIKGAQKAAQL 414 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~------------------~~~~~~-~~~~~~~~~~~~~~~~L 414 (511)
+|+.||...........+......... .... .....+ ..........+..+.+|
T Consensus 234 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 313 (355)
T 2eu9_A 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313 (355)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence 999999764332111111111100000 0000 000000 00001123446789999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 010432 415 AAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 415 i~~cl~~dP~~RPs~~eil~~ 435 (511)
|.+||+.||.+|||+.+++++
T Consensus 314 i~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 314 MRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=351.27 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=200.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCC---CCCCcceEe
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLI 201 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l---~H~nIv~l~ 201 (511)
..++|++.+.||+|+||.||+|++.. .+++.||||++..... .....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 45789999999999999999999852 1577999999964322 1123466787777666 899999999
Q ss_pred eEEE-----eCCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccc
Q 010432 202 GYCI-----EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 202 ~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 275 (511)
+++. .....++||||+. |+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~-- 154 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVT-- 154 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC--
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEc--
Confidence 9987 4567899999996 69999997643 35899999999999999999999998 99999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHH
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi 355 (511)
.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 155 -----------------------~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 208 (326)
T 1blx_A 155 -----------------------SSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208 (326)
T ss_dssp -----------------------TTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred -----------------------CCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHH
Confidence 47789999999998754322 1234578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhc--ccccccc----------ccCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--ERRRFYR----------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
+|||++|+.||........ ......... ....+.. .........+....+..+.+||.+||+.||
T Consensus 209 l~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (326)
T 1blx_A 209 FAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285 (326)
T ss_dssp HHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSST
T ss_pred HHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCc
Confidence 9999999999976532211 111110000 0000000 000000011122335778999999999999
Q ss_pred CCCCCHHHHHHH
Q 010432 424 KARPLMSEVVEA 435 (511)
Q Consensus 424 ~~RPs~~eil~~ 435 (511)
.+||++.+++++
T Consensus 286 ~~Rpt~~e~l~h 297 (326)
T 1blx_A 286 AKRISAYSALSH 297 (326)
T ss_dssp TTSCCHHHHHTS
T ss_pred ccCCCHHHHhcC
Confidence 999999999964
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.15 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=197.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|.+.+.||+|+||.||+|++.. +|+.||||++...... ....+.+|+.+|+.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 3579999999999999999999875 6889999999765332 2356889999999999999999999998
Q ss_pred eCCe------EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 EDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~~------~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
.... .++||||+. |+|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~------ 160 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVN------ 160 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEEC------
T ss_pred cccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeEC------
Confidence 7654 499999996 68888773 25899999999999999999999998 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++||
T Consensus 161 -------------------~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~e 216 (353)
T 3coi_A 161 -------------------EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 216 (353)
T ss_dssp -------------------TTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred -------------------CCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHH
Confidence 4778999999999875432 233578999999999876 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhcc-cc------------ccccccCCccC---CCCCHHHHHHHHHHHHHhcccC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGE-RR------------RFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRD 422 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~---~~~~~~~~~~~~~Li~~cl~~d 422 (511)
|++|+.||.+...... .......... .. .+...+..... .......+..+.+||.+||+.|
T Consensus 217 l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 3coi_A 217 MLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD 293 (353)
T ss_dssp HHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSC
T ss_pred HHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCC
Confidence 9999999976532111 1110000000 00 00000000000 1111234678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 010432 423 PKARPLMSEVVEA 435 (511)
Q Consensus 423 P~~RPs~~eil~~ 435 (511)
|.+|||+.+++++
T Consensus 294 p~~Rpt~~e~l~h 306 (353)
T 3coi_A 294 VDKRLTAAQALTH 306 (353)
T ss_dssp TTTSCCHHHHHTS
T ss_pred cccCCCHHHHhcC
Confidence 9999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.80 Aligned_cols=257 Identities=24% Similarity=0.317 Sum_probs=191.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 206 (511)
..+|.+.++||+|+||+||..... +++.||||++...... .+.+|+.+|+++ +|||||++++++.+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 356888899999999996643322 5779999999765432 356899999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
....|||||||. |+|.+++......+....++.++.||+.||.|||+++ ||||||||+||||+..+..
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~-------- 157 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAH-------- 157 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTT--------
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCC--------
Confidence 999999999995 6999999876656666667899999999999999998 9999999999999642210
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccc---cCCCCccccchhHHHHHHHHHh-
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLT- 361 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DIwSlGvil~ellt- 361 (511)
....+||+|||+++........ .......||+.|+|||++. ...++.++|||||||++|||++
T Consensus 158 ------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~ 225 (432)
T 3p23_A 158 ------------GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225 (432)
T ss_dssp ------------TBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTT
T ss_pred ------------CceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcC
Confidence 2456889999999876543211 1233467999999999997 4577889999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 436 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L 436 (511)
|..||....... .... ... ... . ........+..+.+||.+||+.||.+|||+.+|+++-
T Consensus 226 g~~pf~~~~~~~----~~~~---~~~-~~~-~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 226 GSHPFGKSLQRQ----ANIL---LGA-CSL-D------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp SCBTTBSTTTHH----HHHH---TTC-CCC-T------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred CCCCcchhhHHH----HHHH---hcc-CCc-c------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 899985432110 0000 000 000 0 0011224466789999999999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=348.24 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=200.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhCCC--CCCcc
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNLV 198 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~--H~nIv 198 (511)
..++|++.+.||+|+||.||+|++.. +++.||||++...... ....+.+|+.+++++. |+||+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 45789999999999999999998865 6789999999764322 1234668999999996 59999
Q ss_pred eEeeEEEeCCeEEEEEEccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 199 KLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 199 ~l~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
++++++...+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~--- 184 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL--- 184 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET---
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC---
Confidence 999999999999999999976 8999998654 46899999999999999999999998 999999999999973
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVL 356 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil 356 (511)
+++.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++
T Consensus 185 ---------------------~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 239 (320)
T 3a99_A 185 ---------------------NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239 (320)
T ss_dssp ---------------------TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred ---------------------CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHH
Confidence 36789999999998765432 233579999999999987666 7889999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 357 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|||++|+.||.... . ... ... .+.. ..+..+.+||.+||+.||.+||++.+|+++
T Consensus 240 ~el~~g~~pf~~~~-----~---~~~----~~~--------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 240 YDMVCGDIPFEHDE-----E---IIR----GQV--------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHHHHSSCSCCSHH-----H---HHH----CCC--------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHCCCCCCChh-----h---hhc----ccc--------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999996421 0 000 000 0111 124678999999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=348.05 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=193.3
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc------HHHHHHHHHHHhCC----CCC
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------HKEWLAEVNFLGDL----VHL 195 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l----~H~ 195 (511)
...++|++.+.||+|+||.||+|++.. +++.||||++....... ...+.+|+.++.++ +|+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence 445789999999999999999998765 67799999997654321 12356799999888 899
Q ss_pred CcceEeeEEEeCCeEEEEEEc-cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecc
Q 010432 196 NLVKLIGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (511)
Q Consensus 196 nIv~l~~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~ 274 (511)
||+++++++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence 999999999999999999999 7899999999654 36899999999999999999999998 999999999999973
Q ss_pred ccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHH
Q 010432 275 VRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFG 353 (511)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlG 353 (511)
.++.+||+|||+++...... .....||..|+|||++.+..+ +.++||||||
T Consensus 175 ------------------------~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 226 (312)
T 2iwi_A 175 ------------------------RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLG 226 (312)
T ss_dssp ------------------------TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHH
T ss_pred ------------------------CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHH
Confidence 36779999999998765432 234579999999999887666 4589999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 010432 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 433 (511)
Q Consensus 354 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil 433 (511)
|++|||++|+.||.... ... . .. ..++...+..+.+||.+||+.||.+||++.+++
T Consensus 227 ~il~~l~~g~~pf~~~~-----~~~---~----~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 282 (312)
T 2iwi_A 227 ILLYDMVCGDIPFERDQ-----EIL---E----AE------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282 (312)
T ss_dssp HHHHHHHHSSCSCCSHH-----HHH---H----TC------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHCCCCCCChH-----HHh---h----hc------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 99999999999996321 000 0 00 011122346789999999999999999999999
Q ss_pred HHh
Q 010432 434 EAL 436 (511)
Q Consensus 434 ~~L 436 (511)
++-
T Consensus 283 ~~~ 285 (312)
T 2iwi_A 283 LDP 285 (312)
T ss_dssp HST
T ss_pred cCh
Confidence 854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=339.96 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=182.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-HHH-HHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKE-WLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~-~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|++.+.||+|+||.||+|++.. +|+.||||++....... ..+ +.++..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 4678899999999999999999875 57799999998654322 223 444556788899999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecccCCCcEEeccccccccCCcc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.++..++||||+ ++.+..++......+++..++.++.||+.||.|||+. + |+||||||+|||++
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~----------- 159 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLD----------- 159 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEEC-----------
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEEC-----------
Confidence 999999999999 5566666655456799999999999999999999985 8 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHH
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||++........ .....||+.|+|||++. ...++.++|||||||++|||
T Consensus 160 --------------~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 160 --------------ERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp --------------TTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHH
T ss_pred --------------CCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHH
Confidence 477899999999986544322 23357999999999984 55789999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
++|+.||...... ....... .... .+.+.. ....+..+.+||.+||+.||.+||++.+|+++
T Consensus 223 ~~g~~pf~~~~~~--~~~~~~~---~~~~-------~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 223 ATGQFPYKNCKTD--FEVLTKV---LQEE-------PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHSSCTTTTCCSH--HHHHHHH---HHSC-------CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HhCCCCCCCCCcc--HHHHHHH---hccC-------CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 9999999753221 1111111 1110 000110 01124678999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.48 Aligned_cols=265 Identities=23% Similarity=0.264 Sum_probs=189.1
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCCcceEeeEEEeCC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDD 208 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~ 208 (511)
.|.+.++||+|+||+||.+... +|+.||||++.... .+.+.+|+.+|.++ +|||||++++++.+++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred eeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 4555678999999999875432 57899999997532 35678999999876 8999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~------l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
..+||||||. |+|.+++...... ..+..++.++.||+.||+|||+++ ||||||||+|||++..+......
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCccccccc
Confidence 9999999995 6999999654321 122345679999999999999998 99999999999997532100000
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCccccc-------CCCCccccchhHH
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFG 353 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DIwSlG 353 (511)
.....+..+||+|||+++......... ......||+.|+|||++.+ ..++.++||||||
T Consensus 159 ------------~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG 226 (434)
T 2rio_A 159 ------------QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226 (434)
T ss_dssp ------------TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHH
T ss_pred ------------ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHH
Confidence 000135689999999998765532211 1234579999999999875 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 010432 354 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 432 (511)
Q Consensus 354 vil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~ei 432 (511)
|++|||++ |+.||....... ....... .. .+..........+.++.+||.+||+.||.+|||+.+|
T Consensus 227 ~il~ellt~g~~Pf~~~~~~~----~~i~~~~----~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 293 (434)
T 2rio_A 227 CVFYYILSKGKHPFGDKYSRE----SNIIRGI----FS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293 (434)
T ss_dssp HHHHHHHTTSCCTTCSTTTHH----HHHHHTC----CC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhCCCCCCCCchhhH----HHHhcCC----CC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence 99999999 999996542211 0111100 00 0111122234567889999999999999999999999
Q ss_pred HHHh
Q 010432 433 VEAL 436 (511)
Q Consensus 433 l~~L 436 (511)
+++-
T Consensus 294 l~hp 297 (434)
T 2rio_A 294 LRHP 297 (434)
T ss_dssp HTSG
T ss_pred HhCC
Confidence 9753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=370.14 Aligned_cols=264 Identities=27% Similarity=0.331 Sum_probs=199.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||.||+|.+.. +|..||||++..... ...+.+.+|+.+|++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~ 83 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence 3689999999999999999998765 678999999976532 234568899999999999999999998755
Q ss_pred ------CCeEEEEEEccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 207 ------DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 207 ------~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
++..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g-- 158 (676)
T 3qa8_A 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGP-- 158 (676)
T ss_dssp TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCS--
T ss_pred cccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCC--
Confidence 667899999999999999997543 36889999999999999999999998 99999999999998422
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~e 358 (511)
....+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 159 --------------------~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLye 215 (676)
T 3qa8_A 159 --------------------QRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 215 (676)
T ss_dssp --------------------SSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHH
T ss_pred --------------------CceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHH
Confidence 234589999999987654332 234679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccc---ccccccc--------CCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGER---RRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--------~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP 427 (511)
|++|..||..... ...|........ ....... .......+....+..+.+||.+||..||.+||
T Consensus 216 LltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP 290 (676)
T 3qa8_A 216 CITGFRPFLPNWQ-----PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290 (676)
T ss_dssp HHSSCSSCCSSCH-----HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---
T ss_pred HHHCCCCCCcccc-----hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc
Confidence 9999999975311 111110000000 0000000 00112234455678999999999999999999
Q ss_pred CHHHHH
Q 010432 428 LMSEVV 433 (511)
Q Consensus 428 s~~eil 433 (511)
|+.+++
T Consensus 291 Ta~elL 296 (676)
T 3qa8_A 291 TDPQNP 296 (676)
T ss_dssp CCTTCC
T ss_pred CHHHHh
Confidence 997754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=328.83 Aligned_cols=230 Identities=21% Similarity=0.287 Sum_probs=180.7
Q ss_pred cCCCCC-CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHH-hCCCCCCcceEeeEEEe
Q 010432 129 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL-GDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il-~~l~H~nIv~l~~~~~~ 206 (511)
++|.+. ++||+|+||.||+|.+.. +++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 567777 789999999999999875 6789999999643 5677899988 66699999999999987
Q ss_pred ----CCeEEEEEEccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 207 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 207 ----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
....+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++...
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~----- 154 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR----- 154 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSS-----
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCC-----
Confidence 677899999999999999997653 46999999999999999999999998 99999999999998421
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||++.... +..++.++|||||||++|||++
T Consensus 155 -----------------~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~t 193 (299)
T 3m2w_A 155 -----------------PNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLC 193 (299)
T ss_dssp -----------------TTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHH
Confidence 25779999999986432 2457889999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|+.||.......... .... .+... ...++ ...+..+.+||.+||+.||.+|||+.+++++
T Consensus 194 g~~pf~~~~~~~~~~-------~~~~-----~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 194 GYPPFYSNHGLAISP-------GMKT-----RIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCSCCC-------C-------CSCC-----SSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCcchhhhH-------HHHH-----HHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 999997543211000 0000 00000 00111 1235789999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=326.21 Aligned_cols=230 Identities=13% Similarity=0.078 Sum_probs=183.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||.||+|++.. +++.||||++....... .+.+.+|+.++.+++||||+++++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 3679999999999999999999865 67899999998764432 25688999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
..++..|||||||++++|.+++... .....+..|+.||+.||+|||+++ |+||||||+||||+
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~----------- 163 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVS----------- 163 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEE-----------
T ss_pred EECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEc-----------
Confidence 9999999999999999999998432 345568889999999999999999 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+++| |++ .++.++|||||||+||||++|+.
T Consensus 164 --------------~~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 164 --------------IDGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp --------------TTSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred --------------CCCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence 47778887443 444 36899999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE--GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
||........... ....+..... .......+..+.+||.+||+.||.+| |+.++++.|+.+.
T Consensus 201 Pf~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 201 PLPEAGVRSGLAP-------------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CSCCCSBCCCSEE-------------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CCCcCCcchhhHH-------------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 9986543221000 0000000000 00111235678999999999999999 9999999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=367.47 Aligned_cols=239 Identities=25% Similarity=0.391 Sum_probs=191.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.++||+|+||.||+|++... +++.||||++..... .....+.+|+.+|.+++|||||++++++..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 36899999999999999999998641 467999999875432 233568899999999999999999999987
Q ss_pred CCe-----EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 207 DDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 207 ~~~-----~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
.+. .|||||||++++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~-------- 216 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLT-------- 216 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC--------
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEe--------
Confidence 655 7999999999999988743 6899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
...+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||+||+|++
T Consensus 217 ------------------~~~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~ 271 (681)
T 2pzi_A 217 ------------------EEQLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTL 271 (681)
T ss_dssp ------------------SSCEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHS
T ss_pred ------------------CCcEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHh
Confidence 237999999999876543 335799999999988765 4889999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhc
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 437 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-~~eil~~L~ 437 (511)
|..||........ . ........+..+.+||.+||+.||.+||+ +.++...|.
T Consensus 272 g~~~~~~~~~~~~--------------------~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 272 DLPTRNGRYVDGL--------------------P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp CCCEETTEECSSC--------------------C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCCCcccccccc--------------------c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 9988864211100 0 00011123467889999999999999995 555555554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=347.24 Aligned_cols=242 Identities=19% Similarity=0.187 Sum_probs=182.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhCCCC-CCcce----
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVH-LNLVK---- 199 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~H-~nIv~---- 199 (511)
..+|...++||+|+||+||+|++.. +|+.||||++...... ..+.+.+|+.+++.+.| .|+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~ 147 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred ceeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence 3457778899999999999999876 6789999999844322 24678899999999987 32211
Q ss_pred -----------------EeeEEEe-----CCeEEEEEEccCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHH
Q 010432 200 -----------------LIGYCIE-----DDQRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALGAAKGLAF 251 (511)
Q Consensus 200 -----------------l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~------~~~~~l~~~~~~~i~~qi~~gL~y 251 (511)
+..++.. ....+++|+++ +++|.+++. .....+++..++.++.||+.||+|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 226 (413)
T 3dzo_A 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226 (413)
T ss_dssp TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 1111111 22457788877 789999884 223457788899999999999999
Q ss_pred HhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeecccccc
Q 010432 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 331 (511)
Q Consensus 252 LH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~ 331 (511)
||+++ ||||||||+||||+ .++.+||+|||+++..... ....+| +.
T Consensus 227 LH~~~---iiHrDiKp~NILl~-------------------------~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~ 272 (413)
T 3dzo_A 227 LHHYG---LVHTYLRPVDIVLD-------------------------QRGGVFLTGFEHLVRDGAS-----AVSPIG-RG 272 (413)
T ss_dssp HHHTT---EECSCCCGGGEEEC-------------------------TTCCEEECCGGGCEETTEE-----ECCCCC-TT
T ss_pred HHhCC---cccCCcccceEEEe-------------------------cCCeEEEEeccceeecCCc-----cccCCC-Cc
Confidence 99998 99999999999998 4777999999999875432 334578 99
Q ss_pred ccCCccc----------ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCC
Q 010432 332 YAAPEYV----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 401 (511)
Q Consensus 332 y~aPE~~----------~~~~~~~~~DIwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (511)
|+|||++ .+..|+.++|||||||+||||++|+.||......... ..++.. ..
T Consensus 273 y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~----------------~~~~~~--~~ 334 (413)
T 3dzo_A 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----------------EWIFRS--CK 334 (413)
T ss_dssp TCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS----------------GGGGSS--CC
T ss_pred eeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH----------------HHHHhh--cc
Confidence 9999999 5556888999999999999999999999754321110 001110 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 402 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 402 ~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
. .+..+.+||.+||+.||.+||++.+++++
T Consensus 335 ~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 335 N----IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp C----CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred c----CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 24679999999999999999999998763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=340.51 Aligned_cols=264 Identities=15% Similarity=0.133 Sum_probs=186.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhCCC------
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLV------ 193 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~------ 193 (511)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|+.|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 45788999999999999999987 367999999986532 22367889999998885
Q ss_pred ---CCCcceEeeEEE------------------------------eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHH
Q 010432 194 ---HLNLVKLIGYCI------------------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240 (511)
Q Consensus 194 ---H~nIv~l~~~~~------------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~ 240 (511)
|+|||++++++. ..+..|||||||++|+|.+.+.+ ..+++..++.
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~ 165 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKS 165 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHH
Confidence 778877777653 26789999999999977776643 4689999999
Q ss_pred HHHHHHHHHHHHh-cCCCCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCc
Q 010432 241 IALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK 319 (511)
Q Consensus 241 i~~qi~~gL~yLH-~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~ 319 (511)
|+.||+.||+||| +++ ||||||||+||||+..+.... .++.. ......-.....+||+|||+|+.....
T Consensus 166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~-~~~~~----~~~~~~~~~~~~vkL~DFG~a~~~~~~-- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKL-HYTLN----GKSSTIPSCGLQVSIIDYTLSRLERDG-- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEE-EEEET----TEEEEEECTTEEEEECCCTTCBEEETT--
T ss_pred HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcce-eeecc----CccccccCCCceEEEeeccccEecCCC--
Confidence 9999999999999 888 999999999999985321000 00000 000000001237999999999875432
Q ss_pred ceeeeeccccccccCCcccccCCCCccccchhHHHH-HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCc
Q 010432 320 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 398 (511)
Q Consensus 320 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (511)
..+||+.|||||++.+.. +.++||||||++ .+++++|..||... .............. .....
T Consensus 236 -----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~----~~~~~ 299 (336)
T 2vuw_A 236 -----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM----TFKTK 299 (336)
T ss_dssp -----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC----CCSSC
T ss_pred -----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh----ccCcc
Confidence 247999999999998766 899999998777 78899999988421 00000000000000 00111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 010432 399 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV-EA 435 (511)
Q Consensus 399 ~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil-~~ 435 (511)
.........++++.+||.+||++| |+.|++ ++
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 111123456889999999999977 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-34 Score=305.57 Aligned_cols=185 Identities=17% Similarity=0.102 Sum_probs=129.4
Q ss_pred cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc----------cHHHHHHHHHHHhCC-CCCCcceEeeEEE
Q 010432 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (511)
Q Consensus 137 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----------~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 205 (511)
++.|++|.+..++... .|+.||||++...... ..++|.+|+++|+++ .|+||+++++++.
T Consensus 242 ~~~~~~~~h~~~rr~~---------fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e 312 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYF---------FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE 312 (569)
T ss_dssp -C--------CCEEEE---------ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE
T ss_pred cccCCccccccccccc---------ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Confidence 4556666555554433 5779999999765321 124689999999999 7999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++...|||||||+|++|.++|.+. .+++.. .|+.||+.||+|||++| ||||||||+||||+
T Consensus 313 d~~~~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~------------ 373 (569)
T 4azs_A 313 NAQSGWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVD------------ 373 (569)
T ss_dssp CSSEEEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEEC------------
T ss_pred ECCEEEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEEC------------
Confidence 999999999999999999999654 466654 57899999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+|+....... .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 374 -------------~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 374 -------------ARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------------TTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -------------CCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 478899999999987654322 2345789999999998875 467789999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=274.95 Aligned_cols=185 Identities=18% Similarity=0.234 Sum_probs=146.0
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--------HHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
...++||+|+||.||+|.. .+..+|+|++....... .+.+.+|+++|++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 3456899999999999954 35689999876543221 2347899999999999999976666
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+...+..|||||||++|+|.+++.. ++.++.||+.||.|||+++ ||||||||+|||++
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~---------- 465 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFD---------- 465 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEES----------
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEEC----------
Confidence 6678888999999999999999854 5689999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcce-----eeeeccccccccCCccccc--CCCCccccchhHHHHH
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVL 356 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~--~~~~~~~DIwSlGvil 356 (511)
. .+||+|||+++......... .....+||+.|||||++.. ..|+..+|+|+..+-.
T Consensus 466 ----------------~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~ 528 (540)
T 3en9_A 466 ----------------K-DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILEL 528 (540)
T ss_dssp ----------------S-SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHH
T ss_pred ----------------C-eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHH
Confidence 3 79999999999875532211 1235689999999999986 6788899999999999
Q ss_pred HHHHhCCCCC
Q 010432 357 LEMLTGRRSM 366 (511)
Q Consensus 357 ~elltg~~pf 366 (511)
.+.+.++.+|
T Consensus 529 l~~v~~r~rY 538 (540)
T 3en9_A 529 MKDVERRARY 538 (540)
T ss_dssp HHHHHTCSCC
T ss_pred HHHHHhcccc
Confidence 9888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.9e-26 Score=220.32 Aligned_cols=160 Identities=14% Similarity=0.078 Sum_probs=123.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------------------cHHHHHHHHHH
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNF 188 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------------------~~~~~~~E~~i 188 (511)
....|.+.+.||+|+||.||+|.+ . +|+.||||+++..... ....+.+|+.+
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~ 157 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred CCeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence 345566779999999999999998 4 5789999999753221 23458899999
Q ss_pred HhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 010432 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (511)
Q Consensus 189 l~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~ 268 (511)
|++++ | +++++++.. +..|+|||||+||+|.+ +.. .....++.||+.||.|||+++ ||||||||+
T Consensus 158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~ 222 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 222 (282)
T ss_dssp HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence 99998 5 666665544 45699999999999988 421 224579999999999999999 999999999
Q ss_pred cEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc--------
Q 010432 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------- 340 (511)
Q Consensus 269 NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-------- 340 (511)
|||++ ++.+||+|||+|+. +..|+|||++..
T Consensus 223 NILl~--------------------------~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~ 261 (282)
T 1zar_A 223 NVLVS--------------------------EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITY 261 (282)
T ss_dssp SEEEE--------------------------TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHH
T ss_pred HEEEE--------------------------CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHH
Confidence 99997 45699999999863 345789998753
Q ss_pred --CCCCccccchhH
Q 010432 341 --GHLTSRSDVYSF 352 (511)
Q Consensus 341 --~~~~~~~DIwSl 352 (511)
..|+..+|+|.+
T Consensus 262 f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 262 FSRTYRTEKDINSA 275 (282)
T ss_dssp HHHHHCCCCCHHHH
T ss_pred HHHhcCCCCChHHH
Confidence 345566666643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-22 Score=192.95 Aligned_cols=137 Identities=18% Similarity=0.061 Sum_probs=105.4
Q ss_pred CCCCCccccCCCceEEEEEEcCCCCCCccCCCCcE--EEEEEecCCCccc------------------------HHHHHH
Q 010432 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDGLQG------------------------HKEWLA 184 (511)
Q Consensus 131 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~~~~~------------------------~~~~~~ 184 (511)
|.+.+.||+|+||.||+|.+.. +|.. ||||+++...... ...+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 5678899999999999998843 4778 9999976542110 125788
Q ss_pred HHHHHhCCCCCCc--ceEeeEEEeCCeEEEEEEccCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh-cCC
Q 010432 185 EVNFLGDLVHLNL--VKLIGYCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-EEA 256 (511)
Q Consensus 185 E~~il~~l~H~nI--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~ 256 (511)
|+.+|.+|.|++| ..++++ +..+|||||+.+ | +|.+++.. .++..+..++.||+.||.||| +++
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999988764 344432 356899999932 3 67766432 234567789999999999999 988
Q ss_pred CCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccC
Q 010432 257 ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDG 314 (511)
Q Consensus 257 ~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~ 314 (511)
||||||||+|||++ . .++|+|||+|...
T Consensus 192 ---ivHrDlkp~NILl~--------------------------~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 ---LVHADLSEYNIMYI--------------------------D-KVYFIDMGQAVTL 219 (258)
T ss_dssp ---EECSSCSTTSEEES--------------------------S-SEEECCCTTCEET
T ss_pred ---EEeCCCCHHHEEEc--------------------------C-cEEEEECcccccC
Confidence 99999999999997 3 7999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=9.8e-19 Score=175.83 Aligned_cols=149 Identities=12% Similarity=0.049 Sum_probs=100.8
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--------------cHHH--------HHHHHH
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKE--------WLAEVN 187 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------------~~~~--------~~~E~~ 187 (511)
-|++..+||+|+||.||+|.+. +|+.||||+++..... .... ..+|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 3899999999999999999864 4789999998643110 0111 234667
Q ss_pred HHhCCCCCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 010432 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (511)
Q Consensus 188 il~~l~H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp 267 (511)
.|.+|.+.++....-+... ..+|||||++|++|.++.. . .....++.||+.+|.|||.++ ||||||||
T Consensus 166 nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 7777754443222112122 2379999999988876532 1 224567899999999999998 99999999
Q ss_pred CcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCC
Q 010432 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGP 315 (511)
Q Consensus 268 ~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~ 315 (511)
.|||++..+....... ....+.|+||+-+....
T Consensus 234 ~NILl~~dgd~~d~~~---------------~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 234 FNILIREEKDAEDPSS---------------ITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECSSCTTS---------------EEEEEEECCCTTCEETT
T ss_pred HHEEEeCCCCcccccc---------------cccceEEEEeCCcccCC
Confidence 9999986432110000 12248899999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9e-13 Score=126.65 Aligned_cols=111 Identities=13% Similarity=-0.061 Sum_probs=85.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~ 205 (511)
....|++...++.|+++.||++.. .+..+++|+...........+.+|+.+|+.|. |.++.++++++.
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~ 80 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe
Confidence 345788888889999999999864 24589999987532122235788999999884 677889999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 254 (511)
..+..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHH
T ss_pred cCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhC
Confidence 8889999999999999987631 112234678899999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=3.7e-11 Score=114.70 Aligned_cols=104 Identities=16% Similarity=0.023 Sum_probs=71.6
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCC--cceEeeEEEeC
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIED 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~n--Iv~l~~~~~~~ 207 (511)
.|.+..+.+.|..+.||++... +|..|++|+..... ...+.+|+.+|+.+.+.+ +.+++++...+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 3443333345666999998642 35679999986542 234678999998885444 56688888877
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 255 (511)
+..++||||++|.+|. .. ... ...++.+++..|..||+.
T Consensus 88 ~~~~~v~e~i~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SS----HLA---PAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp SCEEEEEECCSSEETT--TS----CCC---HHHHHHHHHHHHHHHTTS
T ss_pred CCCEEEEEecCCcccC--cC----cCC---HhHHHHHHHHHHHHHhCC
Confidence 7889999999998884 21 111 235677788888888864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.4e-10 Score=116.69 Aligned_cols=108 Identities=16% Similarity=0.179 Sum_probs=77.9
Q ss_pred CCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEec--CCCc-ccHHHHHHHHHHHhCCC--CCCcceEeeEEEeC
Q 010432 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGL-QGHKEWLAEVNFLGDLV--HLNLVKLIGYCIED 207 (511)
Q Consensus 133 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~--~~~~-~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~ 207 (511)
.++.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+|+.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3567899999999998753 3478888876 3321 22345778999999886 45688899888765
Q ss_pred ---CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 010432 208 ---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254 (511)
Q Consensus 208 ---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 254 (511)
+..|+||||++|..|.+.. ...++......++.+++..|..||.
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 3479999999988775421 1246778888899999999999997
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=2.6e-10 Score=111.95 Aligned_cols=185 Identities=19% Similarity=0.202 Sum_probs=118.6
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCC-CCCC--cceEeeEEEeCC--
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLN--LVKLIGYCIEDD-- 208 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~H~n--Iv~l~~~~~~~~-- 208 (511)
++.++.|.+..||+.. ..+++|+.... .....+.+|+.+|+.| .+.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 4568999999999862 35889986533 2235688999999887 3332 345554433332
Q ss_pred -eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 010432 209 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------- 256 (511)
Q Consensus 209 -~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------------------------------- 256 (511)
..|+|||+++|.+|..... ..++......++.+++..|..||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 3479999999988865432 24566777788888888888888511
Q ss_pred ------------------------CCCeEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcc
Q 010432 257 ------------------------ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAK 312 (511)
Q Consensus 257 ------------------------~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~ 312 (511)
...++|+|++|.|||++.. ....+.|+||+.+.
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-----------------------~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-----------------------KNTICGIIDFGDAA 222 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-----------------------TTEEEEECCCTTCE
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-----------------------CCCEEEEEeCCCCc
Confidence 1348999999999999831 03457899999987
Q ss_pred cCCCCCcceeeeeccccccc---cCCccccc-----C---------CCCccccchhHHHHHHHHHhCCCCC
Q 010432 313 DGPEGDKTHVSTRVMGTYGY---AAPEYVMT-----G---------HLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 313 ~~~~~~~~~~~~~~~Gt~~y---~aPE~~~~-----~---------~~~~~~DIwSlGvil~elltg~~pf 366 (511)
....... ......+ ..|+.+.. + ....-.+.|++|.++|.+.+|..+|
T Consensus 223 ~~~~~~D------l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 223 ISDPDND------FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp EECTTHH------HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCChHHH------HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 5322100 0001111 12221110 0 0112358999999999999998766
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1e-06 Score=84.33 Aligned_cols=102 Identities=16% Similarity=0.045 Sum_probs=66.7
Q ss_pred ccccCCCc-eEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEeCCeEEEE
Q 010432 136 LLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 136 ~lG~G~fg-~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv 213 (511)
.+..|..| .||+..... .+..+++|+-... ....+.+|..+|+.|. +-.+.++++++.+++..|+|
T Consensus 31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 34555555 689876543 3557889987543 2346778999998773 44477889999999999999
Q ss_pred EEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 010432 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254 (511)
Q Consensus 214 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 254 (511)
||+++|.++.+..... ......++.+++..|.-||.
T Consensus 99 me~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~ 134 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHS 134 (272)
T ss_dssp EECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHT
T ss_pred EEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcC
Confidence 9999998876654221 11222344455555555553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.2e-06 Score=85.81 Aligned_cols=102 Identities=21% Similarity=0.132 Sum_probs=64.6
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCC---CcceEeeEEE-eCCe
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCI-EDDQ 209 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~---nIv~l~~~~~-~~~~ 209 (511)
++.++.|....||+. +..+++|+-.. ......+.+|+.+|+.|.+. .+.+.+.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 356888888899987 23578888532 12235678999999998652 3566676664 3456
Q ss_pred EEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 010432 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254 (511)
Q Consensus 210 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 254 (511)
.++||||++|..|...... .++......++.+++..|..||+
T Consensus 88 ~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp EEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhc
Confidence 7899999999887653211 23344444444555555554443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=3.1e-06 Score=85.95 Aligned_cols=76 Identities=13% Similarity=0.063 Sum_probs=49.2
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhCCCC--CC-cceEeeE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLVH--LN-LVKLIGY 203 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~il~~l~H--~n-Iv~l~~~ 203 (511)
.+.||.|.++.||++.... .+..|+||....... .....+..|+++|+.+.. +. +.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4579999999999996543 356899998653211 122456789988887632 33 4456543
Q ss_pred EEeCCeEEEEEEccCCC
Q 010432 204 CIEDDQRLLVYEFMPRG 220 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g 220 (511)
+.+..++||||+++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455568999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.3e-06 Score=87.28 Aligned_cols=86 Identities=2% Similarity=-0.118 Sum_probs=53.8
Q ss_pred Ccc-ccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCC-C--CCcceEeeEEEeC
Q 010432 135 SLL-GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLV-H--LNLVKLIGYCIED 207 (511)
Q Consensus 135 ~~l-G~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-H--~nIv~l~~~~~~~ 207 (511)
+.| +.|....+|+......... ...+..+++|+..... ......+.+|+.+|+.|. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~---~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDG---RSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETT---EEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EECCCCCccceEEEEEEecccCC---CCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 467 8888899998865300000 0014578899865432 111134678888888873 2 3567788877554
Q ss_pred ---CeEEEEEEccCCCCHH
Q 010432 208 ---DQRLLVYEFMPRGSLE 223 (511)
Q Consensus 208 ---~~~~lv~E~~~~g~L~ 223 (511)
+..|+||||++|..|.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3468999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=3.2e-05 Score=76.30 Aligned_cols=73 Identities=15% Similarity=0.224 Sum_probs=41.7
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-----CCCcceEe-e--EEEe
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----HLNLVKLI-G--YCIE 206 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----H~nIv~l~-~--~~~~ 206 (511)
+.|+.|..+.||+.... +..+++|+.... ...+..|+.+++.|. .|.++... | +...
T Consensus 38 ~~l~gG~~n~~~~v~~~-----------~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~ 102 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-----------SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH 102 (346)
T ss_dssp EECC----CEEEEEEET-----------TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE
T ss_pred eeccccccCcEEEEEeC-----------CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE
Confidence 34666778999998753 235899998752 233445555555442 34443311 1 2234
Q ss_pred CCeEEEEEEccCCCCH
Q 010432 207 DDQRLLVYEFMPRGSL 222 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L 222 (511)
.+..++||+|++|..+
T Consensus 103 ~~~~~~l~~~i~G~~~ 118 (346)
T 2q83_A 103 GSFLFVVYDWIEGRPF 118 (346)
T ss_dssp TTEEEEEEECCCCBCC
T ss_pred CCEEEEEEEeecCccC
Confidence 6778999999988654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00013 Score=71.29 Aligned_cols=75 Identities=19% Similarity=0.122 Sum_probs=58.6
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC---CCCcceEeeEEEeCCeE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 210 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~~~~ 210 (511)
.+.|+.|.+..+|+... .+..+++|+.... ....+..|+..|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 45689999999999864 2457889987643 2456788999888873 35688899888878889
Q ss_pred EEEEEccCCCCH
Q 010432 211 LLVYEFMPRGSL 222 (511)
Q Consensus 211 ~lv~E~~~~g~L 222 (511)
++||||+++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00021 Score=72.96 Aligned_cols=73 Identities=12% Similarity=0.100 Sum_probs=43.9
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCC------C-c--ccHHHHHHHHHHHh-CCCCCCcceEeeE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-L--QGHKEWLAEVNFLG-DLVHLNLVKLIGY 203 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~------~-~--~~~~~~~~E~~il~-~l~H~nIv~l~~~ 203 (511)
.+.||.|..+.||++.. .+..++||..... . . .....+..|+..+. ......+.+++.+
T Consensus 39 i~~l~~G~~n~vyrv~~-----------~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~ 107 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-----------SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHF 107 (420)
T ss_dssp EEECCCSSSCEEEEEEC-----------SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEE
T ss_pred EEEccCCCcEEEEEEEc-----------CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 45789999999999853 2457999943211 1 0 12223333333222 1223456677766
Q ss_pred EEeCCeEEEEEEcc-CC
Q 010432 204 CIEDDQRLLVYEFM-PR 219 (511)
Q Consensus 204 ~~~~~~~~lv~E~~-~~ 219 (511)
. .+..++||||+ ++
T Consensus 108 ~--~~~~~lv~e~l~~g 122 (420)
T 2pyw_A 108 D--RTMALIGMRYLEPP 122 (420)
T ss_dssp E--TTTTEEEECCCCTT
T ss_pred C--CCccEEEEeecCCc
Confidence 5 56679999999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00089 Score=64.41 Aligned_cols=79 Identities=19% Similarity=0.157 Sum_probs=55.6
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-C--CCcceEeeEEEe
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H--LNLVKLIGYCIE 206 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H--~nIv~l~~~~~~ 206 (511)
...-++.+|.|..+.||+.+.. +|+.|.+|+-..........|..|+..|+.|. . -.+.+++++ .
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~ 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred CeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence 4445567999999999999875 37789999876554443445778999888773 2 234555554 2
Q ss_pred CCeEEEEEEccCCCCH
Q 010432 207 DDQRLLVYEFMPRGSL 222 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L 222 (511)
. .++||||++++..
T Consensus 84 ~--~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 D--RTLAMEWVDERPP 97 (288)
T ss_dssp T--TEEEEECCCCCCC
T ss_pred C--ceEEEEeecccCC
Confidence 2 4789999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00071 Score=66.11 Aligned_cols=88 Identities=7% Similarity=-0.036 Sum_probs=47.8
Q ss_pred hHHHHHHhcCCCC-----CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCC
Q 010432 121 FNDLKLATRNFRP-----ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195 (511)
Q Consensus 121 ~~~~~~~~~~y~~-----~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~ 195 (511)
.+++......|.+ ++.|+.|....||+..... | .+++|+...... ...+..|+.++..|...
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~ 75 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK----------D-PLILTLYEKRVE--KNDLPFFLGLMQHLAAK 75 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC----------c-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHC
Confidence 3344444444544 2356778888999987532 3 588998875311 13455677777666311
Q ss_pred C--cceEee------EEEeCCeEEEEEEccCCCC
Q 010432 196 N--LVKLIG------YCIEDDQRLLVYEFMPRGS 221 (511)
Q Consensus 196 n--Iv~l~~------~~~~~~~~~lv~E~~~~g~ 221 (511)
. +.+++. +....+..++||+|++|..
T Consensus 76 g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~ 109 (322)
T 2ppq_A 76 GLSCPLPLPRKDGELLGELSGRPAALISFLEGMW 109 (322)
T ss_dssp TCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBC
T ss_pred CCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcC
Confidence 1 233332 1223466789999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.09 E-value=0.002 Score=58.64 Aligned_cols=98 Identities=15% Similarity=0.091 Sum_probs=60.9
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccccccccccc
Q 010432 221 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300 (511)
Q Consensus 221 ~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (511)
+|.+.|...+.++++++++.++.|.+.+|.-+-....+ ..+=+-|..|+|.. +
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~-------------------------d 86 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWR-------------------------D 86 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEET-------------------------T
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEec-------------------------C
Confidence 79999988889999999999999999988766211100 12223457777763 5
Q ss_pred CceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 301 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
+.|.+.+ +.+. .....+.|||... ...+.+.=|||||++||.-+-
T Consensus 87 G~V~f~~-~~s~--------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 87 GAVTLAP-AADD--------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp SCEEECC-C--------------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred Cceeccc-cccc--------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 5565543 1110 1123467888653 345677889999999999885
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0029 Score=61.88 Aligned_cols=75 Identities=15% Similarity=0.087 Sum_probs=47.3
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC--CCcceEeeE-----EEeC
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGY-----CIED 207 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~-----~~~~ 207 (511)
..|+ |....||+.... .|..+++|+...... ....+..|+.++..|.. -.+++++.. ....
T Consensus 32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 3566 888899987542 255799999874322 23566778888877632 123444432 2235
Q ss_pred CeEEEEEEccCCCC
Q 010432 208 DQRLLVYEFMPRGS 221 (511)
Q Consensus 208 ~~~~lv~E~~~~g~ 221 (511)
+..++||+|++|..
T Consensus 100 g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQ 113 (328)
T ss_dssp TEEEEEEECCCCEE
T ss_pred CEEEEEEEecCCCC
Confidence 56789999998743
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0022 Score=62.04 Aligned_cols=71 Identities=7% Similarity=0.054 Sum_probs=43.9
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCc-ceEeeEEEeCCeEEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 212 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~l 212 (511)
++.|+.|....+|+. . .+++|+........ ....+|+.+++.+....+ .+++++ +.+.-++
T Consensus 23 i~~l~gG~tN~~~~~---~------------~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---G------------DLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---T------------TEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee---e------------eEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 678999999999998 1 48888876532111 122467777776632223 455554 3444578
Q ss_pred EEEcc-CCCCH
Q 010432 213 VYEFM-PRGSL 222 (511)
Q Consensus 213 v~E~~-~~g~L 222 (511)
|+||+ +|-+|
T Consensus 85 v~e~i~~g~~l 95 (301)
T 3dxq_A 85 VTRYIAGAQTM 95 (301)
T ss_dssp EEECCTTCEEC
T ss_pred EEeecCCCccC
Confidence 99999 65444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0055 Score=60.09 Aligned_cols=76 Identities=11% Similarity=-0.014 Sum_probs=37.5
Q ss_pred CccccCCCce-EEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC--CCCcceEeeEEEeCCeEE
Q 010432 135 SLLGEGGFGC-VFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--HLNLVKLIGYCIEDDQRL 211 (511)
Q Consensus 135 ~~lG~G~fg~-V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~~~~~ 211 (511)
+.|+.|+... +|+.... .+..+++|....... ..+..|+.++..|. .-.+.+++.+.... -+
T Consensus 24 ~~l~gg~s~~~~~r~~~~----------~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ 88 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP----------TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GL 88 (333)
T ss_dssp CC--------CCEEEECT----------TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TE
T ss_pred eECCCCCCCceEEEEEcC----------CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CE
Confidence 3565554443 6676531 145677776544321 12345666666653 22355677653323 37
Q ss_pred EEEEccCCCCHHHH
Q 010432 212 LVYEFMPRGSLENH 225 (511)
Q Consensus 212 lv~E~~~~g~L~~~ 225 (511)
+|||++.+..+.++
T Consensus 89 ll~e~l~~~~l~~~ 102 (333)
T 3csv_A 89 LLIEDLGDALFTEV 102 (333)
T ss_dssp EEECCCCSCBHHHH
T ss_pred EEEeeCCCcchHHH
Confidence 89999976666543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0019 Score=66.03 Aligned_cols=80 Identities=18% Similarity=0.105 Sum_probs=50.0
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCc-ceEeeEEEeCCeEEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 212 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~l 212 (511)
++.|+.|....||++........ ....+..|++|+..... ....+.+|+.+++.|...++ .++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~--~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCccc--cCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 35688888899999976421100 00124689999884321 12456689999988843333 56776543 2 38
Q ss_pred EEEccCCCC
Q 010432 213 VYEFMPRGS 221 (511)
Q Consensus 213 v~E~~~~g~ 221 (511)
||||++|-+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999997633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0033 Score=63.02 Aligned_cols=81 Identities=15% Similarity=0.101 Sum_probs=45.5
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv 213 (511)
+.|..|-...+|++....... .....+..|++|+.... ......+.+|..+++.|. +.-..++++++. + .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred EEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccE
Confidence 467778888999987642100 00113468999986332 233456678999998873 322356666553 3 289
Q ss_pred EEccCCCCH
Q 010432 214 YEFMPRGSL 222 (511)
Q Consensus 214 ~E~~~~g~L 222 (511)
|||++|.+|
T Consensus 129 ~e~i~G~~l 137 (379)
T 3feg_A 129 EQYIPSRPL 137 (379)
T ss_dssp EECCSEEEC
T ss_pred EEEecCccC
Confidence 999987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0079 Score=61.85 Aligned_cols=74 Identities=14% Similarity=0.028 Sum_probs=46.0
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCc-ceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lv 213 (511)
+.|+.|-...+|++.... .+..|++|+....... .-...+|+.+|..|...++ .++++++ .+ .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEE
Confidence 467888889999997642 2367889987543211 1112478888888864444 5677766 23 359
Q ss_pred EEccCCCCH
Q 010432 214 YEFMPRGSL 222 (511)
Q Consensus 214 ~E~~~~g~L 222 (511)
|||++|-+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0038 Score=62.28 Aligned_cols=81 Identities=9% Similarity=0.028 Sum_probs=43.4
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCC-cceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~~~~lv 213 (511)
..|+.|....||+......... ..+..+..|++|+....... ......|..+++.|...+ +.++++.+ . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4678888889999876421000 00011357888887543211 112357888887774333 44666544 2 2689
Q ss_pred EEccCCCC
Q 010432 214 YEFMPRGS 221 (511)
Q Consensus 214 ~E~~~~g~ 221 (511)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.32 E-value=0.03 Score=55.06 Aligned_cols=68 Identities=10% Similarity=0.024 Sum_probs=40.7
Q ss_pred ccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC---CCCcceEeeE------EEeCC
Q 010432 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGY------CIEDD 208 (511)
Q Consensus 138 G~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~------~~~~~ 208 (511)
|.|....||+.... .| .+++|+...... ..|+.++..|. -+++.+.+.. ....+
T Consensus 32 G~g~~N~vy~v~~~----------~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g 94 (339)
T 3i1a_A 32 GADTNAFAYQADSE----------SK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKH 94 (339)
T ss_dssp TSCSSCEEEEEECS----------SC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSS
T ss_pred cCccccceEEEEeC----------CC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECC
Confidence 34446789998643 24 799998765442 24555554442 1224444421 23356
Q ss_pred eEEEEEEccCCCCH
Q 010432 209 QRLLVYEFMPRGSL 222 (511)
Q Consensus 209 ~~~lv~E~~~~g~L 222 (511)
..++||+|++|..+
T Consensus 95 ~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 95 FKIIAYPFIHAPNG 108 (339)
T ss_dssp EEEEEEECCCCCBT
T ss_pred EEEEEEeccCCCcC
Confidence 78999999988655
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.64 E-value=0.18 Score=51.09 Aligned_cols=81 Identities=11% Similarity=-0.008 Sum_probs=47.1
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv 213 (511)
+.|..|-...+|+......... ....+..|++|+....... .-+..+|..+++.|. +.-..++++.+ .+ ++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 4577788889999987521100 0012568999986543211 112347888887774 22245666533 22 789
Q ss_pred EEccCCCCH
Q 010432 214 YEFMPRGSL 222 (511)
Q Consensus 214 ~E~~~~g~L 222 (511)
|||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988553
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.42 E-value=0.061 Score=55.31 Aligned_cols=63 Identities=8% Similarity=0.083 Sum_probs=19.1
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEE------EEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV------KTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAv------K~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
.+.+.|| ||.||+|.+.. ....||| |.++..... ....+.+|..++..++|+|+++.+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~---------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK---------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhcccccc---------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 4556777 99999998854 1236888 766543322 22458889999999999999999987
Q ss_pred EEe
Q 010432 204 CIE 206 (511)
Q Consensus 204 ~~~ 206 (511)
...
T Consensus 213 ~~~ 215 (463)
T 3cxl_A 213 KVH 215 (463)
T ss_dssp EEE
T ss_pred EEe
Confidence 654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.91 E-value=0.33 Score=48.72 Aligned_cols=35 Identities=26% Similarity=0.233 Sum_probs=25.1
Q ss_pred eEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCccc
Q 010432 260 VIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD 313 (511)
Q Consensus 260 iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~ 313 (511)
++|+|+.+.|||+...... .++..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~-------------------~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGREN-------------------SEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGG-------------------CSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCccc-------------------CcCCeEEEechHhccC
Confidence 5799999999999532110 0356799999988753
|
| >2khx_A Ribonuclease 3; drosha, RNA binding domain, hydrolase, gene regulation, NUCL protein, gene regulation,nuclear protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.29 E-value=0.31 Score=37.20 Aligned_cols=28 Identities=14% Similarity=-0.101 Sum_probs=24.4
Q ss_pred ccccccccccchhhhhhhcccccccccc
Q 010432 8 GKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (511)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (511)
+++++.|+|++|++|++.||+.+.+.+.
T Consensus 48 g~~~~~G~G~SKK~AEq~AA~~AL~~L~ 75 (85)
T 2khx_A 48 GERIGCGKGPSIQQAEMGAAMDALEKYN 75 (85)
T ss_dssp TEECCCEEESSHHHHHHHHHHHHHTTCC
T ss_pred CEEEEEEeeCCHHHHHHHHHHHHHHHHh
Confidence 4778999999999999999998887663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 511 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-70 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 3e-70
Identities = 75/315 (23%), Positives = 125/315 (39%), Gaps = 58/315 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+G G FG V+KG VAVK LN Q + + EV
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L H+N++ +GY Q +V ++ SL +HL + IA A+
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
G+ +LH + +I+RD K++NI L +D K+ D
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLH-------------------------EDLTVKIGD 147
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRR 364
FGLA +H ++ G+ + APE + + +SDVY+FG+VL E++TG+
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ- 206
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
P N + +G L ++ + + +L A CL +
Sbjct: 207 -----LPYSNINNRDQIIFMVGRGYLSPDL--SKVRSNCP----KAMKRLMAECLKKKRD 255
Query: 425 ARPLMSEVVEALKPL 439
RPL +++ +++ L
Sbjct: 256 ERPLFPQILASIELL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 6e-63
Identities = 73/334 (21%), Positives = 127/334 (38%), Gaps = 63/334 (18%)
Query: 119 FTFNDLKLATRNFRPE---------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
FTF D A R F E ++G G FG V G ++ G + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 170 TLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
TL + +++L+E + +G H N++ L G + +++ EFM GSL++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288
+ + G A G+ +L + ++RD NIL+++
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNS-------------- 163
Query: 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRV---MGTYGYAAPEYVMTGHLTS 345
+ K+SDFGL++ + T + APE + TS
Sbjct: 164 -----------NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 212
Query: 346 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI 405
SDV+S+G+V+ E+++ RP + + I+ +
Sbjct: 213 ASDVWSYGIVMWEVMSYGE-----RPYWDMTNQDV-----------INAIEQDYRLPPPM 256
Query: 406 KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
QL C +D RP ++V L +
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-62
Identities = 85/351 (24%), Positives = 137/351 (39%), Gaps = 61/351 (17%)
Query: 104 SKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 163
S L EL A + + L + +F ++G G FGCV+ G + +N G
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIV---HF--NEVIGRGHFGCVYHGTLLDND------GKK 55
Query: 164 LTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGS 221
+ AVK+LN G ++L E + D H N++ L+G C+ + L+V +M G
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281
L N + + + L AKG+ FL + ++RD N +LD
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLD-------- 164
Query: 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVM 339
+ + K++DFGLA+D E D H T + A E +
Sbjct: 165 -----------------EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 340 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 399
T T++SDV+SFGV+L E++T P + N + L + RL+ P
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLL----QGRRLLQPEY 258
Query: 400 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSY 450
++ C + RP SE+V + + Y
Sbjct: 259 C-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FSTFIGEHY 300
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-62
Identities = 77/310 (24%), Positives = 125/310 (40%), Gaps = 56/310 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+G G FG V G+ VA+KT+ ++++ E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H LV+L G C+E LV+EFM G L ++L + + + L +G+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
A+L E VI+RD N L+ ++ K+SDFG
Sbjct: 115 AYLE---EACVIHRDLAARNCLVG-------------------------ENQVIKVSDFG 146
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
+ + + D+ ST +A+PE +S+SDV+SFGV++ E+ + + +N
Sbjct: 147 MTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
R N E +VE +RL PRL + Q+ HC P+ RP
Sbjct: 206 RSNSE--VVEDI-------STGFRLYKPRLA-------STHVYQIMNHCWKERPEDRPAF 249
Query: 430 SEVVEALKPL 439
S ++ L +
Sbjct: 250 SRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 8e-62
Identities = 56/309 (18%), Positives = 107/309 (34%), Gaps = 56/309 (18%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
++ LG G FG V G VA+K + E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ +L H LV+L G C + ++ E+M G L N+L +++ +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+ +L + ++RD N L++ K+SDF
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVND-------------------------QGVVKVSDF 144
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
GL++ + D+ S ++ PE +M +S+SD+++FGV++ E+ + + +
Sbjct: 145 GLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
Query: 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428
N E I L + ++K + C RP
Sbjct: 204 RFTNSE----------------TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247
Query: 429 MSEVVEALK 437
++ +
Sbjct: 248 FKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-60
Identities = 67/338 (19%), Positives = 124/338 (36%), Gaps = 68/338 (20%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEW 182
++L +F S LG G G VFK +GL +A K ++ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E+ L + +V G D + + E M GSL+ L + +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 110
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+ KGL +L E+ +++RD K SNIL++
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVN-------------------------SRGE 143
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
KL DFG++ + ++ +GT Y +PE + H + +SD++S G+ L+EM G
Sbjct: 144 IKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 363 RR--------------------------SMDKNRPNGEHNLVEWARPHLGERRRFYRLID 396
R + + +RP + +++
Sbjct: 200 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN 259
Query: 397 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
S + + CL ++P R + +++
Sbjct: 260 EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 7e-60
Identities = 76/311 (24%), Positives = 123/311 (39%), Gaps = 58/311 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V+ G+ VAVK+L +LAE N +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 248
L H LV+L + ++ E+M GSL + L S + L + + +A A+G
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+AF+ E R I+RD + +NIL+ + K++DF
Sbjct: 122 MAFIEE---RNYIHRDLRAANILV-------------------------SDTLSCKIADF 153
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
GLA+ + ++ + APE + G T +SDV+SFG++L E++T R
Sbjct: 154 GLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR---- 208
Query: 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428
P E + R YR++ P + ++ QL C P+ RP
Sbjct: 209 -IPYPGMTNPEVIQNL----ERGYRMVRPD---NCP----EELYQLMRLCWKERPEDRPT 256
Query: 429 MSEVVEALKPL 439
+ L+
Sbjct: 257 FDYLRSVLEDF 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 8e-60
Identities = 69/324 (21%), Positives = 131/324 (40%), Gaps = 56/324 (17%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
++ ++ + + LG G +G V++G V LTVAVKTL D +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTM 55
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPW 235
+ +E+L E + ++ H NLV+L+G C + ++ EFM G+L ++L + +
Sbjct: 56 EV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 114
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNN 295
+ + +A + + +L + + I+RD N L+
Sbjct: 115 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG---------------------- 149
Query: 296 MLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355
+++ K++DFGL++ GD + APE + + +SDV++FGV+
Sbjct: 150 ---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205
Query: 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 415
L E+ T S + Y L++ +K +L
Sbjct: 206 LWEIATYGMSPYPGIDLSQ----------------VYELLEKDYRMERPEGCPEKVYELM 249
Query: 416 AHCLSRDPKARPLMSEVVEALKPL 439
C +P RP +E+ +A + +
Sbjct: 250 RACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-59
Identities = 69/335 (20%), Positives = 120/335 (35%), Gaps = 56/335 (16%)
Query: 123 DLKLATRNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-K 180
L L N + LG G FG V +G + VA+K L + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTE 54
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
E + E + L + +V+LIG C + + +LV E G L L + +P S +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ + G+ +L E + ++RD N+LL
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLV-------------------------NR 145
Query: 301 YNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
+ AK+SDFGL+K G + + + APE + +SRSDV+S+GV + E
Sbjct: 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205
Query: 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419
L+ + +P + E I+ + + L + C
Sbjct: 206 LSYGQ-----KPYKKMKGPE-----------VMAFIEQGKRMECPPECPPELYALMSDCW 249
Query: 420 SRDPKARPLMSEVVEALK-PLPNLKDMASSSYYFQ 453
+ RP V + ++ +L ++
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-59
Identities = 68/329 (20%), Positives = 130/329 (39%), Gaps = 55/329 (16%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
++ + ++G G FG V+KG ++ + + VA+KTL + + ++L
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
G A G+ +L ++RD NIL+++ +
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNS-------------------------NLVC 149
Query: 304 KLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
K+SDFGL++ + + T+ ++ + APE + TS SDV+SFG+V+ E++T
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422
N E + I+ + QL C ++
Sbjct: 210 GERPYWELSNHE----------------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQE 253
Query: 423 PKARPLMSEVVEALKPL----PNLKDMAS 447
RP +++V L L +LK +A
Sbjct: 254 RARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 6e-59
Identities = 70/332 (21%), Positives = 113/332 (34%), Gaps = 71/332 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
N +LG G FG V K G + VAVK L +E ++E+
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------- 231
+ L H N+V L+G C L++E+ G L N+L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 232 ------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285
L + + A AKG+ FL + ++RD N+L+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVT------------ 198
Query: 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 345
K+ DFGLA+D V + APE + G T
Sbjct: 199 -------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 346 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI 405
+SDV+S+G++L E+ + + P + FY+LI +
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDAN---------------FYKLIQNGFKMDQPF 290
Query: 406 KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437
++ + C + D + RP + L
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-58
Identities = 77/339 (22%), Positives = 117/339 (34%), Gaps = 71/339 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
LG G FG V + +K +TVAVK L +E ++E+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------S 230
L L H+N+V L+G C L++ E+ G L N L R+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYG 290
L L + + AKG+AFL + I+RD NILL
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL------------------ 178
Query: 291 LFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 350
K+ DFGLA+D V + APE + T SDV+
Sbjct: 179 -------THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 351 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 410
S+G+ L E+ + S P FY++I +
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSK---------------FYKMIKEGFRMLSPEHAPAE 276
Query: 411 AAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSS 449
+ C DP RP ++V+ ++ K ++ S+
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQIVQLIE-----KQISEST 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 4e-58
Identities = 71/343 (20%), Positives = 117/343 (34%), Gaps = 72/343 (20%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H 179
L+ N +GEG FG VF+ + VAVK L +
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-------- 231
++ E + + + N+VKL+G C L++E+M G L L S
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 232 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276
PL + ++ IA A G+A+L E R ++RD T N L+
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVG--- 174
Query: 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336
++ K++DFGL+++ D + PE
Sbjct: 175 ----------------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212
Query: 337 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 396
+ T+ SDV+++GVVL E+ + + E ++ + R G
Sbjct: 213 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--VIYYVRD--GNILACPENCP 268
Query: 397 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
L L C S+ P RP + L+ +
Sbjct: 269 LEL------------YNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-58
Identities = 70/338 (20%), Positives = 120/338 (35%), Gaps = 60/338 (17%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + AE+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50
Query: 189 LGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
L H N++ I +D+ Q LV ++ GSL ++L R + +K+AL
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALS 108
Query: 245 AAKGLAFLHEEA-----ERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
A GLA LH E + + +RD K+ NIL+ +
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------------------------K 143
Query: 300 DYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYS 351
+ ++D GLA T +GT Y APE + R+D+Y+
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203
Query: 352 FGVVLLEMLTGRR----SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 407
G+V E+ D P + + + + + +L S +
Sbjct: 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 263
Query: 408 AQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 445
+ A++ C + AR + + L L + +
Sbjct: 264 LRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-57
Identities = 71/311 (22%), Positives = 120/311 (38%), Gaps = 64/311 (20%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ + +G+G FG V G G VAVK + +D + +LAE +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAA 246
+ L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
+ + +L ++RD N+L+ +D AK+S
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVS-------------------------EDNVAKVS 145
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366
DFGL K+ T + APE + +++SDV+SFG++L E+ + R
Sbjct: 146 DFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-- 198
Query: 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426
P L + R + ++ +C D R
Sbjct: 199 ---VPYPRIPLKDVV-------PRVEKGYKMDAPDGCP----PAVYEVMKNCWHLDAAMR 244
Query: 427 PLMSEVVEALK 437
P ++ E L+
Sbjct: 245 PSFLQLREQLE 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-57
Identities = 76/313 (24%), Positives = 119/313 (38%), Gaps = 54/313 (17%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE 185
++ R LG+G FG V +G + G ++VAVK L D L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
VN + L H NL++L G + ++ V E P GSL + L + + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
A+G+ +L + I+RD N+LL K+
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLA-------------------------TRDLVKI 152
Query: 306 SDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
DFGL + P+ D +V + + APE + T + SD + FGV L EM T +
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
P N + E R PR E Q + C + P+
Sbjct: 213 -----EPWIGLNGSQILHKIDKEGERL-----PRPEDC-----PQDIYNVMVQCWAHKPE 257
Query: 425 ARPLMSEVVEALK 437
RP + + L
Sbjct: 258 DRPTFVALRDFLL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-56
Identities = 70/321 (21%), Positives = 121/321 (37%), Gaps = 58/321 (18%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGD 191
+ LG G FG V KG+ + TVAVK L ++ E LAE N +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V++IG C E + +LV E G L +L + + +++ + G+ +
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKY 122
Query: 252 LHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLA 311
L E ++RD N+LL + AK+SDFGL+
Sbjct: 123 LEE---SNFVHRDLAARNVLLV-------------------------TQHYAKISDFGLS 154
Query: 312 KDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 370
K + T + APE + +S+SDV+SFGV++ E + + +
Sbjct: 155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----K 209
Query: 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 430
P E +++ ++ L C + D + RP +
Sbjct: 210 PYRGMKGSE-----------VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFA 258
Query: 431 EVVEALKPLPNLKDMASSSYY 451
V L+ D+ + ++
Sbjct: 259 AVELRLRNY--YYDVVNEGHH 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-56
Identities = 61/310 (19%), Positives = 116/310 (37%), Gaps = 51/310 (16%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFL 189
F+ +LG G FG V+KG G + VA+K L + +KE L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ + ++ +L+G C+ +L + + MP G L +++ + + + AKG+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+L + R +++RD N+L+ + K++DFG
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKT-------------------------PQHVKITDFG 156
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
LAK +K + + + A E ++ T +SDV+S+GV + E++T
Sbjct: 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
P E +++ + C D +RP
Sbjct: 217 IPASE----------------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKF 260
Query: 430 SEVVEALKPL 439
E++ +
Sbjct: 261 RELIIEFSKM 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-56
Identities = 72/333 (21%), Positives = 123/333 (36%), Gaps = 72/333 (21%)
Query: 128 TRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
TR+ PE LG+G FG V+K T + A K ++ + ++
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED 55
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
++ E++ L H N+VKL+ ++ ++ EF G+++ + PL S +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
L +LH + +I+RD K NIL D
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTL-------------------------DG 147
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVL 356
+ KL+DFG++ + +GT + APE VM ++DV+S G+ L
Sbjct: 148 DIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205
Query: 357 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 416
+EM P+ E N + + L P +S
Sbjct: 206 IEMAEIE------PPHHELNPMRVLLKIA--KSEPPTLAQPS---RWS----SNFKDFLK 250
Query: 417 HCLSRDPKARPLMSEV-------VEALKPLPNL 442
CL ++ AR S++ V++ KP+ L
Sbjct: 251 KCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-55
Identities = 68/321 (21%), Positives = 111/321 (34%), Gaps = 70/321 (21%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D F LG+G FG V+ + + +A+K L L
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 44
Query: 177 ---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KF 103
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFF 293
A L++ H + VI+RD K N+LL
Sbjct: 104 DEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLG-------------------- 140
Query: 294 NNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353
K++DFG + P +T + GT Y PE + + D++S G
Sbjct: 141 -----SAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLG 191
Query: 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
V+ E L G+ P + E + F + A
Sbjct: 192 VLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDFVTE------------GARD 233
Query: 414 LAAHCLSRDPKARPLMSEVVE 434
L + L +P RP++ EV+E
Sbjct: 234 LISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-55
Identities = 69/343 (20%), Positives = 125/343 (36%), Gaps = 78/343 (22%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
+ +ND+K + ++GEG FG V K I+++G + A+K +
Sbjct: 2 TIYPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKE 47
Query: 174 DGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 231
H+++ E+ L L H N++ L+G C L E+ P G+L + L + +
Sbjct: 48 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 107
Query: 232 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVR 276
L + A A+G+ +L + + I+RD NIL+
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE-- 162
Query: 277 AENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 336
+Y AK++DFGL++ K T + A E
Sbjct: 163 -----------------------NYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIE 196
Query: 337 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 396
+ T+ SDV+S+GV+L E+++ + P E Y +
Sbjct: 197 SLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAEL-----------YEKLP 240
Query: 397 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439
+ + L C P RP ++++ +L +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-55
Identities = 63/312 (20%), Positives = 107/312 (34%), Gaps = 61/312 (19%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
R + + +G G F V+KG + T + VA L L + + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 187 NFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N+V+ +LV E M G+L+ +L R + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWC 118
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
KGL FLH P+I+RD K NI + +
Sbjct: 119 RQILKGLQFLHTRT-PPIIHRDLKCDNIFITG------------------------PTGS 153
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
K+ D GLA + + V+GT + APE + DVY+FG+ +LEM T
Sbjct: 154 VKIGDLGLATL----KRASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATS 208
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422
+ + + + R+ F + ++ C+ ++
Sbjct: 209 EYPYSECQNAAQI---------------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQN 253
Query: 423 PKARPLMSEVVE 434
R + +++
Sbjct: 254 KDERYSIKDLLN 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-55
Identities = 67/311 (21%), Positives = 115/311 (36%), Gaps = 58/311 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ R E LG+G FG V+ G VA+KTL + +L E +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKG 248
L H LV+L ++ +V E+M +GSL + L L + +A A G
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+A++ ++RD + +NIL+ ++ K++DF
Sbjct: 126 MAYVER---MNYVHRDLRAANILVG-------------------------ENLVCKVADF 157
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
GLA+ + ++ + APE + G T +SDV+SFG++L E+ T R
Sbjct: 158 GLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216
Query: 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428
N E ++ + + L C ++P+ RP
Sbjct: 217 GMVNRE----------------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 260
Query: 429 MSEVVEALKPL 439
+ L+
Sbjct: 261 FEYLQAFLEDY 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-54
Identities = 65/307 (21%), Positives = 110/307 (35%), Gaps = 55/307 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNF 188
++ LGEG +G V V T VAVK ++ + + E+
Sbjct: 6 DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L H N+VK G+ E + + L E+ G L + + +P + G
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAG 115
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
+ +LH + +RD K N+LLD + N K+SDF
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLD-------------------------ERDNLKISDF 147
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMD 367
GLA ++ + ++ GT Y APE + + DV+S G+VL ML G D
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
Query: 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
+ + + + + + + K L L +P AR
Sbjct: 208 QPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 252
Query: 428 LMSEVVE 434
+ ++ +
Sbjct: 253 TIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 9e-54
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 62/314 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
++ +G G +G K + G + K L++ + + ++EVN
Sbjct: 5 DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPWSIRMKIA 242
L +L H N+V+ I+ L V E+ G L + + + + L +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 243 LGAAKGLAFLHE--EAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
L H + V++RD K +N+ LD
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-------------------------K 150
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
N KL DFGLA+ T + +GT Y +PE + +SD++S G +L E+
Sbjct: 151 QNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 420
P + E A + R+ +S + ++ L+
Sbjct: 209 ALM------PPFTAFSQKELAGKIREGKF-------RRIPYRYS----DELNEIITRMLN 251
Query: 421 RDPKARPLMSEVVE 434
RP + E++E
Sbjct: 252 LKDYHRPSVEEILE 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 9e-53
Identities = 68/312 (21%), Positives = 110/312 (35%), Gaps = 55/312 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+GEG FG V +G L VA+KT + +E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ H ++VKLIG ++ ++ E G L + L R L + + A +
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDF 308
LA+L + ++RD N+L+ + KL DF
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVS-------------------------SNDCVKLGDF 152
Query: 309 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368
GL++ + + +++ + APE + TS SDV+ FGV + E+L
Sbjct: 153 GLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV---- 207
Query: 369 NRPNGEHNLVEWARPHL-GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
+P + GER P L L C + DP RP
Sbjct: 208 -KPFQGVKNNDVIGRIENGERLPMPPNCPPTL------------YSLMTKCWAYDPSRRP 254
Query: 428 LMSEVVEALKPL 439
+E+ L +
Sbjct: 255 RFTELKAQLSTI 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 1e-52
Identities = 67/314 (21%), Positives = 117/314 (37%), Gaps = 68/314 (21%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 184
+ F +G G FG V+ VA+K +++ G Q +++W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV FL L H N ++ G + + LV E+ + + + PL + G
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHG 123
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
A +GLA+LH +I+RD K NILL + K
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLS-------------------------EPGLVK 155
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLT 361
L DFG A + +GT + APE ++ G + DV+S G+ +E+
Sbjct: 156 LGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 362 GRRSM-DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 420
+ + + N + +++ + P GH+S + CL
Sbjct: 210 RKPPLFNMNAMSALYHIAQNESP-------------ALQSGHWS----EYFRNFVDSCLQ 252
Query: 421 RDPKARPLMSEVVE 434
+ P+ RP +++
Sbjct: 253 KIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 2e-51
Identities = 74/334 (22%), Positives = 130/334 (38%), Gaps = 62/334 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
LG+G FG V++G VK VA+KT+N ++ E+L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---------RRSLPLPWSIRM 239
+ + ++V+L+G + L++ E M RG L+++L P S +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
++A A G+A+L+ ++RD N ++ +
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVA-------------------------E 168
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359
D+ K+ DFG+ +D E D + + + +PE + G T+ SDV+SFGVVL E+
Sbjct: 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228
Query: 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419
T + N + R + +L C
Sbjct: 229 ATLAEQPYQGLSNEQ----------------VLRFVMEGGLLDKPDNCPDMLFELMRMCW 272
Query: 420 SRDPKARPLMSEVVEALKPL--PNLKDMASSSYY 451
+PK RP E++ ++K P +++ S YY
Sbjct: 273 QYNPKMRPSFLEIISSIKEEMEPGFREV--SFYY 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-51
Identities = 63/327 (19%), Positives = 116/327 (35%), Gaps = 61/327 (18%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ + + N+V + + D+ +V E++ GSL + + + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQ 127
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
L FLH VI+RD K+ NILL D + KL+D
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLG-------------------------MDGSVKLTD 159
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367
FG + ++GT + APE V + D++S G++ +EM+ G
Sbjct: 160 FGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---- 213
Query: 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
P N + L +P S CL D + R
Sbjct: 214 --PPYLNENPLRALYLIA--TNGTPELQNPE---KLS----AIFRDFLNRCLDMDVEKRG 262
Query: 428 LMSEVVE-----ALKPLPNLKDMASSS 449
E+++ KPL +L + +++
Sbjct: 263 SAKELLQHQFLKIAKPLSSLTPLIAAA 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-50
Identities = 82/328 (25%), Positives = 118/328 (35%), Gaps = 65/328 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNF 188
+ LG G FG V + K T TVAVK L H+ ++E+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 189 LGDLVH-LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SL 231
L + H LN+V L+G C + L ++ EF G+L +L +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291
L + + AKG+ FL R I+RD NILL
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS------------------ 168
Query: 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 351
+ K+ DFGLA+D + + APE + T +SDV+S
Sbjct: 169 -------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA 411
FGV+L E+ + S P + E L E R R + + +
Sbjct: 222 FGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKEGTR------MRAPDYTT----PEM 266
Query: 412 AQLAAHCLSRDPKARPLMSEVVEALKPL 439
Q C +P RP SE+VE L L
Sbjct: 267 YQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-50
Identities = 75/327 (22%), Positives = 119/327 (36%), Gaps = 63/327 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNF 188
LGEG FG V E G KP VAVK L D + + ++E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------------- 232
+ + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292
L + A A+G+ +L + I+RD N+L+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT------------------- 169
Query: 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352
+D K++DFGLA+D D +T + APE + T +SDV+SF
Sbjct: 170 ------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223
Query: 353 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 412
GV+L E+ T S P E ++L+ +
Sbjct: 224 GVLLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELY 267
Query: 413 QLAAHCLSRDPKARPLMSEVVEALKPL 439
+ C P RP ++VE L +
Sbjct: 268 MMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 9e-50
Identities = 70/367 (19%), Positives = 127/367 (34%), Gaps = 59/367 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V + V+ TG K +N E++ +
Sbjct: 30 YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H L+ L + + +L+ EF+ G L + + + + + A +GL
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+H E +++ D K NI+ + + + K+ DFG
Sbjct: 141 KHMH---EHSIVHLDIKPENIMCET-----------------------KKASSVKIIDFG 174
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
LA + T +AAPE V + +D+++ GV+ +L+G
Sbjct: 175 LATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------ 225
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
P + +E + F + +A + L ++P+ R +
Sbjct: 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVS--------PEAKDFIKNLLQKEPRKRLTV 277
Query: 430 SEVVEA--LKP-LPNLKDMASSSYYFQTMQ--AERIGSSPNTRNGIR--AQGGSLSRNGQ 482
+ +E LK NL SS Y + Q E+ P + I A SL ++
Sbjct: 278 HDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRP 337
Query: 483 RSLSIPN 489
+ I +
Sbjct: 338 QEYQIYD 344
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (433), Expect = 2e-49
Identities = 62/305 (20%), Positives = 98/305 (32%), Gaps = 52/305 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
++ LG G FG V + + TG A K + + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H LV L +D++ +++YEFM G L + + ++ KGL
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+H E ++ D K NI+ R KL DFG
Sbjct: 138 CHMH---ENNYVHLDLKPENIMFTTKR-----------------------SNELKLIDFG 171
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
L V GT +AAPE + +D++S GV+ +L+G
Sbjct: 172 LTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------ 222
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
P G N E R + ++ L DP R +
Sbjct: 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGI--------SEDGKDFIRKLLLADPNTRMTI 274
Query: 430 SEVVE 434
+ +E
Sbjct: 275 HQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-48
Identities = 59/314 (18%), Positives = 100/314 (31%), Gaps = 59/314 (18%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKE 181
K +F+ +LGEG F V + T A+K L +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
E + + L H VKL +D++ + G L ++ + +
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFY 113
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
L +LH + +I+RD K NILL+ +D
Sbjct: 114 TAEIVSALEYLHG---KGIIHRDLKPENILLN-------------------------EDM 145
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+ +++DFG AK K + +GT Y +PE + SD+++ G ++ +++
Sbjct: 146 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205
Query: 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 421
G P N + + F P KA L L
Sbjct: 206 GL------PPFRAGNEYLIFQKIIKLEYDFPEKFFP------------KARDLVEKLLVL 247
Query: 422 DPKARPLMSEVVEA 435
D R E+
Sbjct: 248 DATKRLGCEEMEGY 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (400), Expect = 2e-45
Identities = 64/314 (20%), Positives = 106/314 (33%), Gaps = 59/314 (18%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVN 187
+ +LG GG V VAVK L D + + + E
Sbjct: 9 YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L H +V + + +V E++ +L + + P+ +++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIA 118
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
A + L F H+ +I+RD K +NI++ A A FG
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA------------- 162
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 363
G+ + V+GT Y +PE + +RSDVYS G VL E+LTG
Sbjct: 163 -----------DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
Query: 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423
P + V A H+ E L + + L+++P
Sbjct: 212 ------PPFTGDSPVSVAYQHVREDPIPPSARHEGL--------SADLDAVVLKALAKNP 257
Query: 424 KARPL-MSEVVEAL 436
+ R +E+ L
Sbjct: 258 ENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-45
Identities = 58/373 (15%), Positives = 123/373 (32%), Gaps = 66/373 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V + V+ + T K + G E++ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
H N++ L ++ ++++EF+ + + + L + + L
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
FLH + + D + NI+ R K+ +FG
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRR-----------------------SSTIKIIEFG 149
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
A+ GD + + Y APE +++ +D++S G ++ +L+G
Sbjct: 150 QARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------ 200
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
P + + F + + +A L ++ K+R
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEI--------SIEAMDFVDRLLVKERKSRMTA 252
Query: 430 SEVV------EALKPLPN--LKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG 481
SE + + ++ + ++ + YY ++ + R + GG++
Sbjct: 253 SEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAAR---ISCGGAIRS-- 307
Query: 482 QRSLSIPNGSYAS 494
Q+ +S+ AS
Sbjct: 308 QKGVSVAKVKVAS 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 6e-45
Identities = 52/315 (16%), Positives = 96/315 (30%), Gaps = 42/315 (13%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
+L++ R +R +G G FG ++ G G VA+K H +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E + + I +C + ++ + SLE+ S + +A
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+ ++H + I+RD K N L GK G +Y F ++D
Sbjct: 110 DQMISRIEYIHS---KNFIHRDVKPDNFL------MGLGKKGNLVYIIDFGLAKKYRD-- 158
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
+ + + GT YA+ + + R D+ S G VL+ G
Sbjct: 159 ---------ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422
+ + E + L + + A C S
Sbjct: 210 SLPWQGLKAATKRQKYER------ISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLR 259
Query: 423 PKARPLMSEVVEALK 437
+P S + + +
Sbjct: 260 FDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 4e-44
Identities = 59/305 (19%), Positives = 102/305 (33%), Gaps = 53/305 (17%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 189
+ +LG G F V T VA+K + L+G + E+ L
Sbjct: 11 YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ H N+V L L+ + + G L + + + ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAV 120
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LH+ +++RD K N+L L +D +SDFG
Sbjct: 121 KYLHD---LGIVHRDLKPENLL----------------------YYSLDEDSKIMISDFG 155
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
L+K D V + GT GY APE + + D +S GV+ +L G
Sbjct: 156 LSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------ 206
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
P + N + L F + + A H + +DP+ R
Sbjct: 207 PPFYDENDAKLFEQILKAEYEFDSPYWDDI--------SDSAKDFIRHLMEKDPEKRFTC 258
Query: 430 SEVVE 434
+ ++
Sbjct: 259 EQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (394), Expect = 1e-43
Identities = 70/305 (22%), Positives = 108/305 (35%), Gaps = 64/305 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
+F ++G GGFG V+ K TG A+K L+ + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 187 N---FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
+ +V + D+ + + M G L HL + + +R A
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAA 114
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNA 303
GL +H R V+YRD K +NILLD + +
Sbjct: 115 EIILGLEHMH---NRFVVYRDLKPANILLD-------------------------EHGHV 146
Query: 304 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 362
++SD GLA D + +GT+GY APE + G S +D +S G +L ++L G
Sbjct: 147 RISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 422
+++ +H + L FS + L L RD
Sbjct: 203 HSPFRQHKTKDKHEIDRMTLTM-----------AVELPDSFS----PELRSLLEGLLQRD 247
Query: 423 PKARP 427
R
Sbjct: 248 VNRRL 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 153 bits (387), Expect = 2e-43
Identities = 67/321 (20%), Positives = 110/321 (34%), Gaps = 71/321 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHK 180
N+ P+ +LG G V + + T AVK ++ G + +
Sbjct: 4 NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 181 EWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
L EV+ L + H N+++L + LV++ M +G L ++L + L
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 113
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
KI + + LH + +++RD K NILLD
Sbjct: 114 KIMRALLEVICALH---KLNIVHRDLKPENILLD-------------------------D 145
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL------TSRSDVYSFG 353
D N KL+DFG + G+K V GT Y APE + D++S G
Sbjct: 146 DMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202
Query: 354 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 413
V++ +L G P + R + +F +
Sbjct: 203 VIMYTLLAGS------PPFWHRKQMLMLRMIMSGNYQFGSPEWDDY--------SDTVKD 248
Query: 414 LAAHCLSRDPKARPLMSEVVE 434
L + L P+ R E +
Sbjct: 249 LVSRFLVVQPQKRYTAEEALA 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 7e-43
Identities = 44/315 (13%), Positives = 85/315 (26%), Gaps = 49/315 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ +GEG FG +F+G VA+K + E
Sbjct: 6 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L + + Y ++ ++ + SLE+ L A +
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+HE + ++YRD K N L+ + DFG
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIG--------------------RPNSKNANMIYVVDFG 151
Query: 310 LAKDGPEGD-----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
+ K + + GT Y + + + R D+ + G V + L G
Sbjct: 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 211
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
+ E + L F ++ + + +
Sbjct: 212 PWQGLKAATNKQKYERI------GEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFD 261
Query: 425 ARPLMSEVVEALKPL 439
A P + +
Sbjct: 262 ATPDYDYLQGLFSKV 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-42
Identities = 70/302 (23%), Positives = 103/302 (34%), Gaps = 62/302 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
+F +LG+G FG VF T A+K L D + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 187 NFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H L + + V E++ G L H+ S A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEI 112
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
GL FLH + ++YRD K NILLD +D + K+
Sbjct: 113 ILGLQFLHS---KGIVYRDLKLDNILLD-------------------------KDGHIKI 144
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365
+DFG+ K+ GD GT Y APE ++ D +SFGV+L EML G+
Sbjct: 145 ADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ-- 200
Query: 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425
P + E + + R ++ A L R+P+
Sbjct: 201 ----SPFHGQDEEELFHSIRMDNPFYPRWLEKE------------AKDLLVKLFVREPEK 244
Query: 426 RP 427
R
Sbjct: 245 RL 246
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-41
Identities = 67/333 (20%), Positives = 124/333 (37%), Gaps = 57/333 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
NF+ +GEG +G V+K TG VA+K + D + E++
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+VKL+ +++ LV+EF+ + + +P + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
GLAF H V++RD K N+L++ + KL+D
Sbjct: 114 GLAFCH---SHRVLHRDLKPQNLLIN-------------------------TEGAIKLAD 145
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367
FGLA+ +T+ + V+ + A + + ++ D++S G + EM+T R
Sbjct: 146 FGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204
Query: 368 KNRPN----------GEHNLVEWARP-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 416
+ G + V W + + + + + + L +
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS 264
Query: 417 HCLSRDPKARPLMSEVV------EALKPLPNLK 443
L DP R + + KP+P+L+
Sbjct: 265 QMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-40
Identities = 60/310 (19%), Positives = 101/310 (32%), Gaps = 57/310 (18%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 184
+ LG G F V K + TGL A K + + + ++
Sbjct: 12 YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV+ L ++ H N++ L +L+ E + G L + L + L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 121
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
G+ +LH + + D K NI+L + K
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLL---------------------DRNVPKPRIK 157
Query: 305 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364
+ DFGLA G++ + GT + APE V L +D++S GV+ +L+G
Sbjct: 158 IIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA- 213
Query: 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424
P E F + A L +DPK
Sbjct: 214 -----SPFLGDTKQETLANVSAVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPK 260
Query: 425 ARPLMSEVVE 434
R + + ++
Sbjct: 261 KRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 67/315 (21%), Positives = 111/315 (35%), Gaps = 56/315 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLG 190
LGEG F V+K T VA+K + K+ L E+ L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+L H N++ L+ LV++FM LE + SL L S L +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+LH + +++RD K +N+LLD ++ KL+DFGL
Sbjct: 115 YLH---QHWILHRDLKPNNLLLD-------------------------ENGVLKLADFGL 146
Query: 311 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKN 369
AK ++ + T + T Y APE + + D+++ G +L E+L + +
Sbjct: 147 AKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204
Query: 370 RP----------NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 419
G +W ++ H L
Sbjct: 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF 264
Query: 420 SRDPKARPLMSEVVE 434
+P AR ++ ++
Sbjct: 265 LFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (365), Expect = 6e-40
Identities = 69/302 (22%), Positives = 109/302 (36%), Gaps = 64/302 (21%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 185
++F+ LG G FG V G A+K L + + K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L + H ++++ G + Q ++ +++ G L R+S P + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKL 305
L +LH + +IYRD K NILLD ++ + K+
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLD-------------------------KNGHIKI 145
Query: 306 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365
+DFG AK P+ T GT Y APE V T D +SFG+++ EML G
Sbjct: 146 TDFGFAKYVPDVTYTLC-----GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY-- 198
Query: 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 425
P + N ++ L RF + L + ++RD
Sbjct: 199 ----TPFYDSNTMKTYEKILNAELRFPPFFNE------------DVKDLLSRLITRDLSQ 242
Query: 426 RP 427
R
Sbjct: 243 RL 244
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-39
Identities = 68/340 (20%), Positives = 114/340 (33%), Gaps = 62/340 (18%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---- 182
A + + + +GEG +G VFK +NG G VA+K + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWS 236
+A + L H N+V+L C LV+E + + +P
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNM 296
+ +GL FLH V++RD K NIL+
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVT----------------------- 150
Query: 297 LFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 356
KL+DFGLA+ T V+ T Y APE ++ + D++S G +
Sbjct: 151 --SSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 205
Query: 357 LEMLTGRRSMDKNRPNGEHNLV----------EWARPHLGERRRFYRLIDPRLEGHFSIK 406
EM + + + + +W R R+ F+ +E +
Sbjct: 206 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-D 264
Query: 407 GAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 444
+ L CL+ +P R + + L K+
Sbjct: 265 IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-39
Identities = 60/325 (18%), Positives = 112/325 (34%), Gaps = 55/325 (16%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEV 186
+ S +GEG +G V + + VA+K ++ Q + + L E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALG 244
L H N++ + + ++ + L++ ++ L
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAK 304
+GL ++H V++RD K SN+LL+ + K
Sbjct: 118 ILRGLKYIH---SANVLHRDLKPSNLLLN-------------------------TTCDLK 149
Query: 305 LSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 362
+ DFGLA+ P+ D T T + T Y APE ++ ++S D++S G +L EML+
Sbjct: 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK------------ 410
R + N + + + S+ K
Sbjct: 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS 269
Query: 411 -AAQLAAHCLSRDPKARPLMSEVVE 434
A L L+ +P R + + +
Sbjct: 270 KALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-39
Identities = 61/313 (19%), Positives = 98/313 (31%), Gaps = 73/313 (23%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE------WLA 184
++ LLG GGFG V+ G ++ L VA+K + D + E
Sbjct: 6 YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 185 EVNFLGDL--VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
EV L + +++L+ + D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
+ + H V++RD K NIL+D
Sbjct: 117 WQVLEAVRHCH---NCGVLHRDIKDENILIDL------------------------NRGE 149
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLT 361
KL DFG K V T GT Y+ PE++ RS V+S G++L +M+
Sbjct: 150 LKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
Query: 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 421
G + + ++ S + L CL+
Sbjct: 206 GDIPFE-----HDEEIIRG---------------QVFFRQRVS----SECQHLIRWCLAL 241
Query: 422 DPKARPLMSEVVE 434
P RP E+
Sbjct: 242 RPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 78/306 (25%), Positives = 106/306 (34%), Gaps = 61/306 (19%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
+ E L + H L L D+ V E+ G L HL R
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFY 110
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
L +LH R V+YRD K N++LD +D
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLD-------------------------KDG 142
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
+ K++DFGL K+G T GT Y APE + D + GVV+ EM+
Sbjct: 143 HIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 421
GR P + L E RF R + P +A L A L +
Sbjct: 201 GR------LPFYNQDHERLFELILMEEIRFPRTLSP------------EAKSLLAGLLKK 242
Query: 422 DPKARP 427
DPK R
Sbjct: 243 DPKQRL 248
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 67/346 (19%), Positives = 112/346 (32%), Gaps = 70/346 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
++ ++G G FG V++ +G VA+K + D + E+ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNRELQIM 67
Query: 190 GDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKI 241
L H N+V+L + ++ LV +++P H R LP
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDY 301
+ LA++H + +RD K N+LLD
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDP------------------------DTA 160
Query: 302 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361
KL DFG AK G+ + + Y A TS DV+S G VL E+L
Sbjct: 161 VLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218
Query: 362 GRRSMDKNRPNGEHNLVEWARPHLGE-----------RRRFYRLIDPRLEGHFSIKGAQK 410
G+ + + + +F ++ F + +
Sbjct: 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 278
Query: 411 AAQLAAHCLSRDPKAR---------PLMSEVVEALKPLPNLKDMAS 447
A L + L P AR E+ + LPN +D +
Sbjct: 279 AIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPA 324
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (343), Expect = 4e-37
Identities = 60/318 (18%), Positives = 111/318 (34%), Gaps = 53/318 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +GEG +G V+K G T A+K + + + E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+VKL + +LV+E + L+ L L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
G+A+ H +R V++RD K N+L++ ++ K++D
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLIN-------------------------REGELKIAD 143
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367
FGLA+ + + ++ + A + + ++ D++S G + EM+ G
Sbjct: 144 FGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
Query: 368 KNRPN----------GEHNLVEWAR-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 416
G N W L + + + +P F + L +
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 417 HCLSRDPKARPLMSEVVE 434
L DP R + +E
Sbjct: 263 KMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-37
Identities = 56/305 (18%), Positives = 95/305 (31%), Gaps = 58/305 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
+LG G G V + T A+K L + EV
Sbjct: 19 VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 195 LNLVKLIGYC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGL 249
++V+++ L+V E + G L + + R +I + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 250 AFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFG 309
+LH + +RD K N+L + R + KL+DFG
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKR----------------------PNAILKLTDFG 159
Query: 310 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369
AK+ + T Y APE + D++S GV++ +L G
Sbjct: 160 FAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-- 214
Query: 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429
H L R Y +P S ++ L + L +P R +
Sbjct: 215 ---SNHGLAISPGMKTRIRMGQYEFPNPEWS-EVS----EEVKMLIRNLLKTEPTQRMTI 266
Query: 430 SEVVE 434
+E +
Sbjct: 267 TEFMN 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 63/332 (18%), Positives = 106/332 (31%), Gaps = 65/332 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVN 187
+ + +G+G FG VFK TG VA+K + + + L E+
Sbjct: 11 KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
L L H N+V LI C LV++F S
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIK 120
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQ 299
++ GL ++H +++RD K +N+L+ +
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLIT-------------------------R 152
Query: 300 DYNAKLSDFGLAKDGPEGDKTHVS--TRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVL 356
D KL+DFGLA+ + + T + T Y PE ++ D++ G ++
Sbjct: 153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212
Query: 357 LEMLTGRRSMDKNRPNGEHNLV-------------EWARPHLGERRRFYRLIDPRLEGHF 403
EM T M N + L+ L E+ + +++
Sbjct: 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 272
Query: 404 SIKGAQKAAQ-LAAHCLSRDPKARPLMSEVVE 434
A L L DP R + +
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-33
Identities = 60/319 (18%), Positives = 103/319 (32%), Gaps = 53/319 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +GEG +G VFK T VA+K + D L E+
Sbjct: 3 KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+V+L D + LV+EF + + I K
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLK 112
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSD 307
GL F H R V++RD K N+L++ ++ KL++
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLIN-------------------------RNGELKLAN 144
Query: 308 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367
FGLA+ + + S V+ + ++ D++S G + E+ R +
Sbjct: 145 FGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 368 KNRPN-----------GEHNLVEWAR-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 415
G +W L + + + + K L
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 416 AHCLSRDPKARPLMSEVVE 434
+ L +P R E ++
Sbjct: 264 QNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 9e-32
Identities = 66/348 (18%), Positives = 114/348 (32%), Gaps = 67/348 (19%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 188
+R +G G +G V V TG VA+K L K E+
Sbjct: 20 YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 189 LGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L + H N++ L+ D+ LV FM G+ L + L +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLV 127
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYN 302
KGL ++H +I+RD K N+ ++ +D
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVN-------------------------EDCE 159
Query: 303 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362
K+ DFGLA+ ++ V+ + A + T D++S G ++ EM+TG
Sbjct: 160 LKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
Query: 363 RRSMDKNRPNGEHNLV---------EWARPHLGERRRFYRLIDPRLEG----HFSIKGAQ 409
+ + + + E+ + + + Y P LE +
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275
Query: 410 KAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKDMASSSYYFQTM 455
A L L D + R E + + L + +D Y +
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 9e-32
Identities = 69/339 (20%), Positives = 109/339 (32%), Gaps = 67/339 (19%)
Query: 95 SNAESNSSTSKLEEELKVASR--LRKFTFNDLKLATRN-FRPESLLGEGGFGCVFKGWIE 151
+ A+ S ++E L A L+K+ A + F LG G FG V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV--- 60
Query: 152 ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDD 208
+G A+K L+ + K+ L E L + LVKL ++
Sbjct: 61 ------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
+V E++ G + +HL R A +LH +IYRD K
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 269 NILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMG 328
N+L+D Q +++DFG AK T + G
Sbjct: 171 NLLID-------------------------QQGYIQVTDFGFAKRVKGRTWT-----LCG 200
Query: 329 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 388
T APE +++ D ++ GV++ EM G P ++ + +
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGK 254
Query: 389 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 427
RF L + L D R
Sbjct: 255 VRFPSHFSS------------DLKDLLRNLLQVDLTKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 7e-31
Identities = 73/351 (20%), Positives = 117/351 (33%), Gaps = 58/351 (16%)
Query: 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
R T + K+ NF +LG G +G VF TG A+K L
Sbjct: 10 RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKA 63
Query: 175 GL----QGHKEWLAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
+ + + E L + LV L + + L+ +++ G L HL +R
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123
Query: 230 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYY 289
L LH+ +IYRD K NILLD
Sbjct: 124 E-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLD---------------- 163
Query: 290 GLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRS 347
+ + L+DFGL+K+ + + GT Y AP+ V G
Sbjct: 164 ---------SNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 348 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 407
D +S GV++ E+LTG +++ E +R L + + +
Sbjct: 214 DWWSLGVLMYELLTGASPFT--VDGEKNSQAEISRRILKSEPPYPQEMSA---------- 261
Query: 408 AQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNLKDMASSSYYFQTMQA 457
A L L +DPK R + +K + + + + A
Sbjct: 262 --LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 2e-29
Identities = 53/329 (16%), Positives = 99/329 (30%), Gaps = 70/329 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ LG G + VF+ + V VK L K+ E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKIL 83
Query: 190 GDL-VHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+L N++ L + R LV+E + + L
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEIL 139
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLS 306
K L + H +++RD K N+++D + +L
Sbjct: 140 KALDYCHS---MGIMHRDVKPHNVMIDH------------------------EHRKLRLI 172
Query: 307 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365
D+GLA+ G + + + + PE ++ D++S G +L M+ +
Sbjct: 173 DWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
Query: 366 MDKNRPN-----------GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK---- 410
N G +L ++ + E + I R +
Sbjct: 230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH 289
Query: 411 -----AAQLAAHCLSRDPKARPLMSEVVE 434
A L D ++R E +E
Sbjct: 290 LVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-27
Identities = 60/338 (17%), Positives = 105/338 (31%), Gaps = 76/338 (22%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
+ ++ +G G G V + VA+K L+ K E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ + H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSY 123
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ G+ LH +I+RD K SNI++ D
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK-------------------------SD 155
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
K+ DFGLA+ T + T Y APE ++ D++S G ++ EM+
Sbjct: 156 CTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 361 TGR----------------RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL----- 399
+ + P L R ++ R ++ L P+L
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 400 ---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
+ + A +A L + L DP R + + ++
Sbjct: 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 7e-25
Identities = 65/355 (18%), Positives = 121/355 (34%), Gaps = 65/355 (18%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 185
++ S +G G +G V + TGL VAVK L+ K E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 186 VNFLGDLVHLNLVKLIGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ L + H N++ L+ +E+ + + + L N + + L
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQF 125
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQD 300
+ +GL ++H +I+RD K SN+ ++ +D
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVN-------------------------ED 157
Query: 301 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360
K+ DFGLA+ + +V+TR + A + H D++S G ++ E+L
Sbjct: 158 CELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 361 TGRRSMDKN----------RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS---IKG 407
TGR R G + R + + + + +F+ I
Sbjct: 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 273
Query: 408 AQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKDMASSSYYFQTMQAERI 460
A L L D R ++ + + D + Y Q+ ++ +
Sbjct: 274 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDL 328
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (250), Expect = 6e-24
Identities = 56/360 (15%), Positives = 103/360 (28%), Gaps = 86/360 (23%)
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ D + + LG G F V+ N T VA+K + D +
Sbjct: 9 PYKDAR-----YILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-T 53
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---------------EFMPRGSLEN 224
+ E+ L + + K +LL + E + L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 225 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284
+P +I+ GL ++H +I+ D K N+L++
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLME----------- 160
Query: 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 344
D L +A G T + T Y +PE ++
Sbjct: 161 -------------IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWG 207
Query: 345 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR---------------------- 382
+D++S ++ E++TG + + + +
Sbjct: 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT 267
Query: 383 --PHLGERRRFYRLIDPRLEG------HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434
G R +L LE FS A++ + + L DP+ R +V
Sbjct: 268 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.1 bits (150), Expect = 8e-12
Identities = 25/183 (13%), Positives = 50/183 (27%), Gaps = 41/183 (22%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
L+GEG VF + E+ G VK + K + G +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 195 LNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L KL G + + ++ E + L ++ + +A
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 251 FLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGL 310
+ R +++ D N+L+ + + DF
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVS--------------------------EEGIWIIDFPQ 148
Query: 311 AKD 313
+ +
Sbjct: 149 SVE 151
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 511 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.48 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.72 | |
| d1qu6a2 | 89 | dsRNA-dependent protein kinase pkr {Human (Homo sa | 92.69 | |
| d1x48a1 | 76 | dsRNA-dependent protein kinase pkr {Mouse (Mus mus | 92.48 | |
| d1x49a1 | 85 | dsRNA-dependent protein kinase pkr {Mouse (Mus mus | 85.24 | |
| d1qu6a1 | 90 | dsRNA-dependent protein kinase pkr {Human (Homo sa | 82.67 | |
| d1x47a1 | 85 | Dgcr8 protein {Human (Homo sapiens) [TaxId: 9606]} | 80.11 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-58 Score=445.17 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=207.2
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++++.||+|+||+||+|+++. +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3579999999999999999999876 6889999999765432 33568899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..|||||||++|+|.++|.. ...+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~------------- 137 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLD------------- 137 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC-------------
T ss_pred CceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEEC-------------
Confidence 9999999999999999999854 457999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+|+...........+..+||+.|||||++.+..+ +.++|||||||+||||++|+.|
T Consensus 138 ------------~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p 205 (271)
T d1nvra_ 138 ------------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205 (271)
T ss_dssp ------------TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence 477899999999997655443334455789999999999988876 6789999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|.......... ..... .. .........+.++.+||.+||+.||.+|||+.|++++
T Consensus 206 f~~~~~~~~~~-~~~~~-----~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 206 WDQPSDSCQEY-SDWKE-----KK---------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp CSSSSTTSHHH-HHHHT-----TC---------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCChHHHHH-HHHhc-----CC---------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 97654322111 11100 00 0000111235678899999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-58 Score=444.98 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=204.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~ 203 (511)
+..++|++.+.||+|+||+||+|+++. .||||+++.... ...+.|.+|+.+|++++|||||+++++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 345789999999999999999997642 699999975532 334678999999999999999999998
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+. .+.++||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~---------- 138 (276)
T d1uwha_ 73 ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLH---------- 138 (276)
T ss_dssp EC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE----------
T ss_pred Ee-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEc----------
Confidence 75 45689999999999999999877778999999999999999999999988 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc---CCCCccccchhHHHHHHHHH
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DIwSlGvil~ell 360 (511)
.++.+||+|||+|+...............||+.|||||++.+ ..|+.++|||||||+||||+
T Consensus 139 ---------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~ 203 (276)
T d1uwha_ 139 ---------------EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203 (276)
T ss_dssp ---------------TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred ---------------CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHH
Confidence 478899999999987655443334456789999999999864 45899999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||+.||.+...... +........ ..+. ....+..+++.+.+||.+||+.||.+||||.+|+++|+.+
T Consensus 204 tg~~Pf~~~~~~~~--~~~~~~~~~---------~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 204 TGQLPYSNINNRDQ--IIFMVGRGY---------LSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp HSSCTTTTCCCHHH--HHHHHHHTS---------CCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HCCCCCCCCChHHH--HHHHHhcCC---------CCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99999976533211 111111100 0010 0112223457899999999999999999999999999765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-57 Score=442.62 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=210.1
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++++.||+|+||+||+|+++. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 579999999999999999999865 68899999998765556678999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
.+|||||||++|+|.+++... .+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~--------------- 150 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG--------------- 150 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC---------------
T ss_pred EEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEEC---------------
Confidence 999999999999999988653 6899999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
.++.+||+|||+|+........ ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+
T Consensus 151 ----------~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 151 ----------MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp ----------TTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ----------CCCcEeeccchhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 4778999999999876543322 3446899999999999999999999999999999999999999975
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...... +...... . .+ ....+...+..+.+||.+||+.||.+|||+.|++++
T Consensus 219 ~~~~~~--~~~~~~~---~--------~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 219 ENPLRA--LYLIATN---G--------TP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SCHHHH--HHHHHHH---C--------SC--CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCHHHH--HHHHHhC---C--------CC--CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 432111 1111000 0 00 011122335789999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-57 Score=434.41 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=207.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||+||+|+++. +++.||||++.... ......+.+|+.+|++++|||||++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 479999999999999999999876 67899999996432 233467889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++..|||||||++|+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~------------ 140 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLG------------ 140 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC------------
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceec------------
Confidence 999999999999999999999654 46999999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+|+...... .....||+.|||||++.+..|+.++|||||||+||||++|+.|
T Consensus 141 -------------~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P 203 (263)
T d2j4za1 141 -------------SAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203 (263)
T ss_dssp -------------TTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred -------------CCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC
Confidence 47789999999998765432 2346899999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|.+.... .+..... .. . ..++...++++.+||.+||+.||.+|||+.||+++
T Consensus 204 f~~~~~~---~~~~~i~---~~--------~----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 204 FEANTYQ---ETYKRIS---RV--------E----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TCCSSHH---HHHHHHH---TT--------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCHH---HHHHHHH---cC--------C----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 9754321 1111110 00 0 11122235788999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-57 Score=444.83 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=217.2
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEee
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
.+++..++|++.+.||+|+||+||+|+++. +++.||||+++.+.. ..++|.+|+.+|++++|||||++++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCc
Confidence 344455789999999999999999999876 678999999976543 4577999999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+|.+++..+||||||++|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~-------- 149 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVG-------- 149 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC--------
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEEC--------
Confidence 999999999999999999999999753 457899999999999999999999998 99999999999998
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+|+........ ..+...||+.|||||++.+..|+.++|||||||++|||++
T Consensus 150 -----------------~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~ 211 (287)
T d1opja_ 150 -----------------ENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211 (287)
T ss_dssp -----------------GGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred -----------------CCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 4778999999999976554322 2334568999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 441 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~~ 441 (511)
|..||...... ..+...+. .......+..+++.+.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus 212 ~~~p~~~~~~~--~~~~~~i~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 212 YGMSPYPGIDL--SQVYELLE--------------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TSCCSSTTCCH--HHHHHHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCCCcchH--HHHHHHHh--------------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 87776543221 11111111 111222233345789999999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=442.34 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=209.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
+.|++++.||+|+||+||+|+++. +++.||||+++.......+.+.+|+++|++|+|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999999876 67899999998766566677899999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..+||||||++|+|.+++.+....+++..+..++.||+.||.|||+++ ||||||||+||||+
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~--------------- 144 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFT--------------- 144 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC---------------
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeEC---------------
Confidence 999999999999999998766678999999999999999999999999 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc-----cCCCCccccchhHHHHHHHHHhCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 363 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DIwSlGvil~elltg~ 363 (511)
.++.+||+|||+|+....... .....+||+.|||||++. +..|+.++|||||||+||||++|+
T Consensus 145 ----------~~~~~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~ 212 (288)
T d2jfla1 145 ----------LDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212 (288)
T ss_dssp ----------TTSCEEECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSS
T ss_pred ----------CCCCEEEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCC
Confidence 477899999999976432211 123467999999999984 456899999999999999999999
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.||.+....... ..... ... + ....+...++++.+||.+||+.||.+|||+.|++++
T Consensus 213 ~Pf~~~~~~~~~--~~i~~----~~~-------~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 213 PPHHELNPMRVL--LKIAK----SEP-------P--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CTTTTSCGGGHH--HHHHH----SCC-------C--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCCCHHHHH--HHHHc----CCC-------C--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999765432211 11110 000 0 011122345789999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=435.37 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=199.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++++.||+|+||+||+|++.. +..||||+++... ...++|.+|+.+|++++|||||+++|+|..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 478889999999999999999853 5689999998654 34578999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
..+||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~--------------- 135 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVG--------------- 135 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEEC---------------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeec---------------
Confidence 999999999999999999877778999999999999999999999998 99999999999999
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
+++.+||+|||+++........ ......||+.|||||++.+..|+.++|||||||+||||+|+..|+..
T Consensus 136 ----------~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 136 ----------ENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp ----------GGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred ----------CCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 4778999999999876543322 23345799999999999999999999999999999999996544433
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
... ...+...+... .....+..+++++.+||.+||+.||.+|||+++|+++|+.+
T Consensus 205 ~~~--~~~~~~~i~~~--------------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 205 NRS--NSEVVEDISTG--------------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp SCC--HHHHHHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC--HHHHHHHHHhc--------------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 221 11121111110 01111223357889999999999999999999999999765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=436.24 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=195.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||+||+|+++. +|+.||||++....... .+.+.+|+++|++++|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 579999999999999999999876 68899999998765432 3468899999999999999999999865
Q ss_pred --CCeEEEEEEccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCcEEeccccccc
Q 010432 207 --DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 207 --~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
++.+|||||||++|+|.+++.+ ....+++..++.++.||+.||+|||+++ ..+||||||||+||||+
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~------ 148 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD------ 148 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC------
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC------
Confidence 4568999999999999999863 3457999999999999999999999854 13499999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.++.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||+||||
T Consensus 149 -------------------~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel 207 (269)
T d2java1 149 -------------------GKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 207 (269)
T ss_dssp -------------------TTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------CCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHH
Confidence 478899999999997654322 23457899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+||+.||..... ..+...+.. . . ...++...++++.+||.+||+.||.+|||+.||+++
T Consensus 208 ~tg~~Pf~~~~~---~~~~~~i~~---~--~---------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 208 CALMPPFTAFSQ---KELAGKIRE---G--K---------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHSSCSCCCSSH---HHHHHHHHH---T--C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhCCCCCCCCCH---HHHHHHHHc---C--C---------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999975432 111111110 0 0 001122335789999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-56 Score=439.43 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
++|++.++||+|+||+||+|+++.++. ....||||.+...... ..+.|.+|+.+|++|+|||||++++++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 467788999999999999999875322 2347999998765433 345799999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..+||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~-------------- 162 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVN-------------- 162 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC--------------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEEC--------------
Confidence 9999999999999999999877778999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCccee---eeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHV---STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~ 363 (511)
.++.+||+|||+|+.......... .....||+.|||||++.+..|+.++|||||||+||||+| |+
T Consensus 163 -----------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~ 231 (299)
T d1jpaa_ 163 -----------SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231 (299)
T ss_dssp -----------TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred -----------CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCC
Confidence 478899999999987654322211 122468999999999999999999999999999999998 89
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.||.+.... .+...+.. ......+..++..+.+||.+||+.||.+||||.+|++.|+++
T Consensus 232 ~Pf~~~~~~---~~~~~i~~--------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 232 RPYWDMTNQ---DVINAIEQ--------------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CTTTTCCHH---HHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCHH---HHHHHHHc--------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 999764321 12111111 011112233467899999999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=437.05 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=204.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||+||+|+++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 579999999999999999999876 67899999997532 223467899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~------------ 142 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLN------------ 142 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccC------------
Confidence 999999999999999999988654 47999999999999999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||++|+.|
T Consensus 143 -------------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (288)
T d1uu3a_ 143 -------------EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209 (288)
T ss_dssp -------------TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------CCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCC
Confidence 4778999999999977554433334457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|.+.... .+...+ .... . .++...++++.+||.+||+.||.+|||+.|++++
T Consensus 210 f~~~~~~---~~~~~i---~~~~--------~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 210 FRAGNEY---LIFQKI---IKLE--------Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp SCCSSHH---HHHHHH---HTTC--------C----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCcCHH---HHHHHH---HcCC--------C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 9764321 111111 1000 0 1122335778999999999999999999997653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-56 Score=428.66 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=199.1
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe---
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE--- 206 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~--- 206 (511)
++.+.||+|+||+||+|++.. ++..||||++...... ..+.+.+|+++|++++|||||++++++..
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred EeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 556689999999999999876 6789999999765322 33568899999999999999999999875
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+..+|||||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++ .+||||||||+||||+.
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~----------- 149 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITG----------- 149 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESS-----------
T ss_pred cCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeC-----------
Confidence 35679999999999999999654 47899999999999999999999876 56999999999999963
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
+++.+||+|||+|+...... ....+||+.|||||++.+ .|+.++|||||||+||||++|+.|
T Consensus 150 -------------~~~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~P 211 (270)
T d1t4ha_ 150 -------------PTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 211 (270)
T ss_dssp -------------TTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred -------------CCCCEEEeecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCC
Confidence 36789999999998654322 334689999999998865 699999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|...... ..+...+.... ....++...++++.+||.+||+.||++|||+.|++++
T Consensus 212 f~~~~~~--~~~~~~i~~~~-------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 212 YSECQNA--AQIYRRVTSGV-------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTTCSSH--HHHHHHHTTTC-------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCcccH--HHHHHHHHcCC-------------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 9754321 11111111100 0011111224678999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=445.87 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=206.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
..++|+++++||+|+||+||+|+++. +|+.||||+++..... ....+.+|+.+|++++|||||+++++|.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 35689999999999999999999875 6889999999765333 3457899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
+++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+ ++ ||||||||+||||+
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~----------- 139 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVN----------- 139 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEEC-----------
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeEC-----------
Confidence 999999999999999999999654 469999999999999999999997 47 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+++.+||+|||+|+...... .+..+||+.|||||++.+..|+.++||||||||+|||++|+.
T Consensus 140 --------------~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~ 201 (322)
T d1s9ja_ 140 --------------SRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201 (322)
T ss_dssp --------------TTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 47789999999998653321 234689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHH-Hhhhhhhccc---------------------cc----cccccCCccCCCCCHHHHHHHHHHHHHh
Q 010432 365 SMDKNRPNGEHNLV-EWARPHLGER---------------------RR----FYRLIDPRLEGHFSIKGAQKAAQLAAHC 418 (511)
Q Consensus 365 pf~~~~~~~~~~~~-~~~~~~~~~~---------------------~~----~~~~~~~~~~~~~~~~~~~~~~~Li~~c 418 (511)
||.+.......... .......... .. .................+.++.+||.+|
T Consensus 202 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 281 (322)
T d1s9ja_ 202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281 (322)
T ss_dssp CSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHH
Confidence 99765432110000 0000000000 00 0000000000000111246789999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 010432 419 LSRDPKARPLMSEVVEA 435 (511)
Q Consensus 419 l~~dP~~RPs~~eil~~ 435 (511)
|+.||.+|||+.|++++
T Consensus 282 L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 282 LIKNPAERADLKQLMVH 298 (322)
T ss_dssp TCSSTTTSCCHHHHHTS
T ss_pred cCCChhHCcCHHHHhhC
Confidence 99999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-56 Score=444.17 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=213.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++++.||+|+||+||+|+++. +|+.||||++........+.+.+|+.+|++|+|||||++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3589999999999999999999876 6889999999876655556789999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+.+|||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+..
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~------------ 160 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK------------ 160 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESST------------
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccC------------
Confidence 9999999999999999999766667999999999999999999999999 9999999999999731
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
.++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus 161 -----------~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 161 -----------RSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp -----------TSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -----------CCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 256799999999997655432 344689999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.... .....+. ..... +........++.+.+||.+||+.||.+|||+.|++++
T Consensus 227 ~~~~~---~~~~~i~---~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 227 GENDD---ETLRNVK---SCDWN--------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CSSHH---HHHHHHH---HTCCC--------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCHH---HHHHHHH---hCCCC--------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 54321 1111111 00000 0111111235678999999999999999999999996
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=424.19 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=213.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|+++++||+|+||+||+|+++ ++..||||+++.... ..++|++|+.++++++|||||+++|+|.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 58999999999999999999985 367899999987654 3468999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
.+++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~--------------- 134 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVN--------------- 134 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEEC---------------
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEc---------------
Confidence 999999999999999998777778999999999999999999999998 99999999999998
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 367 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~ 367 (511)
.++.+||+|||+++........ ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 135 ----------~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~ 203 (258)
T d1k2pa_ 135 ----------DQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203 (258)
T ss_dssp ----------TTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ----------CCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCC
Confidence 4788999999999876554332 2334679999999999999999999999999999999998 899997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
..... .+...+.. . .....+...++.+.+||.+||+.||++|||+.+|+++|..+
T Consensus 204 ~~~~~---~~~~~i~~----~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 204 RFTNS---ETAEHIAQ----G----------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TSCHH---HHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCHH---HHHHHHHh----C----------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 65321 12111111 0 01112223357899999999999999999999999998643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-56 Score=436.66 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=194.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.+.|++.+.||+|+||+||+|+++. +++.||||++...... ....+.+|+.+|++++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3579999999999999999999876 6789999999765432 23457899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++.+|||||||+||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+|||+....
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~---------- 144 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLD---------- 144 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSS----------
T ss_pred CCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccC----------
Confidence 9999999999999999999965 457999999999999999999999998 99999999999997421
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.+||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||
T Consensus 145 ------------~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 145 ------------EDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp ------------TTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ------------CCceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence 367899999999987644322 33468999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.+.... .+...... .. ..+........++++.+||.+||+.||.+|||+.|++++
T Consensus 210 ~~~~~~---~~~~~i~~---~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 210 YDENDA---KLFEQILK---AE--------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCSSHH---HHHHHHHT---TC--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCHH---HHHHHHhc---cC--------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 754321 11111110 00 001111222345789999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=430.43 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=207.9
Q ss_pred cCCCCCCc-cccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~-lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|.+.+. ||+|+||+||+|.++..+ ++..||||+++..... ..+.|.+|+++|++++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC-------CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45666664 999999999999886422 4568999999765433 34679999999999999999999999865
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+.+|||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~------------- 143 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLV------------- 143 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE-------------
T ss_pred -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeec-------------
Confidence 5689999999999999998776678999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||+|+......... ......||+.|||||++.+..++.++|||||||+||||+| |+.
T Consensus 144 ------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 144 ------------NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp ------------ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ------------cCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC
Confidence 47789999999999775543322 2234578999999999999999999999999999999998 899
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
||...... .+...+.. ......+..+++++.+||.+||+.||++||||.+|++.|+.
T Consensus 212 Pf~~~~~~---~~~~~i~~--------------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 212 PYKKMKGP---EVMAFIEQ--------------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp TTTTCCTH---HHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCHH---HHHHHHHc--------------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99765322 12211111 00112223345789999999999999999999999998863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-55 Score=441.30 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=213.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeCC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 208 (511)
++|++++.||+|+||+||+|++.. +|+.||||+++.........+.+|+.+|++|+|||||+++++|.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 479999999999999999999875 68899999998765555567889999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeee
Q 010432 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIY 288 (511)
Q Consensus 209 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~ 288 (511)
.+|||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+..
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~------------- 163 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETK------------- 163 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESST-------------
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccccccccccccc-------------
Confidence 999999999999999988777778999999999999999999999999 9999999999999731
Q ss_pred ccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 010432 289 YGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 368 (511)
Q Consensus 289 ~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~ 368 (511)
.++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||+||+.||.+
T Consensus 164 ----------~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 164 ----------KASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp ----------TCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred ----------CCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 257899999999998765432 3446799999999999999999999999999999999999999975
Q ss_pred CCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 369 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.... .....+.. . ...+........++++.+||.+||+.||.+|||+.|++++
T Consensus 231 ~~~~---~~~~~i~~---~--------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 231 EDDL---ETLQNVKR---C--------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSHH---HHHHHHHH---C--------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCHH---HHHHHHHh---C--------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4321 11111110 0 0011111122335788999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=439.96 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=211.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.++||+|+||+||+|++...+. ......||||.+..... .....+.+|+.+|.++ +|||||++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 34679999999999999999999875322 11345799999965432 3345789999999998 899999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH 262 (511)
.+.+..+||||||++|+|.++|..+. ..+++..++.|+.||+.||+|||+++ |||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 99999999999999999999996542 24889999999999999999999998 999
Q ss_pred cccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC
Q 010432 263 RDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 342 (511)
Q Consensus 263 rDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~ 342 (511)
|||||+|||++ .++.+||+|||+|+...............||+.|||||++.+..
T Consensus 188 RDlKp~Nill~-------------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 188 RDLAARNVLVT-------------------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp TTCSGGGEEEE-------------------------TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred ccCchhccccc-------------------------cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC
Confidence 99999999998 47889999999998766554444445567899999999999999
Q ss_pred CCccccchhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccc
Q 010432 343 LTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 421 (511)
Q Consensus 343 ~~~~~DIwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~ 421 (511)
|+.++|||||||+||||+| |+.||.+..... .+..... .......+..+++.+.+||.+||+.
T Consensus 243 ~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~--~~~~~~~--------------~~~~~~~p~~~~~~l~~li~~cl~~ 306 (325)
T d1rjba_ 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA--NFYKLIQ--------------NGFKMDQPFYATEEIYIIMQSCWAF 306 (325)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCcceeccchhHHHHHHHhCCCCCCCCCCHHH--HHHHHHh--------------cCCCCCCCCcCCHHHHHHHHHHcCC
Confidence 9999999999999999998 899997654321 1111111 1111222333467899999999999
Q ss_pred CCCCCCCHHHHHHHhc
Q 010432 422 DPKARPLMSEVVEALK 437 (511)
Q Consensus 422 dP~~RPs~~eil~~L~ 437 (511)
||++|||++||+++|.
T Consensus 307 dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 307 DSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SGGGSCCHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHh
Confidence 9999999999999984
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-55 Score=433.87 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
+.|++++.||+|+||+||+|++.. +|+.||||++....... .+.+.+|+.+|++|+|||||++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 358999999999999999999876 68899999998665432 246889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++..|||||||.+|+|..++.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~------------ 149 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLS------------ 149 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE------------
T ss_pred ECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEC------------
Confidence 99999999999999998766644 357999999999999999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc---CCCCccccchhHHHHHHHHHhC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DIwSlGvil~elltg 362 (511)
.++.+||+|||+|+..... ...+||+.|||||++.+ ..|+.++|||||||++|||++|
T Consensus 150 -------------~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g 210 (309)
T d1u5ra_ 150 -------------EPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (309)
T ss_dssp -------------TTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred -------------CCCCEEEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence 4778999999999875432 33579999999999864 4689999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 363 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
+.||.+.... ..... .... ..+ ...+...++.+.+||.+||+.||.+|||+.+++++
T Consensus 211 ~~Pf~~~~~~---~~~~~---i~~~-------~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 211 KPPLFNMNAM---SALYH---IAQN-------ESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp SCTTTTSCHH---HHHHH---HHHS-------CCC---CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCHH---HHHHH---HHhC-------CCC---CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 9999754321 11100 0000 000 11112235789999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=430.89 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=206.2
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
+..++|++.+.||+|+||+||+|+++ ++..||||+++... ...+.|.+|+.+|++++|||||++++++.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 34568999999999999999999975 35689999997654 34567999999999999999999999875
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
++..+||||||++|+|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~----------- 143 (272)
T d1qpca_ 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVS----------- 143 (272)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------
T ss_pred -cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeee-----------
Confidence 45679999999999999987533 235899999999999999999999988 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+||..
T Consensus 144 --------------~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~ 208 (272)
T d1qpca_ 144 --------------DTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208 (272)
T ss_dssp --------------TTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTC
T ss_pred --------------cccceeeccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCC
Confidence 478899999999998755332 22344679999999999999999999999999999999999766
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
|+..... ...+...+.. ......+..+++++.+||.+||+.||++||||.+|++.|+.
T Consensus 209 ~~~~~~~--~~~~~~~i~~--------------~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 209 IPYPGMT--NPEVIQNLER--------------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CSSTTCC--HHHHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCC--HHHHHHHHHh--------------cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 6543321 1111111111 01111222345788999999999999999999999998864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=423.83 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=198.4
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEeCCeEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 212 (511)
++||+|+||+||+|.++.. .+++.||||+++..... ..+.|.+|+.+|++++|||||+++++|.. +..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 4699999999999987642 24678999999764332 24579999999999999999999999865 45789
Q ss_pred EEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeecccc
Q 010432 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGLF 292 (511)
Q Consensus 213 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~ 292 (511)
|||||++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 85 vmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~------------------- 141 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLV------------------- 141 (277)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE-------------------
T ss_pred EEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhccc-------------------
Confidence 99999999999998654 47999999999999999999999998 99999999999998
Q ss_pred ccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 010432 293 FNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 370 (511)
Q Consensus 293 ~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf~~~~ 370 (511)
.++.+||+|||+|+......... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus 142 ------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 142 ------TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp ------ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ------ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 47889999999998765443322 2334579999999999999999999999999999999998 899997643
Q ss_pred CCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 010432 371 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 437 (511)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~ 437 (511)
.. .+...+.. ......+..++.++.+||.+||+.||.+|||+.+|++.|+
T Consensus 216 ~~---~~~~~i~~--------------~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 216 GS---EVTAMLEK--------------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp HH---HHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HH---HHHHHHHc--------------CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 21 11111111 0111222334578999999999999999999999998875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-55 Score=426.37 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=204.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
+.|++.++||+|+||+||+|.++..+. .....||||+++..... ...+|++|+.+|++++|||||+++|++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCC-----EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 467888999999999999999875321 12357999999765433 234689999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++|||||.+|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~-------------- 144 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVN-------------- 144 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC--------------
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEEC--------------
Confidence 9999999999999999998877778999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||++|..||
T Consensus 145 -----------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 145 -----------SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp -----------TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred -----------CCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 4788999999999876543222 1233457899999999999999999999999999999999976666
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
...... ..+...+. .......+..++..+.+||.+||+.||++||||.+|++.|+.+.
T Consensus 214 ~~~~~~--~~~~~~i~--------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 214 YWELSN--HEVMKAIN--------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp TTTCCH--HHHHHHHH--------------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cccCCH--HHHHHHHh--------------ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 543221 11111111 11122223334678999999999999999999999999997653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=426.75 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=208.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhCCCCCCcceEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGDLVHLNLVKLI 201 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~il~~l~H~nIv~l~ 201 (511)
.++|++++.||+|+||+||+|+++. +|+.||||+++.... ...+.+.+|+.+|++|+|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3579999999999999999999875 688999999975432 1346789999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
+++.+++.+|||||||++|+|.++|... ..+++..++.++.||+.||+|||+++ ||||||||+|||++..+.
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~---- 151 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNV---- 151 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSS----
T ss_pred EEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCC----
Confidence 9999999999999999999999999654 47999999999999999999999999 999999999999985221
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
....+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||++
T Consensus 152 -----------------~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~ 211 (293)
T d1jksa_ 152 -----------------PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211 (293)
T ss_dssp -----------------SSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred -----------------cccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc
Confidence 234699999999987654432 234679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|+.||.+..... ....... .... +........+..+.+||.+||+.||.+|||+.|++++
T Consensus 212 g~~Pf~~~~~~~---~~~~i~~---~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 212 GASPFLGDTKQE---TLANVSA---VNYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp SSCSSCCSSHHH---HHHHHHT---TCCC--------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCCHHH---HHHHHHh---cCCC--------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999997643211 1111100 0000 0000111224678999999999999999999999984
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=430.79 Aligned_cols=250 Identities=30% Similarity=0.366 Sum_probs=208.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++++.||+|+||+||+|+++. +|+.||||++++.. ....+.+.+|+.+|++++|||||++++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 74 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence 3579999999999999999999876 78899999997542 23346788999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+++.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~----------- 139 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLD----------- 139 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC-----------
T ss_pred ccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEec-----------
Confidence 9999999999999999999998654 47899999999999999999999999 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
.++.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.
T Consensus 140 --------------~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~ 203 (337)
T d1o6la_ 140 --------------KDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp --------------TTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCC
Confidence 478899999999997654332 2345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
||.+.... .+... ..... . .++...++++.+||.+||+.||.+||+ +.+|++|
T Consensus 204 pf~~~~~~---~~~~~---i~~~~--------~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 204 PFYNQDHE---RLFEL---ILMEE--------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SSCCSSHH---HHHHH---HHHCC--------C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCcCHH---HHHHH---HhcCC--------C----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 99865421 11111 11110 1 112233577899999999999999995 7888764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-55 Score=423.89 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=200.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
.++|++.+.||+|+||+||+|++...+. .+..||||.++..... ..+.|.+|+.+|++++|||||++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4679999999999999999999875332 4568999999755433 2456899999999999999999999985
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..+||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~------------- 142 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVS------------- 142 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE-------------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeec-------------
Confidence 56789999999999999998877778999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~p 365 (511)
.++.+||+|||+|+........ ..+...||+.|+|||++.+..|+.++|||||||+||||++ |.+|
T Consensus 143 ------------~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P 209 (273)
T d1mp8a_ 143 ------------SNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209 (273)
T ss_dssp ------------ETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ------------CCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCC
Confidence 4778999999999876543322 2344678999999999999999999999999999999998 8999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|....... +...+... ....++..+++.+.+||.+||+.||.+|||+.+|+++|+.+
T Consensus 210 ~~~~~~~~---~~~~i~~~--------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 210 FQGVKNND---VIGRIENG--------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp TTTCCGGG---HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHH---HHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 97654322 11111110 01112233457899999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=427.91 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=206.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+|+++++||+|+||+||+|++..++.. ....||||.++... ....+.|.+|+.+|++++|||||+++++|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4699999999999999999998753221 23479999987543 34457899999999999999999999999865
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
..+++|||+.+|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~-------------- 145 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK-------------- 145 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE--------------
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeC--------------
Confidence 567889999999999999887788999999999999999999999998 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~pf 366 (511)
.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |..||
T Consensus 146 -----------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 146 -----------TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp -----------ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred -----------CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 477899999999998765544444445679999999999999999999999999999999998 78888
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
.+..... +...+... .....+..++..+.+||.+||+.||.+|||+.+|+++|+.+
T Consensus 215 ~~~~~~~---~~~~i~~~--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 215 DGIPASE---ISSILEKG--------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp TTSCGGG---HHHHHHHT--------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHH---HHHHHHcC--------------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 7543322 11111110 11112223457889999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-53 Score=420.80 Aligned_cols=246 Identities=27% Similarity=0.375 Sum_probs=205.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||+||+|+++. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 579999999999999999999876 68899999997532 233467889999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+++.+|+|||||+||+|..++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~------------ 138 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLD------------ 138 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEEC------------
T ss_pred eCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEc------------
Confidence 999999999999999999988654 46889999999999999999999998 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||++|+.|
T Consensus 139 -------------~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 139 -------------KNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp -------------TTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred -------------CCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCC
Confidence 4788999999999986543 2346899999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
|.+.... .+...+ .... . .++...++++.+|+.+||+.||.+|+ |+++|+++
T Consensus 201 f~~~~~~---~~~~~i---~~~~--------~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 201 FYDSNTM---KTYEKI---LNAE--------L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TCCSSHH---HHHHHH---HHCC--------C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCcCHH---HHHHHH---HcCC--------C----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 9764321 111111 1100 0 11122356789999999999999996 88998875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-54 Score=424.15 Aligned_cols=268 Identities=25% Similarity=0.364 Sum_probs=213.8
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCCCCCCcceEee
Q 010432 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 124 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~l~~ 202 (511)
++...++|++++.||+|+||+||+|+++... ...++..||||+++..... ..++|.+|+.+|++++||||+++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCc----cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 4445678999999999999999999986321 1225678999999765433 2457999999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERP 259 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 259 (511)
+|...+..++|||||++|+|.+++.... ..+++..++.|+.||+.||+|||+++
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--- 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--- 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence 9999999999999999999999986431 24889999999999999999999998
Q ss_pred eEecccCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccc
Q 010432 260 VIYRDFKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 339 (511)
Q Consensus 260 iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~ 339 (511)
||||||||+||||+ .++.+||+|||+|+...........+...||+.|||||++.
T Consensus 161 ivHrDlKp~NILld-------------------------~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 161 FVHRDLATRNCLVG-------------------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp CCCSCCSGGGEEEC-------------------------GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred eEeeEEcccceEEC-------------------------CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc
Confidence 99999999999999 47789999999998665444443445578999999999999
Q ss_pred cCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHh
Q 010432 340 TGHLTSRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 418 (511)
Q Consensus 340 ~~~~~~~~DIwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~c 418 (511)
+..|+.++|||||||+||||++|. +||...... .+...+.. .. ....+...++++.+||.+|
T Consensus 216 ~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~---e~~~~v~~----~~----------~~~~p~~~~~~~~~li~~c 278 (301)
T d1lufa_ 216 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---EVIYYVRD----GN----------ILACPENCPLELYNLMRLC 278 (301)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHT----TC----------CCCCCTTCCHHHHHHHHHH
T ss_pred cCCCChhhhhccchhhHHHHHccCCCCCCCCCHH---HHHHHHHc----CC----------CCCCCccchHHHHHHHHHH
Confidence 999999999999999999999996 566543221 11111111 00 1112223356889999999
Q ss_pred cccCCCCCCCHHHHHHHhcCCC
Q 010432 419 LSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 419 l~~dP~~RPs~~eil~~L~~l~ 440 (511)
|+.||++||||.+|++.|+++.
T Consensus 279 l~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 279 WSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=420.15 Aligned_cols=255 Identities=18% Similarity=0.245 Sum_probs=209.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++++.||+|+||+||+|.++. +++.||||+++.... ....+.+|+++|+.++|||||++++++.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3679999999999999999999876 688999999987643 234678999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+.+|||||||+||+|.++|......+++..++.|+.||+.||+|||+++ ||||||||+|||++..
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~------------ 138 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTR------------ 138 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSS------------
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCC------------
Confidence 9999999999999999999776667999999999999999999999999 9999999999999742
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 367 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~ 367 (511)
+...+||+|||+++....... .....||+.|+|||.+.+..|+.++|||||||+||||++|..||.
T Consensus 139 -----------~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 139 -----------RSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp -----------SCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred -----------CceEEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 245799999999988655332 334679999999999999999999999999999999999999997
Q ss_pred CCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 368 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
...... +...+ ......+... .. ...++++.+||.+||+.||.+|||+.|++++
T Consensus 205 ~~~~~~---~~~~i---~~~~~~~~~~----~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 205 AETNQQ---IIENI---MNAEYTFDEE----AF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CSSHHH---HHHHH---HHTCCCCCHH----HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHH---HHHHH---HhCCCCCChh----hc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 653211 11111 1000000000 00 0124678999999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=424.02 Aligned_cols=256 Identities=21% Similarity=0.254 Sum_probs=203.1
Q ss_pred hcCCCCCC-ccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhC-CCCCCcceEeeEEE
Q 010432 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD-LVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~ 205 (511)
.++|.++. +||+|+||+||+|++.. +++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 35788875 69999999999999876 6889999999743 567889998765 48999999999987
Q ss_pred e----CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 206 E----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~----~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
+ +..+|||||||+||+|.++|..+ ...+++..++.|+.||+.||+|||+++ ||||||||+|||++...
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~---- 148 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR---- 148 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSS----
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccc----
Confidence 5 46689999999999999999764 356999999999999999999999999 99999999999998422
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
+.+.+||+|||+|+....... ....+||+.|||||++.+..|+.++||||||||||||+
T Consensus 149 ------------------~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll 207 (335)
T d2ozaa1 149 ------------------PNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207 (335)
T ss_dssp ------------------TTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT
T ss_pred ------------------ccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh
Confidence 356799999999987655432 23468999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
||+.||.+.......... ... .......+........++++.+||.+||+.||++|||+.|++++
T Consensus 208 tg~~Pf~~~~~~~~~~~~---~~~-------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 208 CGYPPFYSNHGLAISPGM---KTR-------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp TSSCSCEETTCC-----------C-------CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hCCCCCCCCCHHHHHHHH---HHH-------HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 999999765432211100 000 00000011111112346789999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=418.59 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=202.0
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.++|++.+.||+|+||+||+|+++. +..||||+++... ...+.|.+|+.+|++++|||||++++++. +
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 4679999999999999999999864 4579999997654 34578999999999999999999999985 4
Q ss_pred CeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+..++|||||++|+|..++... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~------------- 147 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVG------------- 147 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC-------------
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEEC-------------
Confidence 5689999999999999988643 346999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
+++.+||+|||+|+........ ......||+.|+|||++....++.++|||||||+||||++|..||
T Consensus 148 ------------~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 148 ------------ENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp ------------GGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ------------CCCcEEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 4778999999999876543322 234467999999999999999999999999999999999977666
Q ss_pred CCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 367 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
...... ..+...+.. ......+..+++++.+||.+||+.||++||++.+|++.|+.+.
T Consensus 215 ~~~~~~--~~~~~~i~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 215 YPGMVN--REVLDQVER--------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp STTCCH--HHHHHHHHT--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCH--HHHHHHHHh--------------cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 543221 111111111 0111222334578999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-53 Score=409.92 Aligned_cols=260 Identities=24% Similarity=0.319 Sum_probs=201.8
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
.++|++.+.||+|+||+||+|++.. +|+.||||+++...... ...+.+|+.+|+.++|||||++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 3579999999999999999999876 68899999998654433 34688999999999999999999999
Q ss_pred EeCC----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 205 IEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 205 ~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
...+ ..|||||||+||+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~------- 145 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMIS------- 145 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE-------
T ss_pred eeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccC-------
Confidence 8654 378999999999999988654 47999999999999999999999998 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCc-ceeeeeccccccccCCcccccCCCCccccchhHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~el 359 (511)
.+..++|+|||++........ .......+||+.|||||++.+..|+.++|||||||+||||
T Consensus 146 ------------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyel 207 (277)
T d1o6ya_ 146 ------------------ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207 (277)
T ss_dssp ------------------TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------------ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHH
Confidence 477899999999976543322 1223446899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKP 438 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-s~~eil~~L~~ 438 (511)
+||+.||.+..... .............. ......++.+.+||.+||+.||.+|| |++++++.|.+
T Consensus 208 ltG~~Pf~~~~~~~------~~~~~~~~~~~~~~--------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 208 LTGEPPFTGDSPVS------VAYQHVREDPIPPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHSSCSCCCSSHHH------HHHHHHHCCCCCGG--------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HhCCCCCCCcCHHH------HHHHHHhcCCCCCc--------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999997543211 11111111111111 11112357889999999999999999 89999988865
Q ss_pred C
Q 010432 439 L 439 (511)
Q Consensus 439 l 439 (511)
+
T Consensus 274 ~ 274 (277)
T d1o6ya_ 274 V 274 (277)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.2e-53 Score=424.49 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHH---HHHHHHhCCCCCCcceEee
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWL---AEVNFLGDLVHLNLVKLIG 202 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~---~E~~il~~l~H~nIv~l~~ 202 (511)
++|+++++||+|+||.||+|++.. +|+.||||++..... .....+. +|+.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 579999999999999999999876 688999999964321 1122333 4577888889999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCC
Q 010432 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGK 282 (511)
Q Consensus 203 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~ 282 (511)
++.+++.+|||||||++|+|.++|... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~--------- 141 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLD--------- 141 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC---------
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEc---------
Confidence 999999999999999999999999654 46899999999999999999999999 99999999999998
Q ss_pred cceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHh
Q 010432 283 FGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+|+...... ....+||+.|||||++.. ..|+.++|||||||+||||+|
T Consensus 142 ----------------~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt 201 (364)
T d1omwa3 142 ----------------EHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201 (364)
T ss_dssp ----------------SSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ----------------CCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh
Confidence 47889999999998765432 234679999999999874 578999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
|+.||..........+.... ... ...++...++++.+||.+||+.||.+||| +.+|+++
T Consensus 202 G~~Pf~~~~~~~~~~~~~~~---~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 202 GHSPFRQHKTKDKHEIDRMT---LTM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCSSCSSCSSCHHHHHHHS---SSC------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHhc---ccC------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999865443322221111 000 01112223577899999999999999999 6888764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-54 Score=415.39 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=199.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++.+.||+|+||+||+|++..... ....||||+++.... ...++|.+|+.+|++++|||||+++|++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~------~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCC------cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 579999999999999999998764221 345799999976532 22357899999999999999999999996
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
+ +..++|||||++|+|.+++..+...+++..++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~----------- 146 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLAT----------- 146 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEE-----------
T ss_pred e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhcccc-----------
Confidence 5 4678999999999999988776667999999999999999999999998 999999999999984
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcce-eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 363 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~ 363 (511)
+..+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|||+| |+
T Consensus 147 --------------~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~ 212 (273)
T d1u46a_ 147 --------------RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212 (273)
T ss_dssp --------------TTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred --------------ccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCC
Confidence 7789999999999875543332 2334568899999999999999999999999999999998 89
Q ss_pred CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 010432 364 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 438 (511)
Q Consensus 364 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~ 438 (511)
.||.+.... .....+. .. ......+...+..+.+||.+||+.||++||||.+|++.|++
T Consensus 213 ~Pf~~~~~~---~~~~~i~---~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 213 EPWIGLNGS---QILHKID---KE----------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CTTTTCCHH---HHHHHHH---TS----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcCHH---HHHHHHH---hC----------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 999754322 1111111 11 11111222335789999999999999999999999998864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-54 Score=421.32 Aligned_cols=269 Identities=27% Similarity=0.362 Sum_probs=203.0
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceE
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKL 200 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l 200 (511)
.+++..++|++.++||+|+||.||+|++...+. ..+++.||||+++..... ..+.+.+|..++.++ +|+|||.+
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTS----SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 334445789999999999999999999865322 235779999999765432 345678888888777 68999999
Q ss_pred eeEEEeC-CeEEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 010432 201 IGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 264 (511)
Q Consensus 201 ~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrD 264 (511)
++++... ..+++|||||++|+|.++|... ...+++..++.++.||+.||+|||+++ |||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9988764 4689999999999999999643 234889999999999999999999998 99999
Q ss_pred cCCCcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCC
Q 010432 265 FKTSNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 344 (511)
Q Consensus 265 LKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ 344 (511)
|||+||||+ +++.+||+|||+|+...............||+.|||||++.+..|+
T Consensus 160 lKp~NILl~-------------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 214 (299)
T d1ywna1 160 LAARNILLS-------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214 (299)
T ss_dssp CCGGGEEEC-------------------------GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred CCccceeEC-------------------------CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence 999999998 4778999999999876554443334456899999999999999999
Q ss_pred ccccchhHHHHHHHHHhCC-CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC
Q 010432 345 SRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 423 (511)
Q Consensus 345 ~~~DIwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP 423 (511)
.++|||||||++|||++|. .||....... .+...... . .....+...++++.+||.+||+.||
T Consensus 215 ~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~dP 278 (299)
T d1ywna1 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE----G----------TRMRAPDYTTPEMYQTMLDCWHGEP 278 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHHHHH----T----------CCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccceeehHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc----C----------CCCCCCccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999975 5676443221 11111111 0 0111222335788999999999999
Q ss_pred CCCCCHHHHHHHhcCC
Q 010432 424 KARPLMSEVVEALKPL 439 (511)
Q Consensus 424 ~~RPs~~eil~~L~~l 439 (511)
.+|||+.+|+++|+.+
T Consensus 279 ~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 279 SQRPTFSELVEHLGNL 294 (299)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHH
Confidence 9999999999999754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-53 Score=422.65 Aligned_cols=246 Identities=25% Similarity=0.308 Sum_probs=206.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
++|++++.||+|+||+||+|+++. +|+.||||++.... ....+.+++|+.+|+.++|||||++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 579999999999999999999876 68899999996432 233467899999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 206 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.....++||||+.+|+|..++... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~------------ 175 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLID------------ 175 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC------------
T ss_pred cccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccC------------
Confidence 999999999999999999998654 37999999999999999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+|+..... .....||+.|||||++.+..|+.++|||||||+||||+||+.|
T Consensus 176 -------------~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~P 237 (350)
T d1rdqe_ 176 -------------QQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp -------------TTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------CCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCC
Confidence 4778999999999976542 2346799999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 435 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RP-----s~~eil~~ 435 (511)
|.+.... .+...+ .... . .++...++++.+||.+||+.||.+|+ |+.+|++|
T Consensus 238 f~~~~~~---~~~~~i---~~~~--------~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 238 FFADQPI---QIYEKI---VSGK--------V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCCSSHH---HHHHHH---HHCC--------C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCcCHH---HHHHHH---hcCC--------C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 9754321 111111 1100 0 11122357889999999999999994 88998864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-52 Score=408.13 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=206.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc---------HHHHHHHHHHHhCCC-CCCc
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLV-HLNL 197 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~~E~~il~~l~-H~nI 197 (511)
.++|++++.||+|+||+||+|++.. +|+.||||+++...... .+.+.+|+.+|++|+ ||||
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI 72 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred cccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence 3689999999999999999999876 68899999997654221 235789999999997 9999
Q ss_pred ceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 198 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
|++++++.+++.+|||||||++|+|.++|..+ ..+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~---- 144 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD---- 144 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEc----
Confidence 99999999999999999999999999999654 47999999999999999999999998 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc------CCCCccccchh
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYS 351 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~DIwS 351 (511)
.++.+||+|||+++....... ....+||+.|+|||++.+ ..++.++||||
T Consensus 145 ---------------------~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diws 200 (277)
T d1phka_ 145 ---------------------DDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 200 (277)
T ss_dssp ---------------------TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHH
T ss_pred ---------------------CCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcc
Confidence 478899999999998655332 344689999999999863 35788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 352 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 352 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
+||+||||++|+.||.+..... ....+ ...... +........++++.+|+.+||+.||.+|||+.|
T Consensus 201 lGvilyeml~g~~Pf~~~~~~~---~~~~i---~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e 266 (277)
T d1phka_ 201 TGVIMYTLLAGSPPFWHRKQML---MLRMI---MSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266 (277)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cchhhhhhccCCCCCCCCCHHH---HHHHH---HhCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999999998653211 11111 111000 111111234578999999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
|+++
T Consensus 267 il~h 270 (277)
T d1phka_ 267 ALAH 270 (277)
T ss_dssp HTTS
T ss_pred HHcC
Confidence 9875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=409.94 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=197.5
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEe-
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 206 (511)
.++|+++++||+|+||.||+|+++ |..||||+++... ..+.|.+|+++|++++|||||+++|+|.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 356888899999999999999873 5689999997653 34679999999999999999999999865
Q ss_pred CCeEEEEEEccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
.+.++||||||++|+|.++|..+ ...+++..++.|+.||+.||.|||+++ ||||||||+|||++
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~------------ 137 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVS------------ 137 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC------------
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheec------------
Confidence 45689999999999999999653 235899999999999999999999988 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt-g~~ 364 (511)
.++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.
T Consensus 138 -------------~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~ 199 (262)
T d1byga_ 138 -------------EDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199 (262)
T ss_dssp -------------TTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred -------------CCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCC
Confidence 4788999999999875442 223568999999999999999999999999999999998 677
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
||...... .+...+.. .....++...++.+.+||.+||+.||.+||||.+|+++|+.+
T Consensus 200 p~~~~~~~---~~~~~i~~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 200 PYPRIPLK---DVVPRVEK--------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp SCTTSCGG---GHHHHHTT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHH---HHHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 77654322 22222211 111222333457899999999999999999999999999754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-53 Score=417.36 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=204.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHh-CCCCCCcceEeeEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLG-DLVHLNLVKLIGYC 204 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~-~l~H~nIv~l~~~~ 204 (511)
++|++++.||+|+||+||+|+++. +++.||||++++.. ....+.+.+|..++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 579999999999999999999876 78899999997532 223456777877765 68999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFG 284 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~ 284 (511)
.+++..|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~----------- 137 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLD----------- 137 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC-----------
T ss_pred ccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeec-----------
Confidence 9999999999999999999999654 46899999999999999999999998 99999999999998
Q ss_pred eeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 010432 285 FCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~ 364 (511)
+++.+||+|||+++....... ..+...||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus 138 --------------~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 201 (320)
T d1xjda_ 138 --------------KDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201 (320)
T ss_dssp --------------TTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------CCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCC
Confidence 478899999999987654332 2344689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 434 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~-eil~ 434 (511)
||.+.... .+...+. .. .+. ++...++.+.+||.+||+.||.+||++. +|++
T Consensus 202 PF~~~~~~---~~~~~i~---~~--------~~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 202 PFHGQDEE---ELFHSIR---MD--------NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SSCCSSHH---HHHHHHH---HC--------CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCCHH---HHHHHHH---cC--------CCC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 99764322 1111111 00 111 1222357789999999999999999985 6765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=411.45 Aligned_cols=265 Identities=25% Similarity=0.362 Sum_probs=200.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||+||+|++.. +|+.||||+++..... ....+.+|+++|++++|||||++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 589999999999999999999876 6789999999755322 24678999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
++.+|||||||.+ ++.+++ ......+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~------------ 136 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLIN------------ 136 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC------------
T ss_pred ccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeec------------
Confidence 9999999999965 455554 344567999999999999999999999999 99999999999998
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC-CCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DIwSlGvil~elltg~~ 364 (511)
.+..+||+|||+|+........ .....||+.|+|||++.... ++.++|||||||++|+|++|+.
T Consensus 137 -------------~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~ 201 (298)
T d1gz8a_ 137 -------------TEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201 (298)
T ss_dssp -------------TTSCEEECSTTHHHHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------ccCcceeccCCcceeccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCC
Confidence 4778999999999876443322 33457999999999887665 4789999999999999999999
Q ss_pred CCCCCCCCCchhHHHhhhhhhc-cc---cccccc------cCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 365 SMDKNRPNGEHNLVEWARPHLG-ER---RRFYRL------IDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 365 pf~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~------~~~~~~~~---~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
||.+...... +......... .. ...... ........ .....+.++.+||.+||+.||.+|||+.|
T Consensus 202 Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e 279 (298)
T d1gz8a_ 202 LFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279 (298)
T ss_dssp SCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCHHHH--HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9976432111 1111000000 00 000000 00000000 00122467899999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
++++
T Consensus 280 ll~H 283 (298)
T d1gz8a_ 280 ALAH 283 (298)
T ss_dssp HHTS
T ss_pred HhCC
Confidence 9985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=415.35 Aligned_cols=266 Identities=27% Similarity=0.387 Sum_probs=208.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++++.||+|+||.||+|++...+.. ...++..||||+++.+... ...++.+|+..+.++ +|||||+++++|
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 346899999999999999999988653221 1124568999999876543 335788999999888 899999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
.+++..++|||||++|+|.++|..+. ..+++..++.++.||+.||+|||+++ ||||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 99999999999999999999996442 35899999999999999999999999 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ .++.+||+|||+++...............||+.|+|||++.++.|+.++||
T Consensus 166 iLl~-------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Di 220 (299)
T d1fgka_ 166 VLVT-------------------------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220 (299)
T ss_dssp EEEC-------------------------TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHH
T ss_pred eeec-------------------------CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhh
Confidence 9998 477899999999997655444433445679999999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||||++|||++ |.+||...... .+...+. . ......+...++.+.+||.+||+.||.+|||
T Consensus 221 wS~Gvvl~ell~~g~~p~~~~~~~---~~~~~i~----~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps 283 (299)
T d1fgka_ 221 WSFGVLLWEIFTLGGSPYPGVPVE---ELFKLLK----E----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 283 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH----T----------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhHHHHHHhccCCCCCCCCCCHH---HHHHHHH----c----------CCCCCCCccchHHHHHHHHHHccCCHhHCcC
Confidence 999999999998 68888654321 1111111 1 1111122233578999999999999999999
Q ss_pred HHHHHHHhcCC
Q 010432 429 MSEVVEALKPL 439 (511)
Q Consensus 429 ~~eil~~L~~l 439 (511)
|.||++.|+++
T Consensus 284 ~~eil~~L~~i 294 (299)
T d1fgka_ 284 FKQLVEDLDRI 294 (299)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999999765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=414.54 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=203.8
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCc--EEEEEEecCCCc-ccHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~--~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
++|++.++||+|+||+||+|+++. +|. .||||+++.... ...+.|.+|+++|.++ +|||||+++++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 578889999999999999999876 343 578888865432 2345789999999999 799999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~N 269 (511)
.+++.++||||||++|+|.++|... ...+++..++.++.||+.||.|||+++ ||||||||+|
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~N 157 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 157 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccce
Confidence 9999999999999999999998643 356899999999999999999999998 9999999999
Q ss_pred EEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccc
Q 010432 270 ILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 349 (511)
Q Consensus 270 ILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DI 349 (511)
||++ .++.+||+|||+|+....... .....||..|+|||.+.+..|+.++||
T Consensus 158 IL~~-------------------------~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDv 209 (309)
T d1fvra_ 158 ILVG-------------------------ENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDV 209 (309)
T ss_dssp EEEC-------------------------GGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHH
T ss_pred EEEc-------------------------CCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCcccee
Confidence 9998 477899999999986543222 223568999999999999999999999
Q ss_pred hhHHHHHHHHHhCCC-CCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 350 YSFGVVLLEMLTGRR-SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 350 wSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|||||++|||++|.. ||.... ...+...+.. ......+...++++.+||.+||+.||++|||
T Consensus 210 wSfGvil~ell~~~~~p~~~~~---~~~~~~~i~~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 272 (309)
T d1fvra_ 210 WSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPS 272 (309)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred ehhHHHHHHHHhcCCCCCCCCC---HHHHHHHHHh--------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcC
Confidence 999999999999765 565432 1122211111 0111222334578999999999999999999
Q ss_pred HHHHHHHhcCCC
Q 010432 429 MSEVVEALKPLP 440 (511)
Q Consensus 429 ~~eil~~L~~l~ 440 (511)
|.+|+++|+.+.
T Consensus 273 ~~eil~~L~~i~ 284 (309)
T d1fvra_ 273 FAQILVSLNRML 284 (309)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=410.10 Aligned_cols=263 Identities=23% Similarity=0.265 Sum_probs=196.2
Q ss_pred CCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCccc-----HHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 133 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+++||+|+||+||+|+++. +|+.||||+++...... .+.+.+|+.+|++++|||||++++++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 35689999999999999865 68899999997553321 23588999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..|||||||.++++..++ .....+++..+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 73 ~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~-------------- 134 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLD-------------- 134 (299)
T ss_dssp TCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC--------------
T ss_pred CceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEec--------------
Confidence 9999999999877665544 55567999999999999999999999999 99999999999998
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 366 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~pf 366 (511)
.++.+||+|||+|+........ ....+||+.|||||++.. ..|+.++|||||||++|||++|..||
T Consensus 135 -----------~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 201 (299)
T d1ua2a_ 135 -----------ENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 201 (299)
T ss_dssp -----------TTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred -----------CCCccccccCccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC
Confidence 4788999999999876554322 234679999999999875 46899999999999999999999999
Q ss_pred CCCCCCCchhHHHhhhhh-----hccccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 367 DKNRPNGEHNLVEWARPH-----LGERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.+.........+...... +...........-......+ ...++++.+||.+||+.||++|||+.|++++
T Consensus 202 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 765432211111100000 00000000000000000001 1225679999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=412.12 Aligned_cols=265 Identities=26% Similarity=0.377 Sum_probs=214.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhCC-CCCCcceEeeEE
Q 010432 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (511)
Q Consensus 127 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~~~~ 204 (511)
..++|++.++||+|+||.||+|++.... +..+++.||||+++..... ....|.+|+.+++++ +|||||++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLI----KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccc----cCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4468889999999999999999885321 1236789999999865433 334688999999999 799999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp 267 (511)
.+.+..+||||||++|+|.+++.... ..+++..++.|+.||+.||+|||+++ ||||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999986532 25889999999999999999999999 99999999
Q ss_pred CcEEeccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccc
Q 010432 268 SNILLDAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 347 (511)
Q Consensus 268 ~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~ 347 (511)
+|||++ .++.+||+|||+++...........+..+||+.|+|||++.+..++.++
T Consensus 174 ~NIl~~-------------------------~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLT-------------------------HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEE-------------------------TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred cccccc-------------------------ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcc
Confidence 999998 4778999999999987765555555567899999999999999999999
Q ss_pred cchhHHHHHHHHHhCC-CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 010432 348 DVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 348 DIwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
|||||||++|||+|+. +||....... .+...... ......+...+..+.+||.+||+.||.+|
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~--~~~~~i~~--------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~R 292 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDS--KFYKMIKE--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKR 292 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHHHHHH--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred cccchHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc--------------CCCCCCcccccHHHHHHHHHHcCCChhHC
Confidence 9999999999999954 5454432221 11111111 11111222335789999999999999999
Q ss_pred CCHHHHHHHhcCC
Q 010432 427 PLMSEVVEALKPL 439 (511)
Q Consensus 427 Ps~~eil~~L~~l 439 (511)
|||.+|++.|+++
T Consensus 293 Ps~~~il~~L~~~ 305 (311)
T d1t46a_ 293 PTFKQIVQLIEKQ 305 (311)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHh
Confidence 9999999999753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=409.52 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=203.7
Q ss_pred CCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhCCCCCCcceEeeEEEe-CCeEE
Q 010432 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRL 211 (511)
Q Consensus 134 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~ 211 (511)
.++||+|+||+||+|++..++. +...||||+++... ....++|.+|+++|++++|||||+++|++.. +...+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 4679999999999999875321 34579999997543 2334679999999999999999999999876 46889
Q ss_pred EEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceeeeccc
Q 010432 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCIYYGL 291 (511)
Q Consensus 212 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~~~~~ 291 (511)
+|||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~------------------ 164 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLD------------------ 164 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC------------------
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeEC------------------
Confidence 999999999999999877777889999999999999999999988 99999999999998
Q ss_pred cccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 010432 292 FFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 369 (511)
Q Consensus 292 ~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg~~pf~~~ 369 (511)
+++.+||+|||+++......... ......||+.|+|||++....++.++|||||||+||||+||..||...
T Consensus 165 -------~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 165 -------EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp -------TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred -------CCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 47889999999998765432221 222357899999999999999999999999999999999988888653
Q ss_pred CCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 010432 370 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 440 (511)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l~ 440 (511)
.... .+....... . ....+..+++.+.+||.+||+.||++||+|.||+++|+.+.
T Consensus 238 ~~~~--~~~~~i~~g----~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 238 VNTF--DITVYLLQG----R----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp -------CHHHHHTT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHH--HHHHHHHcC----C----------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 3211 111111110 0 11112223578999999999999999999999999998763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=411.93 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=211.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEE
Q 010432 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (511)
Q Consensus 126 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~ 204 (511)
+..++|++.+.||+|+||+||+|.++... +..++..||||+++.... .....|.+|+.+|++++|||||++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 33468899999999999999999885311 111356899999976533 2234689999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccc
Q 010432 205 IEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAV 275 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 275 (511)
..++..++|||||++|+|.+++... ...+++..+..++.||+.||.|||+++ ||||||||+||||+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld-- 167 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA-- 167 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC--
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeec--
Confidence 9999999999999999999988632 234788999999999999999999988 99999999999998
Q ss_pred cccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHH
Q 010432 276 RAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 355 (511)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvi 355 (511)
.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||+
T Consensus 168 -----------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 168 -----------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224 (308)
T ss_dssp -----------------------TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred -----------------------CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHH
Confidence 478899999999987655444433445679999999999999999999999999999
Q ss_pred HHHHHhCC-CCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 356 LLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 356 l~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
||||+||. .||.+.... .....+. ... ....+..++..+.+||.+||+.||++|||+.+|++
T Consensus 225 l~El~t~~~~p~~~~~~~---~~~~~i~----~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 225 LWEIATLAEQPYQGLSNE---QVLRFVM----EGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHTSCCTTTTSCHH---HHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHH---HHHHHHH----hCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999985 666543211 1111111 000 11112233578999999999999999999999999
Q ss_pred HhcCCC
Q 010432 435 ALKPLP 440 (511)
Q Consensus 435 ~L~~l~ 440 (511)
+|+...
T Consensus 288 ~L~~~~ 293 (308)
T d1p4oa_ 288 SIKEEM 293 (308)
T ss_dssp HHGGGS
T ss_pred HHHHhc
Confidence 998653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=405.49 Aligned_cols=269 Identities=23% Similarity=0.275 Sum_probs=201.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCC---CCCCcceEee
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLIG 202 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l---~H~nIv~l~~ 202 (511)
.++|++++.||+|+||+||+|++... +++.||||+++.... .....+.+|+.+|+.| +|||||++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 46899999999999999999998541 366899999965322 1223466788877665 8999999999
Q ss_pred EEEe-----CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccc
Q 010432 203 YCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 203 ~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 277 (511)
+|.. ....+++||||.++++..........+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~---- 150 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVT---- 150 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC----
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEc----
Confidence 9864 34678999999887776665556667999999999999999999999999 99999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHH
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 357 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ 357 (511)
.++.+||+|||+++...... ......||+.|||||++.+..|+.++|||||||++|
T Consensus 151 ---------------------~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ 206 (305)
T d1blxa_ 151 ---------------------SSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206 (305)
T ss_dssp ---------------------TTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ---------------------CCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHH
Confidence 47789999999998654332 234568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhhhhh-----hccccc----cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 358 EMLTGRRSMDKNRPNGEHNLVEWARPH-----LGERRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 358 elltg~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
||++|+.||.+.........+...... +..... ............+....++.+.+||.+||++||.+|||
T Consensus 207 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s 286 (305)
T d1blxa_ 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286 (305)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC
Confidence 999999999765432211111110000 000000 00000000011122233577899999999999999999
Q ss_pred HHHHHHH
Q 010432 429 MSEVVEA 435 (511)
Q Consensus 429 ~~eil~~ 435 (511)
+.|++++
T Consensus 287 a~e~L~H 293 (305)
T d1blxa_ 287 AYSALSH 293 (305)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=402.04 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=198.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhCCC--CCCcceE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNLVKL 200 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~--H~nIv~l 200 (511)
++|++.++||+|+||+||+|++.. +|+.||||+++..... ...++.+|+.+|++++ |||||++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~ 74 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence 579999999999999999999876 6789999999754321 1133678999999986 8999999
Q ss_pred eeEEEeCCeEEEEEEccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 201 IGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
++++.+++..++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~----- 145 (273)
T d1xwsa_ 75 LDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL----- 145 (273)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEET-----
T ss_pred EEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEec-----
Confidence 9999999999999999976 5777777544 47999999999999999999999998 999999999999984
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCC-CccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DIwSlGvil~e 358 (511)
+++.+||+|||+|+...... .+...||+.|||||++.+..+ +.++|||||||+|||
T Consensus 146 -------------------~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilye 202 (273)
T d1xwsa_ 146 -------------------NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 202 (273)
T ss_dssp -------------------TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred -------------------CCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehh
Confidence 35689999999998754432 344689999999999987765 677999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
|++|+.||.... .. .. .. ..+... .++++.+||.+||+.||.+|||+.|++++
T Consensus 203 ll~g~~Pf~~~~-----~i---~~----~~--------~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 203 MVCGDIPFEHDE-----EI---IR----GQ--------VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHSSCSCCSHH-----HH---HH----CC--------CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhhCCCCCCCch-----HH---hh----cc--------cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 999999996421 10 00 00 011112 24778999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=402.12 Aligned_cols=265 Identities=27% Similarity=0.365 Sum_probs=197.5
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHH--HHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN--FLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~--il~~l~H~nIv~l~~~~~~ 206 (511)
++|.+.+.||+|+||.||+|++ +|+.||||+++... ...+.+|.+ .+.+++|||||++++++..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~ 68 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence 5677888999999999999986 46799999996542 234444544 5567899999999999987
Q ss_pred CC----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecccCCCcEEeccccc
Q 010432 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDAVRA 277 (511)
Q Consensus 207 ~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~iiHrDLKp~NILl~~~~~ 277 (511)
.+ .+|||||||++|+|.++|.+. .+++..++.++.|++.||+|||+.. .++||||||||+||||+
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---- 142 (303)
T d1vjya_ 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---- 142 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC----
T ss_pred CCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc----
Confidence 54 579999999999999999764 6899999999999999999999741 23499999999999998
Q ss_pred cccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcce--eeeeccccccccCCcccccC------CCCccccc
Q 010432 278 ENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDV 349 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~------~~~~~~DI 349 (511)
+++.+||+|||+++......... ......||+.|||||++.+. .++.++||
T Consensus 143 ---------------------~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di 201 (303)
T d1vjya_ 143 ---------------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201 (303)
T ss_dssp ---------------------TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred ---------------------CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhh
Confidence 47899999999998765433221 23346899999999998754 36789999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCchh--------HHHhhhhhhccccccccccCCccCCCC-CHHHHHHHHHHHHHhcc
Q 010432 350 YSFGVVLLEMLTGRRSMDKNRPNGEHN--------LVEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLS 420 (511)
Q Consensus 350 wSlGvil~elltg~~pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Li~~cl~ 420 (511)
|||||+||||+||..||.......... ......... .....++.+.... ..+....+.+|+.+||+
T Consensus 202 ~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~ 276 (303)
T d1vjya_ 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276 (303)
T ss_dssp HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCC
T ss_pred hhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcc
Confidence 999999999999998875433221100 000000000 0111122221111 23456779999999999
Q ss_pred cCCCCCCCHHHHHHHhcCC
Q 010432 421 RDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 421 ~dP~~RPs~~eil~~L~~l 439 (511)
.||.+|||+.||++.|+.+
T Consensus 277 ~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 277 ANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SSGGGSCCHHHHHHHHHHH
T ss_pred cCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-50 Score=395.54 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=199.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|+++++||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 58999999999999999999875 4679999999765432 24678999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
++..+++|||+.++.+..+. .....+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~------------- 134 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLIN------------- 134 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC-------------
T ss_pred CCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEc-------------
Confidence 99999999999766555544 55568999999999999999999999998 99999999999998
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~elltg~~p 365 (511)
.++.+||+|||+|......... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 135 ------------~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p 200 (286)
T d1ob3a_ 135 ------------REGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (286)
T ss_dssp ------------TTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------CCCCEEecccccceecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence 4788999999999875443221 233568999999999875 4569999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhh-----hccccccc------cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 010432 366 MDKNRPNGEHNLVEWARPH-----LGERRRFY------RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 434 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~-----~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~ 434 (511)
|.+.........+...... +....... ....+.....+....++.+.+||.+||+.||++|||+.|+++
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9764322111110000000 00000000 000000011112223578899999999999999999999986
Q ss_pred H
Q 010432 435 A 435 (511)
Q Consensus 435 ~ 435 (511)
+
T Consensus 281 H 281 (286)
T d1ob3a_ 281 H 281 (286)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-49 Score=390.51 Aligned_cols=263 Identities=20% Similarity=0.199 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcc-eEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv-~l~~~~~~~ 207 (511)
++|++.+.||+|+||+||+|++.. +|+.||||++...... .++.+|+++++.++|+|+| .+.+++...
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 479999999999999999999875 6789999998765432 3578999999999877655 555666778
Q ss_pred CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcceee
Q 010432 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFCI 287 (511)
Q Consensus 208 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~~ 287 (511)
+..++||||| +|+|.+.+......+++..++.++.||+.||+|||+++ ||||||||+|||++..+
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~----------- 140 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK----------- 140 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGG-----------
T ss_pred CEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccC-----------
Confidence 8999999999 67888877777778999999999999999999999999 99999999999987422
Q ss_pred eccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 010432 288 YYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 362 (511)
Q Consensus 288 ~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~elltg 362 (511)
.+..+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||++|
T Consensus 141 -----------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg 209 (299)
T d1ckia_ 141 -----------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209 (299)
T ss_dssp -----------GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHS
T ss_pred -----------CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhC
Confidence 3567999999999976543221 123346899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhhh-hhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 363 RRSMDKNRPNGEHNLVEWAR-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 363 ~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
+.||................ ..... ..+.+.. .+++++.+||.+||+.||.+||++.+|.+.|+.+
T Consensus 210 ~~P~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 210 SLPWQGLKAATKRQKYERISEKKMST-------PIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp SCTTCCCC-------HHHHHHHHHHS-------CHHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CCcccccchHHHHHHHHHhhcccCCC-------ChhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 99998654433222111110 00000 0000111 1246789999999999999999999988877644
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=402.51 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=195.7
Q ss_pred CCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCcceEeeEEEeC--
Q 010432 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (511)
Q Consensus 130 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 207 (511)
+|+.+++||+|+||+||+|++.. +|+.||||++...... +.+|+.+|++|+|+|||+++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 57788899999999999999876 6889999999765422 34799999999999999999998643
Q ss_pred ----CeEEEEEEccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccC
Q 010432 208 ----DQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYG 281 (511)
Q Consensus 208 ----~~~~lv~E~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~ 281 (511)
.+++||||||+++.+..+.. .....+++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~------- 157 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDP------- 157 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECT-------
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEec-------
Confidence 35789999997654333322 34567999999999999999999999998 999999999999984
Q ss_pred CcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCccccc-CCCCccccchhHHHHHHHHH
Q 010432 282 KFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DIwSlGvil~ell 360 (511)
+...+||+|||+++....... ....+||+.|+|||.+.+ ..|+.++|||||||++|||+
T Consensus 158 -----------------~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~ 217 (350)
T d1q5ka_ 158 -----------------DTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217 (350)
T ss_dssp -----------------TTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred -----------------CCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehh
Confidence 235799999999987654332 234679999999998875 57899999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhhh---------hhhcc--ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 010432 361 TGRRSMDKNRPNGEHNLVEWAR---------PHLGE--RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 429 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~~~---------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~ 429 (511)
+|+.||...........+.... ..... ...+.......+........++++.+||.+||+.||.+|||+
T Consensus 218 ~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta 297 (350)
T d1q5ka_ 218 LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297 (350)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999997654321111110000 00000 000000000001111122345778999999999999999999
Q ss_pred HHHHHH
Q 010432 430 SEVVEA 435 (511)
Q Consensus 430 ~eil~~ 435 (511)
.|++++
T Consensus 298 ~e~L~H 303 (350)
T d1q5ka_ 298 LEACAH 303 (350)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=389.16 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=196.9
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||+||+|++.. +|+.||||++..... ....++.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 689999999999999999999875 688999999865432 234678999999999999999999998865
Q ss_pred --------CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccc
Q 010432 207 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAE 278 (511)
Q Consensus 207 --------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~ 278 (511)
.+..|+|||||.++.+. .+......+++..++.++.||+.||.|||+++ ||||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~----- 151 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLIT----- 151 (318)
T ss_dssp ----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC-----
T ss_pred ccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeec-----
Confidence 34689999999776554 44455567899999999999999999999998 99999999999998
Q ss_pred ccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcc--eeeeeccccccccCCcccccC-CCCccccchhHHHH
Q 010432 279 NYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVV 355 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvi 355 (511)
.++.+||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||+
T Consensus 152 --------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvi 211 (318)
T d3blha1 152 --------------------RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211 (318)
T ss_dssp --------------------TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred --------------------CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCce
Confidence 4788999999999865532221 122335799999999998765 68999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhhhhhhccc-------cccccccCCccCCCCCH-------HHHHHHHHHHHHhccc
Q 010432 356 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-------RRFYRLIDPRLEGHFSI-------KGAQKAAQLAAHCLSR 421 (511)
Q Consensus 356 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-------~~~~~~~~Li~~cl~~ 421 (511)
+|||++|+.||.+.........+.......... ................. ..++.+.+||.+||+.
T Consensus 212 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~ 291 (318)
T d3blha1 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291 (318)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred eeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcC
Confidence 999999999997644322211111111110000 00000000000000010 1145678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 010432 422 DPKARPLMSEVVEA 435 (511)
Q Consensus 422 dP~~RPs~~eil~~ 435 (511)
||++|||+.|++++
T Consensus 292 dP~~R~sa~elL~H 305 (318)
T d3blha1 292 DPAQRIDSDDALNH 305 (318)
T ss_dssp STTTSCCHHHHHHS
T ss_pred ChhHCcCHHHHHcC
Confidence 99999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=395.20 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=196.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|+++++||+|+||+||+|+++. +|+.||||+++..... ..+.+.+|+.+|++++|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4689999999999999999999876 6889999999865432 2356889999999999999999999997
Q ss_pred eCC------eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccc
Q 010432 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAEN 279 (511)
Q Consensus 206 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~ 279 (511)
..+ .+||||||| +++|..++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~------ 155 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVN------ 155 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC------
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcc------
Confidence 654 579999999 6688877654 36999999999999999999999999 99999999999998
Q ss_pred cCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHH
Q 010432 280 YGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLE 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~e 358 (511)
.++.+||+|||+|+..... .+...||+.|+|||++.+. .++.++|||||||++||
T Consensus 156 -------------------~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 211 (346)
T d1cm8a_ 156 -------------------EDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211 (346)
T ss_dssp -------------------TTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred -------------------cccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHH
Confidence 4788999999999876543 2346799999999998764 56899999999999999
Q ss_pred HHhCCCCCCCCCCCCchhHHHhhhhhhcc--------------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCC
Q 010432 359 MLTGRRSMDKNRPNGEHNLVEWARPHLGE--------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 359 lltg~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
|++|+.||.+................... ...+.......+. ......++.+.+||.+||+.||.
T Consensus 212 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~ 290 (346)
T d1cm8a_ 212 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAE 290 (346)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChh
Confidence 99999999765322111111100000000 0000000000000 11122356789999999999999
Q ss_pred CCCCHHHHHHH
Q 010432 425 ARPLMSEVVEA 435 (511)
Q Consensus 425 ~RPs~~eil~~ 435 (511)
+|||+.|||++
T Consensus 291 ~R~ta~eiL~H 301 (346)
T d1cm8a_ 291 QRVTAGEALAH 301 (346)
T ss_dssp TSCCHHHHHHS
T ss_pred HCcCHHHHhcC
Confidence 99999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=394.77 Aligned_cols=268 Identities=21% Similarity=0.283 Sum_probs=196.3
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhCCCCCCcceEeeEEEeC
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 207 (511)
.+|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+++|+.+|++|+|||||++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred CCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 579999999999999999999865 688999999976443 2345788999999999999999999998764
Q ss_pred C----eEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 208 D----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 208 ~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
. ..+++|+|+.+|+|.+++... .+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~---------- 143 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN---------- 143 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC----------
T ss_pred cccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEEC----------
Confidence 3 234445556699999999653 6899999999999999999999999 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcc-eeeeeccccccccCCcccc-cCCCCccccchhHHHHHHHHHh
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DIwSlGvil~ellt 361 (511)
+++.+||+|||+|+........ ......+||+.|+|||++. +..++.++||||+||++|||++
T Consensus 144 ---------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~ 208 (345)
T d1pmea_ 144 ---------------TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208 (345)
T ss_dssp ---------------TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred ---------------CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh
Confidence 4778999999999865442221 1123467999999999985 5577999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccc----------cccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGER----------RRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPL 428 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~---~~~~~~~~~~~~Li~~cl~~dP~~RPs 428 (511)
|+.||...................... ............. ......+.++.+|+.+||+.||.+|||
T Consensus 209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 288 (345)
T d1pmea_ 209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 288 (345)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC
Confidence 999997654322111111110000000 0000000000000 000112467899999999999999999
Q ss_pred HHHHHHH
Q 010432 429 MSEVVEA 435 (511)
Q Consensus 429 ~~eil~~ 435 (511)
+.|++++
T Consensus 289 a~e~L~h 295 (345)
T d1pmea_ 289 VEQALAH 295 (345)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.8e-49 Score=391.95 Aligned_cols=261 Identities=19% Similarity=0.238 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEe-
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE- 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~- 206 (511)
++|+++++||+|+||+||+|++.. +|+.||||+++... .+++.+|+.+|+++. ||||+++++++..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 579999999999999999999876 68899999997543 467889999999995 9999999999985
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCcce
Q 010432 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGF 285 (511)
Q Consensus 207 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~ 285 (511)
...+++|||||.+|+|..+. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~----------- 164 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDH----------- 164 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET-----------
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcC-----------
Confidence 35689999999999997764 36899999999999999999999999 999999999999984
Q ss_pred eeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHHHhCCC
Q 010432 286 CIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 364 (511)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~elltg~~ 364 (511)
++..+||+|||+|+....... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 165 -------------~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~ 228 (328)
T d3bqca1 165 -------------EHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228 (328)
T ss_dssp -------------TTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred -------------CCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCC
Confidence 345699999999987655432 2346799999999998765 57999999999999999999999
Q ss_pred CCCCCCCCCchhH-HHh----------hh-hhhccccccccccCC--------ccCCCCCHHHHHHHHHHHHHhcccCCC
Q 010432 365 SMDKNRPNGEHNL-VEW----------AR-PHLGERRRFYRLIDP--------RLEGHFSIKGAQKAAQLAAHCLSRDPK 424 (511)
Q Consensus 365 pf~~~~~~~~~~~-~~~----------~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~Li~~cl~~dP~ 424 (511)
||........... +.. .. ........+...... ..........++++.+||.+||+.||.
T Consensus 229 pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 308 (328)
T d3bqca1 229 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308 (328)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGG
T ss_pred CCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChh
Confidence 9976543211100 000 00 000000000001000 001111122357789999999999999
Q ss_pred CCCCHHHHHHH
Q 010432 425 ARPLMSEVVEA 435 (511)
Q Consensus 425 ~RPs~~eil~~ 435 (511)
+|||++|+|++
T Consensus 309 ~R~ta~e~L~H 319 (328)
T d3bqca1 309 SRLTAREAMEH 319 (328)
T ss_dssp GSCCHHHHHTS
T ss_pred HCcCHHHHhcC
Confidence 99999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-48 Score=382.04 Aligned_cols=267 Identities=17% Similarity=0.164 Sum_probs=210.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCC-CCcceEeeEEEe
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 206 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~ 206 (511)
.++|+++++||+|+||+||+|++.. +|+.||||++...... ..+.+|+++++.|.| +||+.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 3689999999999999999999876 6889999998654322 346789999999965 899999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
+...++||||| +|+|.+++......++...+..++.|++.||+|||+++ ||||||||+||||+.....
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~-------- 140 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSK-------- 140 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSST--------
T ss_pred CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccc--------
Confidence 99999999999 78999999877778999999999999999999999999 9999999999999742110
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcc-----eeeeeccccccccCCcccccCCCCccccchhHHHHHHHHHh
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ellt 361 (511)
..+.+||+|||+|+........ ......+||+.|||||++.+..++.++|||||||++|||++
T Consensus 141 ------------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt 208 (293)
T d1csna_ 141 ------------NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 208 (293)
T ss_dssp ------------TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ------------cCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHh
Confidence 2567999999999875432211 12334689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 439 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~L~~l 439 (511)
|+.||.+.................. ...... +... .++++.+|+..||..+|++||+++.+.+.|+.+
T Consensus 209 g~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 209 GSLPWQGLKAATNKQKYERIGEKKQ-STPLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SSCTTSSCCSCCHHHHHHHHHHHHH-HSCHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCCcCCCccchhHHHHHHHHHhccC-CCChHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 9999986654433222211111000 000000 1111 246789999999999999999999888877654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=381.22 Aligned_cols=265 Identities=23% Similarity=0.277 Sum_probs=205.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|++++.||+|+||+||+|++.. +++.||||+++..... ....+.+|+.+|+.++|||||++++++..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 579999999999999999999876 6789999999765432 34678999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCccee
Q 010432 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKFGFC 286 (511)
Q Consensus 207 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~~~~ 286 (511)
.+..++|||++.+++|..++. ....+++..+..++.|++.||+|||+++ ||||||||+|||++.
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~------------ 136 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINR------------ 136 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT------------
T ss_pred ccceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCccccccc------------
Confidence 999999999998888877764 4567899999999999999999999998 999999999999983
Q ss_pred eeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCC-CCccccchhHHHHHHHHHhCCCC
Q 010432 287 IYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRS 365 (511)
Q Consensus 287 ~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DIwSlGvil~elltg~~p 365 (511)
+..+||+|||+|+........ .....+++.|+|||++.... ++.++|||||||++|||++|+.|
T Consensus 137 -------------~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p 201 (292)
T d1unla_ 137 -------------NGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp -------------TCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred -------------CCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCC
Confidence 678999999999976554332 23346789999999887655 68999999999999999999999
Q ss_pred CCCCCCCCchhHHHhhhhhhccc-----ccccccc---------CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 010432 366 MDKNRPNGEHNLVEWARPHLGER-----RRFYRLI---------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 431 (511)
Q Consensus 366 f~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~---------~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs~~e 431 (511)
|....... ............. ....... ............++.+.+||.+||+.||.+||||+|
T Consensus 202 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 202 LFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp SCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 85433211 1111111110000 0000000 000011122233577899999999999999999999
Q ss_pred HHHH
Q 010432 432 VVEA 435 (511)
Q Consensus 432 il~~ 435 (511)
|+++
T Consensus 280 ~L~H 283 (292)
T d1unla_ 280 ALQH 283 (292)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=389.89 Aligned_cols=257 Identities=27% Similarity=0.340 Sum_probs=204.4
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhCCCC-CCcceEeeE
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVH-LNLVKLIGY 203 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~H-~nIv~l~~~ 203 (511)
++|++++.||+|+||+||+|++..+. .+|+.||||+++.... ...+.+.+|+.+|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccC------CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 56999999999999999999885432 3788999999975422 223567899999999976 899999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEeccccccccCCc
Q 010432 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENYGKF 283 (511)
Q Consensus 204 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~~~~ 283 (511)
+.+....++|||||.+|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+||||+
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~---------- 163 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLD---------- 163 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC----------
T ss_pred eccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeec----------
Confidence 999999999999999999999986543 6788899999999999999999998 99999999999998
Q ss_pred ceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC--CCCccccchhHHHHHHHHHh
Q 010432 284 GFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT 361 (511)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DIwSlGvil~ellt 361 (511)
.++.+||+|||+|+........ ......||+.|+|||.+.+. .++.++|||||||+||||++
T Consensus 164 ---------------~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt 227 (322)
T d1vzoa_ 164 ---------------SNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227 (322)
T ss_dssp ---------------TTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred ---------------CCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence 4778999999999876543322 23346799999999999754 46889999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 010432 362 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 435 (511)
Q Consensus 362 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~cl~~dP~~RPs-----~~eil~~ 435 (511)
|+.||...........+... .... ...++...+.++.+||.+||++||.+||| ++|++++
T Consensus 228 G~~PF~~~~~~~~~~~i~~~--~~~~------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 228 GASPFTVDGEKNSQAEISRR--ILKS------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp SSCTTSCTTSCCCHHHHHHH--HHHC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHh--cccC------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 99999876544332221111 1000 01112234678999999999999999995 7788753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=387.53 Aligned_cols=263 Identities=23% Similarity=0.274 Sum_probs=191.6
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEEe
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 206 (511)
++|+++++||+|+||+||+|++.. +|+.||||++...... ....+.+|+.+|++++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 579999999999999999999876 7889999999865432 23468899999999999999999999964
Q ss_pred ------CCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 207 ------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 207 ------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
...+|+|||||.+ +|.+.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~------- 153 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK------- 153 (355)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC-------
T ss_pred ccccccCceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccc-------
Confidence 3688999999965 5555553 36899999999999999999999999 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 360 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlGvil~ell 360 (511)
.+..+||+|||+++....... .+..+||+.|+|||++.+..++.++||||+||++|||+
T Consensus 154 ------------------~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell 212 (355)
T d2b1pa1 154 ------------------SDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212 (355)
T ss_dssp ------------------TTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ------------------cccceeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHh
Confidence 477899999999987654332 34467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHh-hh--------h-------hhccc-----cccccccCCcc---CCCCCHHHHHHHHHHHH
Q 010432 361 TGRRSMDKNRPNGEHNLVEW-AR--------P-------HLGER-----RRFYRLIDPRL---EGHFSIKGAQKAAQLAA 416 (511)
Q Consensus 361 tg~~pf~~~~~~~~~~~~~~-~~--------~-------~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~Li~ 416 (511)
+|+.||.+.........+.. .. . ..... ........... ........+.++.+||.
T Consensus 213 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~ 292 (355)
T d2b1pa1 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292 (355)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHH
Confidence 99999976532211110000 00 0 00000 00000000000 01112345788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 010432 417 HCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 417 ~cl~~dP~~RPs~~eil~~ 435 (511)
+||+.||++||||+|||++
T Consensus 293 ~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 293 KMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHSCSSTTTSCCHHHHHTS
T ss_pred HHCcCChhHCcCHHHHhcC
Confidence 9999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=379.80 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=196.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhCCCCCCcceEeeEEE
Q 010432 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (511)
Q Consensus 128 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~l~~~~~ 205 (511)
.++|+++++||+|+||+||+|++.. +|+.||||+++..... ..+.+.+|+.+|++|+|||||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4689999999999999999999875 6889999999865432 2346889999999999999999999986
Q ss_pred eC-----CeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEecccccccc
Q 010432 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAVRAENY 280 (511)
Q Consensus 206 ~~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~~~~ 280 (511)
.. ...++||+|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~------- 155 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN------- 155 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC-------
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccc-------
Confidence 43 334666777889999999854 46999999999999999999999999 99999999999998
Q ss_pred CCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccC-CCCccccchhHHHHHHHH
Q 010432 281 GKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEM 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DIwSlGvil~el 359 (511)
.++.+|++|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 156 ------------------~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~l 212 (348)
T d2gfsa1 156 ------------------EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212 (348)
T ss_dssp ------------------TTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHH
T ss_pred ------------------ccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHH
Confidence 4788999999999865432 2336799999999987765 468899999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHhhhhhhcc----------ccccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCC
Q 010432 360 LTGRRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKAR 426 (511)
Q Consensus 360 ltg~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~---~~~~~~~~~~Li~~cl~~dP~~R 426 (511)
++|+.||.+.........+......... ...............+ ....++.+.+||.+||+.||.+|
T Consensus 213 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (348)
T d2gfsa1 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292 (348)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhC
Confidence 9999999765432211111110000000 0000000000000000 01124678999999999999999
Q ss_pred CCHHHHHHH
Q 010432 427 PLMSEVVEA 435 (511)
Q Consensus 427 Ps~~eil~~ 435 (511)
||+.|++++
T Consensus 293 ~ta~elL~H 301 (348)
T d2gfsa1 293 ITAAQALAH 301 (348)
T ss_dssp CCHHHHHTS
T ss_pred cCHHHHhcC
Confidence 999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-43 Score=352.60 Aligned_cols=269 Identities=21% Similarity=0.239 Sum_probs=194.0
Q ss_pred cCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-----------CCCc
Q 010432 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLNL 197 (511)
Q Consensus 129 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----------H~nI 197 (511)
++|+++++||+|+||+||+|++.. +|+.||||+++.... ..+.+.+|+.+|+.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 459999999999999999999876 688999999986532 2356788999988875 5789
Q ss_pred ceEeeEEEe--CCeEEEEEEccCCCCHHHH--HhhCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCcEEe
Q 010432 198 VKLIGYCIE--DDQRLLVYEFMPRGSLENH--LFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILL 272 (511)
Q Consensus 198 v~l~~~~~~--~~~~~lv~E~~~~g~L~~~--l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiHrDLKp~NILl 272 (511)
|++++++.. ....+++|+++..+..... .......+++..+..++.||+.||+|||+ ++ |+||||||+||||
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence 999998864 4566777777755543322 22345678999999999999999999997 77 9999999999999
Q ss_pred ccccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhH
Q 010432 273 DAVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 352 (511)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSl 352 (511)
+..+.. .....+||+|||.+...... ....+||+.|+|||++.+..|+.++||||+
T Consensus 160 ~~~~~~-------------------~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 215 (362)
T d1q8ya_ 160 EIVDSP-------------------ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWST 215 (362)
T ss_dssp EEEETT-------------------TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred eccCcc-------------------cccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccch
Confidence 853210 01235899999999865432 233679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchh----HHHhhhhhhcc-----------------ccccccccCC----------ccCC
Q 010432 353 GVVLLEMLTGRRSMDKNRPNGEHN----LVEWARPHLGE-----------------RRRFYRLIDP----------RLEG 401 (511)
Q Consensus 353 Gvil~elltg~~pf~~~~~~~~~~----~~~~~~~~~~~-----------------~~~~~~~~~~----------~~~~ 401 (511)
||+++||++|+.||.......... +..... .++. .......+.. ....
T Consensus 216 G~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (362)
T d1q8ya_ 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 294 (362)
T ss_dssp HHHHHHHHHSSCCC---------CHHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT
T ss_pred HHHHHHHHHCCCCCCCCccccccchhHHHHHHHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhccccc
Confidence 999999999999997653322111 111000 0000 0000000000 0122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 010432 402 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 435 (511)
Q Consensus 402 ~~~~~~~~~~~~Li~~cl~~dP~~RPs~~eil~~ 435 (511)
.+....++.+.+||.+||++||.+|||+.|+|++
T Consensus 295 ~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 295 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp CCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred ccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3445678899999999999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=5.6e-26 Score=206.89 Aligned_cols=169 Identities=15% Similarity=0.107 Sum_probs=119.5
Q ss_pred CCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcc-------------c-----HHHHHHHHHHHhCCC
Q 010432 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-------------G-----HKEWLAEVNFLGDLV 193 (511)
Q Consensus 132 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-------------~-----~~~~~~E~~il~~l~ 193 (511)
.+.++||+|+||+||+|++. +|+.||||+++..... . .....+|+..|.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 35678999999999999874 4779999987642110 0 122456889999999
Q ss_pred CCCcceEeeEEEeCCeEEEEEEccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCcEEec
Q 010432 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (511)
Q Consensus 194 H~nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiHrDLKp~NILl~ 273 (511)
|.+++..+++. . .+|+|||+++..+.+ ++...+..++.|++.+|+|||+++ |+||||||+|||++
T Consensus 73 ~~~v~~~~~~~--~--~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~ 137 (191)
T d1zara2 73 GLAVPKVYAWE--G--NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 137 (191)
T ss_dssp TSSSCCEEEEE--T--TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCcceEEEec--C--CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeee
Confidence 99999988653 2 379999998765543 334445678999999999999999 99999999999998
Q ss_pred cccccccCCcceeeeccccccccccccCceeeecCCCcccCCCCCcceeeeeccccccccCCcccccCCCCccccchhHH
Q 010432 274 AVRAENYGKFGFCIYYGLFFNNMLFQDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 353 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DIwSlG 353 (511)
+..++|+|||+|+............+.+.. + .+ +....|+.++|+||+.
T Consensus 138 --------------------------~~~~~liDFG~a~~~~~~~~~~~l~rd~~~---~-~~-~f~r~y~~~~d~~s~~ 186 (191)
T d1zara2 138 --------------------------EEGIWIIDFPQSVEVGEEGWREILERDVRN---I-IT-YFSRTYRTEKDINSAI 186 (191)
T ss_dssp --------------------------TTEEEECCCTTCEETTSTTHHHHHHHHHHH---H-HH-HHHHHHCCCCCHHHHH
T ss_pred --------------------------CCCEEEEECCCcccCCCCCcHHHHHHHHHH---H-HH-HHcCCCCCcccHHHHH
Confidence 344899999999876543221100000000 0 01 1246788999999986
Q ss_pred HHH
Q 010432 354 VVL 356 (511)
Q Consensus 354 vil 356 (511)
--+
T Consensus 187 ~~~ 189 (191)
T d1zara2 187 DRI 189 (191)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=2.8e-07 Score=85.59 Aligned_cols=92 Identities=13% Similarity=-0.038 Sum_probs=63.0
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEe
Q 010432 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLI 201 (511)
Q Consensus 123 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~ 201 (511)
++....+.|+..+..+-++.+.||+... .+..++||+...........+.+|+..|..|. +--+.+++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 3344445676666555455678998753 34578889886543333345678888877663 44467888
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHH
Q 010432 202 GYCIEDDQRLLVYEFMPRGSLENH 225 (511)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~g~L~~~ 225 (511)
.+...++..++||++++|.++...
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHH
T ss_pred EEEecCCceEEEEEeccccccccc
Confidence 888888999999999998877554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=8.2e-05 Score=67.86 Aligned_cols=73 Identities=21% Similarity=0.130 Sum_probs=50.3
Q ss_pred cccCCC-ceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC--CCCcceEeeEEEeCCeEEEE
Q 010432 137 LGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 137 lG~G~f-g~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~~~~~lv 213 (511)
+..|.. +.||+.... .+..+++|........ .+..|+..|+.|. .-.+.+++.+..+++..++|
T Consensus 18 ~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEECT----------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEeC----------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 444543 678988653 3556888987655432 3556777776663 33467788888888889999
Q ss_pred EEccCCCCH
Q 010432 214 YEFMPRGSL 222 (511)
Q Consensus 214 ~E~~~~g~L 222 (511)
|++++|-++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.64 E-value=0.00012 Score=71.64 Aligned_cols=76 Identities=14% Similarity=0.090 Sum_probs=47.7
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCC------C-cccHHHHHHHHHHHhCC-CC--CCcceEeeEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGDL-VH--LNLVKLIGYC 204 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~------~-~~~~~~~~~E~~il~~l-~H--~nIv~l~~~~ 204 (511)
+.||.|....||+..... +++.|+||.-... . .....+...|+.+|+.+ .+ ..+.+++.+
T Consensus 32 ~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~- 101 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS- 101 (392)
T ss_dssp EECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred EEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-
Confidence 468999999999997654 4668999965321 1 11223455688887765 22 345666654
Q ss_pred EeCCeEEEEEEccCCCC
Q 010432 205 IEDDQRLLVYEFMPRGS 221 (511)
Q Consensus 205 ~~~~~~~lv~E~~~~g~ 221 (511)
+++..++|||++.+..
T Consensus 102 -d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 102 -DTEMAVTVMEDLSHLK 117 (392)
T ss_dssp -ETTTTEEEECCCTTSE
T ss_pred -cCCCCEEEEeccCCcc
Confidence 4556689999997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.48 E-value=0.0039 Score=60.49 Aligned_cols=80 Identities=18% Similarity=0.084 Sum_probs=51.4
Q ss_pred CccccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC-CCCcceEeeEEEeCCeEEEE
Q 010432 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (511)
Q Consensus 135 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lv 213 (511)
+.|+-|-.=.+|++....... +.......|.+++.-.. .......+|..+++.+. +.-..++++++. + .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceE
Confidence 468878888999998765321 22224557777776532 22344568999988884 433447777663 2 689
Q ss_pred EEccCCCCH
Q 010432 214 YEFMPRGSL 222 (511)
Q Consensus 214 ~E~~~~g~L 222 (511)
|||++|-.|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.29 E-value=0.011 Score=55.42 Aligned_cols=67 Identities=16% Similarity=0.070 Sum_probs=43.2
Q ss_pred ceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCCCCCc-----ceEe--eEEEeCCeEEEEEE
Q 010432 143 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-----VKLI--GYCIEDDQRLLVYE 215 (511)
Q Consensus 143 g~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H~nI-----v~l~--~~~~~~~~~~lv~E 215 (511)
-.||+++.. .|..|++|+.+.... ..+++..|...|..|....| +..- ..+...+..+.+++
T Consensus 36 N~vy~v~~~----------dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEEcC----------CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 479998764 477899999875532 34667788888877642221 1111 12345677889999
Q ss_pred ccCCC
Q 010432 216 FMPRG 220 (511)
Q Consensus 216 ~~~~g 220 (511)
++.|.
T Consensus 105 ~~~G~ 109 (325)
T d1zyla1 105 SVGGR 109 (325)
T ss_dssp CCCCE
T ss_pred ecCCc
Confidence 99763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.72 E-value=0.055 Score=50.00 Aligned_cols=89 Identities=10% Similarity=-0.002 Sum_probs=46.9
Q ss_pred cChHHHHHHhcCCCCCCcc-----ccCCCceEEEEEEcCCCCCCccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhCCC
Q 010432 119 FTFNDLKLATRNFRPESLL-----GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 193 (511)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~l-----G~G~fg~V~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~ 193 (511)
++-+++.....+|.+.++. ..|---+.|+.+... | .+++|+....... .++..|+.+|..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~----------g-~yVLri~~~~~~~--~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK----------D-PLILTLYEKRVEK--NDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS----------C-CEEEEEECC---C--CHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC----------C-cEEEEEcCCCCCH--HHHHHHHHHHHhhh
Confidence 4456666667778775543 355556789887542 3 5889998653221 33445666666653
Q ss_pred C-----CCcceEe---eEEEeCCeEEEEEEccCCC
Q 010432 194 H-----LNLVKLI---GYCIEDDQRLLVYEFMPRG 220 (511)
Q Consensus 194 H-----~nIv~l~---~~~~~~~~~~lv~E~~~~g 220 (511)
. |..+... .+.........++.++.+.
T Consensus 70 ~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~ 104 (316)
T d2ppqa1 70 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGM 104 (316)
T ss_dssp HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCB
T ss_pred hccccccccceecCCCcceeeecccceeeeecccc
Confidence 2 2222211 0122345566777777663
|
| >d1qu6a2 d.50.1.1 (A:91-179) dsRNA-dependent protein kinase pkr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.69 E-value=0.007 Score=45.12 Aligned_cols=34 Identities=24% Similarity=0.109 Sum_probs=29.3
Q ss_pred cccccccccccchhhhhhhccccccccccccccc
Q 010432 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEE 40 (511)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 40 (511)
++++|+.|.|++|++||+.||+.++..+..+...
T Consensus 53 ~g~~~~~g~G~sKK~Akq~AA~~Al~~L~~~~~~ 86 (89)
T d1qu6a2 53 GQKEYSIGTGSTKQEAKQLAAKLAYLQILSEETG 86 (89)
T ss_dssp ETTBCCEEEESSHHHHHHHHHHHHHHHHHHCCCC
T ss_pred CCccccccccchHHHHHHHHHHHHHHHHHccCCC
Confidence 5678999999999999999999999888765543
|
| >d1x48a1 d.50.1.1 (A:8-83) dsRNA-dependent protein kinase pkr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.48 E-value=0.0071 Score=43.56 Aligned_cols=33 Identities=12% Similarity=0.032 Sum_probs=28.8
Q ss_pred cccccccccccchhhhhhhcccccccccccccc
Q 010432 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEE 39 (511)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 39 (511)
++++|+.|+|++|++|++.||+.+.+.+..+.+
T Consensus 38 ~~~~~~~g~G~sKK~Aeq~AA~~Al~~L~~~~~ 70 (76)
T d1x48a1 38 GQTMYGTGSGVTKQEAKQLAAKEAYQKLLKSPP 70 (76)
T ss_dssp SSCEEEEEEESSHHHHHHHHHHHHHHHHHHSCC
T ss_pred CCEEeCCcCccHHHHHHHHHHHHHHHHHHccCC
Confidence 568899999999999999999999998865543
|
| >d1x49a1 d.50.1.1 (A:8-92) dsRNA-dependent protein kinase pkr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=85.24 E-value=0.063 Score=39.24 Aligned_cols=32 Identities=19% Similarity=0.163 Sum_probs=27.1
Q ss_pred cccccccccccchhhhhhhccccccccccccc
Q 010432 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEE 38 (511)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 38 (511)
+++.|+.|+|++|++|++.||+.+.+.+..+.
T Consensus 47 ~g~~~~~g~g~sKK~Aeq~AA~~aL~~L~~~~ 78 (85)
T d1x49a1 47 DEKEFPEAKGRSKQEARNAAAKLAVDILDNEN 78 (85)
T ss_dssp SSCCCCCEEESSHHHHHHHHHHHHHHHHTTTC
T ss_pred CceEeeccccccHHHHHHHHHHHHHHHHHHcC
Confidence 45778999999999999999999988775543
|
| >d1qu6a1 d.50.1.1 (A:1-90) dsRNA-dependent protein kinase pkr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.67 E-value=0.086 Score=38.92 Aligned_cols=32 Identities=25% Similarity=0.246 Sum_probs=26.9
Q ss_pred cccccccccccchhhhhhhccccccccccccc
Q 010432 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEE 38 (511)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 38 (511)
+++.++.|+|++|++|++.||+.+.+.+.++.
T Consensus 53 ~~~~~~~g~G~sKK~Aeq~AA~~aL~~L~~~~ 84 (90)
T d1qu6a1 53 DGREFPEGEGRSKKEAKNAAAKLAVEILNKEK 84 (90)
T ss_dssp SSSCCCEEECCSSHHHHHHHHHHHHHHHHSCC
T ss_pred CceeeeccCCCcHHHHHHHHHHHHHHHHHhhC
Confidence 35677899999999999999999988776544
|
| >d1x47a1 d.50.1.1 (A:8-92) Dgcr8 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: Dgcr8 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.11 E-value=0.12 Score=37.70 Aligned_cols=29 Identities=28% Similarity=0.251 Sum_probs=24.7
Q ss_pred cccccccccccchhhhhhhcccccccccc
Q 010432 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (511)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (511)
++++|+.|+|++|+.|++.||+.+.+.+.
T Consensus 48 ~g~~~~~g~G~sKK~Aeq~AA~~AL~~L~ 76 (85)
T d1x47a1 48 DGVTYGSGTASSKKLAKNKAARATLEILI 76 (85)
T ss_dssp TTEEEEEEEESSHHHHHHHHHHHHHHHHC
T ss_pred CCEEEecCCcchHHHHHHHHHHHHHHHHH
Confidence 35778999999999999999998876653
|